URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Submission: On February 13 via manual from US — Scanned from US

Summary

This website contacted 158 IPs in 11 countries across 147 domains to perform 1004 HTTP transactions. The main IP is 75.2.24.81, located in United States and belongs to AMAZON-02, US. The main domain is reason.com. The Cisco Umbrella rank of the primary domain is 149060.
TLS certificate: Issued by Amazon RSA 2048 M02 on September 13th 2023. Valid for: a year.
This is the only time reason.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 75.2.24.81 16509 (AMAZON-02)
36 2600:9000:26a... 16509 (AMAZON-02)
18 2600:9000:215... 16509 (AMAZON-02)
13 2606:4700:440... 13335 (CLOUDFLAR...)
18 2607:f8b0:400... 15169 (GOOGLE)
1 2a04:4e42:400... 54113 (FASTLY)
3 2607:f8b0:400... 15169 (GOOGLE)
1 2600:1402:880... 20940 (AKAMAI-ASN1)
10 2600:1402:880... 20940 (AKAMAI-ASN1)
4 2607:f8b0:400... 15169 (GOOGLE)
2 2607:f8b0:400... 15169 (GOOGLE)
3 2600:1408:540... 20940 (AKAMAI-ASN1)
7 2001:4860:480... 15169 (GOOGLE)
3 35.71.166.51 16509 (AMAZON-02)
1 2600:1408:540... 20940 (AKAMAI-ASN1)
3 2607:f8b0:400... 15169 (GOOGLE)
3 3.161.213.13 16509 (AMAZON-02)
1 2001:4860:480... 15169 (GOOGLE)
3 2607:f8b0:400... 15169 (GOOGLE)
2 2a03:2880:f00... 32934 (FACEBOOK)
1 52.85.107.60 16509 (AMAZON-02)
1 2606:4700::68... 13335 (CLOUDFLAR...)
5 2606:4700::68... 13335 (CLOUDFLAR...)
5 23.48.104.105 20940 (AKAMAI-ASN1)
1 52.92.240.192 ()
27 34.160.152.31 396982 (GOOGLE-CL...)
1 34.194.161.83 14618 (AMAZON-AES)
2 3.210.157.252 14618 (AMAZON-AES)
1 2a03:2880:f10... 32934 (FACEBOOK)
2 34.111.152.239 396982 (GOOGLE-CL...)
29 2607:f8b0:400... 15169 (GOOGLE)
1 3 3.162.3.20 16509 (AMAZON-02)
2 2606:4700:440... 13335 (CLOUDFLAR...)
1 1 2606:4700:20:... 13335 (CLOUDFLAR...)
1 2606:4700:10:... 13335 (CLOUDFLAR...)
1 2600:9000:215... 16509 (AMAZON-02)
1 2606:4700:10:... 13335 (CLOUDFLAR...)
6 54.230.49.33 16509 (AMAZON-02)
2 3.161.213.49 16509 (AMAZON-02)
8 27 2600:9000:215... 16509 (AMAZON-02)
1 54.192.51.109 16509 (AMAZON-02)
1 2 2620:100:a001::c 19750 (AS-CRITEO)
21 42 2600:9000:21a... 16509 (AMAZON-02)
2 5 2620:116:800b... 14618 (AMAZON-AES)
1 54.201.22.108 16509 (AMAZON-02)
5 2606:4700:10:... 13335 (CLOUDFLAR...)
2 74.119.119.139 19750 (AS-CRITEO)
19 21 52.223.40.198 16509 (AMAZON-02)
1 34.102.146.192 396982 (GOOGLE-CL...)
1 3.162.3.84 16509 (AMAZON-02)
3 2606:4700:10:... 13335 (CLOUDFLAR...)
1 1 2600:1f18:730... 14618 (AMAZON-AES)
1 44.213.8.90 14618 (AMAZON-AES)
2 18.160.10.80 16509 (AMAZON-02)
10 18.173.138.29 16509 (AMAZON-02)
3 130.211.23.194 396982 (GOOGLE-CL...)
2 2606:4700:20:... 13335 (CLOUDFLAR...)
1 172.253.63.148 15169 (GOOGLE)
18 34.107.140.113 396982 (GOOGLE-CL...)
30 34.237.83.209 14618 (AMAZON-AES)
8 2602:803:c002... 26667 (RUBICONPR...)
10 104.36.115.111 62713 (AS-PUBMATIC)
18 74.119.119.129 19750 (AS-CRITEO)
21 34.233.242.56 14618 (AMAZON-AES)
16 29 68.67.160.117 29990 (ASN-APPNEX)
9 52.21.151.112 14618 (AMAZON-AES)
1 11 35.186.253.211 15169 (GOOGLE)
2 23.4.232.54 16625 (AKAMAI-AS)
1 12 2606:4700:10:... 13335 (CLOUDFLAR...)
1 2 34.120.135.53 396982 (GOOGLE-CL...)
1 2600:9000:26a... 16509 (AMAZON-02)
21 29 162.19.138.83 16276 (OVH)
3 54.144.252.138 14618 (AMAZON-AES)
5 5 23.21.102.83 14618 (AMAZON-AES)
5 21 50.16.144.68 14618 (AMAZON-AES)
2 39 52.46.130.91 16509 (AMAZON-02)
8 15 8.28.7.83 62713 (AS-PUBMATIC)
18 30 69.173.151.100 26667 (RUBICONPR...)
9 15 34.111.113.62 396982 (GOOGLE-CL...)
26 56 172.253.62.154 15169 (GOOGLE)
5 9 198.148.27.131 19189 (PULSEPOINT)
4 4 2607:f350:3:2... 27630 (AS-XFERNET)
11 33 35.244.159.8 396982 (GOOGLE-CL...)
1 2607:f8b0:400... 15169 (GOOGLE)
2 2 213.19.162.90 26667 (RUBICONPR...)
9 9 52.71.22.176 14618 (AMAZON-AES)
2 2 34.207.36.191 14618 (AMAZON-AES)
1 2607:f8b0:400... 15169 (GOOGLE)
1 1 8.2.110.134 46636 (NATCOWEB)
24 25 35.211.178.172 19527 (GOOGLE-2)
2 2 35.211.233.246 15169 (GOOGLE)
4 7 2600:1f18:4e9... 14618 (AMAZON-AES)
7 23.221.241.11 16625 (AKAMAI-AS)
23 2620:100:a001::4 19750 (AS-CRITEO)
23 25 69.194.240.13 26120 (RHYTHMONE)
7 7 2620:112:f002... 6336 (TURN-US-ASN)
28 54.160.241.52 14618 (AMAZON-AES)
2 2 23.222.200.28 16625 (AKAMAI-AS)
2 2 2600:9000:215... 16509 (AMAZON-02)
4 51.222.39.186 16276 (OVH)
5 5 35.194.66.159 396982 (GOOGLE-CL...)
1 6 35.208.249.213 19527 (GOOGLE-2)
2 2 54.163.10.249 14618 (AMAZON-AES)
2 2 64.74.236.31 19024 (INTERNAP-...)
1 2606:4700:10:... 13335 (CLOUDFLAR...)
4 16 172.64.151.101 13335 (CLOUDFLAR...)
1 1 20.127.253.7 8075 (MICROSOFT...)
3 14 23.23.57.217 14618 (AMAZON-AES)
1 52.7.170.209 14618 (AMAZON-AES)
16 23.48.9.103 16625 (AKAMAI-AS)
11 13 34.200.65.202 14618 (AMAZON-AES)
5 13 35.71.139.29 16509 (AMAZON-02)
72 2607:f8b0:400... 15169 (GOOGLE)
9 2607:f8b0:400... 15169 (GOOGLE)
6 9 35.244.154.8 15169 (GOOGLE)
2 2 107.178.254.65 396982 (GOOGLE-CL...)
2 6 2620:1ec:21::14 8068 (MICROSOFT...)
7 9 151.101.194.49 54113 (FASTLY)
1 2607:f8b0:400... 15169 (GOOGLE)
4 4 35.214.211.207 15169 (GOOGLE)
2 2 2600:1f18:612... 14618 (AMAZON-AES)
3 3 63.251.28.234 13789 (INTERNAP-...)
1 1 80.77.87.163 46636 (NATCOWEB)
3 3 23.105.12.170 30633 (LEASEWEB-...)
1 4 37.157.3.26 198622 (ADFORM)
1 1 67.205.191.172 14061 (DIGITALOC...)
8 2600:9000:26a... 16509 (AMAZON-02)
1 99.86.229.12 16509 (AMAZON-02)
4 4 2606:ae80:145... 25751 (VALUECLICK)
2 2 82.145.213.8 39832 (NO-OPERA)
4 8 44.199.10.205 14618 (AMAZON-AES)
14 14 162.248.18.32 62713 (AS-PUBMATIC)
3 3.161.193.117 16509 (AMAZON-02)
2 2 67.202.105.23 32748 (STEADFAST)
2 23.48.8.28 16625 (AKAMAI-AS)
3 3 8.43.72.98 26667 (RUBICONPR...)
2 4 3.93.89.138 14618 (AMAZON-AES)
3 74.119.119.150 19750 (AS-CRITEO)
6 6 54.162.50.120 14618 (AMAZON-AES)
1 2 35.186.193.173 15169 (GOOGLE)
4 4 23.4.226.82 16625 (AKAMAI-AS)
1 23.48.9.151 16625 (AKAMAI-AS)
37 2607:f8b0:400... 15169 (GOOGLE)
2 69.173.151.96 26667 (RUBICONPR...)
2 7 8.28.7.81 62713 (AS-PUBMATIC)
3 23.215.0.12 20940 (AKAMAI-ASN1)
3 141.95.98.64 16276 (OVH)
14 2607:f8b0:400... 15169 (GOOGLE)
4 20 162.248.18.37 62713 (AS-PUBMATIC)
2 2 3.217.51.221 14618 (AMAZON-AES)
1 1 2603:c020:400... 31898 (ORACLE-BM...)
1 1 216.22.16.9 30633 (LEASEWEB-...)
1 38.91.45.7 398989 (DEEPINTENT)
3 3 35.211.118.13 19527 (GOOGLE-2)
3 5 34.202.200.79 14618 (AMAZON-AES)
1 2 18.215.133.183 14618 (AMAZON-AES)
2 2 199.38.167.131 54312 (ROCKETFUEL)
1 3 2606:4700::68... 13335 (CLOUDFLAR...)
2 2 54.144.126.196 14618 (AMAZON-AES)
1 1 69.90.254.78 13768 (COGECO-PEER1)
2 2 216.200.232.249 30419 (MEDIAMATH...)
1 40.76.134.238 8075 (MICROSOFT...)
3 6 8.28.7.84 62713 (AS-PUBMATIC)
5 5 52.70.33.226 14618 (AMAZON-AES)
1 2 38.98.69.175 174 (COGENT-174)
2 54.226.119.24 14618 (AMAZON-AES)
5 5 207.198.113.203 13768 (COGECO-PEER1)
2 2 185.184.8.90 204995 (RTB-HOUSE...)
1 2600:1f18:ed:... 14618 (AMAZON-AES)
1 52.95.115.196 16509 (AMAZON-02)
4 4 185.167.164.53 198622 (ADFORM)
1 1 134.122.57.34 14061 (DIGITALOC...)
2 3.162.125.63 16509 (AMAZON-02)
1 34.111.60.239 396982 (GOOGLE-CL...)
2 2600:9000:215... 16509 (AMAZON-02)
1 16 3.234.97.29 14618 (AMAZON-AES)
3 2620:100:a001... 19750 (AS-CRITEO)
1 151.101.129.108 54113 (FASTLY)
1 104.18.38.76 13335 (CLOUDFLAR...)
2 2 178.250.7.11 44788 (ASN-CRITE...)
2 2 54.243.138.14 ()
2 2 52.72.172.4 14618 (AMAZON-AES)
1 202.233.84.1 131957 (MICROAD M...)
1 1 184.25.127.153 20940 (AKAMAI-ASN1)
1 1 20.121.111.193 ()
2 44.196.23.253 14618 (AMAZON-AES)
1 4 23.39.185.111 16625 (AKAMAI-AS)
1 1 2606:4700:440... 13335 (CLOUDFLAR...)
3 74.119.119.147 19750 (AS-CRITEO)
1 23.203.177.63 16625 (AKAMAI-AS)
1 44.208.49.53 14618 (AMAZON-AES)
3 3 20.253.86.149 8075 (MICROSOFT...)
5 5 35.207.24.140 15169 (GOOGLE)
5 2620:100:a001... 19750 (AS-CRITEO)
1 1 23.51.8.29 16625 (AKAMAI-AS)
3 2620:100:a005... 19750 (AS-CRITEO)
1 1 172.105.221.240 63949 (AKAMAI-LI...)
2 2 52.54.125.86 14618 (AMAZON-AES)
1 23.88.86.2 24940 (HETZNER-AS)
1 195.5.165.20 44968 (IPROM-AS)
2 2 104.66.251.81 16625 (AKAMAI-AS)
1 2 44.197.50.199 14618 (AMAZON-AES)
1 54.84.174.131 14618 (AMAZON-AES)
1 52.54.225.252 14618 (AMAZON-AES)
2 2600:9000:269... 16509 (AMAZON-02)
1 54.209.16.241 14618 (AMAZON-AES)
2 44.226.53.119 16509 (AMAZON-02)
1 54.192.51.117 16509 (AMAZON-02)
1 2 54.224.181.227 14618 (AMAZON-AES)
3 4 52.213.12.53 16509 (AMAZON-02)
1 2 50.57.31.206 19994 (RACKSPACE)
2 2 146.59.148.16 16276 (OVH)
1 1 34.196.196.152 14618 (AMAZON-AES)
1 2 23.105.12.172 30633 (LEASEWEB-...)
1004 158
Apex Domain
Subdomains
Transfer
110 googlesyndication.com
605033cc1a4730890edd7776333db3e4.safeframe.googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 114
tpc.googlesyndication.com — Cisco Umbrella Rank: 160
2 MB
103 doubleclick.net
stats.g.doubleclick.net — Cisco Umbrella Rank: 80
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 209
ad.doubleclick.net — Cisco Umbrella Rank: 157
cm.g.doubleclick.net — Cisco Umbrella Rank: 258
googleads.g.doubleclick.net — Cisco Umbrella Rank: 35
364 KB
79 pubmatic.com
hbopenbid.pubmatic.com — Cisco Umbrella Rank: 452
image2.pubmatic.com — Cisco Umbrella Rank: 929
ads.pubmatic.com — Cisco Umbrella Rank: 539
image8.pubmatic.com — Cisco Umbrella Rank: 640
image6.pubmatic.com — Cisco Umbrella Rank: 826
simage2.pubmatic.com — Cisco Umbrella Rank: 912
image4.pubmatic.com — Cisco Umbrella Rank: 1227
simage4.pubmatic.com — Cisco Umbrella Rank: 1349
78 KB
65 rubiconproject.com
fastlane.rubiconproject.com — Cisco Umbrella Rank: 513
token.rubiconproject.com — Cisco Umbrella Rank: 474
pixel-eu.rubiconproject.com — Cisco Umbrella Rank: 1970
eus.rubiconproject.com — Cisco Umbrella Rank: 604
pixel.rubiconproject.com — Cisco Umbrella Rank: 374
pixel-us-east.rubiconproject.com — Cisco Umbrella Rank: 1252
secure-assets.rubiconproject.com — Cisco Umbrella Rank: 963
prebid-server.rubiconproject.com — Cisco Umbrella Rank: 760
129 KB
58 amazon-adsystem.com
c.amazon-adsystem.com — Cisco Umbrella Rank: 302
config.aps.amazon-adsystem.com — Cisco Umbrella Rank: 606
aax.amazon-adsystem.com — Cisco Umbrella Rank: 394
s.amazon-adsystem.com — Cisco Umbrella Rank: 304
aax-eu.amazon-adsystem.com — Cisco Umbrella Rank: 811
192 KB
50 primis.tech
live.primis.tech — Cisco Umbrella Rank: 1486
video.primis.tech — Cisco Umbrella Rank: 6073
rtb.primis.tech — Cisco Umbrella Rank: 5781
3 MB
46 openx.net
rtb.openx.net — Cisco Umbrella Rank: 651
oajs.openx.net — Cisco Umbrella Rank: 2136
u.openx.net — Cisco Umbrella Rank: 692
google-bidout-d.openx.net — Cisco Umbrella Rank: 2135
us-u.openx.net — Cisco Umbrella Rank: 530
freestar-d.openx.net — Cisco Umbrella Rank: 9656
8 KB
44 sharethrough.com
btlr.sharethrough.com — Cisco Umbrella Rank: 944
match.sharethrough.com — Cisco Umbrella Rank: 505
6 KB
37 bidswitch.net
grid.bidswitch.net — Cisco Umbrella Rank: 1204
x.bidswitch.net — Cisco Umbrella Rank: 368
r.bidswitch.net — Cisco Umbrella Rank: 7182
15 KB
36 cloudfront.net
d2eehagpk5cl65.cloudfront.net
495 KB
32 id5-sync.com
cdn.id5-sync.com — Cisco Umbrella Rank: 854
id5-sync.com — Cisco Umbrella Rank: 419
116 KB
32 pub.network
a.pub.network — Cisco Umbrella Rank: 4513
d.pub.network — Cisco Umbrella Rank: 4809
c.pub.network — Cisco Umbrella Rank: 4539
364 KB
30 adnxs.com
ib.adnxs.com — Cisco Umbrella Rank: 252
secure.adnxs.com — Cisco Umbrella Rank: 459
acdn.adnxs.com — Cisco Umbrella Rank: 620
47 KB
30 intentiq.com
api.intentiq.com — Cisco Umbrella Rank: 1433
sync.intentiq.com — Cisco Umbrella Rank: 908
sync1.intentiq.com — Cisco Umbrella Rank: 2961
28 KB
28 yellowblue.io
cs.yellowblue.io — Cisco Umbrella Rank: 1623
cs-server-s2s.yellowblue.io — Cisco Umbrella Rank: 1786
15 KB
28 criteo.net
static.criteo.net — Cisco Umbrella Rank: 667
csm.us.criteo.net — Cisco Umbrella Rank: 3311
428 KB
27 criteo.com
gum.criteo.com — Cisco Umbrella Rank: 454
mug.criteo.com — Cisco Umbrella Rank: 3029
bidder.criteo.com — Cisco Umbrella Rank: 684
dis.criteo.com — Cisco Umbrella Rank: 598
ads.us.criteo.com — Cisco Umbrella Rank: 3221
dis.eu.criteo.com — Cisco Umbrella Rank: 7822
cat.va.us.criteo.com — Cisco Umbrella Rank: 3386
rtb.da.us.criteo.com — Cisco Umbrella Rank: 9739
66 KB
26 lijit.com
ap.lijit.com — Cisco Umbrella Rank: 687
ce.lijit.com — Cisco Umbrella Rank: 852
33 KB
22 3lift.com
tlx.3lift.com — Cisco Umbrella Rank: 579
eb2.3lift.com — Cisco Umbrella Rank: 414
13 KB
21 gumgum.com
g2.gumgum.com — Cisco Umbrella Rank: 1489
24 KB
21 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 347
data.adsrvr.org — Cisco Umbrella Rank: 5250
10 KB
21 headliner.link
disco.headliner.link — Cisco Umbrella Rank: 26314
api.headliner.link — Cisco Umbrella Rank: 62532
194 KB
19 google.com
www.google.com — Cisco Umbrella Rank: 2
analytics.google.com — Cisco Umbrella Rank: 158
42 KB
18 undertone.com
cdn.undertone.com — Cisco Umbrella Rank: 2927
usr.undertone.com — Cisco Umbrella Rank: 1949
9 KB
18 yahoo.com
pr-bh.ybp.yahoo.com — Cisco Umbrella Rank: 493
ups.analytics.yahoo.com — Cisco Umbrella Rank: 376
7 KB
18 t13.io
s2s.t13.io — Cisco Umbrella Rank: 2138
41 KB
18 ad.gt
id.hadron.ad.gt — Cisco Umbrella Rank: 1664
a.ad.gt — Cisco Umbrella Rank: 1829
p.ad.gt — Cisco Umbrella Rank: 2206
ids.ad.gt — Cisco Umbrella Rank: 1562
pixels.ad.gt — Cisco Umbrella Rank: 1967
74 KB
17 1rx.io
sync.1rx.io — Cisco Umbrella Rank: 549
9 KB
16 casalemedia.com
ssum-sec.casalemedia.com — Cisco Umbrella Rank: 508
dsum-sec.casalemedia.com — Cisco Umbrella Rank: 627
12 KB
15 tapad.com
pixel.tapad.com — Cisco Umbrella Rank: 469
2 KB
13 fontawesome.com
kit.fontawesome.com — Cisco Umbrella Rank: 1431
ka-p.fontawesome.com — Cisco Umbrella Rank: 3198
163 KB
11 typekit.net
p.typekit.net — Cisco Umbrella Rank: 589
use.typekit.net — Cisco Umbrella Rank: 475
213 KB
9 everesttech.net
sync-tm.everesttech.net — Cisco Umbrella Rank: 700
2 KB
9 rlcdn.com
id.rlcdn.com — Cisco Umbrella Rank: 732
api.rlcdn.com Failed
idsync.rlcdn.com — Cisco Umbrella Rank: 437
2 KB
9 googletagservices.com
www.googletagservices.com — Cisco Umbrella Rank: 234
585 KB
9 yieldmo.com
sync-amz.ads.yieldmo.com — Cisco Umbrella Rank: 5614
ads.yieldmo.com — Cisco Umbrella Rank: 658
6 KB
9 mediago.io
trace.mediago.io — Cisco Umbrella Rank: 955
cdn.mediago.io — Cisco Umbrella Rank: 4687
images.mediago.io — Cisco Umbrella Rank: 3504
gtrace.mediago.io — Cisco Umbrella Rank: 3420
79 KB
9 bidr.io
match.prod.bidr.io — Cisco Umbrella Rank: 572
5 KB
9 contextweb.com
bh.contextweb.com — Cisco Umbrella Rank: 550
9 KB
9 liadm.com
b-code.liadm.com — Cisco Umbrella Rank: 3224
rp.liadm.com — Cisco Umbrella Rank: 1506
rp4.liadm.com — Cisco Umbrella Rank: 6537
i.liadm.com — Cisco Umbrella Rank: 560
i6.liadm.com — Cisco Umbrella Rank: 2936
idx.liadm.com — Cisco Umbrella Rank: 2050
19 KB
8 adform.net
cm.adform.net — Cisco Umbrella Rank: 1131
c1.adform.net — Cisco Umbrella Rank: 603
dmp.adform.net — Cisco Umbrella Rank: 3161
3 KB
8 unrulymedia.com
sync.targeting.unrulymedia.com — Cisco Umbrella Rank: 1222
4 KB
7 turn.com
ad.turn.com — Cisco Umbrella Rank: 819
3 KB
7 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 27
23 KB
7 gstatic.com
www.gstatic.com
fonts.gstatic.com
463 KB
6 w55c.net
pm.w55c.net — Cisco Umbrella Rank: 865
5 KB
6 smartadserver.com
ssbsync-global.smartadserver.com — Cisco Umbrella Rank: 1651
ssbsync.smartadserver.com — Cisco Umbrella Rank: 726
rtb-csync.smartadserver.com — Cisco Umbrella Rank: 662
sync.smartadserver.com — Cisco Umbrella Rank: 1356
2 KB
6 linkedin.com
px.ads.linkedin.com — Cisco Umbrella Rank: 333
2 KB
5 mfadsrvr.com
rtb.mfadsrvr.com — Cisco Umbrella Rank: 1125
3 KB
5 sitescout.com
pixel-sync.sitescout.com — Cisco Umbrella Rank: 710
3 KB
5 ipredictive.com
sync.ipredictive.com — Cisco Umbrella Rank: 874
2 KB
5 demdex.net
dpm.demdex.net — Cisco Umbrella Rank: 239
4 KB
5 simpli.fi
um.simpli.fi — Cisco Umbrella Rank: 794
2 KB
5 media.net
cs.media.net — Cisco Umbrella Rank: 1261
contextual.media.net — Cisco Umbrella Rank: 712
hbx.media.net — Cisco Umbrella Rank: 1246
3 KB
5 quantserve.com
secure.quantserve.com — Cisco Umbrella Rank: 1311
pixel.quantserve.com — Cisco Umbrella Rank: 1132
cms.quantserve.com — Cisco Umbrella Rank: 757
12 KB
5 tiktok.com
analytics.tiktok.com — Cisco Umbrella Rank: 628
143 KB
4 audrte.com
a.audrte.com — Cisco Umbrella Rank: 2052
3 KB
4 bluekai.com
stags.bluekai.com — Cisco Umbrella Rank: 910
tags.bluekai.com — Cisco Umbrella Rank: 729
2 KB
4 dotomi.com
pulsepoint-match.dotomi.com — Cisco Umbrella Rank: 7377
pubmatic-match.dotomi.com — Cisco Umbrella Rank: 3473
1 KB
4 loopme.me
csync.loopme.me — Cisco Umbrella Rank: 886
911 B
4 inmobi.com
sync.inmobi.com — Cisco Umbrella Rank: 1530
mweb.ck.inmobi.com — Cisco Umbrella Rank: 4712
2 KB
4 onetag-sys.com
onetag-sys.com — Cisco Umbrella Rank: 702
2 KB
4 sonobi.com
sync.go.sonobi.com — Cisco Umbrella Rank: 973
2 KB
4 crwdcntrl.net
tags.crwdcntrl.net — Cisco Umbrella Rank: 1005
bcp.crwdcntrl.net — Cisco Umbrella Rank: 920
sync.crwdcntrl.net — Cisco Umbrella Rank: 869
13 KB
4 btloader.com
btloader.com — Cisco Umbrella Rank: 851
api.btloader.com — Cisco Umbrella Rank: 942
97 KB
4 parsely.com
cdn.parsely.com — Cisco Umbrella Rank: 2976
p1.parsely.com — Cisco Umbrella Rank: 2286
api.parsely.com — Cisco Umbrella Rank: 9166
28 KB
4 sparemin.com
img.sparemin.com — Cisco Umbrella Rank: 62042
static.sparemin.com — Cisco Umbrella Rank: 81511
268 KB
4 cookiebot.com
consent.cookiebot.com — Cisco Umbrella Rank: 4207
consentcdn.cookiebot.com — Cisco Umbrella Rank: 4838
261 KB
3 tribalfusion.com
a.tribalfusion.com — Cisco Umbrella Rank: 884
s.tribalfusion.com — Cisco Umbrella Rank: 2403
1 KB
3 eu-1-id5-sync.com
lb.eu-1-id5-sync.com — Cisco Umbrella Rank: 932
808 B
3 akamaihd.net
qsearch-a.akamaihd.net — Cisco Umbrella Rank: 2190
888 B
3 openwebmedia.org
cs.openwebmedia.org — Cisco Umbrella Rank: 4895
1 KB
3 stickyadstv.com
ads.stickyadstv.com — Cisco Umbrella Rank: 570
2 KB
3 scorecardresearch.com
sb.scorecardresearch.com — Cisco Umbrella Rank: 175
3 KB
3 amazonaws.com
s3-us-west-2.amazonaws.com
ckjjzdn8vk.execute-api.us-west-2.amazonaws.com — Cisco Umbrella Rank: 30537
59 KB
3 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 37
274 KB
2 onaudience.com
pixel.onaudience.com — Cisco Umbrella Rank: 3134
726 B
2 semasio.net
uipglob.semasio.net — Cisco Umbrella Rank: 1341
1 KB
2 narrative.io
io.narrative.io — Cisco Umbrella Rank: 4336
643 B
2 agkn.com
aa.agkn.com — Cisco Umbrella Rank: 543
1 KB
2 thrtle.com
thrtle.com — Cisco Umbrella Rank: 1359
685 B
2 owneriq.net
px.owneriq.net — Cisco Umbrella Rank: 1776
1 KB
2 pswec.com
t.pswec.com — Cisco Umbrella Rank: 3604
1 KB
2 rtactivate.com
bpi.rtactivate.com — Cisco Umbrella Rank: 1498
217 B
2 creative-serving.com
ads.creative-serving.com — Cisco Umbrella Rank: 4579
1 KB
2 360yield.com
ice.360yield.com — Cisco Umbrella Rank: 1971
1 KB
2 advertising.com
pixel.advertising.com — Cisco Umbrella Rank: 1771
389 B
2 creativecdn.com
creativecdn.com — Cisco Umbrella Rank: 503
1 KB
2 adentifi.com
rtb.adentifi.com — Cisco Umbrella Rank: 1238
69 B
2 mxptint.net
pmp.mxptint.net — Cisco Umbrella Rank: 4996
967 B
2 mathtag.com
sync.mathtag.com — Cisco Umbrella Rank: 1198
1 KB
2 stackadapt.com
sync.srv.stackadapt.com — Cisco Umbrella Rank: 705
2 KB
2 rfihub.com
p.rfihub.com — Cisco Umbrella Rank: 834
1 KB
2 cognitivlabs.com
beacon.lynx.cognitivlabs.com — Cisco Umbrella Rank: 1566
835 B
2 adgrx.com
cm.adgrx.com — Cisco Umbrella Rank: 1424
959 B
2 ctnsnet.com
cm.ctnsnet.com — Cisco Umbrella Rank: 4064
ipac.ctnsnet.com — Cisco Umbrella Rank: 5828
748 B
2 33across.com
ssc-cms.33across.com — Cisco Umbrella Rank: 878
1005 B
2 opera.com
t.adx.opera.com — Cisco Umbrella Rank: 1208
1 KB
2 tremorhub.com
mb9eo.publishers.tremorhub.com — Cisco Umbrella Rank: 6700
720 B
2 pippio.com
pippio.com — Cisco Umbrella Rank: 771
1 KB
2 zemanta.com
b1sync.zemanta.com — Cisco Umbrella Rank: 612
1 KB
2 postrelease.com
jadserve.postrelease.com — Cisco Umbrella Rank: 1128
1 KB
2 smaato.net
s.ad.smaato.net — Cisco Umbrella Rank: 674
882 B
2 sportradarserving.com
a.sportradarserving.com — Cisco Umbrella Rank: 2313
958 B
2 clickagy.com
aorta.clickagy.com — Cisco Umbrella Rank: 1948
1 KB
2 fastclick.net
secure.cdn.fastclick.net — Cisco Umbrella Rank: 1116
35 KB
2 ad-delivery.net
ad-delivery.net — Cisco Umbrella Rank: 898
1 KB
2 confiant-integrations.net
cdn.confiant-integrations.net — Cisco Umbrella Rank: 1538
113 KB
2 optimise.net
optimise.net — Cisco Umbrella Rank: 5141
7 KB
2 facebook.net
connect.facebook.net — Cisco Umbrella Rank: 171
69 KB
2 youtube.com
www.youtube.com — Cisco Umbrella Rank: 74
69 KB
1 adstanding.com
rtb.adstanding.com — Cisco Umbrella Rank: 8073
357 B
1 adswizz.com
synchroscript.deliveryengine.adswizz.com — Cisco Umbrella Rank: 2754
200 B
1 bfmio.com
sync.bfmio.com — Cisco Umbrella Rank: 1558
425 B
1 kargo.com
crb.kargo.com — Cisco Umbrella Rank: 1138
359 B
1 iprom.net
core.iprom.net — Cisco Umbrella Rank: 6187
282 B
1 truffle.bid
matching.truffle.bid — Cisco Umbrella Rank: 6712
1 appier.net
gocm.c.appier.net — Cisco Umbrella Rank: 2784
436 B
1 krxd.net
beacon.krxd.net — Cisco Umbrella Rank: 946
44 B
1 addthis.com
cw.addthis.com — Cisco Umbrella Rank: 2924
427 B
1 media6degrees.com
idpix.media6degrees.com — Cisco Umbrella Rank: 1937
557 B
1 temu.com
www.temu.com — Cisco Umbrella Rank: 3562
518 B
1 pangle-ads.com
analytics.pangle-ads.com — Cisco Umbrella Rank: 2759
932 B
1 microad.jp
aid.send.microad.jp — Cisco Umbrella Rank: 13014
641 B
1 indexww.com
js-sec.indexww.com — Cisco Umbrella Rank: 670
2 KB
1 bidtheatre.com
match.adsby.bidtheatre.com — Cisco Umbrella Rank: 2573
555 B
1 antigena.com
us01.z.antigena.com — Cisco Umbrella Rank: 4109
1 acuityplatform.com
ums.acuityplatform.com — Cisco Umbrella Rank: 1331
674 B
1 deepintent.com
match.deepintent.com — Cisco Umbrella Rank: 1064
339 B
1 technoratimedia.com
sync.technoratimedia.com — Cisco Umbrella Rank: 1921
4 KB
1 teads.tv
a.teads.tv — Cisco Umbrella Rank: 1418
610 B
1 cootlogix.com
sync.cootlogix.com — Cisco Umbrella Rank: 3030
549 B
1 admanmedia.com
cs.admanmedia.com — Cisco Umbrella Rank: 1025
586 B
1 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 31
1017 B
1 krushmedia.com
cs.krushmedia.com — Cisco Umbrella Rank: 2945
551 B
1 2mdn.net
s0.2mdn.net — Cisco Umbrella Rank: 321
490 B
1 quantcount.com
rules.quantcount.com — Cisco Umbrella Rank: 1307
1 KB
1 openxcdn.net
oa.openxcdn.net — Cisco Umbrella Rank: 1783
8 KB
1 usbrowserspeed.com
a.usbrowserspeed.com — Cisco Umbrella Rank: 2970
148 B
1 hadronid.net
cdn.hadronid.net — Cisco Umbrella Rank: 1802
10 KB
1 videoplayerhub.com
freestar-io.videoplayerhub.com — Cisco Umbrella Rank: 6143
459 B
1 facebook.com
www.facebook.com — Cisco Umbrella Rank: 102
185 B
1 mouseflow.com
cdn.mouseflow.com — Cisco Umbrella Rank: 6738
19 KB
1 jsdelivr.net
cdn.jsdelivr.net — Cisco Umbrella Rank: 314
65 KB
1 reason.com
reason.com — Cisco Umbrella Rank: 149060
27 KB
0 mdhv.io Failed
jelly.mdhv.io Failed
0 mrtnsvr.com Failed
ad.mrtnsvr.com Failed
1004 147
Domain Requested by
72 pagead2.googlesyndication.com securepubads.g.doubleclick.net
live.primis.tech
pagead2.googlesyndication.com
reason.com
tpc.googlesyndication.com
googleads.g.doubleclick.net
www.googletagservices.com
56 cm.g.doubleclick.net 26 redirects reason.com
google-bidout-d.openx.net
ce.lijit.com
s.amazon-adsystem.com
eb2.3lift.com
googleads.g.doubleclick.net
cdn.mediago.io
41 live.primis.tech 21 redirects a.pub.network
live.primis.tech
reason.com
39 s.amazon-adsystem.com 2 redirects c.amazon-adsystem.com
s.amazon-adsystem.com
google-bidout-d.openx.net
bh.contextweb.com
u.openx.net
ce.lijit.com
cs-server-s2s.yellowblue.io
sync-amz.ads.yieldmo.com
match.sharethrough.com
ssum-sec.casalemedia.com
ads.pubmatic.com
37 tpc.googlesyndication.com live.primis.tech
tpc.googlesyndication.com
pagead2.googlesyndication.com
googleads.g.doubleclick.net
reason.com
36 d2eehagpk5cl65.cloudfront.net reason.com
30 btlr.sharethrough.com a.pub.network
live.primis.tech
29 id5-sync.com 21 redirects cdn.id5-sync.com
live.primis.tech
reason.com
29 securepubads.g.doubleclick.net a.pub.network
securepubads.g.doubleclick.net
reason.com
www.googletagservices.com
27 sync.intentiq.com 8 redirects reason.com
live.primis.tech
cs-server-s2s.yellowblue.io
s.amazon-adsystem.com
ads.pubmatic.com
26 us-u.openx.net 8 redirects google-bidout-d.openx.net
ce.lijit.com
us-u.openx.net
u.openx.net
freestar-d.openx.net
reason.com
25 x.bidswitch.net 24 redirects reason.com
24 ib.adnxs.com 11 redirects a.pub.network
live.primis.tech
s.amazon-adsystem.com
eb2.3lift.com
acdn.adnxs.com
23 static.criteo.net a.pub.network
static.criteo.net
ads.us.criteo.com
21 ce.lijit.com 5 redirects a.pub.network
ce.lijit.com
s.amazon-adsystem.com
us-u.openx.net
ads.pubmatic.com
21 g2.gumgum.com a.pub.network
20 simage2.pubmatic.com 4 redirects ads.pubmatic.com
reason.com
20 match.adsrvr.org 18 redirects a.pub.network
live.primis.tech
18 pixel.rubiconproject.com 13 redirects s.amazon-adsystem.com
18 cs-server-s2s.yellowblue.io s.amazon-adsystem.com
live.primis.tech
cs-server-s2s.yellowblue.io
18 s2s.t13.io a.pub.network
ce.lijit.com
reason.com
ssum-sec.casalemedia.com
cdn.undertone.com
u.openx.net
18 www.google.com reason.com
www.gstatic.com
www.google.com
googleads.g.doubleclick.net
tpc.googlesyndication.com
18 disco.headliner.link reason.com
disco.headliner.link
17 sync.1rx.io 17 redirects
16 usr.undertone.com 1 redirects cdn.undertone.com
16 eus.rubiconproject.com s.amazon-adsystem.com
eus.rubiconproject.com
cs-server-s2s.yellowblue.io
cdn.undertone.com
live.primis.tech
a.pub.network
15 pixel.tapad.com 9 redirects us-u.openx.net
reason.com
s.amazon-adsystem.com
freestar-d.openx.net
cdn.undertone.com
15 image2.pubmatic.com 8 redirects ads.pubmatic.com
reason.com
14 googleads.g.doubleclick.net pagead2.googlesyndication.com
googleads.g.doubleclick.net
14 c.pub.network a.pub.network
14 image8.pubmatic.com 14 redirects
14 match.sharethrough.com 3 redirects s.amazon-adsystem.com
match.sharethrough.com
13 eb2.3lift.com 5 redirects reason.com
a.pub.network
eb2.3lift.com
13 d.pub.network reason.com
a.pub.network
12 token.rubiconproject.com 5 redirects reason.com
eus.rubiconproject.com
12 ka-p.fontawesome.com kit.fontawesome.com
reason.com
11 ups.analytics.yahoo.com 9 redirects us-u.openx.net
u.openx.net
11 rtb.openx.net 1 redirects a.pub.network
freestar-d.openx.net
10 cs.yellowblue.io s.amazon-adsystem.com
reason.com
cs-server-s2s.yellowblue.io
10 ids.ad.gt 1 redirects reason.com
10 hbopenbid.pubmatic.com a.pub.network
live.primis.tech
10 aax.amazon-adsystem.com c.amazon-adsystem.com
10 use.typekit.net d2eehagpk5cl65.cloudfront.net
9 dsum-sec.casalemedia.com 2 redirects ssum-sec.casalemedia.com
9 sync-tm.everesttech.net 7 redirects u.openx.net
ads.pubmatic.com
9 www.googletagservices.com securepubads.g.doubleclick.net
9 match.prod.bidr.io 9 redirects
9 bh.contextweb.com 5 redirects s.amazon-adsystem.com
bh.contextweb.com
9 tlx.3lift.com a.pub.network
9 grid.bidswitch.net a.pub.network
9 bidder.criteo.com a.pub.network
8 ads.yieldmo.com 4 redirects ce.lijit.com
sync-amz.ads.yieldmo.com
8 video.primis.tech reason.com
live.primis.tech
8 sync.targeting.unrulymedia.com 6 redirects cs-server-s2s.yellowblue.io
sync-amz.ads.yieldmo.com
8 fastlane.rubiconproject.com a.pub.network
7 image6.pubmatic.com 2 redirects ads.pubmatic.com
7 ssum-sec.casalemedia.com 2 redirects s.amazon-adsystem.com
ssum-sec.casalemedia.com
a.pub.network
cdn.undertone.com
7 ad.turn.com 7 redirects
7 ads.pubmatic.com ce.lijit.com
s.amazon-adsystem.com
live.primis.tech
reason.com
a.pub.network
7 pr-bh.ybp.yahoo.com 4 redirects google-bidout-d.openx.net
reason.com
ssum-sec.casalemedia.com
7 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
6 pm.w55c.net 6 redirects
6 px.ads.linkedin.com 2 redirects us-u.openx.net
u.openx.net
s.amazon-adsystem.com
eb2.3lift.com
6 c.amazon-adsystem.com a.pub.network
c.amazon-adsystem.com
live.primis.tech
5 csm.us.criteo.net ads.us.criteo.com
5 rtb.mfadsrvr.com 5 redirects
5 pixel-sync.sitescout.com 5 redirects
5 sync.ipredictive.com 5 redirects
5 dpm.demdex.net 3 redirects ssum-sec.casalemedia.com
cdn.undertone.com
5 id.rlcdn.com 4 redirects freestar-d.openx.net
5 um.simpli.fi 5 redirects
5 u.openx.net 3 redirects s.amazon-adsystem.com
a.pub.network
5 secure.adnxs.com 5 redirects
5 ap.lijit.com 5 redirects
5 analytics.tiktok.com reason.com
analytics.tiktok.com
5 a.pub.network reason.com
a.pub.network
4 a.audrte.com 3 redirects reason.com
4 idsync.rlcdn.com 2 redirects cdn.undertone.com
reason.com
4 image4.pubmatic.com 3 redirects reason.com
4 secure-assets.rubiconproject.com 4 redirects
4 i.liadm.com 2 redirects u.openx.net
reason.com
4 cm.adform.net 1 redirects reason.com
cs-server-s2s.yellowblue.io
4 csync.loopme.me 4 redirects
4 trace.mediago.io 1 redirects googleads.g.doubleclick.net
4 onetag-sys.com s.amazon-adsystem.com
cs-server-s2s.yellowblue.io
4 sync.go.sonobi.com 4 redirects
4 id.hadron.ad.gt a.pub.network
cdn.hadronid.net
4 www.gstatic.com www.google.com
www.gstatic.com
3 rtb.da.us.criteo.com googleads.g.doubleclick.net
3 mweb.ck.inmobi.com 3 redirects
3 tags.bluekai.com 1 redirects cdn.undertone.com
reason.com
3 cat.va.us.criteo.com ads.us.criteo.com
3 ads.us.criteo.com googleads.g.doubleclick.net
3 c1.adform.net 3 redirects
3 r.bidswitch.net 3 redirects
3 lb.eu-1-id5-sync.com cdn.id5-sync.com
live.primis.tech
3 qsearch-a.akamaihd.net reason.com
3 dis.criteo.com ssum-sec.casalemedia.com
ads.pubmatic.com
eb2.3lift.com
3 pixel-us-east.rubiconproject.com 3 redirects
3 cs.openwebmedia.org cs-server-s2s.yellowblue.io
sync-amz.ads.yieldmo.com
3 ads.stickyadstv.com 3 redirects ssum-sec.casalemedia.com
3 api.btloader.com freestar-io.videoplayerhub.com
3 cdn.id5-sync.com securepubads.g.doubleclick.net
reason.com
3 sb.scorecardresearch.com 1 redirects a.pub.network
reason.com
3 stats.g.doubleclick.net www.googletagmanager.com
www.google-analytics.com
3 img.sparemin.com reason.com
3 fonts.gstatic.com www.google.com
fonts.googleapis.com
3 api.headliner.link disco.headliner.link
3 consent.cookiebot.com www.googletagmanager.com
consent.cookiebot.com
3 www.googletagmanager.com reason.com
www.googletagmanager.com
2 sync.smartadserver.com 1 redirects ads.pubmatic.com
2 pixel.onaudience.com 2 redirects
2 uipglob.semasio.net 1 redirects reason.com
2 io.narrative.io 1 redirects reason.com
2 ckjjzdn8vk.execute-api.us-west-2.amazonaws.com s3-us-west-2.amazonaws.com
2 aa.agkn.com u.openx.net
reason.com
2 thrtle.com 1 redirects reason.com
2 px.owneriq.net 2 redirects
2 t.pswec.com 2 redirects
2 simage4.pubmatic.com ads.pubmatic.com
2 bpi.rtactivate.com freestar-d.openx.net
reason.com
2 ads.creative-serving.com 2 redirects
2 ice.360yield.com 2 redirects
2 dis.eu.criteo.com 2 redirects
2 gtrace.mediago.io cdn.mediago.io
googleads.g.doubleclick.net
2 pixel.advertising.com 2 redirects
2 cdn.undertone.com a.pub.network
2 cdn.mediago.io googleads.g.doubleclick.net
2 creativecdn.com 2 redirects
2 rtb.adentifi.com reason.com
googleads.g.doubleclick.net
2 pmp.mxptint.net 1 redirects reason.com
2 pubmatic-match.dotomi.com 2 redirects
2 sync.mathtag.com 2 redirects
2 sync.srv.stackadapt.com 2 redirects
2 a.tribalfusion.com 1 redirects googleads.g.doubleclick.net
2 p.rfihub.com 2 redirects
2 beacon.lynx.cognitivlabs.com 1 redirects ads.pubmatic.com
2 cms.quantserve.com 2 redirects
2 cm.adgrx.com 2 redirects
2 prebid-server.rubiconproject.com live.primis.tech
2 contextual.media.net cs-server-s2s.yellowblue.io
2 ssc-cms.33across.com 2 redirects
2 ssbsync.smartadserver.com 2 redirects
2 t.adx.opera.com 2 redirects
2 pulsepoint-match.dotomi.com 2 redirects
2 mb9eo.publishers.tremorhub.com 2 redirects
2 pippio.com 2 redirects
2 b1sync.zemanta.com 2 redirects
2 jadserve.postrelease.com 2 redirects
2 s.ad.smaato.net 2 redirects
2 cs.media.net 2 redirects
2 a.sportradarserving.com 2 redirects
2 aorta.clickagy.com 2 redirects
2 pixel-eu.rubiconproject.com 2 redirects
2 pixel.quantserve.com reason.com
2 bcp.crwdcntrl.net tags.crwdcntrl.net
reason.com
2 oajs.openx.net 1 redirects reason.com
2 a.ad.gt cdn.hadronid.net
p.ad.gt
2 secure.cdn.fastclick.net reason.com
2 ad-delivery.net reason.com
2 config.aps.amazon-adsystem.com c.amazon-adsystem.com
2 mug.criteo.com reason.com
2 gum.criteo.com 1 redirects
2 api.intentiq.com a.pub.network
live.primis.tech
2 cdn.confiant-integrations.net a.pub.network
cdn.confiant-integrations.net
2 optimise.net a.pub.network
2 api.parsely.com d2eehagpk5cl65.cloudfront.net
2 connect.facebook.net www.googletagmanager.com
connect.facebook.net
2 www.youtube.com d2eehagpk5cl65.cloudfront.net
www.youtube.com
1 rtb.adstanding.com 1 redirects
1 dmp.adform.net 1 redirects
1 sync.crwdcntrl.net reason.com
1 synchroscript.deliveryengine.adswizz.com reason.com
1 idx.liadm.com b-code.liadm.com
1 sync.bfmio.com reason.com
1 crb.kargo.com reason.com
1 core.iprom.net ads.pubmatic.com
1 matching.truffle.bid ads.pubmatic.com
1 ipac.ctnsnet.com ads.pubmatic.com
1 gocm.c.appier.net 1 redirects
1 hbx.media.net 1 redirects
1 beacon.krxd.net cdn.undertone.com
1 cw.addthis.com cdn.undertone.com
1 idpix.media6degrees.com 1 redirects
1 stags.bluekai.com freestar-d.openx.net
1 www.temu.com 1 redirects
1 analytics.pangle-ads.com 1 redirects
1 aid.send.microad.jp googleads.g.doubleclick.net
1 js-sec.indexww.com a.pub.network
1 freestar-d.openx.net a.pub.network
1 acdn.adnxs.com a.pub.network
1 images.mediago.io googleads.g.doubleclick.net
1 match.adsby.bidtheatre.com 1 redirects
1 aax-eu.amazon-adsystem.com s.amazon-adsystem.com
1 i6.liadm.com ssum-sec.casalemedia.com
1 us01.z.antigena.com reason.com
1 ums.acuityplatform.com 1 redirects
1 s.tribalfusion.com ads.pubmatic.com
1 match.deepintent.com ads.pubmatic.com
1 rtb-csync.smartadserver.com 1 redirects
1 sync.technoratimedia.com 1 redirects
1 rtb.primis.tech live.primis.tech
1 a.teads.tv a.pub.network
1 cm.ctnsnet.com 1 redirects
1 static.sparemin.com disco.headliner.link
1 sync.cootlogix.com 1 redirects
1 ssbsync-global.smartadserver.com 1 redirects
1 cs.admanmedia.com 1 redirects
1 fonts.googleapis.com live.primis.tech
1 sync-amz.ads.yieldmo.com s.amazon-adsystem.com
1 sync.inmobi.com 1 redirects
1 pixels.ad.gt p.ad.gt
1 data.adsrvr.org 1 redirects
1 cs.krushmedia.com 1 redirects
1 s0.2mdn.net ce.lijit.com
1 google-bidout-d.openx.net oa.openxcdn.net
1 605033cc1a4730890edd7776333db3e4.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 p.ad.gt a.ad.gt
1 rules.quantcount.com secure.quantserve.com
1 ad.doubleclick.net reason.com
1 rp4.liadm.com reason.com
1 rp.liadm.com 1 redirects
1 tags.crwdcntrl.net securepubads.g.doubleclick.net
1 oa.openxcdn.net securepubads.g.doubleclick.net
1 a.usbrowserspeed.com a.pub.network
1 secure.quantserve.com a.pub.network
1 sync1.intentiq.com reason.com
1 cdn.hadronid.net a.pub.network
1 b-code.liadm.com s3-us-west-2.amazonaws.com
1 btloader.com reason.com
1 freestar-io.videoplayerhub.com 1 redirects
1 www.facebook.com reason.com
1 p1.parsely.com reason.com
1 s3-us-west-2.amazonaws.com reason.com
1 cdn.mouseflow.com www.googletagmanager.com
1 cdn.parsely.com www.googletagmanager.com
1 analytics.google.com www.googletagmanager.com
1 consentcdn.cookiebot.com consent.cookiebot.com
1 p.typekit.net d2eehagpk5cl65.cloudfront.net
1 cdn.jsdelivr.net reason.com
1 kit.fontawesome.com reason.com
1 reason.com
0 api.rlcdn.com Failed live.primis.tech
0 jelly.mdhv.io Failed ssum-sec.casalemedia.com
0 ad.mrtnsvr.com Failed ads.pubmatic.com
1004 245
Subject Issuer Validity Valid
reason.com
Amazon RSA 2048 M02
2023-09-13 -
2024-10-12
a year crt.sh
*.cloudfront.net
Amazon RSA 2048 M01
2023-10-10 -
2024-09-19
a year crt.sh
*.headliner.link
Amazon RSA 2048 M03
2024-02-03 -
2025-03-02
a year crt.sh
*.fontawesome.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-12-04 -
2025-01-03
a year crt.sh
www.google.com
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
jsdelivr.net
GlobalSign Atlas R3 DV TLS CA 2023 Q3
2023-09-27 -
2024-10-28
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
use.typekit.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-02-01 -
2025-03-03
a year crt.sh
*.gstatic.com
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
*.google.com
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
consent.cookiebot.com
DigiCert TLS RSA SHA256 2020 CA1
2023-04-06 -
2024-04-06
a year crt.sh
*.cookiebot.com
DigiCert TLS RSA SHA256 2020 CA1
2023-04-17 -
2024-04-17
a year crt.sh
*.sparemin.com
Amazon RSA 2048 M03
2024-01-04 -
2025-02-01
a year crt.sh
*.g.doubleclick.net
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2023-11-23 -
2024-02-21
3 months crt.sh
*.parsely.com
Amazon RSA 2048 M02
2023-05-06 -
2024-06-03
a year crt.sh
cdn.mouseflow.com
Cloudflare Inc ECC CA-3
2023-10-25 -
2024-10-23
a year crt.sh
pub.network
GTS CA 1P5
2024-01-26 -
2024-04-25
3 months crt.sh
*.tiktok.com
RapidSSL ECC CA 2018
2023-07-14 -
2024-08-13
a year crt.sh
*.s3-us-west-2.amazonaws.com
Amazon RSA 2048 M01
2024-01-23 -
2024-12-31
a year crt.sh
d.pub.network
GTS CA 1D4
2024-01-29 -
2024-04-28
3 months crt.sh
optimise.net
GTS CA 1D4
2024-01-17 -
2024-04-16
3 months crt.sh
*.scorecardresearch.com
Sectigo RSA Organization Validation Secure Server CA
2023-12-11 -
2024-12-10
a year crt.sh
confiant-integrations.net
GTS CA 1P5
2024-01-17 -
2024-04-16
3 months crt.sh
*.liadm.com
Amazon RSA 2048 M03
2023-12-02 -
2024-12-29
a year crt.sh
hadronid.net
GTS CA 1P5
2024-01-31 -
2024-04-30
3 months crt.sh
c.amazon-adsystem.com
Amazon RSA 2048 M01
2023-12-30 -
2024-12-04
a year crt.sh
*.intentiq.com
Amazon RSA 2048 M02
2023-04-11 -
2024-05-08
a year crt.sh
*.criteo.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-02-08 -
2024-05-07
3 months crt.sh
*.primis.tech
Amazon RSA 2048 M01
2023-09-24 -
2024-10-22
a year crt.sh
quantserve.com
R3
2023-12-27 -
2024-03-26
3 months crt.sh
a.usbrowserspeed.com
Amazon RSA 2048 M02
2024-01-01 -
2025-01-29
a year crt.sh
id.hadron.ad.gt
E1
2024-01-27 -
2024-04-26
3 months crt.sh
*.adsrvr.org
GlobalSign GCC R3 DV TLS CA 2020
2023-04-12 -
2024-05-13
a year crt.sh
oa.openxcdn.net
GTS CA 1D4
2024-01-22 -
2024-04-22
3 months crt.sh
*.crwdcntrl.net
Amazon RSA 2048 M01
2023-10-08 -
2024-11-05
a year crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2023-05-07 -
2024-05-06
a year crt.sh
config.aps.amazon-adsystem.com
Amazon RSA 2048 M02
2024-01-21 -
2025-02-19
a year crt.sh
aax-dtb-mobile-cf.amazon-adsystem.com
Amazon RSA 2048 M01
2023-03-16 -
2024-03-08
a year crt.sh
api.btloader.com
GTS CA 1D4
2024-02-06 -
2024-05-06
3 months crt.sh
ad-delivery.net
GTS CA 1P5
2024-01-20 -
2024-04-19
3 months crt.sh
*.doubleclick.net
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
s2s.t13.io
GTS CA 1D4
2024-01-11 -
2024-04-10
3 months crt.sh
*.sharethrough.com
DigiCert Global G3 TLS ECC SHA384 2020 CA1
2023-08-02 -
2024-08-13
a year crt.sh
*.rubiconproject.com
DigiCert TLS RSA SHA256 2020 CA1
2023-03-05 -
2024-04-03
a year crt.sh
*.pubmatic.com
DigiCert Baltimore TLS RSA SHA256 2020 CA1
2023-04-20 -
2024-05-20
a year crt.sh
*.bidswitch.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-01-02 -
2024-04-05
3 months crt.sh
dev.eks.va.adexchange.gumgum.com
Amazon RSA 2048 M02
2023-11-17 -
2024-12-15
a year crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2023-02-13 -
2024-03-15
a year crt.sh
*.3lift.com
Amazon RSA 2048 M02
2023-04-13 -
2024-05-11
a year crt.sh
*.openx.net
RapidSSL TLS RSA CA G1
2023-08-18 -
2024-08-18
a year crt.sh
secure.cdn.fastclick.net
DigiCert TLS RSA SHA256 2020 CA1
2023-10-03 -
2024-10-03
a year crt.sh
a.ad.gt
E1
2024-02-12 -
2024-05-12
3 months crt.sh
*.id5-sync.com
R3
2024-01-01 -
2024-03-31
3 months crt.sh
*.lijit.com
Amazon RSA 2048 M03
2024-02-11 -
2025-03-12
a year crt.sh
s.amazon-adsystem.com
Amazon RSA 2048 M01
2024-01-01 -
2024-12-21
a year crt.sh
p.ad.gt
Cloudflare Inc ECC CA-3
2023-11-09 -
2024-11-07
a year crt.sh
*.ybp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2024-02-12 -
2024-08-07
6 months crt.sh
*.criteo.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-12-15 -
2024-03-10
3 months crt.sh
*.onetag-sys.com
DigiCert Global G3 TLS ECC SHA384 2020 CA1
2024-01-23 -
2025-01-29
a year crt.sh
casalemedia.com
Cloudflare Inc ECC CA-3
2023-05-21 -
2024-05-20
a year crt.sh
*.ads.yieldmo.com
Amazon RSA 2048 M01
2023-03-26 -
2024-04-23
a year crt.sh
*.contextweb.com
DigiCert TLS RSA SHA256 2020 CA1
2023-04-10 -
2024-05-09
a year crt.sh
*.yellowblue.io
Amazon ECDSA 256 M02
2023-04-18 -
2024-05-16
a year crt.sh
*.tapad.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-09-18 -
2024-09-17
a year crt.sh
ups.analytics.yahoo.com
DigiCert SHA2 High Assurance Server CA
2023-12-26 -
2024-06-19
6 months crt.sh
upload.video.google.com
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
*.adform.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-05-25 -
2024-06-18
a year crt.sh
*.media.net
DigiCert TLS RSA SHA256 2020 CA1
2023-12-21 -
2024-12-21
a year crt.sh
teads.tv
R3
2024-01-22 -
2024-04-21
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1C3
2024-01-09 -
2024-04-02
3 months crt.sh
a248.e.akamai.net
DigiCert TLS RSA SHA256 2020 CA1
2023-05-16 -
2024-05-15
a year crt.sh
c.pub.network
GTS CA 1D4
2024-01-27 -
2024-04-26
3 months crt.sh
*.eu-1-id5-sync.com
R3
2024-01-01 -
2024-03-31
3 months crt.sh
*.deepintent.com
Go Daddy Secure Certificate Authority - G2
2023-12-01 -
2025-01-01
a year crt.sh
*.everesttech.net
GlobalSign Atlas R3 DV TLS CA 2023 Q3
2023-08-11 -
2024-09-11
a year crt.sh
beacon.lynx.cognitivlabs.com
Amazon RSA 2048 M02
2023-03-31 -
2024-04-28
a year crt.sh
*.z.antigena.com
Sectigo ECC Domain Validation Secure Server CA
2023-04-03 -
2024-04-02
a year crt.sh
adentifi.com
Amazon RSA 2048 M01
2023-07-06 -
2024-08-03
a year crt.sh
aax-eu.amazon-adsystem.com
Amazon RSA 2048 M01
2024-01-13 -
2024-12-22
a year crt.sh
*.mediago.io
Amazon RSA 2048 M03
2023-08-07 -
2024-09-04
a year crt.sh
*.undertone.com
Amazon RSA 2048 M01
2023-09-11 -
2024-10-08
a year crt.sh
*.us.criteo.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-01-12 -
2024-04-12
3 months crt.sh
cdn.adnxs.com
GeoTrust TLS RSA CA G1
2023-03-27 -
2024-04-26
a year crt.sh
indexww.com
Cloudflare Inc ECC CA-3
2023-09-05 -
2024-09-03
a year crt.sh
www.linkedin.com
DigiCert SHA2 Secure Server CA
2024-01-30 -
2024-07-30
6 months crt.sh
*.send.microad.jp
GlobalSign RSA OV SSL CA 2018
2023-10-03 -
2024-11-03
a year crt.sh
rtactivate.com
Amazon RSA 2048 M03
2024-02-12 -
2025-03-11
a year crt.sh
odc-pixel-prod-01.oracle.com
DigiCert TLS RSA SHA256 2020 CA1
2023-12-11 -
2024-12-11
a year crt.sh
*.rlcdn.com
Sectigo RSA Domain Validation Secure Server CA
2023-02-02 -
2024-03-03
a year crt.sh
*.va.us.criteo.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-01-31 -
2024-05-01
3 months crt.sh
odc-addthis-prod-01.oracle.com
DigiCert TLS RSA SHA256 2020 CA1
2023-12-09 -
2024-12-11
a year crt.sh
*.demdex.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-09-26 -
2024-10-26
a year crt.sh
beacon.krxd.net
DigiCert TLS RSA SHA256 2020 CA1
2024-01-31 -
2025-01-29
a year crt.sh
*.us.criteo.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-12-27 -
2024-03-22
3 months crt.sh
*.da.us.criteo.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-01-14 -
2024-04-11
3 months crt.sh
*.ctnsnet.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-10-13 -
2024-11-10
a year crt.sh
truffle.bid
R3
2024-01-08 -
2024-04-07
3 months crt.sh
*.iprom.net
R3
2024-02-10 -
2024-05-10
3 months crt.sh
*.prod.use1.green.ops.kargo.com
Amazon RSA 2048 M03
2023-12-11 -
2025-01-08
a year crt.sh
*.bfmio.com
Amazon RSA 2048 M02
2023-03-17 -
2024-04-14
a year crt.sh
*.agkn.com
RapidSSL Global TLS RSA4096 SHA256 2022 CA1
2023-09-07 -
2024-09-29
a year crt.sh
*.execute-api.us-west-2.amazonaws.com
Amazon RSA 2048 M01
2023-06-02 -
2024-06-30
a year crt.sh
deliveryengine.adswizz.com
Amazon RSA 2048 M02
2023-07-04 -
2024-08-01
a year crt.sh
*.smartadserver.com
DigiCert Global G3 TLS ECC SHA384 2020 CA1
2024-01-17 -
2025-01-16
a year crt.sh

This page contains 133 frames:

Primary Page: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Frame ID: 3D48FAB7D5D4AD75F04A0A46770461BC
Requests: 379 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
Frame ID: 779E4AF37BF1682436EF08F22541C97A
Requests: 8 HTTP requests in this frame

Frame: https://consentcdn.cookiebot.com/sdk/bc-v4.min.html
Frame ID: 4B692071C28B406CA975FBECD078A5F4
Requests: 1 HTTP requests in this frame

Frame: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Frame ID: C770BA28F5B4F229FC6C889620CBD184
Requests: 55 HTTP requests in this frame

Frame: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Frame ID: C5F108E89757564A4E963259847B9612
Requests: 10 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&dcc=t
Frame ID: A30CD03B41234360EC97B00D9FB43F28
Requests: 1 HTTP requests in this frame

Frame: https://605033cc1a4730890edd7776333db3e4.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 70D0BFD29D424E6265C4B01349F76B1A
Requests: 1 HTTP requests in this frame

Frame: https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Frame ID: FA5583ACD2A242C6D13F45E4AC961385
Requests: 6 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Frame ID: 217EF319CCC4481ED222ECC674CD1E21
Requests: 10 HTTP requests in this frame

Frame: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Frame ID: D0D141D93567B3B48E1661BC363A1883
Requests: 8 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Frame ID: 5A2444854085998803C967D5F860AF15
Requests: 23 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Frame ID: C08140AD58C5DE1DD2824179C6FB0B72
Requests: 10 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Frame ID: 738491153705DC600A5D80A0C2EF223E
Requests: 7 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?ex=inmobi.com&id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ
Frame ID: C3EA25F3C7F954B9695669DE1168141E
Requests: 1 HTTP requests in this frame

Frame: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D%24UID&gdpr=0
Frame ID: 6439FD5DC2E698BA31B090A844015369
Requests: 6 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID&gdpr=0
Frame ID: 7F16114E956C0FFD4FAD7EC74E239BEA
Requests: 6 HTTP requests in this frame

Frame: https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Frame ID: 424C67792672A734511A410F87C44BA5
Requests: 7 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east&gdpr=0
Frame ID: E84671E4A0FEC46D2552DABAC3B7318F
Requests: 20 HTTP requests in this frame

Frame: https://bh.contextweb.com/visitormatch?p=547259,530912,534301,548607,543793,561117&rurl=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%25%25VGUID%25%25%26ex%3DPulsepoint
Frame ID: 806B08CE1332929524F25F5670914446
Requests: 4 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?ex=vmg.com&id=eS0yb2pFVWpsRTJ1SXZ6bVVEVXpJVWhqOFdPOUZMVnNRWH5B&gdpr=0
Frame ID: 78B2DF93CC357E04772BEFD1CC222B75
Requests: 1 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?id=5872803529851156248&ex=appnexus.com&gdpr=0
Frame ID: 8497F761E487454DC6DEEAF1D7351D0D
Requests: 1 HTTP requests in this frame

Frame: https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Frame ID: 1BA636047437E7063E00CCC7E2D20A55
Requests: 7 HTTP requests in this frame

Frame: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Frame ID: B648A0EC06506EA403B5DEF2FEB1F65F
Requests: 17 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?ex=3lift.com&id=3900114537385664774839
Frame ID: CC0AA420E37132DBE46E29AEE412AEDB
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuiBHsGtYyi-dJsBekr9ZNuapoFE_eajwgKh7MeSqW6Bv9162qFWXw_iuEuaP6vEzK9mvihXACNhODTVC6Zpn0hjKUVH_dMOG0EreRCFYczvRqnBnYX7SAZ6Qis_TfLbjAAjBc1_c1tvlM-Ox8Z6XDULW6Ncpk4BdI65TfQrHi6Uuk4s6toeJYsiUUEBwPIhbmE_PmEREgiYjuao3ck0jaD27F5bZNqk1iAllTWkNwiuGvKvYec4z-vknorFQ4U-8qnF3O43q38pBxlQadc9fSHtoIt3nf_JBRntzVSXH3xG4uJA0sRAcy52Fmz_v_RPC4mMxd6be66mcIVIuP3tvnE66tljweebGWY3aHu8poZP526n2IcmPOvzzsfdRl8JA&sai=AMfl-YQiJ-gfiWd2drpKArHAk_gZofa9xtKutwHPeAyrJe3Cf5aLpsHahWe5AyB3XoUC0IjujSSInuoBrBQSm59VVXS9iFXFS9J3_2hkTEcYk5uPiDLPPNYMV4XOBjMrCouZk8UTFsDfHHNeA1ZSj-lJZ5E&sig=Cg0ArKJSzHxb72D43Pf-EAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: 97A3F6AF0A4B9E1A35D618EF4BFA6EF0
Requests: 10 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=159196&userIdMacro=PM_UID&gdpr=0&gdpr_consent=&predirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D91%26advUuid%3DPM_UID
Frame ID: D27EDCE839BCFA564BFBCDD7EE7EEDFC
Requests: 6 HTTP requests in this frame

Frame: https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1486637409&3rdpcid=8b979bf4-7108-4d0c-86a3-3f353964681d
Frame ID: 5C42514486A5681D69BD85D765F481BF
Requests: 1 HTTP requests in this frame

Frame: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Frame ID: 8452762A4F9EEF7A10DB15460253EE0D
Requests: 17 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?pubId=69f48c2160c8113&gdpr=0&gdpr_consent=
Frame ID: 4A04F8916248EA0B8BED6A128DB2FED5
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Frame ID: 1DFF88A615412DF133171FB36B669993
Requests: 3 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?pubId=69f48c2160c8113&gdpr=0&gdpr_consent=
Frame ID: C1E52F5DFD281B19F4841CDCCF856F1D
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Frame ID: CE88D2C377F7F0DA4DE45B1033CE4969
Requests: 4 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvsyO4sHjioSpiDntsycFZx8Vw-xvbKBXn-ycIVI8VEKaV5qF9KG9t51tMjWg-MqWy7JO9X8zgLDT9ffqCWo46uqOzcwtL-FvaZPwNPha-7bDDY5PdPG7iX66MaOpjwPJeibqb6DlPxA4mZ6WcWZBflKmrivAR4yHnimXz_5eFkybazBcuf5YpMHj8ZjFxlLb1FEeUUUNb67ZSe2WnXKxLQi8JorEaV7rYkM6leE8HjPj7XJQWHCwHBFYFPhBGOROFF2uxgSM4xwSUHzx4ZfPxceRJi4fmlkq-kjJbijRjbCltYJnr_3qmPY4IFypmJPc12ETWduvDyOheaFgHwQcxgohxRUl6-nQV3hehovqC-ety_nM_T5_XP1QBSN33kuiUN7cSB_Zaq3FqUgd6YQYLMvz87RgrmpbmTXFUjnkK7Oa4b&sai=AMfl-YQA8YVosXL8OOZXwMuXoniFbPGhNYhAsw5U7NFrBQK05GOjtH1w3a9wtSpf7yV3oHuky6Qc3KBZNGADGXxcxTR-WlxRTATt_bWe_LBjMyjHSP9UIjYPmfNbrmaZ5w4&sig=Cg0ArKJSzNSyO49xsyyCEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: B4CDB42BCD237ABF9266C77D836E65CC
Requests: 9 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/html/r20240208/r20190131/zrt_lookup_fy2021.html
Frame ID: 14DB01DC06E32B954D9AF2A0BD0631EC
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsugosiiKsFkfKKt2wDDnVQqyAUprtcHZEwbU87Oda11KIyjtgIfTUqZdBrrmSdih4MialRpCDpmgCIcrFam82kQM-vH0XQ_MOvp1itf--q50sCAsRPde5eYk9BCJ2p8wlDN66jkrRGuXhemhmknLWju8VWD5HcQtAymtN5XeAMtr7uQyKO9oF9Ow9bYJ1Y5tzg3rtraeyQ5QbtqcQfTBP4yDD4uFYAB6dlIfL5FMG0A8Uj2FgMQTpj52bT_J2ifUuTPkLZgpVwxdtJJPUtCH6AuoIM8f39ZBToI9rsqeDIjlaq7QGd9sHTNcUZoeLSgqMZOaQLQIRNqkkBKsFxrYW6VjjSO_De3ScRtCzH5pQyNRI2TTt3fL_jp&sai=AMfl-YS4i8geK1Myg9zpWRVsxPGAF4MEt1imP-IfMLvyUpfTYrhzVR6NL5eKGGef0WEttnddfn5g7mz3HXhvRv8riHVvfV9l5y9jBjj9bICzPYzAKg8_47IYMYNd3fXOWP4&sig=Cg0ArKJSzFwHuBsL-beWEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: A0798A2321E0451767EE72A7CFBA123B
Requests: 9 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssd1Zj4dUr1132i87jynMm_9-Ltm7ecDSOotsDlOS_PX5cRSxkNTfZBch9DauqDW5BySufT6uJGId9HMXojbXmVcwZ5x2oh4ysTvy-cETMdETckEt-KVTHF-VwQiB9P1dBhrbl8zinPhgrlaIzaQAcVSHekZWn6CYeiCMN1SmNB_OvK-bvIkn_8twBIftBm7eFjwxqtL0AlHrLjYK-cdwrJ84cUx-TrIsTelhnAgNxxB-Hz3iMUIdw6iZddvs1od9gAj85mmuOUsO2k-9XtK2ru6-VR_gGIPmYKRdbi2eapFW2QXJ3l5MNPLT2hpX0aMh5Lg2hbtLSoD8kBMSaIubeRnBtgKx_wINieSoQxqLhnjwU4uq41uaTY&sai=AMfl-YTslyGxWSBDx4AVo7o90eoa1Qo1IRTteu5bX0AxYFiV1OBy5rFIXW8sGRfNqjrGghfZgg9nf2uQ1j-V1kUBMxRkaBDwfWWrR2Zhj7W4ePaaudjwHur93y9VuyXzOw&sig=Cg0ArKJSzLWF3Aa3VFIiEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: F14238E12AF0E8C5F6B829C5382E9F7F
Requests: 9 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Frame ID: 9408A64DA650E1922E0E0DC7D3B554F8
Requests: 10 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-inmobi_n-nativo
Frame ID: 6572719F0286383E749CC56ED621F864
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/LVEN46HQ.html
Frame ID: AB6F3E20273AB9DE1046691A677312A0
Requests: 4 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/dcm?pid=3b882453-6770-4785-baf8-a598533c054a&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&redir=true&gdpr=0&gdpr_consent=
Frame ID: E734097D2EE7536E095E30E560F3D3C1
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTc4JnRsPTE1NzY4MDA=&piggybackCookie=5872803529851156248&gdpr=0&gdpr_consent=
Frame ID: 23C27BB87167BBFD8638A9386346E9B3
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDEmdGw9MTI5NjAw&piggybackCookie=d2f37c96-caa2-11ee-a313-71f04e140079
Frame ID: AB600B2A8FAF600ED0499BA39AF10918
Requests: 1 HTTP requests in this frame

Frame: https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyOTcmdGw9MTI5NjAw&piggybackCookie=AACJ-U7Ll3sAABJaNC07Nw&gdpr=0&gdpr_consent=
Frame ID: 8DA1F913B17312A4B1DCFB0048FBBD51
Requests: 1 HTTP requests in this frame

Frame: https://match.deepintent.com/usersync/141?gdpr=0&gdpr_consent=
Frame ID: 814F7B69C923FB9F7522C40DAE5F2054
Requests: 1 HTTP requests in this frame

Frame: https://sync-tm.everesttech.net/upi/pid/b9pj45k4?redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjE5MSZ0bD0yNTkyMDA=&piggybackCookie=${TM_USER_ID}&gdpr=1&gdpr_consent=
Frame ID: 785791939589535CC28D9A6F17FA5223
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9Mjk0NSZ0bD0xMjk2MDA=&piggybackCookie=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&gdpr_pd=&us_privacy=
Frame ID: 465189919954D51794892CB3CE412484
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzQmdGw9MTI5NjAw&piggybackCookie=uid:MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent=
Frame ID: 5637D2B2EE725AF14C2E666D28CEB57E
Requests: 1 HTTP requests in this frame

Frame: https://image2.pubmatic.com/AdServer/Pug?gdpr=0&vcode=bz0yJnR5cGU9MSZjb2RlPTExMTMmdGw9NDMyMDA=&piggybackCookie=kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-
Frame ID: 1514A2D4A9BE0EC1CBC9BC58F603C5F2
Requests: 1 HTTP requests in this frame

Frame: https://beacon.lynx.cognitivlabs.com/pbmtc.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: 7CCC065067F8069BFB0E4EA0A0711BA2
Requests: 1 HTTP requests in this frame

Frame: https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI3MzkmdGw9MTI5NjAw&piggybackCookie=970314649043819140
Frame ID: AE6E253B739D4B4306A37A1CE943F23B
Requests: 1 HTTP requests in this frame

Frame: https://dis.criteo.com/dis/usersync.aspx?r=3&p=4&cp=pubmaticUS&cu=1&&gdpr=0&gdpr_consent=&url=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTE5MjgmdGw9NDMyMDA=&piggybackCookie=uid:@@CRITEO_USERID@@
Frame ID: FE8CD99C5F6EAEF8D0D0EBB651ABC166
Requests: 1 HTTP requests in this frame

Frame: https://s.tribalfusion.com/z/i.match?p=b11&redirect=https%3A//simage2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMzMjYmdGw9MTI5NjAw%26piggybackCookie%3D%24TF_USER_ID_ENC%24&u=${PUBMATIC_UID}
Frame ID: 5222D453551AC4FC862099CE16241CC6
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MzEmdGw9MTI5NjAw&piggybackCookie=SPs6ha90UKJ-2DermTJBdGAJ-Sw&gdpr=0&gdpr_consent=
Frame ID: 39536E7875BF5F040DED1C768606379F
Requests: 1 HTTP requests in this frame

Frame: https://ad.mrtnsvr.com/sync/pubmatic?gdpr=0&gdpr_consent=
Frame ID: C0E02E609E54948E8A10B56751191845
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode&piggybackCookie={viewer_token}
Frame ID: 691B968946E413535CA1958A7D4DAB02
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI5NDcmdGw9MTI5NjAw&piggybackCookie=888838742219
Frame ID: 1E5379FA5D4789F0DEB6FF712E98A53C
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM2MiZ0bD0xMjk2MDA==&piggybackCookie=uid:a90b65cb-bd6c-4100-b778-a2ca30279172&gdpr=0&gdpr_consent=
Frame ID: 78F8D807A77314404A9086585EC0E3EC
Requests: 1 HTTP requests in this frame

Frame: https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0ODkmdGw9NDMyMDA=&piggybackCookie=OPUab1645795b4b463ba93cb19748df0468
Frame ID: B393DC0B01F7462D0232A6B1EF4788F8
Requests: 1 HTTP requests in this frame

Frame: https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: 5CA17C7EEAF0019E3A63337519E0B5CF
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuy9gWAQerTCE5l15EMPQA5f4J_VmmBz13z5I0s-G-5McMF53lIB9HRr2yNbcr_bf6mg3PEyPuTwWSqQCS04Iu2wfWGg2F1veN3gLT_lCTtt3-PdB6JluhPeTYedUobiXcMWJgV_HRiUfIL2_nPAdALoHSMHgKDk8pD9eEq5sRbyYvMwAhq4URov5RX2HD0CgivtJUpUpOKEJZkajPatc96S_GR7vA97ZMcEbEfj6zdW2QWFirwpL-ecAo_qy8RVCuHc4mV2KNcqWpNtShemdS5kKkEXIBS9jBqhE9i9HqMJOl2cvIsMLZKT1Jbow6f0IJ03aZ1HpyEiIBQPOGeNXc6C0nWjIsFgIsJQJVKmbgsu61FFKz3zYBR3XHkZckS_XJkK6cvCzM&sai=AMfl-YQJiOG7uwk9uPy5MsxRnriGl6wzUnV_jX6uqTpEE55iqcVBU6jr68SgkCKHjB45nOvGZa5SCfhZR6DPScmU9PUcxHa3RqUyfNf6eDDLGbeXa863tyYRUUal3mQvrQ&sig=Cg0ArKJSzPZIpTFrVm7cEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: B84B12DC292D701C928982FB521688BF
Requests: 9 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Frame ID: 670AB62396911B21C5AC29FAE9AA9303
Requests: 5 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstCYg88UMPmKMJfKuWCempo5uf-aczth3ErWSXyHnXFFLIVYYgZ89CcwRreBLzr0ZGjoFPOolTVzULvC6xJ6fU_-PY6psLjEfFCqvXcQDMsFH7F5dJSQpZ25z4_84f_aI6VTvpc-n4ylBbvZ9h6rUaD9gQOyUd9ZvPWxzULuAatdPf4ezpWADZ-cr2kI7DxLNCOV43uhypepT6y4Thtu6MEWQlYQ7xiIQEGLYudlk8KqGKV5VrILg4slPY9xmDbV3xSMUDc6T8lKbMZ6VfEFQTmH-2jQpb8BSk-GcO54oBrSw62KuJcOLJ73d2vv0wvMPtSsaoUTRlJ-Tjf-K7N9gTbNs4a3j3rZzV2qrGq8pExAznR8nqDxc2L4bFDGa2xG4RqjyvYNYqUywgHQ5nAgRORFLOy-ho1EYWN&sai=AMfl-YSBoloZbBK7HYfxiKzD-quAg5gJ4XuGRMFTM-IwGAKiCC5hraz3axxX8RbZg_p7Hi7_X7ZiLp-QN_1Hp7g8HsYeyh0p8NeiCuQVdpP4qvARU_b6CjPQLawwP84RfGU&sig=Cg0ArKJSzM_xBydGkEKrEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: BDF5AEC6B38E57F03055E3CEE66B949F
Requests: 8 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Frame ID: 18AAE807DA50842C0D72D05F35FB581B
Requests: 14 HTTP requests in this frame

Frame: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D$UID
Frame ID: 76B45D73565D405F1EDFD724B5CAB9AE
Requests: 6 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID
Frame ID: 766CC6DE90E62F25977B51C193237D08
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east
Frame ID: 3E93DC84715442872D9D6FDF0E4802A9
Requests: 3 HTTP requests in this frame

Frame: https://bh.contextweb.com/visitormatch?p=547259,530912,534301,548607,543793,561117&rurl=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%25%25VGUID%25%25%26ex%3DPulsepoint
Frame ID: FE86B4743346D83386E96E1BA0C97F25
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuBdDelexgf0yOjTJch3KoMXTRNqd55Jeq6Xlnbe0LJlLE5ym-jWz61mrSYZofjua6K_p0ErmWJzgEK7tZbGsWiSgKJFASmUcKJp4M238KzneOg9pg08j150Ef3CXthhtMn1tmMX85DS_EzwyvdIp9YS34GtZKelTCMnZUABY0DdBqhxaM5cFXw5zGE-g507GK8EbgKuTuz3K2OZH8jper0W14EbPCpmX2htOn4IQCa5gZhV-ZxAytU0FFMKKxPMcP0TPY2B2hWbak1ImA2W6T9ARhGsXrURdFqnLEXwhmselgOYtDP97_rDeO2JEmJfqe5Wvh0h1DUMDWUEcgneRpSlzPjtTfxT-V56giW64PFOb2kqSY8hBDGkrv3JCldaV18riotaOo&sai=AMfl-YT78Fal0CFav7_UJ5Qo0_W6Xpy6r2Bb4EJon9gsc4lIUFboTq6DaQYxOTT-Xq_LeinxztN9m_vI2ZYe21KjA8uYP881PPodyvCxJ90ksVKSX1m3Y8q1I3f1npKsTA&sig=Cg0ArKJSzNCpzY9mOQsWEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: 4BF9B4A1A48C09F80B9A00E29BC5D69C
Requests: 10 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189481&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116601&bpp=3&bdt=448&idt=609&shv=r20240208&mjsv=m202402060101&ptt=9&saldr=aa&cookie=ID%3D4e0f487d75def1f0%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MZukt05BTcjZAKcF-l0HAkucY8ADQ&gpic=UID%3D00000a0d711b7d8c%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MYegQCnliexSNnZXpuvbn-Ts8zKaA&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=1061511107&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=453&ady=2868&biw=1600&bih=1200&isw=300&ish=250&ifk=1980146966&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808398%2C31081034%2C44795921%2C95324580%2C31081006%2C95321963%2C95320868%2C95324154%2C95324161&oid=2&pvsid=895834258692043&tmod=1524724573&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.wfo5pgs8ytlv&btvi=1&fsb=1&dtd=828
Frame ID: F8F6E04E39E3A3B7BE527A81B5D0B689
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss0jOOkNcodhyDydQ1OpIhC4T6p2Uo4KzLZ_jYn3DWgd2ofrNaUKd_PQmWOlrwzVUz2SLKb9RJuegD4TvgRIOIH8pyr2A9G9XJj4dsRd41zTzoiFnX769PCyWsQO_aIgFVMqMN2mocuLwpSjETySz3B9NOrje0jfSgOaewdJxvk4yerhyr2bBkgXY2t0Mc6_GSVnwUEuld1RMq1OWqPJpoDAB2uboqbZy_uSBR5VdibznVm3dIjqCy9AuCY6zWb8TnCRoAHis3hfWIEXcbWEfbP5DvbCuv7PWVuLJjACtq826-AOMS8MBsI_7gasUKVjGZ_UFgmHIANB7h_HKkZZKEevWd_T4j7wbnNcl4L6GeoMcqWtUux6jEZx-DpOtlOlsafRIFxE3t1t9rM7yz-kFmH_G3IBK8__iyl&sai=AMfl-YTC3bnSx3fWH99oHi3lWw1xzPuiQsX7tfitpwerUI1MddfzS9hPvs2R3X2o7k7Fov_WVffCIfwIDB1cc_xNFXnvwPt8zA2ixFSakNgtoFEi3xKIVJ67N09-khOndg&sig=Cg0ArKJSzGkgwRRFSulZEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: E29D4F5D287AA3B3A46A13602D37BB72
Requests: 9 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Frame ID: F299681CA397AA1C7AFCE7BE7B3A5C25
Requests: 8 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Frame ID: 9942C12C43DDA1D9EAFAB5074C2A37DE
Requests: 7 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstv2wdfqQP1jVvFrE3HUgLXK8YS-RlxWHH0YTBkAaZ5NT1s5rhzD73cl2r__FFKCMGReJOUzZmznI4-X0XPwzS4LtLt4lf5VSualT-9uAnmfpFsLp1R1Zd46pTRZPpU5B06dCSYj2mHv96LFWW2gyw9a_XbpKqnTiCoMyGlluvs44HIipdRFxIGGtUub5j4YLOiGgx-CLLOh7h1_m52x351MsNgOEb6kxSMPtUhrSF4-1bIq-K4nLNpkGkOwoPt3paQMUMoO4JI3-7yGkwarT5e09k9ARrzURpYx4iH185WCvoxYwkFTdf3zvUHGrboLtqkz9WOHD7GhziMqGTCP6kh2FNIZ_fZqiD0nhXNazL6-8hJg2-SQmwPwKWxnfnSgUrxR4y4&sai=AMfl-YR21DfEkpnwE87IbFGmObyydwqkbQvLyznBEZisMDyVPyRDrOAEg9MaUWWJ072KdAEVzfIUvC8WXmUc7TuR_1uZlnfnFlqNEtTr4IS82Bo-S9feA_klydaxIopOGe4&sig=Cg0ArKJSzFC1vJvsBfAlEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Frame ID: F5DB32AD08C504E9C1FFCE2EBA36598F
Requests: 9 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: C4D36CD2E021487C214967363FCE0EEE
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: E3E85DCBDB00222DC52F60E17887A8CD
Requests: 2 HTTP requests in this frame

Frame: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Frame ID: DFC85F9DC9E8B2A0EA8195464D3FB4C4
Requests: 9 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=8019747248&adk=2858904547&adf=776189485&pi=t.ma~as.8019747248&w=300&lmt=1707851117&format=300x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117242&bpp=3&bdt=570&idt=424&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1073616266&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1044&ady=2142&biw=1600&bih=1200&isw=300&ish=600&ifk=4242991593&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44808397%2C31081034%2C31081153%2C44795922%2C95322748%2C95324580%2C95320869%2C95324154%2C95324161&oid=2&pvsid=1605499748962416&tmod=1249468064&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C600&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.m3lx0korkxnd&btvi=1&fsb=1&dtd=509
Frame ID: 8AC552E67D2C4A62B53B68C0EDDA79C6
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: B107750069FE6D954C79040468B0D6B6
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: 726797D8C1942D7877A48539DA57FAE9
Requests: 2 HTTP requests in this frame

Frame: https://cdn.mediago.io/js/cookieSync.html?tn=41b6e88a2b85b0e731ef8e73e5558712
Frame ID: BF66B6EA32431761EDC8E597D27F35A8
Requests: 3 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Frame ID: F500A7B2FE7B0E9939A0927B64F69577
Requests: 9 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: 8E2FFA116883CCF8B97C2CD23335C39C
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: 301FC49072F829A9BF090CD1F08D653B
Requests: 2 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?s=197137&cb=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D57%26uid%3D&us_privacy=1---
Frame ID: 4266AA47CA8826E71A3C0357CB100BD3
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?p=12776&us_privacy=1---
Frame ID: DBBD9574CBFE4270C6B4A80B234A9FFA
Requests: 4 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: BAA02CD7E52FAD57F549AF99053863CC
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: 3CE237248AEAD47E73AD8D5A084B9A73
Requests: 2 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Frame ID: DF63B41F82A350A300BE6D326E2A8CEE
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?us_privacy=1---
Frame ID: 17416EB16C9AFF3CDACF7D0D95326B88
Requests: 2 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189474&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117533&bpp=3&bdt=432&idt=383&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3Dee9822135593aa08%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZ20DrTehmWhgnGqgmyoWVZ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=638554288&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&isw=0&ish=0&ifk=766666192&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808398%2C31081024%2C31081035%2C44795921%2C95324580%2C95320378%2C95320869%2C95324154%2C95324161&oid=2&pvsid=1229490704497327&tmod=594984228&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C0%2C0&vis=1&rsz=%7C%7CEr%7C&abl=CS&pfx=0&fu=32772&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.wntnpgjfc9tq&fsb=1&dtd=674
Frame ID: C35D2567D2C457E245B7ED2AAF2AE1E6
Requests: 1 HTTP requests in this frame

Frame: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Frame ID: A65C15ADD5CBED10A60A0C7CD0B40BC1
Requests: 10 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Frame ID: DE6D79792E52DC3FC6E84D71C69BD0D1
Requests: 7 HTTP requests in this frame

Frame: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Frame ID: C5004BBE2B431776A769C1F3B6E56F59
Requests: 11 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Frame ID: 42F316940A6A2EC09F39EFFA4DBFCFFA
Requests: 7 HTTP requests in this frame

Frame: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Frame ID: 679195807B777EAAE685B2CF12D5B758
Requests: 14 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Frame ID: C24E8CAE1CF378D345E37772106AFF5B
Requests: 7 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?us_privacy=1---
Frame ID: B48011CAF8EBB3D0A19BA5AF3B7F0CD1
Requests: 2 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 70C52884F9AEDC649AE2CB1663BE2D40
Requests: 2 HTTP requests in this frame

Frame: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Frame ID: 0B32AF9A26D67287E83B005751EA63D1
Requests: 11 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: 33961E561C8B6D90926DC2DEC4CDF4E8
Requests: 1 HTTP requests in this frame

Frame: https://eb2.3lift.com/sync?us_privacy=1---&
Frame ID: C18544C128F4D59371E6102CBD986745
Requests: 11 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: CF376DA088972BC6A64A46433C0CA776
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: FDAA0664F3A08F4EDE33B7450B0CC55B
Requests: 2 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Frame ID: 8C3DBE6E76C1568597B12B3E05B89348
Requests: 9 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=8019747248&adk=2858904547&adf=776189472&pi=t.ma~as.8019747248&w=300&lmt=1707851118&format=300x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117777&bpp=3&bdt=295&idt=513&shv=r20240208&mjsv=m202402060101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1884187684&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1044&ady=3761&biw=1600&bih=1200&isw=300&ish=600&ifk=4249166667&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808397%2C31081025%2C95324580%2C31080971%2C95320377%2C95320869%2C95324154%2C95324161&oid=2&pvsid=307981162515100&tmod=421356643&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C600&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.o94h2j1to9k1&btvi=1&fsb=1&dtd=721
Frame ID: 24893C7E1794656FF82305F0785B2935
Requests: 1 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?s=197137&cb=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D57%26uid%3D
Frame ID: 99657F76D7EC6AB74FB5BFC11449E4D6
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html?p=12776
Frame ID: 932E0E2C2ABECF74152C1197B1D66B97
Requests: 3 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=90&slotname=9974430123&adk=1204186157&adf=776189473&pi=t.ma~as.9974430123&w=728&lmt=1707851118&format=728x90&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117978&bpp=2&bdt=342&idt=474&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851119&ga_hid=2129080988&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=239&ady=5826&biw=1600&bih=1200&isw=728&ish=90&ifk=4189538061&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C31081034%2C44795922%2C95322745%2C95324581%2C31080970%2C95320376%2C95320869%2C95324154%2C95324161&oid=2&pvsid=1881542223134899&tmod=2045262062&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C728%2C90&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.kjv8pkvbffbo&btvi=1&fsb=1&dtd=823
Frame ID: E49CD81AD56465B10B6C21E4013C29A7
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: D2A7E0EE00E275CA9ECCEFDDD3AE7E47
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: D7795F36FBC78CB151DCACF92E23C76A
Requests: 2 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: E5BBDF134EF051F435419D94B6FCD40A
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: ED77C10108D4A1EB62C9A12DDBBDB17B
Requests: 2 HTTP requests in this frame

Frame: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Frame ID: 02ED69DDBA7BE9C2CDF099DFF2250F2B
Requests: 11 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Frame ID: 8BE6418972F33D3BBB009F636A6C477D
Requests: 7 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: 682362B5BA0904BD3878275BE46A0705
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: F606439B93FE5600F405529D8E3C57DC
Requests: 2 HTTP requests in this frame

Frame: https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDImdGw9MTI5NjAw&piggybackCookie=YDtbzodyBEeUV3z0b73LZQ
Frame ID: FC010B733721B56A58F6264CD10FD9B7
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDMmdGw9NDMyMDA=&piggybackCookie=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Frame ID: 100977EF4941ABFB157D1A7CAED352E8
Requests: 1 HTTP requests in this frame

Frame: https://ipac.ctnsnet.com/int/cm?exc=14&redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MTEmdGw9MjAxNjA=&piggybackCookie=[user_id]
Frame ID: 87BA1437AB380E8B336972E5733C7C60
Requests: 1 HTTP requests in this frame

Frame: https://matching.truffle.bid/sync/pub?sid=161&suid=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0NDQmdGw9MjAxNjA=&piggybackCookie=$UID
Frame ID: B026E79170706445EA481F6900E6362A
Requests: 1 HTTP requests in this frame

Frame: https://core.iprom.net/cookiesync?gdpr=0&gdpr_consent=
Frame ID: 39D49224D41DDBEDF75DD0A15F99864A
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw&piggybackCookie=Q7611375191439378190
Frame ID: 5434D912A7B368313627417113BAA60F
Requests: 1 HTTP requests in this frame

Frame: https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjkzNiZ0bD00MzIwMA==&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67&gdpr=0&gdpr_consent=
Frame ID: C3CD4FCA96D7916DE83493C4245591EE
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: 9A418DC03C03AF28019BBCD07D21AAAE
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: 4761A39A25043E51E313009858B2ED79
Requests: 2 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Frame ID: 559DAA53E85081C69C0617A506E591BE
Requests: 8 HTTP requests in this frame

Frame: https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: 62850A8E6B3FFCD50509295ADA4C8F1F
Requests: 1 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: FCC64278B496C9D4F34109D001C7AA4A
Requests: 1 HTTP requests in this frame

Frame: https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1402230080&3rdpcid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: 950FBE9BD2C522BD17BAA061B6891047
Requests: 1 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: A2FBDFE097CFDF0508548DE738C917EB
Requests: 1 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: 7CDA2FDD8A2338040A33D9B351F1DE8C
Requests: 1 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Frame ID: 8112D27125DC19C627C3BA069BDF36C5
Requests: 1 HTTP requests in this frame

Frame: https://sync.smartadserver.com/getuid?url=https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1881119486&mi=10&csh=793790479;1486637409;1868283820;259151345&rnd=-474335130&pcid=[sas_uid]&cklb=1
Frame ID: 1888E9F8FE5A2E9C8E37A515579149E3
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

New Pain Medication Could Reinforce Crackdown on Prescription Opioids

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link rel=["']stylesheet["'] [^>]+/wp-(?:content|includes)/
  • /wp-(?:content|includes)/

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • consent\.cookiebot\.com

Overall confidence: 100%
Detected patterns
  • 2mdn\.net

Overall confidence: 100%
Detected patterns
  • //connect\.facebook\.([a-z]+)/[^/]*/[a-z]*\.js

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
  • kit\.fontawesome\.com/([0-9a-z]+).js

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/
  • 2mdn\.net

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • <!-- (?:End )?Google Tag Manager -->
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • cdn\.mouseflow\.com

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.openx\.net

Overall confidence: 100%
Detected patterns
  • adnxs\.com/[^"]*(?:prebid|/pb\.js)

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.pubmatic\.com

Overall confidence: 100%
Detected patterns
  • \.quantserve\.com/quant\.js

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.rubiconproject\.com

Overall confidence: 100%
Detected patterns
  • <link [^>]*href="[^"]+use\.typekit\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • \.scorecardresearch\.com/beacon\.js|COMSCORE\.beacon

Overall confidence: 100%
Detected patterns
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • jquery[.-]migrate(?:-([\d.]+))?(?:\.min)?\.js(?:\?ver=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • //cdn\.jsdelivr\.net/

Overall confidence: 100%
Detected patterns
  • /recaptcha/api\.js

Page Statistics

1004
Requests

78 %
HTTPS

29 %
IPv6

147
Domains

245
Subdomains

158
IPs

11
Countries

11152 kB
Transfer

27652 kB
Size

345
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 138
  • https://sb.scorecardresearch.com/b?c1=2&c2=23384447&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1707851114185&ns_c=UTF-8&cs_ucfr=&gdpr=0&gdpr_p1t=&gdpr_li=&gdpr_purps=&gdpr_pcc=&cs_cmp_nc=0&cs_cmp_id=134&cs_cmp_sv=1&cs_cmp_rt=0&c7=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&c8=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=23384447&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1707851114185&ns_c=UTF-8&cs_ucfr=&gdpr=0&gdpr_p1t=&gdpr_li=&gdpr_purps=&gdpr_pcc=&cs_cmp_nc=0&cs_cmp_id=134&cs_cmp_sv=1&cs_cmp_rt=0&c7=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&c8=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&c9=
Request Chain 141
  • https://freestar-io.videoplayerhub.com/gallery.js HTTP 301
  • https://btloader.com/tag?h=freestar-io&upapi=true
Request Chain 149
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&secure=1&dpi=1434517136&rnd=610716&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&tsrnd=846_1707851114483&vrref=reason.com&jsver=5.4&abtp=95&abtg=A HTTP 302
  • https://sync1.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&secure=1&dpi=1434517136&rnd=610716&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&tsrnd=846_1707851114483&vrref=reason.com&jsver=5.4&abtp=95&abtg=A&ckls=true&ci=fbozg6sENr&nc=false&trid=1064888933
Request Chain 156
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Freason.com%2F&domain=reason.com&cw=1&lsw=1&us_privacy=1--- HTTP 302
  • https://mug.criteo.com/sid?cpp=-EjHAHxTdDFTSzAydTNqQTNCbThrNHJHTlErNFgxTDBUaHhVaG9FUUgxdG82enFOUDBKU294blJFd3R6dnl0aEl4ZlM3clF0SnhNMEliT1gxYjFKUldEdDFmUVI1L1U4b01zVExNZkNkM2UwNWJ2TFNvU3hoVWpIaEozOFE2cWhTdVpaSVpMOThhVGRVWlJLQ1RxbUpBZkFTQnF0MzVNbk85L1Y1Q3c4eHRpb0xlTEkweHNFc1EvdERHOXUvKzhhOVhlZ05TNkR3MkZDREtBaXphRzNYYVZyc3ZqZVNOeUczcHlTTFJxWTg2dWE2RUUwPXw&cppv=2
Request Chain 162
  • https://rp.liadm.com/j?dtstmp=1707851114691&se=e30&duid=5cd525e6f15c--01hphxqsz7bxsvc6fz7hzwzwbd&tv=v2.13.1&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&us_privacy=1---&wpn=lc-bundle&gdpr=0&cd=.reason.com HTTP 302
  • https://rp4.liadm.com/j?se=e30&cd=.reason.com&dtstmp=1707851114691&tv=v2.13.1&n3pc=true&wpn=lc-bundle&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&duid=5cd525e6f15c--01hphxqsz7bxsvc6fz7hzwzwbd&gdpr=0&i6=MjYwMjpmZmM4OjI6MTA0OjoxNA%3D%3D&us_privacy=1---
Request Chain 203
  • https://oajs.openx.net/esp?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&rid=esp HTTP 302
  • https://oajs.openx.net/esp?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&rid=esp&cc=1
Request Chain 209
  • https://ap.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID HTTP 302
  • https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID HTTP 302
  • https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Request Chain 211
  • https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain HTTP 302
  • https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&dcc=t
Request Chain 244
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&adnxs_id=$UID&gdpr=0 HTTP 307
  • https://secure.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fmatch%3Fid%3DAU1D-0100-001707851115-UJS0TXCA-MOGT%26adnxs_id%3D%24UID%26gdpr%3D0 HTTP 302
  • https://ids.ad.gt/api/v1/match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&adnxs_id=5872803529851156248&gdpr=0
Request Chain 245
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&ttd_puid=AU1D-0100-001707851115-UJS0TXCA-MOGT&gdpr=0 HTTP 302
  • https://ids.ad.gt/api/v1/t_match?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
Request Chain 246
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3DAU1D-0100-001707851115-UJS0TXCA-MOGT HTTP 302
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3DAU1D-0100-001707851115-UJS0TXCA-MOGT HTTP 302
  • https://ids.ad.gt/api/v1/pbm_match?pbm=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
Request Chain 248
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3185&partner_device_id=AU1D-0100-001707851115-UJS0TXCA-MOGT&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001707851115-UJS0TXCA-MOGT%26tapad_id%3D%24%7BTA_DEVICE_ID%7D HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive/check?partner_id=3185&partner_device_id=AU1D-0100-001707851115-UJS0TXCA-MOGT&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001707851115-UJS0TXCA-MOGT%26tapad_id%3D%24%7BTA_DEVICE_ID%7D HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=tapad&ttd_tpi=1&ttd_puid=2af5462b-1213-435d-a332-7e55bb465ba1%252Chttps%25253A%25252F%25252Fids.ad.gt%25252Fapi%25252Fv1%25252Ftapad_match%25253Fid%25253DAU1D-0100-001707851115-UJS0TXCA-MOGT%252526tapad_id%25253D2af5462b-1213-435d-a332-7e55bb465ba1%252C&gdpr=0&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=1830&partner_device_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttd_puid=2af5462b-1213-435d-a332-7e55bb465ba1%2Chttps%253A%252F%252Fids.ad.gt%252Fapi%252Fv1%252Ftapad_match%253Fid%253DAU1D-0100-001707851115-UJS0TXCA-MOGT%2526tapad_id%253D2af5462b-1213-435d-a332-7e55bb465ba1%2C HTTP 302
  • https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&tapad_id=2af5462b-1213-435d-a332-7e55bb465ba1
Request Chain 249
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=AU1D-0100-001707851115-UJS0TXCA-MOGT HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm=&google_sc=&google_ula=450542624&id=AU1D-0100-001707851115-UJS0TXCA-MOGT&google_tc= HTTP 302
  • https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&google_gid=CAESEPzb4p0T24zu1LnzTsnp6kc&google_cver=1&google_ula=450542624,0
Request Chain 250
  • https://ids.ad.gt/api/v1/g_hosted?id=AU1D-0100-001707851115-UJS0TXCA-MOGT HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcwNzg1MTExNS1VSlMwVFhDQS1NT0dU
Request Chain 251
  • https://bh.contextweb.com/bh/rtset?pid=562316&ev=1&rurl=https://ids.ad.gt/api/v1/ppnt_match?uid=%%VGUID%%&id=AU1D-0100-001707851115-UJS0TXCA-MOGT HTTP 302
  • https://ids.ad.gt/api/v1/ppnt_match?uid=AwN5CTqy8JaW&ev=1&pid=562316&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
Request Chain 252
  • https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&uid=[UID]&gdpr=0 HTTP 302
  • https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8&gdpr=0
Request Chain 253
  • https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3DAU1D-0100-001707851115-UJS0TXCA-MOGT%26auid%3DAU1D-0100-001707851115-UJS0TXCA-MOGT HTTP 302
  • https://ids.ad.gt/api/v1/openx?openx_id=55726421-b4c2-4a03-913d-bd46c253e40c&id=AU1D-0100-001707851115-UJS0TXCA-MOGT&auid=AU1D-0100-001707851115-UJS0TXCA-MOGT
Request Chain 293
  • https://pixel-eu.rubiconproject.com/exchange/sync.php?p=sovrn-onscroll&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
Request Chain 294
  • https://match.prod.bidr.io/cookie-sync/svr?gdpr=0&gdpr_consent= HTTP 303
  • https://match.prod.bidr.io/cookie-sync/svr?gdpr=0&gdpr_consent=&_bee_ppp=1 HTTP 303
  • https://ce.lijit.com/merge?3pid=AACJ-U7Ll3sAABJaNC07Nw&pid=85&gdpr=0
Request Chain 295
  • https://aorta.clickagy.com/pixel.gif?ch=185&cm=IJ_5ATZHwpxocGP7SR6BzHWi&redir=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D84%263pid%3D%7Bvisitor_id%7D&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=84&3pid=Zcu9a11ZdSrn6UNLg9dcZUK2
Request Chain 296
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D92%263pid%3D%24UID&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=92&3pid=5872803529851156248&gdpr=0&gdpr_consent=
Request Chain 297
  • https://ap.lijit.com/dsp/google/cookiematch/beacon?gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=sovrn&google_hm=SUpfNUFUWkh3cHhvY0dQN1NSNkJ6SFdp&gdpr=0 HTTP 302
  • https://s0.2mdn.net/dot.gif?gdpr=0
Request Chain 298
  • https://cs.krushmedia.com/77781087eb9a0621642f9ebec6beb8d1.gif?puid=[UID]&redir=[RED]&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=102&3pid=dc0e4bdf-ffd5-524d-91f0-2def249454e7
Request Chain 299
  • https://data.adsrvr.org/track/cmf/generic?ttd_pid=federatedmedia&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=27&3pid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Request Chain 300
  • https://x.bidswitch.net/sync?ssp=fmx&us_privacy=&gdpr=0&gdpr_consent= HTTP 302
  • https://x.bidswitch.net/ul_cb/sync?ssp=fmx&us_privacy=&gdpr=0&gdpr_consent= HTTP 302
  • https://a.sportradarserving.com/sync?ssp=bidswitch&bidswitch_ssp_id=fmx HTTP 302
  • https://a.sportradarserving.com/ul_cb/sync?ssp=bidswitch&bidswitch_ssp_id=fmx HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=409&expires=14&user_group=1&user_id=f760379d-b183-47ed-b2a7-c21c03c4c07f&ssp=fmx HTTP 302
  • https://ce.lijit.com/merge?pid=26&3pid=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
Request Chain 305
  • https://match.adsrvr.org/track/cmf/openx?oxid=7c327d44-3d4e-75ff-c2c6-a916d52c2b08&gdpr=0 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072971&val=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttd_puid=7c327d44-3d4e-75ff-c2c6-a916d52c2b08&gdpr=0&gdpr_consent=
Request Chain 307
  • https://cm.g.doubleclick.net/pixel?google_nid=openx&google_cm&google_sc HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072991&val=CAESEIZYjK_RxRK9hUANxYMxXHM&google_cver=1
Request Chain 326
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dmediagrid.com%26id%3D%24%7BBSW_UUID%7D?gdpr=0 HTTP 302
  • https://x.bidswitch.net/ul_cb/check_uuid/https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dmediagrid.com%26id%3D%24%7BBSW_UUID%7D?gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=mediagrid.com&id=d9962442-c73f-42a4-adbd-3d9517e387ff
Request Chain 327
  • https://sync.1rx.io/usersync2/rmpssp?sub=amazon&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drhythmone.com%26id%3D%5BRX_UUID%5D&gdpr=0 HTTP 302
  • https://sync.1rx.io/usersync2/rmpssp?sub=amazon&zcc=1&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drhythmone.com%26id%3D%5BRX_UUID%5D&cb=1707851115540 HTTP 302
  • https://ad.turn.com/r/cs?pid=45&rndcb=859521100 HTTP 302
  • https://sync.1rx.io/usersync/turn/7546153649458771999?dspret=1&gdpr=&gdpr_consent=&us_privacy= HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fcs.yellowblue.io%2Fcs%3Faid%3D11599%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005 HTTP 302
  • https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Request Chain 328
  • https://cs.media.net/cksync?cs=31&type=tam&redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dmedia.net%26id%3D%3Cvsid%3E&gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=media.net&id=3508527156634894000V10
Request Chain 329
  • https://s.ad.smaato.net/c/?adExInit=aps&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsmaato.com%26id%3D%24UID HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
Request Chain 331
  • https://um.simpli.fi/amazon/https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsimpli.fi%26id%3D?gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=0E087FD3E115403AB68AFF630D65CE67&ex=simpli.fi&status=ok
Request Chain 332
  • https://trace.mediago.io/ju/cs/amazon?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dbaidu.com%26id%3D%24UID&gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=baidu.com&id=cb83d64ba58ceca72i1qs500lskqgimc
Request Chain 333
  • https://jadserve.postrelease.com/suid/101959?ntv_r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dnativo.com%26id%3DNTV_USER_ID&gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
Request Chain 334
  • https://b1sync.zemanta.com/usersync/amazon_tam/?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Doutbrain.com%26id%3D__ZUID__&gdpr=0 HTTP 302
  • https://b1sync.zemanta.com/usersync/amazon_tam/?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Doutbrain.com%26id%3D__ZUID__&gdpr=0&s=2 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=outbrain.com&id=KtRUPppSGbtrONLvGe1I&gdpr=0
Request Chain 341
  • https://ssum-sec.casalemedia.com/usermatch?s=192259&cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0 HTTP 302
  • https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Request Chain 343
  • https://sync.inmobi.com/TAM?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dinmobi.com%26id%3D%7BID5UID%7D&gdpr=0 HTTP 302
  • https://id5-sync.com/i/495/0.gif?gdpr_consent=&gdpr=0&callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dinmobi.com%26id%3D%7BID5UID%7D HTTP 302
  • https://id5-sync.com/c/495/0/0/1.gif?gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=inmobi.com&id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ
Request Chain 349
  • https://ups.analytics.yahoo.com/ups/58251/sync?redir=true&gdpr=0 HTTP 302
  • https://ups.analytics.yahoo.com/ups/58251/sync?redir=true&gdpr=0&verify=true HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=vmg.com&id=eS0yb2pFVWpsRTJ1SXZ6bVVEVXpJVWhqOFdPOUZMVnNRWH5B&gdpr=0
Request Chain 350
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid=%24UID&ex=appnexus.com&gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=5872803529851156248&ex=appnexus.com&gdpr=0
Request Chain 351
  • https://ap.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0 HTTP 302
  • https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Request Chain 353
  • https://eb2.3lift.com/getuid?redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3D3lift.com%26id%3D%24UID&gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=3lift.com&id=3900114537385664774839
Request Chain 375
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fid.rlcdn.com%2F464246.gif%3Fpartner_uid%3D%7BOPENX_ID%7D HTTP 302
  • https://id.rlcdn.com/464246.gif?partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0 HTTP 307
  • https://id.rlcdn.com/1000.gif?memo=CPaqHBIvCisIARCUaxokMjlmNDAyMjItZjAwOS00MzlmLTlkYmYtMjllNWVjYjc0YWQwEAAaDQjr-q6uBhIFCOgHEABCAEoA HTTP 307
  • https://pippio.com/api/sync?pid=5324&it=1&iv=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&_=2 HTTP 307
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&rand=09785719 HTTP 302
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&rand=09785719&expected_cookie=5142ff3e-55fd-44a6-8078-9b6797d9b068
Request Chain 376
  • https://ib.adnxs.com/getuid?https://us-u.openx.net/w/1.0/sd?id=537072399&val=$UID HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
Request Chain 377
  • https://ad.turn.com/r/cs?pid=9&gdpr=0 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537073061&val=7762326431572555807&gdpr=0&gdpr_consent=&us_privacy=
Request Chain 378
  • https://sync-tm.everesttech.net/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D&_test=Zcu9awAEo_sMqwA9 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537148856&val=Zcu9awAEo_sMqwA9&_test=Zcu9awAEo_sMqwA9
Request Chain 381
  • https://u.openx.net/w/1.0/cm?gdpr=0&gdpr_consent=&id=476b50d3-5ccf-49a1-89b8-1ddf8ea18042&r=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26gdpr%3D0%26gdpr_consent%3D%26advId%3D98%26advUuid%3D HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&gdpr=0&gdpr_consent=&advId=98&advUuid=8b979bf4-7108-4d0c-86a3-3f353964681d HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1486637409&3rdpcid=8b979bf4-7108-4d0c-86a3-3f353964681d
Request Chain 387
  • https://x.bidswitch.net/sync?ssp=sekindo&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=bidswitch_dbm&google_cm&google_sc&ssp=sekindo&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff&google_hm=ZDk5NjI0NDItYzczZi00MmE0LWFkYmQtM2Q5NTE3ZTM4N2Zm&gdpr_consent= HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=16&user_id=CAESEMvaNv_sL-gZ1_dJLOVICn8&google_cver=1&ssp=sekindo&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr_consent= HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=92&advUuid=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1267919208&3rdpcid=d9962442-c73f-42a4-adbd-3d9517e387ff
Request Chain 388
  • https://csync.loopme.me/?pubid=11280&gdpr=0&gdpr_consent=&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D93%26advUuid%3D%7Bviewer_token%7D HTTP 307
  • https://live.primis.tech/live/liveCS.php?source=external&advId=93&advUuid=0b6623f9-af2d-4f76-abfc-fd031a91112a&gdpr_consent=null&gdpr=0 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=417208643&3rdpcid=0b6623f9-af2d-4f76-abfc-fd031a91112a
Request Chain 389
  • https://ssum-sec.casalemedia.com/usermatchredir?s=191923&gdpr=0&gdpr_consent=&cb=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D99%26advUuid%3D HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=99&advUuid=Zcu9a9HM518AACyiADNVcgAA%261404 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2120880633&3rdpcid=Zcu9a9HM518AACyiADNVcgAA%261404
Request Chain 390
  • https://eb2.3lift.com/getuid?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D121%26advUuid%3D%24UID HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=121&advUuid=3900114537385664774839 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=259151345&3rdpcid=3900114537385664774839
Request Chain 391
  • https://pixel.rubiconproject.com/exchange/sync.php?p=primis&gdpr=0&gdpr_consent= HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=100&advUuid=LSKQGI85-W-KKFE&gdpr=0 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
Request Chain 392
  • https://ups.analytics.yahoo.com/ups/58818/sync?redir=true&gdpr=0&gdpr_consent= HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=128&advUuid=y-9LUtz7BE2uLaJKxLoxHd_hmxqhtRQhYE~A HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1028935272&3rdpcid=y-9LUtz7BE2uLaJKxLoxHd_hmxqhtRQhYE~A
Request Chain 393
  • https://mb9eo.publishers.tremorhub.com/pubsync?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D126%26advUuid%3D%5Btvid%5D HTTP 302
  • https://mb9eo.publishers.tremorhub.com/pubsync/verify?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D126%26advUuid%3D%5Btvid%5D HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=126&advUuid=5e680dc7fc904e3fb6284f51d34504d2 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=584182936&3rdpcid=5e680dc7fc904e3fb6284f51d34504d2
Request Chain 394
  • https://cs.media.net/cksync?gdpr=0&gdpr_consent=&cs=34&type=pri&ovsid=65cbbd6ab7b01&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D127%26advUuid%3D%3Cvsid%3E HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=127&advUuid=3508527156634803000V10 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1723987475&3rdpcid=3508527156634803000V10
Request Chain 395
  • https://ap.lijit.com/pixel?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D130%26advUuid%3D%24UID HTTP 307
  • https://live.primis.tech/live/liveCS.php?source=external&advId=130&advUuid=IJ_5ATZHwpxocGP7SR6BzHWi HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=396218182&3rdpcid=IJ_5ATZHwpxocGP7SR6BzHWi
Request Chain 396
  • https://ads.stickyadstv.com/user-matching?id=3586&gdpr=0&gdpr_consent= HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=134&advUuid=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=484859127&3rdpcid=1a414bb82571872ecee8edf55b15cd6
Request Chain 397
  • https://cs.admanmedia.com/3613a31b6329d1c17d5663d05b080db1.gif?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D138%26advUuid%3D%5BUID%5D HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=138&advUuid=ffc0228e-35bf-459d-a326-8230f6a4c437 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2136778551&3rdpcid=ffc0228e-35bf-459d-a326-8230f6a4c437
Request Chain 398
  • https://ssbsync-global.smartadserver.com/api/sync?callerId=21&redirectUri=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D140%26advUuid%3D%5Bssb_sync_pid%5D&gdpr=0&gdpr_consent= HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=140&advUuid=4519564549645433089 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1881119486&3rdpcid=4519564549645433089
Request Chain 400
  • https://match.sharethrough.com/universal/v1?supply_id=Wog2sp89&gdpr=0&gdpr_consent= HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=144&advUuid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2011327056&3rdpcid=c4cec5b2-acca-415c-b738-7e079be8bf78
Request Chain 401
  • https://sync.1rx.io/usersync2/rmpssp?sub=primis&gdpr=0&gdpr_consent= HTTP 302
  • https://ad.turn.com/r/cs?pid=45&rndcb=3297467625 HTTP 302
  • https://sync.1rx.io/usersync/turn/7690268837534627871?dspret=1&gdpr=&gdpr_consent=&us_privacy= HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fcs.yellowblue.io%2Fcs%3Faid%3D11599%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005 HTTP 302
  • https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Request Chain 402
  • https://sync.cootlogix.com/api/user/pixel/?redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D151%26advUuid%3D%24%7BuserId%7D HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=151&advUuid=24574e43-b065-4246-847d-dec6b8b086ac HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=793790479&3rdpcid=24574e43-b065-4246-847d-dec6b8b086ac
Request Chain 411
  • https://cm.g.doubleclick.net/pixel?google_nid=contextweb&google_cm&google_sc&google_hm=c1l2WnRTNmx1ZkREdWNGWW9ZVWpMUQ&gdpr=0&gdpr_consent= HTTP 302
  • https://bh.contextweb.com/bh/rtset?do=add&pid=547259&gdpr=0&gdpr_consent=&ev=CAESEGPGX-NNcdPvBzb0KNcn4Mk&google_cver=1
Request Chain 412
  • https://pulsepoint-match.dotomi.com/match/bounce/current?networkId=14200&version=1&nuid=&gdpr=0&gdpr_consent= HTTP 302
  • https://pulsepoint-match.dotomi.com/match/bounce/current?DotomiTest=77059b99cd5a135c&is_secure=true&networkId=14200&version=1&nuid=&gdpr=0&gdpr_consent= HTTP 302
  • https://bh.contextweb.com/bh/rtset?do=add&pid=530912&ev=AAAHhC0Y0d4HmAN_KBF7AAAAAAA&expiration=1707937515&nuid=&is_secure=true&gdpr_consent=&gdpr=0
Request Chain 416
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fid.rlcdn.com%2F464246.gif%3Fpartner_uid%3D%7BOPENX_ID%7D HTTP 302
  • https://id.rlcdn.com/464246.gif?partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0 HTTP 307
  • https://id.rlcdn.com/1000.gif?memo=CPaqHBIvCisIARCUaxokMjlmNDAyMjItZjAwOS00MzlmLTlkYmYtMjllNWVjYjc0YWQwEAAaDQjr-q6uBhIFCOgHEABCAEoA HTTP 307
  • https://pippio.com/api/sync?pid=5324&it=1&iv=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&_=2 HTTP 307
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&rand=01168948 HTTP 302
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&rand=01168948&expected_cookie=8faa3b5d-ddf0-4250-b703-53eec813505a
Request Chain 417
  • https://ib.adnxs.com/getuid?https://us-u.openx.net/w/1.0/sd?id=537072399&val=$UID HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
Request Chain 418
  • https://ad.turn.com/r/cs?pid=9&gdpr=0 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537073061&val=3510928383334807583&gdpr=0&gdpr_consent=&us_privacy=
Request Chain 419
  • https://sync-tm.everesttech.net/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D&_test=Zcu9awAB77y1BQBj
Request Chain 436
  • https://um.simpli.fi/lj_match?r=1707851115563&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=2&3pid=0E087FD3E115403AB68AFF630D65CE67
Request Chain 437
  • https://ap.lijit.com/dsp/google/cookiematch/dv?gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=lijit_dbm&google_hm=SUpfNUFUWkh3cHhvY0dQN1NSNkJ6SFdp&gdpr=0
Request Chain 438
  • https://t.adx.opera.com/pub/sync?pubid=pub10014056052800&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?3pid=OPUab1645795b4b463ba93cb19748df0468&gdpr=0&gdpr_consent=&pid=103
Request Chain 439
  • https://sync.1rx.io/usersync2/rmpssp?sub=sovrn&gdpr=0&gdpr_consent= HTTP 302
  • https://ad.turn.com/r/cs?pid=45&rndcb=4039413653 HTTP 302
  • https://sync.1rx.io/usersync/turn/4374775086859810847?dspret=1&gdpr=&gdpr_consent=&us_privacy= HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fads.yieldmo.com%2Fv000%2Fsync%3Fpn_id%3Dunl%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005 HTTP 302
  • https://ads.yieldmo.com/v000/sync?pn_id=unl&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Request Chain 440
  • https://pixel-eu.rubiconproject.com/exchange/sync.php?p=sovrn-onscroll&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
Request Chain 442
  • https://sync.1rx.io/usersync2/rmpssp?sub=typeaholdings HTTP 302
  • https://ad.turn.com/r/cs?pid=45&rndcb=8651849632 HTTP 302
  • https://sync.1rx.io/usersync/turn/4374775086859810847?dspret=1&gdpr=&gdpr_consent=&us_privacy= HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fcs.yellowblue.io%2Fcs%3Faid%3D11599%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005 HTTP 302
  • https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Request Chain 443
  • https://us-u.openx.net/w/1.0/cm?id=58ceaaf5-c766-4c17-869a-d76e43401714&gdpr=0&gdpr_consent=&r=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11563%26id%3D HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
Request Chain 444
  • https://ads.stickyadstv.com/user-matching?id=3663&gdpr=0&gdpr_consent= HTTP 302
  • https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
Request Chain 445
  • https://match.sharethrough.com/universal/v1?supply_id=5926d422&gdpr=0&gdpr_consent= HTTP 302
  • https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
Request Chain 446
  • https://ssbsync.smartadserver.com/api/sync?callerId=77&gdpr=0&gdpr_consent= HTTP 302
  • https://cs.yellowblue.io/cs?aid=11600&id=8379257319880423754&gdpr=0&gdpr_consent=
Request Chain 447
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160295&gdpr=0&gdpr_consent=&pu=https%3A%2F%2Fcs.openwebmedia.org%2Fcs%3Faid%3D40020%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26id%3D$UID%3Faid%3D11576%26id%3D%23PMUID HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_hm=QTg5MDNCRUYtQkZCOS00M0FFLThCQjUtQjVBNjhCOUJBRTIw&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjImdGw9MTI5NjAw&gdpr=0&gdpr_consent= HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_cm&google_sc&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTIxNzcmdGw9MTI5NjAw&gdpr=0&gdpr_consent=&piggybackCookie=CAESEN_nfYU13Hor5J3C_uXar3w&google_cver=1 HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 448
  • https://ads.yieldmo.com/pbsync?is=rise&gdpr=0&gdpr_consent=&us_privacy=&redirectUri=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11584%26uid%3D$UID HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
Request Chain 450
  • https://csync.loopme.me/?pubid=11362&gdpr=0&gdpr_consent=&redirect=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11571%26id%3D%7Bdevice_id%7D HTTP 307
  • https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=3d50f1a1-1ac2-4748-94af-adfbb97c9078&gdpr_consent=null&gdpr=0
Request Chain 451
  • https://sync.go.sonobi.com/us?gdpr=0&consent_string=&loc=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D115667%26uid%3D%5BUID%5D HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
Request Chain 452
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11596%26id%3D$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
Request Chain 453
  • https://bh.contextweb.com/bh/rtset?pid=562615&ev=1&us_privacy=[US_PRIVACY]&gdpr=0&gdpr_consent=&rurl=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11592%26uid%3D%25%25VGUID%25%25 HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
Request Chain 454
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11603%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26uid%3D$%7BBSW_UUID%7D HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
Request Chain 455
  • https://ssc-cms.33across.com/ps/?ri=0015a00002hdV5tAAE&ru=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11580%26puid%3D33XUSERID33X HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212319511635068
Request Chain 461
  • https://ssbsync.smartadserver.com/api/sync?callerId=77&gdpr=0&gdpr_consent= HTTP 302
  • https://cs.yellowblue.io/cs?aid=11600&id=5722876075152800063&gdpr=0&gdpr_consent=
Request Chain 462
  • https://bh.contextweb.com/bh/rtset?pid=562615&ev=1&us_privacy=[US_PRIVACY]&gdpr=0&gdpr_consent=&rurl=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11592%26uid%3D%25%25VGUID%25%25 HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
Request Chain 463
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11596%26id%3D$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
Request Chain 464
  • https://sync.go.sonobi.com/us?gdpr=0&consent_string=&loc=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D115667%26uid%3D%5BUID%5D HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
Request Chain 465
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160295&gdpr=0&gdpr_consent=&pu=https%3A%2F%2Fcs.openwebmedia.org%2Fcs%3Faid%3D40020%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26id%3D$UID%3Faid%3D11576%26id%3D%23PMUID HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_hm=QTg5MDNCRUYtQkZCOS00M0FFLThCQjUtQjVBNjhCOUJBRTIw&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjImdGw9MTI5NjAw&gdpr=0&gdpr_consent= HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_cm&google_sc&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTIxNzcmdGw9MTI5NjAw&gdpr=0&gdpr_consent=&piggybackCookie=CAESEN_nfYU13Hor5J3C_uXar3w&google_cver=1 HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 466
  • https://sync.1rx.io/usersync2/rmpssp?sub=typeaholdings HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adconductor&ttd_tpi=1&rndcb=1765159388 HTTP 302
  • https://sync.1rx.io/usersync/tradedesk/29aab174-fe91-4ad7-aa56-1d4732cc27d2 HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Request Chain 467
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11603%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26uid%3D$%7BBSW_UUID%7D HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
Request Chain 468
  • https://ads.stickyadstv.com/user-matching?id=3663&gdpr=0&gdpr_consent= HTTP 302
  • https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
Request Chain 469
  • https://ssc-cms.33across.com/ps/?ri=0015a00002hdV5tAAE&ru=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11580%26puid%3D33XUSERID33X HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212462896368674
Request Chain 470
  • https://ads.yieldmo.com/pbsync?is=rise&gdpr=0&gdpr_consent=&us_privacy=&redirectUri=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11584%26uid%3D$UID HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
Request Chain 471
  • https://csync.loopme.me/?pubid=11362&gdpr=0&gdpr_consent=&redirect=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11571%26id%3D%7Bdevice_id%7D HTTP 307
  • https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=f4a07ad1-72ff-47b5-b780-dd4a5ffcb469&gdpr_consent=null&gdpr=0
Request Chain 472
  • https://match.sharethrough.com/universal/v1?supply_id=5926d422&gdpr=0&gdpr_consent= HTTP 302
  • https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
Request Chain 473
  • https://us-u.openx.net/w/1.0/cm?id=58ceaaf5-c766-4c17-869a-d76e43401714&gdpr=0&gdpr_consent=&r=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11563%26id%3D HTTP 302
  • https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
Request Chain 474
  • https://live.primis.tech/live/liveCS.php?source=external&advId=150&advUuid=c0YoKqF-kj_s HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1660370273&3rdpcid=c0YoKqF-kj_s
Request Chain 476
  • https://bh.contextweb.com/bh/rtset?pid=561118&ev=1&rurl=https%3a%2f%2fads.yieldmo.com/v000/sync?userid=%%VGUID%%&pn_id=pp&gdpr=0&gdpr_consent=&gpp=&gpp_sid=&us_privacy= HTTP 302
  • https://ads.yieldmo.com/v000/sync?userid=AwN5CTqy8JaW&ev=1&pn_id=pp&gpp_sid=&gpp=&us_privacy=&pid=561118&gdpr_consent=&gdpr=0
Request Chain 477
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160648&gdpr=&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D160648%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fsync-pm.ads.yieldmo.com%252Fsync%253Fpn_id%253Dpub%2526id%253D%2523PMUID%2526gdpr%253DPM_GDPR%2526gdpr_consent%253DPM_CONSENT HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_hm=QTg5MDNCRUYtQkZCOS00M0FFLThCQjUtQjVBNjhCOUJBRTIw&gdpr=-1&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjImdGw9MTI5NjAw&gdpr=-1&gdpr_consent= HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_cm&google_sc&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTIxNzcmdGw9MTI5NjAw&gdpr=0&gdpr_consent=&piggybackCookie=CAESEN_nfYU13Hor5J3C_uXar3w&google_cver=1 HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 478
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=yieldmo&ttd_tpi=1&ttd_puid=V_ZrZhhNNrh6QBoKLRmb HTTP 302
  • https://ads.yieldmo.com/v000/sync?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
Request Chain 479
  • https://pixel-us-east.rubiconproject.com/exchange/sync.php?p=yieldmo HTTP 302
  • https://ads.yieldmo.com/sync?pn_id=rc&id=LSKQGI85-W-KKFE
Request Chain 480
  • https://sync.1rx.io/usersync2/rmpssp?sub=yieldmo&redir%3Dhttps%3A%2F%2Fads.yieldmo.com%2Fv000%2Fsync%3Fpn_id%3Dunl%26id%3D%5BRX_UUID%5D HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adconductor&ttd_tpi=1&rndcb=4923233477 HTTP 302
  • https://sync.1rx.io/usersync/tradedesk/29aab174-fe91-4ad7-aa56-1d4732cc27d2 HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Request Chain 482
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sharethrough&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Request Chain 483
  • https://cm.g.doubleclick.net/pixel?google_nid=sharethrough_ob&gdpr=0&gdpr_consent=&google_hm=MDUxZDMxOWYtMDVkOS00OWIzLWE4NDUtNTRiYWY1Mzc1MDM5 HTTP 302
  • https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
Request Chain 484
  • https://secure.adnxs.com/getuid?https://match.sharethrough.com/sync/v1?source_id=0e8893f90b606c9c5d33f1be&gdpr=0&gdpr_consent=&source_user_id=$UID HTTP 302
  • https://match.sharethrough.com/sync/v1?source_id=0e8893f90b606c9c5d33f1be&gdpr=0&gdpr_consent=&source_user_id=5872803529851156248
Request Chain 485
  • https://pr-bh.ybp.yahoo.com/sync/sharethrough/051d319f-05d9-49b3-a845-54baf5375039?gdpr=0&gdpr_consent= HTTP 302
  • https://match.sharethrough.com/sync/v1?source_id=BVbSRuzbUWjBEF6bQrmLHKkX&source_user_id=y-uzf.KHtE2oPgQ257v8MZ3adVdk1Kfc57.YRD7UdYU3Z0~A
Request Chain 486
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=Zcu9a9HM518AACyiADNVcgAA HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEJ3BObNizToNa40yYTsJ3eA&google_cver=1
Request Chain 487
  • https://i.liadm.com/s/31327?bidder_id=14481&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpdr=&gdpr_consent=&us_privacy=&gpp=&gpp_sid= HTTP 303
  • https://dis.criteo.com/dis/usersync.aspx?r=77&p=311&cp=liveintent&cu=1&url=https://i.liadm.com/s/28292?bidder_id%3D71340%26bidder_uuid%3D@@CRITEO_USERID@@
Request Chain 488
  • https://cm.g.doubleclick.net/pixel?google_nid=index&google_cm&google_hm=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gdpr_consent=&us_privacy=&gdpr=&gpp=&gpp_sid= HTTP 302
  • https://ssum-sec.casalemedia.com/usermatchredir?s=184023&gdpr_consent=&gdpr=&gpp=&gpp_sid=&google_gid=CAESEI5VMbmiQ8Q_ck8VHxZdCxQ&google_cver=1
Request Chain 490
  • https://pm.w55c.net/ping_match.gif?ei=CASALE&rurl=https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=_wfivefivec_ HTTP 302
  • https://pm.w55c.net/ping_match.gif?scc=1&ei=CASALE&rurl=https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=_wfivefivec_ HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=MxnNt1pn1RzY5K5
Request Chain 491
  • https://cm.ctnsnet.com/int/cm?exc=19 HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=109&external_user_id=6a10bd53f5634c0fb38fae0ab355416f&expiration=1710443115
Request Chain 492
  • https://sync-tm.everesttech.net/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=88&external_user_id=Zcu9awAEo_sMqwA9
Request Chain 493
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1025&userId=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gdpr_consent=&us_privacy=&gdpr=&gpp=&gpp_sid= HTTP 302
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=1a414bb82571872ecee8edf55b15cd6&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7buser.id%7d%26gdpr%3d0%26gdpr_consent%3d&34673=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=umo2b61_7336290589884669966&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=MWE0MTRiYjgyNTcxODcyZWNlZThlZGY1NWIxNWNkNg==&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESEFi-tQfMO09Z5XfzkVg7EKU&google_cver=1&gdpr=0&gdpr_consent= HTTP 302
  • https://match.prod.bidr.io/cookie-sync/stv?gdpr=0&gdpr_consent= HTTP 303
  • https://ads.stickyadstv.com/user-registering?userId=AACJ-U7Ll3sAABJaNC07Nw&dataProviderId=817&gdpr=0 HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0 HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent= HTTP 302
  • https://pr-bh.ybp.yahoo.com/sync/stickyads/1a414bb82571872ecee8edf55b15cd6?gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=199&userId=y-YmhDCsJE2oNgqzhhd8VyfC8.i4uQsC6x5M_nkB9V~A HTTP 302
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D209%26userId%3D$UID%26gdpr%3D0%26gdpr_consent%3D HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=209&userId=5872803529851156248&gdpr=0&gdpr_consent= HTTP 302
  • https://pm.w55c.net/ping_match.gif?st=FREEWHEEL&rurl=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D593&userId=_wfivefivec_&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=593&userId=MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent= HTTP 302
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=stickyadstv&append=1&cb=8484622&redirect=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D690%26userId%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=690&userId=92a46392-4333-4e17-bc0c-e23a20ef4332 HTTP 302
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=103&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=721&userId=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent= HTTP 302
  • https://ad.turn.com/r/cs?pid=34&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=4374775086859810847&redirectID=0&gdpr=0&gdpr_consent=
Request Chain 496
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=rise_engage&endpoint=us-east HTTP 301
  • https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Request Chain 499
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=rise_engage&endpoint=us-east HTTP 301
  • https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Request Chain 539
  • https://ads.yieldmo.com/pbsync?gdpr=&gdpr_consent=&us_privacy=1---&redirectUri=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dyieldmo%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Di%26uid%3D%24UID HTTP 302
  • https://s2s.t13.io/setuid?bidder=yieldmo&gpp=&gpp_sid=&f=i&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=&gdpr_consent=&us_privacy=1---
Request Chain 568
  • https://pixel-us-east.rubiconproject.com/exchange/sync.php?p=a9us&gdpr=0&gdpr=0&khaos=LSKQGI85-W-KKFE HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
Request Chain 573
  • https://ib.adnxs.com/getuid?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTc4JnRsPTE1NzY4MDA=&piggybackCookie=$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTc4JnRsPTE1NzY4MDA=&piggybackCookie=5872803529851156248&gdpr=0&gdpr_consent=
Request Chain 574
  • https://cm.adgrx.com/bridge?AG_PID=pubmatic&AG_SETCOOKIE&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.adgrx.com/bridge.gif?AG_PID=pubmatic&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDEmdGw9MTI5NjAw&piggybackCookie=d2f37c96-caa2-11ee-a313-71f04e140079
Request Chain 575
  • https://match.prod.bidr.io/cookie-sync/pm?gdpr=0&gdpr_consent= HTTP 303
  • https://cm.g.doubleclick.net/pixel?google_nid=beeswaxio&google_sc=&google_hm=QUFDSi1VN0xsM3NBQUJKYU5DMDdOdw&gdpr=0&gdpr_consent=&bee_sync_partners=syn%2Cpp%2Csas%2Cpm&bee_sync_current_partner=adx&bee_sync_initiator=pm&bee_sync_hop_count=1 HTTP 302
  • https://match.prod.bidr.io/cookie-sync/adx?gdpr=0&gdpr_consent=&bee_sync_partners=syn%2Cpp%2Csas%2Cpm&bee_sync_current_partner=adx&bee_sync_initiator=pm&bee_sync_hop_count=1 HTTP 303
  • https://sync.technoratimedia.com/services?uid=AACJ-U7Ll3sAABJaNC07Nw&srv=cs&pid=73&cb=https%3A%2F%2Fmatch.prod.bidr.io%2Fcookie-sync%3Fgdpr%3D0%26bee_sync_partners%3Dpp%252Csas%252Cpm%26bee_sync_current_partner%3Dsyn%26bee_sync_initiator%3Dadx%26bee_sync_hop_count%3D2&gdpr=0 HTTP 307
  • https://match.prod.bidr.io/cookie-sync?gdpr=0&bee_sync_partners=pp%2Csas%2Cpm&bee_sync_current_partner=syn&bee_sync_initiator=adx&bee_sync_hop_count=2 HTTP 303
  • https://bh.contextweb.com/bh/rtset?ev=AACJ-U7Ll3sAABJaNC07Nw&do=add&pid=558502&rurl=https%3A%2F%2Fmatch.prod.bidr.io%2Fcookie-sync%3Fgdpr%3D0%26bee_sync_partners%3Dsas%252Cpm%26bee_sync_current_partner%3Dpp%26bee_sync_initiator%3Dadx%26bee_sync_hop_count%3D3&gdpr=0 HTTP 302
  • https://match.prod.bidr.io/cookie-sync?gdpr=0&bee_sync_partners=sas%2Cpm&bee_sync_current_partner=pp&bee_sync_initiator=adx&bee_sync_hop_count=3&ev=AACJ-U7Ll3sAABJaNC07Nw&pid=558502&do=add&gdpr=0 HTTP 303
  • https://rtb-csync.smartadserver.com/redir?partneruserid=AACJ-U7Ll3sAABJaNC07Nw&partnerid=127&redirurl=https%3A%2F%2Fmatch.prod.bidr.io%2Fcookie-sync%3Fgdpr%3D0%26gdpr%3D0%26bee_sync_partners%3Dpm%26bee_sync_current_partner%3Dsas%26bee_sync_initiator%3Dadx%26bee_sync_hop_count%3D4%26userid%3DSMART_USER_ID&gdpr=0 HTTP 302
  • https://match.prod.bidr.io/cookie-sync?gdpr=0&gdpr=0&bee_sync_partners=pm&bee_sync_current_partner=sas&bee_sync_initiator=adx&bee_sync_hop_count=4&userid=5722876075152800063&gdpr=0&gdpr_consent= HTTP 303
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyOTcmdGw9MTI5NjAw&piggybackCookie=AACJ-U7Ll3sAABJaNC07Nw&gdpr=0&gdpr_consent=
Request Chain 578
  • https://x.bidswitch.net/sync?ssp=pubmatic&gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://r.bidswitch.net/sync?bidswitch_ssp_id=pubmatic&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3205&partner_device_id=d9962442-c73f-42a4-adbd-3d9517e387ff&partner_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D393%26user_id%3D0%26ssp%3Dpubmatic%26bsw_param%3Dd9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://dpm.demdex.net/ibs:dpid=540&dpuuid=2af5462b-1213-435d-a332-7e55bb465ba1&redir=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DADB%26partner_device_id%3D%24%7BDD_UUID%7D%26pt%3D2af5462b-1213-435d-a332-7e55bb465ba1%252Chttps%25253A%25252F%25252Fx.bidswitch.net%25252Fsync%25253Fdsp_id%25253D393%252526user_id%25253D0%252526ssp%25253Dpubmatic%252526bsw_param%25253Dd9962442-c73f-42a4-adbd-3d9517e387ff%252C HTTP 302
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=540&dpuuid=2af5462b-1213-435d-a332-7e55bb465ba1&redir=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DADB%26partner_device_id%3D%24%7BDD_UUID%7D%26pt%3D2af5462b-1213-435d-a332-7e55bb465ba1%252Chttps%25253A%25252F%25252Fx.bidswitch.net%25252Fsync%25253Fdsp_id%25253D393%252526user_id%25253D0%252526ssp%25253Dpubmatic%252526bsw_param%25253Dd9962442-c73f-42a4-adbd-3d9517e387ff%252C HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=ADB&partner_device_id=11122778653877386402836073635137320709&pt=2af5462b-1213-435d-a332-7e55bb465ba1%2Chttps%253A%252F%252Fx.bidswitch.net%252Fsync%253Fdsp_id%253D393%2526user_id%253D0%2526ssp%253Dpubmatic%2526bsw_param%253Dd9962442-c73f-42a4-adbd-3d9517e387ff%2C HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=393&user_id=0&ssp=pubmatic&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9Mjk0NSZ0bD0xMjk2MDA=&piggybackCookie=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&gdpr_pd=&us_privacy=
Request Chain 579
  • https://pm.w55c.net/ping_match.gif?ei=PUBMATIC&rurl=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzQmdGw9MTI5NjAw&piggybackCookie=uid:_wfivefivec_&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzQmdGw9MTI5NjAw&piggybackCookie=uid:MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent=
Request Chain 580
  • https://cms.quantserve.com/pixel/p-5aWVS_roA1dVM.gif?idmatch=0&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?gdpr=0&vcode=bz0yJnR5cGU9MSZjb2RlPTExMTMmdGw9NDMyMDA=&piggybackCookie=kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-
Request Chain 581
  • https://beacon.lynx.cognitivlabs.com/pbmtc.gif?redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0xJnR5cGU9MSZjb2RlPTM0MzkmdGw9MTI5NjAw&piggybackCookie=$UID HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0xJnR5cGU9MSZjb2RlPTM0MzkmdGw9MTI5NjAw&piggybackCookie=55c46681-ecaa-427d-a807-174744d3e8c6&r=https://beacon.lynx.cognitivlabs.com/pbmtc.gif?puid=${PUBMATIC_UID} HTTP 302
  • https://beacon.lynx.cognitivlabs.com/pbmtc.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 582
  • https://p.rfihub.com/cm?pub=224&in=1&getuid=https%3A//image2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTI3MzkmdGw9MTI5NjAw%26piggybackCookie%3D%24UID%26gdpr%3D0%26gdpr_consent%3D HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI3MzkmdGw9MTI5NjAw&piggybackCookie=970314649043819140
Request Chain 584
  • https://a.tribalfusion.com/i.match?p=b11&redirect=https%3A//simage2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMzMjYmdGw9MTI5NjAw%26piggybackCookie%3D%24TF_USER_ID_ENC%24&u=${PUBMATIC_UID} HTTP 302
  • https://s.tribalfusion.com/z/i.match?p=b11&redirect=https%3A//simage2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMzMjYmdGw9MTI5NjAw%26piggybackCookie%3D%24TF_USER_ID_ENC%24&u=${PUBMATIC_UID}
Request Chain 585
  • https://sync.srv.stackadapt.com/sync?nid=11&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MzEmdGw9MTI5NjAw&piggybackCookie=SPs6ha90UKJ-2DermTJBdGAJ-Sw&gdpr=0&gdpr_consent=
Request Chain 587
  • https://csync.loopme.me/?pubid=11331&redirect=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MzImdGw9MTI5NjAw&piggybackCookie={viewer_token} HTTP 307
  • https://simage2.pubmatic.com/AdServer/Pug?vcode&piggybackCookie={viewer_token}
Request Chain 588
  • https://ums.acuityplatform.com/tum?umid=6 HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI5NDcmdGw9MTI5NjAw&piggybackCookie=888838742219
Request Chain 589
  • https://sync.mathtag.com/sync/img?mt_exid=3&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fsimage2.pubmatic.com%2FAdServer%2FPug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTM2MiZ0bD0xMjk2MDA%3D%3D%26piggybackCookie%3Duid%3A%5BMM_UUID%5D HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM2MiZ0bD0xMjk2MDA==&piggybackCookie=uid:a90b65cb-bd6c-4100-b778-a2ca30279172&gdpr=0&gdpr_consent=
Request Chain 590
  • https://t.adx.opera.com/pub/sync?pubid=pub8730968190912 HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0ODkmdGw9NDMyMDA=&piggybackCookie=OPUab1645795b4b463ba93cb19748df0468
Request Chain 592
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=qJA777-5Q66LtbWmi5uuIA%3D%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156578&predirect=&gdpr=0&gdpr_consent=
Request Chain 593
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3371&partner_device_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20 HTTP 302
  • https://secure.adnxs.com/getuid?https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DAPPNEXUS%26partner_device_id%3D%24UID%26pt%3D2af5462b-1213-435d-a332-7e55bb465ba1%252C%252C HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=5872803529851156248&pt=2af5462b-1213-435d-a332-7e55bb465ba1%2C%2C
Request Chain 596
  • https://um.simpli.fi/pubmatic?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9ODA2JnRsPTUxODQwMA==&piggybackCookie=uid:$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTgwNiZ0bD01MTg0MDA=&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67
Request Chain 597
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=pubmatic&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NDkmdGw9MTI5NjAw&piggybackCookie=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Request Chain 599
  • https://ups.analytics.yahoo.com/ups/58292/sync?_origin=1&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&redir=true&gdpr=0&gdpr_consent= HTTP 302
  • https://image4.pubmatic.com/AdServer/SPug?partnerID=156078&xid=y-m_U4GpJE2uWhHITzlOl13IbOhrlg05M-~A&gdpr=0
Request Chain 600
  • https://sync.ipredictive.com/d/sync/cookie/generic?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzI1MCZ0bD0xMjk2MDA=&piggybackCookie=${ADELPHIC_CUID}&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzI1MCZ0bD0xMjk2MDA=&piggybackCookie=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent=
Request Chain 601
  • https://pubmatic-match.dotomi.com/match/bounce/current?networkId=17100&version=1&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent= HTTP 302
  • https://pubmatic-match.dotomi.com/match/bounce/current?DotomiTest=7dc3561efe81152f&is_secure=true&networkId=17100&version=1&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AAAHlTqr6DHKpwNca_zeAAAAAAA&expiration=1707937516&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&is_secure=true&gdpr_consent=&gdpr=0
Request Chain 602
  • https://ad.turn.com/r/cs?pid=1&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9ODImdGw9MTU3NjgwMCZkcF9pZD0yMg==&piggybackCookie=4374775086859810847&gdpr=0&gdpr_consent=&us_privacy=
Request Chain 603
  • https://pmp.mxptint.net/sn.ashx?&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9Mjc0NCZ0bD0xNTc2ODAw&piggybackCookie=R33646_110D5AB97_665B6E9D&r=https://pmp.mxptint.net/sn.ashx?ak=1 HTTP 302
  • https://pmp.mxptint.net/sn.ashx?ak=1
Request Chain 605
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=3&gdpr=0&gdpr_consent= HTTP 302
  • https://pixel-sync.sitescout.com/dmp/pixelSync?cookieQ=1&nid=3&gdpr=0&gdpr_consent= HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTE5NjkmdGw9MTI5NjAw&piggybackCookie=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
Request Chain 606
  • https://creativecdn.com/cm-notify?pi=pubmatic&gdpr=0&gdpr_consent= HTTP 302
  • https://creativecdn.com/cm-notify?pi=pubmatic&gdpr=0&gdpr_consent=&tc=1 HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNTQmdGw9NDMyMDA%3D&piggybackCookie=TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k&pi=pubmatic&gdpr=0&gdpr_consent=&tc=1
Request Chain 607
  • https://i.liadm.com/s/31327?bidder_id=14481&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpdr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid= HTTP 303
  • https://i6.liadm.com/s/31327?gdpr_consent=&bidder_id=14481&gpp=&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpp_sid=&us_privacy=1---&gpdr=&us_privacy=1---
Request Chain 609
  • https://match.adsrvr.org/track/cmf/casale?us_privacy=1--- HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=39&external_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&expiration=1710443116&gdpr=0&gdpr_consent=
Request Chain 610
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&us_privacy=1--- HTTP 302
  • https://cm.g.doubleclick.net/pixel?us_privacy=1---&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=Zcu9a9HM518AACyiADNVcgAA HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEIzuikneFPsSYGiAeQvRl8U&google_cver=1
Request Chain 611
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1025&userId=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gdpr_consent=&us_privacy=1---&gdpr=&gpp=&gpp_sid= HTTP 302
  • https://pm.w55c.net/ping_match.gif?st=FREEWHEEL&rurl=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D593&userId=_wfivefivec_&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=593&userId=MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent= HTTP 302
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=103&gdpr=0&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/qmap?c=1389&tp=STSC&tpid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=&d=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Fpush%3Fpartner_id%3D2499%26partner_device_id%3D64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553%26partner_url%3Dhttps%253A%252F%252Fads.stickyadstv.com%252Fuser-registering%253FdataProviderId%253D721%2526userId%253D64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553%2526gdpr%253D0%2526gdpr_consent%253D HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2499&partner_device_id=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&partner_url=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D721%26userId%3D64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553%26gdpr%3D0%26gdpr_consent%3D HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=721&userId=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent= HTTP 302
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=stickyadstv&append=1&cb=3830516&redirect=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D690%26userId%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=690&userId=92a46392-4333-4e17-bc0c-e23a20ef4332 HTTP 302
  • https://sync.srv.stackadapt.com/sync?nid=169&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1362&userId=SPs6ha90UKJ-2DermTJBdGAJ-Sw HTTP 302
  • https://eb2.3lift.com/getuid?redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1580%26userId%3D$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1580&userId=3900114537385664774839 HTTP 302
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=${TM_USER_ID}&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=Zcu9awAEo_sMqwA9&gdpr=0&gdpr_consent= HTTP 302
  • https://ad.turn.com/r/cs?pid=34&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=4374775086859810847&redirectID=0&gdpr=0&gdpr_consent= HTTP 302
  • https://dsp.adfarm1.adition.com/cookie/?ssp=12&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=202&userId=7335164693981362326&gdpr=0&gdpr_consent= HTTP 302
  • https://jelly.mdhv.io/v4/pixie?gdpr=0&gdpr_consent=
Request Chain 613
  • https://secure.adnxs.com/getuid?https://dsum-sec.casalemedia.com/crum?cm_dsp_id=46&external_user_id=$UID&us_privacy=1--- HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=46&external_user_id=5872803529851156248&us_privacy=1---
Request Chain 614
  • https://dpm.demdex.net/ibs:dpid=23728&dpuuid=Zcu9a9HM518AACyiADNVcgAA%261404?gdpr_consent=&us_privacy=1---&gdpr=&gpp=&gpp_sid= HTTP 302
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=23728&dpuuid=Zcu9a9HM518AACyiADNVcgAA%261404
Request Chain 624
  • https://pixel.rubiconproject.com/exchange/sync.php?p=a9us&gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
Request Chain 625
  • https://match.adsrvr.org/track/cmf/rubicon?gdpr=0 HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=8981&nid=2307&put=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=&expires=30
Request Chain 626
  • https://cm.g.doubleclick.net/pixel?google_nid=rubicon&google_cm&google_sc&gdpr=0 HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=7751&nid=2249&expires=30&gdpr=0&put=CAESEC2NABVnjlNl1VbE06YztXk&google_cver=1
Request Chain 627
  • https://token.rubiconproject.com/token?pid=2249&pt=n&gdpr=0 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=rubicon&google_hm=YmQ3YWI2ZDIyNTgyZTUzMzA0NzAyOTk4Y2VmOGJjMTcwYWVmYTc0NQ&gdpr=0
Request Chain 628
  • https://token.rubiconproject.com/token?pid=36584&gdpr=0 HTTP 302
  • https://px.ads.linkedin.com/setuid?partner=rubiconDb&dbredirect=true&ruxId=LSKQGI85-W-KKFE&gdpr=0
Request Chain 629
  • https://s.amazon-adsystem.com/dcm?pid=50cd21b7-d8d7-4615-9fb9-a2be831f8488&id=&gdpr=0 HTTP 302
  • https://pixel.rubiconproject.com/token?pid=2179&pt=n&puid=ZwkzgZmUT3Crle0yEe9BSw&rk=usync-na&gdpr=0 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=rubiconprojectHMT&id=ZwkzgZmUT3Crle0yEe9BSw&gdpr=0
Request Chain 630
  • https://token.rubiconproject.com/token?pid=25470&gdpr=0 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=rp&google_cm&google_hm=TFNLUUdJODUtVy1LS0ZF&gdpr=0 HTTP 302
  • https://pixel.rubiconproject.com/exchange/sync.php?p=dfp&gdpr=0&google_gid=CAESEKko_3wvGEPULh72awGDcIg&google_cver=1 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=rp&google_hm=TFNLUUdJODUtVy1LS0ZF&google_push=&gdpr=0
Request Chain 631
  • https://token.rubiconproject.com/token?pid=2974&pt=n&a=1&gdpr=0 HTTP 302
  • https://pr-bh.ybp.yahoo.com/sync/rubicon/Uj2djVWZ01WJWQkvJr-JcA?csrc=&gdpr=0 HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=31950&nid=2974&put=y-rkS9sd1E2oILR8CSLfQIaEnrbiBe9cyewAKaIw--~A
Request Chain 632
  • https://match.prod.bidr.io/cookie-sync/rp?bee_sync_partners=rp&gdpr=0 HTTP 303
  • https://pixel.rubiconproject.com/tap.php?v=183462&nid=4114&put=AACJ-U7Ll3sAABJaNC07Nw&expires=30&gdpr=0
Request Chain 633
  • https://pixel.rubiconproject.com/exchange/sync.php?p=18694&gdpr=0 HTTP 302
  • https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
Request Chain 634
  • https://pixel.rubiconproject.com/exchange/sync.php?p=primis&gdpr=0 HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=100&advUuid=LSKQGI85-W-KKFE&gdpr=0 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
Request Chain 635
  • https://sync.ipredictive.com/d/sync/cookie/generic?https://pixel.rubiconproject.com/tap.php?v=17149&nid=2861&put=${ADELPHIC_CUID}&expires=30&gdpr=0 HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=17149&nid=2861&put=92a46392-4333-4e17-bc0c-e23a20ef4332&expires=30&gdpr=0
Request Chain 636
  • https://pixel.rubiconproject.com/exchange/sync.php?p=pbs-apn&gdpr=0 HTTP 302
  • https://ib.adnxs.com/prebid/setuid?bidder=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0
Request Chain 637
  • https://pixel.rubiconproject.com/exchange/sync.php?p=sovrn&gdpr=0 HTTP 302
  • https://ce.lijit.com/merge?pid=80&3pid=LSKQGI85-W-KKFE&gdpr=0
Request Chain 638
  • https://token.rubiconproject.com/token?pid=37556&a=1&gdpr=0 HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3355&partner_device_id=LSKQGI85-W-KKFE&gdpr=0
Request Chain 641
  • https://pixel-us-east.rubiconproject.com/exchange/sync.php?p=rise_engage&gdpr_consent=undefined&gdpr=0&us_privacy=1---&khaos=LSKQGI85-W-KKFE HTTP 302
  • https://cs.yellowblue.io/cs?aid=11590&id=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
Request Chain 644
  • https://s.ad.smaato.net/c/?adExInit=aps&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsmaato.com%26id%3D%24UID HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
Request Chain 646
  • https://sync.1rx.io/usersync2/rmpssp?sub=amazon&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drhythmone.com%26id%3D%5BRX_UUID%5D HTTP 302
  • https://sync.mathtag.com/sync/img?mt_exid=74&redir=https%3A%2F%2Fsync.1rx.io%2Fusersync3%2Fmediamathtest%2F2069.5%2F%5BMM_UUID%5D%3Fzcc%3D0%26sspret%3D1&rndcb=5352123473 HTTP 302
  • https://sync.1rx.io/usersync3/mediamathtest/2069.5/a90b65cb-bd6c-4100-b778-a2ca30279172?zcc=0&sspret=1 HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005%26ex%3Drhythmone.com HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005&ex=rhythmone.com
Request Chain 647
  • https://jadserve.postrelease.com/suid/101959?ntv_r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dnativo.com%26id%3DNTV_USER_ID HTTP 302
  • https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
Request Chain 672
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sharethrough&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Request Chain 673
  • https://cm.g.doubleclick.net/pixel?google_nid=sharethrough_ob&gdpr=0&gdpr_consent=&google_hm=YzRjZWM1YjItYWNjYS00MTVjLWI3MzgtN2UwNzliZThiZjc4 HTTP 302
  • https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
Request Chain 674
  • https://image8.pubmatic.com/AdServer/ImgSync?p=156557&gdpr=0&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D156557%26pr%3Dhttps%253A%252F%252Fmatch.sharethrough.com%252Fsync%252Fv1%253Fsource_id%253DuFFr5RFBYgoUJbWMAWGEZKS3%2526source_user_id%253D%2523PMUID HTTP 302
  • https://c1.adform.net/serving/cookie/match?party=14&redirect=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NzUmdGw9NDMyMDA=&piggybackCookie=[PLACE%20YOUR%20PIGGYBACK%20COOKIES%20HERE]&gdpr=0&gdpr_consent= HTTP 302
  • https://c1.adform.net/serving/cookie/match?CC=1&party=14&redirect=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NzUmdGw9NDMyMDA=&piggybackCookie=[PLACE%20YOUR%20PIGGYBACK%20COOKIES%20HERE]&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NzUmdGw9NDMyMDA=&gdpr=0&gdpr_consent=&piggybackCookie=1956285366857158953 HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://match.adsby.bidtheatre.com/pubmaticmatch?redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNjImdGw9MTI5NjAw&piggybackCookie=uid:$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?gdpr_consent=&gdpr=0&piggybackCookie=uid:9e45b838-9dbe-4d4e-b7d7-9761fe94fd02&vcode=bz0yJnR5cGU9MSZjb2RlPTMwNjImdGw9MTI5NjAw HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY} HTTP 302
  • https://image4.pubmatic.com/AdServer/SPug?gdpr=0&p=156557&pr=https%3A%2F%2Fmatch.sharethrough.com%2Fsync%2Fv1%3Fsource_id%3DuFFr5RFBYgoUJbWMAWGEZKS3%26source_user_id%3DA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&us_privacy=%24%7BUS_PRIVACY%7D HTTP 302
  • https://match.sharethrough.com/sync/v1?source_id=uFFr5RFBYgoUJbWMAWGEZKS3&source_user_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 675
  • https://pixel.rubiconproject.com/exchange/sync.php?p=18694&gdpr=0&gdpr_consent= HTTP 302
  • https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
Request Chain 695
  • https://ups.analytics.yahoo.com/ups/58827/sync?redir=true&gdpr=&gdpr_consent=&gpp=&gpp_sid= HTTP 302
  • https://s2s.t13.io/setuid?bidder=yahoossp&uid=y-Joo4XdBE2uKXv1FdoD6UcyyjsxTzmvc1~A
Request Chain 734
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=12776&us_privacy=1--- HTTP 301
  • https://eus.rubiconproject.com/usync.html?p=12776&us_privacy=1---
Request Chain 735
  • https://us-u.openx.net/w/1.0/cm?id=fba3d144-1026-4d31-a758-943b9545e305&r=https://usr.undertone.com/userPixel/sync?partnerId=39&uid=&us_privacy=1--- HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=39&uid=&us_privacy=1---375f1a63-3de1-499c-a843-b6d122800b5a
Request Chain 736
  • https://pixel.advertising.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true&us_privacy=1--- HTTP 301
  • https://ups.analytics.yahoo.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true&us_privacy=1--- HTTP 302
  • https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A&us_privacy=1---
Request Chain 737
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sirnsvg&ttd_tpi=1&gdpr=0&gdpr_consent=&us_privacy=1--- HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
Request Chain 738
  • https://pixel.rubiconproject.com/exchange/sync.php?p=12776&us_privacy=1--- HTTP 302
  • https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&us_privacy=1---
Request Chain 739
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160318&gdpr=&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D160318%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fusr.undertone.com%252FuserPixel%252Fsync%253FpartnerId%253D53%2526uid%253D%2523PMUID&us_privacy=1--- HTTP 302
  • https://image4.pubmatic.com/AdServer/SPug?p=160318&pmc=1&pr=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D53%26uid%3DA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&us_privacy=1--- HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 740
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=125&redir=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D54%26uid%3D%7BuserId%7D&us_privacy=1--- HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&us_privacy=1---
Request Chain 741
  • https://ups.analytics.yahoo.com/ups/58545/occ?us_privacy=1--- HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
Request Chain 742
  • https://usr.undertone.com/userPixel/syncr?gdpr=&gdprstr=&partnerId=null&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UIDENC HTTP 302
  • https://s2s.t13.io/setuid?bidder=undertone&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=b&uid=6gc078in3kn3tp77d036y9znt
Request Chain 769
  • https://id5-sync.com/s/441/9.gif?puid=u_152c89a8-84bb-49ef-894e-36b8d2753173&gdpr=0&gdpr_consent= HTTP 302
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=id5&cspid=18&cb=&redirect=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F796%2F8%2F2.gif%3Fpuid%3D%24%7BADELPHIC_CUID%7D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/441/796/8/2.gif?puid=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent= HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8h9u11h&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%% HTTP 302
  • https://ib.adnxs.com/getuid?https://id5-sync.com/c/441/2/6/4.gif?puid=$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/441/2/6/4.gif?puid=5872803529851156248&gdpr=0&gdpr_consent= HTTP 302
  • https://sync.go.sonobi.com/us?loc=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F434%2F5%2F5.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&consent= HTTP 302
  • https://id5-sync.com/c/441/434/5/5.gif?puid=65e4a6df-48af-4fad-a0f0-a3011fc909f8&gdpr=0&gdpr_consent= HTTP 302
  • https://dis.eu.criteo.com/dis/usersync.aspx?r=30&p=59&cp=id5&cu=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F203%2F4%2F6.gif%3Fpuid%3D%40%40CRITEO_USERID%40%40%26gdpr%3D0%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/441/203/4/6.gif?puid=15bd9e41-bde1-46eb-aa5e-ae20396e6b6a&gdpr=0&gdpr_consent= HTTP 302
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F429%2F3%2F7.gif%3Fpuid%3D%23PM_USER_ID%26gdpr%3D0%26gdpr_consent%3D&gdpr_consent=&gdpr=0 HTTP 302
  • https://id5-sync.com/c/441/429/3/7.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent= HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8h9u11h&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%% HTTP 302
  • https://ce.lijit.com/merge?pid=27&3pid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1245%2F1%2F9.gif%3Fpuid%3D%5BSOVRNID%5D%26gdpr%3D0%26gdpr_consent%3D&s=id5 HTTP 302
  • https://id5-sync.com/c/441/1245/1/9.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent= HTTP 302
  • https://ib.adnxs.com/getuid?https://id5-sync.com/c/441/2/0/10.gif?puid=$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/441/2/0/10.gif?puid=5872803529851156248&gdpr=0&gdpr_consent=
Request Chain 770
  • https://x.bidswitch.net/sync?ssp=themediagrid&us_privacy=1--- HTTP 302
  • https://c1.adform.net/serving/cookie/match/?party=24&bidswitch_ssp_id=themediagrid HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=70&user_id=1956285366857158953&ssp=themediagrid
Request Chain 771
  • https://id5-sync.com/s/441/9.gif?puid=u_4f2f92dc-45cb-4e5b-8115-5b45eca27c69&gdpr=0&gdpr_consent= HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8h9u11h&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%%
Request Chain 772
  • https://id5-sync.com/s/441/9.gif?puid=u_a01fb7d6-bacf-4b1d-bb15-d6478605d080&gdpr=0&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F108%2F8%2F2.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/441/108/8/2.gif?puid=2af5462b-1213-435d-a332-7e55bb465ba1&gdpr=0&gdpr_consent= HTTP 302
  • https://match.prod.bidr.io/cookie-sync/id5?us_privacy= HTTP 303
  • https://id5-sync.com/k/155.gif?puid=AACJ-U7Ll3sAABJaNC07Nw&id5AccountNum=155&numCascadesAllowed=9 HTTP 302
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=id5&cspid=18&cb=&redirect=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F796%2F6%2F4.gif%3Fpuid%3D%24%7BADELPHIC_CUID%7D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/441/796/6/4.gif?puid=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent= HTTP 302
  • https://dis.eu.criteo.com/dis/usersync.aspx?r=30&p=59&cp=id5&cu=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F203%2F5%2F5.gif%3Fpuid%3D%40%40CRITEO_USERID%40%40%26gdpr%3D0%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/441/203/5/5.gif?puid=b95796f4-009a-4a9f-852e-b3acc4faf5d2&gdpr=0&gdpr_consent= HTTP 302
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F429%2F4%2F6.gif%3Fpuid%3D%23PM_USER_ID%26gdpr%3D0%26gdpr_consent%3D&gdpr_consent=&gdpr=0 HTTP 302
  • https://id5-sync.com/c/441/429/4/6.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1242%2F3%2F7.gif%3Fpuid%3D%5BSOVRNID%5D%26gdpr%3D0%26gdpr_consent%3D&s=id5 HTTP 302
  • https://id5-sync.com/c/441/1242/3/7.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent= HTTP 302
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F441%2F124%2F2%2F8.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F441%2F124%2F2%2F8.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://id5-sync.com/cq/441/124/2/8.gif?puid=d9288f3f-ce9e-47eb-b7a4-f96ffdea64c1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1242%2F1%2F9.gif%3Fpuid%3D%5BSOVRNID%5D%26gdpr%3D0%26gdpr_consent%3D&s=id5 HTTP 302
  • https://id5-sync.com/c/441/1242/1/9.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=92&3pid=5872803529851156248&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1246%2F0%2F10.gif%3Fpuid%3D%5BSOVRNID%5D%26gdpr%3D0%26gdpr_consent%3D&s=id5 HTTP 302
  • https://id5-sync.com/c/441/1246/0/10.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
Request Chain 786
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=svx9t50&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://eb2.3lift.com/xuid?mid=3658&xuid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&dongle=0cfd&gdpr=0&gdpr_consent=
Request Chain 787
  • https://eb2.3lift.com/ebda?sync=1&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=tl&gdpr=0&gdpr_consent=&us_privacy=&google_hm=MzkwMDExNDUzNzM4NTY2NDc3NDgzOQ%3D%3D HTTP 302
  • https://eb2.3lift.com/ebda?gdpr=0&gdpr_consent=
Request Chain 788
  • https://cm.g.doubleclick.net/pixel?google_nid=triplelift&google_cm&google_sc&gdpr=0&gdpr_consent= HTTP 302
  • https://eb2.3lift.com/xuid?mid=5989&xuid=CAESEDNtdL5U9OMOEAeEKgzK3dg&dongle=c627&gdpr=0&gdpr_consent=&google_cver=1
Request Chain 789
  • https://eb2.3lift.com/sync/google/demand?sync=1&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=triplelift&gdpr=0&gdpr_consent=&us_privacy=&google_hm=MzkwMDExNDUzNzM4NTY2NDc3NDgzOQ%3D%3D
Request Chain 791
  • https://pr-bh.ybp.yahoo.com/sync/triplelift/3900114537385664774839?gdpr=0&gdpr_consent= HTTP 302
  • https://eb2.3lift.com/xuid?mid=2662&xuid=y-VjdPu_JE2oSTJprguvoZCHFoKyoiRDrzzmsQ_jXiQQ--~A&dongle=0883
Request Chain 792
  • https://x.bidswitch.net/sync?ssp=triplelift&user_id=3900114537385664774839&gdpr=0&gdpr_consent=${GDPR_CONSENT} HTTP 302
  • https://ads.creative-serving.com/bsw_sync?bidswitch_ssp_id=triplelift&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.creative-serving.com/ul_cb/bsw_sync?bidswitch_ssp_id=triplelift&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=0&gdpr_consent= HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=4&user_id=34cdbda4-1634-4ded-a028-2069e7dbb885&ssp=triplelift&expires=30&user_group=5&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://eb2.3lift.com/xuid?mid=2409&xuid=d9962442-c73f-42a4-adbd-3d9517e387ff&dongle=d3d3&gdpr=&gdpr_consent=&gdpr_pd=
Request Chain 794
  • https://ib.adnxs.com/getuid?https%3A%2F%2Feb2.3lift.com%2Fxuid%3Fmid%3D3335%26xuid%3D%24UID%26dongle%3D4d58%26gdpr=0%26gdpr_consent= HTTP 302
  • https://eb2.3lift.com/xuid?mid=3335&xuid=5872803529851156248&dongle=4d58&gdpr=0&gdpr_consent=
Request Chain 797
  • https://match.adsrvr.org/track/cmf/google?google_gid=CAESELCAKg01Z9nb9XrutemgUQI&google_cver=1&google_push=AXcoOmSecmXVWYrmjs_6N1Wbrer5LsJP9MzsvcUKMsTBujTsRTtD5UjtE2uh3WMMqsXtNiAYbFrBJa6jCKpWZfJ72SXL2xhmR81jwY0 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=TheTradeDesk&google_hm=MjlhYWIxNzQtZmU5MS00YWQ3LWFhNTYtMWQ0NzMyY2MyN2Qy&google_push&gdpr=0&gdpr_consent=&ttd_tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
Request Chain 799
  • https://pr-bh.ybp.yahoo.com/sync/adx?google_gid=CAESEB0d2yeb36kq5Kd_CnLAxxc&google_cver=1&google_push=AXcoOmTsdGQefvfO2yQAc7R6rZ7JA4_63lZo3H8abc5vtasaxjK6iP1ijBYsLGLXmlAanRgR8VPPOW1FavAiVCYpuITa-y6ynvlc_gg HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=yahoo&google_push=AXcoOmTsdGQefvfO2yQAc7R6rZ7JA4_63lZo3H8abc5vtasaxjK6iP1ijBYsLGLXmlAanRgR8VPPOW1FavAiVCYpuITa-y6ynvlc_gg&google_hm=eS1lNS5NOEdCRTJwR3hETkZTc3dkc2NwSVVNT3lQVTNkOH5B
Request Chain 801
  • https://analytics.pangle-ads.com/api/ad/union/gg_cookie_matching?google_gid=CAESELK0NckH8FRU9X2iT3vbHsk&google_cver=1&google_push=AXcoOmQrYugvnkkclV1ZZfaTlxYx_0_kxonS6TOFSqUc7lTbW0ljikL3di5Itu_vuDrFbquFDKZdslWIC6aU2UCNL9fDQpitTEPHNGyR HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=toutiao_usd&google_push=AXcoOmQrYugvnkkclV1ZZfaTlxYx_0_kxonS6TOFSqUc7lTbW0ljikL3di5Itu_vuDrFbquFDKZdslWIC6aU2UCNL9fDQpitTEPHNGyR
Request Chain 802
  • https://www.temu.com/api/adx/cm/pixel?google_gid=CAESEEOt7czYSLeM29hXlme4ajg&google_cver=1&google_push=AXcoOmRj5Nt9NfrofakZSfSYv_9J_WTZ5sOQVC6yp4EjEEQZshvWdKHg2Ww3c0yTDqoaDL6Fx5DZKNEc80UTG3C_ddKyFIn4sEDHAJ-C HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=1371970550&google_push=AXcoOmRj5Nt9NfrofakZSfSYv_9J_WTZ5sOQVC6yp4EjEEQZshvWdKHg2Ww3c0yTDqoaDL6Fx5DZKNEc80UTG3C_ddKyFIn4sEDHAJ-C
Request Chain 807
  • https://idpix.media6degrees.com/orbserv/hbpix?pixId=856286&pcv=125&ptid=23&tpuv=00&tpu=d09fe8ce-25d6-50c9-35ef-e2e5f0e16bca HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072960&val=1rpulbnwtosko
Request Chain 808
  • https://sync.srv.stackadapt.com/sync?nid=268 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537082476&val=SPs6ha90UKJ-2DermTJBdGAJ-Sw
Request Chain 809
  • https://aorta.clickagy.com/pixel.gif?ch=4&cm=63bc49a1-6f34-49b1-b453-3257311e2539&redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537073026%26val%3D%7Bvisitor_id%7D HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537073026&val=Zcu9a11ZdSrn6UNLg9dcZUK2
Request Chain 810
  • https://rtb.openx.net/sync/dds HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=open&google_hm=o2T3eJTIzNEksuWhBjURsg==&ox_sc=1&ox_init=1 HTTP 302
  • https://rtb.openx.net/sync/dds?ox_sc=1&ox_init=1
Request Chain 811
  • https://sync.ipredictive.com/d/sync/cookie/generic?https://us-u.openx.net/w/1.0/sd?id=537073028&val=${ADELPHIC_CUID} HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537073028&val=92a46392-4333-4e17-bc0c-e23a20ef4332
Request Chain 812
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=4&gdpr=0 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072977&val=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
Request Chain 829
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=12776 HTTP 301
  • https://eus.rubiconproject.com/usync.html?p=12776
Request Chain 830
  • https://us-u.openx.net/w/1.0/cm?id=fba3d144-1026-4d31-a758-943b9545e305&r=https://usr.undertone.com/userPixel/sync?partnerId=39&uid= HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=39&uid=375f1a63-3de1-499c-a843-b6d122800b5a
Request Chain 831
  • https://pixel.advertising.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true HTTP 301
  • https://ups.analytics.yahoo.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true HTTP 302
  • https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A
Request Chain 832
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sirnsvg&ttd_tpi=1&gdpr=0&gdpr_consent= HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
Request Chain 833
  • https://pixel.rubiconproject.com/exchange/sync.php?p=12776 HTTP 302
  • https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE
Request Chain 834
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160318&gdpr=&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D160318%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fusr.undertone.com%252FuserPixel%252Fsync%253FpartnerId%253D53%2526uid%253D%2523PMUID HTTP 302
  • https://image4.pubmatic.com/AdServer/SPug?p=160318&pmc=1&pr=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D53%26uid%3DA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20 HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 835
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=125&redir=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D54%26uid%3D%7BuserId%7D HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553
Request Chain 836
  • https://ups.analytics.yahoo.com/ups/58545/occ HTTP 302
  • https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
Request Chain 840
  • https://idsync.rlcdn.com/403716.gif?partner_uid=6gc078in3kn3tp77d036y9znt HTTP 307
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fidsync.rlcdn.com%2F396846.gif%3Fserved_by%3Devergreen%26partner_uid%3D HTTP 302
  • https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
Request Chain 853
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSFVsVjkXq0sTIrmRdgopaIgTXDObkkTgZyrw8JUyyxkl06UokEJBKHIHlHMRlx0nmvJ1wNHzu5rFZ-_yW3BD5nNidp-hgWUsTx9Xocv6_zFjwI96a160QdJItJij5gBf7PRaxU0uLMdiDicqP8bKuwrg HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSFVsVjkXq0sTIrmRdgopaIgTXDObkkTgZyrw8JUyyxkl06UokEJBKHIHlHMRlx0nmvJ1wNHzu5rFZ-_yW3BD5nNidp-hgWUsTx9Xocv6_zFjwI96a160QdJItJij5gBf7PRaxU0uLMdiDicqP8bKuwrg
Request Chain 854
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQIaCPfbJIG4ACehGy4TJBFdv8aD-EjTW52SPyYglWxnazsJFDA18Ugy4YFEh6nUnN1_yjwL1Be3uxUGKdvHqRpPBZbvOXZG2m00Ht-RXXzIlPHHYPlMMMzxmYoanC-PiIB82tm3t33wcBbuCU4Wx7lQQ HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQIaCPfbJIG4ACehGy4TJBFdv8aD-EjTW52SPyYglWxnazsJFDA18Ugy4YFEh6nUnN1_yjwL1Be3uxUGKdvHqRpPBZbvOXZG2m00Ht-RXXzIlPHHYPlMMMzxmYoanC-PiIB82tm3t33wcBbuCU4Wx7lQQ
Request Chain 855
  • https://mweb.ck.inmobi.com/sync/3?redirect=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dinmobi_pte_limited%26google_hm%3D%24DSP_CKID&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmRi3O1QaNN8fTCMASOzkT7MLZKdkJ6ZtAf1MojLpuCeFabnluXakKD1Mn9GEnPiY8tP0LTdLJV0RTcdh0qzHc-WvO5bxo_5NCPBN6nDzbAgBQZ25i97eymNpxK76-mGoKUCjmN7dMraMStadShAeyA6ng HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmRi3O1QaNN8fTCMASOzkT7MLZKdkJ6ZtAf1MojLpuCeFabnluXakKD1Mn9GEnPiY8tP0LTdLJV0RTcdh0qzHc-WvO5bxo_5NCPBN6nDzbAgBQZ25i97eymNpxK76-mGoKUCjmN7dMraMStadShAeyA6ng
Request Chain 856
  • https://x.bidswitch.net/sync?ssp=google&google_gid=CAESEEJZ1H7xxDQil5yltdO_TY8&google_cver=1&google_push=AXcoOmSNrGZdHwtS50n0gX-qlfG7FwMCtfNWNYttvgZ3lDGTV4hBrK_GkXrvJnDISuCgvDj9YrYFiNn0jyfIpZRnU5AohHS0HTIqQOg37zpJfBW9dSn7LQg1oHBEwbmDRIfb3dXvDLTMtuu7fcRd1COoiKyOkg HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSNrGZdHwtS50n0gX-qlfG7FwMCtfNWNYttvgZ3lDGTV4hBrK_GkXrvJnDISuCgvDj9YrYFiNn0jyfIpZRnU5AohHS0HTIqQOg37zpJfBW9dSn7LQg1oHBEwbmDRIfb3dXvDLTMtuu7fcRd1COoiKyOkg&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Request Chain 857
  • https://rtb.mfadsrvr.com/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUixZLzkosxLlNp7knTc6EDR-vT-iWuOITe55Gb38orH7_ILu7U7F4kS_8Nlxi3BtiWpBZtGU9LQ-yowpSdCliUO9DAR9d7NQQD1FE4Chq1Q HTTP 302
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUixZLzkosxLlNp7knTc6EDR-vT-iWuOITe55Gb38orH7_ILu7U7F4kS_8Nlxi3BtiWpBZtGU9LQ-yowpSdCliUO9DAR9d7NQQD1FE4Chq1Q HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUixZLzkosxLlNp7knTc6EDR-vT-iWuOITe55Gb38orH7_ILu7U7F4kS_8Nlxi3BtiWpBZtGU9LQ-yowpSdCliUO9DAR9d7NQQD1FE4Chq1Q
Request Chain 859
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmRBLKkaVsdpP5gKhNOnIePxAcEzvhD1L0DqDfmQdss28IyXDvaV3Yvz0yRekcF3HckufCKt_Rv7PL2ts3ZdQlM6so9sNlGmn-wFQcM35ZJMhb-igpsdpbqhJ4PkFuL5-T1o0N4swP8e3Q8vfhWpTsemuaM HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmRBLKkaVsdpP5gKhNOnIePxAcEzvhD1L0DqDfmQdss28IyXDvaV3Yvz0yRekcF3HckufCKt_Rv7PL2ts3ZdQlM6so9sNlGmn-wFQcM35ZJMhb-igpsdpbqhJ4PkFuL5-T1o0N4swP8e3Q8vfhWpTsemuaM
Request Chain 860
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQCMhRFuNlPYwsgqZ9eAxopvwIz7lUwsggVuRJXwDA51fptAAOsVbMgVMAKfoWhfg2O1vWSGmn-T5xxSUVXgUIlJ1ju89GdGoB59I0C8N8NCyUJPIgreAjIQllUa5fNieqCCEHwa_PFip18_FXKR-FNnl4 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQCMhRFuNlPYwsgqZ9eAxopvwIz7lUwsggVuRJXwDA51fptAAOsVbMgVMAKfoWhfg2O1vWSGmn-T5xxSUVXgUIlJ1ju89GdGoB59I0C8N8NCyUJPIgreAjIQllUa5fNieqCCEHwa_PFip18_FXKR-FNnl4
Request Chain 861
  • https://mweb.ck.inmobi.com/sync/3?redirect=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dinmobi_pte_limited%26google_hm%3D%24DSP_CKID&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmTV16TTBJPGYiS11zD1D5106Ivo1cC4bLTDzvXYnasTpPw1dCMH3rcob4jrPErbfV9GIvOq3A67CBwzZdwBuWA6g77_y4igI8oIF4vE-3-VTUDL1b0vodDluuE9aBxeSOPIcoTrfs9XQx6wkIBGjyFZxtg HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=OThmMDU2ZmYtYjNlMS00Yzc5LWEzZDgtZWFhYzg0NTEyNTI3&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmTV16TTBJPGYiS11zD1D5106Ivo1cC4bLTDzvXYnasTpPw1dCMH3rcob4jrPErbfV9GIvOq3A67CBwzZdwBuWA6g77_y4igI8oIF4vE-3-VTUDL1b0vodDluuE9aBxeSOPIcoTrfs9XQx6wkIBGjyFZxtg
Request Chain 862
  • https://x.bidswitch.net/sync?ssp=google&google_gid=CAESEEJZ1H7xxDQil5yltdO_TY8&google_cver=1&google_push=AXcoOmS6ZXckMj6MRQuQkUvfueLAYzjI-uBnTiFSPne20jp6bDM8Hw1RZX9xrE_pI5ts9NgGsNI8Kc6aTlt8lSgXmbC2o00xMBlTsmxdbnMvLSUcPlQGo1F791O4XQULk2Ed5YLN8Ll3oXl9iCbDegD2ldsC7bU HTTP 302
  • https://r.bidswitch.net/sync?bidswitch_ssp_id=google&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3205&partner_device_id=d9962442-c73f-42a4-adbd-3d9517e387ff&partner_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D393%26user_id%3D0%26ssp%3Dgoogle%26bsw_param%3Dd9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=393&user_id=0&ssp=google&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmS6ZXckMj6MRQuQkUvfueLAYzjI-uBnTiFSPne20jp6bDM8Hw1RZX9xrE_pI5ts9NgGsNI8Kc6aTlt8lSgXmbC2o00xMBlTsmxdbnMvLSUcPlQGo1F791O4XQULk2Ed5YLN8Ll3oXl9iCbDegD2ldsC7bU&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Request Chain 863
  • https://rtb.mfadsrvr.com/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_FFIZzbbn5EJDWgKUCQNRekhQTpZihIsIcw0Bj93YfwiRJebRehtNO6NGaMdfa_4Dnuy8DoxiIwd-rfFccSIie1TtuyjYxfp4EqbxFrs_IY HTTP 302
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_FFIZzbbn5EJDWgKUCQNRekhQTpZihIsIcw0Bj93YfwiRJebRehtNO6NGaMdfa_4Dnuy8DoxiIwd-rfFccSIie1TtuyjYxfp4EqbxFrs_IY HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_FFIZzbbn5EJDWgKUCQNRekhQTpZihIsIcw0Bj93YfwiRJebRehtNO6NGaMdfa_4Dnuy8DoxiIwd-rfFccSIie1TtuyjYxfp4EqbxFrs_IY
Request Chain 876
  • https://hbx.media.net/cksync.php?cs=1&type=pbs&ovsid=setstatuscode&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dmedianet%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Di%26uid%3D%3Cvsid%3E HTTP 302
  • https://s2s.t13.io/setuid?bidder=medianet&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=3508527156634803000V10
Request Chain 907
  • https://pixel.rubiconproject.com/exchange/sync.php?p=12776&us_privacy=1---&us_privacy=1---&gdpr_consent=undefined&gdpr=0&khaos=LSKQGI85-W-KKFE HTTP 302
  • https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
Request Chain 919
  • https://gocm.c.appier.net/pubmatic HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDImdGw9MTI5NjAw&piggybackCookie=YDtbzodyBEeUV3z0b73LZQ
Request Chain 920
  • https://sync.1rx.io/usersync2/pubmatic&gdpr=0&gdpr_consent= HTTP 302
  • https://x.bidswitch.net/sync?ssp=adconductor&user_id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005&rndcb=4688430332 HTTP 302
  • https://t.pswec.com/bsw_sync?ssp=adconductor&bsw_user_id=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://t.pswec.com/ul_cb/bsw_sync?ssp=adconductor&bsw_user_id=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=2&user_id=93c731c1-bdeb-4853-a081-688267ddafe8&expires=3&user_group=1&ssp=adconductor HTTP 302
  • https://sync.1rx.io/usersync/bidswitch/d9962442-c73f-42a4-adbd-3d9517e387ff?gdpr=&gdpr_consent=&us_privacy= HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fsimage2.pubmatic.com%2FAdServer%2FPug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMyMDMmdGw9NDMyMDA%3D%26piggybackCookie%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005 HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDMmdGw9NDMyMDA=&piggybackCookie=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Request Chain 924
  • https://px.owneriq.net/epm?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw&piggybackCookie=$UID HTTP 302
  • https://px.owneriq.net/ecc?redir=https%3a%2f%2fsimage2.pubmatic.com%2fAdServer%2fPug%3fvcode%3dbz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw%26piggybackCookie%3dQ7611375191439378190&uid=Q7611375191439378190&ref=%2Fepm HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw&piggybackCookie=Q7611375191439378190
Request Chain 925
  • https://um.simpli.fi/pm_match?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjkzNiZ0bD00MzIwMA==&piggybackCookie=uid:$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjkzNiZ0bD00MzIwMA==&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67&gdpr=0&gdpr_consent=
Request Chain 926
  • https://thrtle.com/insync?vxii_pid=10067&vxii_pdid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent= HTTP 302
  • https://thrtle.com/insync?gdpr=0&gdpr_consent=&vxii_pdid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&vxii_pid=12&vxii_pid1=10067&vxii_rcid=8ca19971-6315-4afa-a9aa-726bd1cf013a
Request Chain 939
  • https://cms.quantserve.com/pixel/p-25CIknq_eSg16.gif?idmatch=0&gdpr=0 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072956&gdpr=0&val=FJTvtUDFurUPlbjkFZmh7hCW7bQPlLzjFsOlx_2H
Request Chain 940
  • https://x.bidswitch.net/sync?ssp=openx HTTP 302
  • https://r.bidswitch.net/sync?bidswitch_ssp_id=openx&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3205&partner_device_id=d9962442-c73f-42a4-adbd-3d9517e387ff&partner_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D393%26user_id%3D0%26ssp%3Dopenx%26bsw_param%3Dd9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=393&user_id=0&ssp=openx&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072968&val=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
Request Chain 941
  • https://p.rfihub.com/cm?pub=25&in=1 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537073062&val=970314649043819140
Request Chain 942
  • https://um.simpli.fi/ox_match HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537072966&val=0E087FD3E115403AB68AFF630D65CE67
Request Chain 946
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSkCWQHUETjFjo31SdXhGgr7vD4Xl5gatf2DIvJl8W-VYOSe3dQLW_cHH9t98KILO5-4ReYILmaGE87is__UKOMoflP26hKNo67nNzP1Ohn2oqTzMp2y2TXhxM4XH9vkI-FJCix3ogZg36KjHfLBWkpjQ HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSkCWQHUETjFjo31SdXhGgr7vD4Xl5gatf2DIvJl8W-VYOSe3dQLW_cHH9t98KILO5-4ReYILmaGE87is__UKOMoflP26hKNo67nNzP1Ohn2oqTzMp2y2TXhxM4XH9vkI-FJCix3ogZg36KjHfLBWkpjQ
Request Chain 947
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmSapCtnfsiGQBnydpxpMe_atxVhjtBsugeCg_X1yrJizN_Bd-9wRgmEqZMdax6sV6V2JU5819g01pOfXvLbo0ZZ-mDAiywg5ZFF717wPvN5LfW5iM2yzWaTdG7AjcpyNUzLii4GHGM_xvXJMn16dnWivA HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmSapCtnfsiGQBnydpxpMe_atxVhjtBsugeCg_X1yrJizN_Bd-9wRgmEqZMdax6sV6V2JU5819g01pOfXvLbo0ZZ-mDAiywg5ZFF717wPvN5LfW5iM2yzWaTdG7AjcpyNUzLii4GHGM_xvXJMn16dnWivA
Request Chain 948
  • https://mweb.ck.inmobi.com/sync/3?redirect=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dinmobi_pte_limited%26google_hm%3D%24DSP_CKID&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmQ9NcNRGW7h_5kJ3Bn0LNU2hXDL1Y-nZgvhRXtKr9Q5Wp-SjD9gRWNWcy4TDN-P_3z_AmxI3QBUmf6Js8y_Q14SZ5AoXWVTGTNP8lemQ3KkGrhSjYW78Y4NRppHxxugbrHfypY-eSbIxT5OMFS9J2VlQ88 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmQ9NcNRGW7h_5kJ3Bn0LNU2hXDL1Y-nZgvhRXtKr9Q5Wp-SjD9gRWNWcy4TDN-P_3z_AmxI3QBUmf6Js8y_Q14SZ5AoXWVTGTNP8lemQ3KkGrhSjYW78Y4NRppHxxugbrHfypY-eSbIxT5OMFS9J2VlQ88
Request Chain 949
  • https://x.bidswitch.net/sync?ssp=google&google_gid=CAESEEJZ1H7xxDQil5yltdO_TY8&google_cver=1&google_push=AXcoOmSROxZdh41c99gml7B3apeborMRMlOuQQqzmK4FeDM7KYe_dUC82s0hl0idGXgcPE2gn-env3vjdrVQO6ZUPvxo24iojyipcxMsjGupcjFAY1het0kbGmcCZ407iTyYuSiZX1E2RcECQofwknBoU6v_Wys HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSROxZdh41c99gml7B3apeborMRMlOuQQqzmK4FeDM7KYe_dUC82s0hl0idGXgcPE2gn-env3vjdrVQO6ZUPvxo24iojyipcxMsjGupcjFAY1het0kbGmcCZ407iTyYuSiZX1E2RcECQofwknBoU6v_Wys&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Request Chain 950
  • https://rtb.mfadsrvr.com/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmRVW-uymQU249N9m39VRE_7qFfHilVMv2nuuH1r4m6tl-mxYwEoCUIGcfz6901R9oM0wMPltmLPU5qfldtubR5SHMzAPT8sNpBq6W_n7t0wMtiScuMv44bQjjKbn3dSameMYbtTknQXUSCyI7XdhR5kyp8o HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmRVW-uymQU249N9m39VRE_7qFfHilVMv2nuuH1r4m6tl-mxYwEoCUIGcfz6901R9oM0wMPltmLPU5qfldtubR5SHMzAPT8sNpBq6W_n7t0wMtiScuMv44bQjjKbn3dSameMYbtTknQXUSCyI7XdhR5kyp8o
Request Chain 967
  • https://idsync.rlcdn.com/712188.gif?partner_uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent= HTTP 307
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fidsync.rlcdn.com%2F396846.gif%3Fserved_by%3Devergreen%26partner_uid%3D HTTP 302
  • https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
Request Chain 976
  • https://io.narrative.io/?companyId=673&id=pubmatic_id:A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20 HTTP 302
  • https://io.narrative.io/?io.narrative.guid.v2=d4d5fb11-caa2-11ee-a180-0a02e9f38595&companyId=673&id=pubmatic_id:A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 978
  • https://live.primis.tech/live/liveCS.php?source=external&advId=91&advUuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1402230080&3rdpcid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Request Chain 979
  • https://a.audrte.com/match?gdpr=0&gdpr_consent=&p=M1717054901&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=ar101281&google_hm=ZmM1VmhLV28zOTJULXF6T1BiUWhsNndCQQ%3D%3D&gdpr=0&gdpr_consent=&google_redir=https%3A%2F%2Fa.audrte.com%2Fddp%3Fred%3DeyJ1IjoiaHR0cHM6Ly9hLmF1ZHJ0ZS5jb206NDQzL3AiLCJkIjpbeyJuYW1lIjoiYWRmb3JtIn1dfQ%253D%253D HTTP 302
  • https://a.audrte.com/ddp?red=eyJ1IjoiaHR0cHM6Ly9hLmF1ZHJ0ZS5jb206NDQzL3AiLCJkIjpbeyJuYW1lIjoiYWRmb3JtIn1dfQ%3D%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://dmp.adform.net/serving/cookie/match/?party=1003&r=eyJ1IjoiaHR0cHM6Ly9hLmF1ZHJ0ZS5jb206NDQzL3AiLCJkIjpbXX0%3D&gdpr=0&gdpr_consent= HTTP 302
  • https://a.audrte.com/a?adform_uid=1956285366857158953&r=eyJ1IjoiaHR0cHM6Ly9hLmF1ZHJ0ZS5jb206NDQzL3AiLCJkIjpbXX0%3D HTTP 302
  • https://a.audrte.com/p
Request Chain 981
  • https://uipglob.semasio.net/pubmatic/1/info?sType=sync&sExtCookieId=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&sInitiator=external&gdpr=0&gdpr_consent= HTTP 302
  • https://uipglob.semasio.net/pubmatic/1/info2?sType=sync&sExtCookieId=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&sInitiator=external&gdpr=0&gdpr_consent=
Request Chain 982
  • https://pixel.onaudience.com/?partner=214&mapped=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent= HTTP 302
  • https://pixel.onaudience.com/?partner=109&icm&cver&gdpr=0&smartmap=1&redirect=tags.bluekai.com%2Fsite%2F33141%3F%26id%3D%25m HTTP 302
  • https://tags.bluekai.com/site/33141?&id=ca35505eabb3f550 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=bluekai&google_cm&google_sc&google_hm=UnpWai9BUWw5OWVuK0wraw%3D%3D HTTP 302
  • https://tags.bluekai.com/site/2981?id=&google_gid=CAESEDFth-uZ5uxu5R4z6sjbnjI&google_cver=1
Request Chain 984
  • https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dadf%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Di%26uid%3D%24UID HTTP 303
  • https://s2s.t13.io/setuid?bidder=adf&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=1956285366857158953
Request Chain 1008
  • https://live.primis.tech/live/liveCS.php?source=external&advId=91&advUuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20 HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1402230080&3rdpcid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20 HTTP 302
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1709765917%26mi%3D10%26csh%3D793790479%26rnd%3D393729055&pcid=$UID HTTP 302
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1709765917&mi=10&csh=793790479&rnd=393729055&pcid=5872803529851156248 HTTP 302
  • https://pixel.rubiconproject.com/exchange/sync.php?p=primis&r=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1725065545%26mi%3D10%26csh%3D793790479%3B1709765917%26rnd%3D1734619522%26pcid%3D HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=100&advUuid=LSKQGI85-W-KKFE HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE HTTP 302
  • https://x.bidswitch.net/sync?ssp=sekindo&r=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1267919208%26mi%3D10%26csh%3D793790479%26rnd%3D-1249684381%26pcid%3D HTTP 302
  • https://rtb.adstanding.com/ssp/bidswitch/cookie?bidswitch_ssp_id=sekindo&bidswitch_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=317&user_id=ac862dd225311b326a51d7adb14c026b&expires=30&ssp=sekindo&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://live.primis.tech/live/liveCS.php?source=external&advId=92&advUuid=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 301
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1267919208&3rdpcid=d9962442-c73f-42a4-adbd-3d9517e387ff HTTP 302
  • https://u.openx.net/w/1.0/cm?id=476b50d3-5ccf-49a1-89b8-1ddf8ea18042&r=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1486637409%26mi%3D10%26csh%3D793790479%26rnd%3D822573357%26pcid%3D HTTP 302
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1486637409&mi=10&csh=793790479&rnd=822573357&pcid=8b979bf4-7108-4d0c-86a3-3f353964681d HTTP 302
  • https://ads.yieldmo.com/pbsync?redirectUri=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1868283820%26mi%3D10%26csh%3D793790479%3B1486637409%26rnd%3D-142327749%26pcid%3D%24UID HTTP 302
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1868283820&mi=10&csh=793790479;1486637409&rnd=-142327749&pcid=V_ZrZhhNNrh6QBoKLRmb HTTP 302
  • https://eb2.3lift.com/getuid?redir=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D259151345%26mi%3D10%26csh%3D793790479%3B1486637409%3B1868283820%26rnd%3D-1274868859%26pcid%3D$UID HTTP 302
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=259151345&mi=10&csh=793790479;1486637409;1868283820&rnd=-1274868859&pcid=3900114537385664774839 HTTP 302
  • https://sync.smartadserver.com/getuid?url=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1881119486%26mi%3D10%26csh%3D793790479%3B1486637409%3B1868283820%3B259151345%26rnd%3D-474335130%26pcid%3D%5Bsas_uid%5D HTTP 302
  • https://sync.smartadserver.com/getuid?url=https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1881119486&mi=10&csh=793790479;1486637409;1868283820;259151345&rnd=-474335130&pcid=[sas_uid]&cklb=1

1004 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
118 KB
27 KB
Document
General
Full URL
https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
75.2.24.81 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ac539f5ac2983a882.awsglobalaccelerator.com
Software
nginx/1.12.2 / PHP/8.2.9
Resource Hash
61f46b2b9278c4df3746dc78a252498041bdb872a4d92d89578a3fa6b6dcbe61
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests; frame-ancestors 'self';
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

content-encoding
gzip
content-security-policy
upgrade-insecure-requests; frame-ancestors 'self';
content-type
text/html; charset=UTF-8
date
Tue, 13 Feb 2024 19:05:12 GMT
last-modified
Tue, 13 Feb 2024 18:03:56 GMT
referrer-policy
strict-origin-when-cross-origin
server
nginx/1.12.2
vary
Accept-Encoding
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-powered-by
PHP/8.2.9
x-xss-protection
0
style.min.css
d2eehagpk5cl65.cloudfront.net/wp-includes/css/dist/block-library/
108 KB
14 KB
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/css/dist/block-library/style.min.css
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
0085adfd2d08a45f62a06d8f3f969ddc4a94ebe8d226511db90aa038f11ed180

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:37:59 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088833
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 01 Feb 2024 04:06:04 GMT
server
nginx/1.12.2
etag
W/"65bb18ac-1ae43"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
gFtmb6_BdVI51uaCpzU6feV40CLXtB8a2IQ7O11CWtnY1dextWII3A==
expires
Sat, 02 Mar 2024 04:37:59 GMT
maropress-main.css
d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/wp-content/plugins/maropress/css/
4 KB
1 KB
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/wp-content/plugins/maropress/css/maropress-main.css?ver=1706762445
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
31d27b269e5d7a416b6897033e9c336d30dc10fbb8570da0f51d02fd08d5322f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:40:53 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088659
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 01 Feb 2024 04:40:45 GMT
server
nginx/1.12.2
etag
W/"65bb20cd-f58"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
iHdGXoEy3-iNkntT4098Wjw5YitSpkroVTjjp6cLAezoNd0-YLvHaA==
expires
Sat, 02 Mar 2024 04:40:53 GMT
fontawesome.min.css
d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/ajax/libs/font-awesome/6.2.1/css/
79 KB
17 KB
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/ajax/libs/font-awesome/6.2.1/css/fontawesome.min.css?ver=1706762445
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
ce0391b9b46ccf989341a8f2d17f4476b241ab5bcd9bbd01d995b860a751cb7b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:40:53 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088659
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 01 Feb 2024 04:40:45 GMT
server
nginx/1.12.2
etag
W/"65bb20cd-13b79"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
TpW5LE6JIQ12aSkxjBhe66PGlcGQCW5xIPfRDjTStj00eM4B3SaoGA==
expires
Sat, 02 Mar 2024 04:40:53 GMT
entity-plugin-public.css
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/ttd-entity-plugin/public/css/
100 B
533 B
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/ttd-entity-plugin/public/css/entity-plugin-public.css
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
39bc46065e200b12daf790967d30034f4dd25d9a3af34086bbcab91729af5da0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:46 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480566
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 22 Feb 2023 21:14:15 GMT
server
nginx/1.12.2
etag
W/"63f685a7-64"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
z9-xD-RBB1W5qpvIst9P3IL3mwD5YwoIyQ4tcdmwjZ20aLG0abKRQA==
expires
Sat, 09 Mar 2024 05:35:46 GMT
mediaelementplayer-legacy.min.css
d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/
11 KB
3 KB
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/mediaelementplayer-legacy.min.css
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
b7908a015a567ec2363011df2475368dbff34360e9da3fdff50604d6395fb646

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:37:59 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088833
x-cache
Hit from cloudfront
pragma
public
last-modified
Tue, 26 Jan 2021 18:21:03 GMT
server
nginx/1.12.2
etag
W/"60105d8f-2bf8"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
7kax0IETxZV_gQki8zkMf_3rpVmsqa8fs_XBIECS5zKXNX9KvxxKGA==
expires
Sat, 02 Mar 2024 04:37:59 GMT
wp-mediaelement.min.css
d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/
4 KB
2 KB
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/wp-mediaelement.min.css
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
2e10d353ff038c2cad3492fc17801af3e6ef2669c9e9713bdb78b1dcb104c4fe

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Tue, 16 Jun 2020 21:09:19 GMT
server
nginx/1.12.2
etag
W/"5ee934ff-105a"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
Nvvp0dfaFL0vUifeNVMrePJcGn5QrokhdrfQmBRAYOxDLd2j3gH_PQ==
expires
Sat, 02 Mar 2024 04:38:00 GMT
main_632a503b.css
d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/wp-content/themes/reason-dot-com-theme/dist/styles/
666 KB
89 KB
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/wp-content/themes/reason-dot-com-theme/dist/styles/main_632a503b.css?ver=1706762446
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
daa4cbaee166d4883b6705ca2b999cbe7a814a13b16b1cdccb33a683c04f118b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:40:53 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088659
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 01 Feb 2024 04:40:46 GMT
server
nginx/1.12.2
etag
W/"65bb20ce-a68cb"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
yiEO-Mtl2pKZILTBFZad2KjwfR7b6aQ4hoY4nBrupgCSaNY999lawA==
expires
Sat, 02 Mar 2024 04:40:53 GMT
kdp6eed.css
d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/
8 KB
1 KB
Stylesheet
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
21a61951800bfa0ef218eae43525cc19719dc1326ce9165c53ac97d929a96c90

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:40:53 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088659
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 01 Feb 2024 04:40:46 GMT
server
nginx/1.12.2
etag
W/"65bb20ce-214d"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
njOUl3xhxqoh1rUQM0OmKq8RNnPjCTXAqGFF4W7VaPgkciJ2Hi3Hrg==
expires
Sat, 02 Mar 2024 04:40:53 GMT
jquery.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/jquery/
86 KB
30 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/jquery/jquery.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
cb6f2d32c49d1c2b25e9ffc9aaafa3f83075346c01bcd4ae6eb187392a4292cf

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 15 Nov 2023 06:05:33 GMT
server
nginx/1.12.2
etag
W/"65545fad-15601"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
p73pOkKbb3Xq_6P9Uu6j-PwrW7S0jsLL9OmC0NjnstTFCqbsrMKT-A==
expires
Sat, 02 Mar 2024 04:38:00 GMT
jquery-migrate.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/jquery/
13 KB
5 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/jquery/jquery-migrate.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
5274f11e6fb32ae0cf2dfb9f8043272865c397a7c4223b4cfa7d50ea52fbde89

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 10 Aug 2023 20:14:52 GMT
server
nginx/1.12.2
etag
W/"64d5453c-3509"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
r1unVxUF4S5-sREbrUKMVCxMfaWiU2CmyzMNzjxGadhi7jgKoZZRwA==
expires
Sat, 02 Mar 2024 04:38:00 GMT
widget.js
disco.headliner.link/d/reason/web/js/
173 KB
53 KB
Script
General
Full URL
https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ec8cb2c546610f2da7c4541df230fe743e3fff1027b88f5043dd7d5edd3809cc

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:06 GMT
content-encoding
gzip
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:51 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
264
x-amz-server-side-encryption
AES256
etag
W/"b8bbe6a4ba3805c6985593537999233a"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=300
x-amz-cf-id
lsL_b5nISFQMUGA1j2wNaSEVChtoEj5ESNgUiGB2-2yM55XX3m2-JQ==
jquery.json.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/js/
2 KB
1 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/js/jquery.json.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
998a575c7b376128a98e6d67e29c42e1726aac3489cf2c0b2aaebf6f6ad0b546

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:47 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480565
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 07 Feb 2024 21:35:04 GMT
server
nginx/1.12.2
etag
W/"65c3f788-72c"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
Dexkk2ctBM4sKAhpBmFuWvuY1aB_DaTbNY4qdk3aDu0CTA4fFS44mQ==
expires
Sat, 09 Mar 2024 05:35:47 GMT
gravityforms.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/js/
46 KB
14 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/js/gravityforms.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
8e2ffd596c0b4460f148da17323c71c3a1cacb853b4502e5d6953cda9b107e33

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:47 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480565
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 07 Feb 2024 21:35:04 GMT
server
nginx/1.12.2
etag
W/"65c3f788-b655"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
zcAGUvaD1eoQ5FVQnOOItcXbdwqWDa5z4me-x99d30gfVrcAO46c5A==
expires
Sat, 09 Mar 2024 05:35:47 GMT
utils.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/assets/js/dist/
38 KB
12 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/assets/js/dist/utils.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
05a02a17f79ea82224a296d1b3067e36ae3440fca4172aead3b8fee4a4cfe770

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:47 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480565
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 07 Feb 2024 21:35:04 GMT
server
nginx/1.12.2
etag
W/"65c3f788-97ad"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
UQsuuatM8BfXBFGLSD3iR0_OxeqJTkqI_WolT3C79KuFKXsvlvNS0Q==
expires
Sat, 09 Mar 2024 05:35:47 GMT
fb11e7c284.js
kit.fontawesome.com/
12 KB
5 KB
Script
General
Full URL
https://kit.fontawesome.com/fb11e7c284.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
bf6d2981274c66071015713279ca4880bd86d27e4c4499e793cb042a6090fa55

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:12 GMT
content-encoding
gzip
cf-cache-status
HIT
server
cloudflare
vary
origin, accept-encoding, access-control-request-headers, access-control-request-method
access-control-max-age
3000
access-control-allow-methods
GET, OPTIONS
access-control-allow-origin
*
content-type
text/javascript
cache-control
max-age=60, public, stale-while-revalidate=30
cf-ray
854f576fbed74bc7-BUF
access-control-allow-headers
accept, accept-langauge, content-language, content-type, fa-kit-token
x-request-id
F6_42jcpM5LDTnH6BTch
maropress-main.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/maropress/js/
3 KB
1 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/maropress/js/maropress-main.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
344959bddc64d183467f0279e9b20db8cc07213e21a3744c319df50a29c01a75

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:48 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480564
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 14 Dec 2023 02:50:57 GMT
server
nginx/1.12.2
etag
W/"657a6d91-aae"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
c-la5EAiIyNLdrGmKvklWDIuSXYfrquToEDi4SBzwGipN-HE6aEIQA==
expires
Sat, 09 Mar 2024 05:35:48 GMT
reason-parsely-public.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/reason-parsely/public/js/
8 KB
3 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/reason-parsely/public/js/reason-parsely-public.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
db3cabbff3b86075c9b2d9fc228cfd59d638c5deddc400f21a9ebf065902681f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:48 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480564
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 08 Feb 2023 05:31:49 GMT
server
nginx/1.12.2
etag
W/"63e333c5-1e0f"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
ixbYIlhWnBCW_fHtkMA2rfe1_kKIbf0aygB3Tlmg5mwNYTffA7zA5A==
expires
Sat, 09 Mar 2024 05:35:48 GMT
api.js
www.google.com/recaptcha/
1 KB
1 KB
Script
General
Full URL
https://www.google.com/recaptcha/api.js?render=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&ver=1.4.0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
6162b5a9341d5e302a9f376fc8b4f10793a525eba5c6d6779ccc28f5607054a1
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Tue, 13 Feb 2024 19:05:12 GMT
mediaelement-and-player.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/
154 KB
38 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/mediaelement-and-player.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
b15c3ea03d50c2430490e7416733a254feea4237bb60b54181bd3473ebe4149f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Tue, 15 Nov 2022 05:07:59 GMT
server
nginx/1.12.2
etag
W/"63731eaf-26935"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
xNfZqZp5sGJYkpdYdZzwrpMoyewKzXkTfZSHh4R6EA-pczwukRPIAA==
expires
Sat, 02 Mar 2024 04:38:00 GMT
mediaelement-migrate.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/
1 KB
986 B
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/mediaelement-migrate.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
6d161e98e47ae150b51211443eef37040fb6269dcf85ad2048548066dca99e6f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 29 Jun 2022 01:11:18 GMT
server
nginx/1.12.2
etag
W/"62bba6b6-4a7"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
cOtPYIhFWpazYMnmxesqPMAxEy_HqggQJB_o90P4z9rSoaG9Oir-KQ==
expires
Sat, 02 Mar 2024 04:38:00 GMT
wp-mediaelement.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/
1 KB
984 B
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/mediaelement/wp-mediaelement.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
79cb399203843f65199bec32bc4abac5dfd20f141d3e4ec1424bf00c7108fa45

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 30 Mar 2023 22:05:04 GMT
server
nginx/1.12.2
etag
W/"64260790-453"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
f_emV8LDQp00gGVguvcU7TaKDSL7mSR9S--hZmiXIRh1uyqFwag2Og==
expires
Sat, 02 Mar 2024 04:38:00 GMT
main_024eb38d.js
d2eehagpk5cl65.cloudfront.net/wp-content/themes/reason-dot-com-theme/dist/scripts/
548 KB
147 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/themes/reason-dot-com-theme/dist/scripts/main_024eb38d.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
1650b465508ca02b3d7c2c5e2f627ed7244619e5583f57dfbebf6144e4442526

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:48 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480564
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 01 Feb 2024 21:35:39 GMT
server
nginx/1.12.2
etag
W/"65bc0eab-890a1"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
YZ1LCji4kdYGpeRu72dh26wjxYu2Zlhc728oCSPVaE0s_r3Fm4uHeA==
expires
Sat, 09 Mar 2024 05:35:48 GMT
pdf.min.js
cdn.jsdelivr.net/npm/pdfjs-dist@2.13.216/build/
230 KB
65 KB
Script
General
Full URL
https://cdn.jsdelivr.net/npm/pdfjs-dist@2.13.216/build/pdf.min.js?ver=6.4.3
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a04:4e42:400::485 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
6239fdad01c378ddbd5c5a5937d8a2c5c488e657fd4a97e6bffde0fb0de0a9aa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains; preload
date
Tue, 13 Feb 2024 19:05:12 GMT
x-content-type-options
nosniff
content-encoding
br
age
1800937
x-jsd-version
2.13.216
x-cache
HIT, HIT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
65944
x-served-by
cache-fra-etou8220028-FRA, cache-nyc-kteb1890053-NYC
x-jsd-version-type
version
etag
W/"398c4-2ChgfL5a9olnFR2UMN2Z2sDCAU8"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=31536000, s-maxage=31536000, immutable
accept-ranges
bytes
timing-allow-origin
*
comment-reply.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/
3 KB
2 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/comment-reply.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
e174a58a503ab84b3d1b9de12fd3895788204485170f1289e445f7b5b98ec789

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:02 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088830
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 29 Jun 2022 01:11:18 GMT
server
nginx/1.12.2
etag
W/"62bba6b6-ba5"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
6d8NnpNzsGGCOQb-7XjVJ6n0rxYWSnEu5OCcx4FIFrCYXQ1PsKOXnQ==
expires
Sat, 02 Mar 2024 04:38:02 GMT
wp-polyfill-inert.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/vendor/
8 KB
3 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/vendor/wp-polyfill-inert.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
c1a9a3e223bad631dff12d33b5499eb145cb08d8621c20d9d73870e78d97afe4

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 30 Mar 2023 22:05:04 GMT
server
nginx/1.12.2
etag
W/"64260790-1feb"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
tTjW9n4YDFLZMm7YhogbCsJx5RhqQ24agrDWLK-yoGMsmeYKjTn0Ow==
expires
Sat, 02 Mar 2024 04:38:00 GMT
regenerator-runtime.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/vendor/
6 KB
3 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/vendor/regenerator-runtime.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
1d52e1ac7d3bc25a8b0ffc257153f9dd50249f96fe9a4df5e0d771241a69062c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 15 Nov 2023 06:05:33 GMT
server
nginx/1.12.2
etag
W/"65545fad-19e1"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
gpC17KEjuUcnANpEGo4LUPw1XoLivP-VaAqjaHuCEttCcyMNpei5pw==
expires
Sat, 02 Mar 2024 04:38:00 GMT
wp-polyfill.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/vendor/
112 KB
35 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/vendor/wp-polyfill.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
da9ed5720b674f0d297fe621ac2d8d518c4e622bef1e9b0d4ae489dee9aa43f8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 15 Nov 2023 06:05:33 GMT
server
nginx/1.12.2
etag
W/"65545fad-1c1b7"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
9257ESzJTSb5AAbkR1fLHo0bmpNlJwFYtI4VRbwuqsudFCjYY0bZbA==
expires
Sat, 02 Mar 2024 04:38:00 GMT
dom-ready.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/
498 B
776 B
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/dom-ready.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
166c7c3bb5f76f977a9f2a5490589b3466374eb2b3f064802e56f08bad71fbf0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 29 Jun 2022 01:11:18 GMT
server
nginx/1.12.2
etag
W/"62bba6b6-1f2"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
gUdLAqiqYf69O0RSRsSpghCvgAcPr9r7oiptFoOz0Xb6eL4kVLHSyg==
expires
Sat, 02 Mar 2024 04:38:00 GMT
hooks.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/
5 KB
2 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/hooks.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
7868467c94a5aa0b3f11ef542f45287967f9627b3b5acdc86e47f8f77a126596

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 10 Aug 2023 20:14:52 GMT
server
nginx/1.12.2
etag
W/"64d5453c-1213"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
_j3dUo3oEzA0wtI-B2ccC43Cr2TLyvgqzPTHcVUsPcN6V0prL_r8RA==
expires
Sat, 02 Mar 2024 04:38:00 GMT
i18n.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/
9 KB
4 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/i18n.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
698e93fe491cc7bbf07a470579a33dbd0db53c19142b7be41ebfd39a23aef11f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 10 Aug 2023 20:14:52 GMT
server
nginx/1.12.2
etag
W/"64d5453c-24e5"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
x3M7-GeDqzme3P23T7A37SOTyhG0HPsZ8IOp1w-v-JhUw4LQD9WnOw==
expires
Sat, 02 Mar 2024 04:38:00 GMT
a11y.min.js
d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/
2 KB
1 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/dist/a11y.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
d35faa1c0b45cc142295ae07a0c6e6e7824e0e64b58b81a83e7850251586e0df

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 01 Feb 2024 04:38:00 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
1088832
x-cache
Hit from cloudfront
pragma
public
last-modified
Thu, 10 Aug 2023 20:14:51 GMT
server
nginx/1.12.2
etag
W/"64d5453b-990"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
bh6fmCF0I_BZiKeWX4HrJPOcrGO8Wwx3m2gqbKcNfYiW2XCgH62frw==
expires
Sat, 02 Mar 2024 04:38:00 GMT
placeholders.jquery.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/js/
5 KB
2 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/js/placeholders.jquery.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
d62a7b7ec5313469ebff5c006b9068dc44d6d1c122cf787ffa29a10113b34060

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:49 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480563
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 07 Feb 2024 21:35:04 GMT
server
nginx/1.12.2
etag
W/"65c3f788-121f"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
W7ZxLBqvtnUwhsdSeiPia3ZNkZy7yOG4eHdI1Fk0SHiNZAmMrqoE-A==
expires
Sat, 09 Mar 2024 05:35:49 GMT
vendor-theme.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/assets/js/dist/
17 KB
7 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/assets/js/dist/vendor-theme.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
6b63f93f45b836123619e22860a43538ac0cd157f7afd2f58134e28e5e18fa04

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:49 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480563
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 07 Feb 2024 21:35:04 GMT
server
nginx/1.12.2
etag
W/"65c3f788-438a"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
t-_3taBkW1eqf2vJrNOhKvBRHTb2a_h1dCbjxv3bidfyXG48BGOSbA==
expires
Sat, 09 Mar 2024 05:35:49 GMT
scripts-theme.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/assets/js/dist/
4 KB
2 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityforms/assets/js/dist/scripts-theme.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
fff9001fa9a705871580a83e3c2916c7d136360c55bf0b5ac88d6e055085678d

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:49 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480563
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 07 Feb 2024 21:35:04 GMT
server
nginx/1.12.2
etag
W/"65c3f788-1043"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
LYyIE-X7NSLtyT8ZgrCU3AY7zY3Nd42YZ5Dl9Os4cf_ULrZG6AIX8Q==
expires
Sat, 09 Mar 2024 05:35:49 GMT
frontend.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityformsrecaptcha/js/
1 KB
1007 B
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/gravityformsrecaptcha/js/frontend.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
8b06d3affac3175146480932ddc0324f0f049a625788810d2e5d50a6061a3a57

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:49 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480563
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 17 Jan 2024 23:32:52 GMT
server
nginx/1.12.2
etag
W/"65a863a4-456"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
lPbFm4vRWZSLGH-WWJazg465tQ_Np778ObU-CwjNkTkYQU6C_An7aQ==
expires
Sat, 09 Mar 2024 05:35:49 GMT
akismet-frontend.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/akismet/_inc/
11 KB
4 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/akismet/_inc/akismet-frontend.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
6bc5622bfab1a16855ad49b99a3f9ed8eb24f49da469a113f9000b866f109e2e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:49 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480563
x-cache
Hit from cloudfront
pragma
public
last-modified
Wed, 17 Jan 2024 23:32:49 GMT
server
nginx/1.12.2
etag
W/"65a863a1-2c7c"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
8cOOgwxBCZHkI-4Fyxgu8l3Za_0ZXWL2ldcBIz7_U1frUAAL01mj2A==
expires
Sat, 09 Mar 2024 05:35:49 GMT
lazyload.min.js
d2eehagpk5cl65.cloudfront.net/wp-content/plugins/wp-rocket/assets/js/lazyload/17.8.3/
9 KB
3 KB
Script
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/plugins/wp-rocket/assets/js/lazyload/17.8.3/lazyload.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
f40767552e5e94b2d5f9a65d7f640cfa7d225298023dbd682095e040809a3d1a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 08 Feb 2024 05:35:49 GMT
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
480563
x-cache
Hit from cloudfront
pragma
public
last-modified
Tue, 23 Jan 2024 20:36:32 GMT
server
nginx/1.12.2
etag
W/"65b02350-22bc"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=2592000, public
x-amz-cf-id
S3hBTJ9ELA2mDM_qfOWMHcesNth8UiRUyn18kVzEeImb9H-mty4-Nw==
expires
Sat, 09 Mar 2024 05:35:49 GMT
gtm.js
www.googletagmanager.com/
266 KB
91 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c0b::61 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
2a4b1d50617d6b0c7fa1058c7dac88486ce3a9a48308e25a954e57999486cc51
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:12 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
92844
x-xss-protection
0
pragma
no-cache
server
Google Tag Manager
vary
*
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Fri, 01 Jan 1990 00:00:00 GMT
p.css
p.typekit.net/
5 B
172 B
Stylesheet
General
Full URL
https://p.typekit.net/p.css?s=1&k=kdp6eed&ht=tk&f=12784.12785.12786.12093.12094.12095.12096.12097.12098.39391.39392.39393.39394&a=8312177&app=typekit&e=css
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf39 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
1c0ff118a4290c99f39c90abb38703a866e47251b23cca20266c69c812ccafeb

Request headers

accept-language
en-US,en;q=0.9
Referer
https://d2eehagpk5cl65.cloudfront.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:12 GMT
last-modified
Fri, 07 Jul 2023 12:45:47 GMT
server
nginx
etag
"64a808fb-5"
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
content-length
5
truncated
/
68 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
3a8b9445429ac674bc5de389a101958beb51b842a0536a841f39bea7e503ba03

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
64 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b6dcc1490a0cc33cdeed8970677b89bbec6fa095675af198b8e923b64563c70a

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
69 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
aaf69f969c85107828b863ad90f70534c60fc64cbb1a7f3e28d78692d8854db5

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/svg+xml
l
use.typekit.net/af/b825af/0000000000000000000118b1/27/
15 KB
15 KB
Font
General
Full URL
https://use.typekit.net/af/b825af/0000000000000000000118b1/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n7&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
a67e86b7f5b03d2017080fb3d210007b67a13df1e74251d3cba316c0e080ceca

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"c8dc9b7e7a1d0662534fe35674f59bb3142931dd"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
15568
l
use.typekit.net/af/9cb78a/0000000000000000000118ad/27/
16 KB
16 KB
Font
General
Full URL
https://use.typekit.net/af/9cb78a/0000000000000000000118ad/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n4&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
ade11a781ff76223c32cdda408ec3af85b07a09d566d797fd137bcd65421d928

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"cf85d3e73680abc7bbab8e9752ec31b971a3f801"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
16176
l
use.typekit.net/af/a30f3c/00000000000000003b9b2245/27/
37 KB
37 KB
Font
General
Full URL
https://use.typekit.net/af/a30f3c/00000000000000003b9b2245/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n5&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
a66ddbbc3eb0fc75c9c5d16e34b5453654bd77c155b18fbeb56f7f1a78fd4734

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"db064cb825c6889929885aa58d504bd27fc96346"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
37452
l
use.typekit.net/af/f7c92b/00000000000000003b9b22f3/27/
27 KB
27 KB
Font
General
Full URL
https://use.typekit.net/af/f7c92b/00000000000000003b9b22f3/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n4&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
8547c99c194ebc6cac9f876b0895869e804a4008ab1f9678bf0b1469d894de7a

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"c63edd3712709b7bc13b02c69b356ddcb82906a9"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
27884
l
use.typekit.net/af/a2031c/0000000000000000000118b9/27/
15 KB
15 KB
Font
General
Full URL
https://use.typekit.net/af/a2031c/0000000000000000000118b9/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n7&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
d683d665477acd35775b01968b08f03bcca275c486f295cd8cb081f7eb3c6172

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"a0bb85431e20a75f18ae71734043ea33b1d688c7"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
14964
l
use.typekit.net/af/bb00d4/00000000000000003b9b2244/27/
35 KB
36 KB
Font
General
Full URL
https://use.typekit.net/af/bb00d4/00000000000000003b9b2244/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n4&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
5900ec4e3d1b98ff1c37fe2c93a4f9c178aec22351212a6b6fe8f0e59c6500d4

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"2d5ff04193fe0e1dda3985e4960df2053720af2e"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
36336
l
use.typekit.net/af/494bab/00000000000000003b9b22f4/27/
21 KB
21 KB
Font
General
Full URL
https://use.typekit.net/af/494bab/00000000000000003b9b22f4/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i4&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
0eac165273099823e49dcbbd777c08abf88b79b949c583fef7402b769dc9a122

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"32d733d7fd7e3971a8e59954c3f9695513445bcd"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
21160
recaptcha__en.js
www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/
490 KB
195 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/recaptcha__en.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api.js?render=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&ver=1.4.0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c17::5e Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5aa02ad9ec4550065de8002ea1108be5d10bbb1173d2f3447f88ce1af317d4bd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:34:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1855
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
199529
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 05:00:25 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Wed, 12 Feb 2025 18:34:17 GMT
logo_2ea65906.svg
d2eehagpk5cl65.cloudfront.net/wp-content/themes/reason-dot-com-theme/dist/images/
7 KB
3 KB
Image
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/themes/reason-dot-com-theme/dist/images/logo_2ea65906.svg
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
9c87c65aef78ebdc853db80b3d9506f02b5845000270f2be0d4bde3a4ac26b51
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self';

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-security-policy
frame-ancestors 'self';
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
date
Tue, 13 Feb 2024 03:21:40 GMT
last-modified
Thu, 01 Feb 2024 21:35:39 GMT
server
nginx/1.12.2
x-amz-cf-pop
YUL62-P2
age
56867
etag
W/"65bc0eab-1c2c"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
image/svg+xml
x-amz-cf-id
WGeDt7UTReMNgGfXmaSdTr8gFmKdEWMLvgPrruK5GnbcnzNq5Ybvpw==
r-in-g1-01_36e38c66.svg
d2eehagpk5cl65.cloudfront.net/wp-content/themes/reason-dot-com-theme/dist/images/
341 B
600 B
Image
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/wp-content/themes/reason-dot-com-theme/dist/images/r-in-g1-01_36e38c66.svg
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
56d2b20686b276daeb62693e4fcb77ada044c91ce6f9121060829466efa95a67
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self';

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-security-policy
frame-ancestors 'self';
content-encoding
gzip
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
date
Tue, 13 Feb 2024 09:22:59 GMT
last-modified
Thu, 01 Feb 2024 21:35:39 GMT
server
nginx/1.12.2
x-amz-cf-pop
YUL62-P2
age
39689
etag
W/"65bc0eab-155"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
image/svg+xml
x-amz-cf-id
IQy9pcWyrzj_DqxPMOB19kRL1S1UZKcZtz8NFbmlKPQvUhP-r9nJ0Q==
pain-pills-k-state-flickr-1200x675.jpg.webp
d2eehagpk5cl65.cloudfront.net/img/c1200x675-w1200-q80/uploads/2019/08/
40 KB
41 KB
Image
General
Full URL
https://d2eehagpk5cl65.cloudfront.net/img/c1200x675-w1200-q80/uploads/2019/08/pain-pills-k-state-flickr-1200x675.jpg.webp
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:be00:6:9e1e:cb40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 / PHP/8.2.9
Resource Hash
6a40e82360cdd2a1b4008e0108af1e2f71cdb12aec3ce3801bbc551dc45ba23c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 12:14:28 GMT
via
1.1 2080aae7ace369c71819923852e1b17e.cloudfront.net (CloudFront)
x-ir-quality
80
x-amz-cf-pop
YUL62-P2
age
24644
x-powered-by
PHP/8.2.9
x-cache
Hit from cloudfront
content-disposition
filename="pain-pills-k-state-flickr-1200x675.jpg.webp"
x-ir-cached
1
x-ir-first-gen
0
pragma
public
last-modified
Sat, 30 Dec 2023 17:21:14 GMT
server
nginx/1.12.2
access-control-allow-methods
GET, OPTIONS
content-type
image/webp
access-control-allow-origin
*
cache-control
max-age=2592000, public
access-control-allow-headers
DNT,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Range
x-amz-cf-id
cLqGh7pGVhgoP_E0OlNDqMZRP5DEGPu4RPw8DaoaYSDPpp-6mD5bZw==
expires
Thu, 14 Mar 2024 12:14:28 GMT
pro.min.css
ka-p.fontawesome.com/releases/v5.15.4/css/
315 KB
53 KB
Fetch
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/css/pro.min.css?token=fb11e7c284
Requested by
Host: kit.fontawesome.com
URL: https://kit.fontawesome.com/fb11e7c284.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
37c65071f378cc9582aabdda3b52979ef901f2925e3f3c3dc597f41eac0f1b6d

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:12 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:53:09 GMT
server
cloudflare
age
7020542
etag
"610ae215-d3b2"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57701f0a4bc7-BUF
content-length
54194
pro-v4-shims.min.css
ka-p.fontawesome.com/releases/v5.15.4/css/
26 KB
4 KB
Fetch
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/css/pro-v4-shims.min.css?token=fb11e7c284
Requested by
Host: kit.fontawesome.com
URL: https://kit.fontawesome.com/fb11e7c284.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4245ecca2a4b50d7fd9adc9a965ed1f9b4ec24e9935e34c80efafc0f856d54c6

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:12 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:53:09 GMT
server
cloudflare
age
7086986
etag
"610ae215-1062"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57701f0c4bc7-BUF
content-length
4194
pro-v4-font-face.min.css
ka-p.fontawesome.com/releases/v5.15.4/css/
27 KB
3 KB
Fetch
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/css/pro-v4-font-face.min.css?token=fb11e7c284
Requested by
Host: kit.fontawesome.com
URL: https://kit.fontawesome.com/fb11e7c284.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a8a00b576cc9fad532a52ecdf8024724ddaa83cb0f5ca5d1b1d6eb8841103d60

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:12 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:53:09 GMT
server
cloudflare
age
7086986
etag
"610ae215-a2b"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57701f094bc7-BUF
content-length
2603
vendors~campaign-preview-app~widget-app.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
33 KB
11 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/vendors~campaign-preview-app~widget-app.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
8597c503c5629eb01184c946b63223eb3fa0e4686248f895a4ed85ec06f031c5

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:06 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:51 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385567
etag
W/"798d6ed3d585520ab8f0d5e7a4b1eb16"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
SZI4og7lCYhYZ91l0jSvsCLZ2hRhHEbYZbLrFxkji9-j-j56WKgHcg==
widget-app.chunk.css
disco.headliner.link/artifacts/web/5.28.0-130/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/widget-app.chunk.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b0bb36cb2b9915f737b7a54b5d2bb7406cbabc09eaa0b038c04670488148c6b3

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:06 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385567
etag
W/"37fc120929e0fb86c463be42fa6bda89"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
hEtpMQTDrVkAMw8vIdB0G8k6dmLwItL21TCrv5DPjBegdzyiDHf9Pw==
widget-app.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
31 KB
7 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/widget-app.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
bf361161d465b91280dab6bf9a1e0441011caa3321ebe19a3cea10759aca9b8d

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:06 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:51 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385567
etag
W/"d786426a0ab215fe2e923eac4a01fbc7"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
iZE0XtSuI6t-41bvUbb6AJrETLXTkbe5ZZ3A8xz7uphmMZtYz0PyZA==
iframe_api
www.youtube.com/
993 B
2 KB
Script
General
Full URL
https://www.youtube.com/iframe_api
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/themes/reason-dot-com-theme/dist/scripts/main_024eb38d.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c17::5b Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
8a08b83be0a016087653926673ec3cb72c2403c76c2347d2d2b9a0f61bd8cdde
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
content-encoding
br
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=en for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/javascript; charset=utf-8
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
private, max-age=0
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Tue, 13 Feb 2024 19:05:13 GMT
l
use.typekit.net/af/ce6b1d/0000000000000000000118ba/27/
15 KB
15 KB
Font
General
Full URL
https://use.typekit.net/af/ce6b1d/0000000000000000000118ba/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i7&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
992426e626ddf618e47d796b2a087cf182488ead2568671ddf566f43faea9bfe

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"738db95216f0a77f5d41c4f9989b8ee99a181d12"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
15240
l
use.typekit.net/af/2e6f07/000000000000000000011ce6/27/
15 KB
15 KB
Font
General
Full URL
https://use.typekit.net/af/2e6f07/000000000000000000011ce6/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n5&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
9d649939384a4d75112be65b8f44b602808d7182e9e1dfd57d715d601ec94d9d

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"d998a4e79e8aaf233c29495fe84b529cdc52acfc"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
15628
uc.js
consent.cookiebot.com/
109 KB
34 KB
Script
General
Full URL
https://consent.cookiebot.com/uc.js?cbid=611f3eb1-367f-42c6-859c-19d0fa7244f3&consentmode-dataredaction=dynamic&framework=IAB
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1408:5400:1d::173d:b86 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
92f06f19786b23eef48cbd094d2c2716158a52fc7258250da0e8fdf4bf249fb7

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

request-context
appId=cid-v1:89f47f4b-bed0-4db8-956b-d6e6dfac3fef
date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
gzip
last-modified
Mon, 05 Feb 2024 09:22:29 GMT
etag
"20d92bd71458da1:0"
vary
Accept-Encoding
content-type
application/javascript
access-control-expose-headers
Request-Context
cache-control
public, max-age=955
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
content-length
34339
expires
Tue, 13 Feb 2024 19:21:08 GMT
pro-fa-solid-900-5.0.0.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
19 KB
19 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-solid-900-5.0.0.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1b50aa1d36ea249991fb44f8f6ad2aa74fe360df9cc04c564b5edf3b053b739c

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:39 GMT
server
cloudflare
age
7086985
etag
"610ae35f-4d48"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f8c4bc7-BUF
content-length
19784
pro-fa-regular-400-5.0.11.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
4 KB
4 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-regular-400-5.0.11.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a99869e51e3c5a515bb290ca6f1aa885a2feac8d58984a5e39dd3030e663f9e5

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:36 GMT
server
cloudflare
age
7086985
etag
"610ae35c-f78"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f8e4bc7-BUF
content-length
3960
pro-fa-solid-900-5.10.2.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
13 KB
13 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-solid-900-5.10.2.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
46fa33cc9340603e767415c1829c08b91f3a3680b9800047dbc1bda91b8eb0ac

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:41 GMT
server
cloudflare
age
1113103
etag
"610ae361-33d4"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f8f4bc7-BUF
content-length
13268
pro-fa-solid-900-5.11.0.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
12 KB
12 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-solid-900-5.11.0.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6bcade3d96c0c0fb1950e54b96b0f4cfa7f51e45a99dd8f12224fb0530ac432d

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:41 GMT
server
cloudflare
age
6987961
etag
"610ae361-2f70"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f914bc7-BUF
content-length
12144
pro-fa-brands-400-5.14.0.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
3 KB
3 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-brands-400-5.14.0.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a69381514210cefa9794478d2d379578d97b8a2367b8a1b3b4481e3d0b1afceb

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:26 GMT
server
cloudflare
age
7020543
etag
"610ae352-ca4"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f924bc7-BUF
content-length
3236
pro-fa-brands-400-5.8.2.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
2 KB
2 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-brands-400-5.8.2.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
322c181b1aab5807cd0a7ed9e249ddbd97fa385ca3d338aa59ef1f610ca24601

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:27 GMT
server
cloudflare
age
7086985
etag
"610ae353-96c"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f944bc7-BUF
content-length
2412
pro-fa-brands-400-5.0.0.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
37 KB
37 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-brands-400-5.0.0.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
49fd3e0c64f247cf56cb828bc37b88cf139df6e5c7bb4c3a4507f740e9a52c17

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:25 GMT
server
cloudflare
age
7214906
etag
"610ae351-93a4"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f954bc7-BUF
content-length
37796
pro-fa-solid-900-5.0.9.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
6 KB
6 KB
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-solid-900-5.0.9.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5c6f8529544df44b0b1351226e2f57369c3f955b3f2269e29690c6fa4bc8ad8b

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:41 GMT
server
cloudflare
age
6930203
etag
"610ae361-17e0"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f964bc7-BUF
content-length
6112
pro-fa-brands-400-5.0.9.woff2
ka-p.fontawesome.com/releases/v5.15.4/webfonts/
888 B
963 B
Font
General
Full URL
https://ka-p.fontawesome.com/releases/v5.15.4/webfonts/pro-fa-brands-400-5.0.9.woff2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::6812:2844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d851586da5456374e2663a2b47b2a60f14670dd673f931bf7b198e462f89cc67

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
cf-cache-status
HIT
last-modified
Wed, 04 Aug 2021 18:58:25 GMT
server
cloudflare
age
7086985
etag
"610ae351-378"
vary
Origin, Accept-Encoding, Access-Control-Request-Headers, Access-Control-Request-Method
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
854f57718f984bc7-BUF
content-length
888
js
www.googletagmanager.com/gtag/
268 KB
91 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-JCN3MXE1WR&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c0b::61 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
dfae7a4c50c1e5d9ab353c8a6ef615dbe9db806b4ba7b14dd61c70f3d987f636
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
92753
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 13 Feb 2024 19:05:13 GMT
js
www.googletagmanager.com/gtag/
277 KB
92 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-SYGD5NBRJH&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c0b::61 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
1dcd3cf6e901279ddb6abfbacbad1a4cedc3c3d97f190ab029d5eebe68e3afb1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
94276
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 13 Feb 2024 19:05:13 GMT
analytics.js
www.google-analytics.com/
52 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:38::178 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
date
Tue, 13 Feb 2024 18:06:18 GMT
last-modified
Tue, 12 Dec 2023 18:09:08 GMT
server
Golfe2
age
3535
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20994
expires
Tue, 13 Feb 2024 20:06:18 GMT
anchor
www.google.com/recaptcha/api2/ Frame 779E
45 KB
28 KB
Document
General
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/recaptcha__en.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
96250dc39f244c08bf225a1ae73c85297e7a85e0dfe6b2fcd3640bc8b791e5f4
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-WpNAptMU-OJFbjt9I1kSuw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-WpNAptMU-OJFbjt9I1kSuw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:13 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
widget-request
api.headliner.link/api/v1/widget/
5 KB
5 KB
XHR
General
Full URL
https://api.headliner.link/api/v1/widget/widget-request?q=A%20new%20pain%20medication%20could%20reinforce%20the%20disastrous%20crackdown%20on%20prescription%20opioids&sessionId=SS_clskqggln00003c742edu859z&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&widgetId=WI_cldepvr5t00030tmawcb9slqn
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/artifacts/web/5.28.0-130/js/vendors~campaign-preview-app~widget-app.chunk.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.71.166.51 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a45b8da306d0539af.awsglobalaccelerator.com
Software
uvicorn /
Resource Hash
fc92e758562d600a27485661071e235af2200b582d317a4bf4814a49686a910a

Request headers

Accept
application/json, text/plain, */*
Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
uvicorn
x-amzn-trace-id
Root=1-00000000-000000000000000000000000
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
content-length
5086
x-request-id
hl-b382fbac-53fd-45d5-8117-6840ddcbcd1d
www-widgetapi.js
www.youtube.com/s/player/2b39c590/www-widgetapi.vflset/
216 KB
67 KB
Script
General
Full URL
https://www.youtube.com/s/player/2b39c590/www-widgetapi.vflset/www-widgetapi.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/iframe_api
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c17::5b Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
94d44f36044267c46ca434b1361c433965bb1fed4ebbfa35f4169c946e067b03
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:18:55 GMT
content-encoding
br
x-content-type-options
nosniff
age
2778
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
68438
x-xss-protection
0
last-modified
Mon, 12 Feb 2024 06:43:36 GMT
server
sffe
vary
Accept-Encoding, Origin
report-to
{"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="youtube"
expires
Wed, 12 Feb 2025 18:18:55 GMT
styles__ltr.css
www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/ Frame 779E
55 KB
24 KB
Stylesheet
General
Full URL
https://www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/styles__ltr.css
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::5e Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:34:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1871
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24606
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 05:00:25 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/css
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Wed, 12 Feb 2025 18:34:02 GMT
recaptcha__en.js
www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/ Frame 779E
490 KB
195 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/recaptcha__en.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::5e Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5aa02ad9ec4550065de8002ea1108be5d10bbb1173d2f3447f88ce1af317d4bd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:34:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1856
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
199529
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 05:00:25 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Wed, 12 Feb 2025 18:34:17 GMT
bc-v4.min.html
consentcdn.cookiebot.com/sdk/ Frame 4B69
627 B
812 B
Document
General
Full URL
https://consentcdn.cookiebot.com/sdk/bc-v4.min.html
Requested by
Host: consent.cookiebot.com
URL: https://consent.cookiebot.com/uc.js?cbid=611f3eb1-367f-42c6-859c-19d0fa7244f3&consentmode-dataredaction=dynamic&framework=IAB
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1408:5400:490::f09 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
738e5435f2d18427d291a0d6289eee0ebbc87b596d6003919f255760ac293104

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=30618174
content-encoding
gzip
content-length
392
content-type
text/html
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:13 GMT
etag
"3d08665fa4c7bcf9fa2dcbbc7efe1d0f:1649057029.895163"
expires
Sun, 02 Feb 2025 04:08:07 GMT
last-modified
Mon, 04 Apr 2022 07:23:49 GMT
server
AkamaiNetStorage
server-timing
cdn-cache; desc=HIT edge; dur=1 ak_p; desc="1707851113472_389085575_757510257_38_1115_30_34_255";dur=1
vary
Accept-Encoding
x-akamai-transformed
9 - 0 pmb=mRUM,1
consent-sdk-2.2.js
consent.cookiebot.com/Framework/IAB/
275 KB
86 KB
Script
General
Full URL
https://consent.cookiebot.com/Framework/IAB/consent-sdk-2.2.js
Requested by
Host: consent.cookiebot.com
URL: https://consent.cookiebot.com/uc.js?cbid=611f3eb1-367f-42c6-859c-19d0fa7244f3&consentmode-dataredaction=dynamic&framework=IAB
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1408:5400:1d::173d:b86 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
20a9ebbb6dad9f88d90daffa226a9d08ca44b6f475c867f795561dfdf2b0471d

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

request-context
appId=cid-v1:89f47f4b-bed0-4db8-956b-d6e6dfac3fef
date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
gzip
last-modified
Mon, 05 Feb 2024 09:22:29 GMT
etag
"1e801dd71458da1:0"
vary
Accept-Encoding
content-type
application/javascript
access-control-expose-headers
Request-Context
cache-control
public, max-age=144
accept-ranges
bytes
content-length
87940
expires
Tue, 13 Feb 2024 19:07:37 GMT
cc.js
consent.cookiebot.com/611f3eb1-367f-42c6-859c-19d0fa7244f3/
636 KB
140 KB
Script
General
Full URL
https://consent.cookiebot.com/611f3eb1-367f-42c6-859c-19d0fa7244f3/cc.js?renew=false&referer=reason.com&dnt=false&init=false&framework=TCFv2.2
Requested by
Host: consent.cookiebot.com
URL: https://consent.cookiebot.com/uc.js?cbid=611f3eb1-367f-42c6-859c-19d0fa7244f3&consentmode-dataredaction=dynamic&framework=IAB
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1408:5400:1d::173d:b86 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
6b07c7c1c130a938a4d333c099bbb2469f5f9adab25441b7fcb118cf276e48a8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
gzip
last-modified
Tue, 13 Feb 2024 19:05:13 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
access-control-expose-headers
Request-Context
cache-control
private, max-age=1200
cross-origin-resource-policy
cross-origin
request-context
appId=cid-v1:89f47f4b-bed0-4db8-956b-d6e6dfac3fef
1.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
70 KB
22 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/1.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9ef4011f34a0b31b7d267caa2d75fbb4671afd7acf8fcf3b83ed979d0bf5ca04

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"2328413873dddf53e8af45e75a588a20"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
siCvZwxgMxKfubygomGXi9gFb_mzjmII7Jo9Jpk-gUWGSgYJ2xh1Tw==
2.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
27 KB
6 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/2.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5804c3e4f4284033c2e0ec6ad6670fe3c8544373fd41e59f177864210e5a93ed

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"2126f31efc97136e7f4844235e79a7f9"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
ygs5EDE8jSNjCFj05G8q64zdNiQEWhI0YeFVj5AIalEy24ENKgX1RQ==
0.chunk.css
disco.headliner.link/artifacts/web/5.28.0-130/css/
5 KB
2 KB
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/0.chunk.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
1f2c868589ce0bffbbdd17df0af38aacd32f1ff1e9be47b59f0f8b128d601994

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:47 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"20e70ffa1362ee82ed53c2b1322ddc66"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
fce8HYnoJ7c9YEEgWO7T6b8q36lRxbRQt0SpNDbmyxb_PPWxyPPFtw==
0.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
171 KB
54 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/0.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ff232e33bd6b1ae02d18e4157e250c8c95f434e8fd1356abfe8bfc27d4c50ea9

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"d5cf492ddc70f28d0a133293f10d1b75"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
rQHoLRnl9VGLqyENZZMmgPL6b1zNvHg-AIxi5_PPS_sB_Em9T42rAw==
3.chunk.css
disco.headliner.link/artifacts/web/5.28.0-130/css/
3 KB
1 KB
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/3.chunk.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
60ff2d0d7bba03cdd3ce8a11f0243977d5506cd578976f4d47c42614c088c594

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:47 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"2f5a2a943bc6797f4b0395aea8e7a4b2"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
0sk9c9oUyVr6OPVZDt0WORsuGNara6bg11NwQtw5GdexBTeR2Auc3w==
3.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
17 KB
5 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/3.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
390b5b97e3a94b8fcbd0328c8df857c716e681988ea8818e0c2ab192726df9f3

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"7357c96906e1354f2acc097efe58f9fb"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
DaVKdzxkAJgSy-scL-sfKuhsbIoHVCcWHHpwTFmH5qn_OgdAtRdXtA==
3x1hscroll.chunk.css
disco.headliner.link/artifacts/web/5.28.0-130/css/
4 KB
1 KB
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/3x1hscroll.chunk.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
03ebcebed6049b46439d1598cc6a6703a499cc7bc60e3e3e7b78d9431a8e4862

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Thu, 04 Jan 2024 10:25:28 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:47 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
3487186
etag
W/"239e5a2c16acc69a47d98954045f49c4"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
2nv7qMki011iIhh2hEyHveczq4fc5dl9ZXCIQxgcZpwIv8XiPnEXWg==
3x1hscroll.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
18 KB
5 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/3x1hscroll.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
57d7566cf56f03d8d3e99685ede02587d7aa790b11299715cb5d800a5401e124

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"1b77d09b83a5412e64a756199f8b7199"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
XaQradUXVZw_K7QV4l8YaX5XTKJQsu-feRPOvTCuyrb2a-4OP80hOQ==
defaultTheme.fonts.css
disco.headliner.link/artifacts/web/5.28.0-130/css/theme/
3 KB
776 B
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/theme/defaultTheme.fonts.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
730f4b151c3f8b8ae4d14fee0d49984d31f0f4ed1afaa3e0e6bc7827c7ba3a0c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"3982a9753b8b388d27d38334b2ef688a"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
qeniahRogJaABn_vhQB1JvBxC6pVF1Vkv4GXozvOe_2XD8syQ7jAOA==
defaultTheme.css
disco.headliner.link/artifacts/web/5.28.0-130/css/theme/
3 KB
1 KB
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/theme/defaultTheme.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f4d8b90ffaa60f4db1c4edb1c5bb20c7d793624d88fd75523a2f0c1545a0efb7

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"ee23a0c8ba4d8e363ad847e668f84843"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
3ZHWsbpEOlwRG54IxZZLIDuQDpzVwpvX74nW644PaE9s-2RkuZ93Cg==
DO_cldepvmc800010rmapwbux1kq.css
disco.headliner.link/artifacts/web/5.28.0-130/css/theme/
1014 B
718 B
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/theme/DO_cldepvmc800010rmapwbux1kq.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b349dd488129e5045599095aec4259533e56600fe1c08cc5937935830164aacf

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 04 Dec 2023 18:08:58 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:50 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6137776
etag
W/"599e63dc7a6a5c1e3eab3b95331a33fd"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
Kic2T05F2po8twzbnlEWVjPa7qoISytZdencatO0EJALyYE51BkN7w==
zyvIRxypJp9XsXP7bFrUBd8JY_zCSu2ya-bkldlMTk8.js
www.google.com/js/bg/ Frame 779E
17 KB
7 KB
Script
General
Full URL
https://www.google.com/js/bg/zyvIRxypJp9XsXP7bFrUBd8JY_zCSu2ya-bkldlMTk8.js
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/recaptcha__en.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cf2bc8471ca9269f57b173fb6c5ad405df0963fcc24aedb26be6e495d94c4e4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sat, 10 Feb 2024 13:26:02 GMT
content-encoding
br
x-content-type-options
nosniff
age
279551
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6974
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:30:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Sun, 09 Feb 2025 13:26:02 GMT
logo_48.png
www.gstatic.com/recaptcha/api2/ Frame 779E
2 KB
2 KB
Image
General
Full URL
https://www.gstatic.com/recaptcha/api2/logo_48.png
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/styles__ltr.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::5e Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1b9efb22c938500971aac2b2130a475fa23684dd69e43103894968df83145b8a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.gstatic.com/recaptcha/releases/x5WWoE57Fv0d6ATKsLDIAKnt/styles__ltr.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 09 Feb 2024 20:37:49 GMT
x-content-type-options
nosniff
age
340044
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2228
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
image/png
cache-control
public, max-age=604800
accept-ranges
bytes
expires
Fri, 16 Feb 2024 20:37:49 GMT
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 779E
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxK.woff2
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.google.com/
Origin
https://www.google.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 23:03:05 GMT
x-content-type-options
nosniff
age
72128
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15344
x-xss-protection
0
last-modified
Mon, 16 Oct 2017 17:32:55 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 11 Feb 2025 23:03:05 GMT
KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 779E
15 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v18/KFOlCnqEu92Fr1MmEU9fBBc4.woff2
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5a8c1e7681318caa29e9f44e8a6e271f6a4067a2703e9916dfd4fe9099241db7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.google.com/
Origin
https://www.google.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 16:56:26 GMT
x-content-type-options
nosniff
age
7727
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15552
x-xss-protection
0
last-modified
Mon, 16 Oct 2017 17:33:02 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 12 Feb 2025 16:56:26 GMT
webworker.js
www.google.com/recaptcha/api2/ Frame 779E
102 B
135 B
Other
General
Full URL
https://www.google.com/recaptcha/api2/webworker.js?hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
3b918b6cef39462c9fed66b7ce89d8fd5fe04984c12f689e88327a703d738a0a
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LeMnkUaAAAAALL8T1-XAyB7vxpOeTExu6KwR48-&co=aHR0cHM6Ly9yZWFzb24uY29tOjQ0Mw..&hl=en&v=x5WWoE57Fv0d6ATKsLDIAKnt&size=invisible&cb=xiebnjabl586
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
cross-origin-embedder-policy
require-corp
x-frame-options
SAMEORIGIN
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Tue, 13 Feb 2024 19:05:13 GMT
vendors~disco-logo.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
34 KB
9 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/vendors~disco-logo.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ebbaaa73b099e488985cf58bcb33dba202519891a2f4f02562052d6ce3ce6ebd

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 09 Feb 2024 09:38:26 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:51 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
379608
etag
W/"d09c1ad6298f3c3dbf7359518f4c937a"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
9-JlT6Lp4O1WLmqVdtQWhri0dgdkTBytaQilhBGXtnTn-kgdYNwUag==
disco-logo.chunk.css
disco.headliner.link/artifacts/web/5.28.0-130/css/
3 KB
1 KB
Stylesheet
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/css/disco-logo.chunk.css
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a161220900785b6c1b27e3fa09ae5296775d8355bc603924347522c1e29ee60a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:47 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"fce2a30d3c7266660d104d744396875f"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
cache-control
max-age=31536000
x-amz-cf-id
rf7IMNVrX9hmK_E6jRQ9lzjEBSV--GNmlQNQ_mzbcieDs7xEJPkJJA==
disco-logo.chunk.js
disco.headliner.link/artifacts/web/5.28.0-130/js/
21 KB
6 KB
Script
General
Full URL
https://disco.headliner.link/artifacts/web/5.28.0-130/js/disco-logo.chunk.js
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/d/reason/web/js/widget.js?ver=6.4.3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:ec00:4:daa7:500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9fb11db5b312be6c749b6a136f8ed93d6582cbad3748fb23ff3f78f9908809ae

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Fri, 01 Dec 2023 21:19:59 GMT
content-encoding
br
via
1.1 7b1e72110677f4b48715a174a0db9206.cloudfront.net (CloudFront)
last-modified
Fri, 01 Dec 2023 21:12:51 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-C2
age
6385515
etag
W/"981cbfe86db0b2734df9461b2f580917"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=31536000
x-amz-cf-id
a2UXV4egG1igWs6C3Hz7dUkF5e6QN-sqXW6KoQXllYPdeUf11KcdwQ==
b91b40ecb8211864434053d691e8f49e_450_450.JPEG
img.sparemin.com/background-images/background-images/b9/1b/40/ec/
32 KB
33 KB
Image
General
Full URL
https://img.sparemin.com/background-images/background-images/b9/1b/40/ec/b91b40ecb8211864434053d691e8f49e_450_450.JPEG
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.161.213.13 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-213-13.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
8f105c0b8ae915f75cbb58cef6a935565390b86cb24c045c5404d6059247e710

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 11:05:56 GMT
via
1.1 4abd8708c8464a6586e6829348c23522.cloudfront.net (CloudFront)
last-modified
Tue, 12 Dec 2023 16:54:19 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-P1
age
28758
etag
"b91b40ecb8211864434053d691e8f49e"
x-amz-server-side-encryption
AES256
vary
Origin
x-cache
Hit from cloudfront
content-type
image/jpeg
accept-ranges
bytes
content-length
33254
x-amz-cf-id
htD0CNGa0YIJgFPbwcaNxD9PS1o-SZAsd4PwYUatlyFto0pSnWpqQQ==
c48ad90022a9776c82defda9e5437717_450_450.JPEG
img.sparemin.com/background-images/background-images/c4/8a/d9/00/
43 KB
43 KB
Image
General
Full URL
https://img.sparemin.com/background-images/background-images/c4/8a/d9/00/c48ad90022a9776c82defda9e5437717_450_450.JPEG
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.161.213.13 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-213-13.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
60c0857a9b93635b545fd8d8bd49a2d44fbd5a30860a2f4b5ca0de7d2b812fab

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 15:46:45 GMT
via
1.1 4abd8708c8464a6586e6829348c23522.cloudfront.net (CloudFront)
last-modified
Tue, 13 Feb 2024 15:43:04 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-P1
age
11909
etag
"c48ad90022a9776c82defda9e5437717"
x-amz-server-side-encryption
AES256
vary
Origin
x-cache
Hit from cloudfront
content-type
image/jpeg
accept-ranges
bytes
content-length
44002
x-amz-cf-id
g20XiXtwbRck9u-COf1VU_dGzWEFXeg_jaZ19hjxIWYBsOYxESczxw==
b1f253028f1e28b1f971453fa15fd9e9_450_450.JPEG
img.sparemin.com/background-images/background-images/b1/f2/53/02/
23 KB
23 KB
Image
General
Full URL
https://img.sparemin.com/background-images/background-images/b1/f2/53/02/b1f253028f1e28b1f971453fa15fd9e9_450_450.JPEG
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.161.213.13 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-213-13.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3a1c8555987adade7b0fb125ad27a57d5dd5ae51bba94af5c9d8523ba0185a7

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 02:02:15 GMT
via
1.1 4abd8708c8464a6586e6829348c23522.cloudfront.net (CloudFront)
last-modified
Wed, 22 Nov 2023 16:17:27 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-P1
age
61379
etag
"b1f253028f1e28b1f971453fa15fd9e9"
x-amz-server-side-encryption
AES256
vary
Origin
x-cache
Hit from cloudfront
content-type
image/jpeg
accept-ranges
bytes
content-length
23615
x-amz-cf-id
ikxFL6rbOYelhGd7WjSumBFGpP77KZCnd5vhf06G5U3HlBNoPuW-HA==
receive
api.headliner.link/api/v1/b/
0
178 B
XHR
General
Full URL
https://api.headliner.link/api/v1/b/receive
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/artifacts/web/5.28.0-130/js/vendors~campaign-preview-app~widget-app.chunk.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.71.166.51 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a45b8da306d0539af.awsglobalaccelerator.com
Software
uvicorn /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
application/json, text/plain, */*
Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:13 GMT
access-control-allow-credentials
true
server
uvicorn
x-amzn-trace-id
Root=1-00000000-000000000000000000000000
x-request-id
hl-b953bfaa-bfcf-42f4-b6b8-19edd02cdc56
receive
api.headliner.link/api/v1/b/ Frame
0
0
Preflight
General
Full URL
https://api.headliner.link/api/v1/b/receive
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.71.166.51 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a45b8da306d0539af.awsglobalaccelerator.com
Software
uvicorn /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST, OPTIONS
access-control-allow-origin
*
access-control-max-age
600
content-length
2
content-type
text/plain; charset=utf-8
date
Tue, 13 Feb 2024 19:05:13 GMT
server
uvicorn
x-request-id
hl-a5e0af80-7ccc-43f1-94f8-a4c5f068f5ed
collect
www.google-analytics.com/j/
4 B
205 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j101&a=618980501&t=pageview&_s=1&dl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ul=en-us&de=UTF-8&dt=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=aEBAAEABEAAAACACI~&jid=981647056&gjid=1709266166&cid=415251147.1707851114&tid=UA-283675-2&_gid=1991233376.1707851114&_r=1&_slc=1&gtm=45He42c0n815GHNJLWv830835450za200&cg1=Posts&cg2=jacob-sullum&cd2=jacob-sullum&gcs=G111&gcd=13v3v3n3n5&dma=0&tcfd=10000&z=2031019748
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:38::178 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:13 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/j/
4 B
69 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j101&a=618980501&t=pageview&_s=1&dl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ul=en-us&de=UTF-8&dt=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=aEDAAEABEAAAACACIAC~&jid=2084127174&gjid=1896536960&cid=415251147.1707851114&tid=UA-283675-6&_gid=1991233376.1707851114&_r=1&_slc=1&gtm=45He42c0n815GHNJLWv830835450za200&cg1=Posts&cg2=jacob-sullum&cd2=Posts&gcs=G111&gcd=13v3v3n3n5&dma=0&tcfd=10000&z=960792663
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:38::178 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:13 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
analytics.google.com/g/
0
250 B
Ping
General
Full URL
https://analytics.google.com/g/collect?v=2&tid=G-SYGD5NBRJH&gtm=45je42c0v891195732z8830835450za200&_p=1707851112214&_gaz=1&gcs=G111&gcd=13v3v3n3n5&npa=0&dma=0&tcfd=10000&gdid=dMWZhNz&cid=415251147.1707851114&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_s=1&sid=1707851113&sct=1&seg=0&dl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&dt=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&en=page_view&_fv=1&_ss=1&ep.title=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&tfd=1822
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-SYGD5NBRJH&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::181 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:13 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/g/
0
241 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-SYGD5NBRJH&cid=415251147.1707851114&gtm=45je42c0v891195732z8830835450za200&aip=1&dma=0&gcs=G111&gcd=13v3v3n3n5&npa=0
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-SYGD5NBRJH&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c09::9d Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:13 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/g/
0
47 B
Ping
General
Full URL
https://www.google-analytics.com/g/collect?v=2&tid=G-JCN3MXE1WR&gtm=45je42c0v891186252z8830835450za200&_p=1707851112214&gcs=G111&gcd=13v3v3n3n5&npa=0&dma=0&tcfd=10000&gdid=dMWZhNz&cid=415251147.1707851114&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_s=1&dt=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&sid=1707851113&sct=1&seg=0&dl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&en=page_view&_fv=1&_ss=1&ep.author=jacob-sullum&ep.section=Posts&ep.content_group=Posts&tfd=1831
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-JCN3MXE1WR&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:38::178 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:13 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
fbevents.js
connect.facebook.net/en_US/
214 KB
58 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f003:c0e:face:b00c:0:3 Ashburn, United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
bca51ed2fe251488a1b150edf560d43880f1486740f34d24120ede486f99676b
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

permissions-policy-report-only
autoplay=(), clipboard-read=(), clipboard-write=(), display-capture=(), encrypted-media=(), fullscreen=(), picture-in-picture=(), xr-spatial-tracking=();report-to="permissions_policy"
content-security-policy
default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Tue, 13 Feb 2024 19:05:13 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
57257
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
pragma
public
x-fb-debug
LrwLXYumnkl5+9aE6AfWxqzRSNPy9LJy4ZzQ/BisLMSCpb/8Ic7mGOtstUS91cvdx+U2JAbc4Q4jcILFQAudbg==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), bluetooth=(), camera=(), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), usb=(), window-management=();report-to="permissions_policy"
timing-allow-origin
*
expires
Sat, 01 Jan 2000 00:00:00 GMT
p.js
cdn.parsely.com/keys/reason.com/
72 KB
26 KB
Script
General
Full URL
https://cdn.parsely.com/keys/reason.com/p.js?gtm_ver=3.1
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.85.107.60 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-52-85-107-60.yul62.r.cloudfront.net
Software
nginx /
Resource Hash
e6b2557db71babf9cedeeb45c201bbe8d60450dfd3ca15cb5d2a3d5872a4e974

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
public
date
Tue, 13 Feb 2024 13:25:54 GMT
content-encoding
gzip
via
1.1 0fb05a472bd2fcfe266ed8a7a987ab1e.cloudfront.net (CloudFront)
last-modified
Tue, 26 Sep 2023 16:59:55 GMT
server
nginx
x-amz-cf-pop
YUL62-C2
age
20382
etag
W/"65130e0b-11f8b"
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=86400, public
x-amz-cf-id
e9S-1KOzl3t1AGJXgYFDKMYgRP9l-jCNGmsjyBDsRtqQjzBmLuazbA==
expires
Wed, 14 Feb 2024 13:25:31 GMT
465f8224-4646-48df-9c87-03c1ff77bcb4.js
cdn.mouseflow.com/projects/
65 KB
19 KB
Script
General
Full URL
https://cdn.mouseflow.com/projects/465f8224-4646-48df-9c87-03c1ff77bcb4.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5GHNJLW&gtm_auth=QxpctdM_XW9LaL_mGzTZ1Q&gtm_preview=env-1&gtm_cookies_win=x
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:1a32 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1725cd3076d793e08cc47d2974ed95c61bd2e714558362ca0da00f80bd2b711a
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
strict-transport-security
max-age=15552000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
br
age
459566
x-cache-status
HIT
alt-svc
h3=":443"; ma=86400
x-mf-script-region
US
last-modified
Thu, 18 Jan 2024 09:41:01 GMT
server
cloudflare
etag
W/"e532b872f249da1:0"
vary
Accept-Encoding, Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=86400
cf-ray
854f57759f4a4bc9-BUF
expires
Wed, 14 Feb 2024 19:05:13 GMT
pubfig.min.js
a.pub.network/reason-com/
75 KB
27 KB
Script
General
Full URL
https://a.pub.network/reason-com/pubfig.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:14ce , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ba5e30b4c43cca9c72a49722f85ba84898d742940c6b5ce73183928f04ad4ca2
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
br
cf-cache-status
HIT
age
86549
x-guploader-uploadid
ABPtcPqSHNVp0J6PAeoNQjIS1vu0Gpg7MXKAqRLvNIe21FkJoBV2DYEFoTNDe4Aq_NUzM7SKNzN2P0fNoQ
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=86400
last-modified
Thu, 08 Feb 2024 15:45:50 GMT
server
cloudflare
etag
W/"2683fd161d460c6f2b166e43ad98255a"
vary
Accept-Encoding
x-goog-hash
crc32c=1ijTQQ==, md5=JoP9Fh1GDG8rFm5DrZglWg==
x-goog-generation
1707407150029298
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=1800
x-goog-stored-content-length
76373
cf-ray
854f5775af586aee-BUF
link
<https://d.pub.network/v2/sites/reason-com/configs?env=PROD>; rel="preload"; as="fetch"; crossorigin="use-credentials", <https://optimise.net>; rel="preconnect", <https://api.floors.dev>; rel="preconnect"
expires
Tue, 13 Feb 2024 19:35:13 GMT
events.js
analytics.tiktok.com/i18n/pixel/
4 KB
2 KB
Script
General
Full URL
https://analytics.tiktok.com/i18n/pixel/events.js?sdkid=CCM8GMBC77U8584I7380&lib=ttq
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.104.105 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-48-104-105.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
e1db46b734d554d131d13cceb5df356abd8a34ddea88a751d31d3b3b4d354722

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

x-akamai-request-id
ff107c3b.d07abd05
date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
gzip
x-tt-trace-tag
id=16;cdn-cache=miss;type=dyn
x-tt-trace-id
00-240213190513B246971C76CE32C55908-29BD5ABC733EB8AC-00
x-cache
TCP_MISS from a23-48-100-105.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
x-parent-response-time
7,23.48.100.105
server-timing
cdn-cache; desc=MISS, edge; dur=2, origin; dur=6, inner; dur=3
pragma
no-cache
server
nginx
x-tt-logid
20240213190513B246971C76CE32C55908
x-cache-remote
TCP_MISS from a23-48-200-142.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=0, no-cache, no-store
x-origin-response-time
6,23.48.200.142
x-tt-trace-host
01fb071011a8ae45895a951b39c344d012e7358e9c74177bb04e216c3b28c6563de57d0715d0b6ac604cc653f889e779553e77b473706fd980cfb60c767f2df3bbbac1e3e1eb480b337af9a22c5ff40a41f2af49b06eb0e67a82a7a2b0bf7ea0ffe3bd9572735db142d5dacaeb0927bfbb
expires
Tue, 13 Feb 2024 19:05:13 GMT
ge.js
s3-us-west-2.amazonaws.com/jsstore/a/7Q0H4WE/
58 KB
59 KB
Script
General
Full URL
https://s3-us-west-2.amazonaws.com/jsstore/a/7Q0H4WE/ge.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.92.240.192 Boardman, United States, ASN (),
Reverse DNS
s3-us-west-2.amazonaws.com
Software
AmazonS3 /
Resource Hash
7fe6d485aecd432de7e99db429e7378059cfefb0238a2a7663a3bf2c51965b56

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:15 GMT
Last-Modified
Tue, 06 Feb 2024 21:31:59 GMT
Server
AmazonS3
x-amz-request-id
8ERARWM1W3QC0N9G
ETag
"a4795722ba61e5181516548674b74ace"
x-amz-server-side-encryption
AES256
Content-Type
application/javascript
Cache-Control
max-age=2592000
Accept-Ranges
bytes
Content-Length
59648
x-amz-id-2
Uc6OM/y5uev/0K5ZgJRgCSIv2XOxA/58HYkC03CAhWvyU+Hu2eIwE+KFheIyNMwmbe/7TpvBS6E=
Expires
Thu, 07 Mar 2024 21:31:58 GMT
collect
stats.g.doubleclick.net/j/
2 B
149 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j101&tid=UA-283675-2&cid=415251147.1707851114&jid=981647056&gjid=1709266166&_gid=1991233376.1707851114&_u=aEBAAEAAEAAAACACI~&z=1379394330
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c09::9d Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
6068f86ff5e6d3a3e100e95fd0ab03a5fb9ebfca9386b2c0ee131361a62526c2
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
date
Tue, 13 Feb 2024 19:05:13 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/j/
2 B
68 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j101&tid=UA-283675-6&cid=415251147.1707851114&jid=2084127174&gjid=1896536960&_gid=1991233376.1707851114&_u=aEDAAEABEAAAACACIAC~&z=1649416414
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c09::9d Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
6068f86ff5e6d3a3e100e95fd0ab03a5fb9ebfca9386b2c0ee131361a62526c2
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
date
Tue, 13 Feb 2024 19:05:13 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
l
use.typekit.net/af/2d0302/0000000000000000000118b6/27/
15 KB
15 KB
Font
General
Full URL
https://use.typekit.net/af/2d0302/0000000000000000000118b6/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i4&v=3
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-content/cache/min/1/kdp6eed.css?ver=1706762446
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:1402:8800::1728:cf40 Atlanta, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
063492fc45f85bdf8fb262b9291b08ec03d7e8d001370517bc96b4e6cb4d083f

Request headers

Referer
https://d2eehagpk5cl65.cloudfront.net/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:13 GMT
server
nginx
etag
"a95738adc55c09d395abf2e6dbcf61d4a0f7c568"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
15448
ga-audiences
www.google.com/ads/
42 B
63 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-283675-2&cid=415251147.1707851114&jid=981647056&_u=aEBAAEAAEAAAACACI~&z=1302483956
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.com/ads/
42 B
63 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-283675-6&cid=415251147.1707851114&jid=2084127174&_u=aEDAAEABEAAAACACIAC~&z=395568649
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
configs
d.pub.network/v2/sites/reason-com/
196 KB
10 KB
Other
General
Full URL
https://d.pub.network/v2/sites/reason-com/configs?env=PROD
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
79d57e0ab4fab1839ed5da5ce40911c6d6e8a216036426748c0aa87d45ae9e9c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding, User-Agent
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
main.MTU3YmJkODI0MA.js
analytics.tiktok.com/i18n/pixel/static/
379 KB
102 KB
Script
General
Full URL
https://analytics.tiktok.com/i18n/pixel/static/main.MTU3YmJkODI0MA.js
Requested by
Host: analytics.tiktok.com
URL: https://analytics.tiktok.com/i18n/pixel/events.js?sdkid=CCM8GMBC77U8584I7380&lib=ttq
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.104.105 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-48-104-105.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
3fb856882cd87a671903d75d594f2fb840abbb70a196395fa2197cbadb03149e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

x-akamai-request-id
d07ac1fd
date
Tue, 13 Feb 2024 19:05:13 GMT
content-encoding
gzip
x-tt-trace-tag
id=16;cdn-cache=hit;type=static
server
nginx
x-tt-logid
20240125200847EFCA3A4287CE4C68A305
x-tt-trace-id
00-240125200847EFCA3A4287CE4C68A305-445159D9D2DF2EBC-00
vary
Accept-Encoding
x-cache
TCP_MEM_HIT from a23-48-100-105.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
content-type
application/javascript; charset=UTF-8
cache-control
public, max-age=31536000, immutable
x-tt-trace-host
0149e3c47ee12e80b06b7cda6eb57c9704addf848b8ba991553860558afb3bb536bfdd938af7f7f83f2850754a3b5f4e3182b7e1ae8fe937384c616640c8366dfb51c7791b8984915ab3debc5d681a368cbb67ee5dce593c5882a21487b508b567
server-timing
cdn-cache; desc=HIT, edge; dur=0, origin; dur=0, inner; dur=19
content-length
104105
/
p1.parsely.com/plogger/
43 B
258 B
Image
General
Full URL
https://p1.parsely.com/plogger/?rand=1707851113967&plid=ee56971a-bfdb-4e3b-a1d9-710f71d95b1c&idsite=reason.com&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&urlref=&screen=1600x1200%7C1600x1200%7C24&data=%7B%22parsely%3Ametadata-detection%22%3A%7B%22version%22%3A0%2C%22url%22%3A%22https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F%22%2C%22hash%22%3A2002718362%7D%7D&sid=1&surl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&sref=&sts=1707851113959&slts=0&title=New+Pain+Medication+Could+Reinforce+Crackdown+on+Prescription+Opioids&date=Tue+Feb+13+2024+09%3A05%3A13+GMT-1000+(Hawaii-Aleutian+Standard+Time)&action=pageview&pvid=5fe6a265-1640-4080-991c-d96c41d1420a&u=pid%3Da2bc8d9d-38ae-4d7b-81b2-f9a99bf7647c
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.194.161.83 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-194-161-83.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:14 GMT
Cache-Control
no-cache
Last-Modified
Tuesday, 13-Feb-2024 19:05:14 GMT
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
related
api.parsely.com/v2/
8 KB
2 KB
XHR
General
Full URL
https://api.parsely.com/v2/related?uuid=pid%3Da2bc8d9d-38ae-4d7b-81b2-f9a99bf7647c&limit=5&page=1&apikey=reason.com
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/jquery/jquery.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.210.157.252 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-210-157-252.compute-1.amazonaws.com
Software
nginx /
Resource Hash
31f0460d3943acd93d38990ac0bac1978d3e9f61f470485073f229dcfcca27f5

Request headers

Accept
*/*
Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
server
nginx
x-cache-status
MISS
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=120
expires
Tue, 13 Feb 2024 19:07:14 GMT
profile
api.parsely.com/v2/
337 B
443 B
XHR
General
Full URL
https://api.parsely.com/v2/profile?uuid=pid%3Da2bc8d9d-38ae-4d7b-81b2-f9a99bf7647c&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&apikey=reason.com
Requested by
Host: d2eehagpk5cl65.cloudfront.net
URL: https://d2eehagpk5cl65.cloudfront.net/wp-includes/js/jquery/jquery.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.210.157.252 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-210-157-252.compute-1.amazonaws.com
Software
nginx /
Resource Hash
42623aa3e06e55093118a70661a0b803b3dab22e9184b56000aeae340dde39ca

Request headers

Accept
*/*
Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:14 GMT
server
nginx
content-length
337
content-type
application/json
807449156089636
connect.facebook.net/signals/config/
53 KB
11 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/807449156089636?v=2.9.145&r=stable&domain=reason.com&hme=20c913bdcd4be51a752120153aa5caaecb3ee86c7f26cf737846e40b202aba68&ex_m=62%2C106%2C94%2C98%2C53%2C3%2C88%2C61%2C14%2C86%2C79%2C44%2C46%2C150%2C153%2C164%2C160%2C161%2C163%2C25%2C89%2C45%2C68%2C162%2C145%2C148%2C157%2C158%2C165%2C115%2C13%2C43%2C169%2C168%2C117%2C16%2C29%2C32%2C1%2C36%2C57%2C58%2C59%2C63%2C83%2C15%2C12%2C85%2C82%2C81%2C95%2C97%2C31%2C96%2C26%2C22%2C146%2C149%2C124%2C24%2C9%2C10%2C11%2C5%2C6%2C21%2C19%2C20%2C49%2C54%2C56%2C66%2C90%2C23%2C67%2C8%2C7%2C71%2C41%2C18%2C92%2C91%2C17%2C4%2C73%2C80%2C72%2C78%2C40%2C39%2C77%2C33%2C35%2C76%2C48%2C74%2C28%2C37%2C65%2C0%2C84%2C75%2C2%2C30%2C55%2C34%2C93%2C38%2C70%2C60%2C99%2C52%2C51%2C27%2C87%2C50%2C47%2C42%2C69%2C64%2C100
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f003:c0e:face:b00c:0:3 Ashburn, United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
da7fe3ec98abf263bf88c7865d2e4e88653edd8fc8f3268693cc37dd7284771f
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

permissions-policy-report-only
autoplay=(), clipboard-read=(), clipboard-write=(), display-capture=(), encrypted-media=(), fullscreen=(), picture-in-picture=(), xr-spatial-tracking=();report-to="permissions_policy"
content-security-policy
default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Tue, 13 Feb 2024 19:05:14 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
11034
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
pragma
public
x-fb-debug
9qBPTt5TBiKyzhj1gOVArnwtby7km0kVBiYb0d34RpwYhsPhPjKVGTAcCCQVIQ0huM/nFffX1UODFF3AxIlaQw==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), bluetooth=(), camera=(), display-capture=(), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), usb=(), window-management=();report-to="permissions_policy"
timing-allow-origin
*
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/
0
185 B
Image
General
Full URL
https://www.facebook.com/tr/?id=807449156089636&ev=PageView&dl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&rl=&if=false&ts=1707851114051&sw=1600&sh=1200&v=2.9.145&r=stable&a=tmSimo-GTM-WebTemplate&ec=0&o=4126&fbp=fb.1.1707851114050.995882558&ler=empty&cdl=API_unavailable&it=1707851114002&coo=false&tm=1&exp=e1&rqm=GET
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f103:83:face:b00c:0:25de Ashburn, United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Tue, 13 Feb 2024 19:05:14 GMT
server
proxygen-bolt
content-type
text/plain
access-control-allow-origin
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
0
/
optimise.net/ Frame
0
0
Preflight
General
Full URL
https://optimise.net/?k=0&d=reason.com&t=desktop
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.111.152.239 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
239.152.111.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
x-api-key
Access-Control-Request-Method
GET
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Key, Authorization, x-api-key
access-control-allow-methods
ACL, CANCELUPLOAD, CHECKIN, CHECKOUT, COPY, DELETE, GET, HEAD, LOCK, MKCALENDAR, MKCOL, MOVE, OPTIONS, POST, PROPFIND, PROPPATCH, PUT, REPORT, SEARCH, UNCHECKOUT, UNLOCK, UPDATE, VERSION-CONTROL
access-control-allow-origin
https://reason.com
access-control-expose-headers
fs-client-rtt
access-control-max-age
3600
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-length
0
date
Tue, 13 Feb 2024 19:05:14 GMT
expires
0
fs-client-rtt
26
pragma
no-cache
strict-transport-security
max-age=31536000
via
1.1 google
/
optimise.net/
7 KB
7 KB
Fetch
General
Full URL
https://optimise.net/?k=0&d=reason.com&t=desktop
Requested by
Host: a.pub.network
URL: https://a.pub.network/reason-com/pubfig.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.111.152.239 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
239.152.111.34.bc.googleusercontent.com
Software
/
Resource Hash
57c3010e36e8d707d0ca225625f2bc81db1e650291a3754953c12963cb6be4ec
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
x-api-key
4e799501-b8b6-4ef1-bad5-225b3dd1aa8d

Response headers

strict-transport-security
max-age=31536000
via
1.1 google
date
Tue, 13 Feb 2024 19:04:42 GMT
fs-client-rtt
26
age
32
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6985
pragma
no-cache
access-control-max-age
3600
access-control-allow-methods
ACL, CANCELUPLOAD, CHECKIN, CHECKOUT, COPY, DELETE, GET, HEAD, LOCK, MKCALENDAR, MKCOL, MOVE, OPTIONS, POST, PROPFIND, PROPPATCH, PUT, REPORT, SEARCH, UNCHECKOUT, UNLOCK, UPDATE, VERSION-CONTROL
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-expose-headers
fs-client-rtt
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Key, Authorization, x-api-key
expires
0
gpt.js
securepubads.g.doubleclick.net/tag/js/
98 KB
29 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/reason-com/pubfig.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
bcf2f2d0e78f39187aa1b01a574d2a128baeb671c28750fd7e856be6b158fc57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
29690
x-xss-protection
0
server
cafe
etag
548 / 19766 / m202402070101 / config-hash: 6203399262051852452
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:14 GMT
beacon.js
sb.scorecardresearch.com/
4 KB
2 KB
Script
General
Full URL
https://sb.scorecardresearch.com/beacon.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/reason-com/pubfig.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.162.3.20 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-162-3-20.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
1aee66e2e24e851039801c0dace90f3efb7a1a17b033f7d5bbc12ca7c1d19432

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 21:53:35 GMT
content-encoding
gzip
via
1.1 726979f71f252186e97d38202269f636.cloudfront.net (CloudFront)
last-modified
Thu, 07 Dec 2023 12:13:41 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-P2
age
76300
etag
W/"a06e7a176f40dc26aa5e9567ac9d2d5e"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
x-amz-cf-id
7mB18wUemOKoO2m-hNJwcUmTdr8HYVRenZRbmRB4EknpOg28KdIBEw==
pubfig.engine.js
a.pub.network/core/pubfig/5.36.10/
333 KB
96 KB
Script
General
Full URL
https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/reason-com/pubfig.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:14ce , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
677a5f8597f4ed4686bed63a7ab85c8b5ef5d5d2822b3d87722da796cf305300
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
br
cf-cache-status
HIT
age
88881
x-guploader-uploadid
ABPtcPrxQNV3BPdZEODuAEgQTG386fMB1NQmSMNaoHMRPipsEGLC98R03NYHpUQ7Cqb1VDK2HOAlWk7S8A
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=86400
last-modified
Thu, 08 Feb 2024 15:14:34 GMT
server
cloudflare
etag
W/"27ae6cd6b7d8c2b4fa3c7f708595df04"
vary
Accept-Encoding
x-goog-hash
crc32c=xGnyVg==, md5=J65s1rfYwrT6PH9whZXfBA==
x-goog-generation
1707405274029486
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
*, Content-Length, Date, Server, Transfer-Encoding, X-GUploader-UploadID, X-Google-Trace
cache-control
public, max-age=3600
x-goog-stored-content-length
341408
cf-ray
854f5776ffce6aee-BUF
expires
Tue, 13 Feb 2024 20:05:14 GMT
identify_0a875.js
analytics.tiktok.com/i18n/pixel/static/
137 KB
37 KB
Script
General
Full URL
https://analytics.tiktok.com/i18n/pixel/static/identify_0a875.js
Requested by
Host: analytics.tiktok.com
URL: https://analytics.tiktok.com/i18n/pixel/static/main.MTU3YmJkODI0MA.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.104.105 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-48-104-105.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
a758246f43df5cf0f88a3c46a95cb7e962ec2e16327f7fc6b70d2150981b86df

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

x-akamai-request-id
d07ac703
date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
x-tt-trace-tag
id=16;cdn-cache=hit;type=static
server
nginx
x-tt-logid
202401231515383FDA81009A87DD93DB50
x-tt-trace-id
00-2401231515383FDA81009A87DD93DB50-134771B7DF409359-00
vary
Accept-Encoding
x-cache
TCP_MEM_HIT from a23-48-100-105.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
content-type
application/javascript; charset=UTF-8
cache-control
public, max-age=31536000, immutable
x-tt-trace-host
015461ae0f9a226cb1446965075df7fc4974c4b43a22aa17675ca5e16ba229348c6ff5b62cbf749b6bb72bdd06317200e83a53af33601cd2777b8585fd96daf5e076c03af0fc2a3601fecbdd09c412bbe7b82e7c3a360bacda5593b470fa7a1ed6
server-timing
cdn-cache; desc=HIT, edge; dur=0, origin; dur=0, inner; dur=10
content-length
37043
pixel
analytics.tiktok.com/api/v2/
0
840 B
Ping
General
Full URL
https://analytics.tiktok.com/api/v2/pixel
Requested by
Host: analytics.tiktok.com
URL: https://analytics.tiktok.com/i18n/pixel/static/main.MTU3YmJkODI0MA.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.104.105 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-48-104-105.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

x-akamai-request-id
40e7caa4.d07ac988
date
Tue, 13 Feb 2024 19:05:14 GMT
x-tt-trace-tag
id=16;cdn-cache=miss;type=dyn
x-tt-trace-id
00-240213190514BC9122BFC770E6C6AA14-44A130BE5E0559FD-00
x-cache
TCP_MISS from a23-48-100-105.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
x-parent-response-time
51,23.48.100.105
server-timing
cdn-cache; desc=MISS, edge; dur=9, origin; dur=49, inner; dur=44
content-length
0
pragma
no-cache
server
nginx
x-tt-logid
20240213190514BC9122BFC770E6C6AA14
x-cache-remote
TCP_MISS from a23-218-222-70.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
access-control-allow-methods
GET,POST,PUT,PATCH,DELETE,HEAD,OPTIONS,UPDATE
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
x-origin-response-time
49,23.218.222.70
x-tt-trace-host
01fb071011a8ae45895a951b39c344d012c0a2e4c94abc180daebcd6f7821847e83ecd608215e193028aa181c463938b9125101256b471d7ee755f491fb45eb20eaf6658462bb85de3a1a285c4d3d55a45e0d1ab152a5b8812e05e21a4ce316d16937db7edf0d709df7ec3f68467833e4b
access-control-allow-headers
Authorization,*
expires
Tue, 13 Feb 2024 19:05:14 GMT
prebid-analytics-8.30.1.js
a.pub.network/core/
680 KB
210 KB
Script
General
Full URL
https://a.pub.network/core/prebid-analytics-8.30.1.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:14ce , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e598d726a39330ffe18977f4b83e45a30414b473e31d1172288b704d674994bf
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
br
cf-cache-status
HIT
age
2479
x-guploader-uploadid
ABPtcPoCpOSqsowHjzH_AlARm38meZg2VG2OrN2IW6H0GLh7qctznX3EuJm_c3xSJGjJvZZGZFR-9zlHyQ
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=86400
last-modified
Wed, 31 Jan 2024 17:02:54 GMT
server
cloudflare
etag
W/"621e9a85e715aa0346365f0bc39e1e83"
vary
Accept-Encoding
x-goog-generation
1706720574454207
content-type
text/javascript
access-control-allow-origin
*
x-goog-hash
crc32c=D/nmFA==, md5=Yh6ahecVqgNGNl8Lw54egw==
access-control-expose-headers
*
cache-control
public, max-age=86400
x-goog-stored-content-length
696292
cf-ray
854f5777be956aed-BUF
expires
Wed, 14 Feb 2024 19:05:14 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=23384447&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1707851114185&ns_c=UTF-8&cs_ucfr=&gdpr=0&gdpr_p1t=&gdpr_li=&gdpr_purps=&gdpr_pcc=&cs_cmp_nc=0&cs_cmp_id=134&...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=23384447&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1707851114185&ns_c=UTF-8&cs_ucfr=&gdpr=0&gdpr_p1t=&gdpr_li=&gdpr_purps=&gdpr_pcc=&cs_cmp_nc=0&cs_cmp_id=134...
0
225 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=23384447&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1707851114185&ns_c=UTF-8&cs_ucfr=&gdpr=0&gdpr_p1t=&gdpr_li=&gdpr_purps=&gdpr_pcc=&cs_cmp_nc=0&cs_cmp_id=134&cs_cmp_sv=1&cs_cmp_rt=0&c7=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&c8=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&c9=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
3.162.3.20 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-162-3-20.yul62.r.cloudfront.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 726979f71f252186e97d38202269f636.cloudfront.net (CloudFront)
accept-ch
UA, Platform, Arch, Model, Mobile
x-amz-cf-pop
YUL62-P2
x-amz-cf-id
BJ0hK_AUj_KqlL65VLnlMLZSgVGh-wpdd8adtPmMXtXzPhTaessIyw==
x-cache
Miss from cloudfront

Redirect headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 726979f71f252186e97d38202269f636.cloudfront.net (CloudFront)
accept-ch
UA, Platform, Arch, Model, Mobile
x-amz-cf-pop
YUL62-P2
x-cache
Miss from cloudfront
location
/b2?c1=2&c2=23384447&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1707851114185&ns_c=UTF-8&cs_ucfr=&gdpr=0&gdpr_p1t=&gdpr_li=&gdpr_purps=&gdpr_pcc=&cs_cmp_nc=0&cs_cmp_id=134&cs_cmp_sv=1&cs_cmp_rt=0&c7=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&c8=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&c9=
content-length
0
x-amz-cf-id
odI77PU4PI3EBk6TAGCIq00jaVACWwJI7BAAu1Fbg2Z3RoQVtIhQdA==
pubads_impl.js
securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/
436 KB
137 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
244f9013ff972cac8f03cdac206e08c733ba70140153ed7607ee424b58272341
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 22:47:07 GMT
content-encoding
br
x-content-type-options
nosniff
age
73087
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
139960
x-xss-protection
0
server
cafe
etag
11977059823252198946
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, immutable, max-age=31536000
timing-allow-origin
*
expires
Tue, 11 Feb 2025 22:47:07 GMT
config.js
cdn.confiant-integrations.net/qaKtxuL1KR_2Tfmz0NmPaAudsBc/gpt_and_prebid/
89 KB
21 KB
Script
General
Full URL
https://cdn.confiant-integrations.net/qaKtxuL1KR_2Tfmz0NmPaAudsBc/gpt_and_prebid/config.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::ac40:90a6 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
acfda3f63d96dce3614c57f26f96cd559f1ab193b0be956b61d48061ba19e038

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Tue, 13 Feb 2024 15:45:22 GMT
server
cloudflare
x-amz-request-id
G3FW3R124Y9A35Y8
age
550
etag
W/"afdce9315a05abe8273672cd75a37e7a"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=900, stale-while-revalidate=3600
cf-ray
854f57790c6f4bcf-BUF
alt-svc
h3=":443"; ma=86400
x-amz-id-2
qSoJ9I3GFSd1m+wQyWkUJvP+gK4/7JwQzAfWFG4z9sKnVZsCAtgUCnqHkVerMIWRuAehBt3J/bA=
tag
btloader.com/
Redirect Chain
  • https://freestar-io.videoplayerhub.com/gallery.js
  • https://btloader.com/tag?h=freestar-io&upapi=true
463 KB
96 KB
Script
General
Full URL
https://btloader.com/tag?h=freestar-io&upapi=true
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::6816:4bd8 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8094215f1c9d97e3081e6193d002c0455d90c5416f11407407e9f5205cb0e15f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 google
cf-cache-status
HIT
last-modified
Tue, 13 Feb 2024 18:59:51 GMT
server
cloudflare
age
133
etag
"4abed1e61cc0de3450bfeec34f9c842c"
vary
Origin, Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=300, must-revalidate, stale-if-error=3600, stale-while-revalidate=300
accept-ranges
bytes
cf-ray
854f5779bc734bbb-BUF
content-length
98079

Redirect headers

date
Tue, 13 Feb 2024 19:05:14 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=M3AzYrXGDMQx5XVndoWqF%2FX6Ts7ivbpyIEIyS0LCrRJOq4K735otxA1GsY2Id9wA6Mga4H9hE0ahItne6Fz7Yq1yrGl9V3jHDZ%2FVEcC8iGVlmrmKFjNEmCaATUOn1saX4wTl9iI43BiGmhCTHV48tbY5GPwBjLTOfz7W5A%3D%3D"}],"group":"cf-nel","max_age":604800}
location
https://btloader.com/tag?h=freestar-io&upapi=true
cache-control
max-age=3600
cf-ray
854f57790c704bcf-BUF
expires
Tue, 13 Feb 2024 20:05:14 GMT
lc2.js
b-code.liadm.com/
48 KB
15 KB
Script
General
Full URL
https://b-code.liadm.com/lc2.js
Requested by
Host: s3-us-west-2.amazonaws.com
URL: https://s3-us-west-2.amazonaws.com/jsstore/a/7Q0H4WE/ge.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:bc00:8:8845:1500:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
299505568aa2f41d12271bc6c1fe8fcc1c13c0d91434972fa6ea951f821459e0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 19:12:52 GMT
content-encoding
gzip
via
1.1 b6989f0f2e150081d90f4c11e6692d3e.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
age
85942
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
"public, max-age=86400"
x-amz-cf-id
YMerOY3fFqFetK2VVtjCSsiEuGX6XDdRl5cf9FbvH2xFUCYSEdpfoA==
act
analytics.tiktok.com/api/v2/pixel/
0
842 B
Ping
General
Full URL
https://analytics.tiktok.com/api/v2/pixel/act
Requested by
Host: analytics.tiktok.com
URL: https://analytics.tiktok.com/i18n/pixel/static/main.MTU3YmJkODI0MA.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.104.105 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-48-104-105.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

x-akamai-request-id
ff108fc2.d07ad44d
date
Tue, 13 Feb 2024 19:05:14 GMT
x-tt-trace-tag
id=16;cdn-cache=miss;type=dyn
x-tt-trace-id
00-2402131905141B02210E959401C40ACD-343D877A3DC0AA60-00
x-cache
TCP_MISS from a23-48-100-105.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
x-parent-response-time
48,23.48.100.105
server-timing
cdn-cache; desc=MISS, edge; dur=10, origin; dur=47, inner; dur=44
content-length
0
pragma
no-cache
server
nginx
x-tt-logid
202402131905141B02210E959401C40ACD
x-cache-remote
TCP_MISS from a23-48-200-142.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1-53905076) (-)
access-control-allow-methods
GET,POST,PUT,PATCH,DELETE,HEAD,OPTIONS,UPDATE
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
x-origin-response-time
47,23.48.200.142
x-tt-trace-host
01fb071011a8ae45895a951b39c344d012e7358e9c74177bb04e216c3b28c6563de57d0715d0b6ac604cc653f889e77955f57b011dc9e956399f769e14eb9a6520f7d0c23897ed5539188016961929249bf86c072bbfa103594014d069602cc8497f3d508151d3def79d77518e3efdeae3
access-control-allow-headers
Authorization,*
expires
Tue, 13 Feb 2024 19:05:14 GMT
hadron.js
cdn.hadronid.net/
55 KB
10 KB
Script
General
Full URL
https://cdn.hadronid.net/hadron.js?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ref=&_it=freestar&partner_id=474&ha=_hadron
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:35ad , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2365cc11ef3d43f265b848c7164e5487c7a49d6af06c2938ac9272c8d91fc1a2

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
cf-cache-status
HIT
cf-bgj
minify
last-modified
Wed, 29 Nov 2023 15:31:45 GMT
server
cloudflare
x-amz-request-id
01CADRK6PEVBEZB5
age
2072
etag
W/"13043c1bbaf21ccc6e8ed474a744d3f2"
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=3600
cf-ray
854f5779ade34bcc-BUF
x-amz-id-2
flKA/w3j/xi2gJ65jogAIT1IJi47Xyyg7sUYQQ2R7nOR/7B5jvPTNgJSLJ3NwqiCDc6W3Pg1WdM=
IIQUniversalID.js
a.pub.network/core/intentIQ/20230622/
55 KB
14 KB
Script
General
Full URL
https://a.pub.network/core/intentIQ/20230622/IIQUniversalID.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:14ce , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
48c76c91f2d42a1668fee310da41b7c1f0d97d7ab0fa55fcf794e2cd3e412242
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
br
cf-cache-status
HIT
age
88879
x-guploader-uploadid
ABPtcPoubPjr22VDMqzOKeEmTnS9C6U_mFrqXjAPuzf96UhWHZaR-8n0EgVdK7kgpadRac6gbcgve0X42Q
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=86400
last-modified
Thu, 22 Jun 2023 23:15:14 GMT
server
cloudflare
etag
W/"c45a15a8a50c2a275e14695cf631d08d"
vary
Accept-Encoding
x-goog-generation
1687475714790007
content-type
text/javascript
access-control-allow-origin
*
x-goog-hash
crc32c=6m2COg==, md5=xFoVqKUMKideFGlc9jHQjQ==
access-control-expose-headers
*
cache-control
public, max-age=3600
x-goog-stored-content-length
56442
cf-ray
854f57794f386aed-BUF
expires
Tue, 13 Feb 2024 20:05:14 GMT
apstag.js
c.amazon-adsystem.com/aax2/
286 KB
72 KB
Script
General
Full URL
https://c.amazon-adsystem.com/aax2/apstag.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.230.49.33 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-230-49-33.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
30cd0f962f359605cf5b404dfb9f49cbd91532d8cc6a5421b523121fb767dfc6

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:11:50 GMT
content-encoding
gzip
via
1.1 76a7fdbced88b6eccf433c4e386bae40.cloudfront.net (CloudFront), 1.1 43334f58904cd7106ee523ee0361b402.cloudfront.net (CloudFront)
last-modified
Tue, 06 Feb 2024 20:22:08 GMT
server
AmazonS3
x-amz-cf-pop
IAD89-C3, YUL62-C2
age
3205
x-amz-server-side-encryption
AES256
etag
W/"b9446c9b1fc39deb105769a5bb6def0a"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=3600
x-amz-cf-id
h8X6Eky4rocSw8Eg43UttZbUmKVhvtY_qryjfFSrLzYp-FiUhoNjLQ==
wrap.js
cdn.confiant-integrations.net/gptprebidnative/202402121010/
300 KB
93 KB
Script
General
Full URL
https://cdn.confiant-integrations.net/gptprebidnative/202402121010/wrap.js
Requested by
Host: cdn.confiant-integrations.net
URL: https://cdn.confiant-integrations.net/qaKtxuL1KR_2Tfmz0NmPaAudsBc/gpt_and_prebid/config.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::ac40:90a6 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
83fb5073665d9434da512303204b7628f0e5905071c54bb50f0d46bf807b1963

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 12 Feb 2024 15:11:18 GMT
server
cloudflare
x-amz-request-id
CJ93KNJE5H8WVZ5A
age
86893
etag
W/"3d93a0af15b12fc9dbbc93edd96a2b7f"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
cache-control
public, max-age=31536000
cf-ray
854f57795c9a4bcf-BUF
alt-svc
h3=":443"; ma=86400
x-amz-id-2
Y9nCYWy8c0kpwWGAgG18Jzu28Nm5+mvAFE0wmSly8aqUtUl+Jz5ljLMCtXZO728JUTAFsiKBLAw=
ProfilesEngineServlet
api.intentiq.com/profiles_engine/
91 B
965 B
XHR
General
Full URL
https://api.intentiq.com/profiles_engine/ProfilesEngineServlet?at=39&mi=10&dpi=1434517136&pt=17&dpn=1&jsver=5.4&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&jaesc=0&jafc=0&jaensc=0&iiqlocalstorageenabled=true&tsrnd=765_1707851114482&cttl=43200000&pa=1---&rrtt=0&dud=0&abtg=A&vrref=reason.com&japbjs=true&japs=false
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/intentIQ/20230622/IIQUniversalID.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.161.213.49 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-213-49.yul62.r.cloudfront.net
Software
/
Resource Hash
8e1bf399df76a85bf21f7798504b3b2d93b0aab68a4b8129b0186ef3e0af90f4

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 bc3e3445494dc5a4f9373d4212505c68.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P1
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
patent
https://www.almondnet.com/ip
alt-svc
h3=":443"; ma=86400
pragma
no-cache
access-control-max-age
3600
vary
Origin
content-type
text/html
access-control-allow-origin
https://reason.com
access-control-allow-methods
POST, GET, OPTIONS
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Accept, X-Requested-With, remember-me, DNT,X-CustomHeader,Keep-Alive,User-Agent,If-Modified-Since,Cache-Control
x-amz-cf-id
EfIAozLsHaMcqikXQDqELNSlsKczOTb2qoezWHnb-yJhl49v15bf_w==
expires
Thu, 01 Jan 1970 00:00:00 GMT
ProfilesEngineServlet
sync1.intentiq.com/profiles_engine/
Redirect Chain
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&secure=1&dpi=1434517136&rnd=610716&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&tsr...
  • https://sync1.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&secure=1&dpi=1434517136&rnd=610716&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&ts...
43 B
940 B
Image
General
Full URL
https://sync1.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&secure=1&dpi=1434517136&rnd=610716&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&tsrnd=846_1707851114483&vrref=reason.com&jsver=5.4&abtp=95&abtg=A&ckls=true&ci=fbozg6sENr&nc=false&trid=1064888933
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
54.192.51.109 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-192-51-109.yul62.r.cloudfront.net
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 37504d411c7d230cb5e53aaf2809b804.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
IVr08iXO5PBM9Gf7RHydRezxQNDOId-83-ZR8mhsZXTjI9bjUYi5mQ==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 9ea08c3a2524e99d2bb42ac613eb89a2.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
location
https://sync1.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&secure=1&dpi=1434517136&rnd=610716&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&tsrnd=846_1707851114483&vrref=reason.com&jsver=5.4&abtp=95&abtg=A&ckls=true&ci=fbozg6sENr&nc=false&trid=1064888933
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
patent
https://www.almondnet.com/ip
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
oSecssXSC8tWZSZCfiJkU43rnkV9Uur3xK_vYDcXQxT0UAO5jX5_Qg==
expires
Thu, 01 Jan 1970 00:00:00 GMT
json
gum.criteo.com/sid/ Frame
0
0
Preflight
General
Full URL
https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Freason.com%2F&domain=reason.com&cw=1&lsw=1&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::c , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
GET
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
content-encoding
gzip
content-type
application/json; charset=utf-8
date
Tue, 13 Feb 2024 19:05:13 GMT
expires
0
pragma
no-cache
server
Kestrel
server-processing-duration-in-ticks
327403
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
liveView.php
live.primis.tech/live/
47 KB
18 KB
Script
General
Full URL
https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
8b17da121370a23959ede89248acad08da6dd0d415320414a61d83054ba74c12

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 1ae294433a6f4b338a8136481c1a3232.cloudfront.net (CloudFront)
server
nginx
x-amz-cf-pop
YUL62-C1
age
0
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/javascript; charset=utf-8
access-control-allow-origin
*
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
XZQ9GkTdowSICFTEXMkKFg0phZDe6dSQvrBAD7jUQNE5QK2zuKuQig==
quant.js
secure.quantserve.com/
23 KB
9 KB
Script
General
Full URL
https://secure.quantserve.com/quant.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2620:116:800b:21:b08a:1dc5:659b:4055 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
45a4c240a17a4d5f925ef0e125b86d882c6ad7549028d9cbf6f4f06fd1dd897d

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
etag
"bvEECQq4Zy6gU9J/qv1O6Q=="
vary
Accept-Encoding
content-type
application/javascript
cache-control
private, max-age=604800
accept-ranges
bytes
expires
Tue, 20 Feb 2024 19:05:14 GMT
truncated
/
1 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b60f65161ce3517c2794eecab25981c51ffbcbc951a781270403e2f3572d0290

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/svg+xml
cs
a.usbrowserspeed.com/
0
148 B
Script
General
Full URL
https://a.usbrowserspeed.com/cs?pid=e9129291568be65a74bd70417e1e0f81479e74333ce0e64c33c8b4a5959e1135
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.201.22.108 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-201-22-108.us-west-2.compute.amazonaws.com
Software
awselb/2.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
server
awselb/2.0
hadronid
id.hadron.ad.gt/api/v1/
54 KB
55 KB
Script
General
Full URL
https://id.hadron.ad.gt/api/v1/hadronid?_it=prebid&partner_id=474&_it=prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1bf5435c55a81e3f050dc22ed008eb354bcecd1c042316e81a95a488a6c0ae43

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
cf-cache-status
DYNAMIC
server
cloudflare
access-control-allow-methods
HEAD,GET,POST,PUT,DELETE,OPTIONS
content-type
Content-Type; text/javascript; charset=UTF-8
access-control-allow-origin
*
access-control-allow-credentials
true
debug
NON-OPTIONS
access-control-allow-headers
authorization
content-length
55794
cf-ray
854f577b7e3f4bd8-BUF
sid
mug.criteo.com/
Redirect Chain
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Freason.com%2F&domain=reason.com&cw=1&lsw=1&us_privacy=1---
  • https://mug.criteo.com/sid?cpp=-EjHAHxTdDFTSzAydTNqQTNCbThrNHJHTlErNFgxTDBUaHhVaG9FUUgxdG82enFOUDBKU294blJFd3R6dnl0aEl4ZlM3clF0SnhNMEliT1gxYjFKUldEdDFmUVI1L1U4b01zVExNZkNkM2UwNWJ2TFNvU3hoVWpIaEozOF...
354 B
1005 B
Fetch
General
Full URL
https://mug.criteo.com/sid?cpp=-EjHAHxTdDFTSzAydTNqQTNCbThrNHJHTlErNFgxTDBUaHhVaG9FUUgxdG82enFOUDBKU294blJFd3R6dnl0aEl4ZlM3clF0SnhNMEliT1gxYjFKUldEdDFmUVI1L1U4b01zVExNZkNkM2UwNWJ2TFNvU3hoVWpIaEozOFE2cWhTdVpaSVpMOThhVGRVWlJLQ1RxbUpBZkFTQnF0MzVNbk85L1Y1Q3c4eHRpb0xlTEkweHNFc1EvdERHOXUvKzhhOVhlZ05TNkR3MkZDREtBaXphRzNYYVZyc3ZqZVNOeUczcHlTTFJxWTg2dWE2RUUwPXw&cppv=2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
74.119.119.139 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
5bd2eb88db37b8e314ded8813782495643e4d81f55906c18f2c7c93e916b7078
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
server
Kestrel
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
null
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
1084484
expires
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; preload;
server
Kestrel
access-control-allow-methods
GET
access-control-allow-origin
https://reason.com
location
https://mug.criteo.com/sid?cpp=-EjHAHxTdDFTSzAydTNqQTNCbThrNHJHTlErNFgxTDBUaHhVaG9FUUgxdG82enFOUDBKU294blJFd3R6dnl0aEl4ZlM3clF0SnhNMEliT1gxYjFKUldEdDFmUVI1L1U4b01zVExNZkNkM2UwNWJ2TFNvU3hoVWpIaEozOFE2cWhTdVpaSVpMOThhVGRVWlJLQ1RxbUpBZkFTQnF0MzVNbk85L1Y1Q3c4eHRpb0xlTEkweHNFc1EvdERHOXUvKzhhOVhlZ05TNkR3MkZDREtBaXphRzNYYVZyc3ZqZVNOeUczcHlTTFJxWTg2dWE2RUUwPXw&cppv=2
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
578015
content-length
0
expires
0
pbhid
id.hadron.ad.gt/api/v1/
227 B
342 B
Fetch
General
Full URL
https://id.hadron.ad.gt/api/v1/pbhid?partner_id=474&_it=prebid&t=1&src=id&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1acd4e1a4cc300fed8d41672bc2a36a285a34568bb6c1091bf6e2eef0e699514

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
server
cloudflare
allow
POST, OPTIONS, GET
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
cf-ray
854f577b7e624bcc-BUF
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
rid
match.adsrvr.org/track/
109 B
563 B
Fetch
General
Full URL
https://match.adsrvr.org/track/rid?ttd_pid=6bjin1p&fmt=json
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.223.40.198 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a6370ebea231e0c9a.awsglobalaccelerator.com
Software
Kestrel /
Resource Hash
2b8ded24881b009351d8f72cd0e291dc03600786a932a1bbc94a3771f313dc41

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
server
Kestrel
vary
Origin, Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
private
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Content-Length, Content-Encoding, Vary, Cache-Control, Accept
expires
Thu, 14 Mar 2024 19:05:14 GMT
esp.js
oa.openxcdn.net/
24 KB
8 KB
Script
General
Full URL
https://oa.openxcdn.net/esp.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.102.146.192 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
192.146.102.34.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
544c55ca9f05d425f3beb90f287308d7a408b1f60d17728eff5c605a494bc1b9

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 30 Jan 2024 09:44:46 GMT
content-encoding
gzip
age
1243228
x-guploader-uploadid
ABPtcPrC-6N0WNjzkM5qAh9JaWJNUVWmAuT0EUNe79SUUOq5-JbFZ2q1o6Moq1ulXJNw4mtxq8o8E0tUjSpY48-eCIAGww
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
gzip
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
7927
last-modified
Thu, 27 May 2021 18:30:51 GMT
server
UploadServer
etag
"df5542b88bc0e368c6999754a5b9e2ba"
x-goog-generation
1622140251693895
x-goog-hash
crc32c=f21hYg==, md5=31VCuIvA42jGmZdUpbniug==
content-type
application/javascript
cache-control
no-transform
x-goog-stored-content-length
7927
accept-ranges
bytes
expires
Wed, 29 Jan 2025 09:44:46 GMT
sync.min.js
tags.crwdcntrl.net/lt/c/16589/
39 KB
12 KB
Script
General
Full URL
https://tags.crwdcntrl.net/lt/c/16589/sync.min.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.162.3.84 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-162-3-84.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e885badff253144e188588b5657e13cfa1135d4cd682053c9cca02b83baf1ef2

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 12:30:07 GMT
content-encoding
gzip
via
1.1 302bce0287d24df9c94be17a5fd67262.cloudfront.net (CloudFront)
last-modified
Wed, 06 Sep 2023 15:56:57 GMT
server
AmazonS3
x-amz-cf-pop
YUL62-P2
age
23708
etag
W/"e073e71ed7a44e6f9cdd72904fda5940"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/javascript
cache-control
public, max-age=86400
x-amz-cf-id
DKhVG9K9X0GmZ25Gric1rg_v8yZb-Kdu1fxV9aJgR_XZZyT34glS7A==
esp.js
cdn.id5-sync.com/api/1.0/
89 KB
26 KB
Script
General
Full URL
https://cdn.id5-sync.com/api/1.0/esp.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:3556 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1344f2cf7e2562ce1c954075dda071857f4ff0c6bb6d2022384883f24d3bd1e9
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=15552000; includeSubDomains; preload
content-encoding
gzip
cf-cache-status
HIT
last-modified
Fri, 09 Feb 2024 09:41:43 GMT
server
cloudflare
x-amz-request-id
H26QE7CVA1YJ2D5D
age
898
etag
W/"294eab17112a5071cb7b92bc188fc8b9"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
cache-control
public, max-age=3600
cf-ray
854f577b4cbc4bbd-BUF
x-amz-id-2
6M/MLQKMLerXFuhuclL6TIb6suZr1JUvvCyDKoBBidoF2unOXsF2MZBA1S/yfXzbnp9vyjRa6zc=
j
rp4.liadm.com/
Redirect Chain
  • https://rp.liadm.com/j?dtstmp=1707851114691&se=e30&duid=5cd525e6f15c--01hphxqsz7bxsvc6fz7hzwzwbd&tv=v2.13.1&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-...
  • https://rp4.liadm.com/j?se=e30&cd=.reason.com&dtstmp=1707851114691&tv=v2.13.1&n3pc=true&wpn=lc-bundle&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disast...
13 B
318 B
XHR
General
Full URL
https://rp4.liadm.com/j?se=e30&cd=.reason.com&dtstmp=1707851114691&tv=v2.13.1&n3pc=true&wpn=lc-bundle&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&duid=5cd525e6f15c--01hphxqsz7bxsvc6fz7hzwzwbd&gdpr=0&i6=MjYwMjpmZmM4OjI6MTA0OjoxNA%3D%3D&us_privacy=1---
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
44.213.8.90 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-213-8-90.compute-1.amazonaws.com
Software
/
Resource Hash
efabba3678b85fcab831b778ea2ddaad1e2a1e952584d3566bc39b7ccb3429d9

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
x-pixel-event-id
8a736f6c-2c5c-4f9e-9aaa-4cc45b0bebfc
access-control-allow-methods
GET
content-type
application/json
access-control-allow-origin
null
access-control-expose-headers
*
access-control-allow-credentials
true
content-length
13

Redirect headers

location
https://rp4.liadm.com/j?se=e30&cd=.reason.com&dtstmp=1707851114691&tv=v2.13.1&n3pc=true&wpn=lc-bundle&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&duid=5cd525e6f15c--01hphxqsz7bxsvc6fz7hzwzwbd&gdpr=0&i6=MjYwMjpmZmM4OjI6MTA0OjoxNA%3D%3D&us_privacy=1---
access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
access-control-expose-headers
*
access-control-allow-credentials
true
content-length
0
access-control-allow-methods
GET
hadron.json
id.hadron.ad.gt/v1/
95 B
280 B
XHR
General
Full URL
https://id.hadron.ad.gt/v1/hadron.json?_it=freestar&partner_id=474&sync=0&domain=reason.com&url=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Requested by
Host: cdn.hadronid.net
URL: https://cdn.hadronid.net/hadron.js?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ref=&_it=freestar&partner_id=474&ha=_hadron
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e51d622568374e9a01222e074e7a91cf608e7541ea0630b88d94f8863b16cb4a

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
cf-cache-status
DYNAMIC
server
cloudflare
access-control-allow-methods
HEAD,GET,POST,PUT,DELETE,OPTIONS
content-type
application/json
access-control-allow-origin
*
cache-control
private,max-age=30
access-control-allow-credentials
true
debug
NON-OPTIONS
access-control-allow-headers
authorization
cf-ray
854f577bce7f4bcc-BUF
hadron.json
id.hadron.ad.gt/v1/ Frame
0
0
Preflight
General
Full URL
https://id.hadron.ad.gt/v1/hadron.json?_it=freestar&partner_id=474&sync=0&domain=reason.com&url=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
GET
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
access-control-allow-origin
*
allow
POST, OPTIONS, GET
cache-control
max-age=31536000 public, no-transform
cf-cache-status
DYNAMIC
cf-ray
854f577b7e634bcc-BUF
content-length
0
content-type
application/json
date
Tue, 13 Feb 2024 19:05:14 GMT
debug
OPTIONS block
expires
Wed, 12 Feb 2025 19:05:14 GMT
server
cloudflare
0ab198dd-b265-462a-ae36-74e163ad6159
config.aps.amazon-adsystem.com/configs/
564 B
831 B
Script
General
Full URL
https://config.aps.amazon-adsystem.com/configs/0ab198dd-b265-462a-ae36-74e163ad6159
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.160.10.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-160-10-80.iad12.r.cloudfront.net
Software
CloudFront /
Resource Hash
8c9fed449b21234fe52a857f944ac4936083a01aeda3198f5fd17f530e210d1a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:07:36 GMT
via
1.1 73c5607bdb5db0d651e25c848846d554.cloudfront.net (CloudFront)
server
CloudFront
x-amz-cf-pop
IAD12-P3
age
3458
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=3600
content-length
564
x-amz-cf-id
-kDaQ4QqrgCNvYt7G7Jy68Fo6QH2NTg-Ng6Ifbvzk2X51NZ3l0cVoQ==
config
c.amazon-adsystem.com/cdn/prod/
1 KB
2 KB
XHR
General
Full URL
https://c.amazon-adsystem.com/cdn/prod/config?src=600&u=https%3A%2F%2Freason.com&pubid=0ab198dd-b265-462a-ae36-74e163ad6159
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.230.49.33 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-230-49-33.yul62.r.cloudfront.net
Software
Server /
Resource Hash
c5c46ac5fbb0f9e2d3faa5ab85ee591987acdd97e30d9e5bf0aea9b44624d0a9

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:09:01 GMT
via
1.1 43334f58904cd7106ee523ee0361b402.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
YUL62-C2
age
3372
x-cache
Hit from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
max-age=21550, s-maxage=21600
access-control-allow-credentials
true
content-length
1200
x-amz-cf-id
vOC42qterc5H86BboMFCi7p-BkH5Ex6TeTttqnm79-XJ9pM2s6L9Qg==
bid
aax.amazon-adsystem.com/e/dtb/
767 B
1 KB
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=0&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22reason_320x50_adhesion%22%2C%22s%22%3A%5B%221x1%22%2C%22300x50%22%2C%22320x50%22%2C%22468x60%22%2C%22728x90%22%2C%22970x90%22%2C%22300x100%22%2C%22320x100%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2Freason_320x50_adhesion%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
8fc145fd51f92692f7d843d725c151ec1989e717c1de10138ea507cbc0fb274e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
767
x-amz-cf-id
kcIkNP_8doBUNYVpDFTVb9M9keduiDPEeO1DJG44Bteqj30udiybDw==
bid
aax.amazon-adsystem.com/e/dtb/
274 B
605 B
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=1&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22Reason_320x100_320x50_300x250_incontent_FirstParagraph_SA%22%2C%22s%22%3A%5B%221x3%22%2C%22468x60%22%2C%22728x90%22%2C%22300x250%22%2C%22443x250%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
93af429855e4d0b8e20cb3521845688cb004d315f85c22e235955dd6b5e665b1

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
274
x-amz-cf-id
LkVIvISErAiVGHPvO65I_AKRbu7FeTrS0G1gG5xV4o7YTXXBl6K6YQ==
bid
aax.amazon-adsystem.com/e/dtb/
763 B
1 KB
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=2&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22reason_medrec_12%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2Freason_medrec_1%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
129c9bd63345e377311027006bcb0a448cb5af43d98473f02d1388abde223eeb

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
763
x-amz-cf-id
4sWNA4Zx1hyOKUEV_-oTQAADx0IrpyROFDJ5_YftH5XFumw8MMejqw==
bid
aax.amazon-adsystem.com/e/dtb/
763 B
1 KB
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=3&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22reason_medrec_22%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2Freason_medrec_2%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
2913bf1a88242e555b64cb41ec96eb824844e83e53ec78f965b8dbaee4c85280

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
763
x-amz-cf-id
LIQgYtnvsmLL8Iy4fyNNv6jucTRXK1WDLAXuPoARDSk-G_2pBmKHww==
bid
aax.amazon-adsystem.com/e/dtb/
776 B
1 KB
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=4&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22rcom_freestar_ad_widget-35_ad%22%2C%22s%22%3A%5B%22300x250%22%2C%22120x600%22%2C%22160x600%22%2C%22300x600%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2Freason_120x600_MiniSkyscraper%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
ba958a6b27a6d66c9315586052f6274e0b4ae486a39500b948f3e559bc49b5ec

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
776
x-amz-cf-id
MS91i3BN96zusa018b9ZayG5f4aBDxTUX-SiBdWuy7UvDpMNBQZr7A==
bid
aax.amazon-adsystem.com/e/dtb/
776 B
1 KB
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=5&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22rcom_freestar_ad_widget-34_ad%22%2C%22s%22%3A%5B%22300x250%22%2C%22120x600%22%2C%22160x600%22%2C%22300x600%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2Freason_120x600_MiniSkyscraper%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
27cfebc0c229c3c7e16a3219fd3173e42d17460bf879afef18c796431e5fe5b3

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
776
x-amz-cf-id
lAcDV4u9RmA62SSLIR0nfZ-dANWZ_HhReXKegQiDgQu__eJcU3MaXg==
bid
aax.amazon-adsystem.com/e/dtb/
274 B
604 B
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=6&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22rcom_freestar_ad_widget-31_ad%22%2C%22s%22%3A%5B%22300x250%22%2C%22120x600%22%2C%22160x600%22%2C%22300x600%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
8db652c39ab23485e2672f70eca5811b91609c2858f9ddc2256d3f3215d2b071

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
274
x-amz-cf-id
Gjlmje4hpwjko1FeSapDKISMKieM_NI4iGqE5uNQq-KHUVAC1zXK5g==
bid
aax.amazon-adsystem.com/e/dtb/
274 B
604 B
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=7&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22rcom_freestar_ad_widget-37_ad%22%2C%22s%22%3A%5B%22300x250%22%2C%22120x600%22%2C%22160x600%22%2C%22300x600%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
5ddc76435d2aba40748fbf2d83a0dce88c4d3148457638b3b8b1b110bb20b7d6

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
274
x-amz-cf-id
NwACMBaaXC7Rc3JWKth8DSPzquyV3PVPTs86lwWLYDw3KsuaG8ltnw==
bid
aax.amazon-adsystem.com/e/dtb/
274 B
604 B
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=5bA9IadcgUKUg&cb=8&ws=1600x1200&v=24.205.1508&t=506&slots=%5B%7B%22sd%22%3A%22reason_leaderboard_inconent%22%2C%22s%22%3A%5B%22728x90%22%2C%22300x250%22%5D%2C%22sn%22%3A%22%2F15184186%2C1006247%2Freason_leaderboard_inconent%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22mobile%22%3A0%2C%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22%22%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdpre=0&gdprl=%7B%22status%22%3A%22tcfv2-success%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
56973d0b2d524e339eabdfe0a4a19c26ebab6df15f935efba645e8a4d35207cb

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
274
x-amz-cf-id
l1gwZcMlm5QZP2rDNLvKYuzn-hWtDcvokonICFrDZA57xVK_NYju1Q==
aps_csm.js
c.amazon-adsystem.com/bao-csm/aps-comm/
6 KB
3 KB
XHR
General
Full URL
https://c.amazon-adsystem.com/bao-csm/aps-comm/aps_csm.js
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.230.49.33 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-230-49-33.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
06b99248a163333e36980a6cfb756f1a7de60fa49517162b87b1a44d5d48f844

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

x-amz-version-id
9yABOonr2HqHtwbarUcdbIqN0f4A8Qog
content-encoding
gzip
via
1.1 ac1cb1fdb7cf3984f94f9f190169eb3a.cloudfront.net (CloudFront)
date
Tue, 13 Feb 2024 14:12:33 GMT
x-amz-cf-pop
YUL62-C2
age
17562
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
last-modified
Tue, 29 Aug 2023 08:30:37 GMT
server
AmazonS3
etag
W/"a4d296427fc806b21335359e398c025c"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
vary
Accept-Encoding,Origin
x-amz-cf-id
30geuy1Kj93Nxflmlx43_xNkSCVF3IxunJHCbZFXRTO9mYQL0Jzoiw==
state
api.btloader.com/mw/
40 B
167 B
Fetch
General
Full URL
https://api.btloader.com/mw/state?bt_env=prod
Requested by
Host: freestar-io.videoplayerhub.com
URL: https://freestar-io.videoplayerhub.com/gallery.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.23.194 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
194.23.211.130.bc.googleusercontent.com
Software
/
Resource Hash
862da7a63ed8c7a0ff4fdfe2df7678c4739d6f49dc38eee1067b245553dc9119

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:14 GMT
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
40
vary
Origin
content-type
application/json
px.gif
ad-delivery.net/
43 B
923 B
Image
General
Full URL
https://ad-delivery.net/px.gif?ch=2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:346 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
1753820
x-guploader-uploadid
ABPtcPoOg4SZ5oPFZyTliG4fjSQ26PKj2rjvLiy_9azUqegBtP-FgnbyhSYt9-dD9ifYdmF9TrAo2bdHQw
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
5
x-goog-stored-content-encoding
identity
content-length
43
last-modified
Wed, 05 May 2021 19:25:32 GMT
server
cloudflare
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3"
vary
Accept-Encoding
x-goog-generation
1620242732037093
content-type
image/gif
access-control-allow-origin
*
x-goog-hash
crc32c=cpEfJQ==, md5=rUsPYG4PhGW8TEwXCzfhow==
access-control-expose-headers
*, Content-Length, Date, Server, Transfer-Encoding, X-GUploader-UploadID, X-Google-Trace
cache-control
public, max-age=86400
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=QlDkOQ1jHJKOA58Qmy%2BtE1H2YvMUdIAww1nnaYebdIVYmiJ4G2Y%2FHz%2FXJYP7JuAG0aczysv5gB27auktm1EL9Myw%2BdDMGKFFcuDT5nktSd1DrCsmA%2B%2F57U%2BAk4a5RKKDO1wW8suHdI8YrB4LXA%3D%3D"}],"group":"cf-nel","max_age":604800}
x-goog-stored-content-length
43
accept-ranges
bytes
cf-ray
854f577c1ba04bc7-BUF
expires
Wed, 24 Jan 2024 12:43:00 GMT
favicon.ico
ad.doubleclick.net/
1 KB
571 B
Image
General
Full URL
https://ad.doubleclick.net/favicon.ico?ad=300x250&ad_box_=1&adnet=1&showad=1&size=250x250
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.253.63.148 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bi-in-f148.1e100.net
Software
sffe /
Resource Hash
d961b08e4321250926de6f79087594975fe20ad1518de8f91eb711af5d1a6ef8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 13:30:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
20078
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
104
x-xss-protection
0
last-modified
Tue, 08 May 2012 13:08:06 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/x-icon
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 14 Feb 2024 13:30:36 GMT
px.gif
ad-delivery.net/
43 B
346 B
Image
General
Full URL
https://ad-delivery.net/px.gif?ch=1&e=0.32895086649885985
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:346 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
1753820
x-guploader-uploadid
ABPtcPoOg4SZ5oPFZyTliG4fjSQ26PKj2rjvLiy_9azUqegBtP-FgnbyhSYt9-dD9ifYdmF9TrAo2bdHQw
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
5
x-goog-stored-content-encoding
identity
content-length
43
last-modified
Wed, 05 May 2021 19:25:32 GMT
server
cloudflare
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3"
vary
Accept-Encoding
x-goog-generation
1620242732037093
content-type
image/gif
access-control-allow-origin
*
x-goog-hash
crc32c=cpEfJQ==, md5=rUsPYG4PhGW8TEwXCzfhow==
access-control-expose-headers
*, Content-Length, Date, Server, Transfer-Encoding, X-GUploader-UploadID, X-Google-Trace
cache-control
public, max-age=86400
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=uQZWmP%2BP%2BccXYsTGOtFXF5HAOesePkFmNLPLf%2BVWIXvOp8DLKHzSOIlz5rIyCDAAjIZ03v4WjppkdIpv60kcj%2Bc3spADcsjjRwBnK7hKeiPNZq%2BW2QSC%2B9I%2FEsrZhqfWCwnnnYc0FXEOYb6RTg%3D%3D"}],"group":"cf-nel","max_age":604800}
x-goog-stored-content-length
43
accept-ranges
bytes
cf-ray
854f577c1b9f4bc7-BUF
expires
Wed, 24 Jan 2024 12:43:00 GMT
cookie_sync
s2s.t13.io/
2 KB
843 B
Fetch
General
Full URL
https://s2s.t13.io/cookie_sync
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
c4a23912c37f0ee0f0f47c09570ba8890fd72fa5bfd444f4f48182f1020ed8d0
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
620
expires
0
auction
s2s.t13.io/openrtb2/
1 KB
581 B
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
a8a56797219fd5f6031d31629ae2b6e41cc20de3a695246809b9c731f545a758
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
493
expires
0
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
114 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
fastlane.json
fastlane.rubiconproject.com/a/api/
689 B
1 KB
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=2&alt_size_ids=1%2C19%2C43%2C44%2C55%2C117%2C221&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=stickyFooter&tg_i.pbadslot=%2F15184186%2Freason_320x50_adhesion%2Freason_320x50_adhesion&tk_flint=pbjs_lite_v8.30.0&x_source.tid=313bdf1a-4deb-4b76-a6e3-b98271feaaa1&l_pb_bid_id=367c04516d9e34e&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=07237e2f-cdf5-42e5-9c5f-51f44a22c3ca&rp_maxbids=1&p_gpid=%2F15184186%2Freason_320x50_adhesion%2Freason_320x50_adhesion&m_ch_mobile=%3F0&slots=1&rand=0.4456509689540378
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
84b1b241a452ec1672a8217a5fa354db3f2772b9e7a956ef67a1e0cd1f9b5145

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
expires
Wed, 17 Sep 1975 21:32:10 GMT
translator
hbopenbid.pubmatic.com/
0
112 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cdb
bidder.criteo.com/
0
189 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=34839261938&lsavail=1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
hbjson
grid.bidswitch.net/
24 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
071d40b20d079ad0e996a467b17b8283476626fb58bf33d77731096d1c4340bb
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
49
imp
g2.gumgum.com/hbid/
1 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851114868&to=600&pubProvidedId=%5B%5D&aun=reason_320x50_adhesion&gpid=%2F15184186%2Freason_320x50_adhesion%2Freason_320x50_adhesion&maxw=970&maxh=90&si=80387&pi=3&bf=970x90%2C728x90%2C468x60%2C320x100%2C300x100%2C320x50%2C300x50%2C1x1&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
b56285f7d394acf0853e601f25ecec3e0af8f1ac6fd35d9d9a43c3d42cce8d34

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
1 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851114869&to=600&pubProvidedId=%5B%5D&aun=reason_320x50_adhesion&gpid=%2F15184186%2Freason_320x50_adhesion%2Freason_320x50_adhesion&maxw=970&maxh=90&si=80385&pi=3&bf=970x90%2C728x90%2C468x60%2C320x100%2C300x100%2C320x50%2C300x50%2C1x1&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
34933d5b59d060a298f38c48556aa6aa8426adbf5bc5459bf10c321dc4d64b81

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
1 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851114869&to=600&pubProvidedId=%5B%5D&aun=reason_320x50_adhesion&gpid=%2F15184186%2Freason_320x50_adhesion%2Freason_320x50_adhesion&maxw=970&maxh=90&si=80386&pi=3&bf=970x90%2C728x90%2C468x60%2C320x100%2C300x100%2C320x50%2C300x50%2C1x1&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
118159ce6c73314e633b0ac64f5fd6151952fda25c6fd37dfb05dd655cb7df7f

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
prebid
ib.adnxs.com/ut/v3/
19 B
702 B
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
an-x-request-uuid
7cfd3675-66c9-4d27-a583-f5de86ab491a
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
19
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
auction
tlx.3lift.com/header/
19 B
817 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
accept-ch
sec-ch-viewport-width,sec-ch-downlink,sec-ch-ua-full-version-list,sec-ch-prefers-color-scheme,sec-ch-ua-platform,sec-ch-dpr,user-agent,sec-ch-width,sec-ch-viewport-height,sec-ch-save-data,sec-ch-ect,sec-ch-ua-model,sec-ch-ua-platform-version,sec-ch-device-memory,sec-ch-ua-bitness,sec-ch-ua,sec-ch-ua-full-version,sec-ch-ua-arch,sec-ch-rtt,sec-ch-ua-mobile
x-auction-status
12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
prebidjs
rtb.openx.net/openrtbb/
53 B
336 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
7cfde3ea960b90231b87e5337510579b11cd99626488acb784ede88745c5dee7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
pubcid.min.js
secure.cdn.fastclick.net/js/pubcid/latest/
54 KB
17 KB
Script
General
Full URL
https://secure.cdn.fastclick.net/js/pubcid/latest/pubcid.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.4.232.54 Piscataway, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-4-232-54.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
43f804d38a294c6df1ce8ee64fb95ad0ff5a8d6d5685d9537df02212668a1dff

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
last-modified
Mon, 23 Jan 2023 19:40:17 GMT
server
Apache
x-serial
1
x-check-cacheable
YES
etag
"d734-5f2f3919e751f-gzip"
vary
Accept-Encoding
x-akamai-pragma-client-ip
10.44.130.72, 4.7.166.99
content-type
application/javascript
cache-control
max-age=900
accept-ranges
bytes
content-length
17407
expires
Tue, 13 Feb 2024 19:20:14 GMT
id5-api.js
cdn.id5-sync.com/api/1.0/
88 KB
26 KB
Script
General
Full URL
https://cdn.id5-sync.com/api/1.0/id5-api.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:3556 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4cd07edee68cd765a7cdde6fefbd032242acc261496048c610c9d2b401ef105b
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=15552000; includeSubDomains; preload
content-encoding
gzip
cf-cache-status
HIT
last-modified
Fri, 09 Feb 2024 09:41:43 GMT
server
cloudflare
x-amz-request-id
XYNGXPG3EZ9N41TJ
age
2164
etag
W/"5f1afea320c5039c2b1fe5fdbc5608a7"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
cache-control
public, max-age=3600
cf-ray
854f577c4d0d4bbd-BUF
x-amz-id-2
PayfWhDvN4HbsQOdZqVJWZAU4L6sESYljrPglnh779xiuo7vBPIwehhI8XLqKfuE0NkJqPIwsfU=
sid
mug.criteo.com/ Frame
0
0
Preflight
General
Full URL
https://mug.criteo.com/sid?cpp=-EjHAHxTdDFTSzAydTNqQTNCbThrNHJHTlErNFgxTDBUaHhVaG9FUUgxdG82enFOUDBKU294blJFd3R6dnl0aEl4ZlM3clF0SnhNMEliT1gxYjFKUldEdDFmUVI1L1U4b01zVExNZkNkM2UwNWJ2TFNvU3hoVWpIaEozOFE2cWhTdVpaSVpMOThhVGRVWlJLQ1RxbUpBZkFTQnF0MzVNbk85L1Y1Q3c4eHRpb0xlTEkweHNFc1EvdERHOXUvKzhhOVhlZ05TNkR3MkZDREtBaXphRzNYYVZyc3ZqZVNOeUczcHlTTFJxWTg2dWE2RUUwPXw&cppv=2
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.139 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
GET
Origin
null
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET
access-control-allow-origin
null
cache-control
no-cache, no-store, must-revalidate
content-encoding
gzip
content-type
application/json; charset=utf-8
date
Tue, 13 Feb 2024 19:05:14 GMT
expires
0
pragma
no-cache
server
Kestrel
server-processing-duration-in-ticks
412336
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
474
a.ad.gt/api/v1/u/matches/
12 KB
4 KB
Script
General
Full URL
https://a.ad.gt/api/v1/u/matches/474?_it=freestar
Requested by
Host: cdn.hadronid.net
URL: https://cdn.hadronid.net/hadron.js?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ref=&_it=freestar&partner_id=474&ha=_hadron
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4c9dd45ccdec1ac80302da87aac394510660a5e7ae0e3c0c0d00765ae669f3e3

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Tue, 13 Feb 2024 19:05:09 GMT
server
cloudflare
age
6
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=14400
cross-origin-resource-policy
cross-origin
cf-ray
854f577cd8a56aed-BUF
esp
oajs.openx.net/
Redirect Chain
  • https://oajs.openx.net/esp?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&rid=esp
  • https://oajs.openx.net/esp?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&rid=esp&cc=1
85 B
193 B
Fetch
General
Full URL
https://oajs.openx.net/esp?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&rid=esp&cc=1
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
34.120.135.53 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
53.135.120.34.bc.googleusercontent.com
Software
/ Express
Resource Hash
79e24ab3b6419763342e03324226b3a31a4e65332054d7cef718211091fdaf38

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
x-powered-by
Express
etag
W/"55-Q/WHtd36pXH6tQP18KRAVrowMvo"
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
85

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
x-powered-by
Express
vary
Origin
access-control-allow-origin
https://reason.com
location
/esp?url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&rid=esp&cc=1
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
rules-p-UeXruRVtZz7w6.js
rules.quantcount.com/
2 KB
1 KB
Script
General
Full URL
https://rules.quantcount.com/rules-p-UeXruRVtZz7w6.js
Requested by
Host: secure.quantserve.com
URL: https://secure.quantserve.com/quant.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:5c00:6:44e3:f8c0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a7b5f5f96f81dea4efc53e1d4dae8b37c28bec27a45b42ccf604ee759e20caec

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:00:37 GMT
content-encoding
gzip
via
1.1 05b4905f6074a994b5e52b7e0ee5c01a.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P2
age
279
x-cache
Hit from cloudfront
cross-origin-resource-policy
cross-origin
last-modified
Thu, 07 Dec 2017 17:06:25 GMT
server
AmazonS3
etag
W/"cbc97d16c77ea1fcbbf42d246001e982"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=3600
x-amz-cf-id
JnlcpqpdUk-f0YjJ3ssJL8zkiqZgCdGxlPU2ot9rwCOlLzPSZbIccg==
liveView.php
live.primis.tech/live/ Frame C770
6 KB
2 KB
Script
General
Full URL
https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
cec67735a41f2396e5a19089168acd0feeecaaa20ed19299d4b694f606e8f3e0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 1ae294433a6f4b338a8136481c1a3232.cloudfront.net (CloudFront)
server
nginx
x-amz-cf-pop
YUL62-C1
age
0
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/javascript; charset=utf-8
access-control-allow-origin
*
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
6oxoGiRFW2KfPSzRp05FMOoDRkhndfIwllDc02FrYv4ObczWnKnXBA==
increment
id5-sync.com/api/esp/
0
226 B
XHR
General
Full URL
https://id5-sync.com/api/esp/increment?counter=no-config
Requested by
Host: cdn.id5-sync.com
URL: https://cdn.id5-sync.com/api/1.0/esp.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
access-control-allow-credentials
true
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
map
bcp.crwdcntrl.net/6/
156 B
609 B
XHR
General
Full URL
https://bcp.crwdcntrl.net/6/map
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/lt/c/16589/sync.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.144.252.138 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-252-138.compute-1.amazonaws.com
Software
Jetty(9.4.38.v20210224) /
Resource Hash
706c67ed6913186b7a3a0daaa26aa8c8e46bad6101ac2a97c7e5b52cd8db7721

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Jetty(9.4.38.v20210224)
content-type
application/json;charset=utf-8
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
access-control-allow-origin
https://reason.com
cache-control
no-cache
x-server
10.40.12.78
access-control-allow-credentials
true
content-length
156
expires
0
country
api.btloader.com/
16 B
120 B
Fetch
General
Full URL
https://api.btloader.com/country
Requested by
Host: freestar-io.videoplayerhub.com
URL: https://freestar-io.videoplayerhub.com/gallery.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.23.194 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
194.23.211.130.bc.googleusercontent.com
Software
/
Resource Hash
30c714bf4216e577686d238b98561d093672cb25bf90baab50dd956f75cda4b3

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
vary
Origin
content-type
application/json
access-control-allow-origin
*
cache-control
private, max-age=300, stale-while-revalidate=600, stale-if-error=600
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
16
/
ce.lijit.com/beacon/prebid-server/ Frame C5F1
Redirect Chain
  • https://ap.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%2...
  • https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%2...
  • https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%2...
2 KB
1 KB
Document
General
Full URL
https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
8f4834d3bf3d9daaa439cf9f609044982d519f6ef2575c466673f9cd9875bc95

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
content-encoding
gzip
content-length
826
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Fri, 20 Mar 2009 00:00:00 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
vary
Accept-Encoding, User-Agent

Redirect headers

cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
content-length
0
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Fri, 20 Mar 2009 00:00:00 GMT
location
https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
pv
api.btloader.com/
0
66 B
XHR
General
Full URL
https://api.btloader.com/pv?tid=QuZamYFbk&w=5734277079629824&o=5714937848528896&cv=2.1.33-1-gba855a8&widget=false&r=false&vr=1600x1200&pageURL=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&sid=A9bzXDpWFI&pm=true&upapi=true
Requested by
Host: freestar-io.videoplayerhub.com
URL: https://freestar-io.videoplayerhub.com/gallery.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.23.194 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
194.23.211.130.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache, no-store, must-revalidate
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
vary
Origin
iu3
s.amazon-adsystem.com/ Frame A30C
Redirect Chain
  • https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_...
  • https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_...
444 B
1 KB
Document
General
Full URL
https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&dcc=t
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
81b116445ec274037b8affbdaa2e8c1779ed74e21fad2f68c34d9ce6dc9b574f
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
444
Content-Type
text/html;charset=ISO-8859-1
Date
Tue, 13 Feb 2024 19:05:15 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
x-amz-rid
TFE7P4NCKR02HRB25B4G

Redirect headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
0
Date
Tue, 13 Feb 2024 19:05:15 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Location
https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&dcc=t
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
x-amz-rid
VA5QW6BF6VMWREE7CAD6
auction
s2s.t13.io/openrtb2/
44 KB
18 KB
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
5d59dc58eff48912d3334d06792bbd8bbf22bfa4583ba69e76c0a3a9a5e47a6e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18548
expires
0
prebidjs
rtb.openx.net/openrtbb/
53 B
220 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
9086e83416955cdabc7133c012c5485c30a948726e966acd30218b1b07a01d3e

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
fastlane.json
fastlane.rubiconproject.com/a/api/
736 B
1 KB
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&alt_size_ids=2%2C1&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA&tk_flint=pbjs_lite_v8.30.0&x_source.tid=15e5902e-7275-49fa-80a3-3e1e984da0c8&l_pb_bid_id=8219f3ad812b207&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=c0c68cc2-d21c-4fd4-8522-8fdff719b596&rp_maxbids=1&p_gpid=%2F15184186%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA&m_ch_mobile=%3F0&slots=1&rand=0.17065675284636095
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
10f32b597ddfd3ed5767b32cef7ac625e6e9e913605f0c5b8f4f48e5eadeef71

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
expires
Wed, 17 Sep 1975 21:32:10 GMT
auction
tlx.3lift.com/header/
19 B
832 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
user-agent,sec-ch-dpr,sec-ch-ua-platform,sec-ch-prefers-color-scheme,sec-ch-ua-full-version-list,sec-ch-downlink,sec-ch-viewport-width,sec-ch-ua-mobile,sec-ch-rtt,sec-ch-ua-arch,sec-ch-ua-full-version,sec-ch-ua,sec-ch-ua-bitness,sec-ch-device-memory,sec-ch-ua-platform-version,sec-ch-ua-model,sec-ch-ect,sec-ch-save-data,sec-ch-viewport-height,sec-ch-width
x-auction-status
12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=22310170639&lsavail=1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115042&to=600&pubProvidedId=%5B%5D&aun=Reason_320x100_320x50_300x250_incontent_FirstParagraph_SA&gpid=%2F15184186%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA&maxw=728&maxh=90&si=80383&pi=3&bf=728x90%2C300x250%2C468x60&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c6ebd2bc46e1addacbbcc382b70f9f2a1cf2e069896f9c1b4cc5c44f5e2bd2f8

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115042&to=600&pubProvidedId=%5B%5D&aun=Reason_320x100_320x50_300x250_incontent_FirstParagraph_SA&gpid=%2F15184186%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA%2FReason_320x100_320x50_300x250_incontent_FirstParagraph_SA&maxw=728&maxh=90&si=80385&pi=3&bf=728x90%2C300x250%2C468x60&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
392a979d3a959cd405a28bdc6b5f47318cb23be04c304a3166da22271035c66c

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
prebid
ib.adnxs.com/ut/v3/
139 B
821 B
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
a164bdeb3f9003295f554e9e7e3a54d2e0cd50ae4d7eb3f4aab28d81364415de
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
9c789cee-dc4e-4ab7-b0a2-5ae930aba71b
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
139
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
6734c0e293932956732048132378c904fa347876e4c2c5b69df0529b1dcbcbbd
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
auction
s2s.t13.io/openrtb2/
1 KB
556 B
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
11039908801ee6c9f784113acb6392c1948e52812d5864fab433ad79f9fdc985
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
496
expires
0
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=67022785228&lsavail=1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
prebidjs
rtb.openx.net/openrtbb/
53 B
220 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
036a0fd4ed122cd62dbf0d01461cab2c0e9a76d1443f7bf9dbc23907eb7a598b

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
9e685510eb045c798aef094a7ae1d9eca54a2b2e3a560018c9a5d228fae9af16
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
prebid
ib.adnxs.com/ut/v3/
140 B
823 B
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
f748d3575e0c38f67258ad3f68ba500419e3bb6da0a0a3b4b434185319febfee
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
fa4e4786-ad6b-4ca6-9ffb-0373ec172f6b
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
140
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115054&to=600&pubProvidedId=%5B%5D&aun=reason_medrec_12&gpid=%2F15184186%2Freason_medrec_1%2Freason_medrec_12&maxw=300&maxh=250&si=80383&pi=3&bf=300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad80b064dcf563bf2497574dc0f24862012b02bc386217b57ccc32b974e927f7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
auction
tlx.3lift.com/header/
19 B
832 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
sec-ch-downlink,sec-ch-ua-full-version-list,sec-ch-prefers-color-scheme,sec-ch-ua-platform,sec-ch-dpr,user-agent,sec-ch-width,sec-ch-viewport-height,sec-ch-save-data,sec-ch-ect,sec-ch-ua-model,sec-ch-ua-platform-version,sec-ch-device-memory,sec-ch-ua-bitness,sec-ch-ua,sec-ch-ua-full-version,sec-ch-ua-arch,sec-ch-rtt,sec-ch-ua-mobile,sec-ch-viewport-width
x-auction-status
12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
632 B
977 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2Freason_medrec_1%2Freason_medrec_12&tk_flint=pbjs_lite_v8.30.0&x_source.tid=c2fab2e7-199b-45cf-bad0-ca6b91705845&l_pb_bid_id=134a7c73007e2e51&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=d0b0f62a-8c53-40d9-a6a2-cdffc481dd7e&rp_maxbids=1&p_gpid=%2F15184186%2Freason_medrec_1%2Freason_medrec_12&m_ch_mobile=%3F0&slots=1&rand=0.9352497448670887
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
52a70cc9dfecde147a022a46f159cbd79b781260267eae1e3d99e3e56d523db2

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
expires
Wed, 17 Sep 1975 21:32:10 GMT
deflate.min.js
live.primis.tech/main/js/ Frame C770
13 KB
7 KB
Script
General
Full URL
https://live.primis.tech/main/js/deflate.min.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
407a567abfabf78843c1dfe24457bb650325d8f93e9396a00ce686172756244f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
last-modified
Tue, 15 Aug 2023 09:50:11 GMT
server
nginx
x-amz-cf-pop
YUL62-C1
etag
W/"64db4a53-3217"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
uAn5ZNPqHyjjx8YWuXzSnSxlV1Epl6_ZNgFzrl_ZbYYh28H6Ov86kg==
omweb-v1.min.js
live.primis.tech/content/omid/static/ Frame C770
39 KB
20 KB
Script
General
Full URL
https://live.primis.tech/content/omid/static/omweb-v1.min.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
01172e9ac9330920e66e282d2d77ed1ae863bbab08aec27b168e8d3c82d50c18

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
last-modified
Mon, 07 Aug 2023 08:33:07 GMT
server
nginx
x-amz-cf-pop
YUL62-C1
etag
W/"64d0ac43-9c3c"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
mdLbVMgvfbHjOHTmMlbBxGvB03d-JOVPs0wFH17LN4gP3eLVu6pfyA==
omid-session-client-v1.js
live.primis.tech/content/omid/static/ Frame C770
64 KB
20 KB
Script
General
Full URL
https://live.primis.tech/content/omid/static/omid-session-client-v1.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
0804a138d2373d667829f97ef1789c8563ed2730275ef0a6aba5facb75b29a85

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
last-modified
Mon, 07 Aug 2023 08:33:07 GMT
server
nginx
x-amz-cf-pop
YUL62-C1
etag
W/"64d0ac43-1013e"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
yERxD5rSGHgB7-TnlDWiaQp8fHCW3aD9xDNwtN5al1tl0lLaQYr0bg==
hls.0.12.4_3.min.js
live.primis.tech/content/video/hls/ Frame C770
258 KB
115 KB
Script
General
Full URL
https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
a20010b26bce05ea3cfc83cf3a162b7c16b5d2fa2bcf2253b0394b0eb322347a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
last-modified
Wed, 23 Mar 2022 12:48:35 GMT
server
nginx
x-amz-cf-pop
YUL62-C1
etag
W/"623b1723-409bc"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
cache-control
max-age=31536000, public
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
PEiHvX51MHCXxKOxXAadNQ4Fc1po8AA-Cmvz_-zZcIp2mG5pL-JW-w==
expires
Wed, 12 Feb 2025 19:05:14 GMT
pal.js
live.primis.tech/content/pal/ Frame C770
140 KB
68 KB
Script
General
Full URL
https://live.primis.tech/content/pal/pal.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
678f12cbea984230dc14c0ea0335a149919c34428144e2e80ff951bc49b6e5ee

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
last-modified
Sun, 14 Jan 2024 11:28:37 GMT
server
nginx
x-amz-cf-pop
YUL62-C1
etag
W/"65a3c565-22ffe"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
OTK_3WqWRbzf068-4Q6Hx6hY-f_DJSJpdIeGJylsTxzt6p1U35kkvg==
prebidVid.7.16.0_20.min.js
live.primis.tech/content/prebid/ Frame C770
552 KB
277 KB
Script
General
Full URL
https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
f6bf7aea9882f4dbd44398f5305891472fe323c9799dec1fb2227278b34b1aa8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:14 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
last-modified
Mon, 12 Feb 2024 11:39:16 GMT
server
nginx
x-amz-cf-pop
YUL62-C1
etag
W/"65ca0364-8a1eb"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
cache-control
max-age=31536000, public
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
olL8jYVmENw7u--NtJZ4KP5uPAoFDL0DRGdddysXXIuyIeppW6r2zA==
expires
Wed, 12 Feb 2025 19:05:14 GMT
liveVideo.php
live.primis.tech/live/ Frame C770
619 KB
243 KB
Script
General
Full URL
https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveView.php?s=116322&cbuster=1707851115&pubUrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&x=400&y=272&playerApiId=freestarPrimisPlayer&schain=1.0,1!freestar.com,472,1&cbuster=1707851114&pubUrlAuto=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&videoType=flow&floatWidth=&floatHeight=&floatDirection=&floatVerticalOffset=&floatHorizontalOffset=&floatCloseBtn=&flowMode=&flowCloseButtonPosition=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
0b2ee9a2d371d3fd26b36e7edf037e18e14b1963a7d5b5ce019b6886055e4638

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
x-amz-cf-pop
YUL62-C1
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
XJ2DsJr33a4EloqkQQE6ZfbVn_AOimxM8osgxZbzW-FQJ1bJDa4fdA==
474
p.ad.gt/api/v1/p/
39 KB
13 KB
Script
General
Full URL
https://p.ad.gt/api/v1/p/474
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/474?_it=freestar
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
de1e30a8e8cb65d48dc42e62af94c51d2cfa33185d0a449076e4e7d470a0de27

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Tue, 13 Feb 2024 19:01:30 GMT
server
cloudflare
age
225
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=14400
cf-ray
854f577dcf444bd8-BUF
halo_match
ids.ad.gt/api/v1/
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/halo_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&halo_id=060j9d88fihe9b8df9bkjcbjcaj9djfekefw6k44ousm6g4ko6gywigwiew6kwomy
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577dcf154bcc-BUF
content-length
43
content-type
image/gif
match
ids.ad.gt/api/v1/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&adnxs_id=$UID&gdpr=0
  • https://secure.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fmatch%3Fid%3DAU1D-0100-001707851115-UJS0TXCA-MOGT%26adnxs_id%3D%24UID%26gdpr%3D0
  • https://ids.ad.gt/api/v1/match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&adnxs_id=5872803529851156248&gdpr=0
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&adnxs_id=5872803529851156248&gdpr=0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577def264bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
d48fda77-cd14-4958-968b-2cd04fa2ab1f
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://ids.ad.gt/api/v1/match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&adnxs_id=5872803529851156248&gdpr=0
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
t_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&ttd_puid=AU1D-0100-001707851115-UJS0TXCA-MOGT&gdpr=0
  • https://ids.ad.gt/api/v1/t_match?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
43 B
113 B
Image
General
Full URL
https://ids.ad.gt/api/v1/t_match?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577dcf184bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

location
https://ids.ad.gt/api/v1/t_match?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Kestrel
content-length
259
pbm_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3DAU1D-0100-001707851115-UJS0TXCA-MOGT
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3DAU1D-0100-001707851115-UJS0TXCA-MOGT
  • https://ids.ad.gt/api/v1/pbm_match?pbm=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/pbm_match?pbm=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577e3f3a4bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

location
https://ids.ad.gt/api/v1/pbm_match?pbm=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
token
token.rubiconproject.com/
0
695 B
Image
General
Full URL
https://token.rubiconproject.com/token?pid=50242&puid=AU1D-0100-001707851115-UJS0TXCA-MOGT&gdpr=0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Expires
0
Pragma
no-cache
Cache-Control
no-cache,no-store,must-revalidate
X-RPHost
78008fe701b681dce86a72fc23cacc40
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
tapad_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3185&partner_device_id=AU1D-0100-001707851115-UJS0TXCA-MOGT&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001707851115...
  • https://pixel.tapad.com/idsync/ex/receive/check?partner_id=3185&partner_device_id=AU1D-0100-001707851115-UJS0TXCA-MOGT&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001707...
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=tapad&ttd_tpi=1&ttd_puid=2af5462b-1213-435d-a332-7e55bb465ba1%252Chttps%25253A%25252F%25252Fids.ad.gt%25252Fapi%25252Fv1%25252Ftapad_match%25253Fi...
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=1830&partner_device_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttd_puid=2af5462b-1213-435d-a332-7e55bb465ba1%2Chttps%253A%252F%252Fids.ad.gt%252Fap...
  • https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&tapad_id=2af5462b-1213-435d-a332-7e55bb465ba1
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&tapad_id=2af5462b-1213-435d-a332-7e55bb465ba1
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577eff784bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
access-control-allow-origin
*
location
https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&tapad_id=2af5462b-1213-435d-a332-7e55bb465ba1
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
g_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm=&google_sc=&google_ula=450542624&id=AU1D-0100-001707851115-UJS0TXCA-MOGT&google_tc=
  • https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&google_gid=CAESEPzb4p0T24zu1LnzTsnp6kc&google_cver=1&google_ula=450542624,0
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&google_gid=CAESEPzb4p0T24zu1LnzTsnp6kc&google_cver=1&google_ula=450542624,0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577e8f4b4bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&google_gid=CAESEPzb4p0T24zu1LnzTsnp6kc&google_cver=1&google_ula=450542624,0
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
357
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ids.ad.gt/api/v1/g_hosted?id=AU1D-0100-001707851115-UJS0TXCA-MOGT
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcwNzg1MTExNS1VSlMwVFhDQS1NT0dU
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcwNzg1MTExNS1VSlMwVFhDQS1NT0dU
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcwNzg1MTExNS1VSlMwVFhDQS1NT0dU
date
Tue, 13 Feb 2024 19:05:15 GMT
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577dcf174bcc-BUF
content-type
text/html; charset=utf-8
ppnt_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?pid=562316&ev=1&rurl=https://ids.ad.gt/api/v1/ppnt_match?uid=%%VGUID%%&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
  • https://ids.ad.gt/api/v1/ppnt_match?uid=AwN5CTqy8JaW&ev=1&pid=562316&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/ppnt_match?uid=AwN5CTqy8JaW&ev=1&pid=562316&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577def284bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
location
https://ids.ad.gt/api/v1/ppnt_match?uid=AwN5CTqy8JaW&ev=1&pid=562316&id=AU1D-0100-001707851115-UJS0TXCA-MOGT
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1
son_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&uid=[UID]&gdpr=0
  • https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8&gdpr=0
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8&gdpr=0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577e0f324bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-6-76
content-type
text/plain; charset=utf8
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001707851115-UJS0TXCA-MOGT&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8&gdpr=0
cache-control
no-cache, no-store, private
tcn
Choice
content-length
0
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
openx
ids.ad.gt/api/v1/
Redirect Chain
  • https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3DAU1D-0100-001707851115-UJS0TXCA-MOGT%26auid%3DAU...
  • https://ids.ad.gt/api/v1/openx?openx_id=55726421-b4c2-4a03-913d-bd46c253e40c&id=AU1D-0100-001707851115-UJS0TXCA-MOGT&auid=AU1D-0100-001707851115-UJS0TXCA-MOGT
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/openx?openx_id=55726421-b4c2-4a03-913d-bd46c253e40c&id=AU1D-0100-001707851115-UJS0TXCA-MOGT&auid=AU1D-0100-001707851115-UJS0TXCA-MOGT
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f577eef6e4bcc-BUF
content-length
43
content-type
image/gif

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://ids.ad.gt/api/v1/openx?openx_id=55726421-b4c2-4a03-913d-bd46c253e40c&id=AU1D-0100-001707851115-UJS0TXCA-MOGT&auid=AU1D-0100-001707851115-UJS0TXCA-MOGT
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
pixel;r=258578906;labels=category.Pain%20treatment%2Ccategory.Opioids%2Ccategory.Pharmaceuticals%2Ccategory.Medicine%2Ccategory.Addiction%2Ccategory.Drug%20Policy%2Ccategory.War%20on%20Drugs%2Ccate...
pixel.quantserve.com/
35 B
1 KB
Image
General
Full URL
https://pixel.quantserve.com/pixel;r=258578906;labels=category.Pain%20treatment%2Ccategory.Opioids%2Ccategory.Pharmaceuticals%2Ccategory.Medicine%2Ccategory.Addiction%2Ccategory.Drug%20Policy%2Ccategory.War%20on%20Drugs%2Ccategory.Black%20Markets%2Ccategory.Fentanyl%2Ccategory.Heroin%2Ccategory.Regulation%2Ccategory.Health%2Ccategory.Economics%2Ccategory.War%20on%20Drugs%2Ctitle.A%20new%20pain%20medication%20could%20reinforce%20the%20disastrous%20crackdown%20on%20prescription%20opioids%2Ctitle.A%20new%20pain%20medication%20could%20reinforce%20the%20disastrous%20crackdown%20on%20prescription%20opioids%2Cauthor.https%3A%2F%2Fwww.facebook.com%2Fjacob.sullum%2Cauthor.Jacob%20Sullum;rf=0;a=p-UeXruRVtZz7w6;url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F;uht=2;fpan=1;fpa=P0-1722568456-1707851114932;pbc=;ns=0;ce=1;qjs=1;qv=b70d35e8-20231208114759;cm=;gdpr=0;us_privacy=1---;ref=;d=reason.com;dst=0;et=1707851115099;tzo=600;ogl=locale.en_US%2Ctype.article%2Ctitle.A%20new%20pain%20medication%20could%20reinforce%20the%20disastrous%20crackdown%20on%20prescription%20o%2Cdescription.When%20the%20government%20is%20systematically%20interfering%20with%20medical%20decisions%252C%20a%20non-%2Curl.https%3A%2F%2Freason%252Ecom%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastro%2Csite_name.Reason%252Ecom%2Cimage.https%3A%2F%2Fd2eehagpk5cl65%252Ecloudfront%252Enet%2Fimg%2Fq60%2Fuploads%2F2019%2F08%2Fpain-pills-k-state%2Cimage%3Awidth.2048%2Cimage%3Aheight.1360%2Cimage%3Atype.image%2Fjpeg;ses=48a40dc7-b35a-4bae-8911-700d2f799d59;mdl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2620:116:800b:21:b08a:1dc5:659b:4055 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
a0d3a0aff7dc3bf32d2176fc3dcda6e7aba2867c4f4d1f7af6355d2cfc6c44f8
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
attribution-reporting-register-trigger
{"event_trigger_data":[{"filters":[{"label":["category.Drug Policy"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.War on Drugs"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Economics"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["title.A new pain medication could reinforce the disastrous crackdown on prescription opioids"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["author.https://www.facebook.com/jacob.sullum"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Pain treatment"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Pharmaceuticals"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Medicine"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Addiction"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Black Markets"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Health"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["author.Jacob Sullum"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Opioids"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Regulation"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Heroin"],"pcode":["p-UeXruRVtZz7w6"]},{"label":["category.Fentanyl"],"pcode":["p-UeXruRVtZz7w6"]}],"trigger_data":"1"}]}
strict-transport-security
max-age=86400
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAo PSDo OUR SAMa IND COM NAV"
content-type
image/gif
cache-control
private, no-cache, no-store, proxy-revalidate
content-length
35
expires
Fri, 04 Aug 1978 12:00:00 GMT
auction
s2s.t13.io/openrtb2/
1 KB
520 B
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
ce3420d3e229cea0acb37d841fdb8506b27a505248914ae0ab60f08ca16b53e0
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
499
expires
0
fastlane.json
fastlane.rubiconproject.com/a/api/
632 B
666 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2Freason_medrec_2%2Freason_medrec_22&tk_flint=pbjs_lite_v8.30.0&x_source.tid=4485f424-68b7-4981-bd29-ae3bc83fb10d&l_pb_bid_id=148ae31aaae2a481&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=7165fee7-ecf2-4f3b-ba6a-7072cd95ec3f&rp_maxbids=1&p_gpid=%2F15184186%2Freason_medrec_2%2Freason_medrec_22&m_ch_mobile=%3F0&slots=1&rand=0.19345964745823263
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
4bdb6bf5763cb795ffae998941b3d2c2757fc005aaa6d58854c40a3bb272b5bb

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
632
expires
Wed, 17 Sep 1975 21:32:10 GMT
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=8620360180&lsavail=1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
prebidjs
rtb.openx.net/openrtbb/
53 B
220 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
032b22cc321694eb6e69cca07b71b16ad5e6d9f00c613ec9883bcd62abfa1864

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115113&to=600&pubProvidedId=%5B%5D&aun=reason_medrec_22&gpid=%2F15184186%2Freason_medrec_2%2Freason_medrec_22&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=300&maxh=250&si=80383&pi=3&bf=300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
auction
tlx.3lift.com/header/
19 B
832 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
sec-ch-ect,sec-ch-save-data,sec-ch-viewport-height,sec-ch-width,user-agent,sec-ch-dpr,sec-ch-ua-platform,sec-ch-prefers-color-scheme,sec-ch-ua-full-version-list,sec-ch-downlink,sec-ch-viewport-width,sec-ch-ua-mobile,sec-ch-rtt,sec-ch-ua-arch,sec-ch-ua-full-version,sec-ch-ua,sec-ch-ua-bitness,sec-ch-device-memory,sec-ch-ua-platform-version,sec-ch-ua-model
x-auction-status
12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
prebid
ib.adnxs.com/ut/v3/
140 B
823 B
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
e226135ca8f74f453165efa4a5f61af01cf7f3535784bc57995e9801acac4158
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
e3682044-ed11-45bb-b961-d6cfad9aa38b
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
140
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
ea4e7f31a9d078681321da5423aa8e49852b334240b9178983f20f41add8de1d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:13 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
ads
securepubads.g.doubleclick.net/gampad/
28 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2Creason_320x50_adhesion&enc_prev_ius=%2F0%2F1&prev_iu_szs=1x1%7C300x50%7C320x50%7C468x60%7C728x90%7C970x90%7C300x100%7C320x100&ifi=1&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115160&lmt=1707847436&adxs=631&adys=1150&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=1&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=338x-1&msz=300x-1&fws=516&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrebid%3D0%26fs_uuid%3D398abd07-d4db-49ec-8e20-d75225bf7486%26floors_id%3Dc91a43%26floors_hour%3D19%26fs_placementName%3Dreason_320x50_adhesion%26fs_ad_product%3DstickyFooter%26amznbid%3D1yljlds%26amznp%3Dxa27eo%26fsbid%3D0%26amzniid%3DJCabHYImHHmPZQ1XmPCYA1kAAAGNo9vp1QEAAAJYAQBhcHNfdHhuX2JpZDEgICBhcHNfdHhuX2ltcDEgICATz6d9%26amznsz%3D468x60%26amznactt%3DOPEN&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D0%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=2249185638&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
388bcf59a895db08501cb7190fb2e135782604d5c6f4d4f5b011a34202b60f5c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12488
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442249215
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
605033cc1a4730890edd7776333db3e4.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 70D0
6 KB
3 KB
Document
General
Full URL
https://605033cc1a4730890edd7776333db3e4.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1b::84 Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
468959e93f9b4e6f07c6a8f8d0e93d8fcb37d76a8615a93ec153f5842247ba99
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, immutable, max-age=31536000
content-encoding
br
content-length
2653
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Wed, 12 Feb 2025 19:05:15 GMT
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
28 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2CReason_320x100_320x50_300x250_incontent_FirstParagraph_SA&enc_prev_ius=%2F0%2F1&prev_iu_szs=320x50%7C1x3%7C468x60%7C728x90%7C300x250%7C443x250&fluid=height&ifi=2&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115205&lmt=1707847436&adxs=369&adys=2993&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=1&ucis=2&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=767x3653&msz=767x250&fws=4&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3D9f8a463c-529c-4037-8679-8614567d8da8%26floors_id%3Dfd8df4%26floors_hour%3D19%26fs_placementName%3DReason_320x100_320x50_300x250_incontent_FirstParagraph_SA%26fs_ad_product%3Dbanner%26amznbid%3D2%26amznp%3D2%26fsbid%3Dtimeout&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=3248709317&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
37aa2aa72f403fa72364b38b616e894b4d106bdd753383e9bcc171d8abf677c8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12106
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442970074
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
27 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2Creason_medrec_1&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250&ifi=3&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115221&lmt=1707847436&adxs=261&adys=4363&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=2&ucis=3&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=767x270&msz=300x250&fws=4&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3D5b72b8e6-efbd-4f35-8e62-891ed749ae63%26floors_id%3D6415ef%26floors_hour%3D19%26fs_placementName%3Dreason_medrec_1%26fs_ad_product%3Dbanner%26amznbid%3D1yljlds%26amznp%3Dxa27eo%26fsbid%3Dtimeout%26amzniid%3DJFh8WmR54ltBl1bYhqgY_j0AAAGNo9vqaQEAAAJYAQBhcHNfdHhuX2JpZDEgICBhcHNfdHhuX2ltcDEgICDGv-h5%26amznsz%3D300x250%26amznactt%3DOPEN&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=220238896&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
97cb5c245563e070ad7ac0ac3e81b8473d63f354fd6eceda5babb5e3ef9a19d8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11990
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442249218
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
27 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2Creason_medrec_2&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250&ifi=4&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115237&lmt=1707847436&adxs=645&adys=4363&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=3&ucis=4&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=767x270&msz=300x250&fws=4&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3D0fb8d168-94d6-4236-93c0-40e6dcfd6a0b%26floors_id%3Dad1a00%26floors_hour%3D19%26fs_placementName%3Dreason_medrec_2%26fs_ad_product%3Dbanner%26amznbid%3D1yljlds%26amznp%3Dxa27eo%26fsbid%3Dtimeout%26amzniid%3DJPg29VdURqdF_H0jD9UUQ50AAAGNo9vp9QEAAAJYAQBhcHNfdHhuX2JpZDEgICBhcHNfdHhuX2ltcDEgICDQWKSM%26amznsz%3D300x250%26amznactt%3DOPEN&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=932008785&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
1a11f290d4a31e8cccadbf832257a4ebc5d34b5ea2ea127dc1836b87048b3761
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11968
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442971097
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
28 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2Creason_120x600_MiniSkyscraper&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250%7C120x600%7C160x600%7C300x600&ifi=5&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115249&lmt=1707847436&adxs=1044&adys=530&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=5&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=373x600&msz=373x600&fws=4&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3D62b2c061-376c-4b75-8f07-e95fb98ae4cb%26floors_id%3D2f3232%26floors_hour%3D19%26fs_placementName%3Dreason_120x600_MiniSkyscraper%26fs_ad_product%3Dbanner%26amznbid%3D1yljlds%26amznp%3Dxa27eo%26fsbid%3Dtimeout%26amzniid%3DJFaWGtyeOpbN0Tov25IwVRAAAAGNo9vqKQEAAAJYAQBhcHNfdHhuX2JpZDEgICBhcHNfdHhuX2ltcDEgICDwQL8u%26amznsz%3D120x600%26amznactt%3DOPEN&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=1228468068&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
51ae3f936e61022d5ca02dd0683bfb866616f99c460a5ed74e43c4fd2ff4fe16
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12008
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442249212
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
28 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2Creason_120x600_MiniSkyscraper&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250%7C120x600%7C160x600%7C300x600&ifi=6&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115264&lmt=1707847436&adxs=1044&adys=2442&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=4&ucis=6&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=373x600&msz=373x600&fws=4&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3D36980631-0d71-44ed-bfd3-3ed10c89892d%26floors_id%3D2f3232%26floors_hour%3D19%26fs_placementName%3Dreason_120x600_MiniSkyscraper%26fs_ad_product%3Dbanner%26amznbid%3D1yljlds%26amznp%3Dxa27eo%26fsbid%3Dtimeout%26amzniid%3DJH-X8DXSrbgHs1sU7M4BdrQAAAGNo9vqLQEAAAJYAQBhcHNfdHhuX2JpZDEgICBhcHNfdHhuX2ltcDEgICClvy3j%26amznsz%3D120x600%26amznactt%3DOPEN&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=1228431695&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
44f6395e83ff2efdad19fdefbfb7e861528732c04d46e0d387c8cbb1f9a48c97
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12006
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442970158
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
28 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2CReason_300x600_300x250_160x600_Sidebar_Repeat_SA&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250%7C120x600%7C160x600%7C300x600&ifi=7&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115278&lmt=1707847436&adxs=1044&adys=4061&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=5&ucis=7&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=373x600&msz=373x600&fws=4&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3Dbacd1474-7298-4855-bbe8-c6fd035bd3c3%26floors_id%3D5cd76d%26floors_hour%3D19%26fs_placementName%3DReason_300x600_300x250_160x600_Sidebar_Repeat_SA%26fs_ad_product%3Dbanner%26amznbid%3D2%26amznp%3D2%26fsbid%3Dtimeout&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=4149706675&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a0cd39d914f6197e33fca2a87ec856e45d52725ef45f26a58a16c95336ff928
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12067
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442249221
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
28 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2CReason_300x600_300x250_160x600_Sidebar_Repeat_SA&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250%7C120x600%7C160x600%7C300x600&ifi=8&sfv=1-0-40&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1707851115289&lmt=1707847436&adxs=-12245933&adys=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=-1&ucis=8&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=373x600&msz=0x0&fws=132&ohw=1600&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&a3p=EhsKDGlkNS1zeW5jLmNvbRi-0e-e2jFIAFICCGQSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEhQKBW9wZW54GL7R757aMUgAUgIIZA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3De93ec883-7d85-42d9-8343-af19d4ab5690%26floors_id%3D5cd76d%26floors_hour%3D19%26fs_placementName%3DReason_300x600_300x250_160x600_Sidebar_Repeat_SA%26fs_ad_product%3Dbanner%26amznbid%3D1%26amznp%3D1%26fsbid%3Dtimeout&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=4154900519&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a21b89e9821dcf75881714e577af85802a4c923f1559ab3e4ed829897e9a535d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12058
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442249197
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
analytics.min.js
a.pub.network/core/analytics/1.3.1/
14 KB
6 KB
Script
General
Full URL
https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:14ce , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9bd895d686da93a9ebae3f625de466a67d6a67d77c995311878e3ba2fd3081e7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
br
cf-cache-status
HIT
age
88887
x-guploader-uploadid
ABPtcPok-KkZX40pftQkO1PaCeKvsj_Z1H6yrsJx5H3pWmmYhbD_hWljmYOTdzQuXP_50sYLuOQcVWQjlQ
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=86400
last-modified
Tue, 06 Feb 2024 17:29:01 GMT
server
cloudflare
etag
W/"fcbfd6860adc80d23fb1cdcb598238ad"
vary
Accept-Encoding
x-goog-hash
crc32c=MGVMCQ==, md5=/L/WhgrcgNI/sc3LWYI4rQ==
x-goog-generation
1707240541233069
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=3600
x-goog-stored-content-length
14112
cf-ray
854f577ea9526aed-BUF
expires
Tue, 13 Feb 2024 20:05:15 GMT
pd
google-bidout-d.openx.net/w/1.0/ Frame FA55
725 B
754 B
Document
General
Full URL
https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Requested by
Host: oa.openxcdn.net
URL: https://oa.openxcdn.net/esp.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
40f710fa565366f4ebe06d92c327e5a27fbb1e1b3d8e2d81fb7ae629e3cb4e48

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
gzip
content-length
452
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
via
1.1 google
auction
s2s.t13.io/openrtb2/
1 KB
521 B
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
e8e52d2693c75c2985d22de15be6ee7ce349016ad194855198fb9f5f8e62f8a7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
500
expires
0
v1
btlr.sharethrough.com/universal/
0
37 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
auction
tlx.3lift.com/header/
19 B
848 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
sec-ch-prefers-color-scheme,sec-ch-ua-platform,sec-ch-dpr,user-agent,sec-ch-width,sec-ch-viewport-height,sec-ch-save-data,sec-ch-ect,sec-ch-ua-model,sec-ch-ua-platform-version,sec-ch-device-memory,sec-ch-ua-bitness,sec-ch-ua,sec-ch-ua-full-version,sec-ch-ua-arch,sec-ch-rtt,sec-ch-ua-mobile,sec-ch-viewport-width,sec-ch-downlink,sec-ch-ua-full-version-list
x-auction-status
12, 12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=8759422968&lsavail=1&bundle=VSthyV9rYnJTZTdibjJNJTJCVzQ4MjI0UVBjYW1OV2Y3MUVKUzN0bFJoOGZEb25YSDB6WjRTMHNZd3lSNkk5VlU3allTWEtlcFplRnVRRDVLRW0xVnpTTkl5RnRUVnRibnV5d1N6UWdZR2olMkJtSjBiajE2UDM1OGNDc1ZoTEJLN3RRaW80VVU
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
prebid
ib.adnxs.com/ut/v3/
140 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
f11c56d537304f9eebaedfe13cfce5f30b7c5963cf7c7e48812b8b1c92986697
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
8c27b247-392c-403a-bd62-836c029800e7
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
140
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
fastlane.json
fastlane.rubiconproject.com/a/api/
683 B
717 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&alt_size_ids=9%2C8%2C10&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-35_ad&tk_flint=pbjs_lite_v8.30.0&x_source.tid=954bf2cb-6a13-428e-979b-3650542fe13d&l_pb_bid_id=204d78a978e3af3b&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=a0bc9bd4-a248-4e1e-9f92-cdf69f9d9795&rp_maxbids=1&p_gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-35_ad&m_ch_mobile=%3F0&slots=1&rand=0.1369042702427925
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
0956b4f13d1ccd617475a6b7d78ac985f9270bd131ba58bd6ea30d7755cddda5

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
683
expires
Wed, 17 Sep 1975 21:32:10 GMT
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115332&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-35_ad&gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-35_ad&pv=7adc9286-415b-4b05-8068-76b73c10e0d0&maxw=300&maxh=600&si=80384&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad80b064dcf563bf2497574dc0f24862012b02bc386217b57ccc32b974e927f7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115333&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-35_ad&gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-35_ad&pv=7adc9286-415b-4b05-8068-76b73c10e0d0&maxw=300&maxh=600&si=80383&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
68b5305ac107f2df7a75da819da214e1fe54349bd7b4ca74ab46b968d899d6fc

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115333&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-35_ad&gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-35_ad&pv=7adc9286-415b-4b05-8068-76b73c10e0d0&maxw=300&maxh=600&si=80388&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad80b064dcf563bf2497574dc0f24862012b02bc386217b57ccc32b974e927f7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
05c41a3b8e12ec73e7dcad7c30c1abd7135ed21ace3b9ad0d01562f139832a32
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
prebidjs
rtb.openx.net/openrtbb/
53 B
95 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
ca5c7f27b0fe192760897a6516196f1f2aa5a910af14b312f72287cef71985c0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
pr
s.amazon-adsystem.com/v3/ Frame 217E
5 KB
5 KB
Document
General
Full URL
https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&dcc=t
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
3be483528a4894eab0cfd3e0b87332608d9887517a8658319ec805937e251869
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&gdpr=0&dl=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&dcc=t
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
5149
Content-Type
text/html;charset=ISO-8859-1
Date
Tue, 13 Feb 2024 19:05:15 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
H1PJ9HB5B8M08Q0S3X0W
setuid
s2s.t13.io/ Frame C5F1
0
15 B
Image
General
Full URL
https://s2s.t13.io/setuid?bidder=sovrn&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=b&uid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
strict-transport-security
max-age=31536000
content-type
text/html
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
0
merge
ce.lijit.com/ Frame C5F1
Redirect Chain
  • https://pixel-eu.rubiconproject.com/exchange/sync.php?p=sovrn-onscroll&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
43 B
2 KB
Image
General
Full URL
https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
2eb7d209ab67664d6226c75331547ba1
Expires
0
merge
ce.lijit.com/ Frame C5F1
Redirect Chain
  • https://match.prod.bidr.io/cookie-sync/svr?gdpr=0&gdpr_consent=
  • https://match.prod.bidr.io/cookie-sync/svr?gdpr=0&gdpr_consent=&_bee_ppp=1
  • https://ce.lijit.com/merge?3pid=AACJ-U7Ll3sAABJaNC07Nw&pid=85&gdpr=0
43 B
1 KB
Image
General
Full URL
https://ce.lijit.com/merge?3pid=AACJ-U7Ll3sAABJaNC07Nw&pid=85&gdpr=0
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

location
https://ce.lijit.com/merge?3pid=AACJ-U7Ll3sAABJaNC07Nw&pid=85&gdpr=0
Date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=2592000; includeSubDomains
Server
gunicorn
Connection
keep-alive
Content-Length
0
merge
ce.lijit.com/ Frame C5F1
Redirect Chain
  • https://aorta.clickagy.com/pixel.gif?ch=185&cm=IJ_5ATZHwpxocGP7SR6BzHWi&redir=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D84%263pid%3D%7Bvisitor_id%7D&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=84&3pid=Zcu9a11ZdSrn6UNLg9dcZUK2
43 B
1 KB
Image
General
Full URL
https://ce.lijit.com/merge?pid=84&3pid=Zcu9a11ZdSrn6UNLg9dcZUK2
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
Aorta/20240213.97f95f8e7
expect
0
access-control-max-age
31536000
access-control-allow-methods
POST, GET, OPTIONS
content-type
text/plain
location
https://ce.lijit.com/merge?pid=84&3pid=Zcu9a11ZdSrn6UNLg9dcZUK2
access-control-allow-origin
*
access-control-expose-headers
Set-Cookie
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-aorta-region
us-east-1
x-aorta-host
d044629e0097
access-control-allow-headers
Origin,cache-control,content-type,man,messagetype,soapaction
content-length
0
merge
ce.lijit.com/ Frame C5F1
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D92%263pid%3D%24UID&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=92&3pid=5872803529851156248&gdpr=0&gdpr_consent=
43 B
657 B
Image
General
Full URL
https://ce.lijit.com/merge?pid=92&3pid=5872803529851156248&gdpr=0&gdpr_consent=
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
e628567a-fd9f-46df-bcd3-046c6c757e62
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://ce.lijit.com/merge?pid=92&3pid=5872803529851156248&gdpr=0&gdpr_consent=
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
dot.gif
s0.2mdn.net/ Frame C5F1
Redirect Chain
  • https://ap.lijit.com/dsp/google/cookiematch/beacon?gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=sovrn&google_hm=SUpfNUFUWkh3cHhvY0dQN1NSNkJ6SFdp&gdpr=0
  • https://s0.2mdn.net/dot.gif?gdpr=0
43 B
490 B
Image
General
Full URL
https://s0.2mdn.net/dot.gif?gdpr=0
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
2607:f8b0:4004:c08::95 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 05:06:45 GMT
x-content-type-options
nosniff
age
50310
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
x-xss-protection
0
last-modified
Sun, 01 Feb 2009 08:00:00 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 14 Feb 2024 05:06:45 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://s0.2mdn.net/dot.gif?gdpr=0
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
231
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
merge
ce.lijit.com/ Frame C5F1
Redirect Chain
  • https://cs.krushmedia.com/77781087eb9a0621642f9ebec6beb8d1.gif?puid=[UID]&redir=[RED]&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=102&3pid=dc0e4bdf-ffd5-524d-91f0-2def249454e7
43 B
1 KB
Image
General
Full URL
https://ce.lijit.com/merge?pid=102&3pid=dc0e4bdf-ffd5-524d-91f0-2def249454e7
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Server
nginx
Location
http://ce.lijit.com/merge?pid=102&3pid=dc0e4bdf-ffd5-524d-91f0-2def249454e7
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Length
0
Expires
0
merge
ce.lijit.com/ Frame C5F1
Redirect Chain
  • https://data.adsrvr.org/track/cmf/generic?ttd_pid=federatedmedia&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=27&3pid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
43 B
668 B
Image
General
Full URL
https://ce.lijit.com/merge?pid=27&3pid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

location
https://ce.lijit.com/merge?pid=27&3pid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Kestrel
content-length
223
merge
ce.lijit.com/ Frame C5F1
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=fmx&us_privacy=&gdpr=0&gdpr_consent=
  • https://x.bidswitch.net/ul_cb/sync?ssp=fmx&us_privacy=&gdpr=0&gdpr_consent=
  • https://a.sportradarserving.com/sync?ssp=bidswitch&bidswitch_ssp_id=fmx
  • https://a.sportradarserving.com/ul_cb/sync?ssp=bidswitch&bidswitch_ssp_id=fmx
  • https://x.bidswitch.net/sync?dsp_id=409&expires=14&user_group=1&user_id=f760379d-b183-47ed-b2a7-c21c03c4c07f&ssp=fmx
  • https://ce.lijit.com/merge?pid=26&3pid=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
43 B
2 KB
Image
General
Full URL
https://ce.lijit.com/merge?pid=26&3pid=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

Location
//ce.lijit.com/merge?pid=26&3pid=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
Date
Tue, 13 Feb 2024 19:05:16 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
ecommerce.js
www.google-analytics.com/plugins/ua/
1 KB
655 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ecommerce.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2001:4860:4802:38::178 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:13:16 GMT
content-encoding
br
x-content-type-options
nosniff
age
3119
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
630
x-xss-protection
0
last-modified
Thu, 20 Jul 2023 22:48:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 13 Feb 2024 19:13:16 GMT
ec.js
www.google-analytics.com/plugins/ua/
3 KB
1 KB
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ec.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2001:4860:4802:38::178 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:07:04 GMT
content-encoding
br
x-content-type-options
nosniff
age
3491
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1129
x-xss-protection
0
last-modified
Tue, 27 Jun 2023 17:28:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 13 Feb 2024 19:07:04 GMT
e8f51b00-ade2-e7b6-f311-bfe32a7be641
pr-bh.ybp.yahoo.com/sync/openx/ Frame FA55
43 B
603 B
Image
General
Full URL
https://pr-bh.ybp.yahoo.com/sync/openx/e8f51b00-ade2-e7b6-f311-bfe32a7be641?gdpr=0
Requested by
Host: google-bidout-d.openx.net
URL: https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:4e9:5a02:d2ce:e24a:b8d2:5c54 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
ATS /
Resource Hash
48a33ca9f42b91902d57ad8ac52e1ce32b92c8c10c732f2dbb6fe960ebfd9438
Security Headers
Name Value
Content-Security-Policy sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

accept-language
en-US,en;q=0.9
Referer
https://google-bidout-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
strict-origin-when-cross-origin
server
ATS
content-security-policy
sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-frame-options
DENY
content-type
image/gif
content-length
43
dcm
s.amazon-adsystem.com/ Frame FA55
43 B
855 B
Image
General
Full URL
https://s.amazon-adsystem.com/dcm?pid=6e1b1225-4dd8-4d7d-b277-465574a27014&id=24e40139-21e4-ce05-02c8-2b81bd1fe0e8
Requested by
Host: google-bidout-d.openx.net
URL: https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://google-bidout-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
P37PSMXFWTT1CKGM5EG3
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
sd
us-u.openx.net/w/1.0/ Frame FA55
Redirect Chain
  • https://match.adsrvr.org/track/cmf/openx?oxid=7c327d44-3d4e-75ff-c2c6-a916d52c2b08&gdpr=0
  • https://us-u.openx.net/w/1.0/sd?id=537072971&val=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttd_puid=7c327d44-3d4e-75ff-c2c6-a916d52c2b08&gdpr=0&gdpr_consent=
43 B
62 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072971&val=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttd_puid=7c327d44-3d4e-75ff-c2c6-a916d52c2b08&gdpr=0&gdpr_consent=
Requested by
Host: google-bidout-d.openx.net
URL: https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://google-bidout-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

location
https://us-u.openx.net/w/1.0/sd?id=537072971&val=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttd_puid=7c327d44-3d4e-75ff-c2c6-a916d52c2b08&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Kestrel
content-length
335
pixel
cm.g.doubleclick.net/ Frame FA55
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=openx&google_hm=NTA1ZGFlOGUtZjQzOS0yYjViLWQ3MjYtZjNhZjFmY2VlNTY4
Requested by
Host: google-bidout-d.openx.net
URL: https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://google-bidout-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
sd
us-u.openx.net/w/1.0/ Frame FA55
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=openx&google_cm&google_sc
  • https://us-u.openx.net/w/1.0/sd?id=537072991&val=CAESEIZYjK_RxRK9hUANxYMxXHM&google_cver=1
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072991&val=CAESEIZYjK_RxRK9hUANxYMxXHM&google_cver=1
Requested by
Host: google-bidout-d.openx.net
URL: https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://google-bidout-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://us-u.openx.net/w/1.0/sd?id=537072991&val=CAESEIZYjK_RxRK9hUANxYMxXHM&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
295
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
cm
us-u.openx.net/w/1.0/ Frame D0D1
993 B
894 B
Document
General
Full URL
https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
72d1cc640fd6c0a8b70d52837ac00b5c6c6b2b20cc0db2eea17e0068e17f16dc

Request headers

Referer
https://ce.lijit.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
gzip
content-length
591
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
via
1.1 google
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame 5A24
16 KB
6 KB
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/prebid-server/?gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dsovrn%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID&dnr=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.221.241.11 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-221-241-11.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c861dd92be984fe498ece34c0f3c921861ac51bfee50323fcae21231abf7a82b

Request headers

Referer
https://ce.lijit.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=122053
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Thu, 15 Feb 2024 04:59:28 GMT
last-modified
Tue, 13 Feb 2024 04:57:54 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
publishertag.prebid.144.js
static.criteo.net/js/ld/
96 KB
31 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.144.js
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
66776998b10e583a72f8fd29391a50e2c80eb3bc9a65b0dafe97e576d7d88507
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Fri, 27 Oct 2023 06:43:26 GMT
server
nginx
etag
W/"653b5c0e-1811e"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 14 Feb 2024 19:05:15 GMT
auction
s2s.t13.io/openrtb2/
1 KB
522 B
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
e84308044fc128c132fa6ae03d8c57a9f5d85dfa6d7ac9ace50120a8e46bbce3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
501
expires
0
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=10118988434&lsavail=1&bundle=VSthyV9rYnJTZTdibjJNJTJCVzQ4MjI0UVBjYW1OV2Y3MUVKUzN0bFJoOGZEb25YSDB6WjRTMHNZd3lSNkk5VlU3allTWEtlcFplRnVRRDVLRW0xVnpTTkl5RnRUVnRibnV5d1N6UWdZR2olMkJtSjBiajE2UDM1OGNDc1ZoTEJLN3RRaW80VVU
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
fastlane.json
fastlane.rubiconproject.com/a/api/
683 B
717 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&alt_size_ids=9%2C8%2C10&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-34_ad&tk_flint=pbjs_lite_v8.30.0&x_source.tid=bf179d46-c551-41b0-b9c7-bf209822b2e8&l_pb_bid_id=24784aa845abcd5a&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=3df2f1e1-077e-4e0a-961e-c2dd68ed246f&rp_maxbids=1&p_gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-34_ad&m_ch_mobile=%3F0&slots=1&rand=0.6006800816875368
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
b37e8d3ce5148e106b0c3d120566fe8f73f20c3fd143117678b0b7c2926c6f4a

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
683
expires
Wed, 17 Sep 1975 21:32:10 GMT
auction
tlx.3lift.com/header/
19 B
848 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
sec-ch-dpr,sec-ch-ua-platform,sec-ch-prefers-color-scheme,sec-ch-ua-full-version-list,sec-ch-downlink,sec-ch-viewport-width,sec-ch-ua-mobile,sec-ch-rtt,sec-ch-ua-arch,sec-ch-ua-full-version,sec-ch-ua,sec-ch-ua-bitness,sec-ch-device-memory,sec-ch-ua-platform-version,sec-ch-ua-model,sec-ch-ect,sec-ch-save-data,sec-ch-viewport-height,sec-ch-width,user-agent
x-auction-status
12, 12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
prebid
ib.adnxs.com/ut/v3/
140 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
a32a5a7f0c4510611b18562e37045ed04d234e0efd8cc56656e3678dd4041580
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
986fb538-7db8-44e3-a5d5-a315067267ea
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
140
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
59893f157be1037735ba7584f613fc7f19a27019817b261216b94cad359c2a51
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115434&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-34_ad&gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-34_ad&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=300&maxh=600&si=80384&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115434&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-34_ad&gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-34_ad&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=300&maxh=600&si=80383&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115434&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-34_ad&gpid=%2F15184186%2Freason_120x600_MiniSkyscraper%2Frcom_freestar_ad_widget-34_ad&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=300&maxh=600&si=80388&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
prebidjs
rtb.openx.net/openrtbb/
53 B
95 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
848a48bf555cb67aa080af5b4cfa25db5ceff974426a441750d1817d0c5e2976

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
ecm3
s.amazon-adsystem.com/ Frame 217E
Redirect Chain
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dmediagrid.com%26id%3D%24%7BBSW_UUID%7D?gdpr=0
  • https://x.bidswitch.net/ul_cb/check_uuid/https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dmediagrid.com%26id%3D%24%7BBSW_UUID%7D?gdpr=0
  • https://s.amazon-adsystem.com/ecm3?ex=mediagrid.com&id=d9962442-c73f-42a4-adbd-3d9517e387ff
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=mediagrid.com&id=d9962442-c73f-42a4-adbd-3d9517e387ff
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
PK9WGAZXQ1X5HZCZF31X
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Location
https://s.amazon-adsystem.com/ecm3?ex=mediagrid.com&id=d9962442-c73f-42a4-adbd-3d9517e387ff
Date
Tue, 13 Feb 2024 19:05:15 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
cs
cs.yellowblue.io/ Frame 217E
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=amazon&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drhythmone.com%26id%3D%5BRX_UUID%5D&gdpr=0
  • https://sync.1rx.io/usersync2/rmpssp?sub=amazon&zcc=1&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drhythmone.com%26id%3D%5BRX_UUID%5D&cb=1707851115540
  • https://ad.turn.com/r/cs?pid=45&rndcb=859521100
  • https://sync.1rx.io/usersync/turn/7546153649458771999?dspret=1&gdpr=&gdpr_consent=&us_privacy=
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fcs.yellowblue.io%2Fcs%3Faid%3D11599%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
  • https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
0
315 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
cs.yellowblue.io
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RXe2af2325e28b4fd4b66772f44cc57a3b005
content-type
text/html
ecm3
s.amazon-adsystem.com/ Frame 217E
Redirect Chain
  • https://cs.media.net/cksync?cs=31&type=tam&redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dmedia.net%26id%3D%3Cvsid%3E&gdpr=0
  • https://s.amazon-adsystem.com/ecm3?ex=media.net&id=3508527156634894000V10
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=media.net&id=3508527156634894000V10
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
3B827C3QEM52ERWZFRHY
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Server
Apache
p3p
CP="NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA", CP: NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA
Location
https://s.amazon-adsystem.com/ecm3?ex=media.net&id=3508527156634894000V10
Content-Type
text/html
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Content-Length
154
x-mnet-hl2
E
Expires
Tue, 13 Feb 2024 19:05:15 GMT
ecm3
s.amazon-adsystem.com/ Frame 217E
Redirect Chain
  • https://s.ad.smaato.net/c/?adExInit=aps&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsmaato.com%26id%3D%24UID
  • https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
GBW4NQAT62P7KJ5Y45CG
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:04:56 GMT
via
1.1 90b7b9dc3aa8817f0cef3cfd45fb8916.cloudfront.net (CloudFront)
server
CloudFront
x-amz-cf-pop
YUL62-C2
age
19
x-cache
Hit from cloudfront
location
https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
cache-control
no-cache, must-revalidate
content-length
0
x-amz-cf-id
sOl_weSe9EDTa7oRGhrrWztHD8AOoJSVbWV7xQj4fHM6lE7BdZ-a9w==
/
onetag-sys.com/match/ Frame 217E
0
198 B
Image
General
Full URL
https://onetag-sys.com/match/?int_id=113&callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Donetag.com%26id%3D%24%7BUSER_TOKEN%7D&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=15552000
cache-control
no-transform, no-cache
alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
ecm3
s.amazon-adsystem.com/ Frame 217E
Redirect Chain
  • https://um.simpli.fi/amazon/https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsimpli.fi%26id%3D?gdpr=0
  • https://s.amazon-adsystem.com/ecm3?id=0E087FD3E115403AB68AFF630D65CE67&ex=simpli.fi&status=ok
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=0E087FD3E115403AB68AFF630D65CE67&ex=simpli.fi&status=ok
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
DM3YJAAC7A0FNZVNBAJY
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=63072000; includeSubdomains; preload
x-content-type-options
nosniff
server
openresty
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html
location
https://s.amazon-adsystem.com/ecm3?id=0E087FD3E115403AB68AFF630D65CE67&ex=simpli.fi&status=ok
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-headers
DNT,X-Mx-ReqToken,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type
content-length
142
expires
Mon, 12 Feb 2024 19:05:15 GMT
ecm3
s.amazon-adsystem.com/ Frame 217E
Redirect Chain
  • https://trace.mediago.io/ju/cs/amazon?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dbaidu.com%26id%3D%24UID&gdpr=0
  • https://s.amazon-adsystem.com/ecm3?ex=baidu.com&id=cb83d64ba58ceca72i1qs500lskqgimc
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=baidu.com&id=cb83d64ba58ceca72i1qs500lskqgimc
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
MQS0SVKRGFYVH51QS5HS
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/plain; charset=utf-8
location
https://s.amazon-adsystem.com/ecm3?ex=baidu.com&id=cb83d64ba58ceca72i1qs500lskqgimc
access-control-allow-credentials
true
access-control-allow-headers
Content-Type
content-length
8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
ecm3
s.amazon-adsystem.com/ Frame 217E
Redirect Chain
  • https://jadserve.postrelease.com/suid/101959?ntv_r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dnativo.com%26id%3DNTV_USER_ID&gdpr=0
  • https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
CQ8YYHGNBTNZG5RAS7ZY
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx
p3p
CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
access-control-allow-origin
*
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
content-length
0
expires
Mon, 1 Jan 1990 12:00:00 GMT
ecm3
s.amazon-adsystem.com/ Frame 217E
Redirect Chain
  • https://b1sync.zemanta.com/usersync/amazon_tam/?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Doutbrain.com%26id%3D__ZUID__&gdpr=0
  • https://b1sync.zemanta.com/usersync/amazon_tam/?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Doutbrain.com%26id%3D__ZUID__&gdpr=0&s=2
  • https://s.amazon-adsystem.com/ecm3?ex=outbrain.com&id=KtRUPppSGbtrONLvGe1I&gdpr=0
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=outbrain.com&id=KtRUPppSGbtrONLvGe1I&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
K8TMS611MDMEX1WB35NF
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Content-Type
text/html; charset=utf-8
Location
https://s.amazon-adsystem.com/ecm3?ex=outbrain.com&id=KtRUPppSGbtrONLvGe1I&gdpr=0
P3p
CP="We do not support P3P header."
Cache-Control
no-cache, no-store, must-revalidate
Content-Length
112
Expires
Thu, 01 Dec 1994 16:00:00 GMT
collect
a.ad.gt/api/v1/
0
158 B
XHR
General
Full URL
https://a.ad.gt/api/v1/collect
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/474
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cf-cache-status
DYNAMIC
server
cloudflare
vary
Origin
content-type
text/html; charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
cf-ray
854f57800fd84bcc-BUF
getpixels
pixels.ad.gt/api/v1/
0
108 B
Script
General
Full URL
https://pixels.ad.gt/api/v1/getpixels?tagger_id=0963fa593791003d1a4b3efb84710091&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&code=%27none%27
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/474
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:445 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
854f57800e104bc3-BUF
content-type
text/html; charset=utf-8
primisslate.css
live.primis.tech/content/video/css/
18 KB
7 KB
Stylesheet
General
Full URL
https://live.primis.tech/content/video/css/primisslate.css
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
5904191bceefb2eeb3a93b27faf9c6be9b3e7980c3e0b8683b76c2a7faa1baa8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
last-modified
Tue, 05 Dec 2023 09:00:54 GMT
server
nginx
x-amz-cf-pop
YUL62-C1
etag
W/"656ee6c6-47bd"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/css
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
ArmuuzsLxWCQm7NIUm1xVnwMt1bxb7XOJpAXJ9UPxoR80s_Dmd57sw==
apstag.js
c.amazon-adsystem.com/aax2/ Frame C770
286 KB
72 KB
Script
General
Full URL
https://c.amazon-adsystem.com/aax2/apstag.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.230.49.33 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-230-49-33.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
30cd0f962f359605cf5b404dfb9f49cbd91532d8cc6a5421b523121fb767dfc6

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:11:50 GMT
content-encoding
gzip
via
1.1 76a7fdbced88b6eccf433c4e386bae40.cloudfront.net (CloudFront), 1.1 43334f58904cd7106ee523ee0361b402.cloudfront.net (CloudFront)
last-modified
Tue, 06 Feb 2024 20:22:08 GMT
server
AmazonS3
x-amz-cf-pop
IAD89-C3, YUL62-C2
age
3206
x-amz-server-side-encryption
AES256
etag
W/"b9446c9b1fc39deb105769a5bb6def0a"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=3600
x-amz-cf-id
hENq9Bhn1ceNVXm0CGAckAmchfGLASpo9cyiWv41kPz9RKcuI_wMnA==
ProfilesEngineServlet
api.intentiq.com/profiles_engine/ Frame C770
79 B
854 B
XHR
General
Full URL
https://api.intentiq.com/profiles_engine/ProfilesEngineServlet?at=39&mi=10&dpi=793790479&pt=17&dpn=1&jsver=5.09&dbsaved=false&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&iiqcallcount=0&iiqfailcount=0&iiqnodata=false&iiqlocalstorageenabled=true&tsrnd=805_1707851115462&cttl=43200000&rrtt=0&dud=0&abtg=A&iiqppcc=0&vrref=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ref=reason.com
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.161.213.49 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-213-49.yul62.r.cloudfront.net
Software
/
Resource Hash
2669895d08f196d2e307e5bca2b24094ed2310e789b78c6283117247653e0e58

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 bc3e3445494dc5a4f9373d4212505c68.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-P1
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
patent
https://www.almondnet.com/ip
alt-svc
h3=":443"; ma=86400
pragma
no-cache
access-control-max-age
3600
vary
Origin
content-type
text/html
access-control-allow-origin
https://reason.com
access-control-allow-methods
POST, GET, OPTIONS
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Accept, X-Requested-With, remember-me, DNT,X-CustomHeader,Keep-Alive,User-Agent,If-Modified-Since,Cache-Control
x-amz-cf-id
cifOHhdvxYUttO1UxX3CTRB_dqOh5RXqv6odOeMeNGT0ztRmLnVt9w==
expires
Thu, 01 Jan 1970 00:00:00 GMT
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
43 B
955 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&secure=1&dpi=793790479&rnd=573040&dbsaved=false&iiqidtype=2&iiqpcid=14959cb1-032f-455a-a19f-8db1379de073&iiqpciddate=1707851114482&tsrnd=189_1707851115463&vrref=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&jsver=5.09
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 9ea08c3a2524e99d2bb42ac613eb89a2.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
GFK3DXg58XWG8Km525rrzMwgoeE-Gtsms1TkE-syIIyZE6sy0VQcpQ==
expires
Thu, 01 Jan 1970 00:00:00 GMT
usermatch
ssum-sec.casalemedia.com/ Frame C081
Redirect Chain
  • https://ssum-sec.casalemedia.com/usermatch?s=192259&cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0
  • https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
2 KB
920 B
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
082d5a4da43f3e409a76678ed527420f1719329150d2305caa8c268666be0bfb

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
cf-cache-status
DYNAMIC
cf-ray
854f57808c0a36d2-YYZ
content-encoding
br
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
0
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
pragma
no-cache
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=rnrhBGiEIvr0zkD6gIoixTH2k7f1DS4UesFKSDqNPOSuNyYeMqIjKaH%2FOlRwvenSfX6KJKCQcCmlUaYdWqf7R4w03ZvQ09qXRPdz9iRSl7jwkAcLXwZEEhqlJhM%2FHDG4vSlwinyeJWaOJw%3D%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding

Redirect headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
cf-cache-status
DYNAMIC
cf-ray
854f57802b7436d2-YYZ
content-length
0
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
0
location
/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
pragma
no-cache
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Rsdk2f1LT4gQn7OkpbrJd25ymcQ%2Fa5ss8oR1%2FBhZhEBjQJ%2FlRffQ0xFmbppSBCtwImpXYvyHgI16s15NQ22cg%2B69AjpK9o46l3wWlNy12o%2B4EzGx55C8%2F9umN9Kv2h0nh5sIF%2BvPD9Ai7Q%3D%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
cm
u.openx.net/w/1.0/ Frame 7384
867 B
829 B
Document
General
Full URL
https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
076613ac0b5ccebf60d403b441685b2320224b0cf489444d69b5cca1f2a61d72

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
gzip
content-length
527
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
via
1.1 google
ecm3
s.amazon-adsystem.com/ Frame C3EA
Redirect Chain
  • https://sync.inmobi.com/TAM?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dinmobi.com%26id%3D%7BID5UID%7D&gdpr=0
  • https://id5-sync.com/i/495/0.gif?gdpr_consent=&gdpr=0&callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dinmobi.com%26id%3D%7BID5UID%7D
  • https://id5-sync.com/c/495/0/0/1.gif?gdpr=0&gdpr_consent=&us_privacy=
  • https://s.amazon-adsystem.com/ecm3?ex=inmobi.com&id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=inmobi.com&id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:16 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
QZNPHJVP59DQV30WKASD

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
location
https://s.amazon-adsystem.com/ecm3?ex=inmobi.com&id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ
p3p
CP="CAO PSA OUR"
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
/
match.sharethrough.com/jwumXNuB/v1/ Frame 6439
707 B
893 B
Document
General
Full URL
https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D%24UID&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
956b3d9a7dd47f3ce88d1699c1986ae281b072edc169035f4d98876fcacc2406

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

content-length
707
date
Tue, 13 Feb 2024 19:05:15 GMT
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame 7F16
16 KB
6 KB
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.221.241.11 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-221-241-11.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c861dd92be984fe498ece34c0f3c921861ac51bfee50323fcae21231abf7a82b

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=122053
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Thu, 15 Feb 2024 04:59:28 GMT
last-modified
Tue, 13 Feb 2024 04:57:54 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
tamptsync
sync-amz.ads.yieldmo.com/ Frame 424C
1 KB
1 KB
Document
General
Full URL
https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.7.170.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-7-170-209.compute-1.amazonaws.com
Software
/
Resource Hash
59264e43fce105c78b3ed07f17dbd8d6a997c07ffeee631ff3b5536982e79458

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-headers
Cache-Control, Pragma, *
access-control-allow-methods
POST, GET, OPTIONS
access-control-allow-origin
*
content-encoding
gzip
content-type
text/html;charset=utf-8
date
Tue, 13 Feb 2024 19:05:15 GMT
pragma
no-cache
vary
accept-encoding
usync.html
eus.rubiconproject.com/ Frame E846
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:15 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding
visitormatch
bh.contextweb.com/ Frame 806B
849 B
2 KB
Document
General
Full URL
https://bh.contextweb.com/visitormatch?p=547259,530912,534301,548607,543793,561117&rurl=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%25%25VGUID%25%25%26ex%3DPulsepoint
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.131 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
acbf2137b8ca930148702153662ff496ce528167beefe0eb429644ce05bc5153
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
cache-control
private, max-age=0, no-cache, no-store
content-language
en-US
content-length
849
content-type
text/html;charset=iso-8859-1
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
server
Jetty(10.0.14)
strict-transport-security
max-age=15768000
ecm3
s.amazon-adsystem.com/ Frame 78B2
Redirect Chain
  • https://ups.analytics.yahoo.com/ups/58251/sync?redir=true&gdpr=0
  • https://ups.analytics.yahoo.com/ups/58251/sync?redir=true&gdpr=0&verify=true
  • https://s.amazon-adsystem.com/ecm3?ex=vmg.com&id=eS0yb2pFVWpsRTJ1SXZ6bVVEVXpJVWhqOFdPOUZMVnNRWH5B&gdpr=0
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=vmg.com&id=eS0yb2pFVWpsRTJ1SXZ6bVVEVXpJVWhqOFdPOUZMVnNRWH5B&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:15 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
8983J44CMY0Q0GDHBWN4

Redirect headers

age
0
content-length
0
date
Tue, 13 Feb 2024 19:05:15 GMT
location
https://s.amazon-adsystem.com/ecm3?ex=vmg.com&id=eS0yb2pFVWpsRTJ1SXZ6bVVEVXpJVWhqOFdPOUZMVnNRWH5B&gdpr=0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
server
ATS/9.1.10.94
strict-transport-security
max-age=31536000
ecm3
s.amazon-adsystem.com/ Frame 8497
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid=%24UID&ex=appnexus.com&gdpr=0
  • https://s.amazon-adsystem.com/ecm3?id=5872803529851156248&ex=appnexus.com&gdpr=0
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=5872803529851156248&ex=appnexus.com&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:15 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
4V1JBN8KBY8BF7N0BQJ8

Redirect headers

accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
access-control-allow-credentials
true
access-control-allow-origin
*
an-x-request-uuid
924faa20-b39b-49ed-8d1f-0bcafd453942
cache-control
no-store, no-cache, private
content-length
0
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Sat, 15 Nov 2008 16:00:00 GMT
location
https://s.amazon-adsystem.com/ecm3?id=5872803529851156248&ex=appnexus.com&gdpr=0
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
pragma
no-cache
server
nginx/1.23.4
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
x-xss-protection
0
amazon
ce.lijit.com/beacon/ Frame 1BA6
Redirect Chain
  • https://ap.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
  • https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
1 KB
1 KB
Document
General
Full URL
https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
a24d15cf6e10e1fdccccd3aef238d47febf9499264a40e2f35a61d664f592d2d

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
content-encoding
gzip
content-length
464
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Fri, 20 Mar 2009 00:00:00 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
vary
Accept-Encoding, User-Agent

Redirect headers

content-length
110
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
location
https://ce.lijit.com:443/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
server
awselb/2.0
sync-iframe
cs-server-s2s.yellowblue.io/ Frame B648
3 KB
3 KB
Document
General
Full URL
https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
3349c80c90cf9558afe2523055185e92b4895a2dcf511435dba932a37d3b7868

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
access-control-allow-origin
cs-server-s2s.yellowblue.io
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
x-envoy-upstream-service-time
4
ecm3
s.amazon-adsystem.com/ Frame CC0A
Redirect Chain
  • https://eb2.3lift.com/getuid?redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3D3lift.com%26id%3D%24UID&gdpr=0
  • https://s.amazon-adsystem.com/ecm3?ex=3lift.com&id=3900114537385664774839
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=3lift.com&id=3900114537385664774839
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:15 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
SS52JPCGDFJT217ACBCR

Redirect headers

cache-control
no-cache, no-store, must-revalidate
content-length
0
date
Tue, 13 Feb 2024 19:05:15 GMT
location
https://s.amazon-adsystem.com/ecm3?ex=3lift.com&id=3900114537385664774839
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
auction
s2s.t13.io/openrtb2/
1 KB
521 B
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
78bfd4dc1c52a6f56546ea6128081dd001b4104d7583a6133dbf7d15d53dc3aa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
500
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115497&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-31_ad&gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-31_ad&pv=7adc9286-415b-4b05-8068-76b73c10e0d0&maxw=300&maxh=600&si=80384&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad80b064dcf563bf2497574dc0f24862012b02bc386217b57ccc32b974e927f7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115497&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-31_ad&gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-31_ad&pv=7adc9286-415b-4b05-8068-76b73c10e0d0&maxw=300&maxh=600&si=80383&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad80b064dcf563bf2497574dc0f24862012b02bc386217b57ccc32b974e927f7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115497&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-31_ad&gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-31_ad&pv=7adc9286-415b-4b05-8068-76b73c10e0d0&maxw=300&maxh=600&si=80388&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad80b064dcf563bf2497574dc0f24862012b02bc386217b57ccc32b974e927f7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
fastlane.json
fastlane.rubiconproject.com/a/api/
702 B
735 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&alt_size_ids=9%2C8%2C10&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-31_ad&tk_flint=pbjs_lite_v8.30.0&x_source.tid=4924d6f1-e463-4b2d-ae0f-c32b099e7ecc&l_pb_bid_id=2892d0c5fe540f35&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=8767c2c8-1460-4e5b-853e-20e2856e3a9b&rp_maxbids=1&p_gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-31_ad&m_ch_mobile=%3F0&slots=1&rand=0.07998911759422822
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
209d8a3078416ba3bba13f8a3ba64677d0243d45bebea0707944848001072f5c

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
702
expires
Wed, 17 Sep 1975 21:32:10 GMT
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=76685348676&lsavail=1&bundle=VSthyV9rYnJTZTdibjJNJTJCVzQ4MjI0UVBjYW1OV2Y3MUVKUzN0bFJoOGZEb25YSDB6WjRTMHNZd3lSNkk5VlU3allTWEtlcFplRnVRRDVLRW0xVnpTTkl5RnRUVnRibnV5d1N6UWdZR2olMkJtSjBiajE2UDM1OGNDc1ZoTEJLN3RRaW80VVU
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
12e5996baad533dcc7e7ebe7b3b219b41a26c1784943f23cbc2bbe288d413b2f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
prebid
ib.adnxs.com/ut/v3/
140 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
74ece675bbbae3e84b39ff3827ad38c31293eac7a8ba9e796aba3a8ab8662ee1
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
e034e10b-3b00-4ea8-9c49-22626cf1cae0
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
140
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
prebidjs
rtb.openx.net/openrtbb/
53 B
95 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
db55036a4120aca340f493e4c0274bc7a954e94358e6f0894fa665222195f9a5

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
auction
tlx.3lift.com/header/
19 B
848 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
sec-ch-viewport-width,sec-ch-ua-mobile,sec-ch-rtt,sec-ch-ua-arch,sec-ch-ua-full-version,sec-ch-ua,sec-ch-ua-bitness,sec-ch-device-memory,sec-ch-ua-platform-version,sec-ch-ua-model,sec-ch-ect,sec-ch-save-data,sec-ch-viewport-height,sec-ch-width,user-agent,sec-ch-dpr,sec-ch-ua-platform,sec-ch-prefers-color-scheme,sec-ch-ua-full-version-list,sec-ch-downlink
x-auction-status
12, 12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 97A3
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuiBHsGtYyi-dJsBekr9ZNuapoFE_eajwgKh7MeSqW6Bv9162qFWXw_iuEuaP6vEzK9mvihXACNhODTVC6Zpn0hjKUVH_dMOG0EreRCFYczvRqnBnYX7SAZ6Qis_TfLbjAAjBc1_c1tvlM-Ox8Z6XDULW6Ncpk4BdI65TfQrHi6Uuk4s6toeJYsiUUEBwPIhbmE_PmEREgiYjuao3ck0jaD27F5bZNqk1iAllTWkNwiuGvKvYec4z-vknorFQ4U-8qnF3O43q38pBxlQadc9fSHtoIt3nf_JBRntzVSXH3xG4uJA0sRAcy52Fmz_v_RPC4mMxd6be66mcIVIuP3tvnE66tljweebGWY3aHu8poZP526n2IcmPOvzzsfdRl8JA&sai=AMfl-YQiJ-gfiWd2drpKArHAk_gZofa9xtKutwHPeAyrJe3Cf5aLpsHahWe5AyB3XoUC0IjujSSInuoBrBQSm59VVXS9iFXFS9J3_2hkTEcYk5uPiDLPPNYMV4XOBjMrCouZk8UTFsDfHHNeA1ZSj-lJZ5E&sig=Cg0ArKJSzHxb72D43Pf-EAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame 97A3
147 KB
51 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e764631aadb5668ddc363760e0d45e3162d9edd3cdb1c6e059d463e203e9f802
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51383
x-xss-protection
0
server
cafe
etag
9721828984046679499
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:15 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame 97A3
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:15 GMT
merge
ce.lijit.com/ Frame D0D1
43 B
1023 B
Image
General
Full URL
https://ce.lijit.com/merge?pid=76&3pid=10dca384-d7fa-4ff2-857a-1fb0ad9d145a&gdpr=0&gdpr_consent=
Requested by
Host: us-u.openx.net
URL: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://us-u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif
receive
pixel.tapad.com/idsync/ex/ Frame D0D1
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=1955&partner_device_id=7a4c0eb8-6649-4878-8827-31c0e6a0ea04
Requested by
Host: us-u.openx.net
URL: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://us-u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95
sync
ups.analytics.yahoo.com/ups/58294/ Frame D0D1
0
121 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/58294/sync?_origin=1&uid=52f6fecd-e524-4fb6-91e1-681c428fdf61
Requested by
Host: us-u.openx.net
URL: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.200.65.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-200-65-202.compute-1.amazonaws.com
Software
ATS/9.1.10.94 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://us-u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
db_sync
px.ads.linkedin.com/ Frame D0D1
Redirect Chain
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fid.rlcdn.com%2F464246.gif%3Fpartner_uid%3D%7BOPENX_ID%7D
  • https://id.rlcdn.com/464246.gif?partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
  • https://id.rlcdn.com/1000.gif?memo=CPaqHBIvCisIARCUaxokMjlmNDAyMjItZjAwOS00MzlmLTlkYmYtMjllNWVjYjc0YWQwEAAaDQjr-q6uBhIFCOgHEABCAEoA
  • https://pippio.com/api/sync?pid=5324&it=1&iv=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&_=2
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&rand=09785719
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&rand=09785719&expected_cookie=5142ff3e-55fd-44a6-8078-9b6797d9b068
0
144 B
Image
General
Full URL
https://px.ads.linkedin.com/db_sync?pid=10339&puuid=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&rand=09785719&expected_cookie=5142ff3e-55fd-44a6-8078-9b6797d9b068
Requested by
Host: us-u.openx.net
URL: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Protocol
H2
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://us-u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 0A3AC163A8324D6A8D60EC3AD1CE773E Ref B: EWR311000107037 Ref C: 2024-02-13T19:05:16Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-ltx1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYRSBMeKA5c8L+h9hjFiQ==

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: C215831AE4654082B0D78FD00A1E8035 Ref B: EWR311000107037 Ref C: 2024-02-13T19:05:16Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-ltx1
location
/db_sync?pid=10339&puuid=27ac61463cb1e635d466cd84994162e2c8fe208df69bff090c87e746838db3ae791426b5417dce21&rand=09785719&expected_cookie=5142ff3e-55fd-44a6-8078-9b6797d9b068
x-li-proto
http/2
content-length
0
x-li-uuid
AAYRSBMcMFglS7dfDoQTkA==
sd
us-u.openx.net/w/1.0/ Frame D0D1
Redirect Chain
  • https://ib.adnxs.com/getuid?https://us-u.openx.net/w/1.0/sd?id=537072399&val=$UID
  • https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
Requested by
Host: us-u.openx.net
URL: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://us-u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
c5e4da9f-8f7a-41f7-8d99-20035e14d216
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
sd
us-u.openx.net/w/1.0/ Frame D0D1
Redirect Chain
  • https://ad.turn.com/r/cs?pid=9&gdpr=0
  • https://us-u.openx.net/w/1.0/sd?id=537073061&val=7762326431572555807&gdpr=0&gdpr_consent=&us_privacy=
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537073061&val=7762326431572555807&gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: us-u.openx.net
URL: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://us-u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

location
https://us-u.openx.net/w/1.0/sd?id=537073061&val=7762326431572555807&gdpr=0&gdpr_consent=&us_privacy=
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
content-length
0
p3p
policyref="/w3c/p3p.xml", CP="NOI CURa DEVa TAIa PSAa PSDa IVAa IVDa OUR IND UNI NAV"
sd
us-u.openx.net/w/1.0/ Frame D0D1
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D
  • https://sync-tm.everesttech.net/ct/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D&_test=Zcu9awAEo_sMqwA9
  • https://us-u.openx.net/w/1.0/sd?id=537148856&val=Zcu9awAEo_sMqwA9&_test=Zcu9awAEo_sMqwA9
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537148856&val=Zcu9awAEo_sMqwA9&_test=Zcu9awAEo_sMqwA9
Requested by
Host: us-u.openx.net
URL: https://us-u.openx.net/w/1.0/cm?id=dc2068a3-fa3d-4b5f-8a61-3d5a1a58fc05&ph=21f03281-5b83-4670-a0e0-dc15f7542014&r=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D76%263pid%3D%7BOPENX_ID%7D&gdpr=0&gdpr_consent=
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://us-u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

x-served-by
cache-yyz4546-YYZ
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 varnish
server
Varnish
x-timer
S1707851116.807509,VS0,VE0
x-cache
HIT
location
https://us-u.openx.net/w/1.0/sd?id=537148856&val=Zcu9awAEo_sMqwA9&_test=Zcu9awAEo_sMqwA9
cache-control
no-cache
accept-ranges
bytes
content-length
0
retry-after
0
x-cache-hits
0
css
fonts.googleapis.com/
2 KB
1017 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto&display=swap
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c09::5f Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
838e680ca964a26c94665951577f3f0902ef54de2ee063d3465f22945dc44afa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Tue, 13 Feb 2024 17:30:48 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 13 Feb 2024 19:05:15 GMT
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame D27E
16 KB
6 KB
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?p=159196&userIdMacro=PM_UID&gdpr=0&gdpr_consent=&predirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D91%26advUuid%3DPM_UID
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.221.241.11 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-221-241-11.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c861dd92be984fe498ece34c0f3c921861ac51bfee50323fcae21231abf7a82b

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=122053
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Thu, 15 Feb 2024 04:59:28 GMT
last-modified
Tue, 13 Feb 2024 04:57:54 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame 5C42
Redirect Chain
  • https://u.openx.net/w/1.0/cm?gdpr=0&gdpr_consent=&id=476b50d3-5ccf-49a1-89b8-1ddf8ea18042&r=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26gdpr%3D0%26gdpr_consent%3D%26adv...
  • https://live.primis.tech/live/liveCS.php?source=external&gdpr=0&gdpr_consent=&advId=98&advUuid=8b979bf4-7108-4d0c-86a3-3f353964681d
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1486637409&3rdpcid=8b979bf4-7108-4d0c-86a3-3f353964681d
43 B
864 B
Document
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1486637409&3rdpcid=8b979bf4-7108-4d0c-86a3-3f353964681d
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache, no-store, must-revalidate
content-length
43
content-type
image/gif
date
Tue, 13 Feb 2024 19:05:15 GMT
expires
Thu, 01 Jan 1970 00:00:00 GMT
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
pragma
no-cache
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-id
Ch1z68xnP_njsufCSfgcuyOrRnfs91GM6ma7BO2IeuN4EClKWu8Z-A==
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront

Redirect headers

age
0
alt-svc
h3=":443"; ma=86400
cache-control
no-store
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:15 GMT
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1486637409&3rdpcid=8b979bf4-7108-4d0c-86a3-3f353964681d
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
pragma
no-cache
server
nginx
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
x-amz-cf-id
bSYFRXr8e3QLaURwr8n2MYbNPbc0YvJeNtJkOWq14CgxGYwwPBcBLw==
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
sync-iframe
cs-server-s2s.yellowblue.io/ Frame 8452
3 KB
3 KB
Document
General
Full URL
https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
f169bb965bf76b2cecbc4ac79f60cc74a674975342137fdb8a2c168d15f08c7d

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
access-control-allow-origin
https://reason.com/
content-type
text/html
date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
x-envoy-upstream-service-time
1
liveView.php
live.primis.tech/live/ Frame C770
136 KB
13 KB
XHR
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
31bec35d147efb79ae8d7708a6b454e40cdbb85d206f15ff5535ecb243b44b4f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
content-length
13135
pragma
no-cache
server
nginx
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
V6O2pIxPQesfeKul_0yHXgkus5ug1dhx60NXJXdChyfvADKRefFboQ==
sodar
pagead2.googlesyndication.com/getconfig/ Frame C770
11 KB
9 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?tid=pal&tv=1.0
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/pal/pal.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
60e67b6b1c6d348bf39189520bd671d985e32a97c361fa084cc4df13d7a4f4e4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8424
x-xss-protection
0
liveView.php
live.primis.tech/live/
0
343 B
Image
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
vary
Accept-Encoding
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
*
content-type
text/html; charset=UTF-8
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
PECFBoEb8unc6lZLCSQRpa8Mg-hhIr7okFyNqGR7bCNqzcTiwbalEw==
p-1ZHFxK2kGG5Cz.gif
pixel.quantserve.com/pixel/ Frame C770
35 B
409 B
Image
General
Full URL
https://pixel.quantserve.com/pixel/p-1ZHFxK2kGG5Cz.gif?labels=publisher.27975.space.116322,adsize.400x272
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2620:116:800b:21:b08a:1dc5:659b:4055 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
a0d3a0aff7dc3bf32d2176fc3dcda6e7aba2867c4f4d1f7af6355d2cfc6c44f8
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
attribution-reporting-register-trigger
{"event_trigger_data":[{"filters":[{"label":["publisher.27975.space.116322"],"pcode":["p-1ZHFxK2kGG5Cz"]},{"label":["adsize.400x272"],"pcode":["p-1ZHFxK2kGG5Cz"]}],"trigger_data":"1"}]}
strict-transport-security
max-age=86400
content-type
image/gif
cache-control
private, no-cache, no-store, proxy-revalidate
content-length
35
expires
Fri, 04 Aug 1978 12:00:00 GMT
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=sekindo&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=bidswitch_dbm&google_cm&google_sc&ssp=sekindo&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff&google_hm=ZDk5NjI0NDItYzczZi00MmE0LWFkYmQtM2Q5NTE3ZTM4N2Zm...
  • https://x.bidswitch.net/sync?dsp_id=16&user_id=CAESEMvaNv_sL-gZ1_dJLOVICn8&google_cver=1&ssp=sekindo&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr_consent=
  • https://live.primis.tech/live/liveCS.php?source=external&advId=92&advUuid=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1267919208&3rdpcid=d9962442-c73f-42a4-adbd-3d9517e387ff
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1267919208&3rdpcid=d9962442-c73f-42a4-adbd-3d9517e387ff
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
391E575ho8bC-lOKjnk6HZvx7EePwlugXewfL9lXJJo69W4dQMBdbQ==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1267919208&3rdpcid=d9962442-c73f-42a4-adbd-3d9517e387ff
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
xmH7JsFjvTawEPBQWM0Ybe5SlUuUcEolnZe_23HVJGeQX5d4AsveAg==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://csync.loopme.me/?pubid=11280&gdpr=0&gdpr_consent=&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D93%26advUuid%3D%7Bviewer_token%7D
  • https://live.primis.tech/live/liveCS.php?source=external&advId=93&advUuid=0b6623f9-af2d-4f76-abfc-fd031a91112a&gdpr_consent=null&gdpr=0
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=417208643&3rdpcid=0b6623f9-af2d-4f76-abfc-fd031a91112a
43 B
866 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=417208643&3rdpcid=0b6623f9-af2d-4f76-abfc-fd031a91112a
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
Q4nKvje9hHBUSYFYw3_JezMjcpfiV8aEFFEDxeEo_wIDh-VymBqPDQ==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=417208643&3rdpcid=0b6623f9-af2d-4f76-abfc-fd031a91112a
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
41YcjDFf4m5xSivc6_U1N5VPPwgYiIN6hIsK_zrX8fFmp12FC2SsvA==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://ssum-sec.casalemedia.com/usermatchredir?s=191923&gdpr=0&gdpr_consent=&cb=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D99%26advUuid%3D
  • https://live.primis.tech/live/liveCS.php?source=external&advId=99&advUuid=Zcu9a9HM518AACyiADNVcgAA%261404
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2120880633&3rdpcid=Zcu9a9HM518AACyiADNVcgAA%261404
43 B
866 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2120880633&3rdpcid=Zcu9a9HM518AACyiADNVcgAA%261404
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
Z4WHjK8np2MwaJDsRMEb35MnCriLLoIvP47bp4LQIFJNNGPfZC8LAg==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2120880633&3rdpcid=Zcu9a9HM518AACyiADNVcgAA%261404
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
ZM51ZsJebRbnUBHfRRKvfPtwMiPzNXjEXytwJmwxh6GZvJqPITHHfg==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://eb2.3lift.com/getuid?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D121%26advUuid%3D%24UID
  • https://live.primis.tech/live/liveCS.php?source=external&advId=121&advUuid=3900114537385664774839
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=259151345&3rdpcid=3900114537385664774839
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=259151345&3rdpcid=3900114537385664774839
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
OLTf68EVCAG0a_szoRnnbY6Sn2s-mFgwLNZeeXdSx8b_yJh1hbWUPg==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=259151345&3rdpcid=3900114537385664774839
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
MWOfxs6TkslDHuulkVg82a4JDuRwZc9qwDGvJGtf2v5ZPPBGKjqykA==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=primis&gdpr=0&gdpr_consent=
  • https://live.primis.tech/live/liveCS.php?source=external&advId=100&advUuid=LSKQGI85-W-KKFE&gdpr=0
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
43 B
863 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
m6Di439X82LPCSQMoAlV5GyeeQcNabFp0Of0oTjstNaGSser67W7gg==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
p7FqsKxs49d7w0r7bL0aV7po5CwF14GYWDuV8eChTlYSsXz5_w91Iw==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://ups.analytics.yahoo.com/ups/58818/sync?redir=true&gdpr=0&gdpr_consent=
  • https://live.primis.tech/live/liveCS.php?source=external&advId=128&advUuid=y-9LUtz7BE2uLaJKxLoxHd_hmxqhtRQhYE~A
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1028935272&3rdpcid=y-9LUtz7BE2uLaJKxLoxHd_hmxqhtRQhYE~A
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1028935272&3rdpcid=y-9LUtz7BE2uLaJKxLoxHd_hmxqhtRQhYE~A
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
bcGNlKTSRfzrzxFQjLtdsCistyqFg1xG4VHRH9FRtf89VsGFMe-g9w==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1028935272&3rdpcid=y-9LUtz7BE2uLaJKxLoxHd_hmxqhtRQhYE~A
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
NsIPF61gTK-ONzmHVVxelUF7KaxhEMWi8faz3PMTl_2G8_qkGZPIfw==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://mb9eo.publishers.tremorhub.com/pubsync?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D126%26advUuid%3D%5Btvid%5D
  • https://mb9eo.publishers.tremorhub.com/pubsync/verify?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D126%26advUuid%3D%5Btvid%5D
  • https://live.primis.tech/live/liveCS.php?source=external&advId=126&advUuid=5e680dc7fc904e3fb6284f51d34504d2
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=584182936&3rdpcid=5e680dc7fc904e3fb6284f51d34504d2
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=584182936&3rdpcid=5e680dc7fc904e3fb6284f51d34504d2
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
17UjaTXtFTtRrzsAI7I54e8pKdJsKKaOCXpxg9lDCHD5nXByGv7aSA==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=584182936&3rdpcid=5e680dc7fc904e3fb6284f51d34504d2
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
U0fQJ9s_clLbIglSCM5WeuRFWsvW-I9HrBGBh4gfmhqz681jaJSwag==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://cs.media.net/cksync?gdpr=0&gdpr_consent=&cs=34&type=pri&ovsid=65cbbd6ab7b01&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D127%26advUuid%3D%3Cvsid%3E
  • https://live.primis.tech/live/liveCS.php?source=external&advId=127&advUuid=3508527156634803000V10
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1723987475&3rdpcid=3508527156634803000V10
43 B
866 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1723987475&3rdpcid=3508527156634803000V10
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
WdMPEQvY7ZHMUUzQ53-3C1Aj7Cj0AUHiczupLYlOBEwuAfryTWgcbg==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1723987475&3rdpcid=3508527156634803000V10
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
At2jv5J9YJeDJKEA4AI6wMPicxCSB9Kbiv5dD-Gu5aqXdlChctlqUA==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://ap.lijit.com/pixel?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D130%26advUuid%3D%24UID
  • https://live.primis.tech/live/liveCS.php?source=external&advId=130&advUuid=IJ_5ATZHwpxocGP7SR6BzHWi
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=396218182&3rdpcid=IJ_5ATZHwpxocGP7SR6BzHWi
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=396218182&3rdpcid=IJ_5ATZHwpxocGP7SR6BzHWi
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
lLmqic0NLMPPvkNKkoJt8RxsbXZ08gclTFg6Ldx7lyrO0LzO3HSxMA==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=396218182&3rdpcid=IJ_5ATZHwpxocGP7SR6BzHWi
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
1oe9pTz9BKKUqWoUFBcPCXo5KibkQvLxD6iaaUJC9I8IKlpyVDraBQ==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=3586&gdpr=0&gdpr_consent=
  • https://live.primis.tech/live/liveCS.php?source=external&advId=134&advUuid=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=484859127&3rdpcid=1a414bb82571872ecee8edf55b15cd6
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=484859127&3rdpcid=1a414bb82571872ecee8edf55b15cd6
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
uSSJlv8jp9WaLGptA3doRPd5bxO1ZzCUiFKR2IRVVVpGFALoKTtWDA==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=484859127&3rdpcid=1a414bb82571872ecee8edf55b15cd6
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
whEvhTM69UC3CcvQd9oyMjG9wIjmWoLjGIvuDsLwOknqWRJiwzaKgg==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://cs.admanmedia.com/3613a31b6329d1c17d5663d05b080db1.gif?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D138%26advUuid%3D%5BUID%5D
  • https://live.primis.tech/live/liveCS.php?source=external&advId=138&advUuid=ffc0228e-35bf-459d-a326-8230f6a4c437
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2136778551&3rdpcid=ffc0228e-35bf-459d-a326-8230f6a4c437
43 B
864 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2136778551&3rdpcid=ffc0228e-35bf-459d-a326-8230f6a4c437
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
P4De9c4__llrHVmzEMJrjZIsC6s6AS8W4rp1epQS59Zw6ve1LxseMw==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2136778551&3rdpcid=ffc0228e-35bf-459d-a326-8230f6a4c437
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
QyMgdQklJkXigryvAYt-qTEfaEeABOs9XCRXCqz_pnXgeDtOCrp2vQ==
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://ssbsync-global.smartadserver.com/api/sync?callerId=21&redirectUri=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D140%26advUuid%3D%5Bssb_sync_pid%5D&gdpr=0&...
  • https://live.primis.tech/live/liveCS.php?source=external&advId=140&advUuid=4519564549645433089
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1881119486&3rdpcid=4519564549645433089
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1881119486&3rdpcid=4519564549645433089
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
tfRiRkbvDC7XnOcIvG0n5CCEaz2ajbZjijcD8Exz9Ugi1TGC-WT6Gg==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1881119486&3rdpcid=4519564549645433089
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
8V3pSkSstgsr_jhJxLkkD2SYcvSVJjdK2FizHVuXuRUyMJ4eUTlAjw==
cookie
cm.adform.net/ Frame C770
43 B
105 B
Image
General
Full URL
https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D143%26advUuid%3D%24UID
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.3.26 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx
content-length
43
content-type
image/gif
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://match.sharethrough.com/universal/v1?supply_id=Wog2sp89&gdpr=0&gdpr_consent=
  • https://live.primis.tech/live/liveCS.php?source=external&advId=144&advUuid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2011327056&3rdpcid=c4cec5b2-acca-415c-b738-7e079be8bf78
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2011327056&3rdpcid=c4cec5b2-acca-415c-b738-7e079be8bf78
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
og2Q5UdtwRW9b8PeSBpzSAxI6RfhbFKhEbk--6GK5YzSsjcpeRRnKA==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=2011327056&3rdpcid=c4cec5b2-acca-415c-b738-7e079be8bf78
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
B0AkPAT-V91v-ddq06mahvfNIKsfNBIyAAewW7Kn6QoQ4UQCj68Www==
cs
cs.yellowblue.io/ Frame C770
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=primis&gdpr=0&gdpr_consent=
  • https://ad.turn.com/r/cs?pid=45&rndcb=3297467625
  • https://sync.1rx.io/usersync/turn/7690268837534627871?dspret=1&gdpr=&gdpr_consent=&us_privacy=
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fcs.yellowblue.io%2Fcs%3Faid%3D11599%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
  • https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
0
317 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://reason.com/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RXe2af2325e28b4fd4b66772f44cc57a3b005
content-type
text/html
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame C770
Redirect Chain
  • https://sync.cootlogix.com/api/user/pixel/?redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D151%26advUuid%3D%24%7BuserId%7D
  • https://live.primis.tech/live/liveCS.php?source=external&advId=151&advUuid=24574e43-b065-4246-847d-dec6b8b086ac
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=793790479&3rdpcid=24574e43-b065-4246-847d-dec6b8b086ac
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=793790479&3rdpcid=24574e43-b065-4246-847d-dec6b8b086ac
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
cF2XG8I0CiPXEfNPOPLqpy0Z568uJsVhg8Kh0Mn_tsH3GF5tHYjSVg==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=793790479&3rdpcid=24574e43-b065-4246-847d-dec6b8b086ac
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
bzQplYsXQyIzVdltGLsNtGmoNIBjmbhnAAp-GuUz2nP8bAjwRLaQpQ==
vid65cb9b67b22bf082520539.jpg
video.primis.tech/uploads/cn1/video/users/converted/29874/video_65ba1ab406070534415698/
26 KB
27 KB
Image
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/converted/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.jpg?cbuster=1707842411
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
6575476ee6e827be96bf1d0eb66396c12d6e9ece6413ac99c7d735a08b975b3f

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:36:31 GMT
via
1.1 3ea826f29560ca95cae18534029cc5a6.cloudfront.net (CloudFront), 1.1 327dc9ff74acc5a845efbe2daefaec7a.cloudfront.net (CloudFront)
x-amz-cf-pop
IAD55-P3, YUL62-P2
age
5324
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
26859
last-modified
Tue, 13 Feb 2024 16:42:55 GMT
server
nginx
etag
"212092301edffc13af8027908b81814f"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
max-age=86400
accept-ranges
bytes
x-amz-cf-id
TTCH0D7fXBNNlAM_VtXtvJCejbadpqiufmXM1GyfwXVPAMiL1Qti-Q==
expires
Wed, 14 Feb 2024 17:36:31 GMT
Roboto-Regular.ttf
static.sparemin.com/static/fonts/disco/
167 KB
168 KB
Font
General
Full URL
https://static.sparemin.com/static/fonts/disco/Roboto-Regular.ttf
Requested by
Host: disco.headliner.link
URL: https://disco.headliner.link/artifacts/web/5.28.0-130/css/theme/defaultTheme.fonts.css
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
99.86.229.12 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-229-12.iad79.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
017c0be9aaa6d0359737e1fa762ad304c0e0107927faff5a6c1f415c7f5244ed

Request headers

Referer
https://disco.headliner.link/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 16:31:26 GMT
Via
1.1 6115ccbf06ce7bea7cea8806dfa86752.cloudfront.net (CloudFront)
X-Amz-Cf-Pop
IAD79-C3
Age
9230
x-amz-server-side-encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
171272
Last-Modified
Tue, 07 Feb 2023 22:43:14 GMT
Server
AmazonS3
ETag
"11eabca2251325cfc5589c9c6fb57b46"
Access-Control-Max-Age
3000
Access-Control-Allow-Methods
GET
Content-Type
binary/octet-stream
Access-Control-Allow-Origin
*
Cache-Control
max-age=86400
Vary
Origin,Access-Control-Request-Headers,Access-Control-Request-Method
Accept-Ranges
bytes
X-Amz-Cf-Id
WzzzaNZy54dz7Yxp3_MkUAXyd4A9aBmfCh9hvW72qCEaqTTkBDbatw==
liveView.php
live.primis.tech/live/ Frame C770
143 KB
14 KB
XHR
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
4eb481b64f0f5ff0fa2ab958dcfd0d7cdd9355c558854d99c08a2e85a1737586

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
content-length
14402
pragma
no-cache
server
nginx
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
3HNzW_NXlPbI6w9Kaq7nZ-i7O2T7eXLmhXt5Q-MhMpvv46ZUtb4Z-g==
liveView.php
live.primis.tech/live/ Frame C770
144 KB
14 KB
XHR
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
41e3783bba6a25116751141bd8d373a1063f1d99a71455dc2ee9b31480adae3d

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
content-length
13519
pragma
no-cache
server
nginx
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
WjWcxhHfvtTKoVfYdPAqnQvA_62_hZudaVg1abKKZQRtkaU0C9emoQ==
liveView.php
live.primis.tech/live/ Frame C770
144 KB
14 KB
XHR
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
ed77c8514577b28ad54680dbaf37d8b967f70f3e688d7dc792012b15866dd00b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
content-length
13770
pragma
no-cache
server
nginx
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
APRgAvSmxZAMtp-vGzHrK2qXkrrZVDAe2bNUzNEdC6W7PvXbrnluHQ==
liveView.php
live.primis.tech/live/ Frame C770
127 KB
14 KB
XHR
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
ae37e7797acd0494d82706414514e7726116e461ca5b7de786e0ddb98b49decf

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
content-length
14222
pragma
no-cache
server
nginx
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
cG8p7HjcoBuLRgmp0qBeu8ZMGNAVZQYEC-LJRkjAEj38woz3DNljlQ==
liveView.php
live.primis.tech/live/ Frame C770
152 KB
16 KB
XHR
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
f90e49691d0b37aa097da0c7728d1f46eed983d6b9e296f164e8791ba2548676

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
content-length
16204
pragma
no-cache
server
nginx
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
c0gX-BchXtqaIJq0QRcnW4xH5kdS6_Bn79zEL8lYppRxfDqtCTIqzw==
liveView.php
live.primis.tech/live/ Frame C770
143 KB
15 KB
XHR
General
Full URL
https://live.primis.tech/live/liveView.php?hash=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
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/live/liveVideo.php?vpaidManager=sekindo&s=58057&ri=6C69766553746174737C736B317B54307D7B64323032342D30322D31335F32317D7B7331373236303636367D7B4333307D7B53636D5668633239754C6D4E7662513D3D7D7B626368726F6D657D7B716465736B746F707D7B6F77696E646F77737D7B583430307D7B593237327D7B66317D7B4C31393932367DFEFE&userIpAddr=2602%3Affc8%3A2%3A104%3A%3A14&userUA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F121.0.6167.160+Safari%2F537.36&debugInformation=&isWePassGdpr=1&schain=1.0%2C1%21freestar.com%2C472%2C1&noViewableMidrollPolicy=off&isDoublePreroll=1&autoSkipVideoSec=22&c2pWaitTime=10&sdkv=&isSinglePageFloatSupport=0&availCampaigns=&isAmpIframe=0&tagKeywords=&cbuster=1707851114&csuuid=65cbbd6ab7b01&debugInfo=17260666_&debugPlayerSession=&pubUrlDEMO=&isAsyncDEMO=0&customPlaylistIdDEMO=&sta=17260666&showLogo=0&clkUrl=&plMult=-1&schedule=eyJwcmVfcm9sbCI6MSwibWlkX3JvbGwiOltdLCJnYXAiOiJhdXRvIn0%3D&content=plembed3c97milkwogj&secondaryContent=&x=400&y=272&pubUrl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&contentNum=1&flow_closeBtn=1&flowCloseTimeout=60&flow_closeButtonPosition=right&flow_direction=br&flow_horizontalOffset=10&flow_bottomOffset=105&impGap=1&flow_width=400&flow_height=225&videoType=flow&isOriginImg=0&gdpr=0&gdprConsent=&contentFeedId=&geoLati=42.8867&geoLong=-78.8927&vpTemplate=19926&flowMode=seenboth&isRealPreroll=0&playerApiId=freestarPrimisPlayer&isApp=0&ccpa=0&ccpaConsent=1---&subId=&appName=&appBundleId=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&appStoreUrl=&diaid=&appPrivacyPolicy=&appIsPaid=&appDeveloper=&appId=&appVersion=&sdkv=&enableResizeObserverInapp=0&isAppJs=0
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
3009c08ed4d94547ccfd4f467e19360b3da133600c7f555bf89db6910a6ff85d

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
content-length
14520
pragma
no-cache
server
nginx
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
vxc4zr0GdTIRICKh9V_0x45Qhv4WNM7CNiGXV9IB5Fd9ZcuOU8BU9g==
rtset
bh.contextweb.com/bh/ Frame 806B
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=contextweb&google_cm&google_sc&google_hm=c1l2WnRTNmx1ZkREdWNGWW9ZVWpMUQ&gdpr=0&gdpr_consent=
  • https://bh.contextweb.com/bh/rtset?do=add&pid=547259&gdpr=0&gdpr_consent=&ev=CAESEGPGX-NNcdPvBzb0KNcn4Mk&google_cver=1
49 B
805 B
Image
General
Full URL
https://bh.contextweb.com/bh/rtset?do=add&pid=547259&gdpr=0&gdpr_consent=&ev=CAESEGPGX-NNcdPvBzb0KNcn4Mk&google_cver=1
Requested by
Host: bh.contextweb.com
URL: https://bh.contextweb.com/visitormatch?p=547259,530912,534301,548607,543793,561117&rurl=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%25%25VGUID%25%25%26ex%3DPulsepoint
Protocol
H2
Server
198.148.27.131 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
d0409a1b73dab4e29dc40f92fb431fa9133baa23b4a1ffae4897f39068110e32
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://bh.contextweb.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
content-type
image/gif;charset=iso-8859-1
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://bh.contextweb.com/bh/rtset?do=add&pid=547259&gdpr=0&gdpr_consent=&ev=CAESEGPGX-NNcdPvBzb0KNcn4Mk&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
335
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
rtset
bh.contextweb.com/bh/ Frame 806B
Redirect Chain
  • https://pulsepoint-match.dotomi.com/match/bounce/current?networkId=14200&version=1&nuid=&gdpr=0&gdpr_consent=
  • https://pulsepoint-match.dotomi.com/match/bounce/current?DotomiTest=77059b99cd5a135c&is_secure=true&networkId=14200&version=1&nuid=&gdpr=0&gdpr_consent=
  • https://bh.contextweb.com/bh/rtset?do=add&pid=530912&ev=AAAHhC0Y0d4HmAN_KBF7AAAAAAA&expiration=1707937515&nuid=&is_secure=true&gdpr_consent=&gdpr=0
49 B
849 B
Image
General
Full URL
https://bh.contextweb.com/bh/rtset?do=add&pid=530912&ev=AAAHhC0Y0d4HmAN_KBF7AAAAAAA&expiration=1707937515&nuid=&is_secure=true&gdpr_consent=&gdpr=0
Requested by
Host: bh.contextweb.com
URL: https://bh.contextweb.com/visitormatch?p=547259,530912,534301,548607,543793,561117&rurl=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%25%25VGUID%25%25%26ex%3DPulsepoint
Protocol
H2
Server
198.148.27.131 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
d0409a1b73dab4e29dc40f92fb431fa9133baa23b4a1ffae4897f39068110e32
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://bh.contextweb.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
content-type
image/gif;charset=iso-8859-1
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP NID OUR STP"
location
https://bh.contextweb.com/bh/rtset?do=add&pid=530912&ev=AAAHhC0Y0d4HmAN_KBF7AAAAAAA&expiration=1707937515&nuid=&is_secure=true&gdpr_consent=&gdpr=0
cache-control
no-cache, private, max-age=0, no-store
content-length
0
expires
0
ecm3
s.amazon-adsystem.com/ Frame 806B
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=AwN5CTqy8JaW&ex=Pulsepoint
Requested by
Host: bh.contextweb.com
URL: https://bh.contextweb.com/visitormatch?p=547259,530912,534301,548607,543793,561117&rurl=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%25%25VGUID%25%25%26ex%3DPulsepoint
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://bh.contextweb.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
XH4SJDFTN36PX25DJY53
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
ecm3
s.amazon-adsystem.com/ Frame 7384
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=openx.com&id=24e40139-21e4-ce05-02c8-2b81bd1fe0e8&gdpr=0
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
F2H01XNETE11FV027WKP
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
sync
ups.analytics.yahoo.com/ups/58294/ Frame 7384
0
17 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/58294/sync?_origin=1&uid=52f6fecd-e524-4fb6-91e1-681c428fdf61
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.200.65.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-200-65-202.compute-1.amazonaws.com
Software
ATS/9.1.10.94 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
db_sync
px.ads.linkedin.com/ Frame 7384
Redirect Chain
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fid.rlcdn.com%2F464246.gif%3Fpartner_uid%3D%7BOPENX_ID%7D
  • https://id.rlcdn.com/464246.gif?partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
  • https://id.rlcdn.com/1000.gif?memo=CPaqHBIvCisIARCUaxokMjlmNDAyMjItZjAwOS00MzlmLTlkYmYtMjllNWVjYjc0YWQwEAAaDQjr-q6uBhIFCOgHEABCAEoA
  • https://pippio.com/api/sync?pid=5324&it=1&iv=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&_=2
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&rand=01168948
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&rand=01168948&expected_cookie=8faa3b5d-ddf0-4250-b703-53eec813505a
0
158 B
Image
General
Full URL
https://px.ads.linkedin.com/db_sync?pid=10339&puuid=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&rand=01168948&expected_cookie=8faa3b5d-ddf0-4250-b703-53eec813505a
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Protocol
H2
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
x-li-pop
afd-prod-lva1-x
x-msedge-ref
Ref A: D6794CC89E1B428A93E3B099E9A3DD30 Ref B: EWR311000107037 Ref C: 2024-02-13T19:05:16Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-lva1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYRSBMfO84gV+jAjHOGdQ==

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
x-li-pop
afd-prod-lor1-x
x-msedge-ref
Ref A: 3B7BED32D7294B14B840FA8DB840D35E Ref B: EWR311000107037 Ref C: 2024-02-13T19:05:16Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-lva1
location
/db_sync?pid=10339&puuid=1e70ce84932db37c60193a859f3fd00dbe32734d6f60db7e9a4d401e68230895791426b5417dce21&rand=01168948&expected_cookie=8faa3b5d-ddf0-4250-b703-53eec813505a
x-li-source-fabric
prod-lor1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYRSBMcd0UQB6G9x7l++A==
sd
us-u.openx.net/w/1.0/ Frame 7384
Redirect Chain
  • https://ib.adnxs.com/getuid?https://us-u.openx.net/w/1.0/sd?id=537072399&val=$UID
  • https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
635af03a-6b35-4e4e-9bd0-78322c9755a8
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://us-u.openx.net/w/1.0/sd?id=537072399&val=5872803529851156248
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
sd
us-u.openx.net/w/1.0/ Frame 7384
Redirect Chain
  • https://ad.turn.com/r/cs?pid=9&gdpr=0
  • https://us-u.openx.net/w/1.0/sd?id=537073061&val=3510928383334807583&gdpr=0&gdpr_consent=&us_privacy=
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537073061&val=3510928383334807583&gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

location
https://us-u.openx.net/w/1.0/sd?id=537073061&val=3510928383334807583&gdpr=0&gdpr_consent=&us_privacy=
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
content-length
0
p3p
policyref="/w3c/p3p.xml", CP="NOI CURa DEVa TAIa PSAa PSDa IVAa IVDa OUR IND UNI NAV"
ny75r2x0
sync-tm.everesttech.net/ct/upi/pid/ Frame 7384
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D
  • https://sync-tm.everesttech.net/ct/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D&_test=Zcu9awAB77y1BQBj
85 B
170 B
Image
General
Full URL
https://sync-tm.everesttech.net/ct/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D&_test=Zcu9awAB77y1BQBj
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=e818ca1e-0c23-caa8-0dd3-096b0ada08b7&ph=2d1251ae-7f3a-47cf-bd2a-2f288854a0ba&plm=5&r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dopenx.com%26id%3D%7BOPENX_ID%7D&gdpr=0
Protocol
H2
Server
151.101.194.49 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
Jetty(9.4.35.v20201120) /
Resource Hash
acccc501aa6afa3cfac15e8ddccf1561deed2ed08c2f7d652abbdbe9aa71609a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

x-served-by
cache-yyz4546-YYZ
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 varnish
server
Jetty(9.4.35.v20201120)
age
1176
x-timer
S1707851116.807536,VS0,VE0
x-cache
HIT
content-type
image/png
cache-control
no-cache
accept-ranges
bytes
content-length
85
x-cache-hits
5361

Redirect headers

x-served-by
cache-yyz4546-YYZ
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 varnish
server
Jetty(9.4.35.v20201120)
x-timer
S1707851116.745915,VS0,VE20
x-cache
MISS
p3p
CP="NOI DSP COR LAW PSAo PSDo IVAo IVDo OUR BUS UNI DEM"
access-control-allow-origin
*
location
https://sync-tm.everesttech.net/ct/upi/pid/ny75r2x0?redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537148856%26val%3D%24%7BTM_USER_ID%7D&_test=Zcu9awAB77y1BQBj
cache-control
no-cache
accept-ranges
bytes
content-length
0
x-cache-hits
0
auction
s2s.t13.io/openrtb2/
43 KB
18 KB
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
48c24d5277f44f7797dc7f7151aeb51f2d1ef4297034da243e578ecf704762ac
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18534
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115680&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-37_ad&gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-37_ad&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=300&maxh=600&si=80384&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115680&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-37_ad&gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-37_ad&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=300&maxh=600&si=80383&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115680&to=600&pubProvidedId=%5B%5D&aun=rcom_freestar_ad_widget-37_ad&gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-37_ad&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=300&maxh=600&si=80388&pi=3&bf=300x600%2C160x600%2C120x600%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
prebid
ib.adnxs.com/ut/v3/
140 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
3d4f741f419aace82deeb367c220bde49b8960b1af79f65d445b36690d89743c
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
c798c091-7b9e-49b9-8b7e-95641d49b0c0
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
140
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
prebidjs
rtb.openx.net/openrtbb/
53 B
95 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
ce8d7b8cffd0a011cee0a44691380f02d176fbc6ab927ce8a21dfcff45e52057

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
auction
tlx.3lift.com/header/
19 B
848 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
sec-ch-downlink,sec-ch-ua-full-version-list,sec-ch-prefers-color-scheme,sec-ch-ua-platform,sec-ch-dpr,user-agent,sec-ch-width,sec-ch-viewport-height,sec-ch-save-data,sec-ch-ect,sec-ch-ua-model,sec-ch-ua-platform-version,sec-ch-device-memory,sec-ch-ua-bitness,sec-ch-ua,sec-ch-ua-full-version,sec-ch-ua-arch,sec-ch-rtt,sec-ch-ua-mobile,sec-ch-viewport-width
x-auction-status
12, 12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
5653a0951a50596dd0194080d7e8450079f5ffd08d0a7c48d099aadb9ff60a82
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=97157005100&lsavail=1&bundle=VSthyV9rYnJTZTdibjJNJTJCVzQ4MjI0UVBjYW1OV2Y3MUVKUzN0bFJoOGZEb25YSDB6WjRTMHNZd3lSNkk5VlU3allTWEtlcFplRnVRRDVLRW0xVnpTTkl5RnRUVnRibnV5d1N6UWdZR2olMkJtSjBiajE2UDM1OGNDc1ZoTEJLN3RRaW80VVU
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
fastlane.json
fastlane.rubiconproject.com/a/api/
0
0

ecm3
s.amazon-adsystem.com/ Frame 1BA6
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=IJ_5ATZHwpxocGP7SR6BzHWi&ex=sovrn.com&gdpr=0&gdpr=0&gdpr_consent=
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
4PF48731YMTQSEKSVC5C
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
merge
ce.lijit.com/ Frame 1BA6
Redirect Chain
  • https://um.simpli.fi/lj_match?r=1707851115563&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=2&3pid=0E087FD3E115403AB68AFF630D65CE67
43 B
1 KB
Image
General
Full URL
https://ce.lijit.com/merge?pid=2&3pid=0E087FD3E115403AB68AFF630D65CE67
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=63072000; includeSubdomains; preload
x-content-type-options
nosniff
server
openresty
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html
location
https://ce.lijit.com/merge?pid=2&3pid=0E087FD3E115403AB68AFF630D65CE67
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-headers
DNT,X-Mx-ReqToken,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type
content-length
142
expires
Mon, 12 Feb 2024 19:05:15 GMT
pixel
cm.g.doubleclick.net/ Frame 1BA6
Redirect Chain
  • https://ap.lijit.com/dsp/google/cookiematch/dv?gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=lijit_dbm&google_hm=SUpfNUFUWkh3cHhvY0dQN1NSNkJ6SFdp&gdpr=0
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=lijit_dbm&google_hm=SUpfNUFUWkh3cHhvY0dQN1NSNkJ6SFdp&gdpr=0
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=lijit_dbm&google_hm=SUpfNUFUWkh3cHhvY0dQN1NSNkJ6SFdp&gdpr=0
access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:15 GMT
access-control-allow-credentials
true
access-control-allow-headers
X-Requested-With, Content-Type
content-length
0
access-control-allow-methods
GET, POST, DELETE, PUT
merge
ce.lijit.com/ Frame 1BA6
Redirect Chain
  • https://t.adx.opera.com/pub/sync?pubid=pub10014056052800&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?3pid=OPUab1645795b4b463ba93cb19748df0468&gdpr=0&gdpr_consent=&pid=103
43 B
2 KB
Image
General
Full URL
https://ce.lijit.com/merge?3pid=OPUab1645795b4b463ba93cb19748df0468&gdpr=0&gdpr_consent=&pid=103
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
server
Tengine
access-control-allow-methods
POST, GET
content-type
text/html; charset=utf-8
access-control-allow-origin
*
location
https://ce.lijit.com/merge?3pid=OPUab1645795b4b463ba93cb19748df0468&gdpr=0&gdpr_consent=&pid=103
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, accept, origin, Cache-Control, X-Requested-With
content-length
131
expires
Mon, 01 Jan 1990 00:00:00 GMT
sync
ads.yieldmo.com/v000/ Frame 1BA6
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=sovrn&gdpr=0&gdpr_consent=
  • https://ad.turn.com/r/cs?pid=45&rndcb=4039413653
  • https://sync.1rx.io/usersync/turn/4374775086859810847?dspret=1&gdpr=&gdpr_consent=&us_privacy=
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fads.yieldmo.com%2Fv000%2Fsync%3Fpn_id%3Dunl%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a...
  • https://ads.yieldmo.com/v000/sync?pn_id=unl&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
43 B
617 B
Image
General
Full URL
https://ads.yieldmo.com/v000/sync?pn_id=unl&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Protocol
H2
Server
44.199.10.205 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-199-10-205.compute-1.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-methods
POST, GET, OPTIONS
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
access-control-allow-headers
Cache-Control, Pragma, *
content-length
43

Redirect headers

location
https://ads.yieldmo.com/v000/sync?pn_id=unl&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RXe2af2325e28b4fd4b66772f44cc57a3b005
content-type
text/html
merge
ce.lijit.com/ Frame 1BA6
Redirect Chain
  • https://pixel-eu.rubiconproject.com/exchange/sync.php?p=sovrn-onscroll&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
43 B
2 KB
Image
General
Full URL
https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: ce.lijit.com
URL: https://ce.lijit.com/beacon/amazon?url=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%24UID&ex=sovrn.com&gdpr=0
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ce.lijit.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://ce.lijit.com/merge?pid=83&3pid=LSKQGI85-W-KKFE&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
2eb7d209ab67664d6226c75331547ba1
Expires
0
usync.js
eus.rubiconproject.com/ Frame E846
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east&gdpr=0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:15 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39690
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
cs
cs.yellowblue.io/ Frame B648
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=typeaholdings
  • https://ad.turn.com/r/cs?pid=45&rndcb=8651849632
  • https://sync.1rx.io/usersync/turn/4374775086859810847?dspret=1&gdpr=&gdpr_consent=&us_privacy=
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fcs.yellowblue.io%2Fcs%3Faid%3D11599%26id%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
  • https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
0
329 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs.yellowblue.io/cs?aid=11599&id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RXe2af2325e28b4fd4b66772f44cc57a3b005
content-type
text/html
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://us-u.openx.net/w/1.0/cm?id=58ceaaf5-c766-4c17-869a-d76e43401714&gdpr=0&gdpr_consent=&r=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11563%26id%3D
  • https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
cs
cs.yellowblue.io/ Frame B648
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=3663&gdpr=0&gdpr_consent=
  • https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
0
329 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1707851115822001-105
cs
cs.yellowblue.io/ Frame B648
Redirect Chain
  • https://match.sharethrough.com/universal/v1?supply_id=5926d422&gdpr=0&gdpr_consent=
  • https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
0
329 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
date
Tue, 13 Feb 2024 19:05:15 GMT
content-length
0
cs
cs.yellowblue.io/ Frame B648
Redirect Chain
  • https://ssbsync.smartadserver.com/api/sync?callerId=77&gdpr=0&gdpr_consent=
  • https://cs.yellowblue.io/cs?aid=11600&id=8379257319880423754&gdpr=0&gdpr_consent=
0
329 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11600&id=8379257319880423754&gdpr=0&gdpr_consent=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs.yellowblue.io/cs?aid=11600&id=8379257319880423754&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:15 GMT
content-length
0
cs
cs.openwebmedia.org/ Frame B648
Redirect Chain
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160295&gdpr=0&gdpr_consent=&pu=https%3A%2F%2Fcs.openwebmedia.org%2Fcs%3Faid%3D40020%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26id%3D$UI...
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_hm=QTg5MDNCRUYtQkZCOS00M0FFLThCQjUtQjVBNjhCOUJBRTIw&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjImdGw9MTI5NjAw&gdpr=0&gdpr_consent=
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_cm&google_sc&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTIxNzcmdGw9MTI5NjAw&gdpr=0&gdpr_consent=&piggybackCookie=CAESEN_nfYU13Hor5J3C_uXar3w&google_cver=1
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
0
485 B
Image
General
Full URL
https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
3.161.193.117 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-193-117.atl59.r.cloudfront.net
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 ec79dc4af45a101de582202efa81d03c.cloudfront.net (CloudFront)
server
istio-envoy
x-amz-cf-pop
ATL59-P8
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
x-cache
Miss from cloudfront
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0
x-amz-cf-id
vyonc_-xXlpE1R0w2fJF_PFDJxK1vgaJjPXZTsaNe7z_QyyZJXleFw==

Redirect headers

location
https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
content-length
177
content-type
text/html; charset=utf-8
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://ads.yieldmo.com/pbsync?is=rise&gdpr=0&gdpr_consent=&us_privacy=&redirectUri=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11584%26uid%3D$UID
  • https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json;charset=utf-8
location
https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
access-control-allow-origin
*
access-control-allow-headers
Cache-Control, Pragma, *
content-length
0
cookie
cm.adform.net/ Frame B648
43 B
105 B
Image
General
Full URL
https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11606%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26uid%3D$UID
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.3.26 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx
content-length
43
content-type
image/gif
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://csync.loopme.me/?pubid=11362&gdpr=0&gdpr_consent=&redirect=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11571%26id%3D%7Bdevice_id%7D
  • https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=3d50f1a1-1ac2-4748-94af-adfbb97c9078&gdpr_consent=null&gdpr=0
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=3d50f1a1-1ac2-4748-94af-adfbb97c9078&gdpr_consent=null&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=3d50f1a1-1ac2-4748-94af-adfbb97c9078&gdpr_consent=null&gdpr=0
date
Tue, 13 Feb 2024 19:05:15 GMT
server
_
content-length
0
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://sync.go.sonobi.com/us?gdpr=0&consent_string=&loc=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D115667%26uid%3D%5BUID%5D
  • https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-6-76
content-type
text/plain; charset=utf8
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
cache-control
no-cache, no-store, private
tcn
Choice
content-length
0
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11596%26id%3D$UID&gdpr=0&gdpr_consent=
  • https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
1a6348ba-664f-4e15-aad4-386a2bed5ec1
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?pid=562615&ev=1&us_privacy=[US_PRIVACY]&gdpr=0&gdpr_consent=&rurl=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11592%26uid%3D%25%25VGUID%25%25
  • https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
location
https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11603%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26uid%3D$%7BBSW_UUID%7D
  • https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

Location
https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
Date
Tue, 13 Feb 2024 19:05:15 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
cs
cs-server-s2s.yellowblue.io/ Frame B648
Redirect Chain
  • https://ssc-cms.33across.com/ps/?ri=0015a00002hdV5tAAE&ru=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11580%26puid%3D33XUSERID33X
  • https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212319511635068
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212319511635068
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
referrer-policy
unsafe-url
server
33XP019
x-33x-status
100000000008200000C
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
location
https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212319511635068
cache-control
no-store, no-cache, must-revalidate
content-length
0
expires
Thu, 01-Jan-70 00:00:01 GMT
cksync.php
contextual.media.net/ Frame B648
53 B
474 B
Image
General
Full URL
https://contextual.media.net/cksync.php?cs=25&type=ris&ovsid=%7B%7BAPID%7D%7D&redirect=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11585%26id%3D%3Cvsid%3E
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.8.28 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-8-28.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
9d96b2fe2d8d4a398a846ebee84e5e70ec37e0fc613b3e2a5aaa81b1bf2d8470
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Apache
p3p
CP="NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA", CP: NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA
content-type
image/gif
cache-control
max-age=0, no-cache, no-store
alt-svc
h3=":443"; ma=93600
content-length
53
x-mnet-hl2
E
expires
Tue, 13 Feb 2024 19:05:15 GMT
ecm3
s.amazon-adsystem.com/ Frame B648
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=rise.com&id=LTYBduFzkp_s
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
8DSR84V1DFT938F31FDA
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
aps_csm.js
c.amazon-adsystem.com/bao-csm/aps-comm/ Frame C770
6 KB
3 KB
XHR
General
Full URL
https://c.amazon-adsystem.com/bao-csm/aps-comm/aps_csm.js
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.230.49.33 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-230-49-33.yul62.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
06b99248a163333e36980a6cfb756f1a7de60fa49517162b87b1a44d5d48f844

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

x-amz-version-id
9yABOonr2HqHtwbarUcdbIqN0f4A8Qog
content-encoding
gzip
via
1.1 ac1cb1fdb7cf3984f94f9f190169eb3a.cloudfront.net (CloudFront)
date
Tue, 13 Feb 2024 14:12:33 GMT
x-amz-cf-pop
YUL62-C2
age
17563
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
last-modified
Tue, 29 Aug 2023 08:30:37 GMT
server
AmazonS3
etag
W/"a4d296427fc806b21335359e398c025c"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
vary
Accept-Encoding,Origin
x-amz-cf-id
R2-T1zRLyunKCXshFxa262BoDHDIFMjLCbZfxpaBlnK39ilA7B09EQ==
cookie
cm.adform.net/ Frame 8452
43 B
106 B
Image
General
Full URL
https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11606%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26uid%3D$UID
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.3.26 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx
content-length
43
content-type
image/gif
cksync.php
contextual.media.net/ Frame 8452
53 B
474 B
Image
General
Full URL
https://contextual.media.net/cksync.php?cs=25&type=ris&ovsid=%7B%7BAPID%7D%7D&redirect=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11585%26id%3D%3Cvsid%3E
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.8.28 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-8-28.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
9d96b2fe2d8d4a398a846ebee84e5e70ec37e0fc613b3e2a5aaa81b1bf2d8470
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Apache
p3p
CP="NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA", CP: NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA
content-type
image/gif
cache-control
max-age=0, no-cache, no-store
alt-svc
h3=":443"; ma=93600
content-length
53
x-mnet-hl2
E
expires
Tue, 13 Feb 2024 19:05:15 GMT
cs
cs.yellowblue.io/ Frame 8452
Redirect Chain
  • https://ssbsync.smartadserver.com/api/sync?callerId=77&gdpr=0&gdpr_consent=
  • https://cs.yellowblue.io/cs?aid=11600&id=5722876075152800063&gdpr=0&gdpr_consent=
0
329 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11600&id=5722876075152800063&gdpr=0&gdpr_consent=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs.yellowblue.io/cs?aid=11600&id=5722876075152800063&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:15 GMT
content-length
0
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?pid=562615&ev=1&us_privacy=[US_PRIVACY]&gdpr=0&gdpr_consent=&rurl=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11592%26uid%3D%25%25VGUID%25%25
  • https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
location
https://cs-server-s2s.yellowblue.io/cs?aid=11592&uid=AwN5CTqy8JaW&ev=1&us_privacy=[US_PRIVACY]&pid=562615&gdpr_consent=&gdpr=0
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11596%26id%3D$UID&gdpr=0&gdpr_consent=
  • https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
985d445a-3d36-4410-afe2-aa896499f52d
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://cs-server-s2s.yellowblue.io/cs?aid=11596&id=5872803529851156248&gdpr=0&gdpr_consent=
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://sync.go.sonobi.com/us?gdpr=0&consent_string=&loc=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D115667%26uid%3D%5BUID%5D
  • https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-6-76
content-type
text/plain; charset=utf8
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://cs-server-s2s.yellowblue.io/cs?aid=115667&uid=65e4a6df-48af-4fad-a0f0-a3011fc909f8
cache-control
no-cache, no-store, private
tcn
Choice
content-length
0
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
cs
cs.openwebmedia.org/ Frame 8452
Redirect Chain
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160295&gdpr=0&gdpr_consent=&pu=https%3A%2F%2Fcs.openwebmedia.org%2Fcs%3Faid%3D40020%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26id%3D$UI...
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_hm=QTg5MDNCRUYtQkZCOS00M0FFLThCQjUtQjVBNjhCOUJBRTIw&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjImdGw9MTI5NjAw&gdpr=0&gdpr_consent=
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_cm&google_sc&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTIxNzcmdGw9MTI5NjAw&gdpr=0&gdpr_consent=&piggybackCookie=CAESEN_nfYU13Hor5J3C_uXar3w&google_cver=1
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
0
485 B
Image
General
Full URL
https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
3.161.193.117 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-193-117.atl59.r.cloudfront.net
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 ec79dc4af45a101de582202efa81d03c.cloudfront.net (CloudFront)
server
istio-envoy
x-amz-cf-pop
ATL59-P8
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
x-cache
Miss from cloudfront
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0
x-amz-cf-id
4KvnF9Q78XUCiQ15B7Fkl-wH5FM6UgZQfo4b2h1-YGiMS0kF8tIUdw==

Redirect headers

location
https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
content-length
177
content-type
text/html; charset=utf-8
RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
sync.targeting.unrulymedia.com/csync/ Frame 8452
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=typeaholdings
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adconductor&ttd_tpi=1&rndcb=1765159388
  • https://sync.1rx.io/usersync/tradedesk/29aab174-fe91-4ad7-aa56-1d4732cc27d2
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
43 B
377 B
Image
General
Full URL
https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
69.194.240.13 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-length
43
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"

Redirect headers

location
https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, must-revalidate
expires
0
content-type
text/html
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11603%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BUSER_CONSENT%5D%26uid%3D$%7BBSW_UUID%7D
  • https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

Location
https://cs-server-s2s.yellowblue.io/cs?aid=11603&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&uid=d9962442-c73f-42a4-adbd-3d9517e387ff
Date
Tue, 13 Feb 2024 19:05:15 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
cs
cs.yellowblue.io/ Frame 8452
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=3663&gdpr=0&gdpr_consent=
  • https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
0
329 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://cs.yellowblue.io/cs?aid=11601&id=1a414bb82571872ecee8edf55b15cd6&gdpr_consent=&gdpr=0
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1707851115851063-1150
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://ssc-cms.33across.com/ps/?ri=0015a00002hdV5tAAE&ru=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11580%26puid%3D33XUSERID33X
  • https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212462896368674
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212462896368674
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
referrer-policy
unsafe-url
server
33XP007
x-33x-status
100000000008200000C
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
location
https://cs-server-s2s.yellowblue.io/cs?aid=11580&puid=212462896368674
cache-control
no-store, no-cache, must-revalidate
content-length
0
expires
Thu, 01-Jan-70 00:00:01 GMT
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://ads.yieldmo.com/pbsync?is=rise&gdpr=0&gdpr_consent=&us_privacy=&redirectUri=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11584%26uid%3D$UID
  • https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json;charset=utf-8
location
https://cs-server-s2s.yellowblue.io/cs?aid=11584&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=0&gdpr_consent=&us_privacy=
access-control-allow-origin
*
access-control-allow-headers
Cache-Control, Pragma, *
content-length
0
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://csync.loopme.me/?pubid=11362&gdpr=0&gdpr_consent=&redirect=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11571%26id%3D%7Bdevice_id%7D
  • https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=f4a07ad1-72ff-47b5-b780-dd4a5ffcb469&gdpr_consent=null&gdpr=0
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=f4a07ad1-72ff-47b5-b780-dd4a5ffcb469&gdpr_consent=null&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs-server-s2s.yellowblue.io/cs?aid=11571&id=f4a07ad1-72ff-47b5-b780-dd4a5ffcb469&gdpr_consent=null&gdpr=0
date
Tue, 13 Feb 2024 19:05:15 GMT
server
_
content-length
0
cs
cs.yellowblue.io/ Frame 8452
Redirect Chain
  • https://match.sharethrough.com/universal/v1?supply_id=5926d422&gdpr=0&gdpr_consent=
  • https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
0
329 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

location
https://cs.yellowblue.io/cs?aid=11587&uid=c4cec5b2-acca-415c-b738-7e079be8bf78&gdpr=0
date
Tue, 13 Feb 2024 19:05:15 GMT
content-length
0
cs
cs-server-s2s.yellowblue.io/ Frame 8452
Redirect Chain
  • https://us-u.openx.net/w/1.0/cm?id=58ceaaf5-c766-4c17-869a-d76e43401714&gdpr=0&gdpr_consent=&r=https%3A%2F%2Fcs-server-s2s.yellowblue.io%2Fcs%3Faid%3D11563%26id%3D
  • https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
0
329 B
Image
General
Full URL
https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://cs-server-s2s.yellowblue.io/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://cs-server-s2s.yellowblue.io/cs?aid=11563&id=943261d2-eaa1-48ba-8981-f584f485ff4b
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame 8452
Redirect Chain
  • https://live.primis.tech/live/liveCS.php?source=external&advId=150&advUuid=c0YoKqF-kj_s
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1660370273&3rdpcid=c0YoKqF-kj_s
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1660370273&3rdpcid=c0YoKqF-kj_s
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cs-server-s2s.yellowblue.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
kX39eHtbqjSlwkqN0qQoKKkQdb2bSkAVLS3AKkB3Bl9tFJoFnu2kgQ==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1660370273&3rdpcid=c0YoKqF-kj_s
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
V_ERfE_xVsDWiZ-nflkTyRPZLNZ5zoB44blL7pkZ2Uq8oU7ju3sM-w==
ecm3
s.amazon-adsystem.com/ Frame 424C
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=ym.com&id=V_ZrZhhNNrh6QBoKLRmb&gdpr=0
Requested by
Host: sync-amz.ads.yieldmo.com
URL: https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://sync-amz.ads.yieldmo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
Z5H0B4HGAT9FXKRVDVHP
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
sync
ads.yieldmo.com/v000/ Frame 424C
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?pid=561118&ev=1&rurl=https%3a%2f%2fads.yieldmo.com/v000/sync?userid=%%VGUID%%&pn_id=pp&gdpr=0&gdpr_consent=&gpp=&gpp_sid=&us_privacy=
  • https://ads.yieldmo.com/v000/sync?userid=AwN5CTqy8JaW&ev=1&pn_id=pp&gpp_sid=&gpp=&us_privacy=&pid=561118&gdpr_consent=&gdpr=0
43 B
596 B
Image
General
Full URL
https://ads.yieldmo.com/v000/sync?userid=AwN5CTqy8JaW&ev=1&pn_id=pp&gpp_sid=&gpp=&us_privacy=&pid=561118&gdpr_consent=&gdpr=0
Requested by
Host: sync-amz.ads.yieldmo.com
URL: https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
44.199.10.205 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-199-10-205.compute-1.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

accept-language
en-US,en;q=0.9
Referer
https://sync-amz.ads.yieldmo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-methods
POST, GET, OPTIONS
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
access-control-allow-headers
Cache-Control, Pragma, *
content-length
43

Redirect headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
location
https://ads.yieldmo.com/v000/sync?userid=AwN5CTqy8JaW&ev=1&pn_id=pp&gpp_sid=&gpp=&us_privacy=&pid=561118&gdpr_consent=&gdpr=0
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1
cs
cs.openwebmedia.org/ Frame 424C
Redirect Chain
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160648&gdpr=&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D160648%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fsync-pm.ads.y...
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_hm=QTg5MDNCRUYtQkZCOS00M0FFLThCQjUtQjVBNjhCOUJBRTIw&gdpr=-1&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjImdGw9MTI5NjAw&gdpr=-1&gdpr_consent=
  • https://image8.pubmatic.com/AdServer/ImgSync?gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://cm.g.doubleclick.net/pixel?google_nid=pubmatic&google_cm&google_sc&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTIxNzcmdGw9MTI5NjAw&gdpr=0&gdpr_consent=&piggybackCookie=CAESEN_nfYU13Hor5J3C_uXar3w&google_cver=1
  • https://image8.pubmatic.com/AdServer/ImgSync?sec=1&gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
0
481 B
Image
General
Full URL
https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: sync-amz.ads.yieldmo.com
URL: https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
3.161.193.117 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-193-117.atl59.r.cloudfront.net
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://sync-amz.ads.yieldmo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 ec79dc4af45a101de582202efa81d03c.cloudfront.net (CloudFront)
server
istio-envoy
x-amz-cf-pop
ATL59-P8
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://sync-amz.ads.yieldmo.com/
x-cache
Miss from cloudfront
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0
x-amz-cf-id
Wep3R3HepyaMgw-6aHDmRGkXuL--1_LgYc0_7OAUttm8s_J8FaCOPQ==

Redirect headers

location
https://cs.openwebmedia.org/cs?aid=40020&gdpr=[GDPR]&gdpr_consent=[USER_CONSENT]&id=$UID?aid=11576&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
content-length
177
content-type
text/html; charset=utf-8
sync
ads.yieldmo.com/v000/ Frame 424C
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=yieldmo&ttd_tpi=1&ttd_puid=V_ZrZhhNNrh6QBoKLRmb
  • https://ads.yieldmo.com/v000/sync?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
43 B
610 B
Image
General
Full URL
https://ads.yieldmo.com/v000/sync?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
Requested by
Host: sync-amz.ads.yieldmo.com
URL: https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
44.199.10.205 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-199-10-205.compute-1.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

accept-language
en-US,en;q=0.9
Referer
https://sync-amz.ads.yieldmo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-methods
POST, GET, OPTIONS
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
access-control-allow-headers
Cache-Control, Pragma, *
content-length
43

Redirect headers

location
https://ads.yieldmo.com/v000/sync?tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Kestrel
content-length
181
sync
ads.yieldmo.com/ Frame 424C
Redirect Chain
  • https://pixel-us-east.rubiconproject.com/exchange/sync.php?p=yieldmo
  • https://ads.yieldmo.com/sync?pn_id=rc&id=LSKQGI85-W-KKFE
43 B
598 B
Image
General
Full URL
https://ads.yieldmo.com/sync?pn_id=rc&id=LSKQGI85-W-KKFE
Requested by
Host: sync-amz.ads.yieldmo.com
URL: https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
44.199.10.205 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-199-10-205.compute-1.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

accept-language
en-US,en;q=0.9
Referer
https://sync-amz.ads.yieldmo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-methods
POST, GET, OPTIONS
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
access-control-allow-headers
Cache-Control, Pragma, *
content-length
43

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://ads.yieldmo.com/sync?pn_id=rc&id=LSKQGI85-W-KKFE
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
207bf73b93f199ba0825203b77fa46ae
Expires
0
RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
sync.targeting.unrulymedia.com/csync/ Frame 424C
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=yieldmo&redir%3Dhttps%3A%2F%2Fads.yieldmo.com%2Fv000%2Fsync%3Fpn_id%3Dunl%26id%3D%5BRX_UUID%5D
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adconductor&ttd_tpi=1&rndcb=4923233477
  • https://sync.1rx.io/usersync/tradedesk/29aab174-fe91-4ad7-aa56-1d4732cc27d2
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
43 B
377 B
Image
General
Full URL
https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Requested by
Host: sync-amz.ads.yieldmo.com
URL: https://sync-amz.ads.yieldmo.com/tamptsync?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dym.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
69.194.240.13 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://sync-amz.ads.yieldmo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-length
43
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"

Redirect headers

location
https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, must-revalidate
expires
0
content-type
text/html
ecm3
s.amazon-adsystem.com/ Frame 6439
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=sharethrough.com&id=051d319f-05d9-49b3-a845-54baf5375039
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D%24UID&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
H7458BN7Z8Q592V9KMY8
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
v1
match.sharethrough.com/sync/ Frame 6439
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sharethrough&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

location
https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:15 GMT
server
Kestrel
content-length
323
v1
match.sharethrough.com/sync/ Frame 6439
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=sharethrough_ob&gdpr=0&gdpr_consent=&google_hm=MDUxZDMxOWYtMDVkOS00OWIzLWE4NDUtNTRiYWY1Mzc1MDM5
  • https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
260
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
v1
match.sharethrough.com/sync/ Frame 6439
Redirect Chain
  • https://secure.adnxs.com/getuid?https://match.sharethrough.com/sync/v1?source_id=0e8893f90b606c9c5d33f1be&gdpr=0&gdpr_consent=&source_user_id=$UID
  • https://match.sharethrough.com/sync/v1?source_id=0e8893f90b606c9c5d33f1be&gdpr=0&gdpr_consent=&source_user_id=5872803529851156248
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?source_id=0e8893f90b606c9c5d33f1be&gdpr=0&gdpr_consent=&source_user_id=5872803529851156248
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
bcd1b4b3-1709-4546-a7ed-351186e9d75d
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://match.sharethrough.com/sync/v1?source_id=0e8893f90b606c9c5d33f1be&gdpr=0&gdpr_consent=&source_user_id=5872803529851156248
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
v1
match.sharethrough.com/sync/ Frame 6439
Redirect Chain
  • https://pr-bh.ybp.yahoo.com/sync/sharethrough/051d319f-05d9-49b3-a845-54baf5375039?gdpr=0&gdpr_consent=
  • https://match.sharethrough.com/sync/v1?source_id=BVbSRuzbUWjBEF6bQrmLHKkX&source_user_id=y-uzf.KHtE2oPgQ257v8MZ3adVdk1Kfc57.YRD7UdYU3Z0~A
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?source_id=BVbSRuzbUWjBEF6bQrmLHKkX&source_user_id=y-uzf.KHtE2oPgQ257v8MZ3adVdk1Kfc57.YRD7UdYU3Z0~A
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D%24UID&gdpr=0
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
strict-origin-when-cross-origin
server
ATS
content-security-policy
sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-frame-options
DENY
location
https://match.sharethrough.com/sync/v1?source_id=BVbSRuzbUWjBEF6bQrmLHKkX&source_user_id=y-uzf.KHtE2oPgQ257v8MZ3adVdk1Kfc57.YRD7UdYU3Z0~A
content-length
0
crum
dsum-sec.casalemedia.com/ Frame C081
Redirect Chain
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D
  • https://cm.g.doubleclick.net/pixel?google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=Zcu9a9HM518AACyiADNVcgAA
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEJ3BObNizToNa40yYTsJ3eA&google_cver=1
43 B
772 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEJ3BObNizToNa40yYTsJ3eA&google_cver=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=IyErcxIKT6oeR2O8IS0Csf5o%2F%2Bn6drmjVD8zwUOTxM7%2FWhpexqSy28TtpqxSq%2Ft7JgAPHJppj1IRlxSVWPrZTwZYn8sVxMU0keTH4%2F9LUK6qd0HjknX0Nkm98bjtVwy4kAUPcDi9LVEUJw%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f57824ae439f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEJ3BObNizToNa40yYTsJ3eA&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
314
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
usersync.aspx
dis.criteo.com/dis/ Frame C081
Redirect Chain
  • https://i.liadm.com/s/31327?bidder_id=14481&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpdr=&gdpr_consent=&us_privacy=&gpp=&gpp_sid=
  • https://dis.criteo.com/dis/usersync.aspx?r=77&p=311&cp=liveintent&cu=1&url=https://i.liadm.com/s/28292?bidder_id%3D71340%26bidder_uuid%3D@@CRITEO_USERID@@
43 B
363 B
Image
General
Full URL
https://dis.criteo.com/dis/usersync.aspx?r=77&p=311&cp=liveintent&cu=1&url=https://i.liadm.com/s/28292?bidder_id%3D71340%26bidder_uuid%3D@@CRITEO_USERID@@
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
H2
Server
74.119.119.150 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
x-errorlevel
0
strict-transport-security
max-age=31536000; preload;
server
Kestrel
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
content-type
image/gif
cache-control
no-cache
cross-origin-resource-policy
cross-origin
server-processing-duration-in-ticks
184485
expires
Tue, 13 Feb 2024 00:00:00 GMT

Redirect headers

Location
https://dis.criteo.com/dis/usersync.aspx?r=77&p=311&cp=liveintent&cu=1&url=https://i.liadm.com/s/28292?bidder_id%3D71340%26bidder_uuid%3D@@CRITEO_USERID@@
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=31536000; includeSubDomains
Connection
keep-alive
Content-Length
0
Request-Time
5
usermatchredir
ssum-sec.casalemedia.com/ Frame C081
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=index&google_cm&google_hm=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gdpr_consent=&us_privacy=&gdpr=&gpp=&gpp_sid=
  • https://ssum-sec.casalemedia.com/usermatchredir?s=184023&gdpr_consent=&gdpr=&gpp=&gpp_sid=&google_gid=CAESEI5VMbmiQ8Q_ck8VHxZdCxQ&google_cver=1
43 B
731 B
Image
General
Full URL
https://ssum-sec.casalemedia.com/usermatchredir?s=184023&gdpr_consent=&gdpr=&gpp=&gpp_sid=&google_gid=CAESEI5VMbmiQ8Q_ck8VHxZdCxQ&google_cver=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=AExEbYgEeME1pR7EkuXjX4WAQoSYXl54xACjq02i%2Fd5fPWnTQH6JXHfoUIPFgvgiUnJWO3yTJhhVd6fQnoDG0t62LHMiF2My31PyPsxnm5Z9TBd5yL%2F8lqOglJM0BHv1FMp8l1k0gIfxuw%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f5782bba139f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://ssum-sec.casalemedia.com/usermatchredir?s=184023&gdpr_consent=&gdpr=&gpp=&gpp_sid=&google_gid=CAESEI5VMbmiQ8Q_ck8VHxZdCxQ&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
364
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
dcm
s.amazon-adsystem.com/ Frame C081
43 B
855 B
Image
General
Full URL
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=&gdpr_consent=&id=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
M846RB42D2RGEQ7JZZPV
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
crum
dsum-sec.casalemedia.com/ Frame C081
Redirect Chain
  • https://pm.w55c.net/ping_match.gif?ei=CASALE&rurl=https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=_wfivefivec_
  • https://pm.w55c.net/ping_match.gif?scc=1&ei=CASALE&rurl=https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=_wfivefivec_
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=MxnNt1pn1RzY5K5
43 B
825 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=MxnNt1pn1RzY5K5
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=LOdnId%2FVagiFyNWIgSiA%2BihEeFSY2zxz0bUBtSvhC22zuzxWRR6cqbIfZFcui%2Bhsp1I6Z2Rxau0htIVlF%2FFi6qpatk0To9iTShL9MZiudAmLnOwnmXXDDsd%2FoE4mFqdXoJNwluluoIYUBA%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f5783cd9739f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=2592000; includeSubDomains
Server
PingMatch/v2.0.30-801-g0076fb7#rel-ec2-master i-01da75f8e4c388f9e@us-east-1e@dxedge-app-us-east-1-prod-asg
Location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=47&external_user_id=MxnNt1pn1RzY5K5
Cache-Control
no-cache, must-revalidate
Connection
keep-alive
Content-Length
0
Expires
Fri, 01 Jan 1990 00:00:00 GMT
crum
dsum-sec.casalemedia.com/ Frame C081
Redirect Chain
  • https://cm.ctnsnet.com/int/cm?exc=19
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=109&external_user_id=6a10bd53f5634c0fb38fae0ab355416f&expiration=1710443115
43 B
731 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=109&external_user_id=6a10bd53f5634c0fb38fae0ab355416f&expiration=1710443115
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=IUY0Q0FzNDm7zyuAAYBMC15GREcdBP9CBq81m3nPeL02E5b8sYSCpKlJMFwmGHoxMzbFp6GVc12gb4%2BYl0MadX7rhpevVlhJOZMPOSsix46Yg4N2l4QV2YBCPvzIU5bj97o9vXtp%2BuK3kQ%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f57835ca739f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 google
server
Apache-Coyote/1.1
p3p
CP="NOI DSP COR NID CUR OUR NOR"
status
302
location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=109&external_user_id=6a10bd53f5634c0fb38fae0ab355416f&expiration=1710443115
content-type
text/html;charset=UTF-8
cache-control
no-cache, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
1; mode=block
expires
Fri, 01 Jan 1990 00:00:00 GMT
rum
dsum-sec.casalemedia.com/ Frame C081
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=88&external_user_id=Zcu9awAEo_sMqwA9
43 B
734 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=88&external_user_id=Zcu9awAEo_sMqwA9
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=pwWoqJYQqJPmyXl%2FCcSXHqQiL2A3BUFDrpJjdJOvax5PM0sZziVKWzogdPQ3Om%2F4yxp89dsZLjKy2ojbo8D%2FSoQQAljcq1q0z%2Bs7Lo84ocugctooW2bzPNauJOkeIu2QWr%2BxqH0NmER19w%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f5782bb8839f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

x-served-by
cache-yyz4546-YYZ
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 varnish
server
Varnish
x-timer
S1707851116.894241,VS0,VE0
x-cache
HIT
location
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=88&external_user_id=Zcu9awAEo_sMqwA9
cache-control
no-cache
accept-ranges
bytes
content-length
0
retry-after
0
x-cache-hits
0
user-registering
ads.stickyadstv.com/ Frame C081
Redirect Chain
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1025&userId=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gdpr_consent=&us_privacy=&gdpr=&gpp=&gpp_sid=
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=1a414bb82571872ecee8edf55b15cd6&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7bu...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=umo2b61_7336290589884669966&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=MWE0MTRiYjgyNTcxODcyZWNlZThlZGY1NWIxNWNkNg==&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESEFi-tQfMO09Z5XfzkVg7EKU&google_cver=1&gdpr=0&gdpr_consent=
  • https://match.prod.bidr.io/cookie-sync/stv?gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?userId=AACJ-U7Ll3sAABJaNC07Nw&dataProviderId=817&gdpr=0
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
  • https://pr-bh.ybp.yahoo.com/sync/stickyads/1a414bb82571872ecee8edf55b15cd6?gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=199&userId=y-YmhDCsJE2oNgqzhhd8VyfC8.i4uQsC6x5M_nkB9V~A
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D209%26userId%3D$UID%26gdpr%3D0%26gdpr_consent%3D
  • https://ads.stickyadstv.com/user-registering?dataProviderId=209&userId=5872803529851156248&gdpr=0&gdpr_consent=
  • https://pm.w55c.net/ping_match.gif?st=FREEWHEEL&rurl=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D593&userId=_wfivefivec_&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=593&userId=MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent=
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=stickyadstv&append=1&cb=8484622&redirect=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D690%26userId%3D&gdpr=0&gd...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=690&userId=92a46392-4333-4e17-bc0c-e23a20ef4332
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=103&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=721&userId=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
  • https://ad.turn.com/r/cs?pid=34&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=4374775086859810847&redirectID=0&gdpr=0&gdpr_consent=
0
0

ecm3
s.amazon-adsystem.com/ Frame C081
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=index.com&id=Zcu9a9HM518AACyiADNVcgAABXwAAAAB
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?cb=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dindex.com%26id%3D%24UID&gdpr=0&s=192259&C=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
HK9NMMTRZ7EA2JF78A8Q
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
/
onetag-sys.com/usync/ Frame 4A04
2 KB
863 B
Document
General
Full URL
https://onetag-sys.com/usync/?pubId=69f48c2160c8113&gdpr=0&gdpr_consent=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://cs-server-s2s.yellowblue.io/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
content-type
text/html
strict-transport-security
max-age=15552000
usync.html
eus.rubiconproject.com/ Frame 1DFF
Redirect Chain
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=rise_engage&endpoint=us-east
  • https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?redirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drise.com%26id%3D%7BpartnerId%7D&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Referer
https://cs-server-s2s.yellowblue.io/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:15 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding

Redirect headers

access-control-allow-credentials
true
access-control-allow-origin
*
content-length
0
date
Tue, 13 Feb 2024 19:05:15 GMT
location
https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
server
AkamaiGHost
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v30/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu4mxK.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f6734f8177112c0839b961f96d813fcb189d81b60e96c33278c1983b6f419615
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://reason.com
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 06:43:48 GMT
x-content-type-options
nosniff
age
44487
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15744
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:48 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 12 Feb 2025 06:43:48 GMT
/
onetag-sys.com/usync/ Frame C1E5
2 KB
863 B
Document
General
Full URL
https://onetag-sys.com/usync/?pubId=69f48c2160c8113&gdpr=0&gdpr_consent=
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://cs-server-s2s.yellowblue.io/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
content-type
text/html
strict-transport-security
max-age=15552000
usync.html
eus.rubiconproject.com/ Frame CE88
Redirect Chain
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=rise_engage&endpoint=us-east
  • https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Requested by
Host: cs-server-s2s.yellowblue.io
URL: https://cs-server-s2s.yellowblue.io/sync-iframe?gdpr={{gdpr}}&gdpr_consent={{gdpr_consent}}&redirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D150%26advUuid%3D%7BpartnerId%7D
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Referer
https://cs-server-s2s.yellowblue.io/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:15 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding

Redirect headers

access-control-allow-credentials
true
access-control-allow-origin
*
content-length
0
date
Tue, 13 Feb 2024 19:05:15 GMT
location
https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
server
AkamaiGHost
auction
s2s.t13.io/openrtb2/
1 KB
520 B
Fetch
General
Full URL
https://s2s.t13.io/openrtb2/auction
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
5c5f89307e1dc60403edb4cefdf4314cf489a2255c7a92a91c08e2de4f2e7dc1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
x-prebid
pbs-java/2.6.0
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
499
expires
0
cdb
bidder.criteo.com/
0
188 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.30.0&cb=11038478220&lsavail=1&bundle=VSthyV9rYnJTZTdibjJNJTJCVzQ4MjI0UVBjYW1OV2Y3MUVKUzN0bFJoOGZEb25YSDB6WjRTMHNZd3lSNkk5VlU3allTWEtlcFplRnVRRDVLRW0xVnpTTkl5RnRUVnRibnV5d1N6UWdZR2olMkJtSjBiajE2UDM1OGNDc1ZoTEJLN3RRaW80VVU
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
auction
tlx.3lift.com/header/
19 B
832 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.30.0&referrer=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tmax=506&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.21.151.112 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-21-151-112.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
accept-ch
sec-ch-prefers-color-scheme,sec-ch-ua-full-version-list,sec-ch-downlink,sec-ch-viewport-width,sec-ch-ua-mobile,sec-ch-rtt,sec-ch-ua-arch,sec-ch-ua-full-version,sec-ch-ua,sec-ch-ua-bitness,sec-ch-device-memory,sec-ch-ua-platform-version,sec-ch-ua-model,sec-ch-ect,sec-ch-save-data,sec-ch-viewport-height,sec-ch-width,user-agent,sec-ch-dpr,sec-ch-ua-platform
x-auction-status
12, 12
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
receive-cookie-deprecation
1; Secure; HttpOnly; Path=/; SameSite=None; Partitioned
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
674 B
708 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&alt_size_ids=2&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2Freason_leaderboard_inconent%2Freason_leaderboard_inconent&tk_flint=pbjs_lite_v8.30.0&x_source.tid=992939e6-1905-4d81-bf1d-193114b03468&l_pb_bid_id=3836e6591565d38d&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=f95b0a60-0907-4d89-ac84-a1ea7a289edf&rp_maxbids=1&p_gpid=%2F15184186%2Freason_leaderboard_inconent%2Freason_leaderboard_inconent&m_ch_mobile=%3F0&slots=1&rand=0.7625324210531286
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
e43c6383c2d08e035d2877908397d9dd31d37c9cf356c99785c75b5f192ce36b

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
674
expires
Wed, 17 Sep 1975 21:32:10 GMT
prebid
ib.adnxs.com/ut/v3/
140 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
4a00c45ae8584d97c76a94342eaad6c32340ffdae57970ce54bf357158d92fe4
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
an-x-request-uuid
eb2d7437-c241-467f-90bd-a4b61b97e282
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
140
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
prebidjs
rtb.openx.net/openrtbb/
53 B
95 B
Fetch
General
Full URL
https://rtb.openx.net/openrtbb/prebidjs
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
08bda2a7486f25a2771fb1edd6a2fcad3adf804a90cb33795d1ff3084b5c2af5

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
vary
Origin
content-type
text/plain
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
77
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115865&to=600&pubProvidedId=%5B%5D&aun=reason_leaderboard_inconent&gpid=%2F15184186%2Freason_leaderboard_inconent%2Freason_leaderboard_inconent&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=728&maxh=90&si=80383&pi=3&bf=728x90%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
imp
g2.gumgum.com/hbid/
2 KB
1 KB
Fetch
General
Full URL
https://g2.gumgum.com/hbid/imp?lt=1707851115865&to=600&pubProvidedId=%5B%5D&aun=reason_leaderboard_inconent&gpid=%2F15184186%2Freason_leaderboard_inconent%2Freason_leaderboard_inconent&pv=69dca96c-e201-45c1-8180-60828746f96d&maxw=728&maxh=90&si=80385&pi=3&bf=728x90%2C300x250&uspConsent=1---&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ce=false&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.30.0%22%7D&ogu=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&ns=10240
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.242.56 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-233-242-56.compute-1.amazonaws.com
Software
nginx /
Resource Hash
07421e663b799af2bd50cceeb45ec4017e6cfc3aa18d96599c7db677f441df09

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
private, no-store, must-revalidate, max-age=0
access-control-allow-credentials
true
timing-allow-origin
*
expires
0
bid-request
a.teads.tv/hb/
16 B
610 B
Fetch
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.151 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-151.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA, Sec-CH-UA-Full-Version-List, Sec-CH-UA-WoW64
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 13 Feb 2024 19:05:16 GMT
translator
hbopenbid.pubmatic.com/
0
56 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
hbjson
grid.bidswitch.net/
25 B
259 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.129 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
bidder.va1.vip.prod.criteo.com
Software
nginx /
Resource Hash
d57108d25533b9c6ca097f776ec41638e3803ba6632786269868c76045af64f8
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
btlr.sharethrough.com/universal/
0
14 B
Fetch
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
xdEizrWJ.js
tpc.googlesyndication.com/sodar/ Frame C770
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/xdEizrWJ.js
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/pal/pal.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c5d122ceb58926c5fc3da5d1d664684af89e5dc8f6ee490449ef4e1f4f1da790
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 10:23:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
204106
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15273
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 10 Feb 2025 10:23:29 GMT
truncated
/ Frame 97A3
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
dcd5fa95fa657dea2f03d913fb1ad0d95bfc67cc955c996cb1ebaf84872db598

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
0ab198dd-b265-462a-ae36-74e163ad6159
config.aps.amazon-adsystem.com/configs/ Frame C770
564 B
831 B
Script
General
Full URL
https://config.aps.amazon-adsystem.com/configs/0ab198dd-b265-462a-ae36-74e163ad6159
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.160.10.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-160-10-80.iad12.r.cloudfront.net
Software
CloudFront /
Resource Hash
8c9fed449b21234fe52a857f944ac4936083a01aeda3198f5fd17f530e210d1a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:07:36 GMT
via
1.1 73c5607bdb5db0d651e25c848846d554.cloudfront.net (CloudFront)
server
CloudFront
x-amz-cf-pop
IAD12-P3
age
3460
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=3600
content-length
564
x-amz-cf-id
yxRnzHvayIR67uVi9apyEPq6Q4QK5N7OmxS6kPuZvw8gfjlMYRYVDQ==
config
c.amazon-adsystem.com/cdn/prod/ Frame C770
1 KB
2 KB
XHR
General
Full URL
https://c.amazon-adsystem.com/cdn/prod/config?src=600&u=https%3A%2F%2Freason.com&pubid=0ab198dd-b265-462a-ae36-74e163ad6159
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.230.49.33 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-230-49-33.yul62.r.cloudfront.net
Software
Server /
Resource Hash
c5c46ac5fbb0f9e2d3faa5ab85ee591987acdd97e30d9e5bf0aea9b44624d0a9

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:09:01 GMT
via
1.1 43334f58904cd7106ee523ee0361b402.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
YUL62-C2
age
3374
x-cache
Hit from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
max-age=21550, s-maxage=21600
access-control-allow-credentials
true
content-length
1200
x-amz-cf-id
AJuP-Sz9BcBIS36BbRAN2D4q4AvGRdGnm509qVZmeqknhvSWQgsurw==
liveInternalSsp.php
rtb.primis.tech/live/ Frame C770
25 B
508 B
XHR
General
Full URL
https://rtb.primis.tech/live/liveInternalSsp.php?sspData=%7B%22enc%22%3Atrue%2C%22comp%22%3Atrue%2C%22data%22%3A%22%5C%22rJmgW1gi2mbS%2FwUBqu8x6H55mGXqxm1gGwRN%2B1uQEz2mxSWgSMVOsi0ZUcRIlYdo2O6BpTnA4QhHHHNhH4pw8vl8OHOpR1mD%2B5y73a7%2FYZf%2B%2F%2B1pjihKFBpxn8yW25Q0m8%2F9CMEtLZhCDsbjjaL8ERqgb23J5aX72%2By%2BLlU9fM7CK9zFZEj2u0Ebh2GlWMb%2F8Fl7onQVSiG1aBd8%2B5HyQ385o0H9%2ByRuJRzvtbUtP5IMy7p59Fautdy%2BoxfzVT%2FMCSm%2BoT5PIm5mIY3HSsDF6%2FxgpNyNkZWlboknIhpDLagW93q9%2Fjj%2FxuSm%2Fa9yM9hjdkFFqKYPeBRTnt1Qy2hd2Skq1hVKqBsxxinU76TIbG9PAi6sFXU9benT%2ByRzOO%2F7nFl%2F4ZdSUcbU3z3LBFGHY1HRmFHKzydo3dwPJsC%2FQr18u%2FQGuDcstD160dslzrQ5OaNzPi8i61%2B9QNoNV3tTU3DBBS0tBGAW%2FaUTrP%2BGw%2FOdliF3aPkJtN%2FMq0PTDTvLP%2F%2F4%2Bhzw%2BEMeJj8jDrfDTu9KPhRSKaJzO7ZczYEquCo3Tpr6Q3NUE42PaHKO1GQ9k4jv7eIqTqOVEUZzFDhKvKcdWtyA0Jl6olYU5BzEGHS8nIbf12NtlVuFkqpZiGdMnFzYnozCH47ytLiOLIvrGXsRGTIKiDYdRAcwuTOSItoGNSCU88lbMSazZZ1vtl2kxREKfVOXDTXSGdUPYIHCtL5VwWynx0bMLCgSxtjfA%2F%2BfRLywZY3i6jy%2FAhJgTR5R%2BaRo5vR9zgYEiUUq%2BbkIECp4L6fcPlNm8JwgkfpJPbmJpFBKHog537aGp1mewa1n2d7QQeaTnU1gxVVSn1LNiOGlLKtr65des8r3vNIP%2FStONw05TSgcXfzMN7mILCgXIFwsezgC9ywwuBKzVLqre02KHmwQDPcRaAKflQWeR%2F27ftHg9IOio9U8l2b00noRsDaj0lTJAcSECTrFHIQ37B5Q8JeeT3T0L9byyt7%2Fc2dSyGRzWS8UrtdyDjZcs5rukLPqhWWEAsYNL4jgI7LClJvaThcapZjvVjMagsmYsGH2e%2BR7zkLUEJParV6h8TAklHDSLK65i6lED21otlh6tlioDgmrq5fxJ3TJBZseYRvHxISIMrySWXAeXjGp1wS%2BAfwiTCygVMBlM9YLbtDyxfG8kctlVA9geWaOC9X8ykKCuVntZYgoVZMVbSoDdpuugcuJhnoYgUdWSLPQ1Xq%2FZ9k8U1KvFpTdbhvEEaOIXDfSsLfGkhNTmkHxKMCC%2F12v6fl9Ae35AANaTgDRQPahyrQUvATKOp9Ebk06shBolxMt4uOS3VBnXRpZ3tmpQBiZW2x8PfObWkNnT6VsWHLVN0cOqqf2gR4C6Q4wNvL1CzTJq07rHdsJKzuSXJ10B5E7vDRYauQ4FQmXBpbizvqp30%2BgTRw0bd%2FfqZOQgCldhilJUmZjM5S1jq75sBDK%2FDMBEFY%2B2jVrteJhDRh0UwmLl1Ln2wEuO5FQbzh4QwUe9MDuOXv%2Ffw3rLVEHoiBhzoGGBdaI7mVVQ%2BLFV46JbOZEN3ZvRX0hC51d25EV2DbvPOMsrbBYbAIgHlk0VooRcn14yK7LWt3%2BOLg3Yl92oi6eO0PlbdaEvb4LgY2QzAGhPZ%2FQKKEmiuRrF7AGYvTMCBfDyFOY4s8cUi1vHlXJ6UbwKpNEtP%2FC2xpALpFcAeQCoZO2D2wc408IgIS4ikG0IPiBG7jBul4WrBqzkV633m0Af3mTywi9X4BWHO%2FEeEwJU2RVCWIoxKcCldq02ec912mzvSyEuZlimY5BvjUY4flqQsc8Foh%2B7WiZzpZ1DoE4jZU378fVN2OGhNzXFjJ%2FHaPwoW%2FxN8J2Rq0DXLh1oQChliTi6HcxqPVvX4TL4rwnpgcG1mt%2BDF0H408HXVgkD0sXKIaDOJy7RzuoxrFyVzcEAXINq%2B76ouk4QWSLmcMImMNlYkZY1SkHlOg7HvwigptLz9Xl0SRCzr22FjBt1IQIBjv5c3jBdy1TdhZXSK2jrHq22SHWRJL3Ifn8SoFoOCTT%2FSEO9XK9j9DRYStWMm4GDHFOUmDxK53fBUPn%2BFOCIS7ho0mlhK%2BgykwaOkI8OjdC7eHDd2DzJ6bmtvDpOdYiApaeqdzhWvAzpCRSjb32zoCgu7qQRSNbSmq7oDgvpqjww5G7jRF%2BiKPHo0EPH6bFk0GPygMWrtSWFnhSj9iRYmw%2BqNCwFsq31eWWT2l5tdwogT30Lngooy%2BFHyA7XcIVHoApZSxJZaRpjk9xLu2h1EvNPLRYZe9143yPo9QwLRyIsMqcUIrnqe0kCTjXafEPrB%2BVgTbW%2FkyiB03piGH4TE1%2Fa%2BHXdi4fu6PdDpPPg%2Frse2PA0EIiJibuPCXQQXm4aGDQZZ%2BCX1r8rK%2F4%2FT1j7iAS91HtXHCntHMiPGRPOuk%2FQaAhkP3HVPkfMmeRvu8p9%2BEaPb5p8XhB614Vikq47V3kG%2FIoV%2Fk66u7bKesUQ3BVcc9EV1Y37%2BA6Bypc0uS4qwPv4ObFkjJXjWxCXKPbfFkZH39C4CeE%2FnpV%2FCYdsHfV%2FDmcsX9DkW9vc%2B77MRmfDIn2PXJFxFruc0dCarTiQHVxbIenHOfIQCU4oQOV7sfHAqVt%2FAxByRD3N2nB%2FAAt2tFCeuWFEOriB6HXQMleq%2BHn%2BqaqlSCpwVPQpHa%2FmYa%2F8LUbeDWl7Uqk6MxHUsifICpsn%2B7rQo5DklHQIpk8FOtATcPQppt5g%2BH4x4IOGovHQYpoW5Zgr3AO3b3trIjXuy7xdx3nGFAYHAiOpU7zh06%2BhooVV%2FrO9CkmXz5bVqZfWEeEgNcROHjRay75eEI7cDjFTlb0df77NoPCYXtIeu9sPg%2F8hFo3RGtDgktI3MaRY3Z3KiQLA20D2AhH3aY90XtHfD0AeBisW%2F9Sq3U4O35%2BjW2u%2FHC6ygokrEbA%2BVnYLpgOAP8v6MphdfHdNoi98basn5FaehWNtB%2B6Vta9iIJm3SzDSkzfO9zgDF2tR7JApJ3wIkSIGi2hQXiLd7%2BDMAwtCnatLCjD4or7nrtFi5THpt6hMs6gMLo9LqK17w%2FAZRuJ4rLnN5Q3iYMJs1vRyr5kUfhtxyWy6a5jDQTAUB5va%2F1EpHqM3G8Y3u8DEyjrGDmxuOglWVNec9%2ByU6mQZgwrX4GDdkOYsSQFuigFTD4lxKR82CcZjUFvVdZyebTtBD4iHeE8PrRPXHw6jpffHPNFuPMmg5pvWYFURlEqY120%2Bymyy1AQ74vb6vJH%2FUWbVPmQXZLe7hNBA5eDdwE4ZSHEh4MIZaCeDA3y44GgN8fb%2BQhybmZr%5C%22%22%7D
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
1d16d42e33c80a00df5f4c6a514edbfaa985a2cdf0d33b4f76f90a6625b773b7

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 1ae294433a6f4b338a8136481c1a3232.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C1
age
0
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
alt-svc
h3=":443"; ma=86400
pragma
no-cache
server
nginx
vary
Accept-Encoding
content-type
text/html; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-store
access-control-allow-credentials
true
x-amz-cf-id
N72RPDRrab1sdvF_Dk4qlgJZBbCYhXfavGs0WCGBnmI67h891Gs0pA==
v1
btlr.sharethrough.com/universal/ Frame C770
0
14 B
XHR
General
Full URL
https://btlr.sharethrough.com/universal/v1?supply_id=WYu2BXv1
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.83.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-83-209.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
private, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
prebid
ib.adnxs.com/ut/v3/ Frame C770
138 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
f4617cbc648932cc93554ce741bc155f3d3215622b2924f1ad03443450aaa587
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
an-x-request-uuid
2912688e-8cd5-4787-bc18-b6eb6f0c0753
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://reason.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
138
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
auction
prebid-server.rubiconproject.com/openrtb2/ Frame C770
184 B
467 B
XHR
General
Full URL
https://prebid-server.rubiconproject.com/openrtb2/auction
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
69.173.151.96 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
73df65cbf4f1eab68315465b6efa311c07ee3eea2d764d35f5d0380295122d9f

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
content-encoding
gzip
x-prebid
pbs-java/2.9.0
Content-Type
application/json
access-control-allow-origin
https://reason.com
Cache-Control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
174
Expires
0
auction
prebid-server.rubiconproject.com/openrtb2/ Frame C770
184 B
466 B
XHR
General
Full URL
https://prebid-server.rubiconproject.com/openrtb2/auction
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
69.173.151.96 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
3d88f9ff0123374fe5bc3c5e9fb8afbe75924eb6e30f5ecc0ce5db52b67097db

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
content-encoding
gzip
x-prebid
pbs-java/2.9.0
Content-Type
application/json
access-control-allow-origin
https://reason.com
Cache-Control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
173
Expires
0
translator
hbopenbid.pubmatic.com/ Frame C770
0
56 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.36.115.111 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:14 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
bid
aax.amazon-adsystem.com/e/dtb/ Frame C770
163 B
492 B
XHR
General
Full URL
https://aax.amazon-adsystem.com/e/dtb/bid?src=600&u=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&pid=Cg58lgOvtXFXs&cb=0&ws=1x1&v=24.205.1508&t=2000&slots=%5B%7B%22fc%22%3A%22USD%22%2C%22fp%22%3A300%2C%22id%22%3A%22aps_primis_oustream_ron%22%2C%22mt%22%3A%22v%22%7D%5D&pj=%7B%22device%22%3A%7B%22sua%22%3A%7B%22architecture%22%3A%22%22%2C%22bitness%22%3A%22%22%2C%22mobile%22%3A0%2C%22model%22%3A%22%22%2C%22source%22%3A2%2C%22platform%22%3A%7B%22brand%22%3A%22%22%2C%22version%22%3A%5B%22%22%5D%7D%2C%22browsers%22%3A%5B%5D%7D%7D%7D&schain=1.0%2C1!freestar.com%2C472%2C1%2C%2C%2C&sm=b30f0f42-c3ac-4345-8717-6cbae8845a01&pubid=0ab198dd-b265-462a-ae36-74e163ad6159&gdprl=%7B%22status%22%3A%22no-cmp%22%2C%22cmpTimeout%22%3A75%7D&vm=%7B%22ids%22%3A%7B%22pubcommon%22%3A%225c7a842a-6211-464e-927b-39787b41ef8d%22%2C%22audigent%22%3A%22%257B%2522id%2522%253A%257B%2522hadronId%2522%253A%25220001yum0eabkba98bciae6gibddj96ldclf786khdaabackkc2jl%2522%257D%257D%22%7D%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.173.138.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-173-138-29.jfk52.r.cloudfront.net
Software
Server /
Resource Hash
090a6f670b49984b4c2c04380d4401e3fa0064073baa41b28ab244d235304670

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 3440135ddd9561d60579f0864b6065c0.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
JFK52-P2
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
timing-allow-origin
*
content-length
163
x-amz-cf-id
riIIs92yN3a1MGb68PMGZKPMjXld9eEdmgTop9oiMZctYOJAI5xs9A==
liveView.php
live.primis.tech/live/
43 B
399 B
Image
General
Full URL
https://live.primis.tech/live/liveView.php?hash=ozcmPTEznXRiPTEzqzyxX2V2ZW50PTYzp2VlqzVlVGygZT0kNmA3ODUkMTE1JaZcZF9joGF5ZXJWZXI9Ml4kLwAzpm01ODA1NlZmqGE9MTplNwAjNmpzrD03NwpzrT00MmEzoXN0YT0kNmI2MDY2NvZ2nWRsqzFmqFR5pGU9MlZ2nWRsqzyyq2FvnWkcqHyTqGF0ZT0jJaZcZF9jYXNmRG9gYWyhPXJyYXNiov5wo20zp3VvSWQ9pzVup29hLzNioSZxZWJ1Z0yhZz9loWF0nW9hPSZcp0FjpD0jJaVmZXJJpEFxZHI9MwYjMvUmQWZzYmtyM0ElJTNBMTA0JTNBJTNBMTQzqXNypyVBPU1irzyfoGEyMxY1LwAyMwAyMwuXnW5xo3qmJTIjTyQyMwAkMC4jJTNCJTIjV2yhNwQyM0IyMwB4NwQyMwxyMwBBpHBfZVqyYxgcqCUlRwUmNl4mNvUlMCUlOEgIVE1MJTJDJTIjoGyeZSUlMEqyY2giJTI5JTIjQ2ulo21yJTJGMTIkLwAhNwE2Nl4kNwAyMwBTYWZupzxyMxY1MmphMmYzY3N1qWyxPTY1Y2JvZDZuYwqvMDEzpaZhPSR7VyBsUyZOX01BQ1JPsSZuqHRyoXB0TXVfqGyjoGyypw0lMCZwo250ZW50RzyfZUyxPTAzoWVxnWFQoGF5TGymqEyxPTAzoWVxnWFMnXN0SWQ9MCZjoGFwZW1yoaRTqHJyYW1UrXByPTMzZ2Rjpw0jJzqxpHJDo25mZW50PSZcp1qyUGFmp0qxpHI9MSZwY3BuPTAzY2NjYUNioaNyoaQ9JzNvqXN0ZXI9MTpjNmt1MTEkNTx4OSZ1nWQ9U2VenW5xo1NQoGF5ZXI2NWNvYzQ2YwQmMDA4JaB1YyVloD1bqHRjplUmQSUlRvUlRaJyYXNiov5wo20yMxYlMDI0JTJGMDEyMxYmMCUlRzEgozV3LXBunW4goWVxnWNuqGyiov1wo3VfZC1lZWyhZz9lY2UgqGuyLWRcp2FmqHJiqXMgY3JuY2gxo3qhLW9hLXBlZXNwpzyjqGyiov1ipGyinWRmJTJGJzZfo2F0U3RuqHVmPWZuoHNyJzVcZHNjPWycpSZjrGyxPTI3ZwMjZwAlNmImY2NuMzY0NGQmOTUmZGM1OWE1OGJv
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
42b976597a2d977d0e300f6d06bc903db389e5c112d33c1c8c249690a522d9f2

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
*
content-type
image/gif
cache-control
max-age=315360000
content-disposition
inline; filename="pixel.gif"
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
__nAxbxw8Xln-s83AYBIVilFPDfEBNsIeP3hiVKEefJ6F5ROWg7G5A==
expires
Thu, 31 Dec 2037 23:55:55 GMT
publishertag.prebid.144.js
static.criteo.net/js/ld/
96 KB
31 KB
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.144.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.144.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
66776998b10e583a72f8fd29391a50e2c80eb3bc9a65b0dafe97e576d7d88507
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Fri, 27 Oct 2023 06:43:26 GMT
server
nginx
etag
W/"653b5c0e-1811e"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 14 Feb 2024 19:05:16 GMT
demand-source
d.pub.network/ Frame
0
0
Preflight
General
Full URL
https://d.pub.network/demand-source
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET,PUT,POST,PATCH,DELETE,HEAD,OPTIONS
access-control-allow-origin
https://reason.com
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers Accept-Encoding, User-Agent
via
1.1 google
demand-source
d.pub.network/ Frame
0
0
Preflight
General
Full URL
https://d.pub.network/demand-source
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET,PUT,POST,PATCH,DELETE,HEAD,OPTIONS
access-control-allow-origin
https://reason.com
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers Accept-Encoding, User-Agent
via
1.1 google
view
securepubads.g.doubleclick.net/pcs/ Frame B4CD
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvsyO4sHjioSpiDntsycFZx8Vw-xvbKBXn-ycIVI8VEKaV5qF9KG9t51tMjWg-MqWy7JO9X8zgLDT9ffqCWo46uqOzcwtL-FvaZPwNPha-7bDDY5PdPG7iX66MaOpjwPJeibqb6DlPxA4mZ6WcWZBflKmrivAR4yHnimXz_5eFkybazBcuf5YpMHj8ZjFxlLb1FEeUUUNb67ZSe2WnXKxLQi8JorEaV7rYkM6leE8HjPj7XJQWHCwHBFYFPhBGOROFF2uxgSM4xwSUHzx4ZfPxceRJi4fmlkq-kjJbijRjbCltYJnr_3qmPY4IFypmJPc12ETWduvDyOheaFgHwQcxgohxRUl6-nQV3hehovqC-ety_nM_T5_XP1QBSN33kuiUN7cSB_Zaq3FqUgd6YQYLMvz87RgrmpbmTXFUjnkK7Oa4b&sai=AMfl-YQA8YVosXL8OOZXwMuXoniFbPGhNYhAsw5U7NFrBQK05GOjtH1w3a9wtSpf7yV3oHuky6Qc3KBZNGADGXxcxTR-WlxRTATt_bWe_LBjMyjHSP9UIjYPmfNbrmaZ5w4&sig=Cg0ArKJSzNSyO49xsyyCEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame B4CD
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
19f42a18089748ac647b5eff403355d68a46c3ee54a5cf91862a161c1b6a0977
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51387
x-xss-protection
0
server
cafe
etag
5886431712284547468
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:16 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame B4CD
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:16 GMT
demand-source
d.pub.network/
54 B
222 B
Fetch
General
Full URL
https://d.pub.network/demand-source
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
60ec558d6470335ab06b3c33c1c13a0d6b24cf0b9f66c29d4d91f6693a23155b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding, User-Agent
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
demand-source
d.pub.network/
54 B
231 B
Fetch
General
Full URL
https://d.pub.network/demand-source
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
60ec558d6470335ab06b3c33c1c13a0d6b24cf0b9f66c29d4d91f6693a23155b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding, User-Agent
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
PugMaster
image6.pubmatic.com/AdServer/ Frame 5A24
5 KB
6 KB
Script
General
Full URL
https://image6.pubmatic.com/AdServer/PugMaster?sec=1&async=1&kdntuid=1&rnd=45251367&p=137711&s=137812&a=0&ptask=ALL&np=0&fp=0&rp=0&mpc=0&spug=1&coppa=0&gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.81 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e34c7675a37ba5467437aac2e4f8b851d732f12d972f47718dbbc5bff8d911f4

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
text/html; charset=UTF-8
date
Tue, 13 Feb 2024 19:05:14 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
log
qsearch-a.akamaihd.net/
35 B
296 B
Image
General
Full URL
https://qsearch-a.akamaihd.net/log?logid=kfk&evtid=projectevents&project=prebid&acid=bf179d46-c551-41b0-b9c7-bf209822b2e8&cid=&crid=315461417&adunit_count=1&dn=reason.com&requrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&istop=true&event=client_timeout&value=1&rd=506
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.215.0.12 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-215-0-12.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:16 GMT
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Content-Length
35
Expires
Tue, 13 Feb 2024 19:05:16 GMT
usync.js
eus.rubiconproject.com/ Frame CE88
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:16 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39689
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
usync.js
eus.rubiconproject.com/ Frame 1DFF
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?p=rise_engage&endpoint=us-east
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:16 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39689
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
c
c.pub.network/v2/ Frame
0
0
Preflight
General
Full URL
https://c.pub.network/v2/c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://reason.com
access-control-max-age
1800
allow
GET, HEAD, POST, PUT, DELETE, TRACE, OPTIONS, PATCH
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
via
1.1 google
c
c.pub.network/v2/
36 B
54 B
Fetch
General
Full URL
https://c.pub.network/v2/c
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
bde433056dc7524e1e94944f59ed149f0d1b874dee650009a4c24367294a6554
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36
setuid
s2s.t13.io/
Redirect Chain
  • https://ads.yieldmo.com/pbsync?gdpr=&gdpr_consent=&us_privacy=1---&redirectUri=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dyieldmo%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_si...
  • https://s2s.t13.io/setuid?bidder=yieldmo&gpp=&gpp_sid=&f=i&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=&gdpr_consent=&us_privacy=1---
86 B
116 B
Image
General
Full URL
https://s2s.t13.io/setuid?bidder=yieldmo&gpp=&gpp_sid=&f=i&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=&gdpr_consent=&us_privacy=1---
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
c2ecff291918a3caf0b7e470323e89f2a1f05b92e12a10649e598cacebe62acf
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
content-type
image/png
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
accept-ch
Sec-CH-UA,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Model,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json;charset=utf-8
location
https://s2s.t13.io/setuid?bidder=yieldmo&gpp=&gpp_sid=&f=i&uid=V_ZrZhhNNrh6QBoKLRmb&gdpr=&gdpr_consent=&us_privacy=1---
access-control-allow-origin
*
access-control-allow-headers
Cache-Control, Pragma, *
content-length
0
v1
lb.eu-1-id5-sync.com/lb/
33 B
270 B
Fetch
General
Full URL
https://lb.eu-1-id5-sync.com/lb/v1
Requested by
Host: cdn.id5-sync.com
URL: https://cdn.id5-sync.com/api/1.0/id5-api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
141.95.98.64 , France, ASN16276 (OVH, FR),
Reverse DNS
ns3216658.ip-141-95-98.eu
Software
/
Resource Hash
4c0f3b0182ea833cbdf35e58a311f1b362fd0af61ec49be889355ed36e0b36a9
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/ Frame 97A3
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
48970a4713a380b4e5ce33aa0fadbc1ef64452afca3414f1fe6419bade29701f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141164
x-xss-protection
0
server
cafe
etag
17197434769451015849
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:16 GMT
zrt_lookup_fy2021.html
googleads.g.doubleclick.net/pagead/html/r20240208/r20190131/ Frame 14DB
9 KB
5 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/html/r20240208/r20190131/zrt_lookup_fy2021.html
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9ba2c2b2479cc7044e4af1a0123ec24531e8ad57aa91d4d5655405a148271589
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
51342
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=1209600
content-encoding
br
content-length
4209
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 04:49:34 GMT
etag
3890843268177463596
expires
Tue, 27 Feb 2024 04:49:34 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
pubcid.min.js
secure.cdn.fastclick.net/js/pubcid/latest/ Frame C770
54 KB
17 KB
Script
General
Full URL
https://secure.cdn.fastclick.net/js/pubcid/latest/pubcid.min.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.4.232.54 Piscataway, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-4-232-54.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
43f804d38a294c6df1ce8ee64fb95ad0ff5a8d6d5685d9537df02212668a1dff

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
last-modified
Mon, 23 Jan 2023 19:40:17 GMT
server
Apache
x-serial
1
x-check-cacheable
YES
etag
"d734-5f2f3919e751f-gzip"
vary
Accept-Encoding
x-akamai-pragma-client-ip
10.44.130.72, 4.7.166.99
content-type
application/javascript
cache-control
max-age=900
accept-ranges
bytes
content-length
17407
expires
Tue, 13 Feb 2024 19:20:16 GMT
id5-api.js
cdn.id5-sync.com/api/1.0/ Frame C770
88 KB
26 KB
Script
General
Full URL
https://cdn.id5-sync.com/api/1.0/id5-api.js
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:3556 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4cd07edee68cd765a7cdde6fefbd032242acc261496048c610c9d2b401ef105b
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=15552000; includeSubDomains; preload
content-encoding
gzip
cf-cache-status
HIT
last-modified
Fri, 09 Feb 2024 09:41:43 GMT
server
cloudflare
x-amz-request-id
XYNGXPG3EZ9N41TJ
age
2166
etag
W/"5f1afea320c5039c2b1fe5fdbc5608a7"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
cache-control
public, max-age=3600
cf-ray
854f578568084bbd-BUF
x-amz-id-2
PayfWhDvN4HbsQOdZqVJWZAU4L6sESYljrPglnh779xiuo7vBPIwehhI8XLqKfuE0NkJqPIwsfU=
log
qsearch-a.akamaihd.net/
35 B
296 B
Image
General
Full URL
https://qsearch-a.akamaihd.net/log?logid=kfk&evtid=projectevents&project=prebid&acid=45025a01-b97e-4a8f-9401-e83fa9cbe7cc&cid=&crid=315461417&adunit_count=1&dn=reason.com&requrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&istop=true&event=client_timeout&value=1&rd=506
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.215.0.12 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-215-0-12.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:16 GMT
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Content-Length
35
Expires
Tue, 13 Feb 2024 19:05:16 GMT
demand-source
d.pub.network/ Frame
0
0
Preflight
General
Full URL
https://d.pub.network/demand-source
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET,PUT,POST,PATCH,DELETE,HEAD,OPTIONS
access-control-allow-origin
https://reason.com
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers Accept-Encoding, User-Agent
via
1.1 google
demand-source
d.pub.network/ Frame
0
0
Preflight
General
Full URL
https://d.pub.network/demand-source
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET,PUT,POST,PATCH,DELETE,HEAD,OPTIONS
access-control-allow-origin
https://reason.com
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers Accept-Encoding, User-Agent
via
1.1 google
view
securepubads.g.doubleclick.net/pcs/ Frame A079
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsugosiiKsFkfKKt2wDDnVQqyAUprtcHZEwbU87Oda11KIyjtgIfTUqZdBrrmSdih4MialRpCDpmgCIcrFam82kQM-vH0XQ_MOvp1itf--q50sCAsRPde5eYk9BCJ2p8wlDN66jkrRGuXhemhmknLWju8VWD5HcQtAymtN5XeAMtr7uQyKO9oF9Ow9bYJ1Y5tzg3rtraeyQ5QbtqcQfTBP4yDD4uFYAB6dlIfL5FMG0A8Uj2FgMQTpj52bT_J2ifUuTPkLZgpVwxdtJJPUtCH6AuoIM8f39ZBToI9rsqeDIjlaq7QGd9sHTNcUZoeLSgqMZOaQLQIRNqkkBKsFxrYW6VjjSO_De3ScRtCzH5pQyNRI2TTt3fL_jp&sai=AMfl-YS4i8geK1Myg9zpWRVsxPGAF4MEt1imP-IfMLvyUpfTYrhzVR6NL5eKGGef0WEttnddfn5g7mz3HXhvRv8riHVvfV9l5y9jBjj9bICzPYzAKg8_47IYMYNd3fXOWP4&sig=Cg0ArKJSzFwHuBsL-beWEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame A079
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e692cc976de0d0034057fade483f6258e8fc8ced0d9e4773ca877beea433b65c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51384
x-xss-protection
0
server
cafe
etag
14160984469376824406
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:16 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame A079
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:16 GMT
demand-source
d.pub.network/
54 B
90 B
Fetch
General
Full URL
https://d.pub.network/demand-source
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
60ec558d6470335ab06b3c33c1c13a0d6b24cf0b9f66c29d4d91f6693a23155b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding, User-Agent
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
demand-source
d.pub.network/
54 B
91 B
Fetch
General
Full URL
https://d.pub.network/demand-source
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
60ec558d6470335ab06b3c33c1c13a0d6b24cf0b9f66c29d4d91f6693a23155b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding, User-Agent
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
ping
pagead2.googlesyndication.com/pagead/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/ping?e=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

khaos.json
token.rubiconproject.com/ Frame E846
7 B
777 B
XHR
General
Full URL
https://token.rubiconproject.com/khaos.json?gdpr=0
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
a1dd48c657971696c2087f2a6beb489ee65b25320b763222f10718dd93e9149e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://eus.rubiconproject.com
Cache-Control
no-cache,no-store,must-revalidate
access-control-allow-credentials
true
content-length
7
X-RPHost
f84b118a3f01dd6ffa744f6af941f4e8
Expires
0
log
qsearch-a.akamaihd.net/
35 B
296 B
Image
General
Full URL
https://qsearch-a.akamaihd.net/log?logid=kfk&evtid=projectevents&project=prebid&acid=992939e6-1905-4d81-bf1d-193114b03468&cid=&crid=315461417&adunit_count=1&dn=reason.com&requrl=https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/&istop=true&event=client_timeout&value=1&rd=506
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.215.0.12 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-215-0-12.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:16 GMT
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Content-Length
35
Expires
Tue, 13 Feb 2024 19:05:16 GMT
ads
securepubads.g.doubleclick.net/gampad/
27 KB
12 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=4478923843320192&correlator=2244843761936104&eid=44809527%2C31080777%2C31080782%2C31081149&output=ldjh&gdfp_req=1&vrg=202402070101&ptt=17&impl=fifs&gdpr=0&us_privacy=1---&iu_parts=15184186%3A1006247%2Creason_leaderboard_inconent&enc_prev_ius=%2F0%2F1&prev_iu_szs=728x90%7C300x250&ifi=9&sfv=1-0-40&eri=1&sc=1&cookie=ID%3Db92f00de18e375f9%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MYg9SGiL40fmGbdiW0n3xUy_IswPg&gpic=UID%3D00000a0d70fcf8cf%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbdM7W4xIKnx4pr5Sm85bLMimVoqg&abxe=1&dt=1707851116450&lmt=1707847436&adxs=239&adys=5871&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=6&ucis=9&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&vis=1&psz=767x250&msz=767x250&fws=4&ohw=1600&psts=AOrYGsmqMtGovMSWG_Sh4uCOfUnc4c1iMdwq6XyDnE_7JLWzSXDGs8eSU8HOTeeiwNyjlVM0CalJsXW1Uu53Ot4%2CAOrYGskpLIx8pg7K47NYU3Ec9FTTSic2zLZgbW53ZZJUAF9mriWRNFanuYr8NyzcJbVXEP2MWait_hsfYBEibUM%2CAOrYGslk73sdIoKMu6tc1P-z09dlcjIy1i7d2L_7HFsaI1GMYonbRMy8lLRKDTJvYESqwMItLAvSkFVtMEWjxVc&ga_vid=415251147.1707851114&ga_sid=1707851115&ga_hid=618980501&ga_fc=true&ga_cid=1991233376.1707851114&a3p=EhsKDGlkNS1zeW5jLmNvbRjO1u-e2jFIAFICCGoSGgoNY3J3ZGNudHJsLm5ldBIAGPnU757aMUgAEj4KBW9wZW54EixleUpwSWpvaWNqVTFRMGhhVkVwVFoybFpSVWRJSzNOUmMxazVVVDA5SW4wPRio1u-e2jFIAA..&dlt=1707851112189&idt=2231&prev_scp=fsrefresh%3D0%26fsrebid%3D0%26fs_uuid%3D77acfad6-cd78-4d31-bc84-afcda6960100%26floors_id%3D73f45c%26floors_hour%3D19%26fs_placementName%3Dreason_leaderboard_inconent%26fs_ad_product%3Dbanner%26amznbid%3D2%26amznp%3D2%26fsbid%3D0&cust_params=fs_session_id%3D12109ede-e2d2-43f1-a563-783f22c5058e%26fs_pageview_id%3Dca72c2bc8a1ddc80b22eb67ba7f10fff%26fsitf%3DYYYYYYYYYY-Y----------------------------%26user-agent%3DChrome%26testGroup%3Dfdb500daf1dc11ef085938ddb39ba30e%26fs_iiq_enabled%3Dtrue%26floors_user%3D1%26floors_rtt%3D26%26fs_clientservermask%3D221132222132333131112%26fs_testgroup%3Doptimised&adks=677307366&frm=20
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
67bd911769d40df185163fd8deeed30a0298f49b939f414ea910bcaea0c2ffc6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11856
x-xss-protection
0
google-lineitem-id
6360649097
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138442217780
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://reason.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
demand-source
d.pub.network/ Frame
0
0
Preflight
General
Full URL
https://d.pub.network/demand-source
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET,PUT,POST,PATCH,DELETE,HEAD,OPTIONS
access-control-allow-origin
https://reason.com
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers Accept-Encoding, User-Agent
via
1.1 google
demand-source
d.pub.network/ Frame
0
0
Preflight
General
Full URL
https://d.pub.network/demand-source
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET,PUT,POST,PATCH,DELETE,HEAD,OPTIONS
access-control-allow-origin
https://reason.com
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers Accept-Encoding, User-Agent
via
1.1 google
view
securepubads.g.doubleclick.net/pcs/ Frame F142
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssd1Zj4dUr1132i87jynMm_9-Ltm7ecDSOotsDlOS_PX5cRSxkNTfZBch9DauqDW5BySufT6uJGId9HMXojbXmVcwZ5x2oh4ysTvy-cETMdETckEt-KVTHF-VwQiB9P1dBhrbl8zinPhgrlaIzaQAcVSHekZWn6CYeiCMN1SmNB_OvK-bvIkn_8twBIftBm7eFjwxqtL0AlHrLjYK-cdwrJ84cUx-TrIsTelhnAgNxxB-Hz3iMUIdw6iZddvs1od9gAj85mmuOUsO2k-9XtK2ru6-VR_gGIPmYKRdbi2eapFW2QXJ3l5MNPLT2hpX0aMh5Lg2hbtLSoD8kBMSaIubeRnBtgKx_wINieSoQxqLhnjwU4uq41uaTY&sai=AMfl-YTslyGxWSBDx4AVo7o90eoa1Qo1IRTteu5bX0AxYFiV1OBy5rFIXW8sGRfNqjrGghfZgg9nf2uQ1j-V1kUBMxRkaBDwfWWrR2Zhj7W4ePaaudjwHur93y9VuyXzOw&sig=Cg0ArKJSzLWF3Aa3VFIiEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame F142
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e93c18c53ba080982efb5202d0e0b31e99331717d838c89a032f94591277e4a1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51391
x-xss-protection
0
server
cafe
etag
15716830247259885889
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:16 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame F142
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:16 GMT
demand-source
d.pub.network/
54 B
91 B
Fetch
General
Full URL
https://d.pub.network/demand-source
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
60ec558d6470335ab06b3c33c1c13a0d6b24cf0b9f66c29d4d91f6693a23155b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding, User-Agent
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
demand-source
d.pub.network/
54 B
91 B
Fetch
General
Full URL
https://d.pub.network/demand-source
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/pubfig/5.36.10/pubfig.engine.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
60ec558d6470335ab06b3c33c1c13a0d6b24cf0b9f66c29d4d91f6693a23155b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding, User-Agent
content-type
application/json
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
usermatch
ssum-sec.casalemedia.com/ Frame 9408
2 KB
1 KB
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5aa9d7741b47eb0f627bb12af87dadbba41d500aedfb65574ed2d805ef9c9dd7

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
cf-cache-status
DYNAMIC
cf-ray
854f57863a9c39f0-YYZ
content-encoding
br
content-type
text/html
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
0
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
pragma
no-cache
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=I5eFytyi4QOuqvmJBvhZMDIKeWq38RP7QMxwPZQp5bZyBiStDVS%2Bwp8RWZm6rPe2CvOE7W%2B7bkgB68aoYq58POvWMwphDdtPyviEw%2F3VlNhQVsW4K2m1JTcYFpohlGNW0oCjMjuOpEvHbg%3D%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
iu3
s.amazon-adsystem.com/ Frame 6572
324 B
1 KB
Document
General
Full URL
https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-inmobi_n-nativo
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c706de5577d82253ec2a45191cb10abbf67c4b20c6869abb7ce2a79be4d05107
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
324
Content-Type
text/html;charset=ISO-8859-1
Date
Tue, 13 Feb 2024 19:05:16 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
x-amz-rid
X0R010VBFCKM55VHXHAE
LVEN46HQ.html
tpc.googlesyndication.com/sodar/ Frame AB6F
23 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/LVEN46HQ.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/xdEizrWJ.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
2d510de3a1d076b47340cc5f84fa93285645cb07919480ff0fc6c2cb3cc10ade
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
59707
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
8534
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 02:30:09 GMT
expires
Wed, 12 Feb 2025 02:30:09 GMT
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
truncated
/ Frame B4CD
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
c7e7400f129530103962f5c9937031d657949de83f018571ebc057c187b0c99a

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
ecm3
s.amazon-adsystem.com/ Frame E846
Redirect Chain
  • https://pixel-us-east.rubiconproject.com/exchange/sync.php?p=a9us&gdpr=0&gdpr=0&khaos=LSKQGI85-W-KKFE
  • https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:16 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
MEY4MXVYX7FVRM9FM2XA
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
207bf73b93f199ba0825203b77fa46ae
Expires
0
c
c.pub.network/v2/ Frame
0
0
Preflight
General
Full URL
https://c.pub.network/v2/c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://reason.com
access-control-max-age
1800
allow
GET, HEAD, POST, PUT, DELETE, TRACE, OPTIONS, PATCH
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
via
1.1 google
c
c.pub.network/v2/
36 B
54 B
Fetch
General
Full URL
https://c.pub.network/v2/c
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
bde433056dc7524e1e94944f59ed149f0d1b874dee650009a4c24367294a6554
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/ Frame B4CD
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31081006
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
5c2d55759b380d42990cc574147081e833e55b6f7f965b9353c4186e9721440e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141171
x-xss-protection
0
server
cafe
etag
8517075726745582207
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:16 GMT
dcm
s.amazon-adsystem.com/ Frame E734
43 B
855 B
Document
General
Full URL
https://s.amazon-adsystem.com/dcm?pid=3b882453-6770-4785-baf8-a598533c054a&id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&redir=true&gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:16 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
x-amz-rid
8B5F1PXTNP849CH331GA
Pug
simage2.pubmatic.com/AdServer/ Frame 23C2
Redirect Chain
  • https://ib.adnxs.com/getuid?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTc4JnRsPTE1NzY4MDA=&piggybackCookie=$UID&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTc4JnRsPTE1NzY4MDA=&piggybackCookie=5872803529851156248&gdpr=0&gdpr_consent=
42 B
218 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTc4JnRsPTE1NzY4MDA=&piggybackCookie=5872803529851156248&gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
access-control-allow-credentials
true
access-control-allow-origin
*
an-x-request-uuid
a6ae7b1f-cb28-4e75-be96-530bee9b2c47
cache-control
no-store, no-cache, private
content-length
0
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Sat, 15 Nov 2008 16:00:00 GMT
location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTc4JnRsPTE1NzY4MDA=&piggybackCookie=5872803529851156248&gdpr=0&gdpr_consent=
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
pragma
no-cache
server
nginx/1.23.4
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
x-xss-protection
0
Pug
simage2.pubmatic.com/AdServer/ Frame AB60
Redirect Chain
  • https://cm.adgrx.com/bridge?AG_PID=pubmatic&AG_SETCOOKIE&gdpr=0&gdpr_consent=
  • https://cm.adgrx.com/bridge.gif?AG_PID=pubmatic&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDEmdGw9MTI5NjAw&piggybackCookie=d2f37c96-caa2-11ee-a313-71f04e140079
42 B
243 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDEmdGw9MTI5NjAw&piggybackCookie=d2f37c96-caa2-11ee-a313-71f04e140079
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate, proxy-revalidate
content-length
0
content-type
image/gif
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Thu, 23 Sep 2004 17:42:04 GMT
location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDEmdGw9MTI5NjAw&piggybackCookie=d2f37c96-caa2-11ee-a313-71f04e140079
p3p
CP="NOI OTC OTP OUR NOR"
pragma
no-cache
server
Cowboy
Pug
image2.pubmatic.com/AdServer/ Frame 8DA1
Redirect Chain
  • https://match.prod.bidr.io/cookie-sync/pm?gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=beeswaxio&google_sc=&google_hm=QUFDSi1VN0xsM3NBQUJKYU5DMDdOdw&gdpr=0&gdpr_consent=&bee_sync_partners=syn%2Cpp%2Csas%2Cpm&bee_sync_current_partner=adx&b...
  • https://match.prod.bidr.io/cookie-sync/adx?gdpr=0&gdpr_consent=&bee_sync_partners=syn%2Cpp%2Csas%2Cpm&bee_sync_current_partner=adx&bee_sync_initiator=pm&bee_sync_hop_count=1
  • https://sync.technoratimedia.com/services?uid=AACJ-U7Ll3sAABJaNC07Nw&srv=cs&pid=73&cb=https%3A%2F%2Fmatch.prod.bidr.io%2Fcookie-sync%3Fgdpr%3D0%26bee_sync_partners%3Dpp%252Csas%252Cpm%26bee_sync_cu...
  • https://match.prod.bidr.io/cookie-sync?gdpr=0&bee_sync_partners=pp%2Csas%2Cpm&bee_sync_current_partner=syn&bee_sync_initiator=adx&bee_sync_hop_count=2
  • https://bh.contextweb.com/bh/rtset?ev=AACJ-U7Ll3sAABJaNC07Nw&do=add&pid=558502&rurl=https%3A%2F%2Fmatch.prod.bidr.io%2Fcookie-sync%3Fgdpr%3D0%26bee_sync_partners%3Dsas%252Cpm%26bee_sync_current_par...
  • https://match.prod.bidr.io/cookie-sync?gdpr=0&bee_sync_partners=sas%2Cpm&bee_sync_current_partner=pp&bee_sync_initiator=adx&bee_sync_hop_count=3&ev=AACJ-U7Ll3sAABJaNC07Nw&pid=558502&do=add&gdpr=0
  • https://rtb-csync.smartadserver.com/redir?partneruserid=AACJ-U7Ll3sAABJaNC07Nw&partnerid=127&redirurl=https%3A%2F%2Fmatch.prod.bidr.io%2Fcookie-sync%3Fgdpr%3D0%26gdpr%3D0%26bee_sync_partners%3Dpm%2...
  • https://match.prod.bidr.io/cookie-sync?gdpr=0&gdpr=0&bee_sync_partners=pm&bee_sync_current_partner=sas&bee_sync_initiator=adx&bee_sync_hop_count=4&userid=5722876075152800063&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyOTcmdGw9MTI5NjAw&piggybackCookie=AACJ-U7Ll3sAABJaNC07Nw&gdpr=0&gdpr_consent=
42 B
199 B
Document
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyOTcmdGw9MTI5NjAw&piggybackCookie=AACJ-U7Ll3sAABJaNC07Nw&gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Connection
keep-alive
Content-Length
0
Date
Tue, 13 Feb 2024 19:05:17 GMT
Server
gunicorn
location
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyOTcmdGw9MTI5NjAw&piggybackCookie=AACJ-U7Ll3sAABJaNC07Nw&gdpr=0&gdpr_consent=
strict-transport-security
max-age=2592000; includeSubDomains
141
match.deepintent.com/usersync/ Frame 814F
0
339 B
Document
General
Full URL
https://match.deepintent.com/usersync/141?gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
38.91.45.7 Ashburn, United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
Software
b /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

content-length
0
content-type
image/gif
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
policyref='http://cdn.deepintent.com/p3p.xml', CP='NON CUR DEV TAI'
server
b
b9pj45k4
sync-tm.everesttech.net/upi/pid/ Frame 7857
85 B
250 B
Document
General
Full URL
https://sync-tm.everesttech.net/upi/pid/b9pj45k4?redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjE5MSZ0bD0yNTkyMDA=&piggybackCookie=${TM_USER_ID}&gdpr=1&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.194.49 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
Jetty(9.4.35.v20201120) /
Resource Hash
acccc501aa6afa3cfac15e8ddccf1561deed2ed08c2f7d652abbdbe9aa71609a

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
access-control-allow-origin
*
cache-control
no-cache
content-length
85
content-type
image/png
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW PSAo PSDo IVAo IVDo OUR BUS UNI DEM"
pragma
no-cache
server
Jetty(9.4.35.v20201120)
via
1.1 varnish
x-cache
MISS
x-cache-hits
0
x-served-by
cache-yyz4546-YYZ
x-timer
S1707851117.637619,VS0,VE20
Pug
simage2.pubmatic.com/AdServer/ Frame 4651
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=pubmatic&gdpr=0&gdpr_consent=&us_privacy=
  • https://r.bidswitch.net/sync?bidswitch_ssp_id=pubmatic&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3205&partner_device_id=d9962442-c73f-42a4-adbd-3d9517e387ff&partner_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D393%26user_id%3D0%26ssp%...
  • https://dpm.demdex.net/ibs:dpid=540&dpuuid=2af5462b-1213-435d-a332-7e55bb465ba1&redir=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DADB%26partner_device_id%3D%24%7BDD_UUID%7D...
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=540&dpuuid=2af5462b-1213-435d-a332-7e55bb465ba1&redir=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DADB%26partner_device...
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=ADB&partner_device_id=11122778653877386402836073635137320709&pt=2af5462b-1213-435d-a332-7e55bb465ba1%2Chttps%253A%252F%252Fx.bidswitch.net%252Fs...
  • https://x.bidswitch.net/sync?dsp_id=393&user_id=0&ssp=pubmatic&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9Mjk0NSZ0bD0xMjk2MDA=&piggybackCookie=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&gdpr_pd=&us_privacy=
1 B
166 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9Mjk0NSZ0bD0xMjk2MDA=&piggybackCookie=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&gdpr_pd=&us_privacy=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
36a9e7f1c95b82ffb99743e0c5c4ce95d83c9a430aac59f84ef3cbfab6145068

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
1
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:17 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Length
0
Date
Tue, 13 Feb 2024 19:05:17 GMT
Location
//simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9Mjk0NSZ0bD0xMjk2MDA=&piggybackCookie=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&gdpr_pd=&us_privacy=
Server
nginx
Pug
simage2.pubmatic.com/AdServer/ Frame 5637
Redirect Chain
  • https://pm.w55c.net/ping_match.gif?ei=PUBMATIC&rurl=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzQmdGw9MTI5NjAw&piggybackCookie=uid:_wfivefivec_&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzQmdGw9MTI5NjAw&piggybackCookie=uid:MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent=
42 B
299 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzQmdGw9MTI5NjAw&piggybackCookie=uid:MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Cache-Control
no-cache, must-revalidate
Connection
keep-alive
Content-Length
0
Date
Tue, 13 Feb 2024 19:05:16 GMT
Expires
Fri, 01 Jan 1990 00:00:00 GMT
Location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzQmdGw9MTI5NjAw&piggybackCookie=uid:MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent=
Pragma
no-cache
Server
PingMatch/v2.0.30-801-g0076fb7#rel-ec2-master i-0797b3ebd69e86a8c@us-east-1d@dxedge-app-us-east-1-prod-asg
Strict-Transport-Security
max-age=2592000; includeSubDomains
Pug
image2.pubmatic.com/AdServer/ Frame 1514
Redirect Chain
  • https://cms.quantserve.com/pixel/p-5aWVS_roA1dVM.gif?idmatch=0&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?gdpr=0&vcode=bz0yJnR5cGU9MSZjb2RlPTExMTMmdGw9NDMyMDA=&piggybackCookie=kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-
42 B
438 B
Document
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?gdpr=0&vcode=bz0yJnR5cGU9MSZjb2RlPTExMTMmdGw9NDMyMDA=&piggybackCookie=kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 06:45:57 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

access-control-allow-credentials
true
access-control-allow-origin
*
cache-control
private, no-cache, no-store, proxy-revalidate
content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Fri, 04 Aug 1978 12:00:00 GMT
location
https://image2.pubmatic.com/AdServer/Pug?gdpr=0&vcode=bz0yJnR5cGU9MSZjb2RlPTExMTMmdGw9NDMyMDA=&piggybackCookie=kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAo PSDo OUR SAMa IND COM NAV"
pragma
no-cache
strict-transport-security
max-age=86400
pbmtc.gif
beacon.lynx.cognitivlabs.com/ Frame 7CCC
Redirect Chain
  • https://beacon.lynx.cognitivlabs.com/pbmtc.gif?redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0xJnR5cGU9MSZjb2RlPTM0MzkmdGw9MTI5NjAw&piggybackCookie=$UID
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0xJnR5cGU9MSZjb2RlPTM0MzkmdGw9MTI5NjAw&piggybackCookie=55c46681-ecaa-427d-a807-174744d3e8c6&r=https://beacon.lynx.cognitivlabs.com/pbmtc.gif?puid=$...
  • https://beacon.lynx.cognitivlabs.com/pbmtc.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
42 B
493 B
Document
General
Full URL
https://beacon.lynx.cognitivlabs.com/pbmtc.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.215.133.183 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-215-133-183.compute-1.amazonaws.com
Software
Kestrel /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Connection
keep-alive
Content-Length
42
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:16 GMT
Server
Kestrel

Redirect headers

cache-control
no-store, no-cache, private
date
Tue, 13 Feb 2024 19:05:16 GMT
location
https://beacon.lynx.cognitivlabs.com/pbmtc.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx
Pug
image2.pubmatic.com/AdServer/ Frame AE6E
Redirect Chain
  • https://p.rfihub.com/cm?pub=224&in=1&getuid=https%3A//image2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTI3MzkmdGw9MTI5NjAw%26piggybackCookie%3D%24UID%26gdpr%3D0%26gdpr_consent%3D
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI3MzkmdGw9MTI5NjAw&piggybackCookie=970314649043819140
42 B
194 B
Document
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI3MzkmdGw9MTI5NjAw&piggybackCookie=970314649043819140
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Content-Length
0
Date
Tue, 13 Feb 2024 19:05:16 GMT
Location
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI3MzkmdGw9MTI5NjAw&piggybackCookie=970314649043819140
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Server
Jetty(9.4.51.v20230217)
usersync.aspx
dis.criteo.com/dis/ Frame FE8C
43 B
362 B
Document
General
Full URL
https://dis.criteo.com/dis/usersync.aspx?r=3&p=4&cp=pubmaticUS&cu=1&&gdpr=0&gdpr_consent=&url=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTE5MjgmdGw9NDMyMDA=&piggybackCookie=uid:@@CRITEO_USERID@@
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.150 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-cache
content-type
image/gif
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Tue, 13 Feb 2024 00:00:00 GMT
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
pragma
no-cache
server
Kestrel
server-processing-duration-in-ticks
363310
strict-transport-security
max-age=31536000; preload;
x-errorlevel
0
i.match
s.tribalfusion.com/z/ Frame 5222
Redirect Chain
  • https://a.tribalfusion.com/i.match?p=b11&redirect=https%3A//simage2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMzMjYmdGw9MTI5NjAw%26piggybackCookie%3D%24TF_USER_ID_ENC%24&u=${PUBMATI...
  • https://s.tribalfusion.com/z/i.match?p=b11&redirect=https%3A//simage2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMzMjYmdGw9MTI5NjAw%26piggybackCookie%3D%24TF_USER_ID_ENC%24&u=${PUBMA...
43 B
431 B
Document
General
Full URL
https://s.tribalfusion.com/z/i.match?p=b11&redirect=https%3A//simage2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMzMjYmdGw9MTI5NjAw%26piggybackCookie%3D%24TF_USER_ID_ENC%24&u=${PUBMATIC_UID}
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:18ad , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4f49e616d278a16d9cd55a6d5fe19c99ebd37d7d3848d14422190618b67011e0

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache private
cf-cache-status
DYNAMIC
cf-ray
854f57882f614bd3-BUF
content-length
43
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Thu, 01 Jan 1970 00:00:00 GMT
p3p
CP="NOI DEVo TAIa OUR BUS"
pragma
no-cache
server
cloudflare
x-function
302

Redirect headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache private
cf-cache-status
DYNAMIC
cf-ray
854f57877ee84bd3-BUF
content-type
text/html
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Thu, 01 Jan 1970 00:00:00 GMT
location
https://s.tribalfusion.com/z/i.match?p=b11&redirect=https%3A//simage2.pubmatic.com/AdServer/Pug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMzMjYmdGw9MTI5NjAw%26piggybackCookie%3D%24TF_USER_ID_ENC%24&u=${PUBMATIC_UID}
p3p
CP="NOI DEVo TAIa OUR BUS"
pragma
no-cache
server
cloudflare
x-function
206
x-reuse-index
10392
Pug
simage2.pubmatic.com/AdServer/ Frame 3953
Redirect Chain
  • https://sync.srv.stackadapt.com/sync?nid=11&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MzEmdGw9MTI5NjAw&piggybackCookie=SPs6ha90UKJ-2DermTJBdGAJ-Sw&gdpr=0&gdpr_consent=
42 B
297 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MzEmdGw9MTI5NjAw&piggybackCookie=SPs6ha90UKJ-2DermTJBdGAJ-Sw&gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Connection
keep-alive
Content-Length
188
Content-Type
text/html; charset=utf-8
Date
Tue, 13 Feb 2024 19:05:16 GMT
Location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MzEmdGw9MTI5NjAw&piggybackCookie=SPs6ha90UKJ-2DermTJBdGAJ-Sw&gdpr=0&gdpr_consent=
pubmatic
ad.mrtnsvr.com/sync/ Frame C0E0
0
0

Pug
simage2.pubmatic.com/AdServer/ Frame 691B
Redirect Chain
  • https://csync.loopme.me/?pubid=11331&redirect=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MzImdGw9MTI5NjAw&piggybackCookie={viewer_token}
  • https://simage2.pubmatic.com/AdServer/Pug?vcode&piggybackCookie={viewer_token}
0
74 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode&piggybackCookie={viewer_token}
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-encoding
gzip
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

content-length
0
date
Tue, 13 Feb 2024 19:05:16 GMT
location
https://simage2.pubmatic.com/AdServer/Pug?vcode&piggybackCookie={viewer_token}
server
_
Pug
simage2.pubmatic.com/AdServer/ Frame 1E53
Redirect Chain
  • https://ums.acuityplatform.com/tum?umid=6
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI5NDcmdGw9MTI5NjAw&piggybackCookie=888838742219
42 B
208 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI5NDcmdGw9MTI5NjAw&piggybackCookie=888838742219
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Access-Control-Allow-Origin
*
Content-Length
0
Location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI5NDcmdGw9MTI5NjAw&piggybackCookie=888838742219
Pug
simage2.pubmatic.com/AdServer/ Frame 78F8
Redirect Chain
  • https://sync.mathtag.com/sync/img?mt_exid=3&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fsimage2.pubmatic.com%2FAdServer%2FPug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTM2MiZ0bD0xMjk2MDA%3D%3D%26piggybackCookie%...
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM2MiZ0bD0xMjk2MDA==&piggybackCookie=uid:a90b65cb-bd6c-4100-b778-a2ca30279172&gdpr=0&gdpr_consent=
42 B
209 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM2MiZ0bD0xMjk2MDA==&piggybackCookie=uid:a90b65cb-bd6c-4100-b778-a2ca30279172&gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Content-Length
0
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:16 GMT
Expires
Tue, 13 Feb 2024 19:05:15 GMT
Keep-Alive
timeout=360
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Server
MT3 1487 7fd7a36 master ord ord-pixel-x48 config_version:"1290"
location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM2MiZ0bD0xMjk2MDA==&piggybackCookie=uid:a90b65cb-bd6c-4100-b778-a2ca30279172&gdpr=0&gdpr_consent=
Pug
image2.pubmatic.com/AdServer/ Frame B393
Redirect Chain
  • https://t.adx.opera.com/pub/sync?pubid=pub8730968190912
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0ODkmdGw9NDMyMDA=&piggybackCookie=OPUab1645795b4b463ba93cb19748df0468
42 B
282 B
Document
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0ODkmdGw9NDMyMDA=&piggybackCookie=OPUab1645795b4b463ba93cb19748df0468
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:15 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, accept, origin, Cache-Control, X-Requested-With
access-control-allow-methods
POST, GET
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
content-length
166
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
location
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0ODkmdGw9NDMyMDA=&piggybackCookie=OPUab1645795b4b463ba93cb19748df0468
pragma
no-cache
server
Tengine
merge
ce.lijit.com/ Frame 5CA1
43 B
2 KB
Document
General
Full URL
https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
content-length
43
content-type
image/gif
date
Tue, 13 Feb 2024 19:05:16 GMT
expires
Fri, 20 Mar 2009 00:00:00 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame 5A24
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=qJA777-5Q66LtbWmi5uuIA%3D%3D&gdpr=0&gdpr_consent=
  • https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156578&predirect=&gdpr=0&gdpr_consent=
16 KB
16 KB
Image
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156578&predirect=&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
23.221.241.11 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-221-241-11.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
last-modified
Tue, 13 Feb 2024 04:57:54 GMT
server
Apache
vary
Accept-Encoding
content-type
text/html
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
cache-control
max-age=122052
accept-ranges
bytes
content-length
5685
expires
Thu, 15 Feb 2024 04:59:28 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156578&predirect=&gdpr=0&gdpr_consent=
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
301
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
receive
pixel.tapad.com/idsync/ex/ Frame 5A24
Redirect Chain
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3371&partner_device_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
  • https://secure.adnxs.com/getuid?https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DAPPNEXUS%26partner_device_id%3D%24UID%26pt%3D2af5462b-1213-435d-a332-7e55bb465ba1%252C%252C
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=5872803529851156248&pt=2af5462b-1213-435d-a332-7e55bb465ba1%2C%2C
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=5872803529851156248&pt=2af5462b-1213-435d-a332-7e55bb465ba1%2C%2C
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
an-x-request-uuid
2c4a58b1-b927-49ef-8269-956abb927700
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=5872803529851156248&pt=2af5462b-1213-435d-a332-7e55bb465ba1%2C%2C
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
FZt5psomz79DGe~O1V5PkX7S8-NVJIdw0INR-k~Duu9c36GyIDyElf4y8fa2~-9InNSq4BCadyu-8tQSiIkaVleT~Yh8GI4ocNSeo4~API4DJEsYNIMg2sPMMXvjcckTUFy53ZYw3gzv35jSAchydRkSr2XFgqe-kzzlKTlv1VT7-TlAc0PcX7nFzbKlHypwbpU3A...
us01.z.antigena.com/l/ Frame 5A24
0
0
Image
General
Full URL
https://us01.z.antigena.com/l/FZt5psomz79DGe~O1V5PkX7S8-NVJIdw0INR-k~Duu9c36GyIDyElf4y8fa2~-9InNSq4BCadyu-8tQSiIkaVleT~Yh8GI4ocNSeo4~API4DJEsYNIMg2sPMMXvjcckTUFy53ZYw3gzv35jSAchydRkSr2XFgqe-kzzlKTlv1VT7-TlAc0PcX7nFzbKlHypwbpU3AWUAJgUx%20A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&rnd=RND
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
40.76.134.238 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

xuid
eb2.3lift.com/ Frame 5A24
37 B
355 B
Image
General
Full URL
https://eb2.3lift.com/xuid?mid=7976&xuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&dongle=u6nf&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
Pug
image2.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://um.simpli.fi/pubmatic?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9ODA2JnRsPTUxODQwMA==&piggybackCookie=uid:$UID&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTgwNiZ0bD01MTg0MDA=&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67
42 B
401 B
Image
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTgwNiZ0bD01MTg0MDA=&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 06:29:21 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
42
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=63072000; includeSubdomains; preload
x-content-type-options
nosniff
server
openresty
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html
location
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTgwNiZ0bD01MTg0MDA=&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-headers
DNT,X-Mx-ReqToken,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type
content-length
142
expires
Mon, 12 Feb 2024 19:05:16 GMT
Pug
simage2.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=pubmatic&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NDkmdGw9MTI5NjAw&piggybackCookie=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
42 B
541 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NDkmdGw9MTI5NjAw&piggybackCookie=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
42
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NDkmdGw9MTI5NjAw&piggybackCookie=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:16 GMT
server
Kestrel
content-length
355
A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
pr-bh.ybp.yahoo.com/sync/pubmatic/ Frame 5A24
43 B
604 B
Image
General
Full URL
https://pr-bh.ybp.yahoo.com/sync/pubmatic/A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20?gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:4e9:5a02:d2ce:e24a:b8d2:5c54 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
ATS /
Resource Hash
48a33ca9f42b91902d57ad8ac52e1ce32b92c8c10c732f2dbb6fe960ebfd9438
Security Headers
Name Value
Content-Security-Policy sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
strict-origin-when-cross-origin
server
ATS
content-security-policy
sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-frame-options
DENY
content-type
image/gif
content-length
43
SPug
image4.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://ups.analytics.yahoo.com/ups/58292/sync?_origin=1&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&redir=true&gdpr=0&gdpr_consent=
  • https://image4.pubmatic.com/AdServer/SPug?partnerID=156078&xid=y-m_U4GpJE2uWhHITzlOl13IbOhrlg05M-~A&gdpr=0
0
260 B
Image
General
Full URL
https://image4.pubmatic.com/AdServer/SPug?partnerID=156078&xid=y-m_U4GpJE2uWhHITzlOl13IbOhrlg05M-~A&gdpr=0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
8.28.7.84 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

location
https://image4.pubmatic.com/AdServer/SPug?partnerID=156078&xid=y-m_U4GpJE2uWhHITzlOl13IbOhrlg05M-~A&gdpr=0
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
content-length
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
Pug
simage2.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://sync.ipredictive.com/d/sync/cookie/generic?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzI1MCZ0bD0xMjk2MDA=&piggybackCookie=${ADELPHIC_CUID}&gdpr=0&gdpr_cons...
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzI1MCZ0bD0xMjk2MDA=&piggybackCookie=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent=
1 B
236 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzI1MCZ0bD0xMjk2MDA=&piggybackCookie=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
1
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

Location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzI1MCZ0bD0xMjk2MDA=&piggybackCookie=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent=
Date
Tue, 13 Feb 2024 19:05:16 GMT
Connection
keep-alive
X-CI-RTID
8e79fd9e-e53e-43c6-aaa6-cbb62e18e1e3
Content-Length
205
Content-Type
text/html; charset=utf-8
Pug
simage2.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://pubmatic-match.dotomi.com/match/bounce/current?networkId=17100&version=1&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
  • https://pubmatic-match.dotomi.com/match/bounce/current?DotomiTest=7dc3561efe81152f&is_secure=true&networkId=17100&version=1&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AAAHlTqr6DHKpwNca_zeAAAAAAA&expiration=1707937516&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&...
42 B
296 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AAAHlTqr6DHKpwNca_zeAAAAAAA&expiration=1707937516&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&is_secure=true&gdpr_consent=&gdpr=0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
42
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
server
nginx
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP NID OUR STP"
location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AAAHlTqr6DHKpwNca_zeAAAAAAA&expiration=1707937516&nuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&is_secure=true&gdpr_consent=&gdpr=0
cache-control
no-cache, private, max-age=0, no-store
content-length
0
expires
0
Pug
simage2.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://ad.turn.com/r/cs?pid=1&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9ODImdGw9MTU3NjgwMCZkcF9pZD0yMg==&piggybackCookie=4374775086859810847&gdpr=0&gdpr_consent=&us_privacy=
1 B
220 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9ODImdGw9MTU3NjgwMCZkcF9pZD0yMg==&piggybackCookie=4374775086859810847&gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
1
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9ODImdGw9MTU3NjgwMCZkcF9pZD0yMg==&piggybackCookie=4374775086859810847&gdpr=0&gdpr_consent=&us_privacy=
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
content-length
0
p3p
policyref="/w3c/p3p.xml", CP="NOI CURa DEVa TAIa PSAa PSDa IVAa IVDa OUR IND UNI NAV"
sn.ashx
pmp.mxptint.net/ Frame 5A24
Redirect Chain
  • https://pmp.mxptint.net/sn.ashx?&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9Mjc0NCZ0bD0xNTc2ODAw&piggybackCookie=R33646_110D5AB97_665B6E9D&r=https://pmp.mxptint.net/sn.ashx?ak=1
  • https://pmp.mxptint.net/sn.ashx?ak=1
43 B
266 B
Image
General
Full URL
https://pmp.mxptint.net/sn.ashx?ak=1
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Server
38.98.69.175 North Bergen, United States, ASN174 (COGENT-174, US),
Reverse DNS
Software
/
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a
Security Headers
Name Value
Strict-Transport-Security max-age=-390855916; includeSubDomains

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Expires
-1
Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:15 GMT
Cache-Control
no-cache
Strict-Transport-Security
max-age=-390855916; includeSubDomains
Content-Length
43
Content-Type
image/gif

Redirect headers

location
https://pmp.mxptint.net/sn.ashx?ak=1
date
Tue, 13 Feb 2024 19:05:15 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
CookieSyncPubMatic&gdpr=0&gdpr_consent=
rtb.adentifi.com/ Frame 5A24
0
35 B
Image
General
Full URL
https://rtb.adentifi.com/CookieSyncPubMatic&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.226.119.24 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-226-119-24.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
Pug
image2.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=3&gdpr=0&gdpr_consent=
  • https://pixel-sync.sitescout.com/dmp/pixelSync?cookieQ=1&nid=3&gdpr=0&gdpr_consent=
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTE5NjkmdGw9MTI5NjAw&piggybackCookie=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
42 B
264 B
Image
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTE5NjkmdGw9MTI5NjAw&piggybackCookie=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
42
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
server
A
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
location
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTE5NjkmdGw9MTI5NjAw&piggybackCookie=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
cache-control
max-age=0,no-cache,no-store
content-length
0
expires
Tue, 11 Oct 1977 12:34:56 GMT
Pug
simage2.pubmatic.com/AdServer/ Frame 5A24
Redirect Chain
  • https://creativecdn.com/cm-notify?pi=pubmatic&gdpr=0&gdpr_consent=
  • https://creativecdn.com/cm-notify?pi=pubmatic&gdpr=0&gdpr_consent=&tc=1
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNTQmdGw9NDMyMDA%3D&piggybackCookie=TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k&pi=pubmatic&gdpr=0&gdpr_consent=&tc=1
42 B
430 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNTQmdGw9NDMyMDA%3D&piggybackCookie=TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k&pi=pubmatic&gdpr=0&gdpr_consent=&tc=1
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:17 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
42
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNTQmdGw9NDMyMDA%3D&piggybackCookie=TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k&pi=pubmatic&gdpr=0&gdpr_consent=&tc=1
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT, Tue, 13 Feb 2024 19:05:17 GMT
cache-control
no-cache, no-store, must-revalidate, private, max-age=0
content-length
0
vary
Accept-Encoding
expires
Thu, 01 Jan 1970 00:00:00 GMT
31327
i6.liadm.com/s/ Frame 9408
Redirect Chain
  • https://i.liadm.com/s/31327?bidder_id=14481&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpdr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=
  • https://i6.liadm.com/s/31327?gdpr_consent=&bidder_id=14481&gpp=&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpp_sid=&us_privacy=1---&gpdr=&us_privacy=1---
43 B
548 B
Image
General
Full URL
https://i6.liadm.com/s/31327?gdpr_consent=&bidder_id=14481&gpp=&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpp_sid=&us_privacy=1---&gpdr=&us_privacy=1---
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
HTTP/1.1
Server
2600:1f18:ed:550f:3fca:af0a:5a50:8555 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:16 GMT
Cache-Control
no-store
Strict-Transport-Security
max-age=31536000; includeSubDomains
Connection
keep-alive
Content-Length
43
Request-Time
1
Content-Type
image/gif

Redirect headers

Location
https://i6.liadm.com/s/31327?gdpr_consent=&bidder_id=14481&gpp=&bidder_uuid=Zcu9a9HM518AACyiADNVcgAA%261404&gpp_sid=&us_privacy=1---&gpdr=&us_privacy=1---
Date
Tue, 13 Feb 2024 19:05:16 GMT
Strict-Transport-Security
max-age=31536000; includeSubDomains
Connection
keep-alive
Content-Length
0
Request-Time
2
dcm
s.amazon-adsystem.com/ Frame 9408
43 B
855 B
Image
General
Full URL
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=1---&gdpr=&gdpr_consent=&id=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:16 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
6GE6819K58PSJ791EDJX
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
rum
dsum-sec.casalemedia.com/ Frame 9408
Redirect Chain
  • https://match.adsrvr.org/track/cmf/casale?us_privacy=1---
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=39&external_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&expiration=1710443116&gdpr=0&gdpr_consent=
43 B
737 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=39&external_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&expiration=1710443116&gdpr=0&gdpr_consent=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=MvWF2pFvy51H3KOHlvCxHY0gjkWF7%2F%2FWz4vm7UvRyUf%2BxElcg2IpAGRH8ZxfL1tHXznQ0s5%2BbPMaeskrb%2BYMsWCQ0F35OWFrrwTJzEnnqybSRWoymhxNSxAZH3PRdTk4mBy15SlolBxkvg%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f5787ad4039f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

location
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=39&external_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&expiration=1710443116&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:16 GMT
server
Kestrel
content-length
323
crum
dsum-sec.casalemedia.com/ Frame 9408
Redirect Chain
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&us_privacy=1---
  • https://cm.g.doubleclick.net/pixel?us_privacy=1---&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=Zcu9a9HM518AACyiADNVcgAA
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEIzuikneFPsSYGiAeQvRl8U&google_cver=1
43 B
740 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEIzuikneFPsSYGiAeQvRl8U&google_cver=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=AiiMWLRzX7CWsDhQPuY%2F6P1EPB%2BJpxEp9Xz4it%2F%2Bv45F%2FZiEFZWTYrrcsFsjVhtQmACywumZRP%2FXYaAg%2FCNHC0vnd4MU2aCiauVg2C8g5VWEqZRQeonDCGvQKE2coJ98evYoN0G1A5u%2FJg%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f5788efb439f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEIzuikneFPsSYGiAeQvRl8U&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
314
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixie
jelly.mdhv.io/v4/ Frame 9408
Redirect Chain
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1025&userId=Zcu9a9HM518AACyiADNVcgAABXwAAAAB&gdpr_consent=&us_privacy=1---&gdpr=&gpp=&gpp_sid=
  • https://pm.w55c.net/ping_match.gif?st=FREEWHEEL&rurl=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D593&userId=_wfivefivec_&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=593&userId=MxnNt1pn1RzY5K5&gdpr=0&gdpr_consent=
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=103&gdpr=0&gdpr_consent=
  • https://sync.crwdcntrl.net/qmap?c=1389&tp=STSC&tpid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=&d=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Fpush%3Fpartner_id%3D2499%...
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2499&partner_device_id=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&partner_url=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataPr...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=721&userId=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=stickyadstv&append=1&cb=3830516&redirect=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D690%26userId%3D&gdpr=0&gd...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=690&userId=92a46392-4333-4e17-bc0c-e23a20ef4332
  • https://sync.srv.stackadapt.com/sync?nid=169&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1362&userId=SPs6ha90UKJ-2DermTJBdGAJ-Sw
  • https://eb2.3lift.com/getuid?redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1580%26userId%3D$UID&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1580&userId=3900114537385664774839
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=${TM_USER_ID}&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=Zcu9awAEo_sMqwA9&gdpr=0&gdpr_consent=
  • https://ad.turn.com/r/cs?pid=34&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=4374775086859810847&redirectID=0&gdpr=0&gdpr_consent=
  • https://dsp.adfarm1.adition.com/cookie/?ssp=12&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=202&userId=7335164693981362326&gdpr=0&gdpr_consent=
  • https://jelly.mdhv.io/v4/pixie?gdpr=0&gdpr_consent=
0
0

Zcu9a9HM518AACyiADNVcgAABXwAAAAB
pr-bh.ybp.yahoo.com/sync/casale/ Frame 9408
43 B
604 B
Image
General
Full URL
https://pr-bh.ybp.yahoo.com/sync/casale/Zcu9a9HM518AACyiADNVcgAABXwAAAAB?gdpr_consent=&us_privacy=1---&gdpr=&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:4e9:5a02:d2ce:e24a:b8d2:5c54 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
ATS /
Resource Hash
48a33ca9f42b91902d57ad8ac52e1ce32b92c8c10c732f2dbb6fe960ebfd9438
Security Headers
Name Value
Content-Security-Policy sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
strict-origin-when-cross-origin
server
ATS
content-security-policy
sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-frame-options
DENY
content-type
image/gif
content-length
43
crum
dsum-sec.casalemedia.com/ Frame 9408
Redirect Chain
  • https://secure.adnxs.com/getuid?https://dsum-sec.casalemedia.com/crum?cm_dsp_id=46&external_user_id=$UID&us_privacy=1---
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=46&external_user_id=5872803529851156248&us_privacy=1---
43 B
739 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=46&external_user_id=5872803529851156248&us_privacy=1---
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=4L%2B5fE%2BaR5nXKqJVDz%2F4j3ocf5FissLXKBVIUvWaU0H595L2mXGQ%2BVpXgjWRoihubji1mYCNM56RrreF%2B9PzGo6aLhvqJFUW%2FPShnfrcfrw5zJPHgUP3kHvn7%2BZ77oBhxkOxS5ULlfzYAg%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
854f57889ed639f0-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
an-x-request-uuid
0f810701-2e8b-46e3-bd11-a718acfdc64b
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=46&external_user_id=5872803529851156248&us_privacy=1---
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
demconf.jpg
dpm.demdex.net/ Frame 9408
Redirect Chain
  • https://dpm.demdex.net/ibs:dpid=23728&dpuuid=Zcu9a9HM518AACyiADNVcgAA%261404?gdpr_consent=&us_privacy=1---&gdpr=&gpp=&gpp_sid=
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=23728&dpuuid=Zcu9a9HM518AACyiADNVcgAA%261404
42 B
716 B
Image
General
Full URL
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=23728&dpuuid=Zcu9a9HM518AACyiADNVcgAA%261404
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H2
Server
34.202.200.79 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-202-200-79.compute-1.amazonaws.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

dcs
dcs-prod-va6-2-v053-0bb9673f8.edge-va6.demdex.com 2 ms
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
x-tid
V7w2V9djTKQ=
content-type
image/gif
p3p
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
cache-control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
content-length
59
expires
Thu, 01 Jan 1970 00:00:00 UTC

Redirect headers

dcs
dcs-prod-va6-2-v053-00da4ca7e.edge-va6.demdex.com 0 ms
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000; includeSubDomains
x-tid
0MBruYKDQ88=
p3p
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
location
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=23728&dpuuid=Zcu9a9HM518AACyiADNVcgAA%261404
cache-control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 UTC
setuid
s2s.t13.io/ Frame 9408
0
15 B
Image
General
Full URL
https://s2s.t13.io/setuid?gpp=&gpp_sid=&bidder=ix&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=b&uid=Zcu9a9HM518AACyiADNVcgAA%261404
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?s=184674&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&cb=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dix%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 google
strict-transport-security
max-age=31536000
content-type
text/html
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
0
view
securepubads.g.doubleclick.net/pcs/ Frame B84B
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuy9gWAQerTCE5l15EMPQA5f4J_VmmBz13z5I0s-G-5McMF53lIB9HRr2yNbcr_bf6mg3PEyPuTwWSqQCS04Iu2wfWGg2F1veN3gLT_lCTtt3-PdB6JluhPeTYedUobiXcMWJgV_HRiUfIL2_nPAdALoHSMHgKDk8pD9eEq5sRbyYvMwAhq4URov5RX2HD0CgivtJUpUpOKEJZkajPatc96S_GR7vA97ZMcEbEfj6zdW2QWFirwpL-ecAo_qy8RVCuHc4mV2KNcqWpNtShemdS5kKkEXIBS9jBqhE9i9HqMJOl2cvIsMLZKT1Jbow6f0IJ03aZ1HpyEiIBQPOGeNXc6C0nWjIsFgIsJQJVKmbgsu61FFKz3zYBR3XHkZckS_XJkK6cvCzM&sai=AMfl-YQJiOG7uwk9uPy5MsxRnriGl6wzUnV_jX6uqTpEE55iqcVBU6jr68SgkCKHjB45nOvGZa5SCfhZR6DPScmU9PUcxHa3RqUyfNf6eDDLGbeXa863tyYRUUal3mQvrQ&sig=Cg0ArKJSzPZIpTFrVm7cEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame B84B
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7084d4e01e14f39a1b69b736fcacc4c29fac646c7568c389f2ea045d4398d0e0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51381
x-xss-protection
0
server
cafe
etag
3476705844286832445
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:16 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame B84B
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:16 GMT
khaos.json
token.rubiconproject.com/ Frame CE88
7 B
789 B
XHR
General
Full URL
https://token.rubiconproject.com/khaos.json?gdpr=0&us_privacy=1---&khaos=LSKQGI85-W-KKFE
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
a1dd48c657971696c2087f2a6beb489ee65b25320b763222f10718dd93e9149e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://eus.rubiconproject.com
Cache-Control
no-cache,no-store,must-revalidate
access-control-allow-credentials
true
content-length
7
X-RPHost
d67ad46d58ddbab9fb03c088eabaaff8
Expires
0
khaos.json
token.rubiconproject.com/ Frame 1DFF
7 B
789 B
XHR
General
Full URL
https://token.rubiconproject.com/khaos.json?gdpr=0&us_privacy=1---&khaos=LSKQGI85-W-KKFE
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
a1dd48c657971696c2087f2a6beb489ee65b25320b763222f10718dd93e9149e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://eus.rubiconproject.com
Cache-Control
no-cache,no-store,must-revalidate
access-control-allow-credentials
true
content-length
7
X-RPHost
382e2818ca015d35b02cd449aa60881d
Expires
0
truncated
/ Frame A079
209 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
3a3a3cc4d5fb47dbfe39cfd7b01b4f579e2c26141a5e3c5f8c9e5168287d32de

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
pr
s.amazon-adsystem.com/v3/ Frame 670A
2 KB
2 KB
Document
General
Full URL
https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-inmobi_n-nativo
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
bac7c28e4b3d85e8f8cc66984b2f6bee73c7e598dc93a369054bbdfdbe034b7b
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-inmobi_n-nativo
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
1929
Content-Type
text/html;charset=ISO-8859-1
Date
Tue, 13 Feb 2024 19:05:16 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
YP0CZJXDHPPB8XR29VS9
dcm
aax-eu.amazon-adsystem.com/s/ Frame E846
43 B
855 B
Image
General
Full URL
https://aax-eu.amazon-adsystem.com/s/dcm?pid=a38a8ddf-19a7-4ab8-ba05-0a61de92a7e5&id=&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.95.115.196 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:17 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
9YEZY2KRZ4E10X1PVK8J
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
ecm3
s.amazon-adsystem.com/ Frame E846
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=a9us&gdpr=0
  • https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:16 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
Q9WDNFQJ22WFJVDWT7B2
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://s.amazon-adsystem.com/ecm3?id=LSKQGI85-W-KKFE&ex=d-rubiconproject.com&status=ok&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
0228ab361cece0438ff9eb16e4e5890e
Expires
0
tap.php
pixel.rubiconproject.com/ Frame E846
Redirect Chain
  • https://match.adsrvr.org/track/cmf/rubicon?gdpr=0
  • https://pixel.rubiconproject.com/tap.php?v=8981&nid=2307&put=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=&expires=30
42 B
883 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=8981&nid=2307&put=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=&expires=30
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/gif
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
42
X-RPHost
78008fe701b681dce86a72fc23cacc40
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

location
https://pixel.rubiconproject.com/tap.php?v=8981&nid=2307&put=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=&expires=30
date
Tue, 13 Feb 2024 19:05:16 GMT
server
Kestrel
content-length
289
tap.php
pixel.rubiconproject.com/ Frame E846
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=rubicon&google_cm&google_sc&gdpr=0
  • https://pixel.rubiconproject.com/tap.php?v=7751&nid=2249&expires=30&gdpr=0&put=CAESEC2NABVnjlNl1VbE06YztXk&google_cver=1
42 B
883 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=7751&nid=2249&expires=30&gdpr=0&put=CAESEC2NABVnjlNl1VbE06YztXk&google_cver=1
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/gif
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
42
X-RPHost
0b388c490ecfef74be7d13328a4f3ac3
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://pixel.rubiconproject.com/tap.php?v=7751&nid=2249&expires=30&gdpr=0&put=CAESEC2NABVnjlNl1VbE06YztXk&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
337
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame E846
Redirect Chain
  • https://token.rubiconproject.com/token?pid=2249&pt=n&gdpr=0
  • https://cm.g.doubleclick.net/pixel?google_nid=rubicon&google_hm=YmQ3YWI2ZDIyNTgyZTUzMzA0NzAyOTk4Y2VmOGJjMTcwYWVmYTc0NQ&gdpr=0
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=rubicon&google_hm=YmQ3YWI2ZDIyNTgyZTUzMzA0NzAyOTk4Y2VmOGJjMTcwYWVmYTc0NQ&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://cm.g.doubleclick.net/pixel?google_nid=rubicon&google_hm=YmQ3YWI2ZDIyNTgyZTUzMzA0NzAyOTk4Y2VmOGJjMTcwYWVmYTc0NQ&gdpr=0
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
d3682eda7e5cb79782b1d5475f50e8fc
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
setuid
px.ads.linkedin.com/ Frame E846
Redirect Chain
  • https://token.rubiconproject.com/token?pid=36584&gdpr=0
  • https://px.ads.linkedin.com/setuid?partner=rubiconDb&dbredirect=true&ruxId=LSKQGI85-W-KKFE&gdpr=0
0
144 B
Image
General
Full URL
https://px.ads.linkedin.com/setuid?partner=rubiconDb&dbredirect=true&ruxId=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
x-li-pop
afd-prod-lva1-x
x-msedge-ref
Ref A: D0FDF1F9B4E0430CB5781077E65DA9C8 Ref B: EWR311000107037 Ref C: 2024-02-13T19:05:16Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-lva1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYRSBMnBzQifgDMNSkgDg==

Redirect headers

Location
https://px.ads.linkedin.com/setuid?partner=rubiconDb&dbredirect=true&ruxId=LSKQGI85-W-KKFE&gdpr=0
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
0228ab361cece0438ff9eb16e4e5890e
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
ecm3
s.amazon-adsystem.com/ Frame E846
Redirect Chain
  • https://s.amazon-adsystem.com/dcm?pid=50cd21b7-d8d7-4615-9fb9-a2be831f8488&id=&gdpr=0
  • https://pixel.rubiconproject.com/token?pid=2179&pt=n&puid=ZwkzgZmUT3Crle0yEe9BSw&rk=usync-na&gdpr=0
  • https://s.amazon-adsystem.com/ecm3?ex=rubiconprojectHMT&id=ZwkzgZmUT3Crle0yEe9BSw&gdpr=0
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=rubiconprojectHMT&id=ZwkzgZmUT3Crle0yEe9BSw&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:16 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
KGW61HP38NRJV4AF78PG
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Location
https://s.amazon-adsystem.com/ecm3?ex=rubiconprojectHMT&id=ZwkzgZmUT3Crle0yEe9BSw&gdpr=0
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
84e0f527cd81a00b0210e20b4ee7ed94
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
pixel
cm.g.doubleclick.net/ Frame E846
Redirect Chain
  • https://token.rubiconproject.com/token?pid=25470&gdpr=0
  • https://cm.g.doubleclick.net/pixel?google_nid=rp&google_cm&google_hm=TFNLUUdJODUtVy1LS0ZF&gdpr=0
  • https://pixel.rubiconproject.com/exchange/sync.php?p=dfp&gdpr=0&google_gid=CAESEKko_3wvGEPULh72awGDcIg&google_cver=1
  • https://cm.g.doubleclick.net/pixel?google_nid=rp&google_hm=TFNLUUdJODUtVy1LS0ZF&google_push=&gdpr=0
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=rp&google_hm=TFNLUUdJODUtVy1LS0ZF&google_push=&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://cm.g.doubleclick.net/pixel?google_nid=rp&google_hm=TFNLUUdJODUtVy1LS0ZF&google_push=&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
0190a17a18f2299b1b85aeb1793e601c
Expires
0
tap.php
pixel.rubiconproject.com/ Frame E846
Redirect Chain
  • https://token.rubiconproject.com/token?pid=2974&pt=n&a=1&gdpr=0
  • https://pr-bh.ybp.yahoo.com/sync/rubicon/Uj2djVWZ01WJWQkvJr-JcA?csrc=&gdpr=0
  • https://pixel.rubiconproject.com/tap.php?v=31950&nid=2974&put=y-rkS9sd1E2oILR8CSLfQIaEnrbiBe9cyewAKaIw--~A
42 B
883 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=31950&nid=2974&put=y-rkS9sd1E2oILR8CSLfQIaEnrbiBe9cyewAKaIw--~A
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/gif
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
42
X-RPHost
a0d1cefc91c6f8b22fd2adf3abe06a61
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
strict-origin-when-cross-origin
server
ATS
content-security-policy
sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-frame-options
DENY
location
https://pixel.rubiconproject.com/tap.php?v=31950&nid=2974&put=y-rkS9sd1E2oILR8CSLfQIaEnrbiBe9cyewAKaIw--~A
content-length
0
tap.php
pixel.rubiconproject.com/ Frame E846
Redirect Chain
  • https://match.prod.bidr.io/cookie-sync/rp?bee_sync_partners=rp&gdpr=0
  • https://pixel.rubiconproject.com/tap.php?v=183462&nid=4114&put=AACJ-U7Ll3sAABJaNC07Nw&expires=30&gdpr=0
42 B
883 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=183462&nid=4114&put=AACJ-U7Ll3sAABJaNC07Nw&expires=30&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/gif
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
42
X-RPHost
44e748b6247b033344ab4f6b8c0f8cbb
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

location
https://pixel.rubiconproject.com/tap.php?v=183462&nid=4114&put=AACJ-U7Ll3sAABJaNC07Nw&expires=30&gdpr=0
Date
Tue, 13 Feb 2024 19:05:16 GMT
strict-transport-security
max-age=2592000; includeSubDomains
Server
gunicorn
Connection
keep-alive
Content-Length
0
v1
match.sharethrough.com/sync/ Frame E846
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=18694&gdpr=0
  • https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
84e0f527cd81a00b0210e20b4ee7ed94
Expires
0
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame E846
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=primis&gdpr=0
  • https://live.primis.tech/live/liveCS.php?source=external&advId=100&advUuid=LSKQGI85-W-KKFE&gdpr=0
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
43 B
865 B
Image
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H3
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=86400
content-length
43
x-amz-cf-id
C9cWT_L2bDBmzZg0XklrupS63Mrv3GwNv0pmdZEAFea6Tv4q3W9RJw==
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:16 GMT
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-type
text/html; charset=utf-8
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
3nke3x7fYi5TohJpoMDu4CMUbWrbrJBc8HGBC1P35F_VWFrkOeZH-g==
tap.php
pixel.rubiconproject.com/ Frame E846
Redirect Chain
  • https://sync.ipredictive.com/d/sync/cookie/generic?https://pixel.rubiconproject.com/tap.php?v=17149&nid=2861&put=${ADELPHIC_CUID}&expires=30&gdpr=0
  • https://pixel.rubiconproject.com/tap.php?v=17149&nid=2861&put=92a46392-4333-4e17-bc0c-e23a20ef4332&expires=30&gdpr=0
42 B
883 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=17149&nid=2861&put=92a46392-4333-4e17-bc0c-e23a20ef4332&expires=30&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
HTTP/1.1
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/gif
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
42
X-RPHost
966e54b6201ecd300c4db0efc0f5781a
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

Location
https://pixel.rubiconproject.com/tap.php?v=17149&nid=2861&put=92a46392-4333-4e17-bc0c-e23a20ef4332&expires=30&gdpr=0
Date
Tue, 13 Feb 2024 19:05:16 GMT
Connection
keep-alive
X-CI-RTID
00e44693-d89a-4741-8120-43178f3bc7ec
Content-Length
155
Content-Type
text/html; charset=utf-8
setuid
ib.adnxs.com/prebid/ Frame E846
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=pbs-apn&gdpr=0
  • https://ib.adnxs.com/prebid/setuid?bidder=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/prebid/setuid?bidder=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
an-x-request-uuid
60735a02-308a-4ba4-b13a-44f4df392c77
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
image/gif
cache-control
no-store, no-cache, private
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
43
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://ib.adnxs.com/prebid/setuid?bidder=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
82a6cabd8b3f0d2d2ae6e86e2699f0ba
Expires
0
merge
ce.lijit.com/ Frame E846
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=sovrn&gdpr=0
  • https://ce.lijit.com/merge?pid=80&3pid=LSKQGI85-W-KKFE&gdpr=0
43 B
2 KB
Image
General
Full URL
https://ce.lijit.com/merge?pid=80&3pid=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H2
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
43
content-type
image/gif

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://ce.lijit.com/merge?pid=80&3pid=LSKQGI85-W-KKFE&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
d3682eda7e5cb79782b1d5475f50e8fc
Expires
0
receive
pixel.tapad.com/idsync/ex/ Frame E846
Redirect Chain
  • https://token.rubiconproject.com/token?pid=37556&a=1&gdpr=0
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3355&partner_device_id=LSKQGI85-W-KKFE&gdpr=0
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=3355&partner_device_id=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-mediagrid_n-index_rx_n-MediaNet_ox-db5_n-inmobi_n-smaato_n-sharethrough_n-onetag_pm-db5_n-simpli.fi_ym_rbd_ppt_n-vmg_n-baidu_n-nativo_an-db5_sovrn_n-Rise_3lift_n-Outbrain&fv=1.0&a=cm&cm3ppd=1&dmt=3&gdpr=0
Protocol
H3
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95

Redirect headers

Location
https://pixel.tapad.com/idsync/ex/receive?partner_id=3355&partner_device_id=LSKQGI85-W-KKFE&gdpr=0
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
19ea072139d67f7022c6e463249c998e
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
truncated
/ Frame F142
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d771d344dd8b6983d1c6f367a018b7c27c30d8626c2cbc98d8c3676ee54efb79

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/ Frame A079
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8fb28e5fdf04e76caad9d32dbae833aea23ed789105d17c8bce1c07fe1127a48
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:16 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141171
x-xss-protection
0
server
cafe
etag
13358091141336058060
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:16 GMT
cs
cs.yellowblue.io/ Frame CE88
Redirect Chain
  • https://pixel-us-east.rubiconproject.com/exchange/sync.php?p=rise_engage&gdpr_consent=undefined&gdpr=0&us_privacy=1---&khaos=LSKQGI85-W-KKFE
  • https://cs.yellowblue.io/cs?aid=11590&id=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
0
325 B
Image
General
Full URL
https://cs.yellowblue.io/cs?aid=11590&id=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
54.160.241.52 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-160-241-52.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
server
istio-envoy
access-control-allow-methods
POST, GET, OPTIONS, PUT, DELETE
content-type
application/javascript
access-control-allow-origin
https://eus.rubiconproject.com/
access-control-allow-credentials
true
x-envoy-upstream-service-time
0
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF,X-Requested-With
content-length
0

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://cs.yellowblue.io/cs?aid=11590&id=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
207bf73b93f199ba0825203b77fa46ae
Expires
0
view
securepubads.g.doubleclick.net/pcs/ Frame 97A3
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuXMwAKkRIXkBNdHovIpV_JztjUJ4oDryxajI6RNbtrS14OcLAdENvFHqMCMkzte0lqCT5H_EyiQLsFxZqc89Vl0X3AU53a2srNWXHbBGfXa0G14hRVF9hCM9u3Z35zWiug2O7sIOd-vgtxtVNS_IbLiVr97bQoSy0POpLHnCznQbH0OTNocNQGXisScKhJNWDebRPuXRMSk-QgBdKx3iwdAb63G5z81zPb-KsbJpL4VNYy7zOGrQxwyXrIbrW4Fn9c2HMDrK_sGifhlNM9AiI9YhKvTDX8T8G8bCO_pZH-NB4YobVr-BxAt-EsngqNAQTp-vJvjoMJ6tnn0TV4xwh1VFgwbKVqHdS2h5zwkAAxrYyUQF3yUy5tosTGookZLjRX&sai=AMfl-YTzHp9FaQsWP_AONVV9W8-g5r7Z45Z3GHp2m-CH41xE09E9SrdZhGekOGuz-KTeMjgRi1dSX0aQniIZwSOUY9XdC_Edcsio1on28jUrqf6UT3jIcP-V1Y83sViA3Pg1VK5qXxOkAHRFTDGQ3mZYp9I&sig=Cg0ArKJSzMwI0HqwIwmJEAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:17 GMT
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/ Frame F142
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
86521a91dfcac541d7b0bee1f02ce1cdc62e023b125f1a80dffea0500e42d0eb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141168
x-xss-protection
0
server
cafe
etag
1850510298946941607
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
ecm3
s.amazon-adsystem.com/ Frame 670A
Redirect Chain
  • https://s.ad.smaato.net/c/?adExInit=aps&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsmaato.com%26id%3D%24UID
  • https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:17 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
SKCJ5MTW73EVBJFS1NZC
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:04:57 GMT
via
1.1 90b7b9dc3aa8817f0cef3cfd45fb8916.cloudfront.net (CloudFront)
server
CloudFront
x-amz-cf-pop
YUL62-C2
age
20
x-cache
Hit from cloudfront
location
https://s.amazon-adsystem.com/ecm3?ex=smaato.com&id=25d9952e53
cache-control
no-cache, must-revalidate
content-length
0
x-amz-cf-id
C3KLFUyHgP5hYE5gobO_VKduKv3vGxE8sa71HQj4xpixzVSgxalXCg==
/
onetag-sys.com/match/ Frame 670A
0
197 B
Image
General
Full URL
https://onetag-sys.com/match/?int_id=113&callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Donetag.com%26id%3D%24%7BUSER_TOKEN%7D
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

strict-transport-security
max-age=15552000
cache-control
no-transform, no-cache
alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
ecm3
s.amazon-adsystem.com/ Frame 670A
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=amazon&redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Drhythmone.com%26id%3D%5BRX_UUID%5D
  • https://sync.mathtag.com/sync/img?mt_exid=74&redir=https%3A%2F%2Fsync.1rx.io%2Fusersync3%2Fmediamathtest%2F2069.5%2F%5BMM_UUID%5D%3Fzcc%3D0%26sspret%3D1&rndcb=5352123473
  • https://sync.1rx.io/usersync3/mediamathtest/2069.5/a90b65cb-bd6c-4100-b778-a2ca30279172?zcc=0&sspret=1
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3DRX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005%26ex%3Dr...
  • https://s.amazon-adsystem.com/ecm3?id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005&ex=rhythmone.com
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005&ex=rhythmone.com
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:17 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
XHKTWTEYJWVAZB0DPBA3
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

location
https://s.amazon-adsystem.com/ecm3?id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005&ex=rhythmone.com
date
Tue, 13 Feb 2024 19:05:17 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RXe2af2325e28b4fd4b66772f44cc57a3b005
content-type
text/html
ecm3
s.amazon-adsystem.com/ Frame 670A
Redirect Chain
  • https://jadserve.postrelease.com/suid/101959?ntv_r=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dnativo.com%26id%3DNTV_USER_ID
  • https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
HTTP/1.1
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:17 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
6VCNM02B65SDE3DVE20M
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
server
nginx
p3p
CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://s.amazon-adsystem.com/ecm3?ex=nativo.com&id=6362ade3-65b8-45a5-a76c-a7397ea46a5c
access-control-allow-origin
*
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
content-length
0
expires
Mon, 1 Jan 1990 12:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame C770
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?length=1172&loaderinit=673.2999992370605&nonreq=673.5&nonload=2150.7999992370605&palv=1.21.3&lid=1&id=pal_html5&c=3306962974462419&domain=reason.com
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
v3
id5-sync.com/gm/
693 B
1 KB
XHR
General
Full URL
https://id5-sync.com/gm/v3
Requested by
Host: cdn.id5-sync.com
URL: https://cdn.id5-sync.com/api/1.0/id5-api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
3b16c53aabb39a376280787d2feff6dd638e84f9cb6cdc2c5745b787cb782ff5
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
access-control-allow-credentials
true
p3p
CP="CAO PSA OUR"
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
view
securepubads.g.doubleclick.net/pcs/ Frame BDF5
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstCYg88UMPmKMJfKuWCempo5uf-aczth3ErWSXyHnXFFLIVYYgZ89CcwRreBLzr0ZGjoFPOolTVzULvC6xJ6fU_-PY6psLjEfFCqvXcQDMsFH7F5dJSQpZ25z4_84f_aI6VTvpc-n4ylBbvZ9h6rUaD9gQOyUd9ZvPWxzULuAatdPf4ezpWADZ-cr2kI7DxLNCOV43uhypepT6y4Thtu6MEWQlYQ7xiIQEGLYudlk8KqGKV5VrILg4slPY9xmDbV3xSMUDc6T8lKbMZ6VfEFQTmH-2jQpb8BSk-GcO54oBrSw62KuJcOLJ73d2vv0wvMPtSsaoUTRlJ-Tjf-K7N9gTbNs4a3j3rZzV2qrGq8pExAznR8nqDxc2L4bFDGa2xG4RqjyvYNYqUywgHQ5nAgRORFLOy-ho1EYWN&sai=AMfl-YSBoloZbBK7HYfxiKzD-quAg5gJ4XuGRMFTM-IwGAKiCC5hraz3axxX8RbZg_p7Hi7_X7ZiLp-QN_1Hp7g8HsYeyh0p8NeiCuQVdpP4qvARU_b6CjPQLawwP84RfGU&sig=Cg0ArKJSzM_xBydGkEKrEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame BDF5
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
69e88e1dec6c69bdd5c407c050261907194a892875167ddf846aeba1a02eb5a7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51380
x-xss-protection
0
server
cafe
etag
5571562408044253486
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:17 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame BDF5
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
ads
googleads.g.doubleclick.net/pagead/ Frame 18AA
75 KB
31 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
c8fd676127ff5dcc1ad276b107a5560d6bc40629f25582ca78043ed8e954bf26
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
31245
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame 97A3
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3e372f6a5cd2cea90124fc4db0c0b9a508c2d3fdb8463aaf5966b379ea1c83c4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12280
x-xss-protection
0
c
c.pub.network/v2/ Frame
0
0
Preflight
General
Full URL
https://c.pub.network/v2/c
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://reason.com
access-control-max-age
1800
allow
GET, HEAD, POST, PUT, DELETE, TRACE, OPTIONS, PATCH
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
via
1.1 google
c
c.pub.network/v2/
36 B
54 B
Fetch
General
Full URL
https://c.pub.network/v2/c
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
bde433056dc7524e1e94944f59ed149f0d1b874dee650009a4c24367294a6554
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame AB6F
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/LVEN46HQ.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127748
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
truncated
/ Frame B84B
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9f7bcd3db2d4f33b27b7f11497e42d7810f874a6f3f4bc4072933c9e03077a89

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
/
match.sharethrough.com/jwumXNuB/v1/ Frame 76B4
822 B
1006 B
Document
General
Full URL
https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D$UID
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
66ca02217b0dbbc50fe72b9cf028042d484b475102ff4dbc6b9c2928ce99fb11

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

content-length
822
date
Tue, 13 Feb 2024 19:05:17 GMT
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame 766C
16 KB
6 KB
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.221.241.11 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-221-241-11.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c861dd92be984fe498ece34c0f3c921861ac51bfee50323fcae21231abf7a82b

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=122051
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 13 Feb 2024 19:05:17 GMT
expires
Thu, 15 Feb 2024 04:59:28 GMT
last-modified
Tue, 13 Feb 2024 04:57:54 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
usync.html
eus.rubiconproject.com/ Frame 3E93
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:17 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding
visitormatch
bh.contextweb.com/ Frame FE86
455 B
1 KB
Document
General
Full URL
https://bh.contextweb.com/visitormatch?p=547259,530912,534301,548607,543793,561117&rurl=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fid%3D%25%25VGUID%25%25%26ex%3DPulsepoint
Requested by
Host: s.amazon-adsystem.com
URL: https://s.amazon-adsystem.com/v3/pr?exlist=n-smaato_n-sharethrough_n-onetag_pm-db5_rbd_ppt_rx_n-nativo&fv=1.0&a=cm&cm3ppd=1&dmt=3
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.131 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
2f966062c4b3c885f3ffc07dd1ec451fcfb01892cab5cb26755911ff89b70ca6
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
cache-control
private, max-age=0, no-cache, no-store
content-language
en-US
content-length
455
content-type
text/html;charset=iso-8859-1
cw-server
bh-deployment-8689cbd65d-p4vx2
expires
-1
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
server
Jetty(10.0.14)
strict-transport-security
max-age=15768000
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/ Frame B84B
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e7fd83963f0e9b5d273e8b24a7803b77a09829c6e02de1d6f00265dc7e67d130
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141164
x-xss-protection
0
server
cafe
etag
18347635963922932689
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 4BF9
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuBdDelexgf0yOjTJch3KoMXTRNqd55Jeq6Xlnbe0LJlLE5ym-jWz61mrSYZofjua6K_p0ErmWJzgEK7tZbGsWiSgKJFASmUcKJp4M238KzneOg9pg08j150Ef3CXthhtMn1tmMX85DS_EzwyvdIp9YS34GtZKelTCMnZUABY0DdBqhxaM5cFXw5zGE-g507GK8EbgKuTuz3K2OZH8jper0W14EbPCpmX2htOn4IQCa5gZhV-ZxAytU0FFMKKxPMcP0TPY2B2hWbak1ImA2W6T9ARhGsXrURdFqnLEXwhmselgOYtDP97_rDeO2JEmJfqe5Wvh0h1DUMDWUEcgneRpSlzPjtTfxT-V56giW64PFOb2kqSY8hBDGkrv3JCldaV18riotaOo&sai=AMfl-YT78Fal0CFav7_UJ5Qo0_W6Xpy6r2Bb4EJon9gsc4lIUFboTq6DaQYxOTT-Xq_LeinxztN9m_vI2ZYe21KjA8uYP881PPodyvCxJ90ksVKSX1m3Y8q1I3f1npKsTA&sig=Cg0ArKJSzNCpzY9mOQsWEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame 4BF9
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
d7f272ad94dafa4c9a08df3aa277014d2788fff8736d4c9ce8de2dd58a3b87dc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51388
x-xss-protection
0
server
cafe
etag
1765443585383186202
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:17 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame 4BF9
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
v1
lb.eu-1-id5-sync.com/lb/
33 B
269 B
Fetch
General
Full URL
https://lb.eu-1-id5-sync.com/lb/v1
Requested by
Host: cdn.id5-sync.com
URL: https://cdn.id5-sync.com/api/1.0/id5-api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
141.95.98.64 , France, ASN16276 (OVH, FR),
Reverse DNS
ns3216658.ip-141-95-98.eu
Software
/
Resource Hash
82206ccb53a9bba3a5e7bbb74e7bfa6ea61f0b42aa26b47bac4d0d7709e76d87
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
view
securepubads.g.doubleclick.net/pcs/ Frame B4CD
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvzWPQ7pBMmb_WBtjgfi-BoLIQBW7eQJi7p_7-JmThwx8OwNxupC6XE7o32oB0i9POaWxEAtpauDlLNeelvcJoGKzhhnN4xzwW_oPcll7Q_xZOgbcncvRmfjQgDa0VqL00fE5W6I5jbmToYzqtj_fIKB5_q_2UBL8dESKGucvxyD0gkyOfE1oeLDvffMwkLqTfYypy5h9CKqmIwgXVSUKFRmp1lAJwQz_79iHUiajuOzZL5YRgv7C-oEC8D5QdpsY_vW0nP9aTS6cFMJv6FKE8VEymjpfF3l7QYsqpGrstRcKYYdgWPJLqjEEfMJY-ZVSibcYZ32bRlYGNPd66AQwk-Bh76bo0RF15qNMKW54l16aQcgRshbhJDD1qrzkJD4D1CuxjrE6lgdlHcaRCi4NAEvZqRq5NeyV_3aKxUXyYi5WqrCAg&sai=AMfl-YSKoOm1-oThWJ-bWHVw5MHQ8ysnvgMcgepH5jmfdAxrIEvpRB1O6xjKGSjg66qyyfendxzNtYWzfppD9gkex3gu5o3g0OGZdB8ThA37mU9yWRkvVDBnDw5NQTDFAuQ&sig=Cg0ArKJSzF79Z_D1b34vEAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:17 GMT
sodar2.js
tpc.googlesyndication.com/sodar/ Frame 97A3
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:17 GMT
usync.js
eus.rubiconproject.com/ Frame 3E93
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?p=a9us&endpoint=us-east
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:17 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39688
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
ecm3
s.amazon-adsystem.com/ Frame 76B4
43 B
479 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=sharethrough.com&id=c4cec5b2-acca-415c-b738-7e079be8bf78
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D$UID
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:17 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
FWHFV3ZFCG17AH0XPNHM
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT
v1
match.sharethrough.com/sync/ Frame 76B4
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sharethrough&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D$UID
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

location
https://match.sharethrough.com/sync/v1?source_id=5b286190338513af73f09c28&source_user_id=29aab174-fe91-4ad7-aa56-1d4732cc27d2&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:17 GMT
server
Kestrel
content-length
323
v1
match.sharethrough.com/sync/ Frame 76B4
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=sharethrough_ob&gdpr=0&gdpr_consent=&google_hm=YzRjZWM1YjItYWNjYS00MTVjLWI3MzgtN2UwNzliZThiZjc4
  • https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D$UID
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://match.sharethrough.com/sync/v1?gdpr=0&gdpr_consent=
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
260
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
v1
match.sharethrough.com/sync/ Frame 76B4
Redirect Chain
  • https://image8.pubmatic.com/AdServer/ImgSync?p=156557&gdpr=0&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D156557%26pr%3Dhttps%253A%252F%252Fmatch.sharethrough.com%252F...
  • https://c1.adform.net/serving/cookie/match?party=14&redirect=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NzUmdGw9NDMyMDA=&piggybackCookie=[PLACE%20YOUR%20PIGGYBACK%20COO...
  • https://c1.adform.net/serving/cookie/match?CC=1&party=14&redirect=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NzUmdGw9NDMyMDA=&piggybackCookie=[PLACE%20YOUR%20PIGGYBACK%...
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTI4NzUmdGw9NDMyMDA=&gdpr=0&gdpr_consent=&piggybackCookie=1956285366857158953
  • https://image8.pubmatic.com/AdServer/ImgSync?gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://match.adsby.bidtheatre.com/pubmaticmatch?redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNjImdGw9MTI5NjAw&piggybackCookie=uid:$UID&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?gdpr_consent=&gdpr=0&piggybackCookie=uid:9e45b838-9dbe-4d4e-b7d7-9761fe94fd02&vcode=bz0yJnR5cGU9MSZjb2RlPTMwNjImdGw9MTI5NjAw
  • https://image8.pubmatic.com/AdServer/ImgSync?gdpr=0&gdpr_consent=&us_privacy=${US_PRIVACY}
  • https://image4.pubmatic.com/AdServer/SPug?gdpr=0&p=156557&pr=https%3A%2F%2Fmatch.sharethrough.com%2Fsync%2Fv1%3Fsource_id%3DuFFr5RFBYgoUJbWMAWGEZKS3%26source_user_id%3DA8903BEF-BFB9-43AE-8BB5-B5A68...
  • https://match.sharethrough.com/sync/v1?source_id=uFFr5RFBYgoUJbWMAWGEZKS3&source_user_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?source_id=uFFr5RFBYgoUJbWMAWGEZKS3&source_user_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D$UID
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

location
https://match.sharethrough.com/sync/v1?source_id=uFFr5RFBYgoUJbWMAWGEZKS3&source_user_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
v1
match.sharethrough.com/sync/ Frame 76B4
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=18694&gdpr=0&gdpr_consent=
  • https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
68 B
279 B
Image
General
Full URL
https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
Requested by
Host: match.sharethrough.com
URL: https://match.sharethrough.com/jwumXNuB/v1/?callback=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dsharethrough.com%26id%3D$UID
Protocol
H2
Server
23.23.57.217 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-23-23-57-217.compute-1.amazonaws.com
Software
/
Resource Hash
6019c3c9e47dc991f8d9937deafbb0740c2e61e321324798cb508773b0814824

Request headers

accept-language
en-US,en;q=0.9
Referer
https://match.sharethrough.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
cache-control
no-cache
content-length
68
content-type
image/png

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://match.sharethrough.com/sync/v1?source_id=UiRtTsXAfjmfSDAKnR1FjWsu&source_user_id=LSKQGI85-W-KKFE&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
0b388c490ecfef74be7d13328a4f3ac3
Expires
0
ads
googleads.g.doubleclick.net/pagead/ Frame F8F6
573 B
318 B
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189481&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116601&bpp=3&bdt=448&idt=609&shv=r20240208&mjsv=m202402060101&ptt=9&saldr=aa&cookie=ID%3D4e0f487d75def1f0%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MZukt05BTcjZAKcF-l0HAkucY8ADQ&gpic=UID%3D00000a0d711b7d8c%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MYegQCnliexSNnZXpuvbn-Ts8zKaA&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=1061511107&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=453&ady=2868&biw=1600&bih=1200&isw=300&ish=250&ifk=1980146966&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808398%2C31081034%2C44795921%2C95324580%2C31081006%2C95321963%2C95320868%2C95324154%2C95324161&oid=2&pvsid=895834258692043&tmod=1524724573&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.wfo5pgs8ytlv&btvi=1&fsb=1&dtd=828
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31081006
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
734cc21bb64d0c82e2ee7affc42fc378f7d90cab5bd781a491cb079485eb1209
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
297
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame B4CD
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31081006
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a788243884a83a3865ded07d09e080ddd0fa1d5f886b874c6ebee372fb14978f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12243
x-xss-protection
0
view
securepubads.g.doubleclick.net/pcs/ Frame E29D
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss0jOOkNcodhyDydQ1OpIhC4T6p2Uo4KzLZ_jYn3DWgd2ofrNaUKd_PQmWOlrwzVUz2SLKb9RJuegD4TvgRIOIH8pyr2A9G9XJj4dsRd41zTzoiFnX769PCyWsQO_aIgFVMqMN2mocuLwpSjETySz3B9NOrje0jfSgOaewdJxvk4yerhyr2bBkgXY2t0Mc6_GSVnwUEuld1RMq1OWqPJpoDAB2uboqbZy_uSBR5VdibznVm3dIjqCy9AuCY6zWb8TnCRoAHis3hfWIEXcbWEfbP5DvbCuv7PWVuLJjACtq826-AOMS8MBsI_7gasUKVjGZ_UFgmHIANB7h_HKkZZKEevWd_T4j7wbnNcl4L6GeoMcqWtUux6jEZx-DpOtlOlsafRIFxE3t1t9rM7yz-kFmH_G3IBK8__iyl&sai=AMfl-YTC3bnSx3fWH99oHi3lWw1xzPuiQsX7tfitpwerUI1MddfzS9hPvs2R3X2o7k7Fov_WVffCIfwIDB1cc_xNFXnvwPt8zA2ixFSakNgtoFEi3xKIVJ67N09-khOndg&sig=Cg0ArKJSzGkgwRRFSulZEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame E29D
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e25a452cfceb6ea92add11af978054e0d6b07759b65078599e23bb297268e2d0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51388
x-xss-protection
0
server
cafe
etag
12491652075478075777
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:17 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame E29D
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame A079
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstDkXDVBvTZ1tqAYgxUmlknRnuddqcBo2x1fG7Df7F2ZiioOYgpfu2ojynvJ_xjOQr4odPapaLrkWRJ-Oaq219zexuBhIULxg-rdgu-poTr2hPvYrL2gSKk8KeEhVxwHOJYCRHAdq3zSH4q18CkrjzXkGLuCEiHRdFe5eYWvpbAQ4smvPZt6k7nuB2Lrfmkyf5KaJ4Nv-lQQfw-4_pG46plLxsCEOEeWMxMMPyvuLiD4tHJs1_bXyBgd5Kf9GdM28zhXrnmUNVnj_c9I_XvUtJC7NeowrqGErVBL3EDMTgqaNnWGavNbd4KnBCBOOsoDaqvQHLgAd8vX7QR3aDQPKZzE_57lfdZjQUjZzbfZwKHTRKPpup6haKxBgQ&sai=AMfl-YR4IwRAPNX8JVl9Ev8LDIxK42kjE-gH80noCfFTwUTpVsTQdfhfhsLW6fvSQAVYJv_b57DKMU9h2gvJjq_dqRE4vvNpfCUHfoWe_N0Ub06dUzo_Q2npIiIO4s8_BNE&sig=Cg0ArKJSzOL1fkbr5mJTEAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:17 GMT
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/ Frame BDF5
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
48970a4713a380b4e5ce33aa0fadbc1ef64452afca3414f1fe6419bade29701f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141164
x-xss-protection
0
server
cafe
etag
17197434769451015849
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
style_banner_7c1ffe.css
cdn.mediago.io/js/template/style/ Frame 18AA
1 KB
2 KB
Stylesheet
General
Full URL
https://cdn.mediago.io/js/template/style/style_banner_7c1ffe.css
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.162.125.63 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-162-125-63.iad61.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
95a71d5d3a96dae0c55cc0605e2be8a85c9581c9587dbca9e8bf651f10223273

Request headers

Referer
https://googleads.g.doubleclick.net/
Origin
https://googleads.g.doubleclick.net
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

x-amz-version-id
o9RHzjEAkGNJpAB2HPZ7NgE.sZksZdsg
date
Tue, 13 Feb 2024 08:33:02 GMT
via
1.1 05f4e6c9553ff5b6620e13adbd08b064.cloudfront.net (CloudFront)
last-modified
Wed, 10 Jan 2024 07:10:45 GMT
server
AmazonS3
x-amz-cf-pop
IAD61-P3
age
37939
x-amz-server-side-encryption
AES256
etag
"4178d68db6bddb3e08fa56389e64eea6"
x-cache
Hit from cloudfront
content-type
text/css
access-control-allow-origin
*
accept-ranges
bytes
content-length
1408
x-amz-cf-id
U0ixjSO1217At9SNZLi5EqYdKxWl4NMO_THZuOto339AyUHyI6KN6g==
e7f00c86f8231f85ba6073885cd89a61__scv1__300x175.png
images.mediago.io/ML/ Frame 18AA
55 KB
55 KB
Image
General
Full URL
https://images.mediago.io/ML/e7f00c86f8231f85ba6073885cd89a61__scv1__300x175.png
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.111.60.239 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
239.60.111.34.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
878fd8811af97995e8973e0dc67b9645c6be9720063e5462e950c2f91829a94c

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:07:13 GMT
via
1.1 google
age
3484
x-guploader-uploadid
ABPtcPrnEG2OfkdhCuKNpo2O_paJRFVnvGeD1ZvuAFrk6FrHxJfkU-vKTz5Eg-j_LHVm2OTAKg
x-goog-storage-class
STANDARD
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
56003
last-modified
Thu, 25 Jan 2024 07:43:20 GMT
server
UploadServer
etag
"4675ff39b91c58e23ff813f2371de4a8"
x-goog-generation
1706168600894846
x-goog-hash
crc32c=19YbTQ==, md5=RnX/ObkcWOI/+BPyNx3kqA==
content-type
image/png
cache-control
public,max-age=3600
x-goog-stored-content-length
56003
accept-ranges
bytes
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame 18AA
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/window_focus_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 08:58:05 GMT
content-encoding
br
x-content-type-options
nosniff
age
36432
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 08:58:05 GMT
qs_click_protection_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame 18AA
20 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/qs_click_protection_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
245cec0922828c15b3709eb696bb5a565f2f911f71e242024570698701c9540c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 14:32:53 GMT
content-encoding
br
x-content-type-options
nosniff
age
16344
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8220
x-xss-protection
0
server
cafe
etag
16176141338659805634
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 14:32:53 GMT
l
www.google.com/ads/measurement/ Frame 18AA
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQCGDiWL-yL8OfqKgR0CjFw0wCgByoawP5Y2ptEGYDUoFlLXZhYItASBy1eIj70XNtNUJHexYt9Rg_WtyKr2ziASXfcGA
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame 18AA
203 KB
61 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
23d11567502488b4905a85c8ce6a03d6ce539620fa559b8f24a2a95b292a2c6a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:24:35 GMT
content-encoding
br
x-content-type-options
nosniff
age
2442
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
62553
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:24:35 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame F142
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssVcKrZvTaoHspTQ8hzGA8F2P6U1oDqmOoQzYeyPJYUSkN-hRjPPue0lvLIwQ92xmrumHViI462oWJisLiSLEFAWFXyCwGxzhzcxx9IVP8Z4HKP9hGNavLIUsB7Er9xp0BmwpW2xqy7m6cjMCPKgP6XDubnZHrBBHjqLcJZRoZws1nf701mavNi3gHIWuQWo_KOC6MAjFcNvO5VjLMR2iufNbx-kptf7gm78d69daAn5xK2ZsxWdoo5i9aZ9VZkG3dixb8SsD_PHy4CfVW145GVv1BTlpgfJdtHUwGoKf9vgLnNQyG1CZ3sPIf5py5Netmdy6oqBotYOUDjTCv5zBS31nvWYuaHRCOd3q0v2ITKxknf2ZvAs_x4RaE&sai=AMfl-YRVHR1bmH-qKaEV0XHmNURs_HfqknKu-J8pf2lbBDg0vtqZGQbGyLMkUEfZjFjZ0pj-hYsGVYmC-VodSP56csQKIbD9JXF6Dl5Dm4Z6TTnFdLQk4pVlMaIoCDGcJQ&sig=Cg0ArKJSzKy2whuCslIAEAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:17 GMT
c
c.pub.network/v2/
36 B
54 B
Fetch
General
Full URL
https://c.pub.network/v2/c
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
bde433056dc7524e1e94944f59ed149f0d1b874dee650009a4c24367294a6554
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36
c
c.pub.network/v2/ Frame
0
0
Preflight
General
Full URL
https://c.pub.network/v2/c
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://reason.com
access-control-max-age
1800
allow
GET, HEAD, POST, PUT, DELETE, TRACE, OPTIONS, PATCH
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
via
1.1 google
ads
googleads.g.doubleclick.net/pagead/ Frame F299
38 KB
16 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ece7fe92d62cc63e8697a984d18afab762b17d9c6746b1cb59bee4607ac93d6e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
16439
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame A079
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
5ee35a2a92bc0d42fb48af96cf60d4036ecc830365cb373472aac1984a0caac3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12379
x-xss-protection
0
sodar2.js
tpc.googlesyndication.com/sodar/ Frame B4CD
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31081006
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:17 GMT
setuid
s2s.t13.io/
Redirect Chain
  • https://ups.analytics.yahoo.com/ups/58827/sync?redir=true&gdpr=&gdpr_consent=&gpp=&gpp_sid=
  • https://s2s.t13.io/setuid?bidder=yahoossp&uid=y-Joo4XdBE2uKXv1FdoD6UcyyjsxTzmvc1~A
86 B
116 B
Image
General
Full URL
https://s2s.t13.io/setuid?bidder=yahoossp&uid=y-Joo4XdBE2uKXv1FdoD6UcyyjsxTzmvc1~A
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
c2ecff291918a3caf0b7e470323e89f2a1f05b92e12a10649e598cacebe62acf
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
content-type
image/png
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
0

Redirect headers

location
https://s2s.t13.io/setuid?bidder=yahoossp&uid=y-Joo4XdBE2uKXv1FdoD6UcyyjsxTzmvc1~A
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
content-length
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
ads
googleads.g.doubleclick.net/pagead/ Frame 9942
38 KB
16 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
d177f30e1a2dbff67d452a3a07a645d42aa52a2f3cb5be8e0c0ac7608ccdf5de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
16296
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame F142
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
b1c2d3d12649ed19e208e714c44feffc82e9fdd6c619b99f049ded0299a6062a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12305
x-xss-protection
0
view
securepubads.g.doubleclick.net/pcs/ Frame F5DB
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstv2wdfqQP1jVvFrE3HUgLXK8YS-RlxWHH0YTBkAaZ5NT1s5rhzD73cl2r__FFKCMGReJOUzZmznI4-X0XPwzS4LtLt4lf5VSualT-9uAnmfpFsLp1R1Zd46pTRZPpU5B06dCSYj2mHv96LFWW2gyw9a_XbpKqnTiCoMyGlluvs44HIipdRFxIGGtUub5j4YLOiGgx-CLLOh7h1_m52x351MsNgOEb6kxSMPtUhrSF4-1bIq-K4nLNpkGkOwoPt3paQMUMoO4JI3-7yGkwarT5e09k9ARrzURpYx4iH185WCvoxYwkFTdf3zvUHGrboLtqkz9WOHD7GhziMqGTCP6kh2FNIZ_fZqiD0nhXNazL6-8hJg2-SQmwPwKWxnfnSgUrxR4y4&sai=AMfl-YR21DfEkpnwE87IbFGmObyydwqkbQvLyznBEZisMDyVPyRDrOAEg9MaUWWJ072KdAEVzfIUvC8WXmUc7TuR_1uZlnfnFlqNEtTr4IS82Bo-S9feA_klydaxIopOGe4&sig=Cg0ArKJSzFC1vJvsBfAlEAE&uach_m=%5BUACH%5D&urlfix=1&adurl=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame F5DB
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
6bcaf2e37c43512cf2453e6c07e3d36ce1c168dc71ca8b7214cef3925eda91a7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51388
x-xss-protection
0
server
cafe
etag
1364385156149739437
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 13 Feb 2024 19:05:17 GMT
ufs_web_display.js
www.googletagservices.com/activeview/js/current/ Frame F5DB
205 KB
65 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402070101/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c06::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a89adcd85f7cfd505dc7b42270543241b2e39b7f87f8551012b736ef64bbef19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66416
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1707309907044448"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/ Frame 4BF9
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0ac9bb7914424e1160c180c17fa709ef63fc70f4a369966c6be5e7d444949b47
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141168
x-xss-protection
0
server
cafe
etag
2347942015784400726
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame C4D3
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176334
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame E3E8
829 B
558 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
55748132ac80b1cfbc6d23404696fdb9fe5995dba253754d865576f7e060428d
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-ebjQycTsFMdrCxzGA8_wgw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-ebjQycTsFMdrCxzGA8_wgw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
expires
Tue, 13 Feb 2024 19:05:17 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
v3
id5-sync.com/gm/
1 KB
2 KB
XHR
General
Full URL
https://id5-sync.com/gm/v3
Requested by
Host: cdn.id5-sync.com
URL: https://cdn.id5-sync.com/api/1.0/id5-api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
9d3d3bb082fdea2df4b637c1af6df0db9c2566b49f541ea0dc88a9fdc24c3565
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
access-control-allow-credentials
true
p3p
CP="CAO PSA OUR"
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
sodar2.js
tpc.googlesyndication.com/sodar/ Frame A079
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:17 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame B84B
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstyNcHquIlAV0wVml3y40SX8oAs20cfHqLClhV1dMEnU_dzNAJrZvDVJC3tdqMNQROchf0yN5zsAT8gJbZdv31MPGq3aw3U_NcLaLxkR-RbB4iMMvlN9hV4tn3WTgqxzVrCwMM2NuUpWc6U8ybPeIzJWvvQT-vPEof4nqAYBQ1dumpMgXpR0qMGTGUepEcJ04mYEi3qPPKdTR1xOSR7ClObmyPZ99T9C9Mc7ffchVYNIgavcaaUqUwKsP6t-Euy8P0iuAIbIIyZLHSgzv7WaXJbEL-xuzGd7bRx_WxrnIcLFRAolefActcHkJBHlzczvMb1DHanZ7Ef5cDrTnVA30P0koU7FsWdT1WFyFKMKU6wnRTscHCIgtlohtpiAYxwhYUNHlbdfqbA4Q&sai=AMfl-YQRsLGwZrAxFmjm346xmTLThl70KTPXWS77fYVIduaACBbtLOn7hdNacoYUYetjSGGTXMWKPH92Lj3m0BmBpHo4tvzsk9XgDHACCR4oyZypFSAjwFG5S3IMC1qH5g&sig=Cg0ArKJSzFUKSm9XOgGEEAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:17 GMT
sodar2.js
tpc.googlesyndication.com/sodar/ Frame F142
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:17 GMT
khaos.json
token.rubiconproject.com/ Frame 3E93
7 B
789 B
XHR
General
Full URL
https://token.rubiconproject.com/khaos.json?gdpr=0&us_privacy=1---&khaos=LSKQGI85-W-KKFE
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
a1dd48c657971696c2087f2a6beb489ee65b25320b763222f10718dd93e9149e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://eus.rubiconproject.com
Cache-Control
no-cache,no-store,must-revalidate
access-control-allow-credentials
true
content-length
7
X-RPHost
cdd55fb02049ca8b9389527f6c1a1194
Expires
0
usersync.html
cdn.undertone.com/js/ Frame DFC8
13 KB
4 KB
Document
General
Full URL
https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:5c00:1f:2473:9080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
07378cb9079fe865c12da0f27effd6163adae9ce1ef5e177a527e35b9f093b12

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
22482
content-encoding
gzip
content-type
text/html
date
Tue, 13 Feb 2024 12:50:36 GMT
etag
W/"c0ad5bceb34dc473809dd23603a31cec"
last-modified
Wed, 13 Dec 2023 14:37:07 GMT
server
AmazonS3
vary
Accept-Encoding
via
1.1 18b0fca4845f3542d7f0566683e26626.cloudfront.net (CloudFront)
x-amz-cf-id
HU7eIVsEht0mdgYlP6Y55lwb1CgX5o-R6VO1jiyENLnewF8zXJaU5A==
x-amz-cf-pop
YUL62-C2
x-amz-replication-status
COMPLETED
x-amz-server-side-encryption
AES256
x-amz-version-id
FpPUYNzys4ObbGRuHL8tOpxgUSayXD44
x-cache
Hit from cloudfront
ads
googleads.g.doubleclick.net/pagead/ Frame 8AC5
573 B
319 B
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=8019747248&adk=2858904547&adf=776189485&pi=t.ma~as.8019747248&w=300&lmt=1707851117&format=300x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117242&bpp=3&bdt=570&idt=424&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1073616266&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1044&ady=2142&biw=1600&bih=1200&isw=300&ish=600&ifk=4242991593&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44808397%2C31081034%2C31081153%2C44795922%2C95322748%2C95324580%2C95320869%2C95324154%2C95324161&oid=2&pvsid=1605499748962416&tmod=1249468064&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C600&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.m3lx0korkxnd&btvi=1&fsb=1&dtd=509
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
438d512119ed78d9bb854d4804170aedf3f07ae918baeb864d705e1f8434b732
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
298
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame B84B
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7892aa074a67a470387c304e767a698b97b208f2929abf74969f7e23828f23a7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12426
x-xss-protection
0
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/ Frame E29D
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31080971
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0e65d42fea4e06e6f23d06b96bf0dac7a23d48f6a8e994e1df30bededf5a52bf
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141172
x-xss-protection
0
server
cafe
etag
5202046715354382938
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:17 GMT
truncated
/ Frame 4BF9
215 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
60bb57c88b0f25c838bad9f9b59519be500d335f0a0aa9e06731572c26b09cec

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame B107
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176334
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame 7267
829 B
557 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
3a7f49363e49e7dfc67e3974fe3353d9a8951436921202388246945c66d0a0c7
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-tjS1DWitNcFoGuSaXvDGDg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-tjS1DWitNcFoGuSaXvDGDg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
expires
Tue, 13 Feb 2024 19:05:17 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
truncated
/ Frame E29D
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f6cf4c234998175e4a8c8efaddab3be067523ea9947ae0c7eb83835f035fc2f9

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
truncated
/ Frame F5DB
215 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
04ee8368f465da9e78efe2e1ae64ef1a30d1fee41a22611be44631d73e277fbf

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
cookieSync.html
cdn.mediago.io/js/ Frame BF66
21 KB
21 KB
Document
General
Full URL
https://cdn.mediago.io/js/cookieSync.html?tn=41b6e88a2b85b0e731ef8e73e5558712
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.162.125.63 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-162-125-63.iad61.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
ff17f0a5c2b621ce0625cfd2d947bf0eabf322c95a8e75a27f42d0722329ae9e

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
30249
content-length
21172
content-type
text/html
date
Tue, 13 Feb 2024 10:41:09 GMT
etag
"8dc2756f85fccea2e456061d06bdea5e"
last-modified
Thu, 11 Jan 2024 08:42:47 GMT
server
AmazonS3
vary
Origin
via
1.1 c49971ad4f76a00082eb4f604c635cba.cloudfront.net (CloudFront)
x-amz-cf-id
4lAg22dXHssnI95NVFwVjIZaQ5VJWhPoV_HmI96aq2w0TswRF2RKNw==
x-amz-cf-pop
IAD61-P3
x-amz-server-side-encryption
AES256
x-amz-version-id
EpRYFuQkhW0dw.Fy4ocZ5p9WkDxnjHRY
x-cache
Hit from cloudfront
ic
trace.mediago.io/ju/ Frame 18AA
0
57 B
Image
General
Full URL
https://trace.mediago.io/ju/ic?tn=41b6e88a2b85b0e731ef8e73e5558712&trackingid=7d4e1bd83603179086e59fb6e3a382df&acid=24677&data=WkGVxJzPGH0mPcJcs5cw7DQZ8I1q-aP3ZeNZ-slj9xIXWEyq5S1kRcnCzSdIzuMfPJE6c9kQa1FOYojjTMbVGE8xDCxK-syJLLLLDO8gFX9dwZYajISMbBDHjiA5PeIHujoS8Ofz1355ies3fi6DT3JaPHRNeRmZw9fgClFYCSPwsOIjQIa3pCiDnIO3Rmje3-eB-uroSYKC44dC9PBcjFAna8LqOgDciE7DZXDiC3mm-7N9DPL8SFMh_idmHR1gj_McJ7l96iqpr6nw7uSVMcmKZPaqPt0dEtlhCTD_sNz0XsdlkbSHymZOj759lhtBekDiY6dseffdPadiohG7bSqmTIeDd5cb2ucmuxyz-_cX06bxhMuU_2Bqhpoz-s97AI8UyP32xHEVv4gIZKQTf6y6KtnQ4lOw9ejQyr0IOIuh9GA_H1fQe83eGWbaslXM8JNN9okjKPevJCQgQdO2FQwOLG5TpnZjy_I8-waCfrbq5GvRDFIGREtnvRjdkwzsUC_qM187dfHEPs7LqCHwss0VdWbZ0ExtjStFllixE0qjTqgy50WWJEWJbcSB-736sbK8jGHhIg0EJrhclHd6vDnpxvk2RoypbCIqAkl3RcRoIPbo8JTdx4NJmdJoeHhyv1aFkAV8Fx89RozhRr_ta2ZYJMlUgsdsdN2GVJqrPHcHD9I6oZVkA5aUB4V9dRyTHi4FISE34Q9PmQiMrVeJsdRjUxKR9yP9CR8wu9JR2Ka3mTGA53aWvtsYku-fidv2YEGzR_rPExdvYZdOJRMtvE_5zBgvFyrOh5D8-2ijv9y9d4BeEhJw_eiNLMtUrKBZxNouiM_UX7bL2ezMyTjYyGo66RQ2_Yo1rbjLJlWzw7P0pS1hADP7MqOoBCl0I7l7v7sUpph8gAI5--WInMsk0OGnawGZlutP8KmTQurny_V2TOjfurcqeMEjHOq_cxtYmQJE1vyCKTEUF9bNmXaRra4wMceYIQKJ8D5uLNYwGqLe5-I-HOwQv_6AJhqzob_aIF52yrY9ICrMlFD2I4-EuZD07k1RoMXsXk9gTzhLbRsI4hEMfb4gfrw8CxCIIzfe-q4OiDmVjPdOZtVWepp9QAsYUCk6YR9rC1hg7lQrcy_vFKEMy4_-Xxnsy8ylwhR94gPmdI-yQrimyhBJW-qZQotmQ3zGY2O270c8rc6g0n9-_4ycFRX9gAdeD6AB5QFbTcBlcHKrjKw-B4WLoCWUiRhIVYbTOavoTfZpVOIJylyAE4Bdn6vrMif_1tZdKpSKZ-0fqYiMGGC1EOAALSoj-6S8Su58MWtHdZ7RCt__pBxQxofTEqoPO_B7LhX05OTQHJ8k6_SUgV-DnPEpZugw13OIySu_JS6BNUItlutbIJulXxNsUTxySQES7pZYM5IU&uid=CAESEHfZtabLPTaTx-wyzbcrnzU&mguid=&ap={AUCTION_PRICE}&tid=73
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.208.249.213 Council Bluffs, United States, ASN19527 (GOOGLE-2, US),
Reverse DNS
213.249.208.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-type
text/html; charset=utf-8
sodar2.js
tpc.googlesyndication.com/sodar/ Frame B84B
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:17 GMT
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/ Frame F5DB
406 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js?bust=31080970
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
81253041b07aadbc76bd8f408040ff12c7ab979d8ea9c7128a43a2efca9c5c29
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141167
x-xss-protection
0
server
cafe
etag
3092521544093563327
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:05:18 GMT
cookie_push_onload.html
pagead2.googlesyndication.com/pagead/s/ Frame F500
1 KB
644 B
Document
General
Full URL
https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
80173
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=86400
content-encoding
br
content-length
618
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Mon, 12 Feb 2024 20:49:05 GMT
etag
48472445140208031
expires
Tue, 13 Feb 2024 20:49:05 GMT
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
truncated
/ Frame 18AA
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b53322177db8d359964db8b58b59d74d55d9bcfa35ea98a2a3fa23c893dad404

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame BDF5
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvpSGI6EyIZyURI-JGlBFIpUVg2UEpLvmY0rPGU4vcdeb0DlRt6rf-2XTqQ1LD2nPkMusyZMIAYA7f1UmCOqG80BJUmOkpr29JTA-jcxiVOoO4d1OgXPkfDw2F4x9nlcSx96ShbEhJ0WmXvJrinlpPlQqrPPU3f_LnRLqQPa4qehw5s1GCA7vWcAlzdVtFgSepyiy_euhDsjMb1HdPfnI3CH1vrTtjKiBQ9u539aWBl1WEysVA6E9WrjGCPfH8FKn6_sb1c4nXuGztJcMLwyKTsquGdUZSrP-OlV2fItCYsRkKZnKrta8BgdF6roA1OSnqhh8AB4iftaXva2Kjm3UoFAk4mtTHVpi6jpUerzQar2cMALM1afhEMSmSMQQ6Co7bKNL909stkisLD-pKnfrtgVyWDIWdHpMnlfis&sai=AMfl-YRwmXNp7cOWmEq2QTJX7RvYthK_PDzuTPmY6PfIpD538CfWfG5TfaDxL0M-MlQ9x5scVzWM4d-NmjJtitc8dfl8hgepTr0slZO1cz_R7LqV22pkiHj1h73AyMG5tTg&sig=Cg0ArKJSzHpoEiL8hKUpEAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:18 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame F299
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/window_focus_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 08:58:05 GMT
content-encoding
br
x-content-type-options
nosniff
age
36433
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 08:58:05 GMT
qs_click_protection_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame F299
20 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/qs_click_protection_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
245cec0922828c15b3709eb696bb5a565f2f911f71e242024570698701c9540c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 14:32:53 GMT
content-encoding
br
x-content-type-options
nosniff
age
16345
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8220
x-xss-protection
0
server
cafe
etag
16176141338659805634
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 14:32:53 GMT
l
www.google.com/ads/measurement/ Frame F299
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQzSsee7VnpmZUj7Vq2Ik8ztMewWxPBFtPCbmTxf1yreT-lPNZqsWdCbexT1hAr9TrOD-dl6fs-uge99a_SixwqViSqpQ
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame F299
203 KB
61 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
23d11567502488b4905a85c8ce6a03d6ce539620fa559b8f24a2a95b292a2c6a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:24:35 GMT
content-encoding
br
x-content-type-options
nosniff
age
2443
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
62553
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:24:35 GMT
c
c.pub.network/v2/ Frame
0
0
Preflight
General
Full URL
https://c.pub.network/v2/c
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://reason.com
access-control-max-age
1800
allow
GET, HEAD, POST, PUT, DELETE, TRACE, OPTIONS, PATCH
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
via
1.1 google
c
c.pub.network/v2/
36 B
54 B
Fetch
General
Full URL
https://c.pub.network/v2/c
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
bde433056dc7524e1e94944f59ed149f0d1b874dee650009a4c24367294a6554
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame 8E2F
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176335
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame 301F
829 B
558 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
6c261a751bd9fe4624f9a4e87f85b9a7e7a59fe8bf512b5086d318e1e4a7103b
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-TaeTtbSz32TAJmXnvGoGkg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-TaeTtbSz32TAJmXnvGoGkg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Tue, 13 Feb 2024 19:05:18 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
usermatch
ssum-sec.casalemedia.com/ Frame 4266
0
681 B
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?s=197137&cb=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D57%26uid%3D&us_privacy=1---
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://cdn.undertone.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
cf-cache-status
DYNAMIC
cf-ray
854f57905cfd39f0-YYZ
content-length
0
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
0
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
pragma
no-cache
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=UmHkY3i9qtgH90YUhxntMXr0ipsX7LqBcwHc77jB4%2F7HeOtyPzNV1oAl6u4qjYGVYTzkLSyxHYkh3DKb1nRgo0uoDMEWm34u4Axdqr4MsWEI8hRzXSHQh1DjYLB2UV%2BG4IkuO4233AuEfg%3D%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
usync.html
eus.rubiconproject.com/ Frame DBBD
Redirect Chain
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=12776&us_privacy=1---
  • https://eus.rubiconproject.com/usync.html?p=12776&us_privacy=1---
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?p=12776&us_privacy=1---
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Referer
https://cdn.undertone.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:18 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding

Redirect headers

access-control-allow-credentials
true
access-control-allow-origin
*
content-length
0
date
Tue, 13 Feb 2024 19:05:18 GMT
location
https://eus.rubiconproject.com/usync.html?p=12776&us_privacy=1---
server
AkamaiGHost
sync
usr.undertone.com/userPixel/ Frame DFC8
Redirect Chain
  • https://us-u.openx.net/w/1.0/cm?id=fba3d144-1026-4d31-a758-943b9545e305&r=https://usr.undertone.com/userPixel/sync?partnerId=39&uid=&us_privacy=1---
  • https://usr.undertone.com/userPixel/sync?partnerId=39&uid=&us_privacy=1---375f1a63-3de1-499c-a843-b6d122800b5a
0
37 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=39&uid=&us_privacy=1---375f1a63-3de1-499c-a843-b6d122800b5a
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://usr.undertone.com/userPixel/sync?partnerId=39&uid=&us_privacy=1---375f1a63-3de1-499c-a843-b6d122800b5a
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
sync
usr.undertone.com/userPixel/ Frame DFC8
Redirect Chain
  • https://pixel.advertising.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true&us_privacy=1---
  • https://ups.analytics.yahoo.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true&us_privacy=1---
  • https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A&us_privacy=1---
0
37 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A&us_privacy=1---
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A&us_privacy=1---
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
content-length
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
sync
usr.undertone.com/userPixel/ Frame DFC8
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sirnsvg&ttd_tpi=1&gdpr=0&gdpr_consent=&us_privacy=1---
  • https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
0
151 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
date
Tue, 13 Feb 2024 19:05:18 GMT
server
Kestrel
content-length
249
sync
usr.undertone.com/userPixel/ Frame DFC8
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=12776&us_privacy=1---
  • https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&us_privacy=1---
0
139 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&us_privacy=1---
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:21 GMT
content-length
0

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&us_privacy=1---
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
e1bddfc34a927e97bda010c0d8a62b62
Expires
0
sync
usr.undertone.com/userPixel/ Frame DFC8
Redirect Chain
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160318&gdpr=&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D160318%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fusr.undertone...
  • https://image4.pubmatic.com/AdServer/SPug?p=160318&pmc=1&pr=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D53%26uid%3DA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&us_privacy=1---
  • https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
0
154 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
date
Tue, 13 Feb 2024 06:30:15 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
sync
usr.undertone.com/userPixel/ Frame DFC8
Redirect Chain
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=125&redir=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D54%26uid%3D%7BuserId%7D&us_privacy=1---
  • https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&us_privacy=1---
0
163 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&us_privacy=1---
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
A
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
location
https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&us_privacy=1---
cache-control
max-age=0,no-cache,no-store
content-length
0
expires
Tue, 11 Oct 1977 12:34:56 GMT
sync
usr.undertone.com/userPixel/ Frame DFC8
Redirect Chain
  • https://ups.analytics.yahoo.com/ups/58545/occ?us_privacy=1---
  • https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
0
162 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
content-length
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
setuid
s2s.t13.io/ Frame DFC8
Redirect Chain
  • https://usr.undertone.com/userPixel/syncr?gdpr=&gdprstr=&partnerId=null&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3...
  • https://s2s.t13.io/setuid?bidder=undertone&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=b&uid=6gc078in3kn3tp77d036y9znt
0
15 B
Image
General
Full URL
https://s2s.t13.io/setuid?bidder=undertone&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=b&uid=6gc078in3kn3tp77d036y9znt
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H3
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
strict-transport-security
max-age=31536000
content-type
text/html
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
0

Redirect headers

location
https://s2s.t13.io/setuid?bidder=undertone&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=b&uid=6gc078in3kn3tp77d036y9znt
date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0
activeview
pagead2.googlesyndication.com/pcs/ Frame 97A3
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstEtvxWrH7Uaior0blNQIn0EFLbo5i5kXy4IEJjMvFPXyv49ePbc4wnmCLkFiPAx_gnfRN3f8HFfSZX-57FfKVihnlxcYlhUL77snBZ-CYkw97i7madlBmeFjjm9gPJh-I2rdwd6xvKw8Z429r9m4hsSMeqXp2wcJ8&sig=Cg0ArKJSzOC74DEQVOYOEAE&id=lidar2&mcvt=1135&p=1150,621,1200,941&mtos=1135,1135,1135,1135,1135&tos=1135,0,0,0,0&v=20240207&bin=7&avms=nio&bs=1600,1200&mc=1&vu=1&app=0&itpl=19&adk=2249185638&rs=4&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&vs=4&r=v&co=378391500&rst=1707851115535&rpt=1436&isd=0&lsd=0&met=ie&wmsd=0&pbe=0&vae=0&spb=0&ffslot=0&reach=0&io2=0
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame 9942
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/window_focus_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 08:58:05 GMT
content-encoding
br
x-content-type-options
nosniff
age
36433
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 08:58:05 GMT
qs_click_protection_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame 9942
20 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/qs_click_protection_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
245cec0922828c15b3709eb696bb5a565f2f911f71e242024570698701c9540c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 14:32:53 GMT
content-encoding
br
x-content-type-options
nosniff
age
16345
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8220
x-xss-protection
0
server
cafe
etag
16176141338659805634
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 14:32:53 GMT
ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame 9942
203 KB
61 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
23d11567502488b4905a85c8ce6a03d6ce539620fa559b8f24a2a95b292a2c6a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:24:35 GMT
content-encoding
br
x-content-type-options
nosniff
age
2443
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
62553
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:24:35 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame BAA0
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176335
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame 3CE2
829 B
558 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
926f4410f3445aa557c2597987cd709f10eeb2414ef8b11e1d4ddced3abb2a13
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-o1sXpGDrOfEtXrXRokqpsA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-o1sXpGDrOfEtXrXRokqpsA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Tue, 13 Feb 2024 19:05:18 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
prebid
id5-sync.com/api/config/ Frame C770
135 B
410 B
XHR
General
Full URL
https://id5-sync.com/api/config/prebid
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
25359cb3d49c2e00cb2e97f95643ee30748d54c33daa11c9c6fb0d2b519dfffa
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
access-control-allow-credentials
true
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
envelope
api.rlcdn.com/api/identity/ Frame C770
0
0

rid
match.adsrvr.org/track/ Frame C770
108 B
818 B
XHR
General
Full URL
https://match.adsrvr.org/track/rid?ttd_pid=j6w8ta9&fmt=json
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.223.40.198 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a6370ebea231e0c9a.awsglobalaccelerator.com
Software
Kestrel /
Resource Hash
b49a47d34b377f49ebaa7ab5b6bbab8a209ff669ac94f5050884bc1360639f58

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
server
Kestrel
vary
Origin, Accept-Encoding
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
private
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Content-Length, Content-Encoding, Vary, Cache-Control, Accept
expires
Thu, 14 Mar 2024 19:05:18 GMT
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame DF63
16 KB
6 KB
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.221.241.11 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-221-241-11.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c861dd92be984fe498ece34c0f3c921861ac51bfee50323fcae21231abf7a82b

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=122050
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Thu, 15 Feb 2024 04:59:28 GMT
last-modified
Tue, 13 Feb 2024 04:57:54 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
usync.html
eus.rubiconproject.com/ Frame 1741
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?us_privacy=1---
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:18 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding
ads
googleads.g.doubleclick.net/pagead/ Frame C35D
430 B
227 B
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189474&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117533&bpp=3&bdt=432&idt=383&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3Dee9822135593aa08%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZ20DrTehmWhgnGqgmyoWVZ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=638554288&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&isw=0&ish=0&ifk=766666192&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808398%2C31081024%2C31081035%2C44795921%2C95324580%2C95320378%2C95320869%2C95324154%2C95324161&oid=2&pvsid=1229490704497327&tmod=594984228&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C0%2C0&vis=1&rsz=%7C%7CEr%7C&abl=CS&pfx=0&fu=32772&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.wntnpgjfc9tq&fsb=1&dtd=674
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9cc001c15bd284d427483604152719c0ce444fdcefef91aef0da6973bd397ee5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
206
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame BDF5
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
416c06dd347e006e6ba639a87b4d414a18ed7aa795dbdb67772ea5d7388b52cb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12266
x-xss-protection
0
afr.php
ads.us.criteo.com/delivery/r/ Frame A65C
51 KB
20 KB
Document
General
Full URL
https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::24 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
e494ebfb5c747ac10ee55f971901abb728dc3cf24e544898b4b851042425f389
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
*
access-control-max-age
1000
cache-control
private, max-age=0, no-cache
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
expires
Mon, 26 Jul 1997 05:00:00 GMT
link
<pix.us.criteo.net>; rel=preconnect; crossorigin, <static.criteo.net>; rel=preconnect; crossorigin
p3p
CP='CUR ADM OUR NOR STA NID'
pragma
no-cache
report-to
{"endpoints":[{"url":"https://csm.us.criteo.net/heavyad?cppv=3&cpp=35l3i6LMBFGc69loXdLs-P0jqYBWTSWjk89UotBOTLNkrJ_x-cPWt12qNc4mOXtxflTqQqGX1h7yuRmlK6IaPqDXpa05wLrP3Yfsb8-5Pl7M67quObMx_T13EZbsRKMzgqpBeQv9P-ffVeNS8Xqpl_-bFQIUUf6i6ccqHSZ7kILiIMOIEqhMjgQSmTYkBYSlX_XXszFHvRa0ZTChMmUq-89lghUkXHdHk7ctiHasRa70Q_K1HdjU2bI2sySQ-2bcd6TZnMJedAjsoFKg"}], "max_age": 86400}
server
Kestrel
server-processing-duration-in-ticks
5769731
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
cookie_push_onload.html
pagead2.googlesyndication.com/pagead/s/ Frame DE6D
1 KB
644 B
Document
General
Full URL
https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
80173
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=86400
content-encoding
br
content-length
618
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Mon, 12 Feb 2024 20:49:05 GMT
etag
48472445140208031
expires
Tue, 13 Feb 2024 20:49:05 GMT
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/pagead/ Frame E3E8
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=2426265541848191&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

afr.php
ads.us.criteo.com/delivery/r/ Frame C500
53 KB
20 KB
Document
General
Full URL
https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::24 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
1e705f59bdeda674ad38fcce31606693b8dd16e1326032c4fa67724c4c32540c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
*
access-control-max-age
1000
cache-control
private, max-age=0, no-cache
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:17 GMT
expires
Mon, 26 Jul 1997 05:00:00 GMT
link
<pix.us.criteo.net>; rel=preconnect; crossorigin, <static.criteo.net>; rel=preconnect; crossorigin
p3p
CP='CUR ADM OUR NOR STA NID'
pragma
no-cache
report-to
{"endpoints":[{"url":"https://csm.us.criteo.net/heavyad?cppv=3&cpp=qiesiqLMBFGc69lolc12UwRKNRXYBQ3PTOkI-mLm5CmhYgQPN-MfCYhdR6Xi3ZvZ8AmBT5A_DvRV2YFw2hISLJaBg0kgr1svsR0iO0MWq9N_uxDfj_2D5JIT-jUA17sGLF7t89Qg1pS9Rl-okj5PF9lwytwB29DHeZxq8A9QJVyaneff4mLxz2AGiDRdVvu73zC_8yov97d1rXaJtd6oQIotYEyE9qNtLo2gv82ffAqFvCwBBlVPkMDffF_MknxIDOOeNzW36J0P6Eg0"}], "max_age": 86400}
server
Kestrel
server-processing-duration-in-ticks
4666013
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
cookie_push_onload.html
pagead2.googlesyndication.com/pagead/s/ Frame 42F3
1 KB
644 B
Document
General
Full URL
https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
80173
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=86400
content-encoding
br
content-length
618
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Mon, 12 Feb 2024 20:49:05 GMT
etag
48472445140208031
expires
Tue, 13 Feb 2024 20:49:05 GMT
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
eplist
gtrace.mediago.io/ju/cs/ Frame BF66
153 B
318 B
Script
General
Full URL
https://gtrace.mediago.io/ju/cs/eplist?tn=41b6e88a2b85b0e731ef8e73e5558712&dm=https%253A%252F%252Fcdn.mediago.io&mcb=mmgg_1707851118273_612
Requested by
Host: cdn.mediago.io
URL: https://cdn.mediago.io/js/cookieSync.html?tn=41b6e88a2b85b0e731ef8e73e5558712
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.208.249.213 Council Bluffs, United States, ASN19527 (GOOGLE-2, US),
Reverse DNS
213.249.208.35.bc.googleusercontent.com
Software
/
Resource Hash
17d3d0993ef9650932a91e83836f9220136386b847f26d96710055bfc8f5aa24

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.mediago.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript; charset=utf-8
access-control-allow-origin
https%3A%2F%2Fcdn.mediago.io
access-control-allow-credentials
true
access-control-allow-headers
Content-Type
content-length
153
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
usersync.html
cdn.undertone.com/js/ Frame 6791
13 KB
4 KB
Document
General
Full URL
https://cdn.undertone.com/js/usersync.html?ccpa=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:215f:5c00:1f:2473:9080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
07378cb9079fe865c12da0f27effd6163adae9ce1ef5e177a527e35b9f093b12

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
22483
content-encoding
gzip
content-type
text/html
date
Tue, 13 Feb 2024 12:50:36 GMT
etag
W/"c0ad5bceb34dc473809dd23603a31cec"
last-modified
Wed, 13 Dec 2023 14:37:07 GMT
server
AmazonS3
vary
Accept-Encoding
via
1.1 18b0fca4845f3542d7f0566683e26626.cloudfront.net (CloudFront)
x-amz-cf-id
rFKJQp2uFGDol4NSy-vHyuXD8YBAr6b_TcoQ6Vg5bWgwQBwKQyBCTQ==
x-amz-cf-pop
YUL62-C2
x-amz-replication-status
COMPLETED
x-amz-server-side-encryption
AES256
x-amz-version-id
FpPUYNzys4ObbGRuHL8tOpxgUSayXD44
x-cache
Hit from cloudfront
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame C24E
16 KB
6 KB
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.221.241.11 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-221-241-11.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c861dd92be984fe498ece34c0f3c921861ac51bfee50323fcae21231abf7a82b

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=122050
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Thu, 15 Feb 2024 04:59:28 GMT
last-modified
Tue, 13 Feb 2024 04:57:54 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
usync.html
eus.rubiconproject.com/ Frame B480
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:18 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding
async_usersync.html
acdn.adnxs.com/dmp/ Frame 70C5
52 KB
17 KB
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.129.108 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.18.0 (Ubuntu) /
Resource Hash
3d649c0b3e87fd6abcb983656a0a1b3923a2a59885c3a30538641fd4f7126cbd

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Access-Control-Allow-Origin
*
Age
49315
Cache-Control
max-age=86402
Connection
keep-alive
Content-Encoding
gzip
Content-Length
17053
Content-Type
text/html
Date
Tue, 13 Feb 2024 19:05:18 GMT
ETag
W/"623de86a-cf34"
Expires
Tue, 13 Feb 2024 05:23:23 GMT
Last-Modified
Fri, 25 Mar 2022 16:06:02 GMT
Server
nginx/1.18.0 (Ubuntu)
Vary
Accept-Encoding
Via
1.1 varnish, 1.1 varnish
X-Cache
HIT, HIT
X-Cache-Hits
171, 77389
X-Served-By
cache-lga13626-LGA, cache-yyz4559-YYZ
X-Timer
S1707851118.344616,VS0,VE0
pd
freestar-d.openx.net/w/1.0/ Frame 0B32
1 KB
1003 B
Document
General
Full URL
https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
d38e1ef7c340431324c930884c3fe7324069617d72e4c1ddc7fe80dca4d1fea8

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
gzip
content-length
682
content-type
text/html
date
Tue, 13 Feb 2024 19:05:18 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
via
1.1 google
ixmatch.html
js-sec.indexww.com/um/ Frame 3396
3 KB
2 KB
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.38.76 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
82d2dc44aae1eda52abc17afd30c6031b7175c13ee6955410164c66ae755adfb

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
431
cache-control
public, max-age=14400
cf-cache-status
HIT
cf-ray
854f5791aeb536f9-YYZ
content-encoding
gzip
content-type
text/html; charset=UTF-8
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Tue, 13 Feb 2024 23:05:18 GMT
last-modified
Mon, 25 Jul 2022 19:18:19 GMT
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
server
cloudflare
vary
Accept-Encoding
sync
eb2.3lift.com/ Frame C185
1 KB
2 KB
Document
General
Full URL
https://eb2.3lift.com/sync?us_privacy=1---&
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
a9242550a7ede4dfa18a8c2c86f8dc2f6a904e64b12f2163e96694953c7fdab5

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-cache, no-store, must-revalidate
content-length
1347
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:18 GMT
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
10.gif
id5-sync.com/c/441/2/0/
Redirect Chain
  • https://id5-sync.com/s/441/9.gif?puid=u_152c89a8-84bb-49ef-894e-36b8d2753173&gdpr=0&gdpr_consent=
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=id5&cspid=18&cb=&redirect=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F796%2F8%2F2.gif%3Fpuid%3D%24%7BADELPHIC_CUID%7D%26gdpr%3D0%26gdpr_consent...
  • https://id5-sync.com/c/441/796/8/2.gif?puid=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent=
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8h9u11h&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%%
  • https://ib.adnxs.com/getuid?https://id5-sync.com/c/441/2/6/4.gif?puid=$UID&gdpr=0&gdpr_consent=
  • https://id5-sync.com/c/441/2/6/4.gif?puid=5872803529851156248&gdpr=0&gdpr_consent=
  • https://sync.go.sonobi.com/us?loc=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F434%2F5%2F5.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&consent=
  • https://id5-sync.com/c/441/434/5/5.gif?puid=65e4a6df-48af-4fad-a0f0-a3011fc909f8&gdpr=0&gdpr_consent=
  • https://dis.eu.criteo.com/dis/usersync.aspx?r=30&p=59&cp=id5&cu=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F203%2F4%2F6.gif%3Fpuid%3D%40%40CRITEO_USERID%40%40%26gdpr%3D0%26gdpr_consent%3D
  • https://id5-sync.com/c/441/203/4/6.gif?puid=15bd9e41-bde1-46eb-aa5e-ae20396e6b6a&gdpr=0&gdpr_consent=
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F429%2F3%2F7.gif%3Fpuid%3D%23PM_USER_ID%26gdpr%3D0%26gdpr_consent%3D&gdpr_consent=&gdpr=0
  • https://id5-sync.com/c/441/429/3/7.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8h9u11h&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%%
  • https://ce.lijit.com/merge?pid=27&3pid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1245%2F1%2F9.gif%3Fpuid%3D%5BSOVRNID%5D%...
  • https://id5-sync.com/c/441/1245/1/9.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
  • https://ib.adnxs.com/getuid?https://id5-sync.com/c/441/2/0/10.gif?puid=$UID&gdpr=0&gdpr_consent=
  • https://id5-sync.com/c/441/2/0/10.gif?puid=5872803529851156248&gdpr=0&gdpr_consent=
43 B
2 KB
Image
General
Full URL
https://id5-sync.com/c/441/2/0/10.gif?puid=5872803529851156248&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif;charset=UTF-8
date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
p3p
CP="CAO PSA OUR"

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
an-x-request-uuid
a68eb904-4cf3-45b1-9302-c661c44ffa93
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://id5-sync.com/c/441/2/0/10.gif?puid=5872803529851156248&gdpr=0&gdpr_consent=
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
sync
x.bidswitch.net/
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=themediagrid&us_privacy=1---
  • https://c1.adform.net/serving/cookie/match/?party=24&bidswitch_ssp_id=themediagrid
  • https://x.bidswitch.net/sync?dsp_id=70&user_id=1956285366857158953&ssp=themediagrid
43 B
235 B
Image
General
Full URL
https://x.bidswitch.net/sync?dsp_id=70&user_id=1956285366857158953&ssp=themediagrid
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Server
35.211.178.172 North Charleston, United States, ASN19527 (GOOGLE-2, US),
Reverse DNS
172.178.211.35.bc.googleusercontent.com
Software
nginx /
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:18 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; includeSubDomains
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
GET
location
https://x.bidswitch.net/sync?dsp_id=70&user_id=1956285366857158953&ssp=themediagrid
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate, no-transform
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
content-length
0
expires
-1
264.gif
id5-sync.com/k/
Redirect Chain
  • https://id5-sync.com/s/441/9.gif?puid=u_4f2f92dc-45cb-4e5b-8115-5b45eca27c69&gdpr=0&gdpr_consent=
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8h9u11h&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%%
43 B
43 B
Image
General
Full URL
https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%%
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
5f789ccae156b160492d89a6146b1974d15128790b74abb995d8e89fa44cde5e
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
origin,access-control-request-method,access-control-request-headers,accept-encoding
content-type
text/html;charset=utf-8

Redirect headers

location
https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%%
date
Tue, 13 Feb 2024 19:05:18 GMT
server
Kestrel
content-length
199
10.gif
id5-sync.com/c/441/1246/0/
Redirect Chain
  • https://id5-sync.com/s/441/9.gif?puid=u_a01fb7d6-bacf-4b1d-bb15-d6478605d080&gdpr=0&gdpr_consent=
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F108%2F8%2F2.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D0%26gdpr_consent%3D&gdpr=0&gdpr_con...
  • https://id5-sync.com/c/441/108/8/2.gif?puid=2af5462b-1213-435d-a332-7e55bb465ba1&gdpr=0&gdpr_consent=
  • https://match.prod.bidr.io/cookie-sync/id5?us_privacy=
  • https://id5-sync.com/k/155.gif?puid=AACJ-U7Ll3sAABJaNC07Nw&id5AccountNum=155&numCascadesAllowed=9
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=id5&cspid=18&cb=&redirect=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F796%2F6%2F4.gif%3Fpuid%3D%24%7BADELPHIC_CUID%7D%26gdpr%3D0%26gdpr_consent...
  • https://id5-sync.com/c/441/796/6/4.gif?puid=92a46392-4333-4e17-bc0c-e23a20ef4332&gdpr=0&gdpr_consent=
  • https://dis.eu.criteo.com/dis/usersync.aspx?r=30&p=59&cp=id5&cu=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F203%2F5%2F5.gif%3Fpuid%3D%40%40CRITEO_USERID%40%40%26gdpr%3D0%26gdpr_consent%3D
  • https://id5-sync.com/c/441/203/5/5.gif?puid=b95796f4-009a-4a9f-852e-b3acc4faf5d2&gdpr=0&gdpr_consent=
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F429%2F4%2F6.gif%3Fpuid%3D%23PM_USER_ID%26gdpr%3D0%26gdpr_consent%3D&gdpr_consent=&gdpr=0
  • https://id5-sync.com/c/441/429/4/6.gif?puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1242%2F3%2F7.gif%3Fpuid%3D%5BSOVRNID%5D%...
  • https://id5-sync.com/c/441/1242/3/7.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F441%2F124%2F2%2F8.gif%3Fpuid%3D...
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-2e71O3wMrpAYsahN0TiSaghyg86d2WQmgP08JzPIXQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F441%2F124%2F2%2F8.gif%3Fp...
  • https://id5-sync.com/cq/441/124/2/8.gif?puid=d9288f3f-ce9e-47eb-b7a4-f96ffdea64c1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1242%2F1%2F9.gif%3Fpuid%3D%5BSOVRNID%5D%...
  • https://id5-sync.com/c/441/1242/1/9.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=92&3pid=5872803529851156248&us_privacy=&gdpr=0&gdpr_consent=&location=https%3A%2F%2Fid5-sync.com%2Fc%2F441%2F1246%2F0%2F10.gif%3Fpuid%3D%5BSOVRNID%5D%26gdpr%3D0%26gdp...
  • https://id5-sync.com/c/441/1246/0/10.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
43 B
2 KB
Image
General
Full URL
https://id5-sync.com/c/441/1246/0/10.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif;charset=UTF-8
date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
p3p
CP="CAO PSA OUR"

Redirect headers

location
https://id5-sync.com/c/441/1246/0/10.gif?puid=IJ_5ATZHwpxocGP7SR6BzHWi&gdpr=0&gdpr_consent=
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:20 GMT
cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
expires
Fri, 20 Mar 2009 00:00:00 GMT
content-length
0
p3p
CP="CUR ADM OUR NOR STA NID"
view
securepubads.g.doubleclick.net/pcs/ Frame 4BF9
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjst6otmStmZnIVKfFh4ToYJmqgyqih1tksaw8C2FQffOuhQnOTu22PCxK1_2yxXDoCG6xv_7wbUKgpMKsxlXd2jYMJm4H2GDEK1OzOO2v88jkTfoyV71Fg0ISQTPaWroFsWjukYehE4v3swJFUPW9ImyK3gtw1io_2SFQ7IE-CwbVhUca0St3w0snIXdkvajdxY8xBE_QUlRWcfJUzdPQL9fI8szZd5X3M1S17GBYy8hnZsoLxG_HTJZg2fJhARlfaw88lgMAt43BaaxNohlxNNe2QLC7Tx36A2YSGod8Pufc0Ou5dPvoMLu6gd6BA7Y_OIBE1BTF5rHMXtMonIQ59Nqeluw70bk1mHWehlx84pMUU5SVNMMYCmVwt0OFYI1vipUoAvlxklnzA&sai=AMfl-YSG6Gz1ckwx1DOy2XDkOBxOlssjGCdVJ1G7gyHupv03QJqm9jV-ajwuAHqnf9GvrxmaTdFxlPkd6Vhj46DB4ZQkkrgXs2Z8Q9Vv8rIjtKDD7PvSJE-ohmVNnmB6pA&sig=Cg0ArKJSzBBeju3Ih3bJEAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:18 GMT
usync.js
eus.rubiconproject.com/ Frame DBBD
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?p=12776&us_privacy=1---
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?p=12776&us_privacy=1---
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:18 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39687
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
usync.js
eus.rubiconproject.com/ Frame 1741
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?us_privacy=1---
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?us_privacy=1---
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:18 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39687
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame C4D3
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127749
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
sodar
pagead2.googlesyndication.com/pagead/ Frame 7267
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=895834258692043&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame CF37
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176335
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame FDAA
829 B
558 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
7a9137e4e86db43b0285ef13ddc70f39cf2ffe95cfb0d160528b1145426f457c
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-tcSWx2pnUWxbKgrfeFw1Yw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-tcSWx2pnUWxbKgrfeFw1Yw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Tue, 13 Feb 2024 19:05:18 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
sodar2.js
tpc.googlesyndication.com/sodar/ Frame BDF5
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:18 GMT
v1
lb.eu-1-id5-sync.com/lb/ Frame C770
33 B
269 B
XHR
General
Full URL
https://lb.eu-1-id5-sync.com/lb/v1
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
141.95.98.64 , France, ASN16276 (OVH, FR),
Reverse DNS
ns3216658.ip-141-95-98.eu
Software
/
Resource Hash
b2955473b445f34201228330a36dc019305078ab3ac5a10eb915e574ed4449a7
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:17 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
view
securepubads.g.doubleclick.net/pcs/ Frame E29D
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvq5QqzAmYVbnRiTIP_zKOiazLbWnNw-A6vLHWC0WB223hQdApZpt3LPIjmHz-car_oJpEVlkaZacEVCfyD43iu47glO_tBQU4VUWoL7RglEMnInkODCB0KVJAJR7U7dd6tIRP0XNUEmbQoe6kaGVz2qCVYB_j9kPqcypAQ-jK3aIP5hYumusXuWPPYWZINKRLIVUkxNTpI63seh8YOE7OPOdwW_uc87-NZe-ZxUmTkT6jVleev94hRgWbvB_-AD-145HPkvsNFhd9rr2eF37EdCOipSW-W6FxHw9LJuISaFiniwd78B1vKUzSStLXWm9aX9oGJB-Vj-kTSqozltM2ThW3scm7BUQhjDfAwvLZIcjxPAjXnRURWWQQ0Lf3DLyz4UChLoK6O9wOj2m2abGDzDMocF8dzpdoepU4&sai=AMfl-YRnBH2oen6ZOds0SQBdZucAfdvtQjKp1VKQaV_mYoeW5iFlEUEWYSxrTAqyh8kqGS3jELVezvTo1H7rNfd5VRKZ8sefeoE1BpLeQlyKJ5A_oj5Ih3GLkGCmf65x3A&sig=Cg0ArKJSzBQ9pidUGTp7EAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:18 GMT
ads
googleads.g.doubleclick.net/pagead/ Frame 8C3D
38 KB
16 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
09218915200aeea4e2d4e39ab687706875800f60cd1169ccce1ec9b6991142b0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
16335
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame 4BF9
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7237adc703b7f8e4beb5a2aca09cc7ba9a37dfbafcd961bd0d8119d90f9ce421
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12287
x-xss-protection
0
usync.js
eus.rubiconproject.com/ Frame B480
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?us_privacy=1---
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?us_privacy=1---
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:18 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39687
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
xuid
eb2.3lift.com/ Frame C185
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=svx9t50&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://eb2.3lift.com/xuid?mid=3658&xuid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&dongle=0cfd&gdpr=0&gdpr_consent=
37 B
355 B
Image
General
Full URL
https://eb2.3lift.com/xuid?mid=3658&xuid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&dongle=0cfd&gdpr=0&gdpr_consent=
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"

Redirect headers

location
https://eb2.3lift.com/xuid?mid=3658&xuid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&dongle=0cfd&gdpr=0&gdpr_consent=
date
Tue, 13 Feb 2024 19:05:18 GMT
server
Kestrel
content-length
251
ebda
eb2.3lift.com/ Frame C185
Redirect Chain
  • https://eb2.3lift.com/ebda?sync=1&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=tl&gdpr=0&gdpr_consent=&us_privacy=&google_hm=MzkwMDExNDUzNzM4NTY2NDc3NDgzOQ%3D%3D
  • https://eb2.3lift.com/ebda?gdpr=0&gdpr_consent=
37 B
139 B
Image
General
Full URL
https://eb2.3lift.com/ebda?gdpr=0&gdpr_consent=
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://eb2.3lift.com/ebda?gdpr=0&gdpr_consent=
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
248
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
xuid
eb2.3lift.com/ Frame C185
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=triplelift&google_cm&google_sc&gdpr=0&gdpr_consent=
  • https://eb2.3lift.com/xuid?mid=5989&xuid=CAESEDNtdL5U9OMOEAeEKgzK3dg&dongle=c627&gdpr=0&gdpr_consent=&google_cver=1
37 B
355 B
Image
General
Full URL
https://eb2.3lift.com/xuid?mid=5989&xuid=CAESEDNtdL5U9OMOEAeEKgzK3dg&dongle=c627&gdpr=0&gdpr_consent=&google_cver=1
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://eb2.3lift.com/xuid?mid=5989&xuid=CAESEDNtdL5U9OMOEAeEKgzK3dg&dongle=c627&gdpr=0&gdpr_consent=&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
332
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame C185
Redirect Chain
  • https://eb2.3lift.com/sync/google/demand?sync=1&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=triplelift&gdpr=0&gdpr_consent=&us_privacy=&google_hm=MzkwMDExNDUzNzM4NTY2NDc3NDgzOQ%3D%3D
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=triplelift&gdpr=0&gdpr_consent=&us_privacy=&google_hm=MzkwMDExNDUzNzM4NTY2NDc3NDgzOQ%3D%3D
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=triplelift&gdpr=0&gdpr_consent=&us_privacy=&google_hm=MzkwMDExNDUzNzM4NTY2NDc3NDgzOQ%3D%3D
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
setuid
px.ads.linkedin.com/ Frame C185
0
143 B
Image
General
Full URL
https://px.ads.linkedin.com/setuid?partner=tripleliftdbredirect&tlUid=3900114537385664774839&dbredirect=true&gdpr=0&consent=
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:17 GMT
x-li-pop
afd-prod-lva1-x
x-msedge-ref
Ref A: C18BFC47B838403F98B2BA413D0C362E Ref B: EWR311000107037 Ref C: 2024-02-13T19:05:18Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-lva1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYRSBNA0rs8/EnNZ2SSiA==
xuid
eb2.3lift.com/ Frame C185
Redirect Chain
  • https://pr-bh.ybp.yahoo.com/sync/triplelift/3900114537385664774839?gdpr=0&gdpr_consent=
  • https://eb2.3lift.com/xuid?mid=2662&xuid=y-VjdPu_JE2oSTJprguvoZCHFoKyoiRDrzzmsQ_jXiQQ--~A&dongle=0883
37 B
355 B
Image
General
Full URL
https://eb2.3lift.com/xuid?mid=2662&xuid=y-VjdPu_JE2oSTJprguvoZCHFoKyoiRDrzzmsQ_jXiQQ--~A&dongle=0883
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"

Redirect headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
strict-origin-when-cross-origin
server
ATS
content-security-policy
sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-frame-options
DENY
location
https://eb2.3lift.com/xuid?mid=2662&xuid=y-VjdPu_JE2oSTJprguvoZCHFoKyoiRDrzzmsQ_jXiQQ--~A&dongle=0883
content-length
0
xuid
eb2.3lift.com/ Frame C185
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=triplelift&user_id=3900114537385664774839&gdpr=0&gdpr_consent=${GDPR_CONSENT}
  • https://ads.creative-serving.com/bsw_sync?bidswitch_ssp_id=triplelift&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=0&gdpr_consent=
  • https://ads.creative-serving.com/ul_cb/bsw_sync?bidswitch_ssp_id=triplelift&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=0&gdpr_consent=
  • https://x.bidswitch.net/sync?dsp_id=4&user_id=34cdbda4-1634-4ded-a028-2069e7dbb885&ssp=triplelift&expires=30&user_group=5&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://eb2.3lift.com/xuid?mid=2409&xuid=d9962442-c73f-42a4-adbd-3d9517e387ff&dongle=d3d3&gdpr=&gdpr_consent=&gdpr_pd=
37 B
355 B
Image
General
Full URL
https://eb2.3lift.com/xuid?mid=2409&xuid=d9962442-c73f-42a4-adbd-3d9517e387ff&dongle=d3d3&gdpr=&gdpr_consent=&gdpr_pd=
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"

Redirect headers

Location
//eb2.3lift.com/xuid?mid=2409&xuid=d9962442-c73f-42a4-adbd-3d9517e387ff&dongle=d3d3&gdpr=&gdpr_consent=&gdpr_pd=
Date
Tue, 13 Feb 2024 19:05:18 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
usersync.aspx
dis.criteo.com/dis/ Frame C185
43 B
362 B
Image
General
Full URL
https://dis.criteo.com/dis/usersync.aspx?r=44&p=75&cp=triplelift&cu=1&gdpr=0&gdpr_consent=&us_privacy=1---&gpp=${GPP_STRING_28}&gpp_sid=&url=https%3A%2F%2Feb2.3lift.com%2Fxuid%3Fmid%3D2711%26xuid%3D%40%40CRITEO_USERID%40%40%26dongle%3D013b
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.150 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
x-errorlevel
0
strict-transport-security
max-age=31536000; preload;
server
Kestrel
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
content-type
image/gif
cache-control
no-cache
cross-origin-resource-policy
cross-origin
server-processing-duration-in-ticks
211188
expires
Tue, 13 Feb 2024 00:00:00 GMT
xuid
eb2.3lift.com/ Frame C185
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Feb2.3lift.com%2Fxuid%3Fmid%3D3335%26xuid%3D%24UID%26dongle%3D4d58%26gdpr=0%26gdpr_consent=
  • https://eb2.3lift.com/xuid?mid=3335&xuid=5872803529851156248&dongle=4d58&gdpr=0&gdpr_consent=
37 B
355 B
Image
General
Full URL
https://eb2.3lift.com/xuid?mid=3335&xuid=5872803529851156248&dongle=4d58&gdpr=0&gdpr_consent=
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Server
35.71.139.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-type
image/gif
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
an-x-request-uuid
c946c238-bf37-4e12-816d-15a6259d606f
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://eb2.3lift.com/xuid?mid=3335&xuid=5872803529851156248&dongle=4d58&gdpr=0&gdpr_consent=
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
setuid
ib.adnxs.com/prebid/ Frame C185
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/prebid/setuid?bidder=triplelift_native&gdpr=0&gdpr_consent=&uid=3900114537385664774839
Requested by
Host: eb2.3lift.com
URL: https://eb2.3lift.com/sync?us_privacy=1---&
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eb2.3lift.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
an-x-request-uuid
cb18101c-acdb-42c2-bddc-8e18a559ac02
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
image/gif
cache-control
no-store, no-cache, private
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
43
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
i.match
a.tribalfusion.com/ Frame F500
43 B
481 B
Image
General
Full URL
https://a.tribalfusion.com/i.match?p=b6&u=CAESEMsbKwSsq1JGH8R0d4sNqlw&google_cver=1&google_push=AXcoOmTbKxjzv8cOjSEBtb9ZQKrb8iDDU-mCCwG3-twHkgxKhheNPF_BNf1u6c8yxKuv1aM4VV0AE2CfkQqmCTY3LLv2XxxXbrF54u8&redirect=https%3A//cm.g.doubleclick.net/pixel%3Fgoogle_nid%3Dexp%26google_push%3DAXcoOmTbKxjzv8cOjSEBtb9ZQKrb8iDDU-mCCwG3-twHkgxKhheNPF_BNf1u6c8yxKuv1aM4VV0AE2CfkQqmCTY3LLv2XxxXbrF54u8%26google_ula%3D2786954%26google_hm%3D%24TF_USER_ID_ENC%24
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:18ad , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e586a84d8523747f42e510d78e141015b6424cf67d612854e892a7bcedc8ec9e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
cf-cache-status
DYNAMIC
x-function
302
server
cloudflare
content-type
image/gif; charset=utf-8
p3p
CP="NOI DEVo TAIa OUR BUS"
cache-control
no-cache, private
cf-ray
854f57924d724bd3-BUF
alt-svc
h3=":443"; ma=86400
content-length
43
expires
Thu, 01 Jan 1970 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame F500
Redirect Chain
  • https://match.adsrvr.org/track/cmf/google?google_gid=CAESELCAKg01Z9nb9XrutemgUQI&google_cver=1&google_push=AXcoOmSecmXVWYrmjs_6N1Wbrer5LsJP9MzsvcUKMsTBujTsRTtD5UjtE2uh3WMMqsXtNiAYbFrBJa6jCKpWZfJ72S...
  • https://cm.g.doubleclick.net/pixel?google_nid=TheTradeDesk&google_hm=MjlhYWIxNzQtZmU5MS00YWQ3LWFhNTYtMWQ0NzMyY2MyN2Qy&google_push&gdpr=0&gdpr_consent=&ttd_tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=TheTradeDesk&google_hm=MjlhYWIxNzQtZmU5MS00YWQ3LWFhNTYtMWQ0NzMyY2MyN2Qy&google_push&gdpr=0&gdpr_consent=&ttd_tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=TheTradeDesk&google_hm=MjlhYWIxNzQtZmU5MS00YWQ3LWFhNTYtMWQ0NzMyY2MyN2Qy&google_push&gdpr=0&gdpr_consent=&ttd_tdid=29aab174-fe91-4ad7-aa56-1d4732cc27d2
date
Tue, 13 Feb 2024 19:05:18 GMT
server
Kestrel
content-length
423
CookieSyncAdX
rtb.adentifi.com/ Frame F500
0
34 B
Image
General
Full URL
https://rtb.adentifi.com/CookieSyncAdX?google_gid=CAESELk9TDl5nxWUhFdwKSFy1Wc&google_cver=1&google_push=AXcoOmQjmui8xlhuBAzJZClqJ6y-9UOBjruRnkDwqrPP9MBOrky34VROViWnHoM5WUlundBiHaoCOgXB3OSWCD5zU6psTzwLFDMMXAU
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.226.119.24 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-226-119-24.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
pixel
cm.g.doubleclick.net/ Frame F500
Redirect Chain
  • https://pr-bh.ybp.yahoo.com/sync/adx?google_gid=CAESEB0d2yeb36kq5Kd_CnLAxxc&google_cver=1&google_push=AXcoOmTsdGQefvfO2yQAc7R6rZ7JA4_63lZo3H8abc5vtasaxjK6iP1ijBYsLGLXmlAanRgR8VPPOW1FavAiVCYpuITa-y6...
  • https://cm.g.doubleclick.net/pixel?google_nid=yahoo&google_push=AXcoOmTsdGQefvfO2yQAc7R6rZ7JA4_63lZo3H8abc5vtasaxjK6iP1ijBYsLGLXmlAanRgR8VPPOW1FavAiVCYpuITa-y6ynvlc_gg&google_hm=eS1lNS5NOEdCRTJwR3h...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=yahoo&google_push=AXcoOmTsdGQefvfO2yQAc7R6rZ7JA4_63lZo3H8abc5vtasaxjK6iP1ijBYsLGLXmlAanRgR8VPPOW1FavAiVCYpuITa-y6ynvlc_gg&google_hm=eS1lNS5NOEdCRTJwR3hETkZTc3dkc2NwSVVNT3lQVTNkOH5B
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
strict-origin-when-cross-origin
server
ATS
content-security-policy
sandbox; default-src 'self'; script-src 'none'; object-src 'none'; report-uri http://csp.yahoo.com/beacon/csp?src=generic
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-frame-options
DENY
location
https://cm.g.doubleclick.net/pixel?google_nid=yahoo&google_push=AXcoOmTsdGQefvfO2yQAc7R6rZ7JA4_63lZo3H8abc5vtasaxjK6iP1ijBYsLGLXmlAanRgR8VPPOW1FavAiVCYpuITa-y6ynvlc_gg&google_hm=eS1lNS5NOEdCRTJwR3hETkZTc3dkc2NwSVVNT3lQVTNkOH5B
content-length
0
asr
aid.send.microad.jp/g/ Frame F500
43 B
641 B
Image
General
Full URL
https://aid.send.microad.jp/g/asr?google_gid=CAESEPbLwEjALatdNBwwAatuqKY&google_cver=1&google_push=AXcoOmSAFBfSabbFnlHePoC8BEXiP24IfAviiL2sUrZmqp2c74EdmXG8oHxqdtzbO7DrxVd7nEFVBo8Fp0mBrWwFjEr_9w9ZccNB
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
202.233.84.1 , Japan, ASN131957 (MICROAD MicroAd, Inc., JP),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b
Security Headers
Name Value
Strict-Transport-Security max-age=3600

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:19 GMT
Strict-Transport-Security
max-age=3600
Server
Apache
P3P
policyref="http://www.microad.jp/w3c/p3p.xml",CP="NOI DSP COR NID DEVo PSAo OUR STP STA PRE"
Access-Control-Allow-Origin
*
Content-Type
image/gif
Connection
close
Access-Control-Allow-Headers
origin, x-requested-with, If-Modified-Since, content-type, Pragma, Cache-Control
Content-Length
43
pixel
cm.g.doubleclick.net/ Frame F500
Redirect Chain
  • https://analytics.pangle-ads.com/api/ad/union/gg_cookie_matching?google_gid=CAESELK0NckH8FRU9X2iT3vbHsk&google_cver=1&google_push=AXcoOmQrYugvnkkclV1ZZfaTlxYx_0_kxonS6TOFSqUc7lTbW0ljikL3di5Itu_vuDr...
  • https://cm.g.doubleclick.net/pixel?google_nid=toutiao_usd&google_push=AXcoOmQrYugvnkkclV1ZZfaTlxYx_0_kxonS6TOFSqUc7lTbW0ljikL3di5Itu_vuDrFbquFDKZdslWIC6aU2UCNL9fDQpitTEPHNGyR
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=toutiao_usd&google_push=AXcoOmQrYugvnkkclV1ZZfaTlxYx_0_kxonS6TOFSqUc7lTbW0ljikL3di5Itu_vuDrFbquFDKZdslWIC6aU2UCNL9fDQpitTEPHNGyR
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

x-akamai-request-id
25960701
date
Tue, 13 Feb 2024 19:05:18 GMT
x-bytefaas-request-id
20240213190518E74F5D9925F8AACF92BE
x-tt-trace-tag
id=16;cdn-cache=miss;type=dyn
x-tt-trace-id
00-240213190518E74F5D9925F8AACF92BE-1D60BB9F50D21266-00
x-cache
TCP_MISS from a23-55-171-89.deploy.akamaitechnologies.com (AkamaiGHost/11.4.1.1-53919751) (-)
server-timing
inner; dur=5, cdn-cache; desc=MISS, edge; dur=1, origin; dur=7
content-length
0
pragma
no-cache
server
nginx
x-tt-logid
20240213190518E74F5D9925F8AACF92BE
access-control-max-age
86400
access-control-allow-methods
*
location
https://cm.g.doubleclick.net/pixel?google_nid=toutiao_usd&google_push=AXcoOmQrYugvnkkclV1ZZfaTlxYx_0_kxonS6TOFSqUc7lTbW0ljikL3di5Itu_vuDrFbquFDKZdslWIC6aU2UCNL9fDQpitTEPHNGyR
x-bytefaas-execution-duration
3.89
access-control-allow-origin
*
access-control-allow-credentials
true
x-gw-dst-psm
ad.union.pangle_web_traffic
x-tt-trace-host
01fb071011a8ae45895a951b39c344d01214a000cae7201829104ca20d5960bb8e8eb1bc6ac4b6e6e52b5e9a041f4b0ba119ed16c16e9a79543d7ff6e6aa6fabbe0b47d87384c80ff88f2e3397432cb51b479b8030fd15c629cdf543e3ebbcb744
x-origin-response-time
8,23.55.171.89
cache-control
max-age=0, no-cache, no-store
access-control-allow-headers
*
expires
Tue, 13 Feb 2024 19:05:18 GMT
pixel
cm.g.doubleclick.net/ Frame F500
Redirect Chain
  • https://www.temu.com/api/adx/cm/pixel?google_gid=CAESEEOt7czYSLeM29hXlme4ajg&google_cver=1&google_push=AXcoOmRj5Nt9NfrofakZSfSYv_9J_WTZ5sOQVC6yp4EjEEQZshvWdKHg2Ww3c0yTDqoaDL6Fx5DZKNEc80UTG3C_ddKyFI...
  • https://cm.g.doubleclick.net/pixel?google_nid=1371970550&google_push=AXcoOmRj5Nt9NfrofakZSfSYv_9J_WTZ5sOQVC6yp4EjEEQZshvWdKHg2Ww3c0yTDqoaDL6Fx5DZKNEc80UTG3C_ddKyFIn4sEDHAJ-C
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=1371970550&google_push=AXcoOmRj5Nt9NfrofakZSfSYv_9J_WTZ5sOQVC6yp4EjEEQZshvWdKHg2Ww3c0yTDqoaDL6Fx5DZKNEc80UTG3C_ddKyFIn4sEDHAJ-C
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=2592000
server
nginx
content-security-policy-report-only
default-src 'none';script-src 'report-sample';report-uri /api/sec-csp/110000007/sec-gif
content-language
en-US
location
https://cm.g.doubleclick.net/pixel?google_nid=1371970550&google_push=AXcoOmRj5Nt9NfrofakZSfSYv_9J_WTZ5sOQVC6yp4EjEEQZshvWdKHg2Ww3c0yTDqoaDL6Fx5DZKNEc80UTG3C_ddKyFIn4sEDHAJ-C
x-yak-request-id
1707851118534-4ec86798c2a822b0ee1a7203efaead46
yak-timeinfo
1707851118534|1
cip
96.9.249.44
alt-svc
h3=":443"; ma=604800
content-length
0
attr
cm.g.doubleclick.net/pixel/ Frame F500
0
12 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel/attr?d=AHNF13Lu1mI3dbmL8YVfwbicwsC0xoWwOMg5RXj1AJ7KGMqAu3yK0fQ8fbMGPhQmIcfUXb2SYR7urQg
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
content-type
text/html
/
bpi.rtactivate.com/tag/ Frame 0B32
43 B
109 B
Image
General
Full URL
https://bpi.rtactivate.com/tag/?id=50019&user_id=e21d56bb-e2c6-4783-a46d-861f27d44ed9
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.196.23.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-196-23-253.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
server
awselb/2.0
content-length
43
content-type
image/gif
37274
stags.bluekai.com/site/ Frame 0B32
62 B
540 B
Image
General
Full URL
https://stags.bluekai.com/site/37274?limit=1&id=5b2625e2-0839-487e-b831-36324e7c4bbb
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.39.185.111 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-39-185-111.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
0af3aae90b7de9fdceee2ab421378ea2f54c74be81ef43fc6c1790a032755d80

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
62
bk-server
70c0
content-type
image/gif
709996.gif
id.rlcdn.com/ Frame 0B32
42 B
60 B
Image
General
Full URL
https://id.rlcdn.com/709996.gif
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.244.154.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.154.244.35.bc.googleusercontent.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
sd
us-u.openx.net/w/1.0/ Frame 0B32
Redirect Chain
  • https://idpix.media6degrees.com/orbserv/hbpix?pixId=856286&pcv=125&ptid=23&tpuv=00&tpu=d09fe8ce-25d6-50c9-35ef-e2e5f0e16bca
  • https://us-u.openx.net/w/1.0/sd?id=537072960&val=1rpulbnwtosko
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072960&val=1rpulbnwtosko
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
cf-cache-status
DYNAMIC
server
cloudflare
p3p
CP="COM NAV INT STA NID OUR IND NOI"
location
https://us-u.openx.net/w/1.0/sd?id=537072960&val=1rpulbnwtosko
cache-control
no-cache
cf-ray
854f5793ad1f4bc3-BUF
content-length
0
sd
us-u.openx.net/w/1.0/ Frame 0B32
Redirect Chain
  • https://sync.srv.stackadapt.com/sync?nid=268
  • https://us-u.openx.net/w/1.0/sd?id=537082476&val=SPs6ha90UKJ-2DermTJBdGAJ-Sw
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537082476&val=SPs6ha90UKJ-2DermTJBdGAJ-Sw
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

Location
https://us-u.openx.net/w/1.0/sd?id=537082476&val=SPs6ha90UKJ-2DermTJBdGAJ-Sw
Date
Tue, 13 Feb 2024 19:05:18 GMT
Connection
keep-alive
Content-Length
103
Content-Type
text/html; charset=utf-8
sd
us-u.openx.net/w/1.0/ Frame 0B32
Redirect Chain
  • https://aorta.clickagy.com/pixel.gif?ch=4&cm=63bc49a1-6f34-49b1-b453-3257311e2539&redir=https%3A%2F%2Fus-u.openx.net%2Fw%2F1.0%2Fsd%3Fid%3D537073026%26val%3D%7Bvisitor_id%7D
  • https://us-u.openx.net/w/1.0/sd?id=537073026&val=Zcu9a11ZdSrn6UNLg9dcZUK2
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537073026&val=Zcu9a11ZdSrn6UNLg9dcZUK2
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:05:18 GMT
server
Aorta/20240213.97f95f8e7
expect
0
access-control-max-age
31536000
access-control-allow-methods
POST, GET, OPTIONS
content-type
text/plain
location
https://us-u.openx.net/w/1.0/sd?id=537073026&val=Zcu9a11ZdSrn6UNLg9dcZUK2
access-control-allow-origin
*
access-control-expose-headers
Set-Cookie
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-aorta-region
us-east-1
x-aorta-host
d719a8f6f786
access-control-allow-headers
Origin,cache-control,content-type,man,messagetype,soapaction
content-length
0
dds
rtb.openx.net/sync/ Frame 0B32
Redirect Chain
  • https://rtb.openx.net/sync/dds
  • https://cm.g.doubleclick.net/pixel?google_nid=open&google_hm=o2T3eJTIzNEksuWhBjURsg==&ox_sc=1&ox_init=1
  • https://rtb.openx.net/sync/dds?ox_sc=1&ox_init=1
43 B
58 B
Image
General
Full URL
https://rtb.openx.net/sync/dds?ox_sc=1&ox_init=1
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Server
35.186.253.211 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
211.253.186.35.bc.googleusercontent.com
Software
/
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://rtb.openx.net/sync/dds?ox_sc=1&ox_init=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
249
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
sd
us-u.openx.net/w/1.0/ Frame 0B32
Redirect Chain
  • https://sync.ipredictive.com/d/sync/cookie/generic?https://us-u.openx.net/w/1.0/sd?id=537073028&val=${ADELPHIC_CUID}
  • https://us-u.openx.net/w/1.0/sd?id=537073028&val=92a46392-4333-4e17-bc0c-e23a20ef4332
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537073028&val=92a46392-4333-4e17-bc0c-e23a20ef4332
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

Location
https://us-u.openx.net/w/1.0/sd?id=537073028&val=92a46392-4333-4e17-bc0c-e23a20ef4332
Date
Tue, 13 Feb 2024 19:05:18 GMT
Connection
keep-alive
X-CI-RTID
751238f1-73a5-42e4-af7b-9f7a81d2ffa2
Content-Length
112
Content-Type
text/html; charset=utf-8
sd
us-u.openx.net/w/1.0/ Frame 0B32
Redirect Chain
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=4&gdpr=0
  • https://us-u.openx.net/w/1.0/sd?id=537072977&val=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072977&val=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
A
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
location
https://us-u.openx.net/w/1.0/sd?id=537072977&val=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&gdpr=0&gdpr_consent=
cache-control
max-age=0,no-cache,no-store
content-length
0
expires
Tue, 11 Oct 1977 12:34:56 GMT
receive
pixel.tapad.com/idsync/ex/ Frame 0B32
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=1955&partner_device_id=7a4c0eb8-6649-4878-8827-31c0e6a0ea04
Requested by
Host: freestar-d.openx.net
URL: https://freestar-d.openx.net/w/1.0/pd?us_privacy=1---
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://freestar-d.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95
privacy_small.svg
static.criteo.net/flash/icon/ Frame C500
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/privacy_small.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
a71fdb2af0679f36edbf63eb7944dc2403c85572d9de916cfcb12bf6277c5c37
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Tue, 11 Feb 2020 14:30:28 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e42ba84-6aa"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
adchoices_en.svg
static.criteo.net/flash/icon/ Frame C500
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/adchoices_en.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
60bcafbd631f6fa0805e158ca3b235e76225350db6fbb423596d4c4954b27573
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Tue, 11 Feb 2020 14:27:58 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e42b9ee-759"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
close_button.svg
static.criteo.net/flash/icon/ Frame C500
308 B
636 B
Image
General
Full URL
https://static.criteo.net/flash/icon/close_button.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
8ec89605fe3d580e9539c7b858e8f69ba4e26fe06377ebe04585397de23a7395
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Fri, 14 Feb 2020 13:51:32 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"5e46a5e4-134"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
308
expires
Fri, 07 Feb 2025 19:05:18 GMT
back_button2.svg
static.criteo.net/flash/icon/ Frame C500
293 B
621 B
Image
General
Full URL
https://static.criteo.net/flash/icon/back_button2.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
725e869434fef8013208ed4c233d29744f9b363f867dcfb8f23e862880fa699a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Thu, 28 Apr 2022 09:09:48 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"626a59dc-125"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
293
expires
Fri, 07 Feb 2025 19:05:18 GMT
lg.php
cat.va.us.criteo.com/delivery/ Frame C500
43 B
348 B
Image
General
Full URL
https://cat.va.us.criteo.com/delivery/lg.php?cppv=3&cpp=7rOnOw8aWYOeEkLqOlf00RiT_9ayBucj4oa7Jy7kOTuwapEOVSW4zhKhruo_hZl1GXCn5raWdHTSAnJIyvR2h_voslsiHz-Sm1pRPQS9sH-Zc2N-53t0LUSiIXnJpsl-r_biroATm3Qwzg1zQh5I3_WDnI1EK3-xt0ZxXD1YOBOYNMwC7DXa7w6p_6eRXQR7p3aTregfuca3AOPASi8t5V209pl868JEUdnH6DU6bhuwRpJl9d0du_CY9xHHw2rKam6zXiu-ap9GxO0CapnYETE8_tioC54ILH45Q_0W3NCF953KTa-MgKdf_kQ5_zbQl6-glAgRFcC92upvILZDvabrVaIrq_Wi3pBeGy5q7CpDC2f3v93mSSa3tK34IkwKnKnS2gNZB229zWNEURiBI45Dx5dem_dOjBqleBn-pEC6qmXSXRfdkSpKJe0L4OEmePF7bQ
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.147 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
server
Kestrel
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
content-type
image/gif
cache-control
no-cache
cross-origin-resource-policy
cross-origin
server-processing-duration-in-ticks
2758467
expires
Mon, 26 Jul 1997 05:00:00 GMT
6fd3b22701f54df99bb37635d0746ac0_image_ad_300x250.png
static.criteo.net/design/dt/108887/5290166/ Frame C500
134 KB
134 KB
Image
General
Full URL
https://static.criteo.net/design/dt/108887/5290166/6fd3b22701f54df99bb37635d0746ac0_image_ad_300x250.png
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
26f361cca1054eb3790dbf39149f681d880f775abceb546fd650c11098993d8c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Mon, 12 Feb 2024 13:03:40 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"65ca172c-21803"
content-type
image/png
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
137219
expires
Fri, 07 Feb 2025 19:05:18 GMT
ads
googleads.g.doubleclick.net/pagead/ Frame 2489
430 B
228 B
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=8019747248&adk=2858904547&adf=776189472&pi=t.ma~as.8019747248&w=300&lmt=1707851118&format=300x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117777&bpp=3&bdt=295&idt=513&shv=r20240208&mjsv=m202402060101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1884187684&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1044&ady=3761&biw=1600&bih=1200&isw=300&ish=600&ifk=4249166667&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808397%2C31081025%2C95324580%2C31080971%2C95320377%2C95320869%2C95324154%2C95324161&oid=2&pvsid=307981162515100&tmod=421356643&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C600&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.o94h2j1to9k1&btvi=1&fsb=1&dtd=721
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31080971
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
d753bc26883e63087cfc5ff13ada6504d125627486c872f2a6bab759913cbdfa
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
207
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame E29D
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31080971
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
edc8a64ac56432fd3ce3300654512aee7e0c51e1ce7db94d5b4c6ba0d9917a33
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12381
x-xss-protection
0
privacy_small.svg
static.criteo.net/flash/icon/ Frame A65C
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/privacy_small.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
a71fdb2af0679f36edbf63eb7944dc2403c85572d9de916cfcb12bf6277c5c37
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Tue, 11 Feb 2020 14:30:28 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e42ba84-6aa"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
adchoices_en.svg
static.criteo.net/flash/icon/ Frame A65C
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/adchoices_en.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
60bcafbd631f6fa0805e158ca3b235e76225350db6fbb423596d4c4954b27573
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Tue, 11 Feb 2020 14:27:58 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e42b9ee-759"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
close_button.svg
static.criteo.net/flash/icon/ Frame A65C
308 B
636 B
Image
General
Full URL
https://static.criteo.net/flash/icon/close_button.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
8ec89605fe3d580e9539c7b858e8f69ba4e26fe06377ebe04585397de23a7395
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Fri, 14 Feb 2020 13:51:32 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"5e46a5e4-134"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
308
expires
Fri, 07 Feb 2025 19:05:18 GMT
back_button2.svg
static.criteo.net/flash/icon/ Frame A65C
293 B
621 B
Image
General
Full URL
https://static.criteo.net/flash/icon/back_button2.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
725e869434fef8013208ed4c233d29744f9b363f867dcfb8f23e862880fa699a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Thu, 28 Apr 2022 09:09:48 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"626a59dc-125"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
293
expires
Fri, 07 Feb 2025 19:05:18 GMT
lg.php
cat.va.us.criteo.com/delivery/ Frame A65C
43 B
347 B
Image
General
Full URL
https://cat.va.us.criteo.com/delivery/lg.php?cppv=3&cpp=jZ7fBA8aWYOeEkLqOlf00RiT_9ZR--rSIAH9-CUAbHXwTf-IiiGVWq0eBtuTf40gcp3EzxgDshHviQRxGkpCIFt_ZA38Gp_W572z0zsZ6hFJ96RyFBD31fYkafjnaTXnow3ULn8NiUGR87zCbjBQSyXrBwmb0uRraELVmzgx1buGlEaC2K-4YyI1Dznzu6PxWF2wOc36zC1t1SDFZmonVwJQCaVOfRTm__j0ScZCaD3bBkixt-C79HTIPQyL3qtuAc0BGuKVBM3WpaFKOs1CilyhegvATWjga_aV_Yqkmbegwqoxqoh7kQNXJh3JVMtg227y7QaEfiwsq1UYwFDyb1T0_tOnM0Mwc-P5bQY8MbqUNatVuqmQ0s3ir2MKu0p5FQQC0Erg8-S1gm773nSYeevBiD8ZPim0FzeIDTp-TTuRpjCCr1iHmsxySn66LHEr8AwbEA
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.147 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
server
Kestrel
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
content-type
image/gif
cache-control
no-cache
cross-origin-resource-policy
cross-origin
server-processing-duration-in-ticks
3243029
expires
Mon, 26 Jul 1997 05:00:00 GMT
6fd3b22701f54df99bb37635d0746ac0_image_ad_300x250.png
static.criteo.net/design/dt/108887/5290166/ Frame A65C
134 KB
134 KB
Image
General
Full URL
https://static.criteo.net/design/dt/108887/5290166/6fd3b22701f54df99bb37635d0746ac0_image_ad_300x250.png
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
26f361cca1054eb3790dbf39149f681d880f775abceb546fd650c11098993d8c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Mon, 12 Feb 2024 13:03:40 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"65ca172c-21803"
content-type
image/png
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
137219
expires
Fri, 07 Feb 2025 19:05:18 GMT
usermatch
ssum-sec.casalemedia.com/ Frame 9965
0
689 B
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?s=197137&cb=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D57%26uid%3D
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://cdn.undertone.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
cf-cache-status
DYNAMIC
cf-ray
854f5793096c39f0-YYZ
content-length
0
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
0
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
pragma
no-cache
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=kfW0Nv8iJdfBigSlO4fgoaQkPJGqP6PBzkckKGEENK463XVRHbqER9%2FIpuSLmFIDEUaog0z8yrzAYLPOHT%2Bf7%2BCtjVaJBf8Gan5JvgT9d7Nn%2FGVL%2FElMItSTTj99Nft%2FyMQjfS43UyjpFQ%3D%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
usync.html
eus.rubiconproject.com/ Frame 932E
Redirect Chain
  • https://secure-assets.rubiconproject.com/utils/xapi/multi-sync.html?p=12776
  • https://eus.rubiconproject.com/usync.html?p=12776
281 B
554 B
Document
General
Full URL
https://eus.rubiconproject.com/usync.html?p=12776
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
3fdf2ee487005f6505d00cc9d7a3757a1942d56bcaea69929cbd5ba110494390

Request headers

Referer
https://cdn.undertone.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Encoding
gzip
Content-Length
233
Content-Type
text/html; charset=UTF-8
Date
Tue, 13 Feb 2024 19:05:18 GMT
ETag
"20524-119-60b38417c4040"
Last-Modified
Tue, 28 Nov 2023 15:41:45 GMT
Server
Apache/2.2.15 (CentOS)
Vary
Accept-Encoding

Redirect headers

access-control-allow-credentials
true
access-control-allow-origin
*
content-length
0
date
Tue, 13 Feb 2024 19:05:18 GMT
location
https://eus.rubiconproject.com/usync.html?p=12776
server
AkamaiGHost
sync
usr.undertone.com/userPixel/ Frame 6791
Redirect Chain
  • https://us-u.openx.net/w/1.0/cm?id=fba3d144-1026-4d31-a758-943b9545e305&r=https://usr.undertone.com/userPixel/sync?partnerId=39&uid=
  • https://usr.undertone.com/userPixel/sync?partnerId=39&uid=375f1a63-3de1-499c-a843-b6d122800b5a
0
151 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=39&uid=375f1a63-3de1-499c-a843-b6d122800b5a
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://usr.undertone.com/userPixel/sync?partnerId=39&uid=375f1a63-3de1-499c-a843-b6d122800b5a
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
sync
usr.undertone.com/userPixel/ Frame 6791
Redirect Chain
  • https://pixel.advertising.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true
  • https://ups.analytics.yahoo.com/ups/58293/sync?&gdpr=&gdpr_consent=&redir=true
  • https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A
0
37 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partner=verizon&uid=y-_Yy7ZzFE2uGRqWG3zL9A5XHfP26AYx_L~A
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
content-length
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
sync
usr.undertone.com/userPixel/ Frame 6791
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sirnsvg&ttd_tpi=1&gdpr=0&gdpr_consent=
  • https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
0
151 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partnerId=46&uid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=1710443118
date
Tue, 13 Feb 2024 19:05:18 GMT
server
Kestrel
content-length
249
sync
usr.undertone.com/userPixel/ Frame 6791
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=12776
  • https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE
0
139 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
574abe46412f7df61ec8713ff1a5b646
Expires
0
sync
usr.undertone.com/userPixel/ Frame 6791
Redirect Chain
  • https://image8.pubmatic.com/AdServer/ImgSync?p=160318&gdpr=&gdpr_consent=&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D160318%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fusr.undertone...
  • https://image4.pubmatic.com/AdServer/SPug?p=160318&pmc=1&pr=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D53%26uid%3DA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
  • https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
0
154 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partnerId=53&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
sync
usr.undertone.com/userPixel/ Frame 6791
Redirect Chain
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=125&redir=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D54%26uid%3D%7BuserId%7D
  • https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553
0
162 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:17 GMT
server
A
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
location
https://usr.undertone.com/userPixel/sync?partnerId=54&uid=64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553
cache-control
max-age=0,no-cache,no-store
content-length
0
expires
Tue, 11 Oct 1977 12:34:56 GMT
sync
usr.undertone.com/userPixel/ Frame 6791
Redirect Chain
  • https://ups.analytics.yahoo.com/ups/58545/occ
  • https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
0
162 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
0

Redirect headers

location
https://usr.undertone.com/userPixel/sync?partnerId=56&uid=y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.94
age
0
content-length
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
t.gif
cw.addthis.com/ Frame 6791
0
427 B
Image
General
Full URL
https://cw.addthis.com/t.gif?pid=46&pdid=6d02c9204d134b1cbf8cea0df54486c9
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.203.177.63 Piscataway, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-203-177-63.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
max-age=0, no-cache, no-store
expires
Tue, 13 Feb 2024 19:05:18 GMT
ibs:dpid=152416&dpuuid=6gc078in3kn3tp77d036y9znt
dpm.demdex.net/ Frame 6791
42 B
716 B
Image
General
Full URL
https://dpm.demdex.net/ibs:dpid=152416&dpuuid=6gc078in3kn3tp77d036y9znt
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.202.200.79 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-202-200-79.compute-1.amazonaws.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

dcs
dcs-prod-va6-2-v053-0f32e599b.edge-va6.demdex.com 4 ms
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
x-tid
OIvo5fMXSGw=
content-type
image/gif
p3p
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
cache-control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
content-length
59
expires
Thu, 01 Jan 1970 00:00:00 UTC
15597
tags.bluekai.com/site/ Frame 6791
62 B
437 B
Image
General
Full URL
https://tags.bluekai.com/site/15597?id=6gc078in3kn3tp77d036y9znt
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.39.185.111 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-39-185-111.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
0af3aae90b7de9fdceee2ab421378ea2f54c74be81ef43fc6c1790a032755d80

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
62
content-type
image/gif
396846.gif
idsync.rlcdn.com/ Frame 6791
Redirect Chain
  • https://idsync.rlcdn.com/403716.gif?partner_uid=6gc078in3kn3tp77d036y9znt
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fidsync.rlcdn.com%2F396846.gif%3Fserved_by%3Devergreen%26partner_uid%3D
  • https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
42 B
60 B
Image
General
Full URL
https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H3
Server
35.244.154.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.154.244.35.bc.googleusercontent.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42

Redirect headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
usermatch.gif
beacon.krxd.net/ Frame 6791
0
44 B
Image
General
Full URL
https://beacon.krxd.net/usermatch.gif?partner=undertone&partner_uid=6gc078in3kn3tp77d036y9znt
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.208.49.53 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-208-49-53.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
server
awselb/2.0
receive
pixel.tapad.com/idsync/ex/ Frame 6791
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=3484&partner_device_id=6gc078in3kn3tp77d036y9znt
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?ccpa=1---
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.undertone.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95
gen_204
pagead2.googlesyndication.com/pagead/ Frame AB6F
0
22 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=33&t=2&li=v_h.h.3.2.2&sid=a73LZYuRK4va18cP-9i6uA8&bg=!a2ilaCfNAAaxkZ3akZE7ADQBe5WfOETRokZA4zN38X0peB9a20_4eHpU5ixhhiYxhOI0aWjkoiF9uwtQLVLgZ2H27JYhAgAAAyFSAAAAA2gBBwoBJs2roBs4EXablMGcMZEuRpW0_a92bHg2MVVtdB93FRrQHB-tjp7cdKLsuoOKymwt91FFncIQH4vuaK-L-KnqAdGz28kGQGUdMhuc6qCTjKjO3EWfB9IOCQtH7oBNjTl9nJy0uphgL9qA-hvGIgrJr5LNstMGA9Z1RrwGxg8r6JRTq29CcyiC3xWHv2hFG0eUnZTYx2Uj0FSdGERraIfm2EoXnzE_bk0WYhpmjY85p97E3jH9PJrTV-qjAnYLC93LU_TOyiFPnta-jU7zBeLK_fAdXkZ0pT82RQCbKhHHmbbagJSYOw3sYl8Tdqln5a13EWJSHq2F3oX-bABQTd4WDOJ9dNjejhO_n1KUJHYohrBY_GdXD4TWu29nOSOTGremcE8LzVVNR5kCJiZ01L-VbLOxTkM5GrGdZt26ZJqt_ZtKd8qJH6UniuEyttUaRCpvH73bmHsVhrlpjqnb2Wxd_Q-NaoyEK61L8ce5Dy4fRRVUFAAmDHcXe-6ONkIhH1fJy1EcWv_CDPRiKat2Gq3-4I1cgn2q4BUBhI3sVm0o_qWK_hrb1rTDpB-t_rNkgmQQw4AxhxsVps2JFVuGRocg2LE1EfrHCxOfBfKKB1_Q3YKlTNymFjPsmNXp7CoVN-WGrcNpDIrYJi6--rYbk99YqvQ1jpjPN9inYXTtstVwSBoEjTnn8ydNQZk4IHvJl7FpQyYieERuG3MAkj4hkejg8gcjH0aYzYYKpO21hJTLGMn1mxqxseZTsUfcL3H0Vv4Ub-XSZ8iXUeVgsZ8CPpW5MfuxMYzBQU22oQSzT0xbiKdZ8rhLeNG-jZo9zoPYFJVJYKU0YEVSMWMpQEituXJ3kKuWYOvDaf4C_5Y6Hs9jWKs7hMnQGylT3q9oS58AuY6XKk5varJdYQxauW8Q5bct6dzEviUzV5IgRTqL_tq5ijvCn6BoRbKVzyeR1WDIlbBUVSXMEtXEkpVIj5HAv4Zl-faQr-zkalVd8YdoNOWHBsMbc2gHKTZ3XOgF68QLw1cv7K-HFZedjVd7ddrzxqerqHb_YPnIOOoxT-SEFtp5xrRcjQi6ZG6y4IFhG5b3wVwdM-Miol9wqv1UzlbnsCtxJL0JcMMB5UZBtsUAZSOno2I
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame AB6F
0
22 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=33&t=2&li=v_h.h.3.2.2&sid=a73LZYuRK4va18cP-9i6uA8&sc=3877107475713213&bg=!c3ClcD_NAAaxkZ3akZE7ADQBe5WfOETRokZA4zN38X0peB9a20_4eHpU5ixhhiYxhOI0aWjkoiF9uwtQLVLgZ2H27JYhAgAAAyFSAAAAA2gBBwoBJshpQ8BazfA6IkZW4OXX4-5EcUSWughEbr6_MdIY4uA0i6QieKRkPFldDxYNXEnn2GBVWEv2eOSv_AyeeiSMuxhCt0BNWo9HDrKPdOiEWcDtDOg-Ak6ZeFjXjarC7x1sVPKsGTcHRGc4c0CZ23HnJBcQxYHV33WpJ6k-cWk8iEc2_nycLELJVdmWh9FUaztNlVonuJ_97zToLIO1ZgOj5WBSQnh506PHcUiJTbTtY9YYzsZwXLT6_Zu5PToU9SgK3kUqqtNCBr0MTN57NWIs6dLkxcBB593dO6p5YPGE2Q8W6IR4kSHUx20L1_1taXi1JRqIZIgPu5Y33etALkoKcYhzq_nxmfxV3oCPuPfUtiJYwlc6k4U77NV6dJPmKUS9N1XC_ftE4ZkCJiZ01L-VbLOxTkM5GrGdZt26ZJqt_ZtKd8qJH6UniuEyttUaRCpvH73bmHsVhrlpjqnb2Wxd_Q-NaoyEK61L8ce5Dy4fRRVUFAAmDHcXe-6ONkIhH1fJy1EcWv_CDPRiKat2Gq3-4I1cgn2q4BUBhI3sVm0o_qWK_hrb1rTDpB-t_rNkgmQQw4AxhxsVps2JFVuGRocg2LE1EfrHCxOfBfKKB1_Q3YKlTNymFjPsmNXp7CoVN-WGrcNpDIrYJi6--rYbk99YqvQ1jpjPN9inYXTtstVwSBoEjTnn8ydNQZk4IHvJl7FpQyYieERuG3MAkj4hkejg8gcjH0aYzYYKpO21hJTLGMn1mxqxseZTsUfcL3H0Vv4Ub-XSZ8iXUeVgsZ8CPpW5MfuxMYzBQU22oQSzT0xbiKdZ8rhLeNG-jZo9zoPYFJVJYKU0YEVSMWMpQEituXJ3kKuWYOvDaf4C_5Y6Hs9jWKs7hMnQGylT3q9oS58AuY6XKk5varJdYQxauW8Q5bct6dzEviUzV5IgRTqL_tq5ijvCn6BoRbKVzyeR1WDIlbBUVSXMEtXEkpVIj5HAv4Zl-faQr-zkalVd8YdoNOWHBsMbc2gHKTZ3XOgF68QLw1cv7K-HFZedjVd7ddrzxqVWM2X4xJ5sC7C8esLMW4yz_wATemSxM8gF8OLhq7rW_spX4Og5PWsVS1jokqO9bhzMEyxGDWeL4TbYmk0lgetsnsw
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame F5DB
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuJrfOvSDeuwhkTqdTp7BVVsE65BxJkT_Ji7QM_Uruac_kkXU9ZuDixR_Up-c6CAEpOZY5TxCjs5Efqe4Ox6F_v_0ru29lHLIBQtM6OlRa7VVp5zTWO9EF82sXQlwXGgNYwuRNKTNQDRVZIRFeqG_jp3TKibr3Lb4x95DwHXT0-GORzKHx2BThK5Iq-DOINQie18hFjdCgfejNl5DUMQrz26ctK2AlQP9A6NhzsBBM20UrsjYxds9Qnym-zR2mF6L3qBcjwYQxMb8bZolv6n27bgToco-iCq-odFI3dnw9IZdWkxejBBijCDV779s_M8k1-PjNLVBiBijP6U6wh-vWGRm9tuyRVQSakSmz42np8XaPnzu3WrNSLQ4kAYHS51gfMXS0csKs&sai=AMfl-YRo50Ae1KFNnOE4a6NTiapQm5jTBHfyUCIHbtqtVVyWokFtxHgJXh4HzYgSiAOllBlS1n-ytG026Re7A4ALs3wFemTDW_EHVcHZt9TM5Ooe8aocQdYiVPtEOfoqinY&sig=Cg0ArKJSzIbJLGUxSFf-EAE&uach_m=%5BUACH%5D&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1b::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 13 Feb 2024 19:05:18 GMT
truncated
/ Frame F299
209 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
00d98161fb98a0da8e572010e3b9293a00117353f52bb503434330ac228f79f2

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
sodar2.js
tpc.googlesyndication.com/sodar/ Frame 4BF9
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402070101/show_ads_impl_fy2021.js?bust=31081078
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:18 GMT
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame B107
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127749
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
c
c.pub.network/v2/ Frame
0
0
Preflight
General
Full URL
https://c.pub.network/v2/c
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://reason.com
access-control-max-age
1800
allow
GET, HEAD, POST, PUT, DELETE, TRACE, OPTIONS, PATCH
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
via
1.1 google
c
c.pub.network/v2/
36 B
54 B
Fetch
General
Full URL
https://c.pub.network/v2/c
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
bde433056dc7524e1e94944f59ed149f0d1b874dee650009a4c24367294a6554
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36
212.json
id5-sync.com/g/v2/ Frame C770
625 B
1 KB
XHR
General
Full URL
https://id5-sync.com/g/v2/212.json
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/prebid/prebidVid.7.16.0_20.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.19.138.83 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31532338.ip-162-19-138.eu
Software
/
Resource Hash
1bb5f72de520c5cf4e5c52bf01a3bb749fd425dd4d447ccf6c2a7f455d1ab9d0
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://reason.com
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
access-control-allow-credentials
true
p3p
CP="CAO PSA OUR"
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
truncated
/ Frame 9942
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
e486b285f7693b1570e6ed2765c1c1e0a6f832fd95b6e7c942c065e4358ddbfa

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
pixel
cm.g.doubleclick.net/ Frame DE6D
Redirect Chain
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cve...
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSFVsVjkXq0sTIrmRdgopaIgTXDObkkTgZyrw8JUyy...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSFVsVjkXq0sTIrmRdgopaIgTXDObkkTgZyrw8JUyyxkl06UokEJBKHIHlHMRlx0nmvJ1wNHzu5rFZ-_yW3BD5nNidp-hgWUsTx9Xocv6_zFjwI96a160QdJItJij5gBf7PRaxU0uLMdiDicqP8bKuwrg
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:18 GMT
Strict-Transport-Security
max-age=2592000; includeSubDomains
Server
PingMatch/v2.0.30-801-g0076fb7#rel-ec2-master i-015a3f37dd7aae39f@us-east-1e@dxedge-app-us-east-1-prod-asg
Location
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSFVsVjkXq0sTIrmRdgopaIgTXDObkkTgZyrw8JUyyxkl06UokEJBKHIHlHMRlx0nmvJ1wNHzu5rFZ-_yW3BD5nNidp-hgWUsTx9Xocv6_zFjwI96a160QdJItJij5gBf7PRaxU0uLMdiDicqP8bKuwrg
Cache-Control
no-cache, must-revalidate
Connection
keep-alive
Content-Length
0
Expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame DE6D
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESE...
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQIaCPfbJIG4ACehGy4TJBFdv8aD-...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQIaCPfbJIG4ACehGy4TJBFdv8aD-EjTW52SPyYglWxnazsJFDA18Ugy4YFEh6nUnN1_yjwL1Be3uxUGKdvHqRpPBZbvOXZG2m00Ht-RXXzIlPHHYPlMMMzxmYoanC-PiIB82tm3t33wcBbuCU4Wx7lQQ
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

x-served-by
cache-yyz4546-YYZ
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 varnish
server
Varnish
x-timer
S1707851119.730441,VS0,VE0
x-cache
HIT
location
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQIaCPfbJIG4ACehGy4TJBFdv8aD-EjTW52SPyYglWxnazsJFDA18Ugy4YFEh6nUnN1_yjwL1Be3uxUGKdvHqRpPBZbvOXZG2m00Ht-RXXzIlPHHYPlMMMzxmYoanC-PiIB82tm3t33wcBbuCU4Wx7lQQ
cache-control
no-cache
accept-ranges
bytes
content-length
0
retry-after
0
x-cache-hits
0
pixel
cm.g.doubleclick.net/ Frame DE6D
Redirect Chain
  • https://mweb.ck.inmobi.com/sync/3?redirect=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dinmobi_pte_limited%26google_hm%3D%24DSP_CKID&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=...
  • https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmRi...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmRi3O1QaNN8fTCMASOzkT7MLZKdkJ6ZtAf1MojLpuCeFabnluXakKD1Mn9GEnPiY8tP0LTdLJV0RTcdh0qzHc-WvO5bxo_5NCPBN6nDzbAgBQZ25i97eymNpxK76-mGoKUCjmN7dMraMStadShAeyA6ng
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmRi3O1QaNN8fTCMASOzkT7MLZKdkJ6ZtAf1MojLpuCeFabnluXakKD1Mn9GEnPiY8tP0LTdLJV0RTcdh0qzHc-WvO5bxo_5NCPBN6nDzbAgBQZ25i97eymNpxK76-mGoKUCjmN7dMraMStadShAeyA6ng
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=15724800; includeSubDomains
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame DE6D
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=google&google_gid=CAESEEJZ1H7xxDQil5yltdO_TY8&google_cver=1&google_push=AXcoOmSNrGZdHwtS50n0gX-qlfG7FwMCtfNWNYttvgZ3lDGTV4hBrK_GkXrvJnDISuCgvDj9YrYFiNn0jyfIpZRnU5Ao...
  • https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSNrGZdHwtS50n0gX-qlfG7FwMCtfNWNYttvgZ3lDGTV4hBrK_GkXrvJnDISuCgvDj9YrYFiNn0jyfIpZRnU5AohHS0HTIqQOg37zpJfBW9dSn7LQg1oHBEwbmDRIfb3d...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSNrGZdHwtS50n0gX-qlfG7FwMCtfNWNYttvgZ3lDGTV4hBrK_GkXrvJnDISuCgvDj9YrYFiNn0jyfIpZRnU5AohHS0HTIqQOg37zpJfBW9dSn7LQg1oHBEwbmDRIfb3dXvDLTMtuu7fcRd1COoiKyOkg&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
//cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSNrGZdHwtS50n0gX-qlfG7FwMCtfNWNYttvgZ3lDGTV4hBrK_GkXrvJnDISuCgvDj9YrYFiNn0jyfIpZRnU5AohHS0HTIqQOg37zpJfBW9dSn7LQg1oHBEwbmDRIfb3dXvDLTMtuu7fcRd1COoiKyOkg&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Date
Tue, 13 Feb 2024 19:05:18 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
pixel
cm.g.doubleclick.net/ Frame DE6D
Redirect Chain
  • https://rtb.mfadsrvr.com/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUixZLzkosxLlNp7knTc6EDR-...
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUixZLzkosxLlNp7knT...
  • https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUi...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUixZLzkosxLlNp7knTc6EDR-vT-iWuOITe55Gb38orH7_ILu7U7F4kS_8Nlxi3BtiWpBZtGU9LQ-yowpSdCliUO9DAR9d7NQQD1FE4Chq1Q
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
//cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmSD7TDY84Yn-alquGfIxM423ij9E_9typD-ciEV10jgysFcUixZLzkosxLlNp7knTc6EDR-vT-iWuOITe55Gb38orH7_ILu7U7F4kS_8Nlxi3BtiWpBZtGU9LQ-yowpSdCliUO9DAR9d7NQQD1FE4Chq1Q
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
attr
cm.g.doubleclick.net/pixel/ Frame DE6D
0
12 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel/attr?d=AHNF13LLNEa0zKioSNpm2lHaKs54Tg7MM-UlciGb2IRaBzCJLwmP69CSGErfqnbD
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
content-type
text/html
pixel
cm.g.doubleclick.net/ Frame 42F3
Redirect Chain
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cve...
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmRBLKkaVsdpP5gKhNOnIePxAcEzvhD1L0DqDfmQdss...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmRBLKkaVsdpP5gKhNOnIePxAcEzvhD1L0DqDfmQdss28IyXDvaV3Yvz0yRekcF3HckufCKt_Rv7PL2ts3ZdQlM6so9sNlGmn-wFQcM35ZJMhb-igpsdpbqhJ4PkFuL5-T1o0N4swP8e3Q8vfhWpTsemuaM
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:18 GMT
Strict-Transport-Security
max-age=2592000; includeSubDomains
Server
PingMatch/v2.0.30-801-g0076fb7#rel-ec2-master i-0cc54338381fdb5a6@us-east-1b@dxedge-app-us-east-1-prod-asg
Location
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmRBLKkaVsdpP5gKhNOnIePxAcEzvhD1L0DqDfmQdss28IyXDvaV3Yvz0yRekcF3HckufCKt_Rv7PL2ts3ZdQlM6so9sNlGmn-wFQcM35ZJMhb-igpsdpbqhJ4PkFuL5-T1o0N4swP8e3Q8vfhWpTsemuaM
Cache-Control
no-cache, must-revalidate
Connection
keep-alive
Content-Length
0
Expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 42F3
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESE...
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQCMhRFuNlPYwsgqZ9eAxopvwIz7l...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQCMhRFuNlPYwsgqZ9eAxopvwIz7lUwsggVuRJXwDA51fptAAOsVbMgVMAKfoWhfg2O1vWSGmn-T5xxSUVXgUIlJ1ju89GdGoB59I0C8N8NCyUJPIgreAjIQllUa5fNieqCCEHwa_PFip18_FXKR-FNnl4
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

x-served-by
cache-yyz4546-YYZ
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 varnish
server
Varnish
x-timer
S1707851119.735470,VS0,VE0
x-cache
HIT
location
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmQCMhRFuNlPYwsgqZ9eAxopvwIz7lUwsggVuRJXwDA51fptAAOsVbMgVMAKfoWhfg2O1vWSGmn-T5xxSUVXgUIlJ1ju89GdGoB59I0C8N8NCyUJPIgreAjIQllUa5fNieqCCEHwa_PFip18_FXKR-FNnl4
cache-control
no-cache
accept-ranges
bytes
content-length
0
retry-after
0
x-cache-hits
0
pixel
cm.g.doubleclick.net/ Frame 42F3
Redirect Chain
  • https://mweb.ck.inmobi.com/sync/3?redirect=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dinmobi_pte_limited%26google_hm%3D%24DSP_CKID&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=...
  • https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=OThmMDU2ZmYtYjNlMS00Yzc5LWEzZDgtZWFhYzg0NTEyNTI3&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmTV...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=OThmMDU2ZmYtYjNlMS00Yzc5LWEzZDgtZWFhYzg0NTEyNTI3&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmTV16TTBJPGYiS11zD1D5106Ivo1cC4bLTDzvXYnasTpPw1dCMH3rcob4jrPErbfV9GIvOq3A67CBwzZdwBuWA6g77_y4igI8oIF4vE-3-VTUDL1b0vodDluuE9aBxeSOPIcoTrfs9XQx6wkIBGjyFZxtg
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=OThmMDU2ZmYtYjNlMS00Yzc5LWEzZDgtZWFhYzg0NTEyNTI3&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmTV16TTBJPGYiS11zD1D5106Ivo1cC4bLTDzvXYnasTpPw1dCMH3rcob4jrPErbfV9GIvOq3A67CBwzZdwBuWA6g77_y4igI8oIF4vE-3-VTUDL1b0vodDluuE9aBxeSOPIcoTrfs9XQx6wkIBGjyFZxtg
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=15724800; includeSubDomains
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 42F3
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=google&google_gid=CAESEEJZ1H7xxDQil5yltdO_TY8&google_cver=1&google_push=AXcoOmS6ZXckMj6MRQuQkUvfueLAYzjI-uBnTiFSPne20jp6bDM8Hw1RZX9xrE_pI5ts9NgGsNI8Kc6aTlt8lSgXmbC2...
  • https://r.bidswitch.net/sync?bidswitch_ssp_id=google&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3205&partner_device_id=d9962442-c73f-42a4-adbd-3d9517e387ff&partner_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D393%26user_id%3D0%26ssp%...
  • https://x.bidswitch.net/sync?dsp_id=393&user_id=0&ssp=google&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmS6ZXckMj6MRQuQkUvfueLAYzjI-uBnTiFSPne20jp6bDM8Hw1RZX9xrE_pI5ts9NgGsNI8Kc6aTlt8lSgXmbC2o00xMBlTsmxdbnMvLSUcPlQGo1F791O4XQULk2Ed5Y...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmS6ZXckMj6MRQuQkUvfueLAYzjI-uBnTiFSPne20jp6bDM8Hw1RZX9xrE_pI5ts9NgGsNI8Kc6aTlt8lSgXmbC2o00xMBlTsmxdbnMvLSUcPlQGo1F791O4XQULk2Ed5YLN8Ll3oXl9iCbDegD2ldsC7bU&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
//cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmS6ZXckMj6MRQuQkUvfueLAYzjI-uBnTiFSPne20jp6bDM8Hw1RZX9xrE_pI5ts9NgGsNI8Kc6aTlt8lSgXmbC2o00xMBlTsmxdbnMvLSUcPlQGo1F791O4XQULk2Ed5YLN8Ll3oXl9iCbDegD2ldsC7bU&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Date
Tue, 13 Feb 2024 19:05:18 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
pixel
cm.g.doubleclick.net/ Frame 42F3
Redirect Chain
  • https://rtb.mfadsrvr.com/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_FFIZzbbn5EJDWgKUCQNRekh...
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_FFIZzbbn5EJDWgKUC...
  • https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_F...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_FFIZzbbn5EJDWgKUCQNRekhQTpZihIsIcw0Bj93YfwiRJebRehtNO6NGaMdfa_4Dnuy8DoxiIwd-rfFccSIie1TtuyjYxfp4EqbxFrs_IY
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
//cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmTIJv42ik-ACm9y1K6spCor_20aUilhbMTDTIiFiRLd63rq_FFIZzbbn5EJDWgKUCQNRekhQTpZihIsIcw0Bj93YfwiRJebRehtNO6NGaMdfa_4Dnuy8DoxiIwd-rfFccSIie1TtuyjYxfp4EqbxFrs_IY
date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-cache, no-store, must-revalidate
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
attr
cm.g.doubleclick.net/pixel/ Frame 42F3
0
12 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel/attr?d=AHNF13JygryO66D8lTr4t7Y0NHS4L1qkyoUIU2VrlgPZAcwjZ_eA-n-Arv9V9IqP
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
content-type
text/html
sodar
pagead2.googlesyndication.com/pagead/ Frame 301F
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=3167069287056572&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

sodar
pagead2.googlesyndication.com/pagead/ Frame 3CE2
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=3401264131360314&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

sodar2.js
tpc.googlesyndication.com/sodar/ Frame E29D
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402060101/show_ads_impl_fy2021.js?bust=31080971
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:18 GMT
pixel
cm.g.doubleclick.net/ Frame BF66
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=baidu_mediago&google_hm=cb83d64ba58ceca72i1qs500lskqgimc
Requested by
Host: cdn.mediago.io
URL: https://cdn.mediago.io/js/cookieSync.html?tn=41b6e88a2b85b0e731ef8e73e5558712
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://cdn.mediago.io/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
googleads.g.doubleclick.net/pagead/ Frame E49C
430 B
228 B
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=90&slotname=9974430123&adk=1204186157&adf=776189473&pi=t.ma~as.9974430123&w=728&lmt=1707851118&format=728x90&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117978&bpp=2&bdt=342&idt=474&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851119&ga_hid=2129080988&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=239&ady=5826&biw=1600&bih=1200&isw=728&ish=90&ifk=4189538061&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C31081034%2C44795922%2C95322745%2C95324581%2C31080970%2C95320376%2C95320869%2C95324154%2C95324161&oid=2&pvsid=1881542223134899&tmod=2045262062&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C728%2C90&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.kjv8pkvbffbo&btvi=1&fsb=1&dtd=823
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js?bust=31080970
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
14a314d24106ac8077895995fe8996e3f7d564b0d6a4853b5b2f0b1b2f1b6ece
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
207
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:19 GMT
observe-browsing-topics
?1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
sodar
pagead2.googlesyndication.com/getconfig/ Frame F5DB
16 KB
12 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20240208&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js?bust=31080970
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
603518d3710696f34435f9ff80ca6531968d838a94bf35a16e053cf03cdb664b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
12352
x-xss-protection
0
usync.js
eus.rubiconproject.com/ Frame 932E
39 KB
11 KB
Script
General
Full URL
https://eus.rubiconproject.com/usync.js
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.html?p=12776
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.48.9.103 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-48-9-103.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) / PHP/5.3.3
Resource Hash
e278d64ddfda64508978c39309c6daefbd9c8f6890becf14149f5941ae4096d8

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/usync.html?p=12776
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:18 GMT
Content-Encoding
gzip
Last-Modified
Tue, 13 Feb 2024 06:07:28 GMT
Server
Apache/2.2.15 (CentOS)
X-Powered-By
PHP/5.3.3
Vary
Accept-Encoding
Content-Type
text/html; charset=UTF-8
p3p
CP="NOI CURa ADMa DEVa TAIa OUR # BUS IND UNI COM NAV INT"
Cache-Control
max-age=39687
Connection
keep-alive
Content-Length
10921
Expires
Wed, 14 Feb 2024 06:06:45 GMT
SPug
simage4.pubmatic.com/AdServer/ Frame 5A24
0
48 B
Script
General
Full URL
https://simage4.pubmatic.com/AdServer/SPug?partnerID=137711&gdpr=0&gdpr_consent=&us_privacy=1---
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.84 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
all
csm.us.criteo.net/ Frame C500
0
128 B
Ping
General
Full URL
https://csm.us.criteo.net/all?cppv=3&cpp=qiesiqLMBFGc69lolc12UwRKNRXYBQ3PTOkI-mLm5CmhYgQPN-MfCYhdR6Xi3ZvZ8AmBT5A_DvRV2YFw2hISLJaBg0kgr1svsR0iO0MWq9N_uxDfj_2D5JIT-jUA17sGLF7t89Qg1pS9Rl-okj5PF9lwytwB29DHeZxq8A9QJVyaneff4mLxz2AGiDRdVvu73zC_8yov97d1rXaJtd6oQIotYEyE9qNtLo2gv82ffAqFvCwBBlVPkMDffF_MknxIDOOeNzW36J0P6Eg0&sds=2&rev=90562.7&sendBeacon=true
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::16 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://ads.us.criteo.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
cross-origin-resource-policy
cross-origin
server
Finatra
content-length
0
criteo_logo_2021.svg
static.criteo.net/flash/icon/ Frame C500
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/criteo_logo_2021.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
a0e62ca4a82bef79bbe9dc2aba6c0782a7d8eca046bb1baa30ee91ec37931553
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Thu, 27 May 2021 13:21:59 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"60af9cf7-891"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
privacy.svg
static.criteo.net/flash/icon/ Frame C500
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/privacy.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
095c997695f6a290fdba58b778eb0a0fdcdd9c108669e41265527a262223f1e6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Wed, 19 Feb 2020 10:57:21 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e4d1491-646"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
setuid
s2s.t13.io/
Redirect Chain
  • https://hbx.media.net/cksync.php?cs=1&type=pbs&ovsid=setstatuscode&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dmedianet%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%...
  • https://s2s.t13.io/setuid?bidder=medianet&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=3508527156634803000V10
86 B
116 B
Image
General
Full URL
https://s2s.t13.io/setuid?bidder=medianet&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=3508527156634803000V10
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
c2ecff291918a3caf0b7e470323e89f2a1f05b92e12a10649e598cacebe62acf
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
content-type
image/png
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
0

Redirect headers

pragma
no-cache
strict-transport-security
max-age=86400 ; includeSubDomains, max-age=604800
date
Tue, 13 Feb 2024 19:05:19 GMT
server
Apache
p3p
CP="NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA", CP: NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA
location
https://s2s.t13.io/setuid?bidder=medianet&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=3508527156634803000V10
content-type
text/html
cache-control
max-age=0, no-cache, no-store
content-length
154
x-mnet-hl2
E
expires
Tue, 13 Feb 2024 19:05:19 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame D2A7
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176335
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame D779
829 B
560 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
0609ae3df27a7f47d249da2b9ffb8b640d652739d93682f66520460546e7183d
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-NL5lc5uDjkGSuGccvMNxJQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-NL5lc5uDjkGSuGccvMNxJQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Tue, 13 Feb 2024 19:05:18 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
all
csm.us.criteo.net/ Frame A65C
0
127 B
Ping
General
Full URL
https://csm.us.criteo.net/all?cppv=3&cpp=35l3i6LMBFGc69loXdLs-P0jqYBWTSWjk89UotBOTLNkrJ_x-cPWt12qNc4mOXtxflTqQqGX1h7yuRmlK6IaPqDXpa05wLrP3Yfsb8-5Pl7M67quObMx_T13EZbsRKMzgqpBeQv9P-ffVeNS8Xqpl_-bFQIUUf6i6ccqHSZ7kILiIMOIEqhMjgQSmTYkBYSlX_XXszFHvRa0ZTChMmUq-89lghUkXHdHk7ctiHasRa70Q_K1HdjU2bI2sySQ-2bcd6TZnMJedAjsoFKg&sds=2&rev=90562.7&sendBeacon=true
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::16 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://ads.us.criteo.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
cross-origin-resource-policy
cross-origin
server
Finatra
content-length
0
criteo_logo_2021.svg
static.criteo.net/flash/icon/ Frame A65C
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/criteo_logo_2021.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
a0e62ca4a82bef79bbe9dc2aba6c0782a7d8eca046bb1baa30ee91ec37931553
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Thu, 27 May 2021 13:21:59 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"60af9cf7-891"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
privacy.svg
static.criteo.net/flash/icon/ Frame A65C
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/privacy.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&u=%7CVUhCKAOtdUaLsCy7crBA%2B4dVRY633DesePxIzj13Ewg%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSbzkR07LsYrxL5Vawmq2Jt4LJ85mTuDFyX0TLyVFcpVNZVJhiEGHkQecgSML8U9DMsdJoWWwRWxJeSzUNqWCc82Mks9kz7H0Tg-DKYyAiUeCHWcjXSROM3cAf-0_MwPZ_l5B3f3FsUARRDqBOWLxAC2seEe0blAfOIq8iWZ_FWQ_EiEWXJtA0SFUUpcWn29S1lH_A4lfUbkTdk1bKbB9oXwRStrSO3Hj2YwDkXEz8Sbiqzr0slhJHu4pTCYPJKX61lXJuzyLFlOKrEHhY4NEDryF6KGxaqsSFsLRLl8UaaJuFK6wIcWQajfF0-elYUlyM3c6aVDWh_VXbI-n7dvyhp7NTO0xfhHZfGeVsO7SFY9R0LEnKEvZrG0cKYRe3k4R_uk3pmX26LzPq3OXo5UxnVVgXzamMhuYCf8SpjlwhwJVvpFhvns3Nsy-zrQQQRFdPA4IDSMKe5JvmwiHECIUGnljrAwtSQfeDxRK7hCGkgextapN_sw0iSlTKl-9aS_6RQUyLewIRwv-wd50oG4ynyr_xiHSK_8NPaZA94lxU2gvKKV1ssI66IqY1NXvp55jpuF3PbSEyhCkA&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DCZQQTbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTIAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_admXMXfl1V5n_mpY_u0qVL5huVF2kGN-PSpwkJ5vbZ2vUv9hQpAtMaABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA_oLAggBgAwB0BUBgBcB%26num%3D1%26sig%3DAOD64_0RrsGL90j5Xps94nj-1xic4Sz2nQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
095c997695f6a290fdba58b778eb0a0fdcdd9c108669e41265527a262223f1e6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Wed, 19 Feb 2020 10:57:21 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e4d1491-646"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:18 GMT
PugMaster
image6.pubmatic.com/AdServer/ Frame C24E
2 KB
2 KB
Script
General
Full URL
https://image6.pubmatic.com/AdServer/PugMaster?sec=1&async=1&kdntuid=1&rnd=59063497&p=156696&s=0&a=0&ptask=ALL&np=0&fp=0&rp=0&mpc=0&spug=1&coppa=0&gdpr=0&gdpr_consent=&us_privacy=1---
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.81 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
6b8d39078f65fad9d3a2b2604a3c8d0fe29f795db00dc612269ec5971d4e0928

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
1605
content-type
text/html; charset=UTF-8
adview
googleads.g.doubleclick.net/pagead/ Frame 18AA
0
19 B
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/adview?ai=CEnDPbb3LZdaFCo6ZvPIPpK2MuA-jprHLbIXIn6mtEMCNtwEQASAAYMnujovApIwQggEXY2EtcHViLTQ4NjQyODYzMDAzNTU1MzbIAQmoAwHIAwKqBL8CT9DDVMu_JtR5Mln6BtncpPVFH-RJLmD8TxOruIwxqLbp-C01UN7Q3c9FWCX-gDdi7npfIRxBwcb00xTWjQdA9CaaDdivSi4xbqWTJzrSsJl615tv-rr99Bix_zlGXC1-u7fF3NEyCfMkFxd2VHLL6gXagCbItIsFLw0AVfUH-T20qAv1Rg0f_B11Ea1m_7BDkxpCXn4jMFGCW_gkGpO0BTbdTSnaM2EPguftLfHuZcsrzgNEktPPzTC_hNviEVvs2XbdjGDzXkpLTT288TW0jvCTuBViVLCk7-c8ljdrJQUwDBlGM_secXibpY2QQKddELp_KF3dkC3v-6IaaBuFmHTf0hSXWK4Fsae2dJRtu_5tXuDXCK5zSC9pT5MS8PybNAohP4LWV4lxeV0pxtj-vxGYkZ0yNxHQVPCrwyJUOYAGoYmUhrHRhoGmAaAGIagHpr4bqAeW2BuoB6qbsQKoB4OtsQKoB_-esQKoB9-fsQKoB62-sQLYBwDSCCIIgGEQATICigI6CYBAgMCAgICACEi9_cE6WLW4q5mBqYQDgAoB-gsCCAGADAHQFQGAFwGyFxoKGBIUcHViLTQ4NjQyODYzMDAzNTU1MzYYAA&sigh=ugUc8G32B7I&uach_m=%5BUACH%5D&cid=CAQSPAAvHhf_wxvelvCCCUQ-GyOdpPUbogvRB4jplYbKMwNOOtvoQCKeci3nBwCWZdvh-02PS2lu8Xu7t_igWRgB&cbvp=2&vis=1
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-security-policy
script-src 'none'; object-src 'none'
date
Tue, 13 Feb 2024 19:05:19 GMT
x-content-type-options
nosniff
server
cafe
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
winnotice
trace.mediago.io/api/log/ Frame 18AA
0
41 B
Image
General
Full URL
https://trace.mediago.io/api/log/winnotice?tn=41b6e88a2b85b0e731ef8e73e5558712&winloss=2&id=83b0fa97f3c1158b29604c3d902983c2&seat_id=${AUCTION_SEAT_ID}&currency=${AUCTION_CURRENCY}&bid_id=${AUCTION_BID_ID}&ad_id=${AUCTION_AD_ID}&loss=${AUCTION_LOSS}&imp_id=1&price=${AUCTION_PRICE}&test=0&time=1707851117&dp=wzIfcBUsFEyeWOk2Mm5G51F-mFeY834Yu5m78VeRsFU&dsp_id=22&data=Gd_Y7sPYX0aFEIv88cwGNEyWpDhukZP_DUmlXCL17VZbIsAeIYzhDK0NtkQr9xOH4vdyR5y1pN0UP-ckHaWUtW5yAaani2V-a-a_f0K-U1iPxNoyNvIyDRcm8CDLz3DJMI61OAsVdc8n0iNC3TDcqogvWRMDYeN5XBUGOQ5opr5d6we3mQ5NVVlK92wDqojR1NXmzW2umxCkMizAWz_hDmJGLVdR5yCfEVhgnGL0LgXCi9or7XrwFzk17C6l8oiDuny0srVjnisA4y8heznEbV1TQcY0tx0CPBmMmG_JASXgwY2FvYfUIAQhrXUtE75-zE4KpHVGi9VU3mD3MLccsDkC6poVjrInUAVv8I_uQ5Xxaal3ttOQT1ii-TjTDofGFtvDIaVJ9S05VhghDbmiqyOlgi85mUYYdrGHPF5aHenZTSmBiXn2Dx-Lc2TJaElnSCUDtfZfzZIadTQdTaLyZs7UNowB2yUIo4GfKWVIdTcHOuaqiwEwfVIDobY8OsYKx_xxruLUwRHtvTx72CZ0WgCafq5j-WSg9uxo-N-eQDKUFSX0aM5262vuybVqpG4tGSzBvwD-4VQEdXU8fL-mxEvpwnB57kip6HisYkCtg4JIY6be8KnSBzQHl1rSBG2_Qh1o5Iqnh0cByIv5RJWzJ8qEweRUVFpemrGmsI0ZNKU&trackingid=7d4e1bd83603179086e59fb6e3a382df&sp=wzIfcBUsFEyeWOk2Mm5G51F-mFeY834Yu5m78VeRsFU&cbvp=2
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.208.249.213 Council Bluffs, United States, ASN19527 (GOOGLE-2, US),
Reverse DNS
213.249.208.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
content-type
text/plain; charset=utf-8
async_usersync
ib.adnxs.com/ Frame 70C5
0
914 B
Script
General
Full URL
https://ib.adnxs.com/async_usersync?cbfn=queuePixels
Requested by
Host: acdn.adnxs.com
URL: https://acdn.adnxs.com/dmp/async_usersync.html
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.160.117 New York, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://acdn.adnxs.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
an-x-request-uuid
ebf876d8-99a9-4203-b48e-fa419db6be27
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
cache-control
no-store, no-cache, private
x-proxy-origin
96.9.249.44; 96.9.249.44; 676.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
sodar2.js
tpc.googlesyndication.com/sodar/ Frame F5DB
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402050101/show_ads_impl_fy2021.js?bust=31080970
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Tue, 13 Feb 2024 19:05:18 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame 8C3D
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/window_focus_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 08:58:05 GMT
content-encoding
br
x-content-type-options
nosniff
age
36434
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 08:58:05 GMT
qs_click_protection_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/ Frame 8C3D
20 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240208/r20110914/client/qs_click_protection_fy2021.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
245cec0922828c15b3709eb696bb5a565f2f911f71e242024570698701c9540c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 14:32:53 GMT
content-encoding
br
x-content-type-options
nosniff
age
16346
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8220
x-xss-protection
0
server
cafe
etag
16176141338659805634
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 27 Feb 2024 14:32:53 GMT
l
www.google.com/ads/measurement/ Frame 8C3D
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaTX5nrde88l5inbX804NmGv2_j3pXU-uVgU8hw2ySZlsa_9eT1xFiH4JMyRyhoBRH0-Jfy4bm3LxyH6fNec4R0bHtakKg
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame 8C3D
203 KB
61 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
23d11567502488b4905a85c8ce6a03d6ce539620fa559b8f24a2a95b292a2c6a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 18:24:35 GMT
content-encoding
br
x-content-type-options
nosniff
age
2444
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
62553
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 13 Feb 2024 19:24:35 GMT
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame 8E2F
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127750
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
adview
googleads.g.doubleclick.net/pagead/ Frame 9942
0
19 B
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/adview?ai=C-BSVbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoExQJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVemvywkHijlATzmqIvanS3w0t1aHLTf9-oaCfMnjgTpgy1XJU8zwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAOACgH6CwIIAYAMAdAVAYAXAbIXGgoYEhRwdWItNDg2NDI4NjMwMDM1NTUzNhgA&sigh=ilyXs31L5dE&uach_m=%5BUACH%5D&cid=CAQSOwAvHhf_5UAw0ti__FKsauRbcBXZOogXZXUYEAqcmUnhmY7V_D4fc9b_MuslredCTvC62txhjIPrYYbXGAE&cbvp=2&vis=1
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-security-policy
script-src 'none'; object-src 'none'
date
Tue, 13 Feb 2024 19:05:19 GMT
x-content-type-options
nosniff
server
cafe
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
notify
rtb.da.us.criteo.com/google/auction/ Frame 9942
0
125 B
Image
General
Full URL
https://rtb.da.us.criteo.com/google/auction/notify?profile=14&payload=kZuSGdWCMKwC-gHiIp0XAgAAAPYtF9o25dhCY1GCXxBsvctltN-hanBxF7uP8gAAEgAACgpBUVVEREFFQkRB&wp=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&cbvp=2
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189487&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116987&bpp=3&bdt=516&idt=457&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=579010336&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=645&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=2988651199&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808398%2C31081025%2C95324580%2C31081078%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3401264131360314&tmod=972274635&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sdwikabis3h7&btvi=1&fsb=1&dtd=631
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a005::14 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
server-processing-duration-in-ticks
219463
server
Kestrel
content-length
0
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame BAA0
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127750
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
khaos.json
token.rubiconproject.com/ Frame DBBD
7 B
789 B
XHR
General
Full URL
https://token.rubiconproject.com/khaos.json?gdpr=0&us_privacy=1---&khaos=LSKQGI85-W-KKFE
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
a1dd48c657971696c2087f2a6beb489ee65b25320b763222f10718dd93e9149e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://eus.rubiconproject.com
Cache-Control
no-cache,no-store,must-revalidate
access-control-allow-credentials
true
content-length
7
X-RPHost
8bab65602db075726861004da5629947
Expires
0
sodar
pagead2.googlesyndication.com/pagead/ Frame FDAA
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=1605499748962416&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

adview
googleads.g.doubleclick.net/pagead/ Frame F299
0
19 B
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/adview?ai=CPeLQbb3LZf-GJ4u-998P_c-XGJyB77BcosqnqnTAjbcBEAEgAGDJ7o6LwKSMEIIBF2NhLXB1Yi00ODY0Mjg2MzAwMzU1NTM2yAEJqAMByAMCqgTFAk_Qp3gL8fWkiWL7qGbW6gU2zvXZeKmNl4IENgi3T_b4BOpZTcE-k0Z1mv5QQAuGuIAvNoqFicouUXb7FgebnmKw2gFIQb5iCnLopKusqc1gHbxOLwwAk1yJUaeElJY75U_XINfoVMcEbKK_rcV62DNZwXtnUD3tXUkpdGwVyBlzUPZxTFPhA_zPTQs30a0ZXJOeVK5yK6qdmt7uEotWyQ1lm3_e-Qm6xJg8ivvz2HLceQ1BB8xpu236jJ_7wDoGDQqnhOHd8Eq4ZrPwzXDss8NcIoJeln1i3QXTq4ZClw5ytnvWgAG9BAozewmcMMEKuRaEJz5kdme54bC0x0X-h3iS7GcdRQYNj8vgv45sl_KbmxWyFV1TSo5cRh_LP7Z3_eVkfFcZKr4DFhKWt3eNTvZIic1M9FlJYwfTS4vHo5puPI9pvO2ABsCbiZmQi6aK2gGgBiGoB6a-G6gHltgbqAeqm7ECqAeDrbECqAf_nrECqAffn7ECqAetvrEC2AcA0ggiCIBhEAEyAooCOgmAQIDAgICAgAhIvf3BOli29caZgamEA4AKAfoLAggBgAwB0BUBgBcBshcaChgSFHB1Yi00ODY0Mjg2MzAwMzU1NTM2GAA&sigh=D6bjHL-UZYQ&uach_m=%5BUACH%5D&cid=CAQSOwAvHhf_Mm21G8fZbJJOTT5KsK4HRBZK82wMZwQPiH1irMAsNtuNsHS4QtU8kG_60Kh38RXA5BR7-USwGAE&cbvp=2&vis=1
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-security-policy
script-src 'none'; object-src 'none'
date
Tue, 13 Feb 2024 19:05:19 GMT
x-content-type-options
nosniff
server
cafe
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
notify
rtb.da.us.criteo.com/google/auction/ Frame F299
0
126 B
Image
General
Full URL
https://rtb.da.us.criteo.com/google/auction/notify?profile=14&payload=kZuSGdWCMKwC-gHiIp0XAgAAAPYtF9o25dhCY1GCXxBtvctlJTmsc0sEZsbOegAAEgAACgpBUVVCREFFQkRB&wp=Zcu9bQAJw38F_d8LAAXn_bIsCqZC8MrSZSOEGw&cbvp=2
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a005::14 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=31536000; preload;
server-processing-duration-in-ticks
292560
server
Kestrel
content-length
0
c
c.pub.network/v2/
36 B
54 B
Fetch
General
Full URL
https://c.pub.network/v2/c
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/analytics/1.3.1/analytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
bde433056dc7524e1e94944f59ed149f0d1b874dee650009a4c24367294a6554
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
strict-transport-security
max-age=31536000
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://reason.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36
c
c.pub.network/v2/ Frame
0
0
Preflight
General
Full URL
https://c.pub.network/v2/c
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.160.152.31 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
31.152.160.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://reason.com
access-control-max-age
1800
allow
GET, HEAD, POST, PUT, DELETE, TRACE, OPTIONS, PATCH
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=31536000
vary
Origin Access-Control-Request-Method Access-Control-Request-Headers
via
1.1 google
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame E5BB
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176336
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame ED77
829 B
560 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
4a0043ccec851fa50dff41c3b23b7f8d361eaf51e73636424602ffe8c98130f4
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-1IhJFvuYWJvYrxpMDDwRVA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-1IhJFvuYWJvYrxpMDDwRVA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:19 GMT
expires
Tue, 13 Feb 2024 19:05:19 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
afr.php
ads.us.criteo.com/delivery/r/ Frame 02ED
51 KB
19 KB
Document
General
Full URL
https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::24 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
e79010117f282208fe6f5d9fd76015c4f3833dd007171efce28ddde81b60dbed
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
*
access-control-max-age
1000
cache-control
private, max-age=0, no-cache
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:18 GMT
expires
Mon, 26 Jul 1997 05:00:00 GMT
link
<pix.us.criteo.net>; rel=preconnect; crossorigin, <static.criteo.net>; rel=preconnect; crossorigin
p3p
CP='CUR ADM OUR NOR STA NID'
pragma
no-cache
report-to
{"endpoints":[{"url":"https://csm.us.criteo.net/heavyad?cppv=3&cpp=RiNnO6LMBFGc69loVGzWmoXRpih2mD5x0OOfO4pxa3t_pQGjab9ybJJV63zi71grQcG6L9q19-c58xXoTziY-mJFv0_Jy07Yds2godKebrhC3aMQJZeYiDP72o9QUWuExDxu_9SYFVqtRwzUTjvRuRl5UeQ1RHz2mP5444N5uUJUE3kCQEoVSU4m4o_Eq3vvW_1NKBfik5gPMll0dMzm9XGsczXD9g_FPQUv3FAZEOECPMcRzAePOOx6wVBnhP398dQ1eZWwvaDl2kqI"}], "max_age": 86400}
server
Kestrel
server-processing-duration-in-ticks
2970082
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
cookie_push_onload.html
pagead2.googlesyndication.com/pagead/s/ Frame 8BE6
1 KB
647 B
Document
General
Full URL
https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://googleads.g.doubleclick.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

age
80174
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=86400
content-encoding
br
content-length
618
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Mon, 12 Feb 2024 20:49:05 GMT
etag
48472445140208031
expires
Tue, 13 Feb 2024 20:49:05 GMT
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame 6823
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176336
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame F606
829 B
561 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
da49ef42ece8f8de4d29c11bf20055830195e1cbeadc7c1dd26bfb1ca3d46f60
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-yoqnxG5eKYkQw393vw4qxA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-yoqnxG5eKYkQw393vw4qxA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:19 GMT
expires
Tue, 13 Feb 2024 19:05:19 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
sync
usr.undertone.com/userPixel/ Frame DBBD
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=12776&us_privacy=1---&us_privacy=1---&gdpr_consent=undefined&gdpr=0&khaos=LSKQGI85-W-KKFE
  • https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
0
139 B
Image
General
Full URL
https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
Requested by
Host: cdn.undertone.com
URL: https://cdn.undertone.com/js/usersync.html?gdpr=&gdpr_consent=&us_privacy=1---&redirect=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dundertone%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D%24UID
Protocol
H2
Server
3.234.97.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-97-29.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
content-length
0

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://usr.undertone.com/userPixel/sync?partner=rubicon&uid=LSKQGI85-W-KKFE&gdpr=0&gdpr_consent=undefined&us_privacy=1---
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
f72efbd84733ea5ba734e4e8fe0395a3
Expires
0
c
gtrace.mediago.io/ju/log/ Frame 18AA
0
39 B
Ping
General
Full URL
https://gtrace.mediago.io/ju/log/c?tn=41b6e88a2b85b0e731ef8e73e5558712&trackingid=7d4e1bd83603179086e59fb6e3a382df&mguid=&app=vimpLog&ext={%22name%22:%22REAL_VIMP%22,%22vimp_elapsed_time%22:2022,%22time%22:1707851119148,%22intersectCount%22:1,%22intersectErrCount%22:0}
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.208.249.213 Council Bluffs, United States, ASN19527 (GOOGLE-2, US),
Reverse DNS
213.249.208.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
content-type
text/html; charset=utf-8
ic
trace.mediago.io/ju/ Frame 18AA
0
120 B
Image
General
Full URL
https://trace.mediago.io/ju/ic?tn=41b6e88a2b85b0e731ef8e73e5558712&trackingid=7d4e1bd83603179086e59fb6e3a382df&acid=24677&data=XjU5ojT5QP3AFt1cocgSH1glpBo2Scrxdzjy0VMefhJsBUGf4QYwCCASbQz4hxTr-DKfTnBsQqxr1z1F8cEj2kiOU0esoOi35VDmLIeeNYmsG6OT9JkeYl74MvX-5279WLbE1WwpFFnJNQPSRP7sBtyyl0rPotXczmlWyeKqu02WmxMgjnjaozS3BYnxOFUucpK8URI7OwaZNhKloB72_1pEOS4PBnb-9aW585AFlnKzCtdNCdusZoC-edC6SyxNQaMGf0xJYMVEvsSCW2FEOK_lYIuR0QBLI3Xu9iKX3g5BQMGDB9IWAzC8dQ-47fMmy9I7mJFSnXgsstqGFGtKsa10IPcCGEHz2gPpxQyEbUpVhWs5zE8qluintTJvi25L98N6Cd6mrv8r15ok2JBbqLE7zuwbco3YOZ9OBvtUZommYTEInkDC7TAIDuLsW0kyRCtrMp3u62xYt4wnlcVuxTK0kwF4EpcYQ0Jz3XivBv6Qi8w9sS5W_KHMVAy_ALWy0AtoC20cGV3eOlQ14i3HKMycmH-WlT6sgTgBt7iKMXZidEhYHLt0_kGGmXmDuB8Q2plCvuZN28VVEn3JiritPqRzM3kTe9RgxDljXgoACzqnopiCt9igauZBHbLPSj-UhmVPKPYqG9jPH3clPlV5fH8K0d0unhaxUjaN3zSTWoK2AgJN2V5g39rLg92H6tb1HqmAHDOJb2w0SyRaWldaZRu3lpArttcj6r9agi3_1l5kKcVsvBaGhkbHqIbwYXhnlj5g1M3hNqLPOaM2IL1xpLByayRD3cf1AVS_QOc9unS9dR2lfJlVEoWzKBsdq1f40ap4DY__U1suQ-KEaFIzU2wRIPbzkmeNf_yUSCF_gbZ4mWWgv8vQG5mKqXE-0Kzmn9KHTJ5YWWxYGOOsINT0UbGZwG4hnZCfLyl-4l11eZWWxsAFcaNF0aDjARlyiE4-Q4xD6iaJVEHMzQ8cEwi93nk_c1Y2pPzKnq4ipFM75RzdjXlrqwvWHjpj1-ymPHannyLaN42QdMmpiM1S64ziRGhHcZ_maOCG_GULL0Ox8RdF4dTHoFxAEi6YKpDJLNo2TCZho_cdpSCrukF3kseaJLfLxfbH3Qe0xUa9P2jZ0lstPZl06FIgfY8dQPbhXSI6V1FivaYJ4o02MZWE2etPhNw-UCP_UxHe6xTODEXpXHWSzONxHCWmsu0oaYZjWd8x78CvNawDhtOmmHOqNRoMGyRNcuQL0EAOielx27NlirjsNwJ14AtOY8AEJwdfBs-x7yz7wqUjWWnLDYTOOF4IYjxippEPJnsSFX0BE1k4tvbb_exKiXLe_7h9TZoJYGIHuf6dN0777A4eEnU_JPmM2gJl48o_bf7ns_YyLbFupTUqxv6Tv3hUzRTiAfIb_hSw&uid=CAESEHfZtabLPTaTx-wyzbcrnzU&mguid=&ap={AUCTION_PRICE}&tid=73
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=50&slotname=4196036390&adk=2572591299&adf=776186306&pi=t.ma~as.4196036390&w=320&lmt=1707851117&format=320x50&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116351&bpp=4&bdt=817&idt=399&shv=r20240208&mjsv=m202402050101&ptt=9&saldr=aa&cookie=ID%3Dd5ffbbb955957670%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MY6iDLwpU1qCuRWH13QhHxheOnS-Q&gpic=UID%3D00000a0d70917b1a%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_MbwifL-DcNUp-THU2EKOcKcbKlLeQ&correlator=6558674513952&frm=23&ife=4&pv=2&ga_vid=1991233376.1707851114&ga_sid=1707851117&ga_hid=204674647&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=621&ady=1150&biw=1600&bih=1200&isw=320&ish=50&ifk=712095176&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44808397%2C44795922%2C95324580%2C95320869%2C95322388%2C95324154%2C95324161&oid=2&pvsid=2426265541848191&tmod=186105118&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C320%2C50&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.axwt2io38xwc&fsb=1&dtd=773
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.208.249.213 Council Bluffs, United States, ASN19527 (GOOGLE-2, US),
Reverse DNS
213.249.208.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-type
text/html; charset=utf-8
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame CF37
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127750
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 18AA
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssjYY87W5Gjyc7l26J1up1sMdmouZ9nCwcwWH14C9nHSbv0j346aNpItk-CBTwfWbQ0gvLWAcRdjwH7xx1-6VJpsZtyvXckj2IoJo5bjLxSPMaskDKbcBHouLrKSOFrexgSzqho4h4&sig=Cg0ArKJSzKmrULu4l05JEAE&id=lidar2&mcvt=1068&p=0,0,50,320&mtos=1068,1068,1068,1068,1068&tos=1068,0,0,0,0&v=20240208&bin=7&avms=nio&bs=0,0&mc=1&if=1&vu=1&app=0&itpl=20&adk=2572591299&rs=2&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&vs=4&r=v&co=378391800&rst=1707851117126&rpt=929&met=mue&wmsd=0&pbe=0&vae=0&spb=0&ffslot=0&reach=8&io2=0
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
privacy_small.svg
static.criteo.net/flash/icon/ Frame 02ED
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/privacy_small.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
a71fdb2af0679f36edbf63eb7944dc2403c85572d9de916cfcb12bf6277c5c37
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Tue, 11 Feb 2020 14:30:28 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e42ba84-6aa"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:19 GMT
adchoices_en.svg
static.criteo.net/flash/icon/ Frame 02ED
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/adchoices_en.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
60bcafbd631f6fa0805e158ca3b235e76225350db6fbb423596d4c4954b27573
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Tue, 11 Feb 2020 14:27:58 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e42b9ee-759"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:19 GMT
close_button.svg
static.criteo.net/flash/icon/ Frame 02ED
308 B
636 B
Image
General
Full URL
https://static.criteo.net/flash/icon/close_button.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
8ec89605fe3d580e9539c7b858e8f69ba4e26fe06377ebe04585397de23a7395
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Fri, 14 Feb 2020 13:51:32 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"5e46a5e4-134"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
308
expires
Fri, 07 Feb 2025 19:05:19 GMT
back_button2.svg
static.criteo.net/flash/icon/ Frame 02ED
293 B
621 B
Image
General
Full URL
https://static.criteo.net/flash/icon/back_button2.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
725e869434fef8013208ed4c233d29744f9b363f867dcfb8f23e862880fa699a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Thu, 28 Apr 2022 09:09:48 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"626a59dc-125"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
293
expires
Fri, 07 Feb 2025 19:05:19 GMT
lg.php
cat.va.us.criteo.com/delivery/ Frame 02ED
43 B
347 B
Image
General
Full URL
https://cat.va.us.criteo.com/delivery/lg.php?cppv=3&cpp=mulwsWOyIxMwT1sapC2cs_EGQbMIcyY0z5e2K51vSv8WG0ATzUFMB14-QxCGvFknC2Uy_6Tn_6fnmeNGdbY9cogqZp2FKXOgvzlyKpiSIt8NA1DPXVsdPidcb6jvxzxizNFtyhgTlgG9U3BQw3KJ1bqQ2X1GK3S8_Y4rIH_kuoeVIQ_1unhhq-QCW7Fh77rChP7nsIuyPX6KdhKLG8PYj0T4Fdqd_9XWlY7FqUAWpnYnD0TFZNRWP0MGJ590KL4Gz_uAzDHgXa9y7UqmZoa7h83Ngsjrw534fYQ-lF32nf7rv2I1529GFRMQsapwlQ0GCSFfKqAUoQNGFIJ8h3QsTpv6VZICJJhIks1qmjXX1x9M1hvdvD7xIRbRjh4UCC5ajQ7Ifvotf2bsdM5QbsM14UMGNQMsXpNK1XQzKJC9qsBeK9I1
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.119.147 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
server
Kestrel
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
content-type
image/gif
cache-control
no-cache
cross-origin-resource-policy
cross-origin
server-processing-duration-in-ticks
4351088
expires
Mon, 26 Jul 1997 05:00:00 GMT
75e7b302a8f9469fa34c3ec8b22179ff_image_ad_160x600.gif
static.criteo.net/design/dt/21742/5096633/ Frame 02ED
77 KB
78 KB
Image
General
Full URL
https://static.criteo.net/design/dt/21742/5096633/75e7b302a8f9469fa34c3ec8b22179ff_image_ad_160x600.gif
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
fa5ac517cf39863d92c7777943bf5918517e8a3ccc382bdd87f16210be96af9f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=31536000; preload;
last-modified
Fri, 10 Nov 2023 17:59:56 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
"654e6f9c-135ef"
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
79343
expires
Fri, 07 Feb 2025 19:05:19 GMT
khaos.json
token.rubiconproject.com/ Frame 932E
7 B
797 B
XHR
General
Full URL
https://token.rubiconproject.com/khaos.json?gdpr=0&us_privacy=1---&khaos=LSKQGI85-W-KKFE
Requested by
Host: eus.rubiconproject.com
URL: https://eus.rubiconproject.com/usync.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
69.173.151.100 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
a1dd48c657971696c2087f2a6beb489ee65b25320b763222f10718dd93e9149e

Request headers

accept-language
en-US,en;q=0.9
Referer
https://eus.rubiconproject.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://eus.rubiconproject.com
Cache-Control
no-cache,no-store,must-revalidate
access-control-allow-credentials
true
content-length
7
X-RPHost
d67ad46d58ddbab9fb03c088eabaaff8
Expires
0
Pug
image2.pubmatic.com/AdServer/ Frame FC01
Redirect Chain
  • https://gocm.c.appier.net/pubmatic
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDImdGw9MTI5NjAw&piggybackCookie=YDtbzodyBEeUV3z0b73LZQ
42 B
307 B
Document
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDImdGw9MTI5NjAw&piggybackCookie=YDtbzodyBEeUV3z0b73LZQ
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:19 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

accept-ch
Sec-CH-UA-Model,Sec-CH-UA-Platform-Version
cache-control
no-store
content-length
153
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:19 GMT
location
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDImdGw9MTI5NjAw&piggybackCookie=YDtbzodyBEeUV3z0b73LZQ
p3p
CP="CUR ADM DEV TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
nginx
Pug
simage2.pubmatic.com/AdServer/ Frame 1009
Redirect Chain
  • https://sync.1rx.io/usersync2/pubmatic&gdpr=0&gdpr_consent=
  • https://x.bidswitch.net/sync?ssp=adconductor&user_id=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005&rndcb=4688430332
  • https://t.pswec.com/bsw_sync?ssp=adconductor&bsw_user_id=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://t.pswec.com/ul_cb/bsw_sync?ssp=adconductor&bsw_user_id=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://x.bidswitch.net/sync?dsp_id=2&user_id=93c731c1-bdeb-4853-a081-688267ddafe8&expires=3&user_group=1&ssp=adconductor
  • https://sync.1rx.io/usersync/bidswitch/d9962442-c73f-42a4-adbd-3d9517e387ff?gdpr=&gdpr_consent=&us_privacy=
  • https://sync.targeting.unrulymedia.com/csync/RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005?redir=https%3A%2F%2Fsimage2.pubmatic.com%2FAdServer%2FPug%3Fvcode%3Dbz0yJnR5cGU9MSZjb2RlPTMyMDMmdGw9NDMyMDA%...
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDMmdGw9NDMyMDA=&piggybackCookie=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
42 B
458 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDMmdGw9NDMyMDA=&piggybackCookie=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:19 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

content-type
text/html
date
Tue, 13 Feb 2024 19:05:19 GMT
etag
RXe2af2325e28b4fd4b66772f44cc57a3b005
location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMyMDMmdGw9NDMyMDA=&piggybackCookie=RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
cm
ipac.ctnsnet.com/int/ Frame 87BA
43 B
304 B
Document
General
Full URL
https://ipac.ctnsnet.com/int/cm?exc=14&redir=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MTEmdGw9MjAxNjA=&piggybackCookie=[user_id]
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.186.193.173 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
173.193.186.35.bc.googleusercontent.com
Software
Apache-Coyote/1.1 /
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, must-revalidate
content-length
43
content-type
image/gif
date
Tue, 13 Feb 2024 19:05:19 GMT
expires
Fri, 01 Jan 1990 00:00:00 GMT
p3p
CP="NOI DSP COR NID CUR OUR NOR"
pragma
no-cache
server
Apache-Coyote/1.1
via
1.1 google
pub
matching.truffle.bid/sync/ Frame B026
0
0
Document
General
Full URL
https://matching.truffle.bid/sync/pub?sid=161&suid=https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0NDQmdGw9MjAxNjA=&piggybackCookie=$UID
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
23.88.86.2 Gunzenhausen, Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
static.2.86.88.23.clients.your-server.de
Software
nginx/1.23.1 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Connection
keep-alive
Date
Tue, 13 Feb 2024 19:05:19 GMT
Server
nginx/1.23.1
Strict-Transport-Security
max-age=15768000
cookiesync
core.iprom.net/ Frame 39D4
43 B
282 B
Document
General
Full URL
https://core.iprom.net/cookiesync?gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
195.5.165.20 , Slovenia, ASN44968 (IPROM-AS, SI),
Reverse DNS
Software
/
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Connection
close
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:20 GMT
Vary
Accept-Encoding
X-adserver-worker
avatar-00fdad8cca7d@version_1.6.0-pre8
X-core-time
0ms
X-server-arch
v2
Pug
simage2.pubmatic.com/AdServer/ Frame 5434
Redirect Chain
  • https://px.owneriq.net/epm?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw&piggybackCookie=$UID
  • https://px.owneriq.net/ecc?redir=https%3a%2f%2fsimage2.pubmatic.com%2fAdServer%2fPug%3fvcode%3dbz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw%26piggybackCookie%3dQ7611375191439378190&uid=Q761137519143937...
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw&piggybackCookie=Q7611375191439378190
42 B
113 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw&piggybackCookie=Q7611375191439378190
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
1866961a029c65376fefb7f2ba1e6187e09ff50ea58d97dedfd72c197947d002

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
42
content-type
image/gif; charset=utf-8
date
Tue, 13 Feb 2024 19:05:18 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

Cache-Control
max-age=20314
Connection
keep-alive
Content-Length
154
Content-Type
text/html
Date
Tue, 13 Feb 2024 19:05:19 GMT
Location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMwNzMmdGw9MTI5NjAw&piggybackCookie=Q7611375191439378190
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Server
Apache/2.4.6 (CentOS)
Vary
Accept-Encoding
X-Powered-By
PHP/7.3.33
Pug
simage2.pubmatic.com/AdServer/ Frame C3CD
Redirect Chain
  • https://um.simpli.fi/pm_match?https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjkzNiZ0bD00MzIwMA==&piggybackCookie=uid:$UID&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjkzNiZ0bD00MzIwMA==&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67&gdpr=0&gdpr_consent=
1 B
53 B
Document
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjkzNiZ0bD00MzIwMA==&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67&gdpr=0&gdpr_consent=
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.248.18.37 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
36a9e7f1c95b82ffb99743e0c5c4ce95d83c9a430aac59f84ef3cbfab6145068

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
no-store, no-cache, private
content-length
1
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:19 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
nginx

Redirect headers

access-control-allow-headers
DNT,X-Mx-ReqToken,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
*
cache-control
no-cache
content-length
142
content-type
text/html
date
Tue, 13 Feb 2024 19:05:19 GMT
expires
Mon, 12 Feb 2024 19:05:19 GMT
location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MjkzNiZ0bD00MzIwMA==&piggybackCookie=uid:0E087FD3E115403AB68AFF630D65CE67&gdpr=0&gdpr_consent=
server
openresty
strict-transport-security
max-age=63072000; includeSubdomains; preload
x-content-type-options
nosniff
insync
thrtle.com/ Frame C24E
Redirect Chain
  • https://thrtle.com/insync?vxii_pid=10067&vxii_pdid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
  • https://thrtle.com/insync?gdpr=0&gdpr_consent=&vxii_pdid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&vxii_pid=12&vxii_pid1=10067&vxii_rcid=8ca19971-6315-4afa-a9aa-726bd1cf013a
43 B
295 B
Image
General
Full URL
https://thrtle.com/insync?gdpr=0&gdpr_consent=&vxii_pdid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&vxii_pid=12&vxii_pid1=10067&vxii_rcid=8ca19971-6315-4afa-a9aa-726bd1cf013a
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
44.197.50.199 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-197-50-199.compute-1.amazonaws.com
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI OUR BUS UNI COM NAV"
date
Tue, 13 Feb 2024 19:05:19 GMT
content-length
43
content-type
image/gif

Redirect headers

location
https://thrtle.com/insync?gdpr=0&gdpr_consent=&vxii_pdid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&vxii_pid=12&vxii_pid1=10067&vxii_rcid=8ca19971-6315-4afa-a9aa-726bd1cf013a
date
Tue, 13 Feb 2024 19:05:19 GMT
content-type
text/html; charset=utf-8
content-length
211
p3p
CP="NOI OUR BUS UNI COM NAV"
sd
us-u.openx.net/w/1.0/ Frame C24E
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=540245193&val=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT
Martin
crb.kargo.com/api/v1/dsync/ Frame C24E
43 B
359 B
Image
General
Full URL
https://crb.kargo.com/api/v1/dsync/Martin?exid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.84.174.131 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-84-174-131.compute-1.amazonaws.com
Software
/
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
x-accel-expires
0
vary
Origin
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate, private, max-age=0
content-length
43
expires
Thu, 01 Jan 1970 00:00:00 UTC
sync
sync.bfmio.com/ Frame C24E
0
425 B
Image
General
Full URL
https://sync.bfmio.com/sync?pid=187&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.54.225.252 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-54-225-252.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Connection
keep-alive
Date
Tue, 13 Feb 2024 19:05:18 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame 9A41
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
age
176336
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 11 Feb 2024 18:06:23 GMT
expires
Mon, 10 Feb 2025 18:06:23 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame 4761
829 B
558 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c08::69 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
5a329ae2e2c5dadc6c7dc65a84d2c14e5ff7a25080c0497538f6bbb8ad1544f5
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-8iqOCtpt2LovPmLaqseEZQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-8iqOCtpt2LovPmLaqseEZQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 13 Feb 2024 19:05:19 GMT
expires
Tue, 13 Feb 2024 19:05:19 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
cm
u.openx.net/w/1.0/ Frame 559D
773 B
496 B
Document
General
Full URL
https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Requested by
Host: a.pub.network
URL: https://a.pub.network/core/prebid-analytics-8.30.1.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
078434bb23909b30413e2fdb01c7548dbf2bda13d9de620f08b87ddcc5f5f3d9

Request headers

Referer
https://reason.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
gzip
content-length
477
content-type
text/html
date
Tue, 13 Feb 2024 19:05:19 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
via
1.1 google
sodar
pagead2.googlesyndication.com/pagead/ Frame D779
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=1229490704497327&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

PugMaster
image6.pubmatic.com/AdServer/ Frame 5A24
692 B
1007 B
Script
General
Full URL
https://image6.pubmatic.com/AdServer/PugMaster?sec=1&async=1&kdntuid=1&rnd=45075386&p=137711&s=137812&a=0&ptask=ALL&np=0&fp=0&rp=1&mpc=0&spug=1&coppa=0&gdpr=0&gdpr_consent=&us_privacy=1---
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.81 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
8e8275a95c89838f6d5ab086531c95da83ed2661f5cb743eb7c3ce4721d8cee0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
date
Tue, 13 Feb 2024 19:05:19 GMT
content-length
692
content-type
text/html; charset=UTF-8
truncated
/ Frame 8C3D
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b1677e016666a985f6737f0f592a09a16ea9c02bc56b82fcd7e4d1b8655d3aff

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Type
image/png
PugMaster
image6.pubmatic.com/AdServer/ Frame 7F16
577 B
904 B
Script
General
Full URL
https://image6.pubmatic.com/AdServer/PugMaster?sec=1&async=1&kdntuid=1&rnd=60676740&p=156011&s=165626&a=0&ptask=ALL&np=0&fp=0&rp=1&mpc=0&spug=1&coppa=0&gdpr=0&gdpr_consent=&us_privacy=1---
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID&gdpr=0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.81 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
2ce4c9ca328495ac2424e2610331ac299c0a7f8c4b3bea4d08073a976cd6b174

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
577
content-type
text/html; charset=UTF-8
activeview
pagead2.googlesyndication.com/pcs/ Frame 4BF9
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsugVdt0RjsCWXTq2P664Sx9SiHKDfxVPgaiWstpW9sD1swjHZcTU-WobBz7Y8wslmnEi7DT1CGMV32BD7oY1QW4pGbjBhzHKWVxwPb8ANJuCsgV6MdN3ut9I-IleTe5R9JDD_Ne1Dv9lrux4Zrz8QyA0RhAvU5_MoY&sig=Cg0ArKJSzGUQf6WuOtiyEAE&id=lidar2&mcvt=1151&p=229,1113,829,1273&mtos=1151,1151,1151,1151,1151&tos=1151,0,0,0,0&v=20240207&bin=7&avms=nio&bs=1600,1200&mc=1&vu=1&app=0&itpl=19&adk=1228468068&rs=4&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&vs=4&r=v&co=378391700&rst=1707851117267&rpt=1050&isd=0&lsd=0&met=ie&wmsd=0&pbe=0&vae=0&spb=0&ffslot=0&reach=0&io2=0
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/ufs_web_display.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
setuid
s2s.t13.io/ Frame 559D
0
15 B
Image
General
Full URL
https://s2s.t13.io/setuid?bidder=openx&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=b&uid=45ecf28b-84d1-4616-a94a-69035477e985
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
strict-transport-security
max-age=31536000
content-type
text/html
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
0
sd
us-u.openx.net/w/1.0/ Frame 559D
Redirect Chain
  • https://cms.quantserve.com/pixel/p-25CIknq_eSg16.gif?idmatch=0&gdpr=0
  • https://us-u.openx.net/w/1.0/sd?id=537072956&gdpr=0&val=FJTvtUDFurUPlbjkFZmh7hCW7bQPlLzjFsOlx_2H
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072956&gdpr=0&val=FJTvtUDFurUPlbjkFZmh7hCW7bQPlLzjFsOlx_2H
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=86400
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAo PSDo OUR SAMa IND COM NAV"
location
https://us-u.openx.net/w/1.0/sd?id=537072956&gdpr=0&val=FJTvtUDFurUPlbjkFZmh7hCW7bQPlLzjFsOlx_2H
cache-control
private, no-cache, no-store, proxy-revalidate
content-length
0
expires
Fri, 04 Aug 1978 12:00:00 GMT
sd
us-u.openx.net/w/1.0/ Frame 559D
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=openx
  • https://r.bidswitch.net/sync?bidswitch_ssp_id=openx&bsw_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3205&partner_device_id=d9962442-c73f-42a4-adbd-3d9517e387ff&partner_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D393%26user_id%3D0%26ssp%...
  • https://x.bidswitch.net/sync?dsp_id=393&user_id=0&ssp=openx&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://us-u.openx.net/w/1.0/sd?id=537072968&val=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072968&val=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

Location
//us-u.openx.net/w/1.0/sd?id=537072968&val=d9962442-c73f-42a4-adbd-3d9517e387ff&gdpr=&gdpr_consent=&us_privacy=
Date
Tue, 13 Feb 2024 19:05:19 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
sd
us-u.openx.net/w/1.0/ Frame 559D
Redirect Chain
  • https://p.rfihub.com/cm?pub=25&in=1
  • https://us-u.openx.net/w/1.0/sd?id=537073062&val=970314649043819140
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537073062&val=970314649043819140
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

Location
https://us-u.openx.net/w/1.0/sd?id=537073062&val=970314649043819140
Date
Tue, 13 Feb 2024 19:05:19 GMT
Server
Jetty(9.4.51.v20230217)
Content-Length
0
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
sd
us-u.openx.net/w/1.0/ Frame 559D
Redirect Chain
  • https://um.simpli.fi/ox_match
  • https://us-u.openx.net/w/1.0/sd?id=537072966&val=0E087FD3E115403AB68AFF630D65CE67
43 B
61 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537072966&val=0E087FD3E115403AB68AFF630D65CE67
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H3
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=63072000; includeSubdomains; preload
x-content-type-options
nosniff
server
openresty
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html
location
https://us-u.openx.net/w/1.0/sd?id=537072966&val=0E087FD3E115403AB68AFF630D65CE67
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-headers
DNT,X-Mx-ReqToken,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type
content-length
142
expires
Mon, 12 Feb 2024 19:05:19 GMT
57424
i.liadm.com/s/ Frame 559D
43 B
573 B
Image
General
Full URL
https://i.liadm.com/s/57424?bidder_id=206088&bidder_uuid=7c84a1c0-0a94-4f8e-8040-55105fbaeae7
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.93.89.138 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-93-89-138.compute-1.amazonaws.com
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:19 GMT
Cache-Control
no-store
Strict-Transport-Security
max-age=31536000; includeSubDomains
Connection
keep-alive
Content-Length
43
Request-Time
2
Content-Type
image/gif
g.pixel
aa.agkn.com/adscores/ Frame 559D
43 B
656 B
Image
General
Full URL
https://aa.agkn.com/adscores/g.pixel?sid=9212314908&puid=60b09d3a-7282-4e6e-a884-259c55eab92e
Requested by
Host: u.openx.net
URL: https://u.openx.net/w/1.0/cm?id=891039ac-a916-42bb-a651-4be9e3b201da&ph=a3aece0c-9e80-4316-8deb-faf804779bd1&gdpr=&gdpr_consent=&r=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dopenx%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Db%26uid%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:269f:a800:1a:609a:6780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AAWebServer /
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://u.openx.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 7476af8f062782a67347b5ad36d9410e.cloudfront.net (CloudFront)
server
AAWebServer
x-amz-cf-pop
YUL62-P1
access-control-allow-methods
GET, POST, OPTIONS
p3p
policyref="https://www.agkn.com/p3p/p3p.xml",CP="NOI NID"
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
x-cache
Miss from cloudfront
access-control-allow-headers
accept, cache-control, origin, x-requested-with, x-file-name, content-type
content-length
43
x-amz-cf-id
xwM04GKVbA5kPfljPvOcBgVZzfjz0K9tLPG56w3gcP4RYu4RJzdEKw==
expires
0
72731
idx.liadm.com/idex/unknown/
42 B
445 B
XHR
General
Full URL
https://idx.liadm.com/idex/unknown/72731?duid=5cd525e6f15c--01hphxqsz7bxsvc6fz7hzwzwbd&us_privacy=1---&gdpr=0&cd=.reason.com&qf=0.1&resolve=md5
Requested by
Host: b-code.liadm.com
URL: https://b-code.liadm.com/lc2.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.209.16.241 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-209-16-241.compute-1.amazonaws.com
Software
/
Resource Hash
6fd7a9479be49487a0d351a707a60ca28e591fd961d3c2259a8fc9df5b6f6c08
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=31536000; includeSubDomains
vary
Origin
request-time
7
content-type
application/json
access-control-allow-origin
https://reason.com
cache-control
max-age=86399, private
access-control-allow-credentials
true
trace-id
cd637cd74c7366ed
content-length
42
expires
Wed, 14 Feb 2024 19:05:19 GMT
pixel
cm.g.doubleclick.net/ Frame 8BE6
Redirect Chain
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cve...
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSkCWQHUETjFjo31SdXhGgr7vD4Xl5gatf2DIvJl8W...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSkCWQHUETjFjo31SdXhGgr7vD4Xl5gatf2DIvJl8W-VYOSe3dQLW_cHH9t98KILO5-4ReYILmaGE87is__UKOMoflP26hKNo67nNzP1Ohn2oqTzMp2y2TXhxM4XH9vkI-FJCix3ogZg36KjHfLBWkpjQ
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:19 GMT
Strict-Transport-Security
max-age=2592000; includeSubDomains
Server
PingMatch/v2.0.30-801-g0076fb7#rel-ec2-master i-0df888bac8fca6b47@us-east-1e@dxedge-app-us-east-1-prod-asg
Location
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=TXhuTnQxcG4xUnpZNUs1&google_gid=CAESEEQ4sc6MEEypTzENqq7eewA&google_cver=1&google_push=AXcoOmSkCWQHUETjFjo31SdXhGgr7vD4Xl5gatf2DIvJl8W-VYOSe3dQLW_cHH9t98KILO5-4ReYILmaGE87is__UKOMoflP26hKNo67nNzP1Ohn2oqTzMp2y2TXhxM4XH9vkI-FJCix3ogZg36KjHfLBWkpjQ
Cache-Control
no-cache, must-revalidate
Connection
keep-alive
Content-Length
0
Expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 8BE6
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESE...
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmSapCtnfsiGQBnydpxpMe_atxVhjt...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmSapCtnfsiGQBnydpxpMe_atxVhjtBsugeCg_X1yrJizN_Bd-9wRgmEqZMdax6sV6V2JU5819g01pOfXvLbo0ZZ-mDAiywg5ZFF717wPvN5LfW5iM2yzWaTdG7AjcpyNUzLii4GHGM_xvXJMn16dnWivA
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

x-served-by
cache-yyz4546-YYZ
pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 varnish
server
Varnish
x-timer
S1707851120.528092,VS0,VE0
x-cache
HIT
location
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=WmN1OWF3QUVvX3NNcXdBOQ==&google_gid=CAESEEFKhgqO0q0iNVFG_ZZQ7dQ&google_cver=1&google_push=AXcoOmSapCtnfsiGQBnydpxpMe_atxVhjtBsugeCg_X1yrJizN_Bd-9wRgmEqZMdax6sV6V2JU5819g01pOfXvLbo0ZZ-mDAiywg5ZFF717wPvN5LfW5iM2yzWaTdG7AjcpyNUzLii4GHGM_xvXJMn16dnWivA
cache-control
no-cache
accept-ranges
bytes
content-length
0
retry-after
0
x-cache-hits
0
pixel
cm.g.doubleclick.net/ Frame 8BE6
Redirect Chain
  • https://mweb.ck.inmobi.com/sync/3?redirect=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dinmobi_pte_limited%26google_hm%3D%24DSP_CKID&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=...
  • https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmQ9...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmQ9NcNRGW7h_5kJ3Bn0LNU2hXDL1Y-nZgvhRXtKr9Q5Wp-SjD9gRWNWcy4TDN-P_3z_AmxI3QBUmf6Js8y_Q14SZ5AoXWVTGTNP8lemQ3KkGrhSjYW78Y4NRppHxxugbrHfypY-eSbIxT5OMFS9J2VlQ88
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=inmobi_pte_limited&google_hm=YjM2M2MzNGUtYTBhNC00MDJmLWExNzEtOTk1ODRjYTMxYzE0&google_gid=CAESEL6aA-wpAZnrNMqWb_h4ch4&google_cver=1&google_push=AXcoOmQ9NcNRGW7h_5kJ3Bn0LNU2hXDL1Y-nZgvhRXtKr9Q5Wp-SjD9gRWNWcy4TDN-P_3z_AmxI3QBUmf6Js8y_Q14SZ5AoXWVTGTNP8lemQ3KkGrhSjYW78Y4NRppHxxugbrHfypY-eSbIxT5OMFS9J2VlQ88
date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=15724800; includeSubDomains
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 8BE6
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=google&google_gid=CAESEEJZ1H7xxDQil5yltdO_TY8&google_cver=1&google_push=AXcoOmSROxZdh41c99gml7B3apeborMRMlOuQQqzmK4FeDM7KYe_dUC82s0hl0idGXgcPE2gn-env3vjdrVQO6ZUPvxo...
  • https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSROxZdh41c99gml7B3apeborMRMlOuQQqzmK4FeDM7KYe_dUC82s0hl0idGXgcPE2gn-env3vjdrVQO6ZUPvxo24iojyipcxMsjGupcjFAY1het0kbGmcCZ407iTyYuS...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSROxZdh41c99gml7B3apeborMRMlOuQQqzmK4FeDM7KYe_dUC82s0hl0idGXgcPE2gn-env3vjdrVQO6ZUPvxo24iojyipcxMsjGupcjFAY1het0kbGmcCZ407iTyYuSiZX1E2RcECQofwknBoU6v_Wys&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
//cm.g.doubleclick.net/pixel?google_nid=bdsw&google_push=AXcoOmSROxZdh41c99gml7B3apeborMRMlOuQQqzmK4FeDM7KYe_dUC82s0hl0idGXgcPE2gn-env3vjdrVQO6ZUPvxo24iojyipcxMsjGupcjFAY1het0kbGmcCZ407iTyYuSiZX1E2RcECQofwknBoU6v_Wys&google_hm=2ZYkQsc_QqStvT2VF-OH_w==
Date
Tue, 13 Feb 2024 19:05:19 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
pixel
cm.g.doubleclick.net/ Frame 8BE6
Redirect Chain
  • https://rtb.mfadsrvr.com/sync?ssp=google&ssp_init=step1&google_gid=CAESEJ0etaitLIOPArJedRyDNr4&google_cver=1&google_push=AXcoOmRVW-uymQU249N9m39VRE_7qFfHilVMv2nuuH1r4m6tl-mxYwEoCUIGcfz6901R9oM0wMPl...
  • https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmRVW-uymQU249N9m39VRE_7qFfHilVMv2nuuH1r4m6tl-mxYw...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmRVW-uymQU249N9m39VRE_7qFfHilVMv2nuuH1r4m6tl-mxYwEoCUIGcfz6901R9oM0wMPltmLPU5qfldtubR5SHMzAPT8sNpBq6W_n7t0wMtiScuMv44bQjjKbn3dSameMYbtTknQXUSCyI7XdhR5kyp8o
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
//cm.g.doubleclick.net/pixel?google_nid=media_force_communications_2007_ltd&google_hm=E39-acZWTHCXlVyF_VVTgg==&no_redirect=1&google_push=AXcoOmRVW-uymQU249N9m39VRE_7qFfHilVMv2nuuH1r4m6tl-mxYwEoCUIGcfz6901R9oM0wMPltmLPU5qfldtubR5SHMzAPT8sNpBq6W_n7t0wMtiScuMv44bQjjKbn3dSameMYbtTknQXUSCyI7XdhR5kyp8o
date
Tue, 13 Feb 2024 19:05:19 GMT
cache-control
no-cache, no-store, must-revalidate
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
attr
cm.g.doubleclick.net/pixel/ Frame 8BE6
0
12 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel/attr?d=AHNF13Jd4n0O6V7J3AV96qK8E2tTTx_SVgstQF0AS6PJXL41WRdZ4346kc-AxwFk
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.253.62.154 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
bc-in-f154.1e100.net
Software
HTTP server (unknown) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
server
HTTP server (unknown)
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
content-type
text/html
all
csm.us.criteo.net/ Frame 02ED
0
127 B
Ping
General
Full URL
https://csm.us.criteo.net/all?cppv=3&cpp=RiNnO6LMBFGc69loVGzWmoXRpih2mD5x0OOfO4pxa3t_pQGjab9ybJJV63zi71grQcG6L9q19-c58xXoTziY-mJFv0_Jy07Yds2godKebrhC3aMQJZeYiDP72o9QUWuExDxu_9SYFVqtRwzUTjvRuRl5UeQ1RHz2mP5444N5uUJUE3kCQEoVSU4m4o_Eq3vvW_1NKBfik5gPMll0dMzm9XGsczXD9g_FPQUv3FAZEOECPMcRzAePOOx6wVBnhP398dQ1eZWwvaDl2kqI&sds=2&rev=90562.7&sendBeacon=true
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::16 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://ads.us.criteo.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
cross-origin-resource-policy
cross-origin
server
Finatra
content-length
0
criteo_logo_2021.svg
static.criteo.net/flash/icon/ Frame 02ED
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/criteo_logo_2021.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
a0e62ca4a82bef79bbe9dc2aba6c0782a7d8eca046bb1baa30ee91ec37931553
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Thu, 27 May 2021 13:21:59 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"60af9cf7-891"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:19 GMT
privacy.svg
static.criteo.net/flash/icon/ Frame 02ED
2 KB
1 KB
Image
General
Full URL
https://static.criteo.net/flash/icon/privacy.svg
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
095c997695f6a290fdba58b778eb0a0fdcdd9c108669e41265527a262223f1e6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.us.criteo.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Wed, 19 Feb 2020 10:57:21 GMT
server
nginx
cross-origin-embedder-policy
require-corp
etag
W/"5e4d1491-646"
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
max-age=31104000, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Fri, 07 Feb 2025 19:05:19 GMT
PugMaster
image6.pubmatic.com/AdServer/ Frame D27E
625 B
963 B
Script
General
Full URL
https://image6.pubmatic.com/AdServer/PugMaster?sec=1&async=1&kdntuid=1&rnd=58965731&p=159196&s=0&a=0&ptask=ALL&np=0&fp=0&rp=1&mpc=0&spug=1&coppa=0&gdpr=0&gdpr_consent=&us_privacy=1---
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=159196&userIdMacro=PM_UID&gdpr=0&gdpr_consent=&predirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D91%26advUuid%3DPM_UID
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.81 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
23acc04f8c92a668746da9ac53a896401fc89d1c7235c305a6e551c5e0d6ecb6

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
date
Tue, 13 Feb 2024 19:05:18 GMT
content-length
625
content-type
text/html; charset=UTF-8
sodar
pagead2.googlesyndication.com/pagead/ Frame ED77
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=562060643048275&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame D2A7
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127750
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
generate_204
tpc.googlesyndication.com/ Frame C4D3
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?W_hQzg
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
sodar
pagead2.googlesyndication.com/pagead/ Frame F606
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=307981162515100&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

adview
googleads.g.doubleclick.net/pagead/ Frame 8C3D
0
19 B
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/adview?ai=C0BtTbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEvwJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx4N_54q3p9c-0i2MPd2XlxSVai7sxslZs0YpM04X6KzGR57ouWigAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAOACgH6CwIIAYAMAdAVAYAXAbIXGgoYEhRwdWItNDg2NDI4NjMwMDM1NTUzNhgA&sigh=-K2vxjdG0-w&uach_m=%5BUACH%5D&cid=CAQSOwAvHhf_bZD_armfXtgZd3xr4n4Rc5YKpaUYOw_3hu6tU149MtcU_tf9hmToVFbpVQuj_rVJR1AVdZ-KGAE&cbvp=2&vis=1
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c1d::9a Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

content-security-policy
script-src 'none'; object-src 'none'
date
Tue, 13 Feb 2024 19:05:19 GMT
x-content-type-options
nosniff
server
cafe
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
notify
rtb.da.us.criteo.com/google/auction/ Frame 8C3D
0
125 B
Image
General
Full URL
https://rtb.da.us.criteo.com/google/auction/notify?profile=14&payload=kfWzE9SCMKAB2ATiIp0XAgAAAM9LG_O9ycqvY1GCXxBtvctlUhiOnIiUytHJkAAAEgAACgpBUVVCREFFQkRB&wp=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&cbvp=2
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=600&slotname=6247484664&adk=2929324375&adf=776189475&pi=t.ma~as.6247484664&w=160&lmt=1707851118&format=160x600&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851117658&bpp=3&bdt=390&idt=533&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&eo_id_str=ID%3De7d20d661d0ab102%3AT%3D1707851117%3ART%3D1707851117%3AS%3DAA-AfjZrxx2p6-t-wS0KkqyLHmoJ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=1752083412&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=1114&ady=230&biw=1600&bih=1200&isw=160&ish=600&ifk=1432566504&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C44808398%2C44809530%2C95324580%2C31081078%2C95322329%2C95320869%2C95324154%2C95324161&oid=2&pvsid=562060643048275&tmod=533263721&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C160%2C600&vis=1&rsz=%7C%7CeE%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.h5x0c0abpchb&fsb=1&dtd=745
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a005::14 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:18 GMT
strict-transport-security
max-age=31536000; preload;
server-processing-duration-in-ticks
222934
server
Kestrel
content-length
0
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame E5BB
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127750
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
li
ckjjzdn8vk.execute-api.us-west-2.amazonaws.com/ Frame
0
0
Preflight
General
Full URL
https://ckjjzdn8vk.execute-api.us-west-2.amazonaws.com/li
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
44.226.53.119 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-44-226-53-119.us-west-2.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://reason.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
content-length
0
content-type
application/json
date
Tue, 13 Feb 2024 19:05:20 GMT
x-amz-apigw-id
TFqJjEQjvHcES7A=
x-amzn-requestid
02a27876-493c-44d8-87d4-37ce3e91391b
li
ckjjzdn8vk.execute-api.us-west-2.amazonaws.com/
312 B
516 B
Fetch
General
Full URL
https://ckjjzdn8vk.execute-api.us-west-2.amazonaws.com/li
Requested by
Host: s3-us-west-2.amazonaws.com
URL: https://s3-us-west-2.amazonaws.com/jsstore/a/7Q0H4WE/ge.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
44.226.53.119 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-44-226-53-119.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
796a893e622cf16330be6e09818cf0f74599adbb0442ef88bfa9637d51034a41

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
application/json

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:20 GMT
x-amzn-trace-id
Root=1-65cbbd70-7123eadc582144b11e1fd407
x-amzn-requestid
92d75bcd-4241-4fe4-b11c-edcd961f90f8
content-length
312
x-amz-apigw-id
TFqJjEOyvHcEmQg=
content-type
application/json
merge
ce.lijit.com/ Frame 6285
43 B
2 KB
Document
General
Full URL
https://ce.lijit.com/merge?pid=58&3pid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=137711&s=137812&predirect=https%3A%2F%2Fce.lijit.com%2Fmerge%3Fpid%3D58%263pid%3D&gdpr=0&gdpr_consent=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
50.16.144.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-16-144-68.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
content-length
43
content-type
image/gif
date
Tue, 13 Feb 2024 19:05:19 GMT
expires
Fri, 20 Mar 2009 00:00:00 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
syncMe
synchroscript.deliveryengine.adswizz.com/ Frame 5A24
0
200 B
Image
General
Full URL
https://synchroscript.deliveryengine.adswizz.com/syncMe?partnerDomain=mrtnsvr.com&idType=cookie&partnerUserId=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.192.51.117 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-54-192-51-117.yul62.r.cloudfront.net
Software
CloudFront /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 0cf68108b8820db4a096a661da0108ba.cloudfront.net (CloudFront)
server
CloudFront
x-amz-cf-pop
YUL62-C2
content-length
0
x-amz-cf-id
2dnYC6X6GxmGi0ojb4tZhnmNqOXWxE84Mc6H6JmLY90scbT1NFdpHQ==
x-cache
Error from cloudfront
396846.gif
idsync.rlcdn.com/ Frame 5A24
Redirect Chain
  • https://idsync.rlcdn.com/712188.gif?partner_uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fidsync.rlcdn.com%2F396846.gif%3Fserved_by%3Devergreen%26partner_uid%3D
  • https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
42 B
60 B
Image
General
Full URL
https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
35.244.154.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.154.244.35.bc.googleusercontent.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 google
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42

Redirect headers

date
Tue, 13 Feb 2024 19:05:19 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=29f40222-f009-439f-9dbf-29e5ecb74ad0
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
gdpr_consent=
bcp.crwdcntrl.net/map/c=14701/tp=MTAI/tpid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20/gdpr=0/ Frame 5A24
49 B
264 B
Image
General
Full URL
https://bcp.crwdcntrl.net/map/c=14701/tp=MTAI/tpid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20/gdpr=0/gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.144.252.138 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-252-138.compute-1.amazonaws.com
Software
Jetty(9.4.38.v20210224) /
Resource Hash
2f561b02a49376e3679acd5975e3790abdff09ecbadfa1e1858c7ba26e3ffcef

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
server
Jetty(9.4.38.v20210224)
content-type
image/gif
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
access-control-allow-origin
*
cache-control
no-cache
x-server
10.40.12.94
content-length
49
expires
0
receive
pixel.tapad.com/idsync/ex/ Frame 5A24
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=3203&partner_device_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95
sodar
pagead2.googlesyndication.com/pagead/ Frame 4761
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20240208&jk=1881542223134899&rc=null
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

generate_204
tpc.googlesyndication.com/ Frame B107
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?HZIjDA
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
ecm3
s.amazon-adsystem.com/ Frame FCC6
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:19 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
DXVVCMH4BP0973HW6E0A
/
bpi.rtactivate.com/tag/ Frame 7F16
43 B
108 B
Image
General
Full URL
https://bpi.rtactivate.com/tag/?id=20909&user_id=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.196.23.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-196-23-253.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
server
awselb/2.0
content-length
43
content-type
image/gif
75145
i.liadm.com/s/ Frame 7F16
43 B
573 B
Image
General
Full URL
https://i.liadm.com/s/75145?bidder_id=195755&bidder_uuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.93.89.138 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-93-89-138.compute-1.amazonaws.com
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:19 GMT
Cache-Control
no-store
Strict-Transport-Security
max-age=31536000; includeSubDomains
Connection
keep-alive
Content-Length
43
Request-Time
1
Content-Type
image/gif
qmap
sync.crwdcntrl.net/ Frame 7F16
49 B
264 B
Image
General
Full URL
https://sync.crwdcntrl.net/qmap?c=240&tp=PUBM&tpid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.144.252.138 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-252-138.compute-1.amazonaws.com
Software
Jetty(9.4.38.v20210224) /
Resource Hash
2f561b02a49376e3679acd5975e3790abdff09ecbadfa1e1858c7ba26e3ffcef

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
server
Jetty(9.4.38.v20210224)
content-type
image/gif
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
access-control-allow-origin
*
cache-control
no-cache
x-server
10.40.7.225
content-length
49
expires
0
/
io.narrative.io/ Frame 7F16
Redirect Chain
  • https://io.narrative.io/?companyId=673&id=pubmatic_id:A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
  • https://io.narrative.io/?io.narrative.guid.v2=d4d5fb11-caa2-11ee-a180-0a02e9f38595&companyId=673&id=pubmatic_id:A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
0
247 B
Image
General
Full URL
https://io.narrative.io/?io.narrative.guid.v2=d4d5fb11-caa2-11ee-a180-0a02e9f38595&companyId=673&id=pubmatic_id:A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Server
54.224.181.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-224-181-227.compute-1.amazonaws.com
Software
nginx/1.22.1 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:19 GMT
Cache-Control
no-cache
Server
nginx/1.22.1
Connection
keep-alive

Redirect headers

Location
https://io.narrative.io/?io.narrative.guid.v2=d4d5fb11-caa2-11ee-a180-0a02e9f38595&companyId=673&id=pubmatic_id:A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Date
Tue, 13 Feb 2024 19:05:19 GMT
Server
nginx/1.22.1
Connection
keep-alive
Content-Length
0
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame 6823
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127750
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
ProfilesEngineServlet
sync.intentiq.com/profiles_engine/ Frame 950F
Redirect Chain
  • https://live.primis.tech/live/liveCS.php?source=external&advId=91&advUuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1402230080&3rdpcid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
43 B
865 B
Document
General
Full URL
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1402230080&3rdpcid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=159196&userIdMacro=PM_UID&gdpr=0&gdpr_consent=&predirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D91%26advUuid%3DPM_UID
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:215f:600:1b:6b7d:2300:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache, no-store, must-revalidate
content-length
43
content-type
image/gif
date
Tue, 13 Feb 2024 19:05:19 GMT
expires
Thu, 01 Jan 1970 00:00:00 GMT
p3p
CP="NOI DSP COR NID CURa ADMo TAIa PSAo PSDo OUR SAMo BUS UNI PUR COM NAV INT DEM CNT STA PRE LOC"
pragma
no-cache
via
1.1 fdced9a893123e4285bf6f674dce492c.cloudfront.net (CloudFront)
x-amz-cf-id
F5xMasVJb6y222u00zqM6EBWqbt5abPdA5kQkXh8RIY30F6ARU_HMQ==
x-amz-cf-pop
YUL62-C2
x-cache
Miss from cloudfront

Redirect headers

age
0
alt-svc
h3=":443"; ma=86400
cache-control
no-store
content-type
text/html; charset=utf-8
date
Tue, 13 Feb 2024 19:05:19 GMT
location
https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1402230080&3rdpcid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
pragma
no-cache
server
nginx
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
x-amz-cf-id
dbMWgQkRxilgboyF5ltIqfiCZTDq-yqBmK6oqtCZGZhuntzbsNK64w==
x-amz-cf-pop
YUL62-C1
x-cache
Miss from cloudfront
p
a.audrte.com/ Frame D27E
Redirect Chain
  • https://a.audrte.com/match?gdpr=0&gdpr_consent=&p=M1717054901&uid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
  • https://cm.g.doubleclick.net/pixel?google_nid=ar101281&google_hm=ZmM1VmhLV28zOTJULXF6T1BiUWhsNndCQQ%3D%3D&gdpr=0&gdpr_consent=&google_redir=https%3A%2F%2Fa.audrte.com%2Fddp%3Fred%3DeyJ1IjoiaHR0cHM6...
  • https://a.audrte.com/ddp?red=eyJ1IjoiaHR0cHM6Ly9hLmF1ZHJ0ZS5jb206NDQzL3AiLCJkIjpbeyJuYW1lIjoiYWRmb3JtIn1dfQ%3D%3D&gdpr=0&gdpr_consent=
  • https://dmp.adform.net/serving/cookie/match/?party=1003&r=eyJ1IjoiaHR0cHM6Ly9hLmF1ZHJ0ZS5jb206NDQzL3AiLCJkIjpbXX0%3D&gdpr=0&gdpr_consent=
  • https://a.audrte.com/a?adform_uid=1956285366857158953&r=eyJ1IjoiaHR0cHM6Ly9hLmF1ZHJ0ZS5jb206NDQzL3AiLCJkIjpbXX0%3D
  • https://a.audrte.com/p
68 B
424 B
Image
General
Full URL
https://a.audrte.com/p
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Server
52.213.12.53 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-213-12-53.eu-west-1.compute.amazonaws.com
Software
nginx/1.22.1 /
Resource Hash
2aa4fa20701cdd6d8d56046069001186b5267e3ee7d0ef618ad2f4a683723e11

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Date
Tue, 13 Feb 2024 19:05:20 GMT
Server
nginx/1.22.1
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST, GET, OPTIONS
Content-Type
image/png
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
68

Redirect headers

Date
Tue, 13 Feb 2024 19:05:20 GMT
Server
nginx/1.22.1
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST, GET, OPTIONS
Access-Control-Allow-Origin
*
Location
https://a.audrte.com:443/p
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
g.pixel
aa.agkn.com/adscores/ Frame D27E
43 B
653 B
Image
General
Full URL
https://aa.agkn.com/adscores/g.pixel?sid=9212308278&puid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:269f:a800:1a:609a:6780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AAWebServer /
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:19 GMT
via
1.1 7476af8f062782a67347b5ad36d9410e.cloudfront.net (CloudFront)
server
AAWebServer
x-amz-cf-pop
YUL62-P1
access-control-allow-methods
GET, POST, OPTIONS
p3p
policyref="https://www.agkn.com/p3p/p3p.xml",CP="NOI NID"
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
x-cache
Miss from cloudfront
access-control-allow-headers
accept, cache-control, origin, x-requested-with, x-file-name, content-type
content-length
43
x-amz-cf-id
w4fd5HhUGPqTS3bLcvraFdi7l2WOgqqaTlnafKcgbx90RpKJYuw1oQ==
expires
0
info2
uipglob.semasio.net/pubmatic/1/ Frame D27E
Redirect Chain
  • https://uipglob.semasio.net/pubmatic/1/info?sType=sync&sExtCookieId=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&sInitiator=external&gdpr=0&gdpr_consent=
  • https://uipglob.semasio.net/pubmatic/1/info2?sType=sync&sExtCookieId=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&sInitiator=external&gdpr=0&gdpr_consent=
42 B
603 B
Image
General
Full URL
https://uipglob.semasio.net/pubmatic/1/info2?sType=sync&sExtCookieId=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&sInitiator=external&gdpr=0&gdpr_consent=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
HTTP/1.1
Server
50.57.31.206 , United States, ASN19994 (RACKSPACE, US),
Reverse DNS
Software
/
Resource Hash
99c2917ee5b2a01459a923bdd1c676f15ee73b62b87f696e6735312d26f51e12

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:20 GMT
Frontend-ID
2
P3P
policyref="http://uip.semasio.net/w3c/p3p.xml", CP="NOI PSAa PSDa OUR IND UNI CNT"
Content-Type
image/gif
UIP-Response-Status
Ok
Cache-Control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Access-Control-Allow-Origin
*
Content-Length
42
Routing-Server-ID
-1
Expires
Sat, 01 Jan 2011 12:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 13 Feb 2024 19:05:19 GMT
Frontend-ID
1
P3P
policyref="http://uip.semasio.net/w3c/p3p.xml", CP="NOI PSAa PSDa OUR IND UNI CNT"
Location
/pubmatic/1/info2?sType=sync&sExtCookieId=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&sInitiator=external&gdpr=0&gdpr_consent=
UIP-Response-Status
Ok
Cache-Control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Access-Control-Allow-Origin
*
Connection
Keep-Alive
Content-Length
0
Routing-Server-ID
-1
Expires
Sat, 01 Jan 2011 12:00:00 GMT
2981
tags.bluekai.com/site/ Frame D27E
Redirect Chain
  • https://pixel.onaudience.com/?partner=214&mapped=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&gdpr=0&gdpr_consent=
  • https://pixel.onaudience.com/?partner=109&icm&cver&gdpr=0&smartmap=1&redirect=tags.bluekai.com%2Fsite%2F33141%3F%26id%3D%25m
  • https://tags.bluekai.com/site/33141?&id=ca35505eabb3f550
  • https://cm.g.doubleclick.net/pixel?google_nid=bluekai&google_cm&google_sc&google_hm=UnpWai9BUWw5OWVuK0wraw%3D%3D
  • https://tags.bluekai.com/site/2981?id=&google_gid=CAESEDFth-uZ5uxu5R4z6sjbnjI&google_cver=1
62 B
304 B
Image
General
Full URL
https://tags.bluekai.com/site/2981?id=&google_gid=CAESEDFth-uZ5uxu5R4z6sjbnjI&google_cver=1
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H2
Server
23.39.185.111 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-39-185-111.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
0af3aae90b7de9fdceee2ab421378ea2f54c74be81ef43fc6c1790a032755d80

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
date
Tue, 13 Feb 2024 19:05:20 GMT
content-length
62
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:20 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://tags.bluekai.com/site/2981?id=&google_gid=CAESEDFth-uZ5uxu5R4z6sjbnjI&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
296
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
pagead2.googlesyndication.com/bg/ Frame 9A41
39 KB
15 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/s6Lo-ySsTFszeicWuLCsm9BIHYA2isJaSryvoQutTtY.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b3a2e8fb24ac4c5b337a2716b8b0ac9bd0481d80368ac25a4abcafa10bad4ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Mon, 12 Feb 2024 07:36:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
127750
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15173
x-xss-protection
0
last-modified
Mon, 05 Feb 2024 17:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Tue, 11 Feb 2025 07:36:09 GMT
setuid
s2s.t13.io/
Redirect Chain
  • https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fs2s.t13.io%2Fsetuid%3Fbidder%3Dadf%26gdpr%3D%26gdpr_consent%3D%26us_privacy%3D1---%26gpp%3D%26gpp_sid%3D%26f%3Di%26uid%3D%24UID
  • https://s2s.t13.io/setuid?bidder=adf&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=1956285366857158953
86 B
116 B
Image
General
Full URL
https://s2s.t13.io/setuid?bidder=adf&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=1956285366857158953
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Server
34.107.140.113 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
113.140.107.34.bc.googleusercontent.com
Software
/
Resource Hash
c2ecff291918a3caf0b7e470323e89f2a1f05b92e12a10649e598cacebe62acf
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:20 GMT
content-encoding
gzip
via
1.1 google
strict-transport-security
max-age=31536000
content-type
image/png
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
0

Redirect headers

location
https://s2s.t13.io/setuid?bidder=adf&gdpr=&gdpr_consent=&us_privacy=1---&gpp=&gpp_sid=&f=i&uid=1956285366857158953
date
Tue, 13 Feb 2024 19:05:19 GMT
server
nginx
content-length
0
content-type
text/plain
generate_204
tpc.googlesyndication.com/ Frame 8E2F
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?mt_M0w
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:19 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
generate_204
tpc.googlesyndication.com/ Frame BAA0
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?0fk_Lw
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:20 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
generate_204
tpc.googlesyndication.com/ Frame CF37
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?oXp-JA
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:20 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
generate_204
tpc.googlesyndication.com/ Frame D2A7
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?DVcUhw
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:20 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
generate_204
tpc.googlesyndication.com/ Frame E5BB
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?_HIekQ
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:20 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
generate_204
tpc.googlesyndication.com/ Frame 6823
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?yNq2XA
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:20 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
generate_204
tpc.googlesyndication.com/ Frame 9A41
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?qtGMNw
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c0b::84 Ashburn, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 19:05:20 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
sodar
pagead2.googlesyndication.com/pagead/ Frame 97A3
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=2426265541848191&bg=!a2ilaCfNAAaxkZ3akZE7ADQBe5WfOPhkEbgo_te3dNKDwanD-HevkitpySnydqAJ6-nvR-BLe8IoO2EiBEymBhFNViBtAgAAA6ZSAAAAA2gBBwoAB6-4453zPw-ZAtJAckDprFTQy4VJ2Z9ZqUlGj5YpwFcYe5bL6vrSxQy49klb3yVxy7M0igxi-tUygqZpFsP1y3EoWh_ohPBmivl2nmYacTU9fMCGTTQuO_aagni7-1QgVVvHDyYRUOz8nd1me45Uy5lIhC2ZVVOE21pDrY78rZ_dnPdLDhQ4SO0iOsFAqRDqsm3s7GGsFw7JSFdHoYISAN8XwZImJZERryP2VG_ECNHXWLXS22JOmDtAKdd4z1faVFZyytOm4fYMhqEnXamH-9Ldw243cgbNk2BLvnyyprnZh_93y4deA0bk-A-4WN937NnuU5nOW2LMsVDcr957PYutRj3StYAAQQbgEH0xRQwWH_o1xf3DgrIan4jL6HKX5SNWPp0SLaBmLI8QScpPjOLFXUzRGrqSvnjWzZi2GWEHR1YP5E443hkjobo0aQru1cJEXO7NNXgvsuSU9-NaYXvvOiL_Tb0Zm2JmkKf0udRwkFo_CNWwqF-jxXXMayVmgr2ht_DEkJYJBqJFOgRpnkHz7p8KIZNGfQv5J1bNP8AzQkkbQVVWUdj50Uwgt6CaU8jX1SX6U0cyHDNk9lp5I9jfH4gziszWFTJjmLNAiL4Nb1h92pBrbAxzNVKjpXExmutl272aFVsLeBWYSBdo-PDPx8LsXTbpqnZGmvXl8a3WuxKysxNzQruSqAywSGHDn1YxFZytxzvlAAAKILYZN9fQ9yHgg4huR7zgMAJj7QC_Q3IqLnjqY-JNKs9iCvwuOI3lpeFW4G38hvbKy_ZnuMUyACdbJCJYLSsEKVFodXJcE90j6j2AsOeU75iloFH5jb8TrKVReQTmiGlN7gD5KYh2edZcnSAeo-Al5dPYRVLX3JQrytpREhl35NcpXM1Sglc1IanUB9fyjxibyeMWWmBlcfQIDs-ZmwNdVbuxGgtHd2-F66HWMCMB4td-u5UPbOhPkQJNeamqPoFYfQ
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

sodar
pagead2.googlesyndication.com/pagead/ Frame B4CD
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=895834258692043&bg=!6-il6KfNAAaxkZ3akZE7ADQBe5WfOCqW4InFbnICSHmH4dtqS26EMfDoktJSLNHTTPIHCylkLEjYB8SKQFWYUnNN9CCzAgAAA1NSAAAAA2gBBwoAkVMayiU9QA-IJdux83jFr6-hevvx-_FVsQn0vsLNDzrFsE0WdNJFNGS65Kl4pZiLinL26qel1BeM6QmIArZuOBGR1AkRuZrQOJiEa2BIumS8YaAkMWVlNY_GSwit6JmQjnpUqh6vRBBzB68qgLrMs5m0-D-D_vkFXsfoDg6Lx1u4Sul-NI_3PNOnbAKM1nHTi7mZAtizXQ2D2Lx-zt_x7ixyhckdipTF_lOHDumyStz3F4CcrEYmU1tIx8b_Yk2fYP6SkwfldlPVWL75nHIWgFODeht8hGBjFUpAhQ0rwbBSWh2x_jOtEWHh66qBFq-QpQs3vsfiAKZ12Nln7XM78cWgeke0nD97Hw8xz3TBu_JwUgQC-0XI_C-DaF6ZbVI9FRLsvyz0WP5WiFzeh1Mre6M9ubF9yf73U0T0ytDdO4Ni_9y3NiGkq33RKawsOpUwtdnc04oNMftv5jQ8D3COhBH_VuXftBHASzVrRuL3Dlwv5GuyIYtlYMzFFf1nn-NvQmqJmMEHaBCJaFjAlTuegvKtNqQT2FaTj5nSkG6-RJ5stmU0mtnlcOEmVarL3zvfh4jDTRt3sL-cXaMdfy6UMrXZBmZKYrrqufb-y_o1QtWIOm3RVjWyb3J4pLV5Dwa1WQhm_GbSUQNbR4ejUnzwP_g75bYxSwf6l0wEY-5sZLV0xSakQ4O-lFn4I4qlea5gYtfdIIvDyC67djtwAT95lYHNO01iPe9WjPWh2M-o2eT2w7NxwqaaUhQ-PomaJ_SqFsCOMiNDERlJZ3vo_clMs1JzggzAnFS7iXL1dHM29di4W2ewmFIGb1a0TDZHSMoxK1X7cu_OOhQFdIJjXrUu6U-HhUELcPZscky8ui0HMinwYOZBs3PidrmPx3UawRSnxlGXtLMDToSV01jrDW72JG6JFLaM_2Dl5fa4bOEg072FHsy4IxAAsbJZgeoDrkEvKE9Ny0kUyofOu8boXhFTum-k58JnuJwou8D6MG7dfXkzGwy6Iy_eBv2ZS1YmSJgzl33eTre69VuwvrHW9czy4g9o0QveWb5xK-PK8UyhHrQoj_pvIPbNe3RYbHS6_MQ8klGgYQtLS2xZ3OdLVD5df4sCNYZzpZII0b9Cs7AD4rBX5liyaQGee3LzZ2v9p73xfBmOWDQ-hF-qifxfVw
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

activeview
pagead2.googlesyndication.com/pcs/ Frame 8C3D
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstGUFLoiQqlSMFgQTAW6gL70K68Ho63sQ78T1pqCX7KDXfO7S7nogBiIZN5r8wPFg2-YT7cIV7BTURXsXraMh2mSthgA9O99OVMGwM674OUKPhCms5j1TOy7cMeXNVAZrtVK7t48w&sig=Cg0ArKJSzJ1B2JEUZcDyEAE&id=lidar2&mcvt=1000&p=0,0,600,160&mtos=1000,1000,1000,1000,1000&tos=1000,0,0,0,0&v=20240208&bin=7&avms=nio&bs=0,0&mc=1&if=1&vu=1&app=0&itpl=20&adk=2929324375&rs=2&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0%3D&vs=4&r=v&co=378391900&rst=1707851118405&rpt=1017&met=ie&wmsd=0&pbe=0&vae=0&spb=0&ffslot=0&reach=8&io2=0
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-US,en;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:20 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
sodar
pagead2.googlesyndication.com/pagead/ Frame A079
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=3167069287056572&bg=!nZ6lntHNAAaxkZ3akZE7ADQBe5WfOIlkqnK1Qcc8FTyIdxXTnDPqyoDX9332baB4WFMiHIn5YiNb0t6hCFZptFFSgnfPAgAAAttSAAAABGgBB5kCzfmJ8LkWPWvEzZ1-5k5MDJX3W_BdkUhPCT1LfEKOUTlBxaQOzk36WauSP5KzNpxNrpU_79eS5EuCOhI9wFLdB8M_qc64HXkSONcEBwqqAfsOUKozhM89TzZpLdd8i3JaisIwrWc_kOV6f_7_Hlf1i2vzVer_za7vGFk4oPrxLcgorLYyAbtFxFKR8Z2FXatYdlQH_hif5fLKRfGEOt5fIEn5hvBxTigjDz3wrtvm2vQemBv-hMPwylJ2TPfcliQP3q_pSlcatBfWIkrEJjkkFvBiagRY5Mfbe9aIxO2Yw2stZRJApdisPcxGTot-uAHd2U5QhPdWAfthIVdhNGeoSLlkirPKOX2Cs_A2GxPG-8gYsc0_SGVOBUZwqq0D78ocPQa5ome54jUr4tQHlfTlbcgbFG6tBhC0PVALUrzs-Bwa95Sb5fEOVWfEzgj8jms4fz2vIq_ZfQtfQN46d70CxSprLaRg31rj2M-luKoE_RLIhiMvfHxJ6G6Wu8ULMmY0-VSanowAN1RhlYckwXM50wjPZcI7gi2RIv4lFTcIDXN4pNdmJ3780FFx4herNlTrlkEIwwgGys_idZCUqyXHM6JbPV0QKWFTaEEVkI4paptLYDYeQpTfEHXdZNy9Aaw8NxMuxJTJdXTRmHIklpOwoM2J8n1PGg-oZBlyRRNlQP0jYMld7_gySpn_b6lEDlcICSMtunY9RcfdHohSxCPTOBoC1_uu1Lhnlx76FoKiPpxf3btM8OH5sKJI5RA-mD0DZuGsKPrWGL3WtCjQAoeCgQkFpL2Iavq7dNmVljiL_IxK1HQ2lZmY3cLFikMS-zub35rhw0A3ia6Ivdb6xvChgM42XG3JssZv5S3HpxhMlnuCZtW7kN3u80A2wtERLTXBeYBu3uFchQBylxteYsBUJXBrrY4MmcERyw5xFXEwxwn6YSFhHsl3kK9wo7uAYg
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

collect
www.google-analytics.com/g/
0
17 B
Ping
General
Full URL
https://www.google-analytics.com/g/collect?v=2&tid=G-JCN3MXE1WR&gtm=45je42c0v891186252za200&_p=1707851112214&gcs=G111&gcd=13v3v3n3n5&npa=0&dma=0&tcfd=10000&gdid=dMWZhNz&cid=415251147.1707851114&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_eu=AEI&dt=New%20Pain%20Medication%20Could%20Reinforce%20Crackdown%20on%20Prescription%20Opioids&sid=1707851113&sct=1&seg=0&dl=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&_s=2&tfd=8708
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-JCN3MXE1WR&l=dataLayer&cx=c
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2001:4860:4802:38::178 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://reason.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:20 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://reason.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
sodar
pagead2.googlesyndication.com/pagead/ Frame F142
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=3401264131360314&bg=!BQalBknNAAaxkZ3akZE7ADQBe5WfOLaHPsJHLOTnCnjWteW3DCKdwWckCk2mkPZmTyHh20wwIfc8ubejRQjn14NOi5F6AgAAAx1SAAAABGgBBwoAjGRrkE0YaOmVGlVaiBV1NpW5I9MmlbStoPiJC_ZhBvQMC84CyO7YnUhLqmAXrs99lZuIUAZyC_Drk-A9OBzPYUL68WS1HOKFTILL2ys2wacE6mmQngZZ86WBqTSZ_Q3LKYYvL5r6kfnJRsZ7EzeVOUN1Cou1jWSZk2nX70OaxbpswUXkvmV8Jl8O8_uCmQLQ19Aq9vcebjNY_RA-TBNe19hbLRVQPG78Oae0f6tdHQOhSORsBnX7jMLidq-A3bBYgMTvl3R09Vjl8rDB7Vuze_1cmlHR05nlGAeVxhHZSgsHQiwTQyny5VlBiq9gEOrwaEo_zcKNvxJc3hID9wbxKFSCYWL-UYLNyOZYUKBMgJv-vfRd4tCE3r2JjjRxEWXxWYQ8b32_uxBRCPguekCtHTh0OUJR7tEoNeNMN5mNRn3-C6IsEc3yw66jWNz55vJZhfsMpSwzkAI7_FWJ5j373giIrPB124XdwMJ23in4o2ClQCvChtwo0kMjU6xjJGMaX46JQJVGG858TqwFg3SgF0Tq4-PH4iE-1TND0tLmjbd-70Ohzry_aAvQaelJploys43NAeGp59dXkYcRH4SvHg-wMRX8u9xfqkKIkhAdqWecaZCyRkBkiGzi7HVUQ-Tm9CsPfxvKnsNzFs3MSxeJ74DYQ_tlNUcFwFXfTnNT1q9HpTLHBB0PAQiGAeqxindNbB5g6RHqXTkLsbCa7QDZGbazWzFK4IRilXeBmNNMFana_7uybQAyTYu1EqzqNRcuBexXNl_ecIUHf0GsjasZzyE6A_MJ8JY312HCqU7RFXBu1ZxB1Pb397n8Ptjyo-z2Mah5fkKF3P62dH8b9QLxpLwly4bWh6ebv2siHGPNT-hSsHHgWbz1FOWtBABkISl_1zPFpiJNojBRxvloU7ObCWQvzjZbB9pE7hyzpBkOKRBNivFWgUhMBkb43sPmmb9vOehhGe6WMIRWkMVg20-nimGLIRq5vEkW4js2VcXUoiaZS5TFBOmZR0kc8C3b2qIZmg3Xc2l5U7Sq1zRCj27_4DW9RSutdDxer3cx9-BVaLXin25H7wnCHjEA3aFz1JsRXs8tIAjNu5RDPBfZVw8zaa84gt70OJDT7Vsrzj-9GBVbyA1f0-yGBXAS6hQyK8U0
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

ecm3
s.amazon-adsystem.com/ Frame A2FB
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:20 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
3428GCBZ2Z9J5JE397Q3
ecm3
s.amazon-adsystem.com/ Frame 7CDA
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:20 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
FW6QMYH61FDZKWZAM411
all
csm.us.criteo.net/ Frame 02ED
0
127 B
Ping
General
Full URL
https://csm.us.criteo.net/all?cppv=3&cpp=RiNnO6LMBFGc69loVGzWmoXRpih2mD5x0OOfO4pxa3t_pQGjab9ybJJV63zi71grQcG6L9q19-c58xXoTziY-mJFv0_Jy07Yds2godKebrhC3aMQJZeYiDP72o9QUWuExDxu_9SYFVqtRwzUTjvRuRl5UeQ1RHz2mP5444N5uUJUE3kCQEoVSU4m4o_Eq3vvW_1NKBfik5gPMll0dMzm9XGsczXD9g_FPQUv3FAZEOECPMcRzAePOOx6wVBnhP398dQ1eZWwvaDl2kqI&sds=2&rev=90562.7&sendBeacon=true
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bgAHIJkF_flcAA--j3iEi7oQmyM6imHtlw&u=%7CKlh9g5zrkiX77bHnabJKC5a3mltqwxn14N9G7m2HCb0%3D%7C&c1=mOd7Dh6zPV-mqNyBk81vPbZQiC09DurE6LvhJEVfnpona7yZr6CGip8a0O0VRnOfDVSJxtXdF-KD2x_baMKvqQjJurCWqLtuNiVxsTFjXUd0fWJE4P35ygD94_3eLUw4UETaV7j8-uuoGD4y33H32Wcuxd74I_DVF7s1AL7p4VcIWOKysyhvYBHzVLFEJlm10PIJq9SE7qapFXjZat5CXywqFbl-gqiyWIZ1Md40r7deLlR5gUHU29bKjS20Xb4_wWlFkQNLSwwdFPr2gxcGeFVPj4d9VHFrsujAESO60WPFFEpUa4MoG2km-fimN6-GXwJxZsQnyok64xmEqrcIKcjupOYAnKzblnA4kVuyPCIpalFzkgSLobO5ghvik3YAqsCJGQhDxLOFU4xOSMsJh0u-SXVpmizIesHvHMNPFl5cg6V8wzjGS8eZM8GSEXiCrjRSeonXFTyaJL9ZOiei0wAnRidnTgR9xcdPmf-dEuYVLr0D330e-AKj-_HuOLfNKk-Y1JzY_rh8lHr8JotxBM-C1_Vzx_pANcvReo4ONZHeNbHl5eYzjqDPdRp2Pg7wPaYCakx8cmhI4QG7FBMXKR2wPjuPf8j-0WjdwZk3WbCTbJNZ31rZ4bDDYUvE08NtgKwIlXHxivBZKqW1hJ4FtbJ8LsxAmchN&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DClLevbr3LZZnBHNzy998Pj_2--AGcge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEwgJP0P6aQrPG4ihkozu6Wlb3Y1er44UbctyBJwE9acLapzRj_S7JLh0-lZqVedI-GxaNr-359AmKuY9e660afsgpzP4DXZiyxISXeu99UCKvNBPUChKSmuQmB7GLI-FMAVZtoDM1ZZZakEDFtf3AiNEQCtIA7i4xtvs4B8U-MLSDD50YSBl9aBl3vx8qbSGiTjn0QOgRmNU0kw-2OA9QZ2bQFSbGOC4kT-BPZ7M-_CO4yJK_j17ckFFU8qkT2M-Sf5Iuol1e-cEzqBc2YKtc9sVZH2qAn-uGIKuuMJzocRkHQ8viyjuEwxhkMXECZbn-Nvwpy1gjvclR2L2TZ2-jelqtFAGbDTRUrU0MuFXKcn6jch6RroU7VGCppx5P_b64GCK3gcFdDyP6Z7v25KeTujU9olbr3kTx4byfAZ-_NtxFAtLogAam-IPM6dui7q0BoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpY-Lb5mYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_3xyThsjia6XCpsejl9dP0Slc7fSA%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::16 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://ads.us.criteo.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:20 GMT
strict-transport-security
max-age=31536000; preload;
cross-origin-resource-policy
cross-origin
server
Finatra
content-length
0
sodar
pagead2.googlesyndication.com/pagead/ Frame B84B
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=1605499748962416&bg=!hIelh8jNAAaxkZ3akZE7ADQBe5WfONI2K4aCnESSmodb0jXWwHTpNs7_eU65FQFSVVr--iDJQF97Q3Rtm4utc4biwjN9AgAAAkJSAAAABGgBB5kCxsX0IHQSx_0JeQU-pCmSZxiiKpoJlPIeqYldPB0ZJk27TEW6gpQ6nE2AARk7ke4jvKHbFlUBvVWe76zuBb_5J8iyyXVtlRNw_Pom3d-2r4PPqvR2eHs92P7oYyrhallCZCjpmbR3jmKcIwJk7-L__oRsHULT0I5bOLOxqF6qedkd6irLaMa0ioifjcQzDDDMPJqAdmaMK13M_JEZx-8eylZX-I33C62DF4zCgCK9XV4LrZrM_6HmeQVtSFWd5dP6Edn0Z9Q7rUSfE7M_RCzm0JHr8t7rU9quPzvlvQj3NO5U8QhbeKdueDiGkK94FqjmEPHfXG8qzhx3wNCLYfuAigPnFOS-WeeWomuIRW04kUfV-v4mAM0SF34dWZMbHV4YVEiStJgr0K_QOokXdv6QBppLm0UsPClcfXgQA_J1iayW4mmjMsAZUnYW55f-I_QcnL-FIwamvG_TuIymsyBroZm0gEfByuDxmKLc5uyVgzJlXmLAIx4tvVGKLHMnelYLbKaYit1gJV3lZSa0jsYTQZZkE4J4t_pWztwru1CVD_oJxNBpeUuMGtmuRYD9UmWi8UmUO_eR3Fs_vTS8yxcu6XfGGZHUI-vvGM7cxn-QAfP6Gh5H4nBQNLSXGBMe6P3m0ywG3ASGcRCtQ5SObr5hRLw-yPqHzlGt29EdpYO75NJn14JtFasYeFCd_9YthIoZH2W6pndOyNh-5XfpaB7LJFTZ_KLCHAbThRdEHqH5Z7gk-xh8OVwIg0oKYviURszCOoP9MCmZTS57xu2fc9amZtw5cUefJ42sAoqHfx1UQB38umjy9sYAICEKjlV3t6lKnQnB8fvhBFRQm_1csR5Fe8mfw8zuOilXW6hafMfs0FoAPYHWmKDO3YwzbhfvqPEd5pX4I9F_migVjzpLkOV6HwD5r3KWCKd4YeZfDXNC6dz4nRlvPh5e
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

sodar
pagead2.googlesyndication.com/pagead/ Frame BDF5
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=1229490704497327&bg=!vr2lvfLNAAaxkZ3akZE7ADQBe5WfOBQDzEJI7jCn3-13YKJRW3b0SfUJs-8RnFUkAwBCyTLrJ-MVnYcpoFhAeF7psv4jAgAAAb9SAAAABGgBBwoASd7uI9I7zVx9RN6NbAwI5Mi25M10mWn1evMu6XprKmniamI_Me4AUxRQ0w-QWRl7EtYw4BuF0aYC41DIV5w0awhIHmODutwPxbGZAtOnrXM0QOiwRv-pRKCHiMRuco2uXyd5uvWPRu8_h209CUUWkzlhifq0APjuBkxjohk0nFiqh6QhDarkX7lmQm3mwQZnrDk8iVwLVS3hkR_JBbcOl20yDVvJ8xDX0RdHNrLIoID6bYrz5mfnr0cWi5_U_WrBptbk7yGq5mBpIRN2jW1QoC5YcJkIVwRysM_iRKdGBpooUTf4OFLLGmd55KvBg6sVDpEWlIwmwPjqs3YGbBt-nEv5E_18iFHTAS3DBS-MHDHm6DGhu2E2tKjsHAIrg2gj4eEHdZHOgI3wci7XkVvuzigMw8axihGdKnDnclYJ7U0rcfWkXI25rpisjMBF24vRrdgroH8xkyZVf7TdqXkJFnrlivOM8EXW0tVjQyDIJlxZLLaJ2hsNfIbVBnae3gLCaZ7cvaCtt3HaWTA-spsCj04aiaOFemA1JnCPmfuQR_clnORNvVgiDcYY8zBPUVs16WMT_wi7e33eAwkirvd2-4nruQtffb-1EPefpys4g4E-rrD3_aGMyaqHNFdWX-YixZMIFKFS8IBBLOuG_CT7_vzp5ARA5Enb6CbooajBdk-WWKD2ECrUOzYxC18_T8wD8DGs2u9jjpP2I2YTuDLADEIAdE10kiy4QQHqjMba8vPF0_ouHAG7p9-FCPzMzsFFHaFu3K2gho7qlcsIslV66NG-eEk1Y9j9BI_E7rkDMxwbAfxDOHvFbMv-MCHbj_a7GTBPbLLMk0CE05r8g_BaniITS0nvSvdM9iGD0thBNHJEyJE_LovXuTCyeZ3TaMZAbVNLRtuUPrbsJrvVZT6S_4-jWKetq4MVyVj2WP-PvN-zqlSQLEKGgyM-nabFKgohfQAPSjuNN1cd6q8fTpOzZvHNBVR01EhcIukMIEPKlR7JholS68zLVDXTzAb89G5-FMHbP13AsFIExb9iFHBzwqnB39NF18m88yd19MhoCH4
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

sodar
pagead2.googlesyndication.com/pagead/ Frame 4BF9
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=562060643048275&bg=!7e6l7qHNAAaxkZ3akZE7ADQBe5WfOOqA_F8xA3b5w6W5-V-CD0qtqqavct-kVarM4r6xLgw5FOnxNv2UMHjR45aABGBtAgAAAWZSAAAAA2gBBwoAfSTXGfcDwA9r5jUaWaclDcBSs5Q5aJ8h4SI-S--g4Oe4pbaCd6wbr3RWDgLp8Nb7SLPjf843BMlstZQVxOZTNCUJJNfrSYYiUpJkR5hD-8FJcmEquMSu1QKAtJ-p6XqsES03pYkYjlI8OskHND7fwieHYBf2bZO3KeqCL4anmQLQ2dDlvtf4twp0pMkYWaRFLRUBM1uO8sjJ-3VL7ACSP2JLMT5GZ0pKF-incq88fIYK06Fw2WKU5tzdd6tVFo-NE3--Ee2Fh1PhgKiIX7cepkB4fZXKxlq2Ghz68QOqdP5OaKVzI3jk3mK5Y77e5gaQYh55cqFXv6MB4F86fGoHmjPVaOf8bYP_JNQOBMWXXDHUK3JXQNP_aBoK0yvIzAaXoElpre72Y8awUoOkcNPASlyn0yTt_LjrSKmgID6ePenIsBwlDjozWTp2mVDnuIQsCNOqtePeItRT5_5rE5eN4gIlKQ2N1PRlO_GeHVRhH6anTCaJYHCsDv8o-EUYb5dxAb58cx4_IPhcUS8babMU01w3fgqWxAt8HDTorlzvHs2BFP0KHnByPsWtN-eaWCcGpjQ7VZfaYzwRvtDpW6Hygu37F96gQ0gl1GRxr7ARaiJbX8rL8xuCrpzGv3vYYwamMMmm04KKVqE55pioxMdn1qBbTw9jnSzFDN4KAG3Qr0qTAGSKMQntLITbvCCTwyrFDJ5g0CY46lGnDdXACHKNjaaM-Z4mrC9im6CnOVZ6flen-n0HXtl1ocl-MZqEDUQfkNsMc5A3aZqhfL_GCe0TuYpg1E0BnBfYBili189p9-yASKa6tWEvzaRZqzFzr9CpuvJxoVFZe5ONO_t5yO7xSAQus3CIpDHMqgjzz5MbtGrn2jLQMAUgLt9dwBQWG0oYRglCybCPWwwWUZYZNYJhvMREidKAzZy1-5jtTWrrZpoogTjlNdHt7LJTUKNh0PKNZl4zWql9FqpW-V0bSx9-wroywdPiMTq9_LHgLhoecmvk_9QTrc3hMglYGvjGpsLuv0PlGKt1KN-1ELO5Kc4tTykNIpDi5e0ciuLY3gdCJDzKcVIFlQONSoV8wnek_SFGJp0UN_CYOWRSpLs6z150joEX3yKqdiZg53Vos3BvrUvK
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

sodar
pagead2.googlesyndication.com/pagead/ Frame E29D
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=307981162515100&bg=!UlGlUR7NAAaxkZ3akZE7ADQBe5WfOJfr7S6j4eiD6ADhFiEsZXLm4xF_vmS5S0Xj20b5HAes2MMZTdTBeVPTO5pRuEKAAgAAAUFSAAAAA2gBBwoANMgocXkXTwUNJR4f5zaM1xYH5U7aVx26H-_3SfpGOfQQRzkoSPi5yX4f0T3kSbIjdHj4UMuZAtngddEhlo6xTSk7xwptdKRiRlTeTGXZhbFYFDjyU_B12oW8-c_7vBKLuo4W0VMLS3kKPNwXQ1pgiFlqLciiDFHZQfKNKmfezFWL9flzLvZlo760VJ-wXi053oGyrCvxmhqMZPy3n0PpJpvw6EdJ34gSTUcvXeWXgATvC0sDHggosTFkjVs-_h752pIlsvRR1OaZRk46TiUxqBOBiJI4n0pT7YMPT4kQjr0fo8PpSrlpcbAsKA6LSOp6BADH_xAc16AK9MEE1-p6d-_TE1_F3gcMmj1Z5H9h3iStXjxQaXcAMxCWxiRrBA6gK0bz8SD0FWz00-btL-saum3DxKCNM3HvC0cmKsl1UwNteVwgTpxpbo3mYoeXFyk3NDpiIhLrizK1KFqSPnUJ68lLndR93gqD_EmUgRNGnKKVOlJjU_lXfUZolcNiDgTBEkmm1fi-ZCyrwlnVog8AvKVlty5UEP4xOvL281VWKli9UN6-SjHde1y1iNEoidYz69jN45BBK84OO7vTZ4mnCZ6bYSasCNOujT7i1R0Gtx3fzdjavCiLpxxxFxndqkT5Tyu_yStKmT6ZlCFZ7MODrdW5-VORalfwTVxHLqt4oXpqxnCqm6lK5m6cypWxAyYHVcofgFPJ0jW4TeYBMsVzJInM2NsJa41RDRWv-kWHjKp0kZHQK5IpZ0YZ_JYWNOXBcEfj3864lAZilHoiIjz4qr1nH0DAwDzN2AtRfTj4CSLTEmbWL5qXYUgQgOuuA62ru0PExYXDfc6vfVo7tClIxPYeS3NTd_MEfBxtMk5qO_i770S5yzyYGtAxBYupvepBHMPncrk-qMQhI1xTVoAhJtvdVIhNqPnWqRyMLuCqjCIOlzNTTmYMFyvFO3oJ81AtjontF0Yh3W1b_wpuWlKL9P-8IhsDODzsV9VxVmzArritC6zTYK1iWyms6i1z1rwAbnxKQHxXDbcKJCtAMX70Q1o
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

sodar
pagead2.googlesyndication.com/pagead/ Frame F5DB
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20240208&jk=1881542223134899&bg=!CwilCEfNAAaxkZ3akZE7ADQBe5WfONd20H0wioAXD3Xn7V2V1ci6UyBhBEMY3mZ5MipOs3k61Rrm8AEdjNCVpQWaCxA4AgAAAP1SAAAABGgBB5kC21EFWh0gUCaNJJqhZg8WHEi7n_dX2CBqEqJJ1HsdZUj4JIZS8wkjsXpSFDHkKFYwXFs0W321E7-GXb643TS6Jm5fIkzBvcFd1__mTvbTLZmrokdeB5LO8C_YxUKa5tjTwVjOMDPDeupvl72g3-nkLM9Lc3JMq6koNAupgHca35ya-LFVgosE5gdMyYuX4AikGBiguQzfx0MAuDSqq5EDw5HC_vVCV9D26DlOFnvRyW3jPbTgjutZ02tSans1BB5Z-TQ71ZA9n6wriyoTPfja623xkl1g-SmdNxHzWuL2F3DNmdHqUnhyT5XIzr-UknWfzgNE9Ry5RBPk_XEr7-PJkxYyeJAh8nNUp-JQcDptnLj8NEt71FesJxRlqQ3zzSozdZNqnd9NYr3yVPIz3CAUynQ0h5p3JUbdhRe7spvhSAvgmcK7huhRXAbnIWzxG0WW35KAZomIHu_bU9gKmzsYytJThYGT_CDVG0US8XVldEvEYKlABqRXPLgDMKt3NocwAqYh6agP3W9YsGWJN7jhuSjFRJxP7zmj2OhWaz2IxndO1l80l73-5vlet3DECz4nGYInfcq9u1pne71QXQynXTsQUpRWHjX68iaERVM__Y-11hyeqizOJTgLnFtyJRfigZOdn2DyatsXgBy94vxgysJPcA3APxRvyJKGyPO47fV0yV5M_X7-O0kaSvDI7FkcMqK7jCNVt_mvSq_nkhvkaGbOb1B7Z2rBCbdQT0iZR-UjSUOTsYQURhFWDGc5RfDQb2bKoHCpQDIk5pxUiSX2wh3_IQtV22vgeZLEqthfd0n7vQUjlL7p9vS33luTKXz3azLugwJ3bVKcnHrBjphmo2TafRTAmVpxMPvvSAc5HLkO0pTwLQ2JdNqfcptURa2ilX4osGtEtlTX1sYLv47pJkZDV1uq1691oFOy975nMNwwU4la4KrUITrmZG7EXQRDFDlRFzLUx4aZxzCQ
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2607:f8b0:4004:c17::9d Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

SPug
simage4.pubmatic.com/AdServer/ Frame C24E
0
128 B
Script
General
Full URL
https://simage4.pubmatic.com/AdServer/SPug?partnerID=156696&gdpr=0&gdpr_consent=&us_privacy=1---
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=156696&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
8.28.7.84 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://ads.pubmatic.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 06:30:18 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
ecm3
s.amazon-adsystem.com/ Frame 8112
43 B
479 B
Document
General
Full URL
https://s.amazon-adsystem.com/ecm3?ex=pubmatic.com&id=PM_UIDA8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=156011&s=165626&predirect=https%3A%2F%2Fs.amazon-adsystem.com%2Fecm3%3Fex%3Dpubmatic.com%26id%3DPM_UID&gdpr=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.46.130.91 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
Date
Tue, 13 Feb 2024 19:05:22 GMT
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Pragma
no-cache
Server
Server
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Vary
Content-Type,Accept-Encoding,User-Agent
x-amz-rid
KDWM4KE2P26FAVBPBA86
getuid
sync.smartadserver.com/ Frame 1888
Redirect Chain
  • https://live.primis.tech/live/liveCS.php?source=external&advId=91&advUuid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1402230080&3rdpcid=A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1709765917%26mi%3D10%26csh%3D793790479%26rnd%3D393729055&pcid=$UID
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1709765917&mi=10&csh=793790479&rnd=393729055&pcid=5872803529851156248
  • https://pixel.rubiconproject.com/exchange/sync.php?p=primis&r=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1725065545%26mi%3D10%26csh%3D793790479%3B17...
  • https://live.primis.tech/live/liveCS.php?source=external&advId=100&advUuid=LSKQGI85-W-KKFE
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1725065545&3rdpcid=LSKQGI85-W-KKFE
  • https://x.bidswitch.net/sync?ssp=sekindo&r=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1267919208%26mi%3D10%26csh%3D793790479%26rnd%3D-1249684381%26p...
  • https://rtb.adstanding.com/ssp/bidswitch/cookie?bidswitch_ssp_id=sekindo&bidswitch_custom_parameter=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://x.bidswitch.net/sync?dsp_id=317&user_id=ac862dd225311b326a51d7adb14c026b&expires=30&ssp=sekindo&bsw_param=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://live.primis.tech/live/liveCS.php?source=external&advId=92&advUuid=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&mi=10&dpi=793790479&3rddpi=1267919208&3rdpcid=d9962442-c73f-42a4-adbd-3d9517e387ff
  • https://u.openx.net/w/1.0/cm?id=476b50d3-5ccf-49a1-89b8-1ddf8ea18042&r=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1486637409%26mi%3D10%26csh%3D79379...
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1486637409&mi=10&csh=793790479&rnd=822573357&pcid=8b979bf4-7108-4d0c-86a3-3f353964681d
  • https://ads.yieldmo.com/pbsync?redirectUri=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1868283820%26mi%3D10%26csh%3D793790479%3B1486637409%26rnd%3D-1...
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1868283820&mi=10&csh=793790479;1486637409&rnd=-142327749&pcid=V_ZrZhhNNrh6QBoKLRmb
  • https://eb2.3lift.com/getuid?redir=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D259151345%26mi%3D10%26csh%3D793790479%3B1486637409%3B1868283820%26rnd%...
  • https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=259151345&mi=10&csh=793790479;1486637409;1868283820&rnd=-1274868859&pcid=3900114537385664774839
  • https://sync.smartadserver.com/getuid?url=https%3A%2F%2Fsync.intentiq.com%2Fprofiles_engine%2FProfilesEngineServlet%3Fat%3D20%26dpi%3D1881119486%26mi%3D10%26csh%3D793790479%3B1486637409%3B186828382...
  • https://sync.smartadserver.com/getuid?url=https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1881119486&mi=10&csh=793790479;1486637409;1868283820;259151345&rnd=-474335130&pci...
0
75 B
Document
General
Full URL
https://sync.smartadserver.com/getuid?url=https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1881119486&mi=10&csh=793790479;1486637409;1868283820;259151345&rnd=-474335130&pcid=[sas_uid]&cklb=1
Requested by
Host: ads.pubmatic.com
URL: https://ads.pubmatic.com/AdServer/js/user_sync.html?p=159196&userIdMacro=PM_UID&gdpr=0&gdpr_consent=&predirect=https%3A%2F%2Flive.primis.tech%2Flive%2FliveCS.php%3Fsource%3Dexternal%26advId%3D91%26advUuid%3DPM_UID
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.105.12.172 Manassas, United States, ASN30633 (LEASEWEB-USA-WDC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://ads.pubmatic.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

content-length
0
date
Tue, 13 Feb 2024 19:05:23 GMT

Redirect headers

cache-control
no-cache,no-store
content-length
0
date
Tue, 13 Feb 2024 19:05:23 GMT
location
https://sync.smartadserver.com:443/getuid?url=https://sync.intentiq.com/profiles_engine/ProfilesEngineServlet?at=20&dpi=1881119486&mi=10&csh=793790479;1486637409;1868283820;259151345&rnd=-474335130&pcid=[sas_uid]&cklb=1
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
pragma
no-cache
chunklist_480.m3u8
video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/
641 B
1 KB
XHR
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/chunklist_480.m3u8
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
3262cf7514b00bc2afdf3d00275e425210173c47edeea36bb1c7d8b5a162e953

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:39:17 GMT
via
1.1 1dfba6c05648522e13059c944a28466e.cloudfront.net (CloudFront), 1.1 275c32bc50366db37e8c3324dfc942a6.cloudfront.net (CloudFront)
age
5165
x-amz-cf-pop
IAD55-P3, YUL62-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
641
last-modified
Tue, 13 Feb 2024 16:54:50 GMT
server
nginx
etag
"74edbe19acc80ed166cf8055fe7a9e6a"
access-control-max-age
604800
access-control-allow-methods
GET, HEAD
content-type
application/vnd.apple.mpegurl
access-control-allow-origin
*
cache-control
max-age=86400
vary
Accept-Encoding
accept-ranges
bytes
x-amz-cf-id
qW8FQYXTWnFE82elKyOuc2FgipKSTwpfub3_ycr0Fl_9TZyWJBkIYQ==
expires
Wed, 14 Feb 2024 17:39:17 GMT
w_480_00000.ts
video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/
399 KB
399 KB
XHR
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/w_480_00000.ts
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
98935eb259b4c37e6b9616a2e2a0665455755c9dd7f8eb9bf3746f6e921d1a64

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:37:59 GMT
via
1.1 3ea826f29560ca95cae18534029cc5a6.cloudfront.net (CloudFront), 1.1 275c32bc50366db37e8c3324dfc942a6.cloudfront.net (CloudFront)
age
5243
x-amz-cf-pop
IAD55-P3, YUL62-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
408148
last-modified
Tue, 13 Feb 2024 16:54:51 GMT
server
nginx
etag
"e1352414dce7bbe55b088a688d4c1d81"
access-control-max-age
604800
access-control-allow-methods
GET, HEAD
content-type
video/mp2t
access-control-allow-origin
*
cache-control
max-age=1209600
accept-ranges
bytes
x-amz-cf-id
LPFBNmx0ncZ_QROv0gGcxdeR98G6QvYRR9MbOxmnO_jC7AmFh05Ltg==
expires
Tue, 27 Feb 2024 17:37:59 GMT
8fb84f6e-f312-4c4d-a950-5158289880d9
https://reason.com/
67 KB
0
Other
General
Full URL
blob:https://reason.com/8fb84f6e-f312-4c4d-a950-5158289880d9
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b3e57eb372e8b405c816875571e184854b2846261c7477c6c9bdb7782faa1a30

Request headers

accept-language
en-US,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

Content-Length
68465
Content-Type
text/javascript
w_480_00001.ts
video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/
442 KB
442 KB
XHR
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/w_480_00001.ts
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
678fbcbd7f4fcf64a2dd65a562e0f84a86af160f3309e31c49d9adcaef1ff661

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:37:59 GMT
via
1.1 1dfba6c05648522e13059c944a28466e.cloudfront.net (CloudFront), 1.1 275c32bc50366db37e8c3324dfc942a6.cloudfront.net (CloudFront)
age
5243
x-amz-cf-pop
IAD55-P3, YUL62-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
452516
last-modified
Tue, 13 Feb 2024 16:54:51 GMT
server
nginx
etag
"768d740706b01bd848d932034b13d920"
access-control-max-age
604800
access-control-allow-methods
GET, HEAD
content-type
video/mp2t
access-control-allow-origin
*
cache-control
max-age=1209600
accept-ranges
bytes
x-amz-cf-id
fkfwqYO3nFx8TN666TO8NCpOmVOF5qnnz_lvRgk8iNyMfFdlOI-dKA==
expires
Tue, 27 Feb 2024 17:37:59 GMT
w_480_00002.ts
video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/
283 KB
283 KB
XHR
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/w_480_00002.ts
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
7bd090535437370c64ae5c5103d46edda6a700f0f6464901e0d4f9fff5ae05ab

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:37:59 GMT
via
1.1 765ade8c6b70e0e7c0b0572f4e039b98.cloudfront.net (CloudFront), 1.1 275c32bc50366db37e8c3324dfc942a6.cloudfront.net (CloudFront)
age
5243
x-amz-cf-pop
IAD55-P3, YUL62-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
289520
last-modified
Tue, 13 Feb 2024 16:54:51 GMT
server
nginx
etag
"11d696cbf05b6b5cc808599378c77e26"
access-control-max-age
604800
access-control-allow-methods
GET, HEAD
content-type
video/mp2t
access-control-allow-origin
*
cache-control
max-age=1209600
accept-ranges
bytes
x-amz-cf-id
EkFK84OBn7sbFZMKGVNzttDybezXRmo4KSMXecCk0XI_KU5wQ6NRDg==
expires
Tue, 27 Feb 2024 17:37:59 GMT
w_480_00003.ts
video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/
320 KB
321 KB
XHR
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/w_480_00003.ts
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
bb9069c12e7090bed09e92bc71afe15e4746ae1cd38b50ab99d40b8155d00c72

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:37:58 GMT
via
1.1 4ae0902ea4e10dc74700d1753a74440a.cloudfront.net (CloudFront), 1.1 275c32bc50366db37e8c3324dfc942a6.cloudfront.net (CloudFront)
age
5244
x-amz-cf-pop
IAD55-P3, YUL62-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
327872
last-modified
Tue, 13 Feb 2024 16:54:51 GMT
server
nginx
etag
"bec33a724a1a06ba69193929d02c278f"
access-control-max-age
604800
access-control-allow-methods
GET, HEAD
content-type
video/mp2t
access-control-allow-origin
*
cache-control
max-age=1209600
accept-ranges
bytes
x-amz-cf-id
0k72pJadKftcg4fAPf1MAzwZ6EtJboXmNgNx3-tnmZahq8-kF_1i2w==
expires
Tue, 27 Feb 2024 17:37:58 GMT
w_480_00004.ts
video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/
296 KB
296 KB
XHR
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/w_480_00004.ts
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
a0a90f5fb879ecf6e5908af785a51c95f3929e86b0b207b879e433cfef8e1163

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:37:59 GMT
via
1.1 4ec656d2dfbb59cd7fab2ac94a540522.cloudfront.net (CloudFront), 1.1 275c32bc50366db37e8c3324dfc942a6.cloudfront.net (CloudFront)
age
5244
x-amz-cf-pop
IAD55-P3, YUL62-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
303056
last-modified
Tue, 13 Feb 2024 16:54:51 GMT
server
nginx
etag
"d8a2abe9992752f6f9712c88722a20e3"
access-control-max-age
604800
access-control-allow-methods
GET, HEAD
content-type
video/mp2t
access-control-allow-origin
*
cache-control
max-age=1209600
vary
Accept-Encoding
accept-ranges
bytes
x-amz-cf-id
1O1VhR7n3QLrzBgvJ3tRo7TnjtO0dK4-xnJVkQdKlmQbh8U4aRjsHA==
expires
Tue, 27 Feb 2024 17:37:59 GMT
w_480_00005.ts
video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/
298 KB
298 KB
XHR
General
Full URL
https://video.primis.tech/uploads/cn1/video/users/hls/29874/video_65ba1ab406070534415698/vid65cb9b67b22bf082520539.mp4/w_480_00005.ts
Requested by
Host: live.primis.tech
URL: https://live.primis.tech/content/video/hls/hls.0.12.4_3.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:26a0:2800:1:6448:6d00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
1db58aad28cb890fd1f9ab313db28d4099e075f5359d584ba12fef38ebff5047

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Tue, 13 Feb 2024 17:37:59 GMT
via
1.1 d6b2e9bf1f40c8fcec509faeb60f8c54.cloudfront.net (CloudFront), 1.1 275c32bc50366db37e8c3324dfc942a6.cloudfront.net (CloudFront)
age
5244
x-amz-cf-pop
IAD55-P3, YUL62-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
305124
last-modified
Tue, 13 Feb 2024 16:54:51 GMT
server
nginx
etag
"7f07d23e9fa38c74c16fd7456e0d534d"
access-control-max-age
604800
access-control-allow-methods
GET, HEAD
content-type
video/mp2t
access-control-allow-origin
*
cache-control
max-age=1209600
accept-ranges
bytes
x-amz-cf-id
ph7P8wIByNQ763B_rFZ8SqL8_OHOpY7MepqvCLx9jTu7fnTgNejMqw==
expires
Tue, 27 Feb 2024 17:37:59 GMT
liveView.php
live.primis.tech/live/
0
343 B
Image
General
Full URL
https://live.primis.tech/live/liveView.php?hash=ozcmPTEznXRiPTEzqzyxX2V2ZW50PTI1JaNypaZypyRcoWU9MTpjNmt1MTEkNSZ2nWRspGkurWVlVzVlPTMhMS4jJaM9MTE2MmIlJaN0YT0jJat9NDAjJax9MwplJaZcZF9jYXNmRG9gYWyhPXJyYXNiov5wo20zp3VvSWQ9pzVup29hLzNioSZxZWJ1Z0yhZz9loWF0nW9hPSZcp0FjpD0jJaNxn3Y9JaVmZXJJpEFxZHI9MwYjMvUmQWZzYmtyM0ElJTNBMTA0JTNBJTNBMTQzqXNypyVBPU1irzyfoGEyMxY1LwAyMwAyMwuXnW5xo3qmJTIjTyQyMwAkMC4jJTNCJTIjV2yhNwQyM0IyMwB4NwQyMwxyMwBBpHBfZVqyYxgcqCUlRwUmNl4mNvUlMCUlOEgIVE1MJTJDJTIjoGyeZSUlMEqyY2giJTI5JTIjQ2ulo21yJTJGMTIkLwAhNwE2Nl4kNwAyMwBTYWZupzxyMxY1MmphMmYzY3N1qWyxPTY1Y2JvZDZuYwqvMDEzY29hqGVhqEZcoGVJZD0jJz1yZGyuUGkurUkcp3RJZD0jJz1yZGyuTGymqEyxPTAzZHVlPTtjMCZaZHBlPTAzZ2RjpxNioaNyoaQ9JzymV2VQYXNmR2Rjpw0kJzNwpGE9MCZwY3BuQ29hp2VhqD0zY2J1p3Rypw0kNmA3ODUkMTImNwA5JaVcZD1TZWgcozRiU1BfYXyypwY1Y2JvZDZvNDMjMDtzpHVvVXJfPWu0qHBmJTNBJTJGJTJGpzVup29hLzNioSUlRwIjMwQyMxYjMSUlRwMjJTJGYS1hZXpgpGFcov1gZWRcY2F0nW9hLWNiqWkxLXJynW5zo3JwZS10nGUgZGymYXN0pz91pl1wpzFwn2Riq24go24gpHJyp2NlnXB0nW9hLW9jnW9cZHMyMxYzZzkiYXRTqGF0qXM9ZzFfp2UzZWyxp3A9nWykJaB4nWQ9OWUkMGUkMTtjOWU5ZwA3MWUmMDqwODU3MDJzYTYmZTp=
Requested by
Host: reason.com
URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2600:9000:21a2:4200:1a:5235:f980:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-US,en;q=0.9
Referer
https://reason.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 13 Feb 2024 19:05:23 GMT
content-encoding
gzip
via
1.1 0af7b45c1245bf01064b3a3ce0d489f6.cloudfront.net (CloudFront)
server
nginx
age
0
x-amz-cf-pop
YUL62-C1
vary
Accept-Encoding
x-cache
Miss from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
*
content-type
text/html; charset=UTF-8
cache-control
no-store
alt-svc
h3=":443"; ma=86400
x-amz-cf-id
mWn69DL9pl6f0KGthLrWAyXkaoPQHs4HwcjQxX7sDm68IHPUHVY-IQ==
all
csm.us.criteo.net/ Frame C500
0
127 B
Ping
General
Full URL
https://csm.us.criteo.net/all?cppv=3&cpp=qiesiqLMBFGc69lolc12UwRKNRXYBQ3PTOkI-mLm5CmhYgQPN-MfCYhdR6Xi3ZvZ8AmBT5A_DvRV2YFw2hISLJaBg0kgr1svsR0iO0MWq9N_uxDfj_2D5JIT-jUA17sGLF7t89Qg1pS9Rl-okj5PF9lwytwB29DHeZxq8A9QJVyaneff4mLxz2AGiDRdVvu73zC_8yov97d1rXaJtd6oQIotYEyE9qNtLo2gv82ffAqFvCwBBlVPkMDffF_MknxIDOOeNzW36J0P6Eg0&sds=2&rev=90562.7&sendBeacon=true
Requested by
Host: ads.us.criteo.com
URL: https://ads.us.criteo.com/delivery/r/afr.php?z=Zcu9bQAKY3oIuNttAA-2pVaHp1GavkBQUxBPFQ&u=%7CVUhCKAOtdUZQJYiOi3lzurd1AcOOJgb8PN0rpXERrFw%3D%7C&c1=TUPLs6ok1IhDgnvJmJgq2b8G6XvEBIvqAb79lxbNLn-Y29LVqxBSOQhZKVxZui5pXNlU4WPrBd9-dzZ-iTLkdkSl-LizjqX25oAL47XMhSYWO3JuoWxauvT0WWC73yk4MA9nA-mrOXgG7LcrB49GArB-1u7bsTIJNAHDlluWtU5j5JaI8ufz8lqAtz2MIi8-3AAMx09ROYQ-G7r9cwdlDuXDfTvG4Fy1LMAqYI-ju4a705hasIZDRMKs23swV3nUVbbqDZwbeCajAwEeqr_5sJhxSYZkZ8efI8JHrES1wtaLEOoONU3t675wCEwV3RvUA4_NdwAs860FRNhvR3E164P6guvgYDzUSl2Qdoo4Kjk5iNy9YvKPjECC9yzops1pst90zxRFQGtcbWY1CR49ikZ6MpUK6VWi3xZMIMxWurFUt4qvHuZpoykycfLKIHMUu7l64fyQbtGLJsjByFfnnPAGQ-2N9z2mpgszRH5Sip5IPaW10MCd7XiNxnMcXUcgFJubhZPMNF8oFj6ywCb2kn2mkiczinaTDomN67Oqy2xZkn6cyDi6CF2tUP1zctzXn5nGecfw2Ggu37Ayae7LZyI_wRth8AkF6nNsHipicVDYsUqufE_GSgkVAZH_wfaQoBDoQbPJ4BtX9gJSfbbpIn8bllIF9vLYe4_J4jE1h4A&ct0=https://adclick.g.doubleclick.net/aclk%3Fsa%3DL%26ai%3DC8vXvbb3LZfrGKe224_UPpe2-4Aycge-wXKLKp6p0wI23ARABIABgye6Oi8CkjBCCARdjYS1wdWItNDg2NDI4NjMwMDM1NTUzNsgBCagDAcgDAqoEyAJP0O5uWdEy_l-pFp2VhNnsQMhWrsiViy1d5NksicT8sx-XpIjEfpfDG3vxt8rVom2itW6jpaa4iFqL6__SaqK2Mp_FK3kKvc__RNq6mJHrrd46t54UzO1QR1oB-X_wMU4bz-jbT20OoQPNkeMwbpRaqkpdtbNYIFf-ekKKXjOQ_qNMDhurGN92jja6ZJrqz85Ww2cR_BDDalAgIHPw7RxCLMUhhpBaDlWIxG9CzNpd_sNghiEsODpkjxvpeHYg7L95O3I1C4WdDWuhX6WCqoL63JyTz_1b7DuSjTW3N_tW8jiwPxpjbilqNG160665Yq_go7l0f3KNGKZo1Mw5enzzL_japlMswn27M4YlMiQYJF3GhCCp3E5mbYnSpiJEVentySmVTISrNbBBHSIrcpuQBlmvJBnlPh1xBkAqPyRM09QNx_UXzWRwgAbAm4mZkIumitoBoAYhqAemvhuoB5bYG6gHqpuxAqgHg62xAqgH_56xAqgH35-xAqgHrb6xAtgHANIIIgiAYRABMgKKAjoJgECAwICAgIAISL39wTpYk7nJmYGphAP6CwIIAYAMAdAVAYAXAQ%26num%3D1%26sig%3DAOD64_2ulk1Tni9kVtnMfjjR-cc_TJXHVQ%26client%3Dca-pub-4864286300355536%26adurl%3D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a001::16 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://ads.us.criteo.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 13 Feb 2024 19:05:25 GMT
strict-transport-security
max-age=31536000; preload;
cross-origin-resource-policy
cross-origin
server
Finatra
content-length
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
fastlane.rubiconproject.com
URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=16924&site_id=500600&zone_id=2983354&size_id=15&alt_size_ids=9%2C8%2C10&us_privacy=1---&rp_schain=1.0,1!freestar.com,472,1,,,&rf=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_v.id=fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9&tg_i.domain=reason.com&tg_i.page=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&tg_i.name=reason-com&tg_i.cat=IAB11%2CIAB11-4&tg_i.sectioncat=IAB11%2CIAB11-4&tg_i.pagecat=IAB11%2CIAB11-4&tg_i.mobile=0&tg_i.fs_optimized=false&tg_i.fs_site=624&tg_i.fs_ad_product=banner&tg_i.pbadslot=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-37_ad&tk_flint=pbjs_lite_v8.30.0&x_source.tid=45025a01-b97e-4a8f-9401-e83fa9cbe7cc&l_pb_bid_id=3611b2cb651a0d83&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=938ef48b-1b37-431b-96df-804fe6b08df1&rp_maxbids=1&p_gpid=%2F15184186%2FReason_300x600_300x250_160x600_Sidebar_Repeat_SA%2Frcom_freestar_ad_widget-37_ad&m_ch_mobile=%3F0&slots=1&rand=0.30565426079701963
Domain
ads.stickyadstv.com
URL
https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=4374775086859810847&redirectID=0&gdpr=0&gdpr_consent=
Domain
ad.mrtnsvr.com
URL
https://ad.mrtnsvr.com/sync/pubmatic?gdpr=0&gdpr_consent=
Domain
jelly.mdhv.io
URL
https://jelly.mdhv.io/v4/pixie?gdpr=0&gdpr_consent=
Domain
api.rlcdn.com
URL
https://api.rlcdn.com/api/identity/envelope?pid=34

Verdicts & Comments Add Verdict or Comment

426 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| 11 object| 12 object| 13 object| 14 object| 15 object| 16 object| 17 object| 18 object| 19 object| 20 object| 21 object| 22 object| 23 object| 24 object| 25 object| 26 object| 27 object| 28 object| 29 object| 30 object| 31 object| 32 object| 33 object| 34 object| 35 object| 36 object| 37 object| 38 object| gform object| dataLayer object| gform_i18n object| gf_legacy_multi object| gform_gravityforms object| gf_global function| powerpress_pinw boolean| RCOM_SHOW_ADS boolean| FREESTAR_PUSHDOWN_ACTIVE boolean| RCOM_AD_LITE object| adManager object| methods boolean| DEBUG object| gforms_recaptcha_recaptcha_strings object| ___grecaptcha_cfg object| grecaptcha string| __recaptcha_api boolean| __google_recaptcha_client object| mejsL10n object| _wpmejsSettings object| rcom_ajax_obj object| wp function| sprintf function| vsprintf object| gform_theme_config object| lazyLoadOptions undefined| $ function| jQuery object| addComment function| LazyLoad object| FontAwesomeKitConfig object| webpackJsonpdisco-web object| regeneratorRuntime object| disco function| announceAJAXValidationErrors function| gformBindFormatPricingFields function| Currency function| gformCleanNumber function| gformGetDecimalSeparator function| gformIsNumber function| gformIsNumeric function| gformDeleteUploadedFile object| _gformPriceFields undefined| _anyProductSelected function| gformIsHidden function| gformCalculateTotalPrice function| gformUpdateTotalFieldPrice function| gformGetShippingPrice function| gformGetFieldId function| gformCalculateProductPrice function| gformGetProductQuantity function| gformIsProductSelected function| gformGetBasePrice function| gformFormatMoney function| gformFormatPricingField function| gformToNumber function| gformGetPriceDifference function| gformGetOptionLabel function| gformGetProductIds function| gformGetPrice function| gformRoundPrice function| gformRegisterPriceField function| gformInitPriceFields function| gformShowPasswordStrength function| gformPasswordStrength function| gformToggleShowPassword function| gformToggleCheckboxes function| gformToggleRadioOther function| gformAddListItem function| gformDeleteListItem function| gformAdjustClasses function| gformAdjustRowAttributes function| gformToggleIcons function| gformAddRepeaterItem function| gformDeleteRepeaterItem function| gformResetRepeaterAttributes function| gformToggleRepeaterButtons function| gformMatchCard function| gformFindCardType function| gformToggleCreditCard function| gformInitChosenFields function| gformInitCurrencyFormatFields function| GFMergeTag function| GFCalc undefined| __gf_keyup_timeout function| gformFormatNumber function| getMatchGroups function| gf_get_field_number_format function| gformValidateFileSize function| gformInitSpinner function| gformInitializeSpinner function| gformRemoveSpinner function| gformAddSpinner function| gformReInitTinymceInstance function| gf_raw_input_change function| gf_get_input_id_by_html_id function| gf_get_form_id_by_html_id function| gf_get_ids_by_html_id function| gf_input_change function| gformExtractFieldId function| gformExtractInputIndex function| rgars function| rgar function| HandleUnsavedChanges function| renderRecaptcha function| gformIsRecaptchaPending object| gfMultiFileUploader object| mejs function| MediaElement object| HtmlMediaElement function| onYouTubePlayerAPIReady function| DefaultPlayer function| MediaElementPlayer function| Waypoint object| analytics object| sidebarManager function| onYouTubeIframeAPIReady object| videoManager object| breakpoints object| pdfjsLib object| pdfjs-dist/build/pdf object| runtime object| images boolean| is_image object| iframes boolean| is_iframe object| rocket_lazy object| Placeholders object| webpackChunkgravityforms boolean| inlineAdsPopulated function| copyToClipboard string| waypointContextKey object| google_tag_manager function| postscribe object| google_tag_manager_external object| google_tag_data string| GoogleAnalyticsObject function| ga object| recaptcha object| closure_lm_477417 object| scriptUrl object| ttPolicy object| YT object| YTConfig function| onYTReady object| gaplugins object| googletag object| CookieControl function| __uspapi function| addUspapiLocatorFrame function| __handleUspapiMessage function| propagateIABStub object| Cookiebot function| __tcfapi object| CookieConsent object| yt function| ytDomDomGetNextId object| ytEventsEventsListeners object| ytEventsEventsCounter object| ytglobal object| ytPubsub2Pubsub2Instance object| ytPubsub2Pubsub2SubscribedKeys object| ytPubsub2Pubsub2TopicToKeys object| ytPubsub2Pubsub2IsAsync object| ytPubsub2Pubsub2SkipSubKey object| ytNetworklessLoggingInitializationOptions object| ytPubsubPubsubInstance object| ytPubsubPubsubTopicToKeys object| ytPubsubPubsubIsSynchronous object| ytPubsubPubsubSubscribedKeys object| ytLoggingTransportTokensToCttTargetIds_ object| ytLoggingTransportTokensToJspbCttTargetIds_ object| ytLoggingGelSequenceIdObj_ object| CookieConsentIABCMP object| CookiebotCMPControl object| iabbundle object| CookieConsentDialog object| gaGlobal object| gaData function| fbq function| _fbq object| _fbq_gtm_ids number| mouseflowHtmlDelay boolean| debug object| freestar string| TiktokAnalyticsObject object| ttq object| geq object| mouseflowHeatmap object| mouseflow function| _typeof object| PARSELY object| _pubfigInstanceManagerConfig object| _comscore object| fsprebid object| webpackJsonp.TiktTokAnalytics object| JSBridge object| Native2JSBridge object| ToutiaoJSBridge function| TiktokJelly object| _jelly_sdks function| load_script object| COMSCORE object| ns_p object| ggeac object| google_js_reporting_queue object| confiant function| GeAnalytics function| _0x518e function| geLoadLi function| _0x4ee6 boolean| geqpreprun function| run_ge object| gekx function| _0x2611e6 object| liQ object| _geq object| fsprebidChunk object| _pbjsGlobals object| mnet undefined| google_measure_js_timing function| _hadron object| apstag object| __li__evt_bus object| liQ_instances function| _createForOfIteratorHelper function| _unsupportedIterableToArray function| _arrayLikeToArray function| IntentIqObject function| PartnersWinEvent object| iiq_object_array boolean| sekindoFlowingPlayerOn object| _qevents function| pubHadronCb object| hadron boolean| __halo_loaded__ object| _aps boolean| apstagLOADED object| apscustom object| __bt object| __bt_intrnl object| __bt_tag_d object| __bt_tag_am object| Criteo boolean| creativeVendorLibraryLoaded object| au object| ox_esp function| quantserve function| __qc object| ezt object| _qoptions object| paramMatch object| viewPortSize object| debugIp object| debugId number| sekindoDisplayedPlacement object| PrimisApiConfig function| constructsekindoParent347 object| __id5_finalization_registry function| lotameIsCompatible function| sync16589_aa function| sync16589_c undefined| sync16589_d undefined| sync16589_ba undefined| sync16589_e function| sync16589_f object| sync16589_h function| sync16589_ca function| sync16589_j function| sync16589_da object| sync16589_ object| sync16589_ga object| sync16589_v object| sync16589_oa object| sync16589_xa object| sync16589_ya function| sync16589_a function| sync16589_b function| sync16589_g function| sync16589_i function| sync16589_k function| sync16589_l function| sync16589_m function| sync16589_n function| sync16589_o function| sync16589_p function| sync16589_q function| sync16589_r function| sync16589_fa function| sync16589_ea function| sync16589_s function| sync16589_t function| sync16589_u function| sync16589_w function| sync16589_ha function| sync16589_ia function| sync16589_y function| sync16589_ja function| sync16589_z function| sync16589_A function| sync16589_x function| sync16589_B function| sync16589_ka function| sync16589_C function| sync16589_D function| sync16589_E function| sync16589_F function| sync16589_G function| sync16589_H function| sync16589_I function| sync16589_J function| sync16589_K function| sync16589_L function| sync16589_la function| sync16589_ma function| sync16589_na function| sync16589_M function| sync16589_N function| sync16589_pa function| sync16589_O function| sync16589_qa function| sync16589_ra function| sync16589_sa function| sync16589_P function| sync16589_ta function| sync16589_ua function| sync16589_va function| sync16589_wa function| sync16589_Q function| sync16589_R function| sync16589_za function| sync16589_S function| sync16589_T function| sync16589_U function| sync16589_V function| sync16589_Aa function| sync16589_W function| sync16589_X function| sync16589_Y function| sync16589_Z function| sync16589__ function| sync16589_0 function| sync16589_Ea function| sync16589_Ba function| sync16589_1 function| sync16589_Da function| sync16589_Ca function| sync16589_2 function| sync16589_3 function| sync16589_4 function| sync16589_5 function| sync16589_Ga function| sync16589_Ha function| sync16589_Ja function| sync16589_Fa function| sync16589_7 function| sync16589_Ia function| sync16589_La function| sync16589_Ka function| sync16589_8 function| sync16589_6 function| sync16589_9 function| sync16589_Ma function| sync16589_Na function| sync16589_Oa function| sync16589_Pa function| sync16589_$ function| sync16589_Qa function| sync16589_Ra function| sync16589_Sa function| sync16589_Ta object| lotame_sync_16589 boolean| __bt_already_invoked object| ID5 object| auvars object| PublisherCommonId number| google_unique_id number| google_global_correlator function| docReady object| autag object| criteo_syncframe_state object| criteo_pubtag object| criteo_pubtag_prebid_144 object| Criteo_prebid_144 object| google_reactive_ads_global_state object| google_ad_modifications object| google_prev_clients

345 Cookies

Domain/Path Name / Value
.3lift.com/sync Name: sync
Value: CgoIoQEQ5e3vntoxCgoIkQIQ5e3vntoxCgoItAIQ5e3vntoxCgoI5gEQ5e3vntoxCgoIhwIQ5e3vntoxCgoItwIQ5e3vntoxCgkIOhDl7e-e2jEKCgiMAhDl7e-e2jEKCQhfEOXt757aMQoJCB8Q5e3vntox
.liadm.com/j Name: lidid
Value: 19716c8e-4afc-4ffe-a1a8-a597f5666370
i.liadm.com/s Name: _li_ss
Value: ChMKBgjdARCaFwoJCP____8HEKQX
i6.liadm.com/s Name: _li_ss
Value: CgA
reason.com/ Name: rcomVisitsToday
Value: 1
reason.com/ Name: rcomArticlesToday
Value: 1
.youtube.com/ Name: YSC
Value: yRpjxWBr6Jc
.youtube.com/ Name: VISITOR_INFO1_LIVE
Value: krKn9EjcISg
reason.com/ Name: CookieConsent
Value: {stamp:%27-1%27%2Cnecessary:true%2Cpreferences:true%2Cstatistics:true%2Cmarketing:true%2Cmethod:%27implied%27%2Cver:2%2Cutc:1707851113740%2Ciab2:%27%27%2Cregion:%27US%27}
.reason.com/ Name: _gid
Value: GA1.2.1991233376.1707851114
.reason.com/ Name: _gat_UA-283675-2
Value: 1
.reason.com/ Name: _gat_UA-283675-6
Value: 1
.reason.com/ Name: _ga_SYGD5NBRJH
Value: GS1.1.1707851113.1.0.1707851113.60.0.0
.tiktok.com/ Name: _ttp
Value: 2cKCvRtscnpeB74E1mQmtWXafFh
.reason.com/ Name: _parsely_session
Value: {%22sid%22:1%2C%22surl%22:%22https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/%22%2C%22sref%22:%22%22%2C%22sts%22:1707851113959%2C%22slts%22:0}
.reason.com/ Name: _parsely_visitor
Value: {%22id%22:%22pid=a2bc8d9d-38ae-4d7b-81b2-f9a99bf7647c%22%2C%22session_count%22:1%2C%22last_session_ts%22:1707851113959}
.pub.network/ Name: _fsuid
Value: fbbb0fd1-65ef-4bc1-a0fe-fbff40915cf9
.reason.com/ Name: _fbp
Value: fb.1.1707851114050.995882558
.reason.com/ Name: _tt_enable_cookie
Value: 1
.reason.com/ Name: _ttp
Value: xBbCdqSQXlfm1TMrHF2jUwa-Pcb
.scorecardresearch.com/ Name: UID
Value: 104cd2779e4923eb86da0c21707851114
.reason.com/ Name: _li_dcdm_c
Value: .reason.com
.reason.com/ Name: _lc2_fpi
Value: 5cd525e6f15c--01hphxqsz7bxsvc6fz7hzwzwbd
.reason.com/ Name: _lc2_fpi_meta
Value: {%22w%22:1707851114471}
.intentiq.com/ Name: IQver
Value: 1.9
.intentiq.com/ Name: intentIQCDate
Value: 1707851114580
.intentiq.com/ Name: intentIQ
Value: fbozg6sENr
.reason.com/ Name: cookie
Value: 1caf0629-2394-444a-b2cf-7c603c523670
.reason.com/ Name: cookie_cst
Value: VyxHLMwsHQ%3D%3D
.primis.tech/ Name: csuuid
Value: 65cbbd6ab7b01
.adsrvr.org/ Name: TDID
Value: 29aab174-fe91-4ad7-aa56-1d4732cc27d2
.liadm.com/ Name: lidid
Value: 19716c8e-4afc-4ffe-a1a8-a597f5666370
.intentiq.com/ Name: ASDT
Value: 0
.a.usbrowserspeed.com/ Name: tuid
Value: 1ef8933a-8f4e-404b-aeac-1d7b1e2b0ac8
.adnxs.com/ Name: receive-cookie-deprecation
Value: 1
.3lift.com/ Name: tluid
Value: 3900114537385664774839
.gumgum.com/ Name: cs
Value: true
.gumgum.com/ Name: vst
Value: u_a01fb7d6-bacf-4b1d-bb15-d6478605d080
.openx.net/ Name: i
Value: af9e421d-94c9-4a08-9810-61feb10b18f5|1707851115
.openx.net/ Name: receive-cookie-deprecation
Value: 1
.reason.com/ Name: _au_1d
Value: AU1D-0100-001707851115-UJS0TXCA-MOGT
.reason.com/ Name: _au_last_seen_pixels
Value: eyJhcG4iOjE3MDc4NTExMTUsInR0ZCI6MTcwNzg1MTExNSwicHViIjoxNzA3ODUxMTE1LCJydWIiOjE3MDc4NTExMTUsInRhcGFkIjoxNzA3ODUxMTE1LCJhZHgiOjE3MDc4NTExMTUsImdvbyI6MTcwNzg1MTExNSwicHBudCI6MTcwNzg1MTExNSwic29uIjoxNzA3ODUxMTE1LCJvcGVueCI6MTcwNzg1MTExNX0%3D
.criteo.com/ Name: partitioned_bundle
Value: qV6GmF9rYnJTZTdibjJNJTJCVzQ4MjI0UVBjYW1OV2Y3MUVKUzN0bFJoOGZEb25YSDB6WjRTMHNZd3lSNkk5VlU3allTWEtlcFplRnVRRDVLRW0xVnpTTkl5RnRUVnRibnV5d1N6UWdZR2olMkJtSjBiajM5QVJYZHRGcVh1RE9GTVNOaUtNNDclMkZkZDJoa21IUmJ3dm9HZnBYNkloaUElM0QlM0Q
.crwdcntrl.net/ Name: _cc_dc
Value: 0
.crwdcntrl.net/ Name: _cc_id
Value: 5a54ad22423e41a36226df9868cede65
.reason.com/ Name: _cc_id
Value: 5a54ad22423e41a36226df9868cede65
.reason.com/ Name: panoramaId_expiry
Value: 1707937515098
.adnxs.com/ Name: XANDR_PANID
Value: pKvoD3mjqGEmxn_AOt0poMp_nAEgy_LbMMf-Nua8y-IN2k8NWOlyUbU999YxOacn24tq7Cs_kzQ51kaTtdZBbsWFbi0aOf3Yss7k3gfOyyI.
.adnxs.com/ Name: uuid2
Value: 5872803529851156248
.contextweb.com/ Name: V
Value: AwN5CTqy8JaW
bh.contextweb.com/ Name: INGRESSCOOKIE
Value: 7f5927bad69b5e85
.reason.com/ Name: cto_bundle
Value: VSthyV9rYnJTZTdibjJNJTJCVzQ4MjI0UVBjYW1OV2Y3MUVKUzN0bFJoOGZEb25YSDB6WjRTMHNZd3lSNkk5VlU3allTWEtlcFplRnVRRDVLRW0xVnpTTkl5RnRUVnRibnV5d1N6UWdZR2olMkJtSjBiajE2UDM1OGNDc1ZoTEJLN3RRaW80VVU
.reason.com/ Name: cto_bidid
Value: NJE_pV80ZlZ6QzNNNzFERDRvJTJGNGQ0a1BrTW5aJTJGOUVQWjhLN05HQkFkVUExRHE3TjJZb3M0V2ZGVHljNU5rckZWNjllSEFtSlhacjZvbHFxTU9DOG82RmkwT2clM0QlM0Q
.amazon-adsystem.com/ Name: ad-id
Value: A2c8O3KNWUsUp5vcGgwLEtw
.amazon-adsystem.com/ Name: ad-privacy
Value: 0
.tapad.com/ Name: TapAd_TS
Value: 1707851115173
.tapad.com/ Name: TapAd_DID
Value: 2af5462b-1213-435d-a332-7e55bb465ba1
.go.sonobi.com/ Name: __uis
Value: 65e4a6df-48af-4fad-a0f0-a3011fc909f8
.pubmatic.com/ Name: KADUSERCOOKIE
Value: A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
.rubiconproject.com/ Name: khaos
Value: LSKQGI85-W-KKFE
.lijit.com/ Name: ljt_reader
Value: IJ_5ATZHwpxocGP7SR6BzHWi
.quantserve.com/ Name: mc
Value: 65cbbd6b-44378-927ac-5044b
.reason.com/ Name: __qca
Value: P0-1722568456-1707851114932
.reason.com/ Name: _ga
Value: GA1.2.415251147.1707851114
.lijit.com/ Name: _ljtrtb_27
Value: 29aab174-fe91-4ad7-aa56-1d4732cc27d2
.lijit.com/ Name: _ljtrtb_92
Value: 5872803529851156248
.openx.net/ Name: univ_id
Value: 537072971|29aab174-fe91-4ad7-aa56-1d4732cc27d2|1707851115545561
.krushmedia.com/ Name: krm_usr
Value: dc0e4bdf-ffd5-524d-91f0-2def249454e7
.krushmedia.com/ Name: krm_r
Value: 572
.clickagy.com/ Name: cb
Value: Zcu9a11ZdSrn6UNLg9dcZUK2
.smaato.net/ Name: SCM
Value: 25d9952e53
.smaato.net/ Name: SCMaps
Value: 25d9952e53
.casalemedia.com/ Name: CMID
Value: Zcu9a9HM518AACyiADNVcgAA
.casalemedia.com/ Name: CMPS
Value: 1404
.casalemedia.com/ Name: CMPRO
Value: 1404
.simpli.fi/ Name: suid
Value: 0E087FD3E115403AB68AFF630D65CE67
.lijit.com/ Name: _ljtrtb_76
Value: 10dca384-d7fa-4ff2-857a-1fb0ad9d145a
.lijit.com/ Name: ljtrtbexp
Value: eJxdzLsRgDAMBNFeHBNItj53tMbQO2NHSOHbYJ%2BBNW5NoYSk%2BjVgzV6tMmtwHCdoa3tGcx7D3LmdUc32I4l%2FeT9u1CCN
reason.com/ Name: _pbjs_userid_consent_data
Value: 3524755945110770
.bidswitch.net/ Name: c
Value: 1707851115
.bidswitch.net/ Name: tuuid_lu
Value: 1707851115
.bidswitch.net/ Name: tuuid
Value: d9962442-c73f-42a4-adbd-3d9517e387ff
.mediago.io/ Name: __mguid_
Value: cb83d64ba58ceca72i1qs500lskqgimc
.postrelease.com/ Name: visitor
Value: 6362ade3-65b8-45a5-a76c-a7397ea46a5c
.postrelease.com/ Name: status
Value: 1
.yellowblue.io/ Name: wrvUserID
Value: c0YoKqF-kj_s
.yieldmo.com/ Name: yieldmo_id
Value: V_ZrZhhNNrh6QBoKLRmb%7C1707782400000%7C0
.ads.yieldmo.com/ Name: re_sync
Value: pp%3D1186847%7Crc%3D1186847%7Cunl%3D1186847%7Ct%3D1186847%7Cpub%3D1186847
.zemanta.com/ Name: zuid
Value: KtRUPppSGbtrONLvGe1I
.sharethrough.com/ Name: stx_user_id
Value: c4cec5b2-acca-415c-b738-7e079be8bf78
.lijit.com/ Name: _ljtrtb_102
Value: dc0e4bdf-ffd5-524d-91f0-2def249454e7
.lijit.com/ Name: _ljtrtb_84
Value: Zcu9a11ZdSrn6UNLg9dcZUK2
.bidr.io/ Name: bito
Value: AACJ-U7Ll3sAABJaNC07Nw
.bidr.io/ Name: bitoIsSecure
Value: ok
.yahoo.com/ Name: A3
Value: d=AQABBGu9y2UCEKorTSkU9xODnZQYlYXatewFEgEBAQEOzWXVZdxH0iMA_eMAAA&S=AQAAAnNSZZMywkP7QbEJXCBxj9I
.lijit.com/ Name: _ljtrtb_85
Value: AACJ-U7Ll3sAABJaNC07Nw
.tremorhub.com/ Name: tvid
Value: 5e680dc7fc904e3fb6284f51d34504d2
.media.net/ Name: visitor-id
Value: 3508527156634803000V10
.media.net/ Name: data-pri
Value: 65cbbd6ab7b01~~34
.everesttech.net/ Name: everest_g_v2
Value: g_surferid~Zcu9awAEo_sMqwA9
.ads.stickyadstv.com/ Name: UID
Value: 1a414bb82571872ecee8edf55b15cd6
.lijit.com/ Name: _ljtrtb_2
Value: 0E087FD3E115403AB68AFF630D65CE67
.rubiconproject.com/ Name: receive-cookie-deprecation
Value: 1
.tremorhub.com/ Name: tvssa
Value: 1707851115773
.turn.com/ Name: uid
Value: 4374775086859810847
.admanmedia.com/ Name: admtr
Value: ffc0228e-35bf-459d-a326-8230f6a4c437
.admanmedia.com/ Name: ac_r
Value: CS116
.cootlogix.com/ Name: vdz_sync
Value: 24574e43-b065-4246-847d-dec6b8b086ac
.lijit.com/ Name: _ljtrtb_83
Value: LSKQGI85-W-KKFE
.smartadserver.com/ Name: pid
Value: 5722876075152800063
.media.net/ Name: data-ris
Value: {{APID}}~~25
.33across.com/ Name: 33x_ps
Value: u%3D212462896368674%3As1%3D1707851115902%3Ats%3D1707851115902
.ads.stickyadstv.com/ Name: uid-bp-34673
Value: Zcu9a9HM518AACyiADNVcgAABXwAAAAB
.sportradarserving.com/ Name: zuuid
Value: f760379d-b183-47ed-b2a7-c21c03c4c07f
.sportradarserving.com/ Name: c
Value: 1707851115
.sportradarserving.com/ Name: zuuid_lu
Value: 1707851115
.targeting.unrulymedia.com/ Name: _rxuuid
Value: %7B%22rx_uuid%22%3A%22RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005%22%7D
.sportradarserving.com/ Name: zuuid_k
Value: 1
.sportradarserving.com/ Name: zuuid_k_lu
Value: 1707851115
.ads.yieldmo.com/ Name: ptrt
Value: 29aab174-fe91-4ad7-aa56-1d4732cc27d2
.ads.yieldmo.com/ Name: ptrpp
Value: AwN5CTqy8JaW
.teads.tv/ Name: tt_viewer
Value: ed7d4bc5-1e97-4661-bf3b-2bbe5861d1c7
.teads.tv/ Name: receive-cookie-deprecation
Value: 1
.w55c.net/ Name: wfivefivec
Value: MxnNt1pn1RzY5K5
.pippio.com/ Name: didts
Value: 1707851116
.pippio.com/ Name: nnls
Value:
.pippio.com/ Name: pxrc
Value: COz6rq4GEgYIgr0rEAA=
.pippio.com/ Name: did
Value: LJGb1i95Gr992wH_
.csync.loopme.me/ Name: viewer_token
Value: f4a07ad1-72ff-47b5-b780-dd4a5ffcb469
.ads.yieldmo.com/ Name: ptrrc
Value: LSKQGI85-W-KKFE
.w55c.net/ Name: matchcasale
Value: 5
.ads.yieldmo.com/ Name: ptrunl
Value: RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
.adx.opera.com/ Name: UID
Value: OPUab1645795b4b463ba93cb19748df0468
.lijit.com/ Name: _ljtrtb_26
Value: d9962442-c73f-42a4-adbd-3d9517e387ff
.lijit.com/ Name: _ljtrtb_103
Value: OPUab1645795b4b463ba93cb19748df0468
.pubmatic.com/ Name: KRTBCOOKIE_80
Value: 22987-CAESEN_nfYU13Hor5J3C_uXar3w&KRTB&23025-CAESEN_nfYU13Hor5J3C_uXar3w&KRTB&23386-CAESEN_nfYU13Hor5J3C_uXar3w
.fwmrm.net/ Name: _uid
Value: umo2b61_7336290589884669966
.ads.stickyadstv.com/ Name: uid-bp-36033
Value: umo2b61_7336290589884669966
.ads.stickyadstv.com/ Name: MRM_UID
Value: umo2b61_7336290589884669966
.linkedin.com/ Name: li_sugr
Value: 8faa3b5d-ddf0-4250-b703-53eec813505a
.linkedin.com/ Name: bcookie
Value: "v=2&28aa0c93-089e-4a02-8822-bebe4e3acb81"
.linkedin.com/ Name: lidc
Value: "b=VGST08:s=V:r=V:a=V:p=V:g=2809:u=1:x=1:i=1707851116:t=1707937516:v=2:sig=AQHaEIH83XJqYJcd2lcw5ftMGhdS98Rz"
.ads.stickyadstv.com/ Name: uid-bp-159
Value: CAESEFi-tQfMO09Z5XfzkVg7EKU
.ads.stickyadstv.com/ Name: uid-bp-26913
Value: AACJ-U7Ll3sAABJaNC07Nw
.ads.stickyadstv.com/ Name: uid-bp-892
Value: 29aab174-fe91-4ad7-aa56-1d4732cc27d2
.w55c.net/ Name: matchpubmatic
Value: 5
.lijit.com/ Name: _ljtrtb_58
Value: A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
.pubmatic.com/ Name: KRTBCOOKIE_153
Value: 1923-kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-&KRTB&19420-kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-&KRTB&22979-kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-&KRTB&23462-kfywAMWt5QCK_edRkPH-W5X-sgGK_ONWk6toQ0K-
.dotomi.com/ Name: DotomiTest
Value: 7dc3561efe81152f
.pubmatic.com/ Name: KRTBCOOKIE_148
Value: 19421-uid:0E087FD3E115403AB68AFF630D65CE67&KRTB&23486-uid:0E087FD3E115403AB68AFF630D65CE67&KRTB&23489-uid:0E087FD3E115403AB68AFF630D65CE67&KRTB&23539-uid:0E087FD3E115403AB68AFF630D65CE67
.rfihub.com/ Name: ruds
Value: H4sIAAAAAAAA_-MSsjQ3MDY0MTOxNDAxtjC0NDQxEOIz1C3y97SMLHNKy0k3dgYA5C29tSQAAAA
.rfihub.com/ Name: rud
Value: H4sIAAAAAAAA_-MSsjQ3MDY0MTOxNDAxtjC0NDQxEOIz1C3y97SMLHNKy0k3dgYA5C29tSQAAAA
.sitescout.com/ Name: ssi
Value: 64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba#1707851116732
.pubmatic.com/ Name: KRTBCOOKIE_377
Value: 6810-29aab174-fe91-4ad7-aa56-1d4732cc27d2&KRTB&22918-29aab174-fe91-4ad7-aa56-1d4732cc27d2&KRTB&22926-29aab174-fe91-4ad7-aa56-1d4732cc27d2&KRTB&23031-29aab174-fe91-4ad7-aa56-1d4732cc27d2
.pubmatic.com/ Name: KRTBCOOKIE_57
Value: 22776-5872803529851156248&KRTB&23339-5872803529851156248
.pubmatic.com/ Name: KRTBCOOKIE_22
Value: 14911-4374775086859810847&KRTB&23150-4374775086859810847&KRTB&23527-4374775086859810847
.pubmatic.com/ Name: KRTBCOOKIE_107
Value: 1471-uid:MxnNt1pn1RzY5K5&KRTB&23421-uid:MxnNt1pn1RzY5K5
.deepintent.com/ Name: CDIUSER
Value: di_7f19edbf4040454cbcb65
.deepintent.com/ Name: CDIPARTNERS
Value: %7B%221%22%3A%2220240213%22%7D
.ads.stickyadstv.com/ Name: uid-bp-717
Value: y-YmhDCsJE2oNgqzhhd8VyfC8.i4uQsC6x5M_nkB9V~A
.acuityplatform.com/ Name: auid
Value: 888838742219
.acuityplatform.com/ Name: aum
Value: "OikKAfqbdXNlck1hdGNoQnlVc2VyTWF0Y2hpbmdJZE1hcPqANvqNdXNlck1hdGNoaW5nSWTMkWxhc3REcm9wVGltZU1pbGxpcyUBRmh7PwWumGxhc3RTdWNjZXNzZnVsTWF0Y2hNaWxsaXMlAUZoez8Fro90aGlyZFBhcnR5VXNlcklkIfv7hnZlcnNpb27C+w=="
.mathtag.com/ Name: uuid
Value: a90b65cb-bd6c-4100-b778-a2ca30279172
.mxptint.net/ Name: mxpim
Value: R33646_110D5AB97_665B6E9D.1.000000000000000065CBBD6C
.pubmatic.com/ Name: KRTBCOOKIE_18
Value: 22947-970314649043819140
.pubmatic.com/ Name: KRTBCOOKIE_469
Value: 8273-888838742219&KRTB&23428-888838742219
.pubmatic.com/ Name: KRTBCOOKIE_27
Value: 16735-uid:a90b65cb-bd6c-4100-b778-a2ca30279172
.pubmatic.com/ Name: KRTBCOOKIE_52
Value: 22772-R33646_110D5AB97_665B6E9D&KRTB&23092-R33646_110D5AB97_665B6E9D
.pubmatic.com/ Name: KRTBCOOKIE_1323
Value: 23480-OPUab1645795b4b463ba93cb19748df0468&KRTB&23485-OPUab1645795b4b463ba93cb19748df0468&KRTB&23524-OPUab1645795b4b463ba93cb19748df0468
.adgrx.com/ Name: ADGRX_UID
Value: d2f37c96-caa2-11ee-a313-71f04e140079
.pubmatic.com/ Name: KRTBCOOKIE_32
Value: 11175-AAAHlTqr6DHKpwNca_zeAAAAAAA&KRTB&22713-AAAHlTqr6DHKpwNca_zeAAAAAAA&KRTB&22715-AAAHlTqr6DHKpwNca_zeAAAAAAA&KRTB&23519-AAAHlTqr6DHKpwNca_zeAAAAAAA
.pubmatic.com/ Name: KRTBCOOKIE_188
Value: 3189-64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553&KRTB&23418-64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553
.pubmatic.com/ Name: KRTBCOOKIE_1278
Value: 23329-55c46681-ecaa-427d-a807-174744d3e8c6&KRTB&23340-55c46681-ecaa-427d-a807-174744d3e8c6&KRTB&23498-55c46681-ecaa-427d-a807-174744d3e8c6
sync.srv.stackadapt.com/ Name: sa-user-id
Value: s%3A0-48fb3a85-af74-50a2-7ed8-37ab99324174.p4YZcsGqqWupSdNKFv8CbijZk%2FOP%2BGjf0YlCjoGA4G8
.srv.stackadapt.com/ Name: sa-user-id
Value: s%3A0-48fb3a85-af74-50a2-7ed8-37ab99324174.p4YZcsGqqWupSdNKFv8CbijZk%2FOP%2BGjf0YlCjoGA4G8
sync.srv.stackadapt.com/ Name: sa-user-id-v2
Value: s%3ASPs6ha90UKJ-2DermTJBdGAJ-Sw.H2jUp6HYWJRtMcI0sSDyFeAK%2BrMK32fRL2Ce%2BqCsiQE
.srv.stackadapt.com/ Name: sa-user-id-v2
Value: s%3ASPs6ha90UKJ-2DermTJBdGAJ-Sw.H2jUp6HYWJRtMcI0sSDyFeAK%2BrMK32fRL2Ce%2BqCsiQE
sync.srv.stackadapt.com/ Name: sa-user-id-v3
Value: s%3AAQAKIFbuZhR1SdhjUh14pEG1c4QPe-BslSSK3sWYiUoi4djGEHwYBCDs-q6uBjABOgRZmQvUQgQaOnhr.8bxxZoudOlFh6QllvznEkmWLlAwY3opjboKLSMGO%2BoQ
.srv.stackadapt.com/ Name: sa-user-id-v3
Value: s%3AAQAKIFbuZhR1SdhjUh14pEG1c4QPe-BslSSK3sWYiUoi4djGEHwYBCDs-q6uBjABOgRZmQvUQgQaOnhr.8bxxZoudOlFh6QllvznEkmWLlAwY3opjboKLSMGO%2BoQ
.adgrx.com/ Name: ADGRX_CM_PUBMATIC_BRIDGED
Value: 1
.ipredictive.com/ Name: cu
Value: 92a46392-4333-4e17-bc0c-e23a20ef4332|1707851116846
.pubmatic.com/ Name: KRTBCOOKIE_860
Value: 16335-SPs6ha90UKJ-2DermTJBdGAJ-Sw&KRTB&23334-SPs6ha90UKJ-2DermTJBdGAJ-Sw&KRTB&23417-SPs6ha90UKJ-2DermTJBdGAJ-Sw&KRTB&23426-SPs6ha90UKJ-2DermTJBdGAJ-Sw
.pubmatic.com/ Name: KRTBCOOKIE_1003
Value: 22761-d2f37c96-caa2-11ee-a313-71f04e140079&KRTB&23275-d2f37c96-caa2-11ee-a313-71f04e140079
.technoratimedia.com/ Name: tads_uidp_16
Value: 1547975003335
.technoratimedia.com/ Name: tads_uidp_37
Value: c67fc625-ece6-3d77-b7ec-6114a5419dfe
.technoratimedia.com/ Name: tads_uidp_44
Value: LSJHPQD0-C-K6UT
.technoratimedia.com/ Name: tads_uidp_45
Value: A6016292-7C09-4AAF-B0D3-62E359EF2284
.technoratimedia.com/ Name: tads_uidp_46
Value: 3056121928622533857
.technoratimedia.com/ Name: tads_uidp_48
Value: d25fe073-ef08-44b5-936e-519782a87488
.technoratimedia.com/ Name: tads_uidp_49
Value: AAAGMZo_5iX7eQMVz6jfAAAAAAA
.technoratimedia.com/ Name: tads_uidp_50
Value: 48b6eb48-9d8e-0362-2b88-5e174da546b0
.technoratimedia.com/ Name: tads_uidp_61
Value: 212461571566687
.technoratimedia.com/ Name: tads_uidp_62
Value: 3508279116634771000V10
.technoratimedia.com/ Name: tads_uidp_7
Value: 070e5ab6-f1fb-4527-b3fe-5ccc4142ed10
.technoratimedia.com/ Name: tads_uidp_70
Value: 1674043991941-957306093047-001464-009-005972
.technoratimedia.com/ Name: tads_uidp_73
Value: AACJ-U7Ll3sAABJaNC07Nw
.technoratimedia.com/ Name: tads_uidp_76
Value: RX-55d29542-0b4e-4017-be62-ecd68db1c6ce-005
.technoratimedia.com/ Name: tads_uidp_77
Value: cL31aWv2btuDVm48UG11oHHKhlTi836nfNYyD5wA4Do
.technoratimedia.com/ Name: tads_uidp_79
Value: 310b3b28-dcfe-41c5-8eaf-ab86eeb38c31
.technoratimedia.com/ Name: tads_uidp_80
Value: y-lTor4ldE2uHpfH5j_ElZRotcXKadu_9Y~A
.technoratimedia.com/ Name: tads_uidp_82
Value: ZcuM9NHM6rsAAHzkABs0EgAA&3825
.technoratimedia.com/ Name: tads_uidp_83
Value: ELWDeiSWkKiw
.technoratimedia.com/ Name: tads_uidp_88
Value: 3901852205461028781332
.technoratimedia.com/ Name: tads_uidp_90
Value: 62420b2c-93b6-4958-86ee-d0a539a95879
.technoratimedia.com/ Name: tads_uidp_91
Value: 6493335838109300398brt76151639261561881074b6
.technoratimedia.com/ Name: tads_uid
Value: 5E15D2A62FC44EC58D52C87AC88A86C7
.technoratimedia.com/ Name: tads_uid_cd
Value: 20230719045631+0000
.technoratimedia.com/ Name: tads_zora
Value: 2
.technoratimedia.com/ Name: envelope_liveramp.com
Value: 1693142250488
beacon.lynx.cognitivlabs.com/ Name: UID
Value: 76a6a121-045a-4702-8a95-f98934ca22ac
beacon.lynx.cognitivlabs.com/ Name: ss
Value: 21W1fD3yxJstwgl%2BjIaUxpA8NXFKN%2F3YSIPJmxB1PFkOd%2F3FXN3EQ1MEJ3kZa7bqCvh0Advg6QAuPNTkiW1Y2g%3D%3D
.pubmatic.com/ Name: KRTBCOOKIE_279
Value: 22890-92a46392-4333-4e17-bc0c-e23a20ef4332&KRTB&23011-92a46392-4333-4e17-bc0c-e23a20ef4332&KRTB&23355-92a46392-4333-4e17-bc0c-e23a20ef4332
.ads.stickyadstv.com/ Name: uid-bp-951
Value: 5872803529851156248
.w55c.net/ Name: matchfreewheel
Value: 5
.ads.stickyadstv.com/ Name: uid-bp-23329
Value: MxnNt1pn1RzY5K5
.creativecdn.com/ Name: g
Value: 6l94DFUQspx7U1vmoZyk_1707851116937
.creativecdn.com/ Name: ts
Value: 1707851116
.doubleclick.net/ Name: IDE
Value: AHWqTUm7Lt27bxDTjEjcYMFljyTc3CFRelju8eO2qwUvaXHoiCV3rlYOwu8lA25uRVM
.dpm.demdex.net/ Name: dpm
Value: 11122778653877386402836073635137320709
.demdex.net/ Name: demdex
Value: 11122778653877386402836073635137320709
.lijit.com/ Name: _ljtrtb_80
Value: LSKQGI85-W-KKFE
.tapad.com/ Name: TapAd_3WAY_SYNCS
Value: 1!1075-2!1075-3!1075
.smartadserver.com/ Name: csync
Value: 127:AACJ-U7Ll3sAABJaNC07Nw
.pubmatic.com/ Name: KRTBCOOKIE_632
Value: 23041-TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k&KRTB&23047-TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k&KRTB&23234-TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k&KRTB&23361-TQ6dDsX-0y8cN6J9g5ZQm2UmDMeu8ZN9yIUu7bWxE6k
.pubmatic.com/ Name: KRTBCOOKIE_466
Value: 16530-d9962442-c73f-42a4-adbd-3d9517e387ff
.postrelease.com/ Name: ver
Value: 1
.pubmatic.com/ Name: KRTBCOOKIE_699
Value: 22727-AACJ-U7Ll3sAABJaNC07Nw
.ads.stickyadstv.com/ Name: uid-bp-25522
Value: 64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553
.contextweb.com/ Name: pb_rtb_ev
Value: 3-1poe|4is.0.CAESEGPGX-NNcdPvBzb0KNcn4Mk|7TY.0|2N.0.AAAHhC0Y0d4HmAN_KBF7AAAAAAA|3oy.0
.ads.stickyadstv.com/ Name: uid-bp-25746
Value: 92a46392-4333-4e17-bc0c-e23a20ef4332
.ads.stickyadstv.com/ Name: uid-bp-40306
Value: SPs6ha90UKJ-2DermTJBdGAJ-Sw
.reason.com/ Name: __gads
Value: ID=0d357e91042b1a51:T=1707851115:RT=1707851115:S=ALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg
.reason.com/ Name: __gpi
Value: UID=00000a0d70fde380:T=1707851115:RT=1707851115:S=ALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ
.ads.stickyadstv.com/ Name: uid-bp-41396
Value: 3900114537385664774839
.ads.stickyadstv.com/ Name: uid-bp-45
Value: Zcu9awAEo_sMqwA9
.adform.net/ Name: C
Value: 1
.ads.stickyadstv.com/ Name: uid-bp-171
Value: 4374775086859810847
.adform.net/ Name: uid
Value: 1956285366857158953
.pubmatic.com/ Name: KRTBCOOKIE_391
Value: 22924-1956285366857158953&KRTB&23263-1956285366857158953&KRTB&23481-1956285366857158953
.adfarm1.adition.com/ Name: UserID1
Value: 7335164693981362326
.ads.stickyadstv.com/ Name: uid-bp-772
Value: 7335164693981362326
.adsby.bidtheatre.com/ Name: __kuid
Value: 9e45b838-9dbe-4d4e-b7d7-9761fe94fd02.477065117
.advertising.com/ Name: A3
Value: d=AQABBG69y2UCEOVuP0wVNVRyX4hOQFzisK4FEgEBAQEOzWXVZdxH0iMA_eMAAA&S=AQAAAoVXHaQrmn5uS7rRYg952Yk
reason.com/ Name: _lr_retry_request
Value: true
reason.com/ Name: _lr_env_src_ats
Value: false
.undertone.com/ Name: UID_EXT_54
Value: 64aeb3b4-c4d3-4e1e-94b0-8d65ac4393ba-65cbbd6c-5553
.undertone.com/ Name: UID_EXT_53
Value: A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
.undertone.com/ Name: UTID
Value: 6d02c9204d134b1cbf8cea0df54486c9
.undertone.com/ Name: UTID_ENC
Value: 6gc078in3kn3tp77d036y9znt
.undertone.com/ Name: UID_EXT_46
Value: 29aab174-fe91-4ad7-aa56-1d4732cc27d2
.undertone.com/ Name: UID_EXT_56
Value: y-7bPlxkdE2uH8uLfx3_4pULQHDX1SQhUPiFJsk04-~A
gtrace.mediago.io/ Name: cst_70
Value: ts=1707851118
reason.com/ Name: pbjs-unifiedid
Value: %7B%22TDID%22%3A%2229aab174-fe91-4ad7-aa56-1d4732cc27d2%22%2C%22TDID_LOOKUP%22%3A%22TRUE%22%2C%22TDID_CREATED_AT%22%3A%222024-01-13T19%3A05%3A18%22%7D
reason.com/ Name: pbjs-unifiedid_last
Value: Tue%2C%2013%20Feb%202024%2019%3A05%3A18%20GMT
.tribalfusion.com/ Name: ANON_ID
Value: aAnwQRqO2c8U2OqnuyrSRZch9UqCa7KU3OCdXHl5cQMxDAZbQhfB5Sv73s3HVXQTRqeZaHRZdgPivTEoCvfLVgAIRJUqEl0smOhnwftxxdjFQxkC3NADvtbVaClrj3WV
.analytics.yahoo.com/ Name: IDSYNC
Value: "18za~2gqj:18z8~2gqj:19e3~2gqj:18z9~2gqj:1969~2gqj"
.sitescout.com/ Name: _ssuma
Value: eyI0NSI6MTcwNzg1MTExNjc3NCwiNTkiOjE3MDc4NTExMTc1NzQsIjM5IjoxNzA3ODUxMTE3MDA4LCIxNyI6MTcwNzg1MTExODU5OSwiNyI6MTcwNzg1MTExNzAwOCwiODAiOjE3MDc4NTExMTgxNDh9
.adnxs.com/ Name: anj
Value: dTM7k!M4/0EVNsVF']wIg2E?hqjS[g!]tbh8bhzs#DNB)PYwUr*ZegQKK+VKOwNy#^1*r3]5-MxqinA73M6[>E1)n-Q(FQ=*e73`Uq?K8BJ>pMVD)N8A?^9PbW!17Db6_:!5a!ahnA'K
.adnxs.com/ Name: uids
Value: eyJ0ZW1wVUlEcyI6eyJydWJpY29uIjp7InVpZCI6IkxTS1FHSTg1LVctS0tGRSIsImV4cGlyZXMiOiIyMDI0LTA1LTEzVDE5OjA1OjE3WiJ9LCJ0cmlwbGVsaWZ0X25hdGl2ZSI6eyJ1aWQiOiIzOTAwMTE0NTM3Mzg1NjY0Nzc0ODM5IiwiZXhwaXJlcyI6IjIwMjQtMDUtMTNUMTk6MDU6MThaIn19LCJiaXJ0aGRheSI6IjIwMjQtMDItMTNUMTk6MDU6MTdaIn0=
aorta.clickagy.com/ Name: chs
Value: [{"ch":"185","t":"2024-02-13 19:05:15"},{"ch":"4","t":"2024-02-13 19:05:18"}]
.undertone.com/ Name: UID_EXT_47
Value: LSKQGI85-W-KKFE
.bluekai.com/ Name: bkdc
Value: phx
.bluekai.com/ Name: bku
Value: fEy99sb20tUWpoAi
.undertone.com/ Name: UID_EXT_39
Value: 375f1a63-3de1-499c-a843-b6d122800b5a
.media6degrees.com/ Name: clid
Value: 2s8t6cu01171rpulbnwtosko0000000118010701201
.media6degrees.com/ Name: acs
Value: 012020k1s8t6cuxzt10
.addthis.com/ Name: ouid
Value: 65cbbd6e0001b60f006b8b7893af8657081f2b30f9779ed70830
.addthis.com/ Name: uid
Value: 65cbbd6effd25549
.addthis.com/ Name: na_id
Value: 2024021319051872000511175623
.w55c.net/ Name: matchgoogle
Value: 5
.id5-sync.com/ Name: id5
Value: fc9b6b52-93ee-79fa-9337-408c937c1041#1707851115869#6
.creative-serving.com/ Name: tuuid
Value: 34cdbda4-1634-4ded-a028-2069e7dbb885
.creative-serving.com/ Name: c
Value: 1707851118
.creative-serving.com/ Name: tuuid_lu
Value: 1707851118
.inmobi.com/ Name: idsp_c
Value: b363c34e-a0a4-402f-a171-99584ca31c14
.mfadsrvr.com/ Name: c
Value: 1707851118
.mfadsrvr.com/ Name: tuuid_lu
Value: 1707851118
.mfadsrvr.com/ Name: tuuid
Value: 137f7e69-c656-4c70-9795-5c85fd555382
.reason.com/ Name: __eoi
Value: ID=dcfd42c4754bc9a2:T=1707851117:RT=1707851117:S=AA-AfjY2mGPjj00jc7gc6BQuQm3b
.pubmatic.com/ Name: SyncRTB3
Value: 1709078400%3A35%7C1710374400%3A224%7C1708992000%3A46_96_48_22_220_104_3_13_249_214_7_56_250_54_5_165_178_176_166_240_238_243_264_55_71_99_81_8_233_234_21_266_231%7C1708646400%3A63%7C1708387200%3A223_38_2_15%7C1712966400%3A69
.go.sonobi.com/ Name: HAPLB8G
Value: s8676|Zcu9c
.send.microad.jp/ Name: TR
Value: 298077c6308473f5454a555c40e8eac20b7abdba74df7ddd
.media.net/ Name: data-pbs
Value: setstatuscode~~1
.criteo.com/ Name: uid
Value: 15bd9e41-bde1-46eb-aa5e-ae20396e6b6a
.ctnsnet.com/ Name: cid
Value: 6a10bd53f5634c0fb38fae0ab355416f
.openx.net/ Name: pd
Value: v2|1707851115.3.1|iKbwvPvMgahEgKkWg2gy.wvmmuYwDwtvJeSwrf8wI.g6fYmKvuvRwi
.owneriq.net/ Name: p2
Value: pmc
.owneriq.net/ Name: si
Value: Q7611375191439378190P
.owneriq.net/ Name: pmc
Value: 1
.kargo.com/ Name: ktcid
Value: 11cc7ef2-9f4c-0902-51f8-09fcb4d6ff90
.thrtle.com/ Name: mc
Value: eyJpZCI6IjhjYTE5OTcxLTYzMTUtNGFmYS1hOWFhLTcyNmJkMWNmMDEzYSIsImwiOjE3MDc4NTExMTk0MjAsInQiOjF9
.bfmio.com/ Name: __187_cid
Value: A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20
.bfmio.com/ Name: __io_cid
Value: 22033df5d8792490a2159328469b56ca60f48115
reason.com/ Name: _geuid
Value: cdddd702-9f19-4895-9407-6b144f862d5c
reason.com/ Name: _geps
Value: true
.quantserve.com/ Name: d
Value: EOMBEQGRK_ijCJiTAA
.lijit.com/ Name: ljtrtb
Value: eJxt0DtPxDAMAOD%2F0hlLedixzZbctQjudIDQCem2tG5YEAMIMSD%2BOykzq%2F35%2BT2E4XpwoxOe9nH0ntDFXJLkaUrR7RPtxsTD1eDdBm1xK87WoDUjoIAG6puDYGsLqEi4bpik2yzqYhknKFNRwJhHkFIICuUkRUseg%2FtrHDu%2BfzjX2SckVppxxhTnqnGZvTKKNYdJug1p20E1BcQAC8cGGCpCtdkgmpLnNQq3tlnuNmjtbRmhreoBqzHUSgm8IcewLIEtdCuu2%2BPT4fHmVgie4XCYxh7W7WQSDuIiBRXq7%2Bmjt00k%2Flsh2MOX5VOr9xd7en9L59PxRW25nA9%2Fg2h7TN7dwZmPr%2FEj53JXTzvHp6%2Be5e0872ypURCMWwVsLYAQV%2FBtdtXUPFIdfn4BSUBrPQ%3D%3D
.mfadsrvr.com/ Name: ssh
Value: !google,1707851119
.pswec.com/ Name: tuuid
Value: 93c731c1-bdeb-4853-a081-688267ddafe8
.pswec.com/ Name: c
Value: 1707851119
.pswec.com/ Name: tuuid_lu
Value: 1707851119
.pubmatic.com/ Name: chkChromeAb67Sec
Value: 12
.pubmatic.com/ Name: DPSync3
Value: 1708819200%3A257%7C1708992000%3A235_228_226_258_245_236_259_219_263_256_262_260_201_261%7C1708387200%3A265_253_252%7C1707868800%3A248_255
.bidswitch.net/ Name: google_push
Value: AXcoOmSROxZdh41c99gml7B3apeborMRMlOuQQqzmK4FeDM7KYe_dUC82s0hl0idGXgcPE2gn-env3vjdrVQO6ZUPvxo24iojyipcxMsjGupcjFAY1het0kbGmcCZ407iTyYuSiZX1E2RcECQofwknBoU6v_Wys
.adsrvr.org/ Name: TDCPM
Value: CAESFAoFdGFwYWQSCwioq-nol7TWPBAFEhsKDHNoYXJldGhyb3VnaBILCLLWi_2XtNY8EAUSFwoIcHVibWF0aWMSCwiUtYr2l7TWPBAFEhUKBmNhc2FsZRILCJzSxPaXtNY8EAUSFgoHcnViaWNvbhILCODpu_eXtNY8EAUSFQoGZ29vZ2xlEgsIkpuXh5i01jwQBRgBIAEoAjILCOLK2L6utNY8EAU4AVoHOGg5dTExaGAC
.rfihub.com/ Name: eud
Value: H4sIAAAAAAAA_9vEyGtobmBuYWpoaGhmbmi5C4lvaWppCgCzGSEqIAAAAA
.reason.com/ Name: _ga_JCN3MXE1WR
Value: GS1.1.1707851113.1.0.1707851119.0.0.0
.1rx.io/ Name: _rxuuid
Value: %7B%22rx_uuid%22%3A%22RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005%22%2C%22nxtrdr%22%3Afalse%7D
.agkn.com/ Name: ab
Value: 0001%3AGmOFjB5l1BqzzlIhfpQ4Zz8q2uTxhraf
.pubmatic.com/ Name: KRTBCOOKIE_594
Value: 17105-RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005&KRTB&17107-RX-e2af2325-e28b-4fd4-b667-72f44cc57a3b-005
.pubmatic.com/ Name: PugT
Value: 1707851119
.ads.pubmatic.com/ Name: pubsyncexp
Value: 1707872719786
.rlcdn.com/ Name: rlas3
Value: Vw/MvqxBCBC9hatY7ExxAlN/oOKmfK8pUpA1xyOan/A=
.rlcdn.com/ Name: pxrc
Value: COv6rq4GEgUI6AcQABIFCOhHEAASBgi46wEQBA==
.360yield.com/ Name: tuuid
Value: d9288f3f-ce9e-47eb-b7a4-f96ffdea64c1
.360yield.com/ Name: tuuid_lu
Value: 1707851119
.360yield.com/ Name: um
Value: !79,qIakksyoHG5XLbCBQqHZggT4f534JlD9Drg6Me04uOqcPm9pPtWL4HLZWuAwaehOGobyGsJGmrH6986g,1715627119
.360yield.com/ Name: umeh
Value: !79,0,1770059119,-1
.c.appier.net/ Name: _auid
Value: YDtbzodyBEeUV3z0b73LZQ
.pubmatic.com/ Name: KRTBCOOKIE_904
Value: 23554-YDtbzodyBEeUV3z0b73LZQ&KRTB&23557-YDtbzodyBEeUV3z0b73LZQ
io.narrative.io/ Name: io.narrative.guid.v2
Value: d4d5fb11-caa2-11ee-a180-0a02e9f38595
.semasio.net/ Name: SEUNCY
Value: 2FCE49C7CD498EA5
s2s.t13.io/ Name: uids
Value: 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
.onaudience.com/ Name: cookie
Value: 0bb4679dd03eaf2c
.onaudience.com/ Name: done_redirects109
Value: 1
.audrte.com/ Name: arcki2
Value: fc5VhKWo392T-qzOPbQhl6wBA!20220908!1707851120189!ip#96.9.249.44
.audrte.com/ Name: arcki2_pubmatic
Value: A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20!20220908!1707851120189
.id5-sync.com/ Name: 3pi
Value: 434#1707851119082#2042437681|2#1707851119955#-185535047#5872803529851156248|264#1707851119628#302321059#29aab174-fe91-4ad7-aa56-1d4732cc27d2|441#1707851118345#-1352564532#u_a01fb7d6-bacf-4b1d-bb15-d6478605d080|1242#1707851120080#-650243106|155#1707851118696#-755737386#AACJ-U7Ll3sAABJaNC07Nw|203#1707851119302#2122002558#15bd9e41-bde1-46eb-aa5e-ae20396e6b6a|108#1707851118521#2058931927|796#1707851118867#833221502|429#1707851119481#939940038#A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20|1245#1707851119790#-650243106|1246#1707851120342#-650243106
.audrte.com/ Name: arcki2_ddp2
Value: fc5VhKWo392T-qzOPbQhl6wBA!20220908!1707851120395
.audrte.com/ Name: arcki2_adform
Value: 1956285366857158953!20220908!1707851120542
.pubmatic.com/ Name: SPugT
Value: 1707805818
.intentiq.com/ Name: IQPubmaticCookieSync
Value: 1707851122632_939940038_44
.intentiq.com/ Name: IQAppnexusCookieSync
Value: 1707851122741_-185535047_44
.rubiconproject.com/ Name: audit
Value: 1|tcR/wBEzWcLScRXjCLhWzFYvo2XO8wv+z0QnGM0pmGRQbDgHMhLCw+f1eNZbcvwaCeR+Jk+fedFymPvo8pleP4C1ETSYCCMLtb0SQjHphbHxXSTExHpjkV9byk9TjXUW
.intentiq.com/ Name: IQRubiconPrimisCookieSync
Value: 1707851122878_2420918_44
.adstanding.com/ Name: _adstanding_id
Value: ac862dd225311b326a51d7adb14c026b
.intentiq.com/ Name: IQBidswitchPrebidCookieSync
Value: 1707851123212_89803191_44
.intentiq.com/ Name: IQOpenxPrimisCookieSync
Value: 1707851123316_1771573918_44
.intentiq.com/ Name: IQYieldmoCookieSync
Value: 1707851123411_-746707217_44
.intentiq.com/ Name: IQSmartAdServerCookieSync
Value: 1707851123499_0_44
.intentiq.com/ Name: CSDT
Value: UEQ6MTUwNzJfMCZVNEM5RUlUIzE1MTA2XzAmVTRDOUdVRiMxNTA0NF8wJlU0QzlHWXMjMTUwNDhfMCZVNEM5R1hSIzEwMTM5XzAmVTRDOUdNZSMxNTExNV8wJlU0QzlHVnY
.intentiq.com/ Name: IQTripleLiftCookieSync
Value: 1707851123499_1344092537_44
.intentiq.com/ Name: IQPData
Value: 1611266338#1707851123494#0#1707851114789
.smartadserver.com/ Name: TestIfCookieP
Value: ok
.smartadserver.com/ Name: pbw
Value: %24b%3d16999%3b%24o%3d11100

5582 Console Messages

Source Level URL
Text
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://disco.headliner.link/artifacts/web/5.28.0-130/js/0.chunk.js
Message:
The AudioContext was not allowed to start. It must be resumed (or created) after a user gesture on the page. https://goo.gl/7K7WLu
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://connect.facebook.net/signals/config/807449156089636?v=2.9.145&r=stable&domain=reason.com&hme=20c913bdcd4be51a752120153aa5caaecb3ee86c7f26cf737846e40b202aba68&ex_m=62%2C106%2C94%2C98%2C53%2C3%2C88%2C61%2C14%2C86%2C79%2C44%2C46%2C150%2C153%2C164%2C160%2C161%2C163%2C25%2C89%2C45%2C68%2C162%2C145%2C148%2C157%2C158%2C165%2C115%2C13%2C43%2C169%2C168%2C117%2C16%2C29%2C32%2C1%2C36%2C57%2C58%2C59%2C63%2C83%2C15%2C12%2C85%2C82%2C81%2C95%2C97%2C31%2C96%2C26%2C22%2C146%2C149%2C124%2C24%2C9%2C10%2C11%2C5%2C6%2C21%2C19%2C20%2C49%2C54%2C56%2C66%2C90%2C23%2C67%2C8%2C7%2C71%2C41%2C18%2C92%2C91%2C17%2C4%2C73%2C80%2C72%2C78%2C40%2C39%2C77%2C33%2C35%2C76%2C48%2C74%2C28%2C37%2C65%2C0%2C84%2C75%2C2%2C30%2C55%2C34%2C93%2C38%2C70%2C60%2C99%2C52%2C51%2C27%2C87%2C50%2C47%2C42%2C69%2C64%2C100(Line 95)
Message:
Unrecognized feature: 'attribution-reporting'.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://p.ad.gt/api/v1/p/474
Message:
Unrecognized feature: 'attribution-reporting'.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
network error URL: https://us01.z.antigena.com/l/FZt5psomz79DGe~O1V5PkX7S8-NVJIdw0INR-k~Duu9c36GyIDyElf4y8fa2~-9InNSq4BCadyu-8tQSiIkaVleT~Yh8GI4ocNSeo4~API4DJEsYNIMg2sPMMXvjcckTUFy53ZYw3gzv35jSAchydRkSr2XFgqe-kzzlKTlv1VT7-TlAc0PcX7nFzbKlHypwbpU3AWUAJgUx%20A8903BEF-BFB9-43AE-8BB5-B5A68B9BAE20&rnd=RND
Message:
Failed to load resource: the server responded with a status of 403 ()
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
network error URL: https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=4374775086859810847&redirectID=0&gdpr=0&gdpr_consent=
Message:
Failed to load resource: net::ERR_TOO_MANY_REDIRECTS
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1---&client=ca-pub-4864286300355536&output=html&h=250&slotname=1749155563&adk=101652655&adf=776189486&pi=t.ma~as.1749155563&w=300&lmt=1707851117&format=300x250&url=https%3A%2F%2Freason.com%2F2024%2F01%2F30%2Fa-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids%2F&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.&dt=1707851116926&bpp=2&bdt=509&idt=461&shv=r20240208&mjsv=m202402070101&ptt=9&saldr=aa&cookie=ID%3D0d357e91042b1a51%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mb5NLbpWQ2Y12OATjMMWQvn7D83Gg&gpic=UID%3D00000a0d70fde380%3AT%3D1707851115%3ART%3D1707851115%3AS%3DALNI_Mbk8NPIwUhm4pI0ESntQd3R_0ewTQ&correlator=6558674513952&frm=23&ife=4&pv=1&ga_vid=1991233376.1707851114&ga_sid=1707851118&ga_hid=926873386&ga_fc=1&nhd=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=261&ady=4238&biw=1600&bih=1200&isw=300&ish=250&ifk=1116731849&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44808397%2C31080650%2C44795922%2C44809005%2C95324580%2C95325067%2C31081078%2C95321963%2C95320869%2C95324154%2C95324161&oid=2&pvsid=3167069287056572&tmod=1657972243&uas=0&nvt=1&fc=640&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C300%2C250&vis=1&rsz=%7C%7CeEbr%7C&abl=CS&pfx=0&fu=4&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=1.sx6bnfg6n09t&btvi=1&fsb=1&dtd=648
Message:
Origin trial controlled feature not enabled: 'attribution-reporting'.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
network error URL: https://ssum-sec.casalemedia.com/usermatch?s=197137&cb=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D57%26uid%3D&us_privacy=1---
Message:
Failed to load resource: the server responded with a status of 400 ()
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
javascript error URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Access to XMLHttpRequest at 'https://api.rlcdn.com/api/identity/envelope?pid=34' from origin 'https://reason.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://api.rlcdn.com/api/identity/envelope?pid=34
Message:
Failed to load resource: net::ERR_FAILED
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
network error URL: https://id5-sync.com/k/264.gif?puid=29aab174-fe91-4ad7-aa56-1d4732cc27d2&ttl=%%TTL%%
Message:
Failed to load resource: the server responded with a status of 404 ()
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
network error URL: https://ssum-sec.casalemedia.com/usermatch?s=197137&cb=https%3A%2F%2Fusr.undertone.com%2FuserPixel%2Fsync%3FpartnerId%3D57%26uid%3D
Message:
Failed to load resource: the server responded with a status of 400 ()
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://reason.com/2024/01/30/a-new-pain-medication-could-reinforce-the-disastrous-crackdown-on-prescription-opioids/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy upgrade-insecure-requests; frame-ancestors 'self';
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

605033cc1a4730890edd7776333db3e4.safeframe.googlesyndication.com
a.ad.gt
a.audrte.com
a.pub.network
a.sportradarserving.com
a.teads.tv
a.tribalfusion.com
a.usbrowserspeed.com
aa.agkn.com
aax-eu.amazon-adsystem.com
aax.amazon-adsystem.com
acdn.adnxs.com
ad-delivery.net
ad.doubleclick.net
ad.mrtnsvr.com
ad.turn.com
ads.creative-serving.com
ads.pubmatic.com
ads.stickyadstv.com
ads.us.criteo.com
ads.yieldmo.com
aid.send.microad.jp
analytics.google.com
analytics.pangle-ads.com
analytics.tiktok.com
aorta.clickagy.com
ap.lijit.com
api.btloader.com
api.headliner.link
api.intentiq.com
api.parsely.com
api.rlcdn.com
b-code.liadm.com
b1sync.zemanta.com
bcp.crwdcntrl.net
beacon.krxd.net
beacon.lynx.cognitivlabs.com
bh.contextweb.com
bidder.criteo.com
bpi.rtactivate.com
btloader.com
btlr.sharethrough.com
c.amazon-adsystem.com
c.pub.network
c1.adform.net
cat.va.us.criteo.com
cdn.confiant-integrations.net
cdn.hadronid.net
cdn.id5-sync.com
cdn.jsdelivr.net
cdn.mediago.io
cdn.mouseflow.com
cdn.parsely.com
cdn.undertone.com
ce.lijit.com
ckjjzdn8vk.execute-api.us-west-2.amazonaws.com
cm.adform.net
cm.adgrx.com
cm.ctnsnet.com
cm.g.doubleclick.net
cms.quantserve.com
config.aps.amazon-adsystem.com
connect.facebook.net
consent.cookiebot.com
consentcdn.cookiebot.com
contextual.media.net
core.iprom.net
crb.kargo.com
creativecdn.com
cs-server-s2s.yellowblue.io
cs.admanmedia.com
cs.krushmedia.com
cs.media.net
cs.openwebmedia.org
cs.yellowblue.io
csm.us.criteo.net
csync.loopme.me
cw.addthis.com
d.pub.network
d2eehagpk5cl65.cloudfront.net
data.adsrvr.org
dis.criteo.com
dis.eu.criteo.com
disco.headliner.link
dmp.adform.net
dpm.demdex.net
dsum-sec.casalemedia.com
eb2.3lift.com
eus.rubiconproject.com
fastlane.rubiconproject.com
fonts.googleapis.com
fonts.gstatic.com
freestar-d.openx.net
freestar-io.videoplayerhub.com
g2.gumgum.com
gocm.c.appier.net
google-bidout-d.openx.net
googleads.g.doubleclick.net
grid.bidswitch.net
gtrace.mediago.io
gum.criteo.com
hbopenbid.pubmatic.com
hbx.media.net
i.liadm.com
i6.liadm.com
ib.adnxs.com
ice.360yield.com
id.hadron.ad.gt
id.rlcdn.com
id5-sync.com
idpix.media6degrees.com
ids.ad.gt
idsync.rlcdn.com
idx.liadm.com
image2.pubmatic.com
image4.pubmatic.com
image6.pubmatic.com
image8.pubmatic.com
images.mediago.io
img.sparemin.com
io.narrative.io
ipac.ctnsnet.com
jadserve.postrelease.com
jelly.mdhv.io
js-sec.indexww.com
ka-p.fontawesome.com
kit.fontawesome.com
lb.eu-1-id5-sync.com
live.primis.tech
match.adsby.bidtheatre.com
match.adsrvr.org
match.deepintent.com
match.prod.bidr.io
match.sharethrough.com
matching.truffle.bid
mb9eo.publishers.tremorhub.com
mug.criteo.com
mweb.ck.inmobi.com
oa.openxcdn.net
oajs.openx.net
onetag-sys.com
optimise.net
p.ad.gt
p.rfihub.com
p.typekit.net
p1.parsely.com
pagead2.googlesyndication.com
pippio.com
pixel-eu.rubiconproject.com
pixel-sync.sitescout.com
pixel-us-east.rubiconproject.com
pixel.advertising.com
pixel.onaudience.com
pixel.quantserve.com
pixel.rubiconproject.com
pixel.tapad.com
pixels.ad.gt
pm.w55c.net
pmp.mxptint.net
pr-bh.ybp.yahoo.com
prebid-server.rubiconproject.com
pubmatic-match.dotomi.com
pulsepoint-match.dotomi.com
px.ads.linkedin.com
px.owneriq.net
qsearch-a.akamaihd.net
r.bidswitch.net
reason.com
rp.liadm.com
rp4.liadm.com
rtb-csync.smartadserver.com
rtb.adentifi.com
rtb.adstanding.com
rtb.da.us.criteo.com
rtb.mfadsrvr.com
rtb.openx.net
rtb.primis.tech
rules.quantcount.com
s.ad.smaato.net
s.amazon-adsystem.com
s.tribalfusion.com
s0.2mdn.net
s2s.t13.io
s3-us-west-2.amazonaws.com
sb.scorecardresearch.com
secure-assets.rubiconproject.com
secure.adnxs.com
secure.cdn.fastclick.net
secure.quantserve.com
securepubads.g.doubleclick.net
simage2.pubmatic.com
simage4.pubmatic.com
ssbsync-global.smartadserver.com
ssbsync.smartadserver.com
ssc-cms.33across.com
ssum-sec.casalemedia.com
stags.bluekai.com
static.criteo.net
static.sparemin.com
stats.g.doubleclick.net
sync-amz.ads.yieldmo.com
sync-tm.everesttech.net
sync.1rx.io
sync.bfmio.com
sync.cootlogix.com
sync.crwdcntrl.net
sync.go.sonobi.com
sync.inmobi.com
sync.intentiq.com
sync.ipredictive.com
sync.mathtag.com
sync.smartadserver.com
sync.srv.stackadapt.com
sync.targeting.unrulymedia.com
sync.technoratimedia.com
sync1.intentiq.com
synchroscript.deliveryengine.adswizz.com
t.adx.opera.com
t.pswec.com
tags.bluekai.com
tags.crwdcntrl.net
thrtle.com
tlx.3lift.com
token.rubiconproject.com
tpc.googlesyndication.com
trace.mediago.io
u.openx.net
uipglob.semasio.net
um.simpli.fi
ums.acuityplatform.com
ups.analytics.yahoo.com
us-u.openx.net
us01.z.antigena.com
use.typekit.net
usr.undertone.com
video.primis.tech
www.facebook.com
www.google-analytics.com
www.google.com
www.googletagmanager.com
www.googletagservices.com
www.gstatic.com
www.temu.com
www.youtube.com
x.bidswitch.net
ad.mrtnsvr.com
ads.stickyadstv.com
api.rlcdn.com
fastlane.rubiconproject.com
jelly.mdhv.io
104.18.38.76
104.36.115.111
104.66.251.81
107.178.254.65
130.211.23.194
134.122.57.34
141.95.98.64
146.59.148.16
151.101.129.108
151.101.194.49
162.19.138.83
162.248.18.32
162.248.18.37
172.105.221.240
172.253.62.154
172.253.63.148
172.64.151.101
178.250.7.11
18.160.10.80
18.173.138.29
18.215.133.183
184.25.127.153
185.167.164.53
185.184.8.90
195.5.165.20
198.148.27.131
199.38.167.131
20.121.111.193
20.127.253.7
20.253.86.149
2001:4860:4802:32::181
2001:4860:4802:38::178
202.233.84.1
207.198.113.203
213.19.162.90
216.200.232.249
216.22.16.9
23.105.12.170
23.105.12.172
23.203.177.63
23.21.102.83
23.215.0.12
23.221.241.11
23.222.200.28
23.23.57.217
23.39.185.111
23.4.226.82
23.4.232.54
23.48.104.105
23.48.8.28
23.48.9.103
23.48.9.151
23.51.8.29
23.88.86.2
2600:1402:8800::1728:cf39
2600:1402:8800::1728:cf40
2600:1408:5400:1d::173d:b86
2600:1408:5400:490::f09
2600:1f18:4e9:5a02:d2ce:e24a:b8d2:5c54
2600:1f18:612b:4232:b45c:2ea4:feea:e8e2
2600:1f18:730:b150:c189:1063:47d2:4071
2600:1f18:ed:550f:3fca:af0a:5a50:8555
2600:9000:215f:5800:1b:5138:8a40:93a1
2600:9000:215f:5c00:1f:2473:9080:93a1
2600:9000:215f:600:1b:6b7d:2300:93a1
2600:9000:215f:bc00:8:8845:1500:93a1
2600:9000:215f:ec00:4:daa7:500:93a1
2600:9000:21a2:4200:1a:5235:f980:93a1
2600:9000:269f:a800:1a:609a:6780:93a1
2600:9000:26a0:2800:1:6448:6d00:93a1
2600:9000:26a0:5c00:6:44e3:f8c0:93a1
2600:9000:26a0:be00:6:9e1e:cb40:21
2602:803:c002:200::32
2603:c020:400d:3000:67b7:1059:7283:c690
2606:4700:10::6816:3556
2606:4700:10::6816:35ad
2606:4700:10::6816:445
2606:4700:10::6816:4bd8
2606:4700:10::6816:545
2606:4700:10::ac43:17ea
2606:4700:20::681a:346
2606:4700:20::681a:832
2606:4700:4400::6812:2844
2606:4700:4400::ac40:90a6
2606:4700:4400::ac40:97ee
2606:4700::6812:14ce
2606:4700::6812:18ad
2606:4700::6812:1a32
2606:ae80:1450:16::2040
2607:f350:3:2569:0:10:0:d
2607:f8b0:4004:c06::9a
2607:f8b0:4004:c08::69
2607:f8b0:4004:c08::95
2607:f8b0:4004:c09::5f
2607:f8b0:4004:c09::9d
2607:f8b0:4004:c0b::61
2607:f8b0:4004:c0b::84
2607:f8b0:4004:c17::5b
2607:f8b0:4004:c17::5e
2607:f8b0:4004:c17::9d
2607:f8b0:4004:c1b::5e
2607:f8b0:4004:c1b::84
2607:f8b0:4004:c1b::9c
2607:f8b0:4004:c1d::9a
2620:100:a001::16
2620:100:a001::24
2620:100:a001::4
2620:100:a001::c
2620:100:a005::14
2620:112:f002:bbbb::21
2620:116:800b:21:b08a:1dc5:659b:4055
2620:1ec:21::14
2a03:2880:f003:c0e:face:b00c:0:3
2a03:2880:f103:83:face:b00c:0:25de
2a04:4e42:400::485
3.161.193.117
3.161.213.13
3.161.213.49
3.162.125.63
3.162.3.20
3.162.3.84
3.210.157.252
3.217.51.221
3.234.97.29
3.93.89.138
34.102.146.192
34.107.140.113
34.111.113.62
34.111.152.239
34.111.60.239
34.120.135.53
34.160.152.31
34.194.161.83
34.196.196.152
34.200.65.202
34.202.200.79
34.207.36.191
34.233.242.56
34.237.83.209
35.186.193.173
35.186.253.211
35.194.66.159
35.207.24.140
35.208.249.213
35.211.118.13
35.211.178.172
35.211.233.246
35.214.211.207
35.244.154.8
35.244.159.8
35.71.139.29
35.71.166.51
37.157.3.26
38.91.45.7
38.98.69.175
40.76.134.238
44.196.23.253
44.197.50.199
44.199.10.205
44.208.49.53
44.213.8.90
44.226.53.119
50.16.144.68
50.57.31.206
51.222.39.186
52.21.151.112
52.213.12.53
52.223.40.198
52.46.130.91
52.54.125.86
52.54.225.252
52.7.170.209
52.70.33.226
52.71.22.176
52.72.172.4
52.85.107.60
52.92.240.192
52.95.115.196
54.144.126.196
54.144.252.138
54.160.241.52
54.162.50.120
54.163.10.249
54.192.51.109
54.192.51.117
54.201.22.108
54.209.16.241
54.224.181.227
54.226.119.24
54.230.49.33
54.243.138.14
54.84.174.131
63.251.28.234
64.74.236.31
67.202.105.23
67.205.191.172
68.67.160.117
69.173.151.100
69.173.151.96
69.194.240.13
69.90.254.78
74.119.119.129
74.119.119.139
74.119.119.147
74.119.119.150
75.2.24.81
8.2.110.134
8.28.7.81
8.28.7.83
8.28.7.84
8.43.72.98
80.77.87.163
82.145.213.8
99.86.229.12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